Citrus Sinensis ID: 005953
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 667 | 2.2.26 [Sep-21-2011] | |||||||
| Q3ECH2 | 892 | Probable receptor-like pr | no | no | 0.847 | 0.633 | 0.358 | 4e-92 | |
| Q9FID5 | 806 | Probable receptor-like pr | no | no | 0.443 | 0.367 | 0.516 | 4e-83 | |
| Q9FID6 | 813 | Probable receptor-like pr | no | no | 0.439 | 0.360 | 0.508 | 1e-81 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.410 | 0.333 | 0.436 | 1e-59 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.452 | 0.364 | 0.410 | 6e-58 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.425 | 0.325 | 0.428 | 2e-57 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.421 | 0.352 | 0.439 | 3e-57 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.443 | 0.357 | 0.4 | 1e-56 | |
| Q9LMB9 | 615 | Cysteine-rich receptor-li | no | no | 0.454 | 0.492 | 0.386 | 6e-52 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.500 | 0.323 | 0.359 | 5e-51 |
| >sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 339 bits (870), Expect = 4e-92, Method: Compositional matrix adjust.
Identities = 232/648 (35%), Positives = 336/648 (51%), Gaps = 83/648 (12%)
Query: 35 QSQNDTSYEDCSP-FKCGNLT-FSFPFSSSSTSGYCGLPNYQITCDSSSVPKLLLSGRLY 92
Q D Y CS F CG+ ++P CG PN+++ C S ++ ++ +
Sbjct: 244 QHSADEVYRRCSESFSCGSQRDLNYPLWKPGREE-CGHPNFKLNC-SGGFAEINIASVKF 301
Query: 93 QVRNFFSSQDDRLITVVDTQLIKDLSSGSCESLYNLSVAINSYSIGSLTLPSGNLNLT-F 151
++ + + S LI + + I DL + L+ + L L LT +
Sbjct: 302 RILDSYRS----LIRLARSDYIGDLCPAN-----PLTAPFIEKFLPVLELTGETELLTLY 352
Query: 152 FKCPRRLSLSQNFTDKGVSNVSCNDGHVLYLWRN----------------RTQSGRPSFD 195
+ C R + S + V + C++G Y+ RN R R
Sbjct: 353 YGC--RFNSSDIPANIYVGELGCDEGRSYYVTRNLSSPLLDSSRGVLNNLREMCKRNVSV 410
Query: 196 PVSAPSGCDSVVVPVSSVTSLYLGADVFDTLRQGFPLEWPKLDDCEKCQNRSGRCGYNGS 255
P S P+ D P + L QGF + DCE+C+ G CGYN +
Sbjct: 411 PASGPALFDLQTRPNQDNLKM--------ALDQGFRMLITS--DCERCRGSGGACGYNQT 460
Query: 256 LKKITCFCKGGRC-----DSVKRRKSRL-------PLIIAGSCC-MVLVAVALLVFRKRI 302
C+CK G+C D RR R I G+ +V+V + LL R+
Sbjct: 461 SSGFGCYCKDGKCGYEYDDGFFRRHRRFIATLVRYTFIALGALTGVVIVFLVLLCPCFRV 520
Query: 303 PSFFKKPFSEERQNIGDGLNVKQFIKTYRSAL-LSNYSYNDIKKMTNGFKEKLGTGGYGN 361
F K+ S+E + ++ ++ + L +Y+Y ++KKMT F E +G GG+G
Sbjct: 521 QIFRKRKTSDEVR-----------LQKLKALIPLKHYTYAEVKKMTKSFTEVVGRGGFGI 569
Query: 362 VYKGKFPDGRLVAVKVLEKTSNF-SDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420
VY G D +VAVKVL+ + ++FINEVA++ + HVNI+ LLGFCC+GS RA+IY
Sbjct: 570 VYSGTLSDSSMVAVKVLKDSKGTDGEDFINEVASMSQTSHVNIVSLLGFCCEGSRRAIIY 629
Query: 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 480
E++ NGSL +S +K +++L L IALGVA +EYLH GC+ RI+H DIKPQNVLL
Sbjct: 630 EFLGNGSLDKFIS-DKSSVNLDLKTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLL 688
Query: 481 DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGML 540
D + PKVSDFGLAK + S++++ RGTIGYIAPE+ R G+ S KSDVYSYGML
Sbjct: 689 DDNLCPKVSDFGLAKLCEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGML 748
Query: 541 LLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF------------VEEED 588
+LEMI +K R + S S+ + YFP+WIY L + +D + E+
Sbjct: 749 VLEMIGARKKER-FDQNSRSDGSSIYFPEWIYKDLEKANIKDIEKTENGGLIENGISSEE 807
Query: 589 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKPLF 636
+ IARKM +VGLWCIQ +P DRP M +VVEM+ S +A+E+PP+P+
Sbjct: 808 EEIARKMTLVGLWCIQSSPSDRPPMNKVVEMM-EGSLDALEVPPRPVL 854
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 310 bits (793), Expect = 4e-83, Method: Compositional matrix adjust.
Identities = 158/306 (51%), Positives = 212/306 (69%), Gaps = 10/306 (3%)
Query: 334 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVA 393
LL+ Y+Y ++KK+T F +G GG+G VY G +GR VAVKVL+ +++FINEVA
Sbjct: 484 LLNMYTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVA 543
Query: 394 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGV 453
++ + HVNI+ LLGFC +GS RA++YE++ NGSL +SR K +L+ L IALG+
Sbjct: 544 SMSQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNK-SLTQDVTTLYGIALGI 602
Query: 454 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 513
A +EYLH GC+ RI+H DIKPQN+LLD + PKVSDFGLAK + SV+++ RGTI
Sbjct: 603 ARGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTI 662
Query: 514 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK-KHLRPTETTSGSNTTEAYFPDWIY 572
GYIAPE+F R G S KSDVYS+GML+++MI + K + T ++ S+T YFPDWIY
Sbjct: 663 GYIAPEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASST---YFPDWIY 719
Query: 573 DKLIQPEKE----DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAI 628
L E+ D + +E+ IA+KMI+VGLWCIQ P DRPSM RVVEM+ S +A+
Sbjct: 720 KDLEDGEQTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMM-EGSLDAL 778
Query: 629 EMPPKP 634
E+PPKP
Sbjct: 779 EIPPKP 784
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 304 bits (779), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 156/307 (50%), Positives = 206/307 (67%), Gaps = 14/307 (4%)
Query: 334 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVA 393
LL Y Y ++KK+T F +G GG+G VY+G +GR VAVKVL+ D+FINEV
Sbjct: 482 LLKQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVT 541
Query: 394 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKP--ARLLEIAL 451
++ + HVNI+ LLGFC +GS RA+I E++ +GSL +SR K SL P L IAL
Sbjct: 542 SMSQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFISRNK---SLTPNVTTLYGIAL 598
Query: 452 GVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG 511
G+A +EYLH GC+ RI+H DIKPQN+LLD +F PKV+DFGLAK + S++++ RG
Sbjct: 599 GIARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRG 658
Query: 512 TIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI 571
TIGYIAPE+ R G S KSDVYSYGML+L+MI + + ETT+ N + AYFPDWI
Sbjct: 659 TIGYIAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKV---ETTT-CNGSTAYFPDWI 714
Query: 572 YDKLIQPEKE----DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEA 627
Y L ++ D + EED+ I +KMI+V LWCI+ P DRP M +VVEM+ S +A
Sbjct: 715 YKDLENGDQTWIIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMI-EGSLDA 773
Query: 628 IEMPPKP 634
+E+PPKP
Sbjct: 774 LELPPKP 780
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 231 bits (590), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 127/291 (43%), Positives = 182/291 (62%), Gaps = 17/291 (5%)
Query: 338 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGR 397
++Y D++ TN F KLG GG+G+VY+G PDG +AVK LE F EV+ IG
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGS 542
Query: 398 IHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKE-NLSLKPARLLEIALGVAHA 456
IHH++++ L GFC +G+ R L YE++ GSL + R+K+ ++ L IALG A
Sbjct: 543 IHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKG 602
Query: 457 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 516
+ YLH C+ RI+H DIKP+N+LLD +F KVSDFGLAK +R +S V T RGT GY+
Sbjct: 603 LAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHV-FTTMRGTRGYL 661
Query: 517 APEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 576
APE ++ N S KSDVYSYGM+LLE+I +K+ P+ET+ + +FP + + K+
Sbjct: 662 APE-WITNYA-ISEKSDVYSYGMVLLELIGGRKNYDPSETSE-----KCHFPSFAFKKME 714
Query: 577 QPEKEDFVEEE-------DDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
+ + D V+ + D+ + R M LWCIQ + + RPSM++VV+ML
Sbjct: 715 EGKLMDIVDGKMKNVDVTDERVQRAM-KTALWCIQEDMQTRPSMSKVVQML 764
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 226 bits (575), Expect = 6e-58, Method: Compositional matrix adjust.
Identities = 135/329 (41%), Positives = 189/329 (57%), Gaps = 27/329 (8%)
Query: 335 LSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVAT 394
LS +SY +++ T F +KLG GG+G+V+KG PD +AVK LE S F EV T
Sbjct: 480 LSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVT 539
Query: 395 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGD--LLSREKENLSLKPARLLEIALG 452
IG I HVN++ L GFC +GS + L+Y+YMPNGSL L++ +E + L +IALG
Sbjct: 540 IGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALG 599
Query: 453 VAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT 512
A + YLH+ C I+H DIKP+N+LLD F PKV+DFGLAK R+ S V +T RGT
Sbjct: 600 TARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRV-LTTMRGT 658
Query: 513 IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW-- 570
GY+APE ++ + + K+DVYSYGM+L E++ +++ +E N +FP W
Sbjct: 659 RGYLAPE-WISGVA-ITAKADVYSYGMMLFELVSGRRNTEQSE-----NEKVRFFPSWAA 711
Query: 571 -IYDK------LIQPEKE-DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
I K L+ P E D V+ E+ A K V WCIQ RP+M++VV++L
Sbjct: 712 TILTKDGDIRSLVDPRLEGDAVDIEEVTRACK---VACWCIQDEESHRPAMSQVVQILEG 768
Query: 623 ASAEAIEMPPKPLFPSPPQLQTQNEIISF 651
+E+ P P S L +E + F
Sbjct: 769 ----VLEVNPPPFPRSIQALVVSDEDVVF 793
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 224 bits (570), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 132/308 (42%), Positives = 183/308 (59%), Gaps = 24/308 (7%)
Query: 338 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKT-SNFSDNFINEVATIG 396
++Y D++ TN F + LG+GG+G VYKG LVAVK L++ S+ FI EV TIG
Sbjct: 520 FTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTIG 579
Query: 397 RIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARL-LEIALGVAH 455
+HH+N++ L G+C + S R L+YEYM NGSL + ++ +L R EIA+ A
Sbjct: 580 SMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQ 639
Query: 456 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS-VVTMTGPRGTIG 514
I Y H C RI+H DIKP+N+LLD +F PKVSDFGLAK R S VVTM RGT G
Sbjct: 640 GIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMI--RGTRG 697
Query: 515 YIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573
Y+APE ++ N P + K+DVYSYGMLLLE++ +++L + + + ++P W Y
Sbjct: 698 YLAPE-WVSN--RPITVKADVYSYGMLLLEIVGGRRNLDMS-----YDAEDFFYPGWAYK 749
Query: 574 KLIQ-------PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626
+L ++ V EE++ + K + V WCIQ RPSM VV++L S E
Sbjct: 750 ELTNGTSLKAVDKRLQGVAEEEEVV--KALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDE 807
Query: 627 AIEMPPKP 634
I +PP P
Sbjct: 808 -INLPPMP 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (569), Expect = 3e-57, Method: Compositional matrix adjust.
Identities = 130/296 (43%), Positives = 171/296 (57%), Gaps = 15/296 (5%)
Query: 335 LSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVA 393
L +S+ +++ TNGF +K+G GG+G V+KG P VAVK LE+ + F EV
Sbjct: 448 LKVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGESEFRAEVC 507
Query: 394 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGV 453
TIG I HVN++ L GFC + R L+Y+YMP GSL LSR L R IALG
Sbjct: 508 TIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPKLLSWETRF-RIALGT 566
Query: 454 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 513
A I YLH GC I+H DIKP+N+LLD D+ KVSDFGLAK R+ S V T RGT
Sbjct: 567 AKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLAT-MRGTW 625
Query: 514 GYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE---AYFPD 569
GY+APE G P + K+DVYS+GM LLE+I ++++ T G TE +FP
Sbjct: 626 GYVAPEWIS---GLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPP 682
Query: 570 WIYDKLIQPEKEDFVE-----EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
W ++IQ + V+ E + +M V +WCIQ N + RP+M VV+ML
Sbjct: 683 WAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKML 738
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (563), Expect = 1e-56, Method: Compositional matrix adjust.
Identities = 126/315 (40%), Positives = 172/315 (54%), Gaps = 19/315 (6%)
Query: 330 YRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFI 389
Y S ++Y ++++ T FKEKLG GG+G VY+G + +VAVK LE F
Sbjct: 466 YASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFR 525
Query: 390 NEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEI 449
EVATI HH+N++ L+GFC G R L+YE+M NGSL + L L I
Sbjct: 526 MEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNI 585
Query: 450 ALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 509
ALG A I YLH C I+H DIKP+N+L+D +F KVSDFGLAK + + M+
Sbjct: 586 ALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSV 645
Query: 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPD 569
RGT GY+APE ++ NL S KSDVYSYGM+LLE++ K++ +E T F
Sbjct: 646 RGTRGYLAPE-WLANLPITS-KSDVYSYGMVLLELVSGKRNFDVSE-----KTNHKKFSI 698
Query: 570 WIYDKLIQPEKEDFVE---EEDDCI----ARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
W Y++ + + ++ ED + +M+ WCIQ P RP+M +VV+ML
Sbjct: 699 WAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQML-- 756
Query: 623 ASAEAIEMPPKPLFP 637
E I PL P
Sbjct: 757 ---EGITEIKNPLCP 768
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LMB9|CRK1_ARATH Cysteine-rich receptor-like protein kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 206 bits (523), Expect = 6e-52, Method: Compositional matrix adjust.
Identities = 122/316 (38%), Positives = 186/316 (58%), Gaps = 13/316 (4%)
Query: 337 NYSYNDIKKMTNGFKE--KLGTGGYGNVYKGKFPDGRLVAVKVLE-KTSNFSDNFINEVA 393
N+ Y ++K T F + KLG GG G+VYKG PDGR+VAVK L T ++D F NEV
Sbjct: 305 NFKYEMLEKATESFHDSMKLGQGGAGSVYKGILPDGRIVAVKKLFFNTREWADQFFNEVN 364
Query: 394 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGV 453
I + H N++ LLG +G L+YEY+ N SL +L + L + I +G+
Sbjct: 365 LISGVQHKNLVRLLGCSIEGPKSLLVYEYVHNRSLDQILFMKNTVHILSWKQRFNIIIGI 424
Query: 454 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 513
+ +EYLH G E++I+H DIK N+LLD + +PK++DFGL ++ +++ T TG GT+
Sbjct: 425 SEGLEYLHRGSEVKIIHRDIKTSNILLDRNLSPKIADFGLIRSMGTDKT-QTNTGIAGTL 483
Query: 514 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS-NTTEAYFPDWIY 572
GY+APE ++ G + K+DVY++G+L++E++ KK+ T+ TS + +F
Sbjct: 484 GYLAPEYLIK--GQLTEKADVYAFGVLIIEIVTGKKNNAFTQGTSSVLYSVWEHFKANTL 541
Query: 573 DKLIQPE-KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMP 631
D+ I P K FVEEE A K++ +GL C+Q + + RPSM+ +V ML + ++ E P
Sbjct: 542 DRSIDPRLKGSFVEEE----ALKVLQIGLLCVQSSVELRPSMSEIVFMLQNKDSK-FEYP 596
Query: 632 PKPLFPSPPQLQTQNE 647
+P F S L E
Sbjct: 597 KQPPFLSASVLMPDEE 612
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 202 bits (515), Expect = 5e-51, Method: Compositional matrix adjust.
Identities = 137/381 (35%), Positives = 205/381 (53%), Gaps = 47/381 (12%)
Query: 272 KRRKSRLPLIIAGSCCM-VLVAVALLVFRKRIPSFFKKPFSEERQNIGDGLNVKQFIKTY 330
K R + +I G + +L V + RKR +K ++++ + +G ++VK +I
Sbjct: 632 KNRTGTIVGVIVGVGLLSILAGVVMFTIRKR-----RKRYTDDEELLG--MDVKPYI--- 681
Query: 331 RSALLSNYSYNDIKKMTNGF--KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-NFSDN 387
++Y+++K T F KLG GG+G VYKG DGR+VAVK+L S
Sbjct: 682 -------FTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQ 734
Query: 388 FINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL 447
F+ E+ I + H N++ L G C +G R L+YEY+PNGSL L +K L L +
Sbjct: 735 FVAEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDK-TLHLDWSTRY 793
Query: 448 EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507
EI LGVA + YLH +RI+H D+K N+LLD P++SDFGLAK + ++ ++ T
Sbjct: 794 EICLGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHIS-T 852
Query: 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE--A 565
GTIGY+APE MR G+ + K+DVY++G++ LE++ RP S N E
Sbjct: 853 RVAGTIGYLAPEYAMR--GHLTEKTDVYAFGVVALELVSG----RP---NSDENLEEEKK 903
Query: 566 YFPDWIYD--------KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVV 617
Y +W ++ +LI + DF EE A++MI + L C Q + RP M+RVV
Sbjct: 904 YLLEWAWNLHEKSRDIELIDDKLTDFNMEE----AKRMIGIALLCTQTSHALRPPMSRVV 959
Query: 618 EMLSSASAEAIEMPPKPLFPS 638
ML S E ++ KP + S
Sbjct: 960 AML-SGDVEIGDVTSKPGYVS 979
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 667 | ||||||
| 359472680 | 689 | PREDICTED: probable receptor-like protei | 0.953 | 0.923 | 0.532 | 0.0 | |
| 147769069 | 689 | hypothetical protein VITISV_027278 [Viti | 0.953 | 0.923 | 0.530 | 0.0 | |
| 255572126 | 597 | serine/threonine kinase, putative [Ricin | 0.866 | 0.968 | 0.556 | 1e-174 | |
| 147769070 | 941 | hypothetical protein VITISV_027279 [Viti | 0.566 | 0.401 | 0.591 | 1e-125 | |
| 255551426 | 638 | serine/threonine kinase, putative [Ricin | 0.898 | 0.938 | 0.392 | 1e-109 | |
| 54290824 | 629 | putative receptor serine/threonine kinas | 0.853 | 0.904 | 0.386 | 1e-108 | |
| 357133266 | 629 | PREDICTED: probable receptor-like protei | 0.875 | 0.928 | 0.381 | 1e-107 | |
| 224127698 | 580 | predicted protein [Populus trichocarpa] | 0.830 | 0.955 | 0.391 | 1e-106 | |
| 326494772 | 673 | predicted protein [Hordeum vulgare subsp | 0.896 | 0.888 | 0.370 | 1e-104 | |
| 145839451 | 627 | receptor-like protein kinase [Capsicum a | 0.877 | 0.933 | 0.380 | 1e-104 |
| >gi|359472680|ref|XP_002279518.2| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 687 bits (1772), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/695 (53%), Positives = 471/695 (67%), Gaps = 59/695 (8%)
Query: 17 SLMIIAMGMATFPDFIHSQSQNDTSYED-CSPFKCGNLTFSFPFSSSSTSGY----CGLP 71
SL + ++TF IHSQS DTSY + C PF CGN+TFSFPFS + G+ CGLP
Sbjct: 5 SLPFLIFFISTFLTLIHSQS--DTSYYNLCKPFDCGNITFSFPFSLGADFGFGPRDCGLP 62
Query: 72 NYQITCDSSSVPKLLLSGRLYQVRNFFSS-----QDDRLITVVDTQLIKDLSSGSCESLY 126
YQI C+SSS P+L+LS R YQV+ + S Q ITVVD LI DLSSGSC SL
Sbjct: 63 GYQIFCESSSNPRLMLSDRFYQVKQLYLSPHHEQQSSNFITVVDHPLINDLSSGSCVSLG 122
Query: 127 NLSVAINSYSIGSLTLPSGNLNLTFFKCPRRLSLSQNFTDKGVSNVS--CNDGHVLYLWR 184
NLS+ N+ + L LPS ++LTFF+C RL L Q+F D V+N + C +G+ L+L R
Sbjct: 123 NLSIPTNA--VAPLKLPSWGVDLTFFQCSTRLPLPQDFLDTLVNNFTYNCQEGYALHLLR 180
Query: 185 ----NRTQSGRPSFDPVSAPSGCDSVVVPVSSVTSLYLG-------------------AD 221
N ++ P PV PSGC V +PVS + G
Sbjct: 181 EVRGNESRLDSPPLSPVLIPSGCGLVSLPVSRASLTRYGLLNSSDGENRMVLKAHMELEQ 240
Query: 222 VFDTLRQGFPLEWPKLDDCEKCQNRSGRCGYNGSLKKITCFCKGGRCDSVKRRKSRLPLI 281
+ LR GFPL+W CE C+N+ GRCGY+ L K+ CFC+ G C ++ ++S+ LI
Sbjct: 241 LLHVLRDGFPLQWSSFGVCESCKNKGGRCGYDSILGKVDCFCEAGHCQQLRHQQSQRKLI 300
Query: 282 I---AGSCCMVLVAVALLVF--RKRIPSFFKKPFSEERQNIGDGLNVKQFIKTYRSALLS 336
+ AG +V+ AV L +F +KRI KK +S + Q +G G N +QFIK Y+SA+L+
Sbjct: 301 VGVAAGGSFIVVAAVVLSIFEFKKRI----KKSYSRKTQTVGGGRNAEQFIKEYQSAVLT 356
Query: 337 NYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN-FSDNFINEVATI 395
NYSYND+KKM++GFK+KLG GG+GNVY GK DGRL+A+K+LEK+++ S +F+NEVA+I
Sbjct: 357 NYSYNDMKKMSSGFKDKLGQGGFGNVYLGKMLDGRLIAMKMLEKSNHEISHDFVNEVASI 416
Query: 396 GRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAH 455
GRIHHVN+I LLGFC DGS +ALIYEYMPNGSLGDL+S+E LSL ARLLEIA+GVAH
Sbjct: 417 GRIHHVNVIRLLGFCWDGSKQALIYEYMPNGSLGDLMSKEGARLSLGLARLLEIAIGVAH 476
Query: 456 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGY 515
IEYLHNGCE RILHLDIKPQN+LLD + PK+SDFGLAK +SR+RS V++T RGTIGY
Sbjct: 477 GIEYLHNGCESRILHLDIKPQNILLDHNLNPKISDFGLAKVYSRDRSAVSVTCARGTIGY 536
Query: 516 IAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575
IAPEIFMRN+G+PS KSDVYSYGMLLL+M+ KKH+ S +E+YFPDWI+DK+
Sbjct: 537 IAPEIFMRNVGSPSHKSDVYSYGMLLLDMVGGKKHVVSKMMAS----SESYFPDWIHDKV 592
Query: 576 IQPEKED----FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMP 631
++ E + V EE+ IA+KMI+VG WCIQ++P+DRPSM RVVEML + SAEAI+MP
Sbjct: 593 MEEEGMEEPIFSVAEEEVGIAKKMIMVGSWCIQMDPRDRPSMARVVEML-NGSAEAIQMP 651
Query: 632 PKPLFPSPPQLQTQNEIISFDSIT-SELPLQHDSQ 665
PKP F S + EI +S T + LPL SQ
Sbjct: 652 PKPFFSSSSPAHFEQEITYSESDTGASLPLFESSQ 686
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147769069|emb|CAN72504.1| hypothetical protein VITISV_027278 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 683 bits (1762), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/695 (53%), Positives = 469/695 (67%), Gaps = 59/695 (8%)
Query: 17 SLMIIAMGMATFPDFIHSQSQNDTSYED-CSPFKCGNLTFSFPFSSSSTSGY----CGLP 71
SL + ++T IHSQS DTSY + C PF CGN+TFSFPFS + G+ CGLP
Sbjct: 5 SLPFLIFFISTXLTLIHSQS--DTSYYNLCKPFDCGNITFSFPFSLGADFGFGPRDCGLP 62
Query: 72 NYQITCDSSSVPKLLLSGRLYQVRNFFSS-----QDDRLITVVDTQLIKDLSSGSCESLY 126
YQI C+SSS P+L+LS R YQV+ + S Q ITVVD LI DLSSGSC SL
Sbjct: 63 GYQIFCESSSNPRLMLSDRFYQVKQLYLSPHHEQQSSNFITVVDHPLINDLSSGSCVSLG 122
Query: 127 NLSVAINSYSIGSLTLPSGNLNLTFFKCPRRLSLSQNFTDKGVSNVS--CNDGHVLYLWR 184
NLS+ N+ + L LPS ++LTFF+C RL L Q F D V+N + C +G+ L+L R
Sbjct: 123 NLSIPTNA--VAPLKLPSWGVDLTFFQCSTRLPLPQXFLDTLVNNFTYNCQEGYALHLXR 180
Query: 185 ----NRTQSGRPSFDPVSAPSGCDSVVVPVSSVTSLYLG-------------------AD 221
N ++ P PV PSGC V +PVS + G
Sbjct: 181 EVRGNESRLDSPPLSPVLIPSGCGLVSLPVSRASLTRYGLLNSSDGENRMVLKAHMELEQ 240
Query: 222 VFDTLRQGFPLEWPKLDDCEKCQNRSGRCGYNGSLKKITCFCKGGRCDSVKRRKSRLPLI 281
+ LR GFPL+W CE C+N+ GRCGY+ L K+ CFC+ G C ++ ++S+ LI
Sbjct: 241 LLHVLRDGFPLQWSSFGVCESCKNKGGRCGYDSILGKVDCFCEAGHCQQLRHQQSQRKLI 300
Query: 282 I---AGSCCMVLVAVALLVF--RKRIPSFFKKPFSEERQNIGDGLNVKQFIKTYRSALLS 336
+ AG +V+ AV L +F +KRI KK +S + Q +G G N +QFIK Y+SA+L+
Sbjct: 301 VGVAAGGSFIVVAAVVLSIFEFKKRI----KKSYSRKTQTVGGGRNAEQFIKEYQSAVLT 356
Query: 337 NYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN-FSDNFINEVATI 395
NYSYND+KKM++GFK+KLG GG+GNVY GK DGRL+A+K+LEK+++ S +F+NEVA+I
Sbjct: 357 NYSYNDMKKMSSGFKDKLGQGGFGNVYLGKMLDGRLIAMKMLEKSNHEISHDFVNEVASI 416
Query: 396 GRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAH 455
GRIHHVN+I LLGFC DGS +ALIYEYMPNGSLGDL+S+E LSL ARLLEIA+GVAH
Sbjct: 417 GRIHHVNVIRLLGFCWDGSKQALIYEYMPNGSLGDLMSKEGARLSLGLARLLEIAIGVAH 476
Query: 456 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGY 515
IEYLHNGCE RILHLDIKPQN+LLD + PK+SDFGLAK +SR+RS V++T RGTIGY
Sbjct: 477 GIEYLHNGCESRILHLDIKPQNILLDHNLNPKISDFGLAKVYSRDRSAVSVTCARGTIGY 536
Query: 516 IAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575
IAPEIFMRN+G+PS KSDVYSYGMLLL+M+ KKH+ S +E+YFPDWI+DK+
Sbjct: 537 IAPEIFMRNVGSPSHKSDVYSYGMLLLDMVGGKKHVVSKMMAS----SESYFPDWIHDKV 592
Query: 576 IQPEKED----FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMP 631
++ E + V EE+ IA+KMI+VG WCIQ++P+DRPSM RVVEML + SAEAI+MP
Sbjct: 593 MEEEGMEEPIFSVAEEEVGIAKKMIMVGSWCIQMDPRDRPSMARVVEML-NGSAEAIQMP 651
Query: 632 PKPLFPSPPQLQTQNEIISFDSIT-SELPLQHDSQ 665
PKP F S + EI +S T + LPL SQ
Sbjct: 652 PKPFFSSSSPAHFEQEITYSESDTGASLPLFESSQ 686
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572126|ref|XP_002527003.1| serine/threonine kinase, putative [Ricinus communis] gi|223533638|gb|EEF35375.1| serine/threonine kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 619 bits (1596), Expect = e-174, Method: Compositional matrix adjust.
Identities = 339/609 (55%), Positives = 423/609 (69%), Gaps = 31/609 (5%)
Query: 8 PAP-SSIISVSLMIIAMGMAT-FPDFIHSQSQNDTS-YEDCSPFKCGNLTFSFPFSS--- 61
PAP SS++S ++ +++ ++T FP H +SQN TS Y+ C+PFKCGN+TFSFPFSS
Sbjct: 5 PAPVSSVLSSFIITLSLIISTTFP--THIKSQNSTSDYDLCTPFKCGNITFSFPFSSLTF 62
Query: 62 SSTSGYCGLPNYQITCDSSSVPKLLLSGRLYQVRNFFSSQDDRLITVVDTQLIKDLSSGS 121
S CGLP+YQITCD S ++LSGR +QV++ + S DRLIT VD QLIKDL++GS
Sbjct: 63 GSGPKTCGLPSYQITCDDLS-SGIILSGRFFQVKDLYLS--DRLITAVDIQLIKDLTAGS 119
Query: 122 CESLYNLSVAINSYSIGSLTLPSGNLNLTFFKCPRRLSLSQNFTDKGVSNVSCNDGHVLY 181
C SL N +V+ SL+LP G LN T CP L LS++F +KG + +C +G LY
Sbjct: 120 CSSLRNFTVSSTYNPSLSLSLPPGTLNFTLLMCPAELELSKDFLEKGSYSFTCMEGDKLY 179
Query: 182 LWRNRTQSGRPSFDPVSAPSGCDSVVVPVSSVTSLYLGA------DVFDTLRQGFPLEWP 235
+W +Q P+ APS C V VP +S ++ G + L GF L WP
Sbjct: 180 VWDPPSQ---LKLSPLLAPSECSVVTVPSNSFLNISNGTSDDHRIQLAHILVDGFALTWP 236
Query: 236 KLDDCEKCQNRSGRCGYNGSLKKITCFCKGGRCDSVKRRKSRLPLIIAGSCCMVLVAVAL 295
+C C + GRCG++GSL +I CF K G +K L + IA C L+ V L
Sbjct: 237 DFKECTNCSSIGGRCGFDGSLGRIVCFHKPGSSKK-NPKKGELIIGIATGSCFTLLLVVL 295
Query: 296 LVFRKRIPSFFKKPFSEERQNIGDGLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLG 355
LV + R+P+ +K + QN + NV+QF+KTY+SALLSNYSY DI+KMTNGF+EKLG
Sbjct: 296 LVLKGRVPALKRK----KNQNTENRKNVEQFVKTYQSALLSNYSYRDIRKMTNGFREKLG 351
Query: 356 TGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGST 415
GGYGNVYKG+ DGRLVA+K+LEK S+ +F+NEVATIG IHH N+I LLGF +GS
Sbjct: 352 EGGYGNVYKGRLSDGRLVAIKLLEKLSSNGRDFVNEVATIGTIHHFNVIRLLGFSWNGSK 411
Query: 416 RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKP 475
+ALIYEYMPNGSL DLLS + +LSL+ +R+LEIA+G+AH IEYLHNGCE RILHLDIKP
Sbjct: 412 QALIYEYMPNGSLADLLSNGEFSLSLRLSRMLEIAIGIAHGIEYLHNGCESRILHLDIKP 471
Query: 476 QNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVY 535
QNVLLD + PK+SDFGLAK +SRNRSVVTMT RGTIGYIAPEIFMRNLGNPS KSDVY
Sbjct: 472 QNVLLDQNLNPKISDFGLAKIYSRNRSVVTMTDARGTIGYIAPEIFMRNLGNPSHKSDVY 531
Query: 536 SYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP---EKEDFVEEEDDCIA 592
SYGMLLLEM+ +K + E S ++EAYFPDWIYDKLI+ E D + EEDD I+
Sbjct: 532 SYGMLLLEMVGGRKQV---ERNILSTSSEAYFPDWIYDKLIEEKNIEIADSIAEEDDDIS 588
Query: 593 RKMIIVGLW 601
RKMI VGLW
Sbjct: 589 RKMITVGLW 597
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147769070|emb|CAN72505.1| hypothetical protein VITISV_027279 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 454 bits (1168), Expect = e-125, Method: Compositional matrix adjust.
Identities = 232/392 (59%), Positives = 300/392 (76%), Gaps = 14/392 (3%)
Query: 281 IIAGSCCMVLVAVALLVFRKRI---PSFFKKPFSEERQNIGDGLNVKQFIKTYRSALLSN 337
+ +GS +++ + L+F+ + P F F + R++ DG N +QFIK Y+S +L+
Sbjct: 551 VASGSSVILVTVIFFLIFKYKKGTSPFFRAFNFRKNRRSTEDGRNAQQFIKEYQSTILTK 610
Query: 338 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-NFSDNFINEVATIG 396
YSY+D+KKM+ GFK+KLG GG+GNVYKGK PDGRL+A+K+LE++ + + NF+NEV TIG
Sbjct: 611 YSYHDLKKMSGGFKDKLGEGGFGNVYKGKMPDGRLIAIKILERSXHDMNQNFVNEVVTIG 670
Query: 397 RIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHA 456
RIHH+N+I LLGFC DG +AL+YEYMPNGSLGD LS+ +LSL ARLLEIA+GVAH
Sbjct: 671 RIHHLNVIRLLGFCWDGGKQALVYEYMPNGSLGDFLSQXGXSLSLGLARLLEIAIGVAHG 730
Query: 457 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 516
IEYLH GCE RILHLDIKPQNVLLD + PK+SDFGLAK +SR+RS ++MT RGTIGYI
Sbjct: 731 IEYLHFGCESRILHLDIKPQNVLLDQNLNPKISDFGLAKLYSRDRSAISMTNARGTIGYI 790
Query: 517 APEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 576
APEIFMRNJGNPS KSDVYSYGMLLL+M+ KKH+ P +TS +E YFPDWIYDKL+
Sbjct: 791 APEIFMRNJGNPSHKSDVYSYGMLLLDMVGGKKHVPPEMSTS----SEKYFPDWIYDKLM 846
Query: 577 QPEKEDFVE---EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPK 633
+ E+ + ++ EE+ IA+KM++VGLWCIQ++P+DRPSMTRVVEML + S EAI+ PPK
Sbjct: 847 EEEEMEAIDSIVEEEVGIAKKMVVVGLWCIQVDPRDRPSMTRVVEML-NGSVEAIKTPPK 905
Query: 634 PLFPSPPQLQTQNEII--SFDSITSELPLQHD 663
P F SPP+ + EI DS ++ L +Q D
Sbjct: 906 PFFFSPPREDFEQEITYSKSDSDSTSLVIQED 937
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255551426|ref|XP_002516759.1| serine/threonine kinase, putative [Ricinus communis] gi|223544132|gb|EEF45657.1| serine/threonine kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 400 bits (1029), Expect = e-109, Method: Compositional matrix adjust.
Identities = 257/655 (39%), Positives = 365/655 (55%), Gaps = 56/655 (8%)
Query: 10 PSSIISVSLMIIAMGMATFPDFIHSQSQNDTSYEDCS-PFKCGNL-TFSFPFSSSSTSGY 67
P S S+SL + + + PD +Q D +CS FKCGN+ +PF S+ Y
Sbjct: 3 PHSPQSMSLFFLFIAIILVPDSTPVYAQIDM---NCSQKFKCGNIPDIGYPFWGSNRPQY 59
Query: 68 CGLPNYQITCDSSSVPKLLLSGRLYQVRNFFSSQDDRLITVVDTQLIKDLS-SGSCESLY 126
CG P +++ C + + + YQV S +++ + V T I ++ S +
Sbjct: 60 CGHPEFELNC-TGQTAVITVEELTYQVLEINS--EEKTLKVARTDYIDNICPSNPVSTTL 116
Query: 127 NLSVAINSYSIGSLTLPSGNLNLTFFKCPRR--LSLSQNFTDKGVSNVSCNDGHVLYLWR 184
N + + I +TL ++ CP+ + Q+FT++ SCND + ++ R
Sbjct: 117 NFNYFSYTSDIQIITL--------YYGCPQSNPMPTLQDFTNQ----FSCNDSNGFFVTR 164
Query: 185 NRTQSGRPSFDPVSAPSGCD-SVVVPV--SSVTSLYL---GADVFDTLRQGFPLEWPKLD 238
N + + ++ CD V+VP S+V SL ++ L QGF LEW +
Sbjct: 165 NLSNL---TAALMTYFRTCDVEVIVPANQSAVQSLENRPNQENLVIALEQGFGLEWRENS 221
Query: 239 DCEKCQNRSGRCGYNGSLKKI-TCFCKGGRCDSVKRRKSRLPLIIAGSCCMVLVAVALLV 297
CE C G+CG N + + C+C G D +S+ + A + + +
Sbjct: 222 TCETCNMSGGQCGSNSTDPSLFACYCTNGP-DPFSCGRSQSSGLGAAAAVLTICLGIYYC 280
Query: 298 FRKRIPSFFKKPFSEER-QNIGDGLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGT 356
F +R+ + S+ R +N+ ++ FI Y+S + YSY+DI++MTN F KLG
Sbjct: 281 FTRRV-----RFLSDTRWKNVKKDEKIENFILNYQSFMPKRYSYSDIQRMTNSFNHKLGQ 335
Query: 357 GGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTR 416
GG+G VYKGK DGR+VAVKVL K++ + FINEVA+I R H+N++ LLGFC + S R
Sbjct: 336 GGFGGVYKGKLLDGRVVAVKVLSKSTGDGEEFINEVASISRTSHINVVTLLGFCYERSKR 395
Query: 417 ALIYEYMPNGSLGDLL---SREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDI 473
ALIYEYMPNGSL + + N L L +I +G+A +EYLH GC RI+H DI
Sbjct: 396 ALIYEYMPNGSLDKFIYDQGSQGVNKHLDWKTLYDITVGIARGLEYLHRGCNTRIVHFDI 455
Query: 474 KPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSD 533
KP N+LLD DF PKVSDFGLAK S++TM G RGTIGYIAPEIF+RN G S KSD
Sbjct: 456 KPHNILLDKDFCPKVSDFGLAKLCKGKESIITMLGARGTIGYIAPEIFIRNFGGVSYKSD 515
Query: 534 VYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK-----EDFVEEED 588
VYSYGM++LE+ R S++ E YFP+ IY K I+ E+ E +EE
Sbjct: 516 VYSYGMMILEICGG----RNKSDVGVSHSGEVYFPECIY-KYIESEQVSTLHEKITDEEG 570
Query: 589 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKP-LF-PSPPQ 641
+ + R++ IVGLWCIQ NP DRPSMT+VVEML +S E++++PPKP LF P+ PQ
Sbjct: 571 E-MVRRLTIVGLWCIQTNPSDRPSMTKVVEMLEGSSLESLQIPPKPSLFAPTTPQ 624
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|54290824|dbj|BAD61463.1| putative receptor serine/threonine kinase PR5K [Oryza sativa Japonica Group] gi|125568940|gb|EAZ10455.1| hypothetical protein OsJ_00288 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 397 bits (1021), Expect = e-108, Method: Compositional matrix adjust.
Identities = 234/606 (38%), Positives = 333/606 (54%), Gaps = 37/606 (6%)
Query: 45 CSPFKCGNLTFSFPFS-SSSTSGYCGLPNYQITC-DSSSVPKLLLSGRLYQVRNFFSSQD 102
C P CGNLT ++PF S CG P++Q+TC D +S P L +V F
Sbjct: 30 CPPATCGNLTITYPFWLGSQNQSSCGPPSFQLTCNDRASGP--FLRNSYIKVLGF--DYG 85
Query: 103 DRLITVVDTQLIKDLSSGSCESLYNLSVAINSYSIGSLTLPSGNLNLTFFKCPRRLSLSQ 162
R + V L D +C ++N+S A S++ + L +C RL
Sbjct: 86 RRSLVAVHALLAAD---AACTVMFNVSSAFAITDRFSISQSNREL-YVLSRCRERLPPPD 141
Query: 163 NFTDKGVSNVSCNDGHVLYLWRNRTQSGRPSFDPVSAPSGCDSVVVPV--SSVTSLYLGA 220
V+N N + +G+ PV+ GC+ V V SS + A
Sbjct: 142 AVP---VTNCRANSSGMYAYLGGSYGTGQ---TPVNN-GGCELSVFLVLGSSNAADMTAA 194
Query: 221 DVFDTLRQGFPLEWPKLDDCEKCQNRSGRCGYNGSLKKITCFCKGGR-----CDSVKRRK 275
+ + GF LEW + DC C GRC Y+ S C C G CD R K
Sbjct: 195 NYRQLIAGGFLLEWEPVGDCNACTASGGRCRYDASTSAFACLCSDGGMRPSICDGKNRGK 254
Query: 276 SRLPLIIAGSCCMVLVAVALLVFRKRIPSFFKKPFSEERQNI--GDGLNVKQFIKTYRSA 333
L + ++ + +V +A L++R+R + F + G+ N ++ +K S
Sbjct: 255 LALIVSLSAAAGLVFAFLAWLMYRQR------QKFRSAICGVYSGNTKNEEEMLKKCESL 308
Query: 334 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVA 393
L Y Y+++KK+T F++ LG GGYG V+KG+ +GR+VAVK+L + ++F+NEV
Sbjct: 309 ALKRYKYSELKKITKSFEDNLGEGGYGVVFKGRLQNGRMVAVKILTVSKGNGEDFLNEVM 368
Query: 394 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGV 453
+I R HVNI+ LLGFC +G RAL+YEYMPNGSL + + E NL+ LL+I +G+
Sbjct: 369 SISRTSHVNIVTLLGFCLEGPKRALVYEYMPNGSLKNYIHSESSNLATGWEMLLKIVIGI 428
Query: 454 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 513
A +EYLH GC RI+H DIKP+N+LLD +F PK++DFGLAK N S+++M RGTI
Sbjct: 429 ARGLEYLHQGCNTRIIHFDIKPRNILLDHEFCPKIADFGLAKLCHLNESILSMAEARGTI 488
Query: 514 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573
G+IAPE+F R G S KSDVYSYGMLLLE+++ +K+++ N +E +FP W+YD
Sbjct: 489 GFIAPEVFSRGFGVVSTKSDVYSYGMLLLEIVKVRKNIKGI----ADNFSETFFPHWVYD 544
Query: 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPK 633
L+ + + IARKM IVGLWCIQ+ P+ RPSM+RV+EML + +E +EMPPK
Sbjct: 545 SLVSEMQCCETAYGTEEIARKMTIVGLWCIQMTPETRPSMSRVIEMLERSISE-LEMPPK 603
Query: 634 PLFPSP 639
P SP
Sbjct: 604 PFLCSP 609
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357133266|ref|XP_003568247.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 395 bits (1016), Expect = e-107, Method: Compositional matrix adjust.
Identities = 243/637 (38%), Positives = 348/637 (54%), Gaps = 53/637 (8%)
Query: 40 TSYEDCSPFKCGNLTFSFPF----SSSSTSGYCGLPNYQITCDSSSVPKLLLSGRLYQVR 95
T+ C P CGNLT ++PF CG P +Q+TC ++ L R ++
Sbjct: 25 TNDAGCPPATCGNLTLAYPFWLAGGQEDQQPSCGPPAFQLTCHNNGSAFL----RTSYMK 80
Query: 96 NFFSSQDDRLITVVDTQLIKDLSSGSCESLYNLSVAI---NSYSIGSLTLPSGNLNLTFF 152
R + V L D +C ++N+S A + Y I S
Sbjct: 81 VLNVDYGSRSLVAVHALLAAD---AACTVMFNVSSAFAITDRYRISR----SNRELYVLS 133
Query: 153 KCPRRLSLSQNFTDKGVSNVSCNDGHVLYLWRNRTQSGRPSFDPVSAPSGCDSVVVPVSS 212
+C R V+N S + R + +P + S C+ + PV
Sbjct: 134 RCRERRPPPGAVP---VANCSATSSGMYAYLGGRYGTAQPPANEGS----CEISMFPV-- 184
Query: 213 VTSLYLGADVFDTL-RQGFPLEWPKLDDCEKCQNRSGRCGYNGSLKKITCFCKGG----- 266
+ S A+ + L + GF LEW + DC+ C GRC Y+ S C C G
Sbjct: 185 IASEATTAENYRRLIKGGFLLEWEPVGDCKACTASGGRCRYDSSTAAFVCLCSDGGLRAS 244
Query: 267 RCDSVKRRKSRLPLIIAGSCCMVL--VAVALLVFRKR--IPSFFKKPFSEERQNIGDGLN 322
CD +RK+ L LI++ S VL +A LV+R+R I S K +S N
Sbjct: 245 TCDGKHKRKT-LTLIVSLSVAAVLSLACLAWLVYRRRRKIRSTISKIYSSNTSN------ 297
Query: 323 VKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS 382
V++ ++ S L Y Y+++KK+T F+++LG GGYG VYKG DGR+VAVK+L+ +
Sbjct: 298 VEEMLRKCGSLSLKKYKYSELKKITRSFEDELGEGGYGVVYKGSLKDGRMVAVKLLKGSK 357
Query: 383 NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLK 442
++F+NEV +IG+ HVNI+ LLGFC +GS RALIYEYM NGSL + E L++
Sbjct: 358 GNGEDFLNEVMSIGQTSHVNIVSLLGFCLEGSQRALIYEYMSNGSLQKHIYSESSKLAIG 417
Query: 443 PARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502
L+IA+G+A +EYLH GC RI+H DIKP N+LLD +F+PK++DFGLAK S
Sbjct: 418 WEMFLKIAIGIARGLEYLHQGCNTRIIHFDIKPNNILLDHEFSPKIADFGLAKLFHLKDS 477
Query: 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT 562
V++M RGTIG+IAPE+F R G S KSDVYSYGMLLLEM++ KK L+ +S
Sbjct: 478 VLSMAEARGTIGFIAPEVFSRGFGVVSTKSDVYSYGMLLLEMVQGKKDLKRNVGSS---- 533
Query: 563 TEAYFPDWIYDKLIQPEKEDF-VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621
+E +FP W++D+L++ + V + + I RKM ++GLWCIQ+ P++RPSM+RV+EML
Sbjct: 534 SETFFPHWVHDRLVRDLQGSCEVTQGTEEIVRKMTMIGLWCIQMTPENRPSMSRVIEMLE 593
Query: 622 SASAEAIEMPPKPLFPSPPQLQTQNEIISFDSITSEL 658
+ E +EMPPKP SP L + N + S+ S+ E+
Sbjct: 594 RSINE-LEMPPKPFLCSP--LHSTN-VSSYASVQIEM 626
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127698|ref|XP_002329342.1| predicted protein [Populus trichocarpa] gi|222870796|gb|EEF07927.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 392 bits (1008), Expect = e-106, Method: Compositional matrix adjust.
Identities = 244/624 (39%), Positives = 337/624 (54%), Gaps = 70/624 (11%)
Query: 39 DTSYEDCSP-FKCGNL-TFSFPFSSSSTSGYCGLPNYQITCDSSSVPKLLLSGRLYQVRN 96
D Y CS F+CGN+ ++PF + YCG P + + C S P + +S YQV
Sbjct: 1 DERYLSCSKSFECGNIQNITYPFWGVNRPQYCGYPGFHLDC-SGDAPVIKISEVAYQVLE 59
Query: 97 FFSSQDDRLITVVDTQLIKDLSSGSCESLYNLSVAINSYSIGSLTLPSGNLNLTFFKCPR 156
S LI+ T I + N + + +S S T N+ L ++ CP
Sbjct: 60 IKSMSRVHLISTEYTDNICSIPP------VNSTFDSDRFSYASNT---KNIML-YYGCPT 109
Query: 157 -------RLSLSQNFTDKGVSNVSCNDGHVLYLWRNRTQSGRPSF--DPVSAPSGCD-SV 206
L LS F+ N+S D YL RN + S SF + S C+ SV
Sbjct: 110 IPSQFLPTLGLSYQFS----CNISRTDMVGYYLTRNLSMSATGSFAANISSYLESCNHSV 165
Query: 207 VVP-----VSSVTSLYLGADVFDTLRQGFPLEWPKLDD-CEKCQNRSGRCGYNGSLKKIT 260
++P V S+ S A++ + L +GF L+W D C KC+ G+CGYN K T
Sbjct: 166 LIPAYESAVRSIESHPTAANLTNALHRGFWLQWTANDSLCNKCKFSGGQCGYNTDTSKFT 225
Query: 261 CFCKGGRCDSVKRRKSRLPLIIAGSCCMVLVAVALLVFRK-----RIPSFFKKPFSEERQ 315
C+ + M+ V + +L R+ R+ SF+ RQ
Sbjct: 226 CY-----------------FVTLAMYTMIAVTIIVLCSRRGLSRGRMTSFW-------RQ 261
Query: 316 NIGDGLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAV 375
N LN++ I S Y+Y++IKKMTN F +KLG GG+G VYKG+ PDGR VAV
Sbjct: 262 NAQHNLNIETIIMNSHSLTPKRYTYSEIKKMTNSFVDKLGQGGFGGVYKGELPDGRPVAV 321
Query: 376 KVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSRE 435
KVL+ + + F+NEV +I R HVNI+ LLGFC + + RALIYEYMPNGSL + R+
Sbjct: 322 KVLKNSKGDGEEFVNEVVSISRTSHVNIVTLLGFCFERTKRALIYEYMPNGSLDKFIYRQ 381
Query: 436 KE---NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG 492
+L+ +L EIA+G+ +EYLH GC RI+H DIKP N+LLD DF PK+SDFG
Sbjct: 382 TSLHGKYNLQWEKLYEIAVGIGRGLEYLHRGCNTRIVHFDIKPHNILLDTDFCPKISDFG 441
Query: 493 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLR 552
LAK R S+V+MTG RGT GYIAPE+F +N G S KSDVYSYGM++LEM+ K+++
Sbjct: 442 LAKLCKREESMVSMTGARGTAGYIAPEVFCKNFGGVSYKSDVYSYGMMVLEMVGGKRNID 501
Query: 553 PTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
E S ++E + P+ +Y+ + +E + +KM+ VGLWC+Q NP DRPS
Sbjct: 502 IGE----SQSSEIFLPNCMYESEEVSSLHGVITDETEETIKKMVTVGLWCVQTNPLDRPS 557
Query: 613 MTRVVEMLSSASAEAIEMPPKPLF 636
MT+VVEML S + ++ PPKP
Sbjct: 558 MTKVVEML-EGSLQFLQTPPKPFL 580
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|326494772|dbj|BAJ94505.1| predicted protein [Hordeum vulgare subsp. vulgare] | Back alignment and taxonomy information |
|---|
Score = 385 bits (990), Expect = e-104, Method: Compositional matrix adjust.
Identities = 248/670 (37%), Positives = 350/670 (52%), Gaps = 72/670 (10%)
Query: 33 HSQSQNDTSYEDCSPFKCGNLTFSFPF-----SSSSTSGYCGLPNYQITCDSSSVPKLLL 87
H + + C+P CGN+T +PF ++ TS CG +Q+ C S L
Sbjct: 20 HGTAPASAAVATCAPRACGNVTIQYPFWLTEDGAAQTSPPCGPSAFQVDCRGGSASLALS 79
Query: 88 SGRLYQVRNFFSSQDDRLITVVDTQLIKDLSSGSCESLYNLSVAINSYSIGSLTLPSGNL 147
R Y++ S DR + V + + D ++G ++S S S+ + N
Sbjct: 80 FRRGYKLLRV--SYADRAVVVANDNVQTD-AAGCPVPKIDVSA---SLSLAPFSASPANR 133
Query: 148 NLTF-FKCPRRLSLSQNFTDKGVSNVSCNDGHVLYLWRNRTQSGRPSFDPVSAPSGCDSV 206
L F F C T G NV+C + R + + D + +GCD
Sbjct: 134 QLLFLFNC--------TSTATGFVNVTCPSTAAVV----RLDARYNTTDARAVAAGCDYA 181
Query: 207 VVPVSSVTSLYLGADVF--DTLRQGFPLEW-PKLDDCEKCQNRSGRCGYNGSLKKITCFC 263
VPV+ S GA V LR+G+ L+W DC C G+CGY+ + C C
Sbjct: 182 AVPVAGSLSPGAGAGVEYPRLLREGYLLQWRASAGDCGACGASGGQCGYDSDAEAFACVC 241
Query: 264 KGG-----RCDSVKRRKSRLPLIIAGSCCMVLVAVALLV----FRKRIP--SFFKKPFSE 312
G RCD K+ +++ LI + S + L+ +A LV F ++I SFF
Sbjct: 242 ANGSSRPARCDG-KKSSNKVILIASLSVTIGLILLACLVIALKFHRQIRNLSFFS---VM 297
Query: 313 ERQNIGDGLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDG-- 370
++ + D NV++ +K + S Y Y+++KK+TN FK KLG GGYG V+ G P G
Sbjct: 298 DKTSKADNANVEKLLKKHGSLAPRRYKYSELKKITNNFKHKLGEGGYGAVFLGTLPTGDR 357
Query: 371 RLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGD 430
R VAVK L + ++F+NEV +IGR HVNI+ LLGFC +GS RAL+YE+MPNGSL
Sbjct: 358 RTVAVKFLHHSRPNGEDFLNEVISIGRTSHVNIVTLLGFCLEGSKRALVYEHMPNGSLDR 417
Query: 431 LL---------SREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD 481
+ S E LK L EIA GVA +EYLH GC RI+H D+KP NVLLD
Sbjct: 418 YIYSSPSSKPESPESSTTRLKWETLQEIATGVARGLEYLHEGCNTRIIHFDVKPHNVLLD 477
Query: 482 PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLL 541
F PKV+DFG+AK S+++M RGT+G+IAPE+F R G S KSDVYSYGMLL
Sbjct: 478 EGFRPKVADFGMAKLCDPKESILSMADARGTVGFIAPEVFSRGFGVVSAKSDVYSYGMLL 537
Query: 542 LEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED-------DCIARK 594
LEM+ + +++ + + T+ +FP WIYD L+ ++ ED + IARK
Sbjct: 538 LEMVGGRSNVK---AYAAAKETDMFFPLWIYDHLLGDGGVLVMQGEDGSTGTREEMIARK 594
Query: 595 MIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKPLFPSPPQLQTQNEIISFDSI 654
M +VGLWCIQ P +RPSM++V+EML S + + MPP+P P+ P + S+
Sbjct: 595 MALVGLWCIQTVPANRPSMSKVLEMLER-SIDELAMPPRPYHPTSPS--------NSPSL 645
Query: 655 TSELPLQHDS 664
+ LPL + S
Sbjct: 646 SHSLPLSYPS 655
|
Source: Hordeum vulgare subsp. vulgare Species: Hordeum vulgare Genus: Hordeum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145839451|gb|ABP96804.1| receptor-like protein kinase [Capsicum annuum] | Back alignment and taxonomy information |
|---|
Score = 385 bits (988), Expect = e-104, Method: Compositional matrix adjust.
Identities = 237/623 (38%), Positives = 337/623 (54%), Gaps = 38/623 (6%)
Query: 32 IHSQSQNDTSYEDC-SPFKCGNLT-FSFPFSSSSTSGYCGLPNYQITCDSSSVPKL-LLS 88
+ ++ +ND++ C F CGN T SFPFS S+ CG+ CD PK+ LL
Sbjct: 18 VQAKGRNDST---CPKSFSCGNFTNLSFPFSLSAQPE-CGILRMS-GCDDKPFPKIRLLP 72
Query: 89 GRLYQVRNFFSSQDDRLITVVDTQLIKDLSSGSCESLYNLSVAINSYSIGSLTLPSGNLN 148
GR + + Q D + + D +L L+ C++ NS SI + N+N
Sbjct: 73 GRDWY---YALQQHDSSVWLGDQKLQTTLTQHKCQAFNKNFSLPNSPSISFNMI---NIN 126
Query: 149 LTFFKCPRRLSLSQNFTDKGVSNVSCNDGHVLYLWRNRTQSGRPSFDPVSAPSGCDSVVV 208
F KC + F + N C + Y T+ + + + P+ C + +
Sbjct: 127 -NFIKCSSTQKKNDRFAGYNMYN-GCEGFSIYY---KLTRDDDKNIEAHNLPTNCSLIKL 181
Query: 209 PVSSVTSLYLGADVFDTLRQGFPLEWPKLDDCEKCQNRSGRCGYNGSLKKITCFCKGGRC 268
P+ D+F+ L F +EW DDC +C + GRC + + K C
Sbjct: 182 PIHKND-----GDLFNRLGPEFLVEWKLSDDCSECHHYGGRCQTDKT-NKFYCLKDVAEV 235
Query: 269 DSVKRRKS-RLPLIIAGSCCMVLVAVALLVFRKRIPSFFKKPFSEERQNIGDGLNVKQFI 327
+ S R + A + V + +L+F R + K + D N+++F+
Sbjct: 236 SKLPAGISKRFWFLAATGASLFTVGLLVLLFFFRNKVLWYKYIRLWGSKVEDHRNIEEFL 295
Query: 328 KTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDN 387
K Y S Y+Y DIK++T+ FK KL GG+G VY+G +G VAVKVL + +N
Sbjct: 296 KNYGSYAPKRYNYTDIKRITSRFKNKLVQGGFGTVYRGSLGNGSQVAVKVLNELKGSGEN 355
Query: 388 FINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENL--SLKPAR 445
FINEVA+I R HVN++ L+GFC +G RAL+YE+MPNGSL + E+ + L
Sbjct: 356 FINEVASISRTSHVNVVSLVGFCFEGRKRALVYEFMPNGSLEKFIYEERSDTVRQLGWPT 415
Query: 446 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505
L +IALG+A +EYLH GC RILH DIKP N+LLD DF PK+SDFGLAK +N S+V+
Sbjct: 416 LYKIALGIARGLEYLHRGCTTRILHFDIKPHNILLDEDFCPKISDFGLAKLCMKNESIVS 475
Query: 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEA 565
M G RGTIGYIAPEI RNLG S KSD YSYGM++LEMI +K++ T+E
Sbjct: 476 MLGARGTIGYIAPEIVCRNLGGVSHKSDAYSYGMMVLEMIGGRKNV----DAGADRTSEI 531
Query: 566 YFPDWIYDKLIQPEKEDFV----EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621
YFP W+Y ++ E V EEE++C ARKM+I LWCIQ +P +RPSM++VVEML
Sbjct: 532 YFPHWLYQRIELDEDLQLVGIMNEEENEC-ARKMVIASLWCIQTDPSNRPSMSKVVEML- 589
Query: 622 SASAEAIEMPPKPLFPSPPQLQT 644
+++++PPKP SP +++
Sbjct: 590 EGKLDSLQIPPKPYLYSPSRIEV 612
|
Source: Capsicum annuum Species: Capsicum annuum Genus: Capsicum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 667 | ||||||
| TAIR|locus:2176717 | 638 | AT5G38260 [Arabidopsis thalian | 0.574 | 0.600 | 0.438 | 1e-90 | |
| TAIR|locus:2019713 | 892 | AT1G67000 [Arabidopsis thalian | 0.865 | 0.646 | 0.357 | 1.9e-83 | |
| TAIR|locus:2019688 | 674 | AT1G66930 [Arabidopsis thalian | 0.437 | 0.433 | 0.511 | 1.2e-81 | |
| TAIR|locus:2204480 | 666 | AT1G66910 [Arabidopsis thalian | 0.841 | 0.842 | 0.362 | 1.4e-80 | |
| TAIR|locus:2020583 | 799 | AT1G70250 [Arabidopsis thalian | 0.436 | 0.364 | 0.524 | 2.6e-79 | |
| TAIR|locus:2141862 | 853 | AT4G18250 [Arabidopsis thalian | 0.437 | 0.342 | 0.504 | 6.8e-79 | |
| TAIR|locus:2176697 | 588 | AT5G38240 [Arabidopsis thalian | 0.385 | 0.437 | 0.528 | 2.9e-76 | |
| TAIR|locus:2176737 | 665 | PR5K "PR5-like receptor kinase | 0.437 | 0.439 | 0.501 | 6.3e-76 | |
| TAIR|locus:2177152 | 806 | AT5G39030 [Arabidopsis thalian | 0.467 | 0.387 | 0.484 | 4.5e-75 | |
| TAIR|locus:2177142 | 813 | AT5G39020 [Arabidopsis thalian | 0.436 | 0.357 | 0.498 | 2.2e-73 |
| TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 820 (293.7 bits), Expect = 1.0e-90, Sum P(2) = 1.0e-90
Identities = 178/406 (43%), Positives = 243/406 (59%)
Query: 229 GFPLEWPKLDDCEKCQNRSGRCGYNGSLKKITCFCKGGRCDSVKRRKSRLPLIIAGSCCM 288
GF L + DC C G CG+N S K C+CK + + ++ + I C
Sbjct: 217 GFELGFNS--DCSLCVASKGACGFNQSSKAFVCYCKD---EPHEHTCGKMGIGIGLGCGF 271
Query: 289 XXXXXXXXXFRKRIPSFFKKPFSEERQNIGDGLNVKQFIKTYRSALLSNYSYNDIKKMTN 348
+ FF+K + D N+K ++ L YSY +++K+T
Sbjct: 272 LGATLITVCL---LCFFFQKRRTSHHLRPRDN-NLKGLVQ------LKQYSYAEVRKITK 321
Query: 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
F LG GG+G VY G DGR VAVK+L+ + ++FINEVA++ + HVNI+ LLG
Sbjct: 322 LFSHTLGKGGFGTVYGGNLCDGRKVAVKILKDFKSNGEDFINEVASMSQTSHVNIVSLLG 381
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
FC +GS RA++YE++ NGSL LS EK++L+L + L IALGVA ++YLH+GC+ RI
Sbjct: 382 FCYEGSKRAIVYEFLENGSLDQFLS-EKKSLNLDVSTLYRIALGVARGLDYLHHGCKTRI 440
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
+H DIKPQN+LLD F PKVSDFGLAK + S++++ RGTIGYIAPE+F G
Sbjct: 441 VHFDIKPQNILLDDTFCPKVSDFGLAKLCEKRESILSLLDARGTIGYIAPEVFSGMYGRV 500
Query: 529 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE----DFV 584
S KSDVYSYGML+LEMI K + E T+ SN++ AYFPDWIY L E D +
Sbjct: 501 SHKSDVYSYGMLVLEMIGAKN--KEIEETAASNSSSAYFPDWIYKNLENGEDTWKFGDEI 558
Query: 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEM 630
ED +A+KM +VGLWCIQ +P +RP M R+VEM+ S + +E+
Sbjct: 559 SREDKEVAKKMTLVGLWCIQPSPLNRPPMNRIVEMMEG-SLDVLEV 603
|
|
| TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 836 (299.3 bits), Expect = 1.9e-83, P = 1.9e-83
Identities = 223/624 (35%), Positives = 325/624 (52%)
Query: 35 QSQNDTSYEDCSP-FKCGNLXXXXXXXXXXXXGYCGLPNYQITCDSSSVPKLLLSGRLYQ 93
Q D Y CS F CG+ CG PN+++ C S ++ ++ ++
Sbjct: 244 QHSADEVYRRCSESFSCGSQRDLNYPLWKPGREECGHPNFKLNC-SGGFAEINIASVKFR 302
Query: 94 VRNFFSSQDDRLITVVDTQLIKDLSSGSCESLYNLSVAINSY-SIGSLTLPSGNLNLTFF 152
+ + + S LI + + I DL C + + I + + LT + L L ++
Sbjct: 303 ILDSYRS----LIRLARSDYIGDL----CPANPLTAPFIEKFLPVLELTGETELLTL-YY 353
Query: 153 KCPRRLSLSQNFTDKGVSNVSCNDGHVLYLWRNRTQSGRPSFDPV--SAPSGCDXXXXXX 210
C R + S + V + C++G Y+ RN + S V + C
Sbjct: 354 GC--RFNSSDIPANIYVGELGCDEGRSYYVTRNLSSPLLDSSRGVLNNLREMCKRNVSVP 411
Query: 211 XXXXXLY-LGADVF-DTLRQGFPLEWPKL--DDCEKCQNRSGRCGYNGSLKKITCFCKGG 266
L+ L D L+ + L DCE+C+ G CGYN + C+CK G
Sbjct: 412 ASGPALFDLQTRPNQDNLKMALDQGFRMLITSDCERCRGSGGACGYNQTSSGFGCYCKDG 471
Query: 267 RC-----DSVKRRKSRL--PLIIAGSCCMXXXXXXXXXFRKRIPSFFKKPFSEERQNIGD 319
+C D RR R L+ + F + F+ +R+ D
Sbjct: 472 KCGYEYDDGFFRRHRRFIATLVRYTFIALGALTGVVIVFLVLLCPCFRVQIFRKRKT-SD 530
Query: 320 GLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLE 379
+ +++ +K L +Y+Y ++KKMT F E +G GG+G VY G D +VAVKVL+
Sbjct: 531 EVRLQK-LKALIP--LKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLK 587
Query: 380 KTSNFS-DNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKEN 438
+ ++FINEVA++ + HVNI+ LLGFCC+GS RA+IYE++ NGSL +S +K +
Sbjct: 588 DSKGTDGEDFINEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFIS-DKSS 646
Query: 439 LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498
++L L IALGVA +EYLH GC+ RI+H DIKPQNVLLD + PKVSDFGLAK
Sbjct: 647 VNLDLKTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCE 706
Query: 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS 558
+ S++++ RGTIGYIAPE+ R G+ S KSDVYSYGML+LEMI +K R + S
Sbjct: 707 KKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKER-FDQNS 765
Query: 559 GSNTTEAYFPDWIYDKLIQP-----EK-------EDFVEEEDDCIARKMIIVGLWCIQIN 606
S+ + YFP+WIY L + EK E+ + E++ IARKM +VGLWCIQ +
Sbjct: 766 RSDGSSIYFPEWIYKDLEKANIKDIEKTENGGLIENGISSEEEEIARKMTLVGLWCIQSS 825
Query: 607 PKDRPSMTRVVEMLSSASAEAIEM 630
P DRP M +VVEM+ S +A+E+
Sbjct: 826 PSDRPPMNKVVEMMEG-SLDALEV 848
|
|
| TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 756 (271.2 bits), Expect = 1.2e-81, Sum P(2) = 1.2e-81
Identities = 155/303 (51%), Positives = 208/303 (68%)
Query: 335 LSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVL-EKTSNFSDNFINEVA 393
L +Y+Y +K+MT F E +G GG+G VY+G DGR+VAVKVL E N S++FINEV+
Sbjct: 333 LKHYTYAQVKRMTKSFAEVVGRGGFGIVYRGTLCDGRMVAVKVLKESKGNNSEDFINEVS 392
Query: 394 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGV 453
++ + HVNI+ LLGFC +GS RA+IYE++ NGSL +S EK ++ L L IALGV
Sbjct: 393 SMSQTSHVNIVSLLGFCSEGSRRAIIYEFLENGSLDKFIS-EKTSVILDLTALYGIALGV 451
Query: 454 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 513
A +EYLH GC+ RI+H DIKPQNVLLD + +PKVSDFGLAK + SV+++ RGTI
Sbjct: 452 ARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMSLMDTRGTI 511
Query: 514 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573
GYIAPE+ R G+ S KSDVYSYGML+ EMI +K R + ++ N + YFP+WIY
Sbjct: 512 GYIAPEMISRVYGSVSHKSDVYSYGMLVFEMIGARKKERFGQNSA--NGSSMYFPEWIYK 569
Query: 574 KLIQPEKEDF------VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEA 627
L + + D + E++ IA+KM +VGLWCIQ +P DRP M +VVEM+ S +A
Sbjct: 570 DLEKADNGDLEHIEIGISSEEEEIAKKMTLVGLWCIQSSPSDRPPMNKVVEMMEG-SLDA 628
Query: 628 IEM 630
+E+
Sbjct: 629 LEV 631
|
|
| TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 809 (289.8 bits), Expect = 1.4e-80, P = 1.4e-80
Identities = 224/618 (36%), Positives = 313/618 (50%)
Query: 45 CSP-FKCGNLXXXXXXXXXXXXGYCGLPNYQITCDSSSVPKLLLSGRLYQVRNFFSSQDD 103
CSP F CGN CG P++++ C++ VP+L +S +++ + D
Sbjct: 38 CSPSFTCGNQRGLLYPFWIAGRKECGHPDFELDCNAG-VPELSISSVKFRILG--ADYDS 94
Query: 104 RLITVVDTQLIKDLSSGSCESLYNLSVAINSYSIGSLTLPSGNLNLT-FFKCPRRLSLSQ 162
+IT+ + I D C L N S++ L L S LT ++ C R +S
Sbjct: 95 GIITLARSDNIDD----PC--LPNSFTT--SFNETVLPLASTTDLLTIYYDCNRNVS--- 143
Query: 163 NFTDKGVSNVSC-NDG----HVLYLWRNRT------QSGRPSFDPVSAPSGCDXXXXXXX 211
+F V + C +DG YL RN T + SF C
Sbjct: 144 SFVSTFVKELDCPDDGTDDRRNYYLTRNLTFLPPSLKLEGNSFLLNDFGGSCSRNVSNPA 203
Query: 212 XXXXLYLGADVFDT------LRQGFPLEWPKLDDCEKCQNRSGRCGYNGSLKKITCFCKG 265
L T L GF LE DC C + G CG++ + + C+ +
Sbjct: 204 SRTALNTLESTPSTDNLKIALEDGFALEVNS--DCRTCIDSKGACGFSQTSSRFVCYYRQ 261
Query: 266 GRCDSVKRRKSRLPLII---------AGSCCMXXXXXXXXXFRKRIPSFFKKPFSEERQN 316
+ R K L L A S M I +K ++ R
Sbjct: 262 -EPQNPTRNKVILKLFFIVIYVLGIGAASFAMMGVILVVTCLNCLIRRQ-RKTLNDPRMR 319
Query: 317 IGDGLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVK 376
D +Q +K L +YSY + +T F E +G GG+G VY+G DGR VAVK
Sbjct: 320 TSDDSR-QQNLKALIP--LKHYSYAQVTSITKSFAEVIGKGGFGTVYRGTLYDGRSVAVK 376
Query: 377 VLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREK 436
VL+++ ++FINEVA++ + HVNI+ LLGFC +G RA+IYE+M NGSL +S +K
Sbjct: 377 VLKESQGNGEDFINEVASMSQTSHVNIVTLLGFCSEGYKRAIIYEFMENGSLDKFISSKK 436
Query: 437 ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496
+ ++ L IALGVA +EYLH+GC RI+H DIKPQNVLLD + +PKVSDFGLAK
Sbjct: 437 SS-TMDWRELYGIALGVARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKL 495
Query: 497 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTET 556
R S++++ RGTIGYIAPE+F R G S KSDVYSYGML+L++I + +T
Sbjct: 496 CERKESILSLMDTRGTIGYIAPEVFSRVYGRVSHKSDVYSYGMLVLDIIGARNKTSTEDT 555
Query: 557 TSGSNTTEAYFPDWIYDKLIQPEK----EDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
TS +T+ YFP+WIY L + E + E+D IA+KM +VGLWCIQ P DRP+
Sbjct: 556 TS--STSSMYFPEWIYRDLEKAHNGKSIETAISNEEDEIAKKMTLVGLWCIQPWPLDRPA 613
Query: 613 MTRVVEMLSSASAEAIEM 630
M RVVEM+ + +A+E+
Sbjct: 614 MNRVVEMMEG-NLDALEV 630
|
|
| TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 797 (285.6 bits), Expect = 2.6e-79, P = 2.6e-79
Identities = 160/305 (52%), Positives = 211/305 (69%)
Query: 334 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDG-RLVAVKVLEKTSNFSDNFINEV 392
+L +SY +KKMT F+ LG GG+G VYKGK PDG R VAVK+L++++ ++FINE+
Sbjct: 445 MLKRFSYVQVKKMTKSFENVLGKGGFGTVYKGKLPDGSRDVAVKILKESNEDGEDFINEI 504
Query: 393 ATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPA--RLLEIA 450
A++ R H NI+ LLGFC +G +A+IYE MPNGSL +S+ N+S K L IA
Sbjct: 505 ASMSRTSHANIVSLLGFCYEGRKKAIIYELMPNGSLDKFISK---NMSAKMEWKTLYNIA 561
Query: 451 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR 510
+GV+H +EYLH+ C RI+H DIKPQN+L+D D PK+SDFGLAK N S+++M R
Sbjct: 562 VGVSHGLEYLHSHCVSRIVHFDIKPQNILIDGDLCPKISDFGLAKLCKNNESIISMLHAR 621
Query: 511 GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW 570
GTIGYIAPE+F +N G S KSDVYSYGM++LEMI + R +GS+ T YFPDW
Sbjct: 622 GTIGYIAPEVFSQNFGGVSHKSDVYSYGMVVLEMIGARNIGRAQN--AGSSNTSMYFPDW 679
Query: 571 IYDKLIQPEKEDFV-----EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625
IY L + E F+ EEED+ I +KM++VGLWCIQ NP DRP M++VVEML S
Sbjct: 680 IYKDLEKGEIMSFLADQITEEEDEKIVKKMVLVGLWCIQTNPYDRPPMSKVVEMLEG-SL 738
Query: 626 EAIEM 630
EA+++
Sbjct: 739 EALQI 743
|
|
| TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 793 (284.2 bits), Expect = 6.8e-79, P = 6.8e-79
Identities = 155/307 (50%), Positives = 209/307 (68%)
Query: 334 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPD--GRLVAVKVLEKTSNFSDNFINE 391
+L YS+ +KKMTN F +G GG+G VYKGK PD GR +A+K+L+++ + FINE
Sbjct: 505 MLKRYSFEKVKKMTNSFDHVIGKGGFGTVYKGKLPDASGRDIALKILKESKGNGEEFINE 564
Query: 392 VATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPA--RLLEI 449
+ ++ R HVNI+ L GFC +GS RA+IYE+MPNGSL +S EN+S K L I
Sbjct: 565 LVSMSRASHVNIVSLFGFCYEGSQRAIIYEFMPNGSLDKFIS---ENMSTKIEWKTLYNI 621
Query: 450 ALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 509
A+GVA +EYLHN C +I+H DIKPQN+L+D D PK+SDFGLAK + S+++M
Sbjct: 622 AVGVARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPKISDFGLAKLCKKKESIISMLDA 681
Query: 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPD 569
RGT+GYIAPE+F +N G S KSDVYSYGM++LEMI K R TS ++ + YFPD
Sbjct: 682 RGTVGYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIGATK--REEVETSATDKSSMYFPD 739
Query: 570 WIYDKLIQPEK----EDFV--EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623
W+Y+ L + E ED + EEE++ I ++M +VGLWCIQ NP DRP M +VVEML +
Sbjct: 740 WVYEDLERKETMRLLEDHIIEEEEEEKIVKRMTLVGLWCIQTNPSDRPPMRKVVEMLEGS 799
Query: 624 SAEAIEM 630
EA+++
Sbjct: 800 RLEALQV 806
|
|
| TAIR|locus:2176697 AT5G38240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 694 (249.4 bits), Expect = 2.9e-76, Sum P(2) = 2.9e-76
Identities = 147/278 (52%), Positives = 189/278 (67%)
Query: 351 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFC 410
+E +G GG+G VYKG DGR VAVK+L+ ++ ++FINEVA+I + HVNI+ LLGFC
Sbjct: 284 QEVVGRGGFGTVYKGNLRDGRKVAVKILKDSNGNCEDFINEVASISQTSHVNIVSLLGFC 343
Query: 411 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 470
+ S RA++YE++ NGSL + NL + + L IALGVA IEYLH GC+ RI+H
Sbjct: 344 FEKSKRAIVYEFLENGSLD-----QSSNLDV--STLYGIALGVARGIEYLHFGCKKRIVH 396
Query: 471 LDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSG 530
DIKPQNVLLD + PKV+DFGLAK + S++++ RGTIGYIAPE+F R GN S
Sbjct: 397 FDIKPQNVLLDENLKPKVADFGLAKLCEKQESILSLLDTRGTIGYIAPELFSRVYGNVSH 456
Query: 531 KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE----- 585
KSDVYSYGML+LEM + R + SN + AYFPDWI+ L E D+V+
Sbjct: 457 KSDVYSYGMLVLEMTGARNKERVQN--ADSNNSSAYFPDWIFKDL---ENGDYVKLLADG 511
Query: 586 ---EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
EE+D IA+KMI+VGLWCIQ P DRPSM +VV M+
Sbjct: 512 LTREEED-IAKKMILVGLWCIQFRPSDRPSMNKVVGMM 548
|
|
| TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 765 (274.4 bits), Expect = 6.3e-76, P = 6.3e-76
Identities = 153/305 (50%), Positives = 207/305 (67%)
Query: 333 ALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINE 391
A+L YSY +KKMTN F LG GG+G VYKGK D GR VAVK+L+ + + FINE
Sbjct: 316 AMLKRYSYTRVKKMTNSFAHVLGKGGFGTVYKGKLADSGRDVAVKILKVSEGNGEEFINE 375
Query: 392 VATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPA--RLLEI 449
VA++ R HVNI+ LLGFC + + RA+IYE+MPNGSL +S N+S K RL ++
Sbjct: 376 VASMSRTSHVNIVSLLGFCYEKNKRAIIYEFMPNGSLDKYISA---NMSTKMEWERLYDV 432
Query: 450 ALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 509
A+G++ +EYLHN C RI+H DIKPQN+L+D + PK+SDFGLAK S+++M
Sbjct: 433 AVGISRGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKISDFGLAKLCKNKESIISMLHM 492
Query: 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPD 569
RGT GYIAPE+F +N G S KSDVYSYGM++LEMI K ++ E SGSN YFP+
Sbjct: 493 RGTFGYIAPEMFSKNFGAVSHKSDVYSYGMVVLEMIGAK-NIEKVEY-SGSNNGSMYFPE 550
Query: 570 WIYDKLIQPEKE----DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625
W+Y + E D + +E++ IA+K+++V LWCIQ+NP DRP M +V+EML +
Sbjct: 551 WVYKDFEKGEITRIFGDSITDEEEKIAKKLVLVALWCIQMNPSDRPPMIKVIEMLEG-NL 609
Query: 626 EAIEM 630
EA+++
Sbjct: 610 EALQV 614
|
|
| TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 757 (271.5 bits), Expect = 4.5e-75, P = 4.5e-75
Identities = 156/322 (48%), Positives = 215/322 (66%)
Query: 334 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVA 393
LL+ Y+Y ++KK+T F +G GG+G VY G +GR VAVKVL+ +++FINEVA
Sbjct: 484 LLNMYTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVA 543
Query: 394 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGV 453
++ + HVNI+ LLGFC +GS RA++YE++ NGSL +SR K +L+ L IALG+
Sbjct: 544 SMSQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNK-SLTQDVTTLYGIALGI 602
Query: 454 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 513
A +EYLH GC+ RI+H DIKPQN+LLD + PKVSDFGLAK + SV+++ RGTI
Sbjct: 603 ARGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTI 662
Query: 514 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK-KHLRPTETTSGSNTTEAYFPDWIY 572
GYIAPE+F R G S KSDVYS+GML+++MI + K + T ++ S+T YFPDWIY
Sbjct: 663 GYIAPEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASST---YFPDWIY 719
Query: 573 DKLIQPEKE----DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAI 628
L E+ D + +E+ IA+KMI+VGLWCIQ P DRPSM RVVEM+ S +A+
Sbjct: 720 KDLEDGEQTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEG-SLDAL 778
Query: 629 EMXXXXXXXXXXQLQTQNEIIS 650
E+ ++ T++ +S
Sbjct: 779 EIPPKPSMHISTEVITESSSLS 800
|
|
| TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 741 (265.9 bits), Expect = 2.2e-73, P = 2.2e-73
Identities = 150/301 (49%), Positives = 203/301 (67%)
Query: 334 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVA 393
LL Y Y ++KK+T F +G GG+G VY+G +GR VAVKVL+ D+FINEV
Sbjct: 482 LLKQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVT 541
Query: 394 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGV 453
++ + HVNI+ LLGFC +GS RA+I E++ +GSL +SR K +L+ L IALG+
Sbjct: 542 SMSQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFISRNK-SLTPNVTTLYGIALGI 600
Query: 454 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 513
A +EYLH GC+ RI+H DIKPQN+LLD +F PKV+DFGLAK + S++++ RGTI
Sbjct: 601 ARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGTI 660
Query: 514 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573
GYIAPE+ R G S KSDVYSYGML+L+MI + + ETT+ + +T AYFPDWIY
Sbjct: 661 GYIAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKV---ETTTCNGST-AYFPDWIYK 716
Query: 574 KLIQPEKE----DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIE 629
L ++ D + EED+ I +KMI+V LWCI+ P DRP M +VVEM+ S +A+E
Sbjct: 717 DLENGDQTWIIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEG-SLDALE 775
Query: 630 M 630
+
Sbjct: 776 L 776
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 667 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-28 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-26 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-20 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-12 | |
| pfam14380 | 94 | pfam14380, WAK_assoc, Wall-associated receptor kin | 2e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 7e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| pfam13947 | 106 | pfam13947, GUB_WAK_bind, Wall-associated receptor | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 2e-51
Identities = 87/273 (31%), Positives = 135/273 (49%), Gaps = 23/273 (8%)
Query: 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFI---NEVATIGRIHHVNIIH 405
KLG+G +G VYK K G++VAVK+L+K S S E+ + R+ H NI+
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
L+ D L+ EY G L D LSR LS A+ IAL + +EYLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKK--IALQILRGLEYLH---S 116
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
I+H D+KP+N+LLD + K++DFGLAK ++ S +T GT Y+APE+ +
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS--LTTFVGTPWYMAPEVLLGGN 174
Query: 526 GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585
G K DV+S G++L E++ SG N + + +++ P E F E
Sbjct: 175 GYGP-KVDVWSLGVILYELLT--GKPPF----SGENILDQLQ---LIRRILGPPLE-FDE 223
Query: 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ + + + C+ +P RP+ +++
Sbjct: 224 PKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-48
Identities = 79/271 (29%), Positives = 127/271 (46%), Gaps = 60/271 (22%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIHLLGFC 410
LG GG+G VY + G+ VA+K++ E +S+ + + E+ + +++H NI+ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 411 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 470
D + L+ EY GSL DLL + LS +L I L + +EYLH I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSED--EILRILLQILEGLEYLH---SNGIIH 115
Query: 471 LDIKPQNVLLD-PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 529
D+KP+N+LLD + K++DFGL+K + ++S + GT Y+APE+ G S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVL-LGKGYYS 172
Query: 530 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589
KSD++S G++L E+ + D LI+
Sbjct: 173 EKSDIWSLGVILYEL------------------------PELKD-LIR------------ 195
Query: 590 CIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
+Q +P+ RPS ++E L
Sbjct: 196 -----------KMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-47
Identities = 79/282 (28%), Positives = 125/282 (44%), Gaps = 38/282 (13%)
Query: 350 FKEKLGTGGYGNVYKGK-----FPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVN 402
+KLG G +G VYKGK VAVK L++ ++ F+ E + ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
++ LLG C + ++ EYM G L L + + LSL LL AL +A +EYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLS--DLLSFALQIARGMEYLE- 119
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
+H D+ +N L+ + K+SDFGL++ + G + I ++APE
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGKLPIRWMAPESLK 176
Query: 523 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW----IYDKLIQP 578
KSDV+S+G+LL E+ T G E +P + + L
Sbjct: 177 EGKFTS--KSDVWSFGVLLWEIF-----------TLG----EQPYPGMSNEEVLEYLKNG 219
Query: 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
+ + M L C +P+DRP+ + +VE+L
Sbjct: 220 YRLPQPPNCPPELYDLM----LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 3e-47
Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 37/282 (13%)
Query: 350 FKEKLGTGGYGNVYKGK-----FPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVN 402
+KLG G +G VYKG VAVK L++ ++ F+ E + ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
I+ LLG C + ++ EYMP G L D L R+ L + LL AL +A +EYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLE- 120
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
+H D+ +N L+ + K+SDFGL++ + + G + I ++APE
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPESLK 177
Query: 523 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW----IYDKLIQP 578
KSDV+S+G+LL E+ T G E +P + + L +
Sbjct: 178 EGKFTS--KSDVWSFGVLLWEIF-----------TLG----EEPYPGMSNAEVLEYLKKG 220
Query: 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
+ + + M L C +P+DRP+ + +VE+L
Sbjct: 221 YRLPKPPNCPPELYKLM----LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 4e-47
Identities = 75/266 (28%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKT--SNFSDNFINEVATIGRIHHVNIIHL 406
EKLG G +G VY + G+LVA+KV++K + + E+ + ++ H NI+ L
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
D L+ EY G L DLL + L + A+EYLH
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRG---RLSEDEARFYLRQILSALEYLH---SK 116
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
I+H D+KP+N+LLD D K++DFGLA+ +T GT Y+APE+ +
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGK-- 171
Query: 527 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586
D++S G++L E++ K P G + F K P E +
Sbjct: 172 GYGKAVDIWSLGVILYELL-TGKPPFP-----GDDQLLELFKKIGKPKPPFPPPEWDISP 225
Query: 587 EDDCIARKMIIVGLWCIQINPKDRPS 612
E A+ +I + +P+ R +
Sbjct: 226 E----AKDLI---RKLLVKDPEKRLT 244
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 3e-42
Identities = 84/287 (29%), Positives = 133/287 (46%), Gaps = 47/287 (16%)
Query: 350 FKEKLGTGGYGNVYKG-----KFPDGRLVAVKVLEK--TSNFSDNFINEVATIGRIHHVN 402
+KLG G +G VYKG VAVK L++ + + F+ E + + ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
I+ LLG C G ++ EYMP G L D L + E L+LK LL++AL +A +EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLK--DLLQMALQIAKGMEYLE- 119
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
+H D+ +N L+ + K+SDFGL++ + G + I ++APE
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 523 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582
+ KSDV+S+G+LL E+ T P Y + E +
Sbjct: 178 DGKF--TSKSDVWSFGVLLWEIF-----------------TLGEQP---YPGMSNEEVLE 215
Query: 583 FVEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEML 620
+E+ ++C + M L C +P+DRP+ + +VE L
Sbjct: 216 LLEDGYRLPRPENCPDELYELM----LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 6e-41
Identities = 81/284 (28%), Positives = 135/284 (47%), Gaps = 38/284 (13%)
Query: 352 EKLGTGGYGNVYKGKFPDG----RLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNIIH 405
+KLG G +G VYKGK VAVK L++ ++ + +F+ E + ++ H N++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENL------SLKPARLLEIALGVAHAIEY 459
LLG C + L+ EYM G L D L + + +L LL A+ +A +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 519
L + +H D+ +N L+ D K+SDFGL++ + TG + I ++APE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 520 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI--- 576
+ KSDV+S+G+LL E+ T G+ + + + L
Sbjct: 178 SLKDGIFTS--KSDVWSFGVLLWEIF-----------TLGATPYPGLSNEEVLEYLRKGY 224
Query: 577 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
+ K ++ +E + M L C Q++P+DRP+ + +VE L
Sbjct: 225 RLPKPEYCPDE---LYELM----LSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 74/277 (26%), Positives = 117/277 (42%), Gaps = 48/277 (17%)
Query: 352 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDN---FINEVATIGRIHHVNIIHLL 407
E LG G +G+VY D G L+AVK +E + + + E+ + + H NI+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 408 GFCCDGSTRAL-IY-EYMPNGSLGDLLSREK---ENLSLKPAR-LLEIALGVAHAIEYLH 461
G D L I+ EY+ GSL LL + E + K R +LE + YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE-------GLAYLH 118
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 521
I+H DIK N+L+D D K++DFG AK + RGT ++APE+
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 522 MRNLGNPSGKSDVYSYGMLLLEMI------EEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575
+D++S G ++EM E + GS+ P+ + ++
Sbjct: 176 RG--EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEA 233
Query: 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
DF+ + C++ +PK RP+
Sbjct: 234 K-----DFLRK---------------CLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 2e-35
Identities = 87/318 (27%), Positives = 135/318 (42%), Gaps = 20/318 (6%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEK----TSNFSDNFINEVATIGRI-HHVNII 404
KLG G +G VY + D +LVA+KVL K S + F+ E+ + + H NI+
Sbjct: 4 ILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
L F D + L+ EY+ GSL DLL + L + L I + A+EYLH
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH--- 118
Query: 465 ELRILHLDIKPQNVLLDPD-FTPKVSDFGLAK----AHSRNRSVVTMTGPRGTIGYIAPE 519
I+H DIKP+N+LLD D K+ DFGLAK S + + GT GY+APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 520 IFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578
+ + +L S SD++S G+ L E++ + +S ++ T + L P
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKPLFPS 638
E + ++ + +PK+R S + + A + E L
Sbjct: 239 LSPSNPELISKAASD--LLKK--LLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKP 294
Query: 639 PPQLQTQNEIISFDSITS 656
+ +
Sbjct: 295 DDSAPLRLSLPPSLEALI 312
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 78/272 (28%), Positives = 128/272 (47%), Gaps = 42/272 (15%)
Query: 351 KEKLGTGGYGNVYKGKF-PDGRLVAVKVL-EKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
EK+G GG+G VYK + G+ VA+KV+ ++ + INE+ + + H NI+ G
Sbjct: 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
++ E+ GSL DLL + N +L +++ + + +EYLH+ I
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS---NGI 119
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
+H DIK N+LL D K+ DFGL+ S ++ TM GT ++APE+ N
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVI--NGKPY 174
Query: 529 SGKSDVYSYGMLLLEMIEEK---KHLRPTET-----TSGSNTTEAYFPDWIYDKLIQPEK 580
K+D++S G+ +E+ E K L P + T+G P + E
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG-------PPGLRNPEKWSDEF 227
Query: 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
+DF+++ C+Q NP+ RP+
Sbjct: 228 KDFLKK---------------CLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 69/196 (35%), Positives = 102/196 (52%), Gaps = 14/196 (7%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
+G G +G+V G + G+ VAVK L+ S + F+ E + + + H N++ LLG
Sbjct: 10 LGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 410 CCDGSTRALIYEYMPNGSLGDLL-SREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
G+ ++ EYM GSL D L SR + ++L A+ L AL V +EYL E
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITL--AQQLGFALDVCEGMEYLE---EKNF 123
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
+H D+ +NVL+ D KVSDFGLAK S+ + + + APE
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-----QDSGKLPVKWTAPEAL--REKKF 176
Query: 529 SGKSDVYSYGMLLLEM 544
S KSDV+S+G+LL E+
Sbjct: 177 STKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 8e-30
Identities = 77/283 (27%), Positives = 129/283 (45%), Gaps = 38/283 (13%)
Query: 350 FKEKLGTGGYGNVYKGK--FPD---GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVN 402
F ++LG G +G V + G VAVK L + +F E+ + + H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 403 IIHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 460
I+ G C R+ LI EY+P+GSL D L R ++ ++LK RLL + + ++YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--RLLLFSSQICKGMDYL 125
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPE 519
+ R +H D+ +N+L++ + K+SDFGLAK ++ + P + I + APE
Sbjct: 126 GS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 520 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579
+ S SDV+S+G+ L E+ + P+++ F I Q
Sbjct: 183 CLRTS--KFSSASDVWSFGVTLYELF---TYGDPSQSPPAE------FLRMIGIAQGQMI 231
Query: 580 KEDFVE--EEDDCIARK--------MIIVGLWCIQINPKDRPS 612
+E +E + + R ++ W + P+DRPS
Sbjct: 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCW--EAEPQDRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 5e-29
Identities = 78/278 (28%), Positives = 130/278 (46%), Gaps = 23/278 (8%)
Query: 343 IKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN 402
I F ++LG+G +G V+ GK+ VA+K++ + + D+FI E + ++ H N
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPN 60
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
++ L G C ++ EYM NG L + L K L LL++ V A+EYL +
Sbjct: 61 LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLES 118
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
+H D+ +N L+ D KVSDFGLA+ + + + G + + + PE+F
Sbjct: 119 NG---FIHRDLAARNCLVGEDNVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFD 174
Query: 523 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582
+ S KSDV+S+G+L+ E+ E K P E S S E+ + + E
Sbjct: 175 YS--RFSSKSDVWSFGVLMWEVFSEGK--MPYERFSNSEVVESVSAGYRLYRPKLAPTEV 230
Query: 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
+ I+ C P+DRP+ +++ L
Sbjct: 231 YT------------IMYS-CWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 5e-28
Identities = 72/273 (26%), Positives = 136/273 (49%), Gaps = 25/273 (9%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
+++G+G +G V+ G + + R VA+K + + + ++FI E + ++ H ++ L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
C + S L++E+M +G L D L ++ S + LL + L V + YL + ++
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQET--LLGMCLDVCEGMAYLESSN---VI 122
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 529
H D+ +N L+ + KVSDFG+ + + + TG + + + +PE+F + S
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVF--SFSKYS 179
Query: 530 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589
KSDV+S+G+L+ E+ E K P E S S E + +L +P
Sbjct: 180 SKSDVWSFGVLMWEVFSEGK--TPYENRSNSEVVETINAGF---RLYKPR---------- 224
Query: 590 CIARKMII-VGLWCIQINPKDRPSMTRVVEMLS 621
+A + + + C + P+DRPS + ++ L+
Sbjct: 225 -LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 75/285 (26%), Positives = 117/285 (41%), Gaps = 51/285 (17%)
Query: 353 KLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNF------INEVATIGRIHHVNIIH 405
LG G G VYK + P G++ A+K + + + + E+ T+ ++
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKI----HVDGDEEFRKQLLRELKTLRSCESPYVVK 63
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
G +++ EYM GSL DLL K+ + L IA + ++YLH +
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHT--K 118
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
I+H DIKP N+L++ K++DFG++K N T GT+ Y++PE R
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISK-VLENTLDQCNTF-VGTVTYMSPE---RIQ 173
Query: 526 GNPSG-KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI-------YDKLIQ 577
G +D++S G+ LLE K P P +
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----------PSFFELMQAICDGPPPS 222
Query: 578 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
E+F E D I+ C+Q +PK RPS E+L
Sbjct: 223 LPAEEFSPEFRDFISA--------CLQKDPKKRPS---AAELLQH 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 85/270 (31%), Positives = 127/270 (47%), Gaps = 29/270 (10%)
Query: 351 KEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
K KLG G YG VY+G + VAVK L++ + + F+ E A + I H N++ LLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
C +I E+M G+L D L RE + LL +A ++ A+EYL +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT---IGYIAPEIFMRNLG 526
H D+ +N L+ + KV+DFGL++ + + T T G I + APE N
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYN-- 180
Query: 527 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586
S KSDV+++G+LL E+ T G + +Y+ L EK +E
Sbjct: 181 KFSIKSDVWAFGVLLWEI-----------ATYGMSPYPGIDLSQVYELL---EKGYRMER 226
Query: 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRV 616
+ C K+ + C Q NP DRPS +
Sbjct: 227 PEGC-PPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 85/275 (30%), Positives = 126/275 (45%), Gaps = 30/275 (10%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNIIHLLGFC 410
KLG+G +G V++G + + VA+K+L+ +F EV + R+ H ++I L C
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 411 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 470
G +I E M GSL L R E L A L+++A VA + YL E +H
Sbjct: 72 SVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIH 127
Query: 471 LDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSG 530
D+ +N+L+ D KV+DFGLA+ V + + + APE + G S
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAA--SHGTFST 183
Query: 531 KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD--KLIQPEKEDFVEEED 588
KSDV+S+G+LL EM + P G N E Y D I ++ P K
Sbjct: 184 KSDVWSFGILLYEMFTYGQVPYP-----GMNNHEVY--DQITAGYRMPCPAK-------- 228
Query: 589 DCIAR-KMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
C I++ W P+DRPS + E L +
Sbjct: 229 -CPQEIYKIMLECWA--AEPEDRPSFKALREELDN 260
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 82/286 (28%), Positives = 125/286 (43%), Gaps = 51/286 (17%)
Query: 350 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
EK+G G G VYK G+ VA+K + + INE+ + H NI+
Sbjct: 23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD 82
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
G ++ EYM GSL D++ + + + ++ + V +EYLH+ +
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDII--TQNFVRMNEPQIAYVCREVLQGLEYLHS---QNV 137
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLA----KAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
+H DIK N+LL D + K++DFG A K S+ SVV GT ++APE+ R
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV------GTPYWMAPEVIKRK 191
Query: 525 LGNPSGKSDVYSYGMLLLEMIE-EKKHLR--PTE-----TTSGSNTTEAYFPDWIYDKLI 576
P K D++S G++ +EM E E +LR P TT G P +
Sbjct: 192 DYGP--KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-------PPLKNPEKW 242
Query: 577 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
PE +DF+ C+ +P+ RPS E+L
Sbjct: 243 SPEFKDFLN---------------KCLVKDPEKRPS---AEELLQH 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 84/281 (29%), Positives = 127/281 (45%), Gaps = 34/281 (12%)
Query: 352 EKLGTGGYGNVYKGKF--PDGRL--VAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIH 405
+KLG G +G V +G++ G++ VAVK L +K S+ D+F+ E A + + H N+I
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
L G ++ E P GSL D L ++ L L + A+ +A+ + YL +
Sbjct: 61 LYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLIS-TLCDYAVQIANGMRYLESK-- 116
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPEIFMRN 524
R +H D+ +N+LL D K+ DFGL +A +N M + APE
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL--R 173
Query: 525 LGNPSGKSDVYSYGMLLLEMI---EEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581
S SDV+ +G+ L EM EE P SGS + D ++L +PE
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEE-----PWAGLSGSQILKKI--DKEGERLERPE-- 224
Query: 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
C + + V L C NP DRP+ + E L
Sbjct: 225 -------AC-PQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 78/280 (27%), Positives = 133/280 (47%), Gaps = 36/280 (12%)
Query: 352 EKLGTGGYGNVYKG--KFPDGR--LVAVKVLEKTSNFSD--NFINEVATIGRIHHVNIIH 405
+ +G G +G V +G K P + VA+K L+ S+ +F+ E + +G+ H NII
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
L G +I EYM NGSL L RE + +L+ + G+A ++YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFL-RENDG-KFTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE-IFMRN 524
+H D+ +N+L++ + KVSDFGL++ + + T G + I + APE I R
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 525 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584
+ SDV+S+G+++ E++ + RP S + +A + +L P
Sbjct: 185 F---TSASDVWSFGIVMWEVMSYGE--RPYWDMSNQDVIKAVEDGY---RLPPPM----- 231
Query: 585 EEEDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621
DC + + M L C Q + +RP+ +++V L
Sbjct: 232 ----DCPSALYQLM----LDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 351 KEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIH 405
+++G G +G VY + DG+L +K + SN S+ +NEV + +++H NII
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEI-DLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLL-SREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
+ ++ EY G L + ++KE ++L+ + + A++YLH
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--- 120
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV-VTMTGPRGTIGYIAPEIFMR 523
+ILH DIKPQN+ L + K+ DFG++K S + T+ GT Y++PE+
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV---GTPYYLSPELCQ- 176
Query: 524 NLGNP-SGKSDVYSYGMLLLEM 544
P + KSD++S G +L E+
Sbjct: 177 --NKPYNYKSDIWSLGCVLYEL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 89/292 (30%), Positives = 140/292 (47%), Gaps = 41/292 (14%)
Query: 343 IKKMTNGFKEK-LGTGGYGNVYKGKF-PDGRL----VAVKVLEKTSNFSDN--FINEVAT 394
I K T K K LG+G +G VYKG + P+G VA+KVL + ++ N ++E
Sbjct: 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV 62
Query: 395 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVA 454
+ + H +++ LLG C S LI + MP G L D + K+N+ LL + +A
Sbjct: 63 MASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIG--SQYLLNWCVQIA 119
Query: 455 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTP---KVSDFGLAKAHSRNRSVVTMTGPRG 511
+ YL E R++H D+ +NVL+ TP K++DFGLAK + G +
Sbjct: 120 KGMSYLE---EKRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173
Query: 512 TIGYIAPE-IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW 570
I ++A E I R + KSDV+SYG+ + E++ +P E G E PD
Sbjct: 174 PIKWMALESILHRIY---THKSDVWSYGVTVWELMTFGA--KPYE---GIPAVE--IPDL 223
Query: 571 IYDKLIQPEKEDFVEEEDDC-IARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621
+ EK + + + C I M++V W I+ + RP+ ++ S
Sbjct: 224 L-------EKGERLPQPPICTIDVYMVLVKCW--MIDAESRPTFKELINEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 69/223 (30%), Positives = 115/223 (51%), Gaps = 12/223 (5%)
Query: 342 DIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV 401
D K +T F ++LGTG +G V GK+ VA+K++++ S D FI E + ++ H
Sbjct: 2 DPKDLT--FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHE 59
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
++ L G C ++ EYM NG L + L RE +P++LLE+ V + YL
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGK-RFQPSQLLEMCKDVCEGMAYLE 117
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 521
+ + +H D+ +N L+D KVSDFGL++ + + + G + + + PE+
Sbjct: 118 SK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 522 MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE 564
+ S KSDV+++G+L+ E+ K P E + S T E
Sbjct: 174 L--YSKFSSKSDVWAFGVLMWEVYSLGK--MPYERFNNSETVE 212
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 82/280 (29%), Positives = 135/280 (48%), Gaps = 31/280 (11%)
Query: 342 DIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV 401
+++K+T G E +G G +G V +G++ G+ VAVK + K + F+ E A + ++HH
Sbjct: 4 NLQKLTLG--EIIGEGEFGAVLQGEYT-GQKVAVKNI-KCDVTAQAFLEETAVMTKLHHK 59
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
N++ LLG ++ E M G+L + L R + + +LL+ +L VA +EYL
Sbjct: 60 NLVRLLGVILHNGLY-IVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 521
+ +++H D+ +N+L+ D KVSDFGLA+ S + + + + APE
Sbjct: 118 SK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVKWTAPEAL 169
Query: 522 MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581
S KSDV+SYG+LL E+ + P S E EK
Sbjct: 170 KHK--KFSSKSDVWSYGVLLWEVFSYGR--APYPKMSLKEVKECV------------EKG 213
Query: 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621
+E + C A +++ C + PK RPS ++ E L
Sbjct: 214 YRMEPPEGCPADVYVLMTS-CWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 2e-25
Identities = 75/202 (37%), Positives = 105/202 (51%), Gaps = 25/202 (12%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLG 408
LG G +G V + D G+L A+KVL+K ++ + E + RI+H I+ L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 409 FCCDGSTRAL--IYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGC 464
+ L + EY P G L LS+E S + AR EI L A+EYLH+
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVL----ALEYLHS-- 111
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
L I++ D+KP+N+LLD D K++DFGLAK S S GT Y+APE+
Sbjct: 112 -LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVL--- 165
Query: 525 LGNPSGKS-DVYSYGMLLLEMI 545
LG GK+ D +S G+LL EM+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 86/293 (29%), Positives = 124/293 (42%), Gaps = 55/293 (18%)
Query: 351 KEKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSN-FSDNFINEVATIGRIHHVNIIHL 406
EKLG G YG VYK + G +VA+K L+ + E++ + + H NI+ L
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
L L++EY L L + LS P + I + + Y H+
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLS--PNLIKSIMYQLLRGLAYCHSH--- 117
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN-----RSVVTMTGPRGTIGYIAPEIF 521
RILH D+KPQN+L++ D K++DFGLA+A VVT+ Y APEI
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW-------YRAPEIL 170
Query: 522 MRNLGNP--SGKSDVYSYGMLLLEMIEEKKHLRPTET----------TSGSNTTEAY--- 566
LG+ S D++S G + EMI K L P ++ G+ T E++
Sbjct: 171 ---LGSKHYSTAVDIWSVGCIFAEMI-TGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226
Query: 567 --FPDWIYDKLIQPEK--EDFVEEEDD---CIARKMIIVGLWCIQINPKDRPS 612
PD+ P K E + D + KM +Q NP R S
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKM-------LQYNPAKRIS 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 7e-25
Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 7/195 (3%)
Query: 351 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFC 410
+ KLG G +G V+ G + VAVK L+ + + F+ E + ++ H ++ L C
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 411 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 470
+ ++ EYM GSL D L + E L+ +L+++A +A + YL +H
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIH 126
Query: 471 LDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSG 530
D+ +N+L+ + K++DFGLA+ + G + I + APE N G +
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARL-IEDDEYTAREGAKFPIKWTAPEAA--NYGRFTI 183
Query: 531 KSDVYSYGMLLLEMI 545
KSDV+S+G+LL E++
Sbjct: 184 KSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 69/276 (25%), Positives = 113/276 (40%), Gaps = 48/276 (17%)
Query: 350 FKEKLGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDN---FINEVATIGRIHHVNIIH 405
+ +G G +G VYKG G VA+K + + + E+ + + H NI+
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSR-EKENLSLKPARLLEIALGVAHAIEYLHNGC 464
+G + +I EY NGSL ++ + SL + ++ G + YLH
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQG----LAYLH--- 116
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLA----KAHSRNRSVVTMTGPRGTIGYIAPEI 520
E ++H DIK N+L D K++DFG+A + SVV GT ++APE+
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV------GTPYWMAPEV 170
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEMIEEKK---HLRPTETTSG-SNTTEAYFPDWIYDKLI 576
+ S SD++S G ++E++ L P P + I
Sbjct: 171 I--EMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLP-----EGI 223
Query: 577 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
PE +DF+ + C Q +P RP+
Sbjct: 224 SPELKDFLMQ---------------CFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 62/196 (31%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
EK+G G +G+VYKG VAVK + F+ E + + H NI+ L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
C ++ E +P GSL L ++K L++K +LL+++L A +EYL + +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLESKN---CI 115
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI--GYIAPEIFMRNLGN 527
H D+ +N L+ + K+SDFG+++ + T++ I + APE N G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEAL--NYGR 171
Query: 528 PSGKSDVYSYGMLLLE 543
+ +SDV+SYG+LL E
Sbjct: 172 YTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 72/271 (26%), Positives = 123/271 (45%), Gaps = 39/271 (14%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
EKLG G YG+VYK G++VA+KV+ + + I E++ + + I+ G
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE-IIKEISILKQCDSPYIVKYYG 65
Query: 409 FCCDGSTRALIYEYMPNGSLGDLL-SREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
+ ++ EY GS+ D++ K +L + I +EYLH+ +
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHS---NK 119
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLA-KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
+H DIK N+LL+ + K++DFG++ + T+ GT ++APE+
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI---GTPFWMAPEVIQEIGY 176
Query: 527 NPSGKSDVYSYGMLLLEMIEEK---KHLRPTETTSGSNTTEAYF--PDWIYDKLIQPEKE 581
N K+D++S G+ +EM E K + P A F P+ L PEK
Sbjct: 177 N--NKADIWSLGITAIEMAEGKPPYSDIHP---------MRAIFMIPNKPPPTLSDPEK- 224
Query: 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
+ E +D + + C+ +P++RPS
Sbjct: 225 -WSPEFNDFVKK--------CLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 342 DIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV 401
+I + + KLG G +G V++G + + VAVK L+ + +F+ E + ++ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL- 460
+I L C ++ E M GSL + L +LK +L+++A VA + YL
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLE 120
Query: 461 -HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 519
N +H D+ +NVL+ + KV+DFGLA+ + G + I + APE
Sbjct: 121 AQN-----YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR-EGAKFPIKWTAPE 174
Query: 520 IFMRNLGNPSGKSDVYSYGMLLLEMI 545
+ N S KSDV+S+G+LL E++
Sbjct: 175 AALYN--RFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 9e-23
Identities = 75/277 (27%), Positives = 121/277 (43%), Gaps = 31/277 (11%)
Query: 352 EKLGTGGYGNVYKGKF--PDGRL--VAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIH 405
++LG G +G+V KG + G+ VAVK L E + F+ E + + ++ H I+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
L+G C G L+ E P G L L K+ + + L E+A VA + YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYL---KKRREIPVSDLKELAHQVAMGMAYLE---S 113
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM-TGPRGTIGYIAPEIFMRN 524
+H D+ +NVLL K+SDFG+++A T R + + APE N
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI--N 171
Query: 525 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584
G S KSDV+SYG+ L E +P G+ E + +
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGA--KPYGEMKGAEVIA------------MLESGERL 217
Query: 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621
++C +++ + L C + P+DRP+ + +
Sbjct: 218 PRPEEC-PQEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 71/287 (24%), Positives = 128/287 (44%), Gaps = 41/287 (14%)
Query: 352 EKLGTGGYGNVYKGKFPDG--RLVAVKVL------------EKTSNFSDNFINEVATIG- 396
E LG+G +G VYK + + L+A+K + E+ + + ++EV I
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSI-GDIVSEVTIIKE 64
Query: 397 RIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKE-NLSLKPARLLEIALGVAH 455
++ H NI+ + ++ + + LG+ + KE R+ I + +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 456 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGY 515
A+ YLH E RI+H D+ P N++L D ++DFGLAK +T GTI Y
Sbjct: 125 ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTILY 179
Query: 516 IAPEIFMRNLGNPSG-KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 574
PEI ++N P G K+DV+++G +L +M L+P ++ + + +Y+
Sbjct: 180 SCPEI-VKNE--PYGEKADVWAFGCILYQMCT----LQPPFYSTNMLSLATKIVEAVYEP 232
Query: 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621
L + + + V C+ + + RP + +V M+S
Sbjct: 233 L-----------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 3e-22
Identities = 70/273 (25%), Positives = 125/273 (45%), Gaps = 25/273 (9%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
F ++LG+G +G V+ GK+ VA+K + + + ++FI E + ++ H ++ L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
C ++ E+M NG L + L + + LS LL + V +EYL +
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLS--KDMLLSMCQDVCEGMEYLERN---SFI 122
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 529
H D+ +N L+ KVSDFG+ + + + + +G + + + PE+F N S
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVF--NFSKYS 179
Query: 530 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589
KSDV+S+G+L+ E+ E K P E S E +L +P+
Sbjct: 180 SKSDVWSFGVLMWEVFTEGK--MPFEKKSNYEVVEMISRG---FRLYRPK---------- 224
Query: 590 CIARKMII-VGLWCIQINPKDRPSMTRVVEMLS 621
+A + V C P+ RP+ ++ ++
Sbjct: 225 -LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 36/221 (16%)
Query: 350 FKEKLGTGGYGNVYKGKF--PDGRL----VAVKVLEKTSN--FSDNFINEVATIGRIHHV 401
F E+LG G +G VYKG+ P+ RL VA+K L++ + F E + + H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKEN-------------LSLKPARLLE 448
NI+ LLG C +++EY+ +G L + L R + SL + L
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 449 IALGVAHAIEYL--HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK---AHSRNRSV 503
IA+ +A +EYL H+ +H D+ +N L+ T K+SDFGL++ + R
Sbjct: 129 IAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 544
P + ++ PE + G + +SD++S+G++L E+
Sbjct: 184 SKSLLP---VRWMPPEAIL--YGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 75/287 (26%), Positives = 127/287 (44%), Gaps = 45/287 (15%)
Query: 352 EKLGTGGYGNVYKG-KFPDGRLVAVKVLE--KTSNFSDN---------FINEVATIGRIH 399
E +G G YG VY G ++AVK +E T + +E+ T+ +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 400 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIE 458
H+NI+ LGF ++ EY+P GS+G L + L ++ G+A
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA---- 122
Query: 459 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN--RSVVTMTGPRGTIGYI 516
YLH+ ILH D+K N+L+D D K+SDFG++K S + + M+ +G++ ++
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISK-KSDDIYDNDQNMS-MQGSVFWM 177
Query: 517 APEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS-----GSNTTEAYFPDWI 571
APE+ S K D++S G ++LEM ++ E + G+ + P +
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237
Query: 572 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ P DF+ C INP +RP+ +++
Sbjct: 238 SMN-LSPVALDFLNA---------------CFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 72/207 (34%), Positives = 107/207 (51%), Gaps = 30/207 (14%)
Query: 350 FKEKLGTGGYGNV----YKGKFPDGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHV 401
F + LGTG +G V +KG G+ A+K+L K ++ +NE + I H
Sbjct: 5 FIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEY 459
+++L G D S L+ EY+P G L L R+ AR ++ L A+EY
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFYAAQVVL----ALEY 116
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 519
LH+ L I++ D+KP+N+LLD D K++DFG AK + R T T GT Y+APE
Sbjct: 117 LHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGR---TYT-LCGTPEYLAPE 168
Query: 520 IFMRNLGNPSGKS-DVYSYGMLLLEMI 545
I L GK+ D ++ G+L+ EM+
Sbjct: 169 II---LSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 3e-21
Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 14/197 (7%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCC 411
+KLG G +G V+ G + VA+K L++ S + F+ E + ++ H ++ L
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV- 70
Query: 412 DGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
T+ IY EYM NGSL D L + E + L +L+++A +A + ++
Sbjct: 71 ---TQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNY 123
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
+H D++ N+L+ K++DFGLA+ N G + I + APE N G
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--NYGTF 180
Query: 529 SGKSDVYSYGMLLLEMI 545
+ KSDV+S+G+LL E++
Sbjct: 181 TIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 31/211 (14%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVL--------EKTSNFSDNFINEVATIGRIHHVN 402
E +G G +G V K + DG+++ K + EK ++EV + + H N
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-----QQLVSEVNILRELKHPN 60
Query: 403 IIHLLGFCCDGSTRAL--IYEYMPNGSLGDLLSR-EKENLSLKPARLLEIALGVAHAIEY 459
I+ D S + L + EY G L L+ + +KE ++ + I + A+
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 460 LHNGCEL--RILHLDIKPQNVLLDPDFTPKVSDFGLAK----AHSRNRSVVTMTGPRGTI 513
HN + +LH D+KP N+ LD + K+ DFGLAK S ++ V GT
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV------GTP 174
Query: 514 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 544
Y++PE + KSD++S G L+ E+
Sbjct: 175 YYMSPEQLNHMSYDE--KSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 48/290 (16%)
Query: 354 LGTGGYGNVYKGKF--PDGRL--VAVKVLEKTSNFS----DNFINEVATIGRIHHVNIIH 405
LG G +G+V +G+ DG VAVK + K + + F++E A + H N++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 406 LLGFCCDGSTRA------LIYEYMPNGSLGDLL--SREKENLSLKPAR-LLEIALGVAHA 456
L+G C + S+ +I +M +G L L SR P + LL+ + +A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 457 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-----HSRNRSVVTMTGPRG 511
+EYL N +H D+ +N +L D T V+DFGL+K + R + M
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM----- 177
Query: 512 TIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI 571
+ +IA E + KSDV+++G+ + E+ + P G E I
Sbjct: 178 PVKWIAIESLADRVYTS--KSDVWAFGVTMWEIATRGQTPYP-----GVENHE------I 224
Query: 572 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621
YD L + +++ +DC+ ++ C + +PKDRP+ T++ E+L
Sbjct: 225 YDYLRHGNR---LKQPEDCLDELYDLM-YSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 9e-21
Identities = 63/227 (27%), Positives = 107/227 (47%), Gaps = 36/227 (15%)
Query: 343 IKKMTNGFKEKLGTGGYGNVYKGK----FPDG--RLVAVKVLEKTSNFS--DNFINEVAT 394
+++ T K +LG G +G V+ G+ P+ LVAVK L++T++ +F E
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61
Query: 395 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLS-----------LKP 443
+ H NI+ G C +G +++EYM +G L L + + L
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 444 ARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503
++LL+IA+ +A + YL +H D+ +N L+ D K+ DFG++ R V
Sbjct: 122 SQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS------RDV 172
Query: 504 VTMTGPR--GT----IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 544
T R G I ++ PE M + +SDV+S+G++L E+
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 73/279 (26%), Positives = 113/279 (40%), Gaps = 59/279 (21%)
Query: 352 EKLGTGGYGNVYKGKFPD-GRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
E +G G +G VYK ++VA+KV LE+ + ++ E+ + + I G
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG 66
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE-----IALGVAHAIEYLHNG 463
GS +I EY GS DLL KP +L E I V +EYLH
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDLL---------KPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPE 519
+H DIK N+LL + K++DFG L S+ + V GT ++APE
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV------GTPFWMAPE 168
Query: 520 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYF------PDWIYD 573
+ + K+D++S G+ +E+ + + L S + F P +
Sbjct: 169 VIKQ--SGYDEKADIWSLGITAIELAKGEPPL------SDLHPMRVLFLIPKNNPPSLEG 220
Query: 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
+DFV C+ +PK+RPS
Sbjct: 221 NKFSKPFKDFVSL---------------CLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 82/294 (27%), Positives = 131/294 (44%), Gaps = 62/294 (21%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFS-------DNFINEVATIGRIHHVNI 403
++LGTG + + Y+ + G L+AVK + N S + E+ + R++H +I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 404 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSRE---KENLSLKPARLLEIALGVAHAIEYL 460
I +LG C+ S L E+M GS+ LLS+ KE + + ++ G++ YL
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN--YTEQLLRGLS----YL 119
Query: 461 HNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSVVTMTGP-----RGTIG 514
H E +I+H D+K N+L+D +++DFG A +R + T G GTI
Sbjct: 120 H---ENQIIHRDVKGANLLIDSTGQRLRIADFGAA---ARLAAKGTGAGEFQGQLLGTIA 173
Query: 515 YIAPEIFMRNLGNPSGKS-DVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYF------ 567
++APE+ G G+S DV+S G +++EM K P SN F
Sbjct: 174 FMAPEVLR---GEQYGRSCDVWSVGCVIIEMATAKP---PWNAEKHSNHLALIFKIASAT 227
Query: 568 -PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
I + L P D L C+++ P+DRP E+L
Sbjct: 228 TAPSIPEHL-SPGLRDVT---------------LRCLELQPEDRPP---SRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 14/194 (7%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCC 411
+ +G G +G+V G + G VAVK + K + F+ E + + ++ H N++ LLG
Sbjct: 12 QTIGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 412 -DGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 470
+ ++ EYM GSL D L R + L LL+ +L V A+EYL +H
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVH 125
Query: 471 LDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSG 530
D+ +NVL+ D KVSDFGL K S + + + + APE S
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKF--ST 178
Query: 531 KSDVYSYGMLLLEM 544
KSDV+S+G+LL E+
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 63/184 (34%), Positives = 92/184 (50%), Gaps = 23/184 (12%)
Query: 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSD-----NF--INEVATIGRIHHV 401
+KLG G Y VYK + GR+VA+K + K + NF + E+ + + H
Sbjct: 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKI-KLGERKEAKDGINFTALREIKLLQELKHP 62
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDL--LSREKENLSLKPARLLEIALGVAHAIEY 459
NII LL S L++E+M DL + ++K ++ L PA + L +EY
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFME----TDLEKVIKDK-SIVLTPADIKSYMLMTLRGLEY 117
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAP 518
LH+ ILH D+KP N+L+ D K++DFGLA++ S NR MT T Y AP
Sbjct: 118 LHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK---MTHQVVTRWYRAP 171
Query: 519 EIFM 522
E+
Sbjct: 172 ELLF 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 18/205 (8%)
Query: 351 KEKLGTGGYGNVYKGKF-PDGR---LVAVKVLEK--TSNFSDNFINEVATIGRIHHVNII 404
+E +G G +G V +G+ G+ VA+K L+ T +F++E + +G+ H NII
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
HL G +I E+M NG+L L R+ + +L+ + G+A ++YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFL-RQNDG-QFTVIQLVGMLRGIAAGMKYL---S 123
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG---TIGYIAPE-I 520
E+ +H D+ +N+L++ + KVSDFGL++ + S T T G I + APE I
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEMI 545
R + SDV+SYG+++ E++
Sbjct: 184 AYRKF---TSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 80/290 (27%), Positives = 130/290 (44%), Gaps = 47/290 (16%)
Query: 349 GFK--EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSD----NFINEVATIGRIHHV 401
FK +KLG G YG+VYK K D + A+K + + S + +NE+ + ++H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEV-DLGSMSQKEREDAVNEIRILASVNHP 59
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL-EIALGVAHAIEYL 460
NII DG+ ++ EY P G L +S+ K+ L P + + I + + ++ L
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 520
H E +ILH D+K N+LL + K+ D G++K + T GT Y+APE+
Sbjct: 120 H---EQKILHRDLKSANILLVANDLVKIGDLGISKV-LKKNMAKTQI---GTPHYMAPEV 172
Query: 521 FMRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN----TTEAYFPDWIYDKL 575
+ G P S KSD++S G LL EM P E S + +P
Sbjct: 173 WK---GRPYSYKSDIWSLGCLLYEMATFAP---PFEARSMQDLRYKVQRGKYP------- 219
Query: 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625
P + ++ + +Q+ PK RP+ ++L+S +
Sbjct: 220 --PIPPIY--------SQDLQNFIRSMLQVKPKLRPNCD---KILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 72/212 (33%), Positives = 107/212 (50%), Gaps = 35/212 (16%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSD-------NFINEVATIGRIHHVNII 404
E LG G YG VY G G+L+AVK +E ++ EV + + HVNI+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSR---EKENLSLKPARLLEIALGVAHAIEYLH 461
LG C D +T ++ E++P GS+ +L+R E + K + +I GVA YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK--QILDGVA----YLH 119
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK------AHSRNRSVVTMTGPRGTIGY 515
N C ++H DIK NV+L P+ K+ DFG A+ H + ++ + GT +
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM--LKSMHGTPYW 174
Query: 516 IAPEIFMRNLGNPSG---KSDVYSYGMLLLEM 544
+APE+ N SG KSD++S G + EM
Sbjct: 175 MAPEVI-----NESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 75/282 (26%), Positives = 122/282 (43%), Gaps = 48/282 (17%)
Query: 352 EKLGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDN------FINEVATIGRIHHVNII 404
E LG+G +G+VY+G DG AVK + + E+A + ++ H NI+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSRE---KENLSLKPARLLEIALGVAHAIEYLH 461
LG + + E +P GSL LL + E + R +I LG +EYLH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR--QILLG----LEYLH 119
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 521
+ +H DIK N+L+D + K++DFG+AK + +G+ ++APE+
Sbjct: 120 DR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF---KGSPYWMAPEVI 173
Query: 522 MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS-----GSNTTEAYFPDWIYDKLI 576
+ G +D++S G +LEM K E + G + PD +
Sbjct: 174 AQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPD-----HL 227
Query: 577 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
E +DF+ L C+Q +P RP+ ++E
Sbjct: 228 SDEAKDFI---------------LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 350 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKT----SNFSDNFINEVATIGRI-HHVNI 403
F + +G G + V K + A+K+L+K E + R+ H I
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 404 IHLLGFCC--DGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
I L + D + EY PNG L + R+ +L K R A + A+EYLH
Sbjct: 65 IKL--YYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRF--YAAEILLALEYLH 119
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA------------------------H 497
+ I+H D+KP+N+LLD D K++DFG AK
Sbjct: 120 S---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 498 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGK-SDVYSYGMLLLEMI 545
R S V GT Y++PE+ P+GK SD+++ G ++ +M+
Sbjct: 177 RRFASFV------GTAEYVSPELL---NEKPAGKSSDLWALGCIIYQML 216
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 30/278 (10%)
Query: 348 NGFKEKLGTGGYGNVYKGKFPDGRL-VAVK-VLEKTSNFSDNFINEVATIGRIHHVNIIH 405
NG + LG G YG VY + ++ +A+K + E+ S + E+A + H NI+
Sbjct: 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ 69
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
LG + + E +P GSL LL + L ++ + ++YLH +
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---D 126
Query: 466 LRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSR-NRSVVTMTGPRGTIGYIAPEIF-- 521
+I+H DIK NVL++ K+SDFG +K + N T T GT+ Y+APE+
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEVIDK 183
Query: 522 -MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580
R G P +D++S G ++EM K P G A F ++ I PE
Sbjct: 184 GPRGYGAP---ADIWSLGCTIVEMATGK----PPFIELG-EPQAAMFKVGMFK--IHPE- 232
Query: 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ E A+ I L C + +P R S +++
Sbjct: 233 ---IPESLSAEAKNFI---LRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-20
Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 12/195 (6%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKT--SNFSDNFINEVATIGRIHHVNIIHLLGF 409
E LG G +G V+KG D VAVK ++ F++E + + H NI+ L+G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
C ++ E +P G L ++K+ L K +L++ AL A + YL + +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTK--QLVKFALDAAAGMAYLESK---NCI 115
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPEIFMRNLGNP 528
H D+ +N L+ + K+SDFG+++ + + + +G + I + APE N G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEAL--NYGRY 171
Query: 529 SGKSDVYSYGMLLLE 543
S +SDV+SYG+LL E
Sbjct: 172 SSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 350 FKEKLGTGGYGNVYKGKFP-----DGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNI 403
F ++LG G +G+V ++ G +VAVK L+ ++ +F E+ + + H NI
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 404 IHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
+ G C R L+ EY+P GSL D L + +E L + +LL A + +EYL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR--KLLLYASQICKGMEYLG 125
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP-RGTIGYIAPEI 520
R +H D+ +N+L++ + K+ DFGL K +++ + P I + APE
Sbjct: 126 ---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES 182
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEM 544
+ S SDV+S+G++L E+
Sbjct: 183 LTESKF--SVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 71/277 (25%), Positives = 126/277 (45%), Gaps = 35/277 (12%)
Query: 354 LGTGGYGNVYKG--KFPDGR--LVAVKVLEKTSNFSDN--FINEVATIGRIHHVNIIHLL 407
LGTG +G + +G K P R VA+ L + F+ E T+G+ H NI+ L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
G G+T ++ EYM NG+L L + + L +L+ + G+A ++YL E+
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVA--GQLMGMLPGLASGMKYL---SEMG 127
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
+H + VL++ D K+S F + ++ ++ T + + + APE +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQ-EDKSEAIYTTMSGKSPVLWAAPEAI--QYHH 184
Query: 528 PSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 587
S SDV+S+G+++ E++ + RP SG + +A + D P
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGE--RPYWDMSGQDVIKA-----VEDGFRLPAPR------ 231
Query: 588 DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621
+C + + M L C Q +RP +++ +LS
Sbjct: 232 -NCPNLLHQLM----LDCWQKERGERPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 58/200 (29%), Positives = 105/200 (52%), Gaps = 16/200 (8%)
Query: 354 LGTGGYGNVYKG--KFPDGRLVAVKVLEKTSNFSD----NFINEVATIGRIHHVNIIHLL 407
+G G +G V G K P R + V + + +++ +F++E + +G+ H NIIHL
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
G ++ EYM NGSL L + ++ +L+ + G+A ++YL ++
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYL---SDMG 126
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN-RSVVTMTGPRGTIGYIAPE-IFMRNL 525
+H D+ +N+L++ + KVSDFGL++ + + T G + I + APE I R
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 526 GNPSGKSDVYSYGMLLLEMI 545
+ SDV+SYG+++ E++
Sbjct: 187 ---TSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 75/232 (32%), Positives = 114/232 (49%), Gaps = 53/232 (22%)
Query: 350 FKEKLGTGGYGNV----------YKGKFP---DGR--LVAVKVL--EKTSNFSDNFINEV 392
KEKLG G +G V + G+ DG+ LVAVK+L + T ++F+ E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 393 ATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLS-REKENL--------SLKP 443
+ R+ + NII LLG C +I EYM NG L LS RE E+ S+
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 444 ARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN--- 500
A LL +A+ +A ++YL L +H D+ +N L+ +T K++DFG+ SRN
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGM----SRNLYS 181
Query: 501 --------RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 544
R+V+ I ++A E + LG + SDV+++G+ L EM
Sbjct: 182 GDYYRIQGRAVL-------PIRWMAWESIL--LGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 72/295 (24%), Positives = 123/295 (41%), Gaps = 57/295 (19%)
Query: 354 LGTGGYGNVYKG-------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNII 404
LG G +G VY+G P+ R VA+K + + ++ + F+NE + + + +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETR-VAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLL--SREKENLSLKPA-----RLLEIALGVAHAI 457
LLG G ++ E M G L L R + + + +++A +A +
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 458 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK---AHSRNRSVVTMTGPRGT-- 512
YL + +H D+ +N ++ D T K+ DFG+ + R G +G
Sbjct: 133 AYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK-----GGKGLLP 184
Query: 513 IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 572
+ ++APE G + KSDV+S+G++L EM T A P Y
Sbjct: 185 VRWMAPESLKD--GVFTTKSDVWSFGVVLWEM-----------------ATLAEQP---Y 222
Query: 573 DKLIQPEKEDFVEEED-----DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
L E FV + + K++ + C Q NPK RP+ +V L
Sbjct: 223 QGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 74/266 (27%), Positives = 129/266 (48%), Gaps = 40/266 (15%)
Query: 354 LGTGGYGNVYKGKF-PDGRL----VAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIH 405
LG+G +G V+KG + P+G VA+K ++ S F + + + +G + H I+
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQE-ITDHMLAMGSLDHAYIVR 73
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
LLG C G++ L+ + P GSL D + + +++L P RLL + +A + YL E
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLD--PQRLLNWCVQIAKGMYYLE---E 127
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
R++H ++ +N+LL D +++DFG+A + + + I ++A E +
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL--F 185
Query: 526 GNPSGKSDVYSYGMLLLEMI----EEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581
G + +SDV+SYG+ + EM+ E +RP E PD + EK
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-----------PDLL-------EKG 227
Query: 582 DFVEEEDDC-IARKMIIVGLWCIQIN 606
+ + + C I M++V W I N
Sbjct: 228 ERLAQPQICTIDVYMVMVKCWMIDEN 253
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 52/200 (26%), Positives = 86/200 (43%), Gaps = 16/200 (8%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVL---EKTSNFSDNFINEVATIGRIHHVNIIHLL 407
++G G +G V+K K G VA+K + + + E+ + H ++ LL
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
GS L+ EYMP L ++L E+ L + L + Y+H
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMH---ANG 119
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
I+H D+KP N+L+ D K++DFGLA+ S + T Y APE+ G
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFS-EEEPRLYSHQVATRWYRAPELL---YGA 175
Query: 528 P--SGKSDVYSYGMLLLEMI 545
D+++ G + E++
Sbjct: 176 RKYDPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 7/207 (3%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCC 411
+KLG G +G V+ G + + VAVK L+ + F+ E + + H ++ L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 412 DGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHL 471
+I EYM GSL D L ++ L P +L++ + +A + Y+ +H
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP-KLIDFSAQIAEGMAYIERK---NYIHR 127
Query: 472 DIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGK 531
D++ NVL+ K++DFGLA+ N G + I + APE N G+ + K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFGSFTIK 184
Query: 532 SDVYSYGMLLLEMIEEKKHLRPTETTS 558
SDV+S+G+LL E++ K P + S
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMSNS 211
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 5e-19
Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 19/205 (9%)
Query: 351 KEK-LGTGGYGNVYKG--KFPDGR---LVAVKVLEK--TSNFSDNFINEVATIGRIHHVN 402
K+K +G G +G V++G K P GR VA+K L+ T +F++E + +G+ H N
Sbjct: 9 KQKVIGAGEFGEVFRGILKMP-GRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
II L G +I EYM NG+L L R+ + +L+ + G+A ++YL +
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYL-RDHDG-EFSSYQLVGMLRGIAAGMKYLSD 125
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN-RSVVTMTGPRGTIGYIAPE-I 520
+ +H D+ +N+L++ + KVSDFGL++ + T +G + I + APE I
Sbjct: 126 ---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEMI 545
R + SDV+S+G+++ E++
Sbjct: 183 AYRKF---TSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 21/199 (10%)
Query: 353 KLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN--FINEVATIGRIHHVNIIHLLGF 409
+LG G G V K P G+++AVK + N + + E+ + + + I+ G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL-EIALGVAHAIEYLHNGCELRI 468
+ ++ EYM GSL +L + + P R+L +IA+ V + YLH + +I
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRI---PERILGKIAVAVLKGLTYLHE--KHKI 122
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAK--AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
+H D+KP N+L++ K+ DFG++ +S ++ V GT Y+APE R G
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV------GTSSYMAPE---RIQG 173
Query: 527 NPSG-KSDVYSYGMLLLEM 544
N KSD++S G+ L+E+
Sbjct: 174 NDYSVKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 58/194 (29%), Positives = 101/194 (52%), Gaps = 8/194 (4%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCC 411
+KLG G +G V+ G + VAVK L+ + ++F+ E + ++ H ++ L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 412 DGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHL 471
+ ++ EYM GSL D L ++ E +LK L+++A VA + Y+ + +H
Sbjct: 72 EEPIY-IVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 472 DIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGK 531
D++ N+L+ K++DFGLA+ N G + I + APE + G + K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAAL--YGRFTIK 183
Query: 532 SDVYSYGMLLLEMI 545
SDV+S+G+LL E++
Sbjct: 184 SDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 7e-19
Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHL 406
++G G YG VYK + G LVA+K + + N + F I E+ + ++ H NI+ L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 407 LGFC--CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR-----LLEIALGVAHAIEY 459
+ +++EYM + L LL + + + LLE ++Y
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLE-------GLQY 115
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 519
LH+ ILH DIK N+L++ D K++DFGLA+ +++ S T T+ Y PE
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD-YTNRVITLWYRPPE 171
Query: 520 IFMRNLG--NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS----------GSNTTEAY- 566
+ LG + D++S G +L E+ K + T GS T E +
Sbjct: 172 LL---LGATRYGPEVDMWSVGCILAELF-LGKPIFQGSTELEQLEKIFELCGSPTDENWP 227
Query: 567 ----FPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
P + K +P K E I + + + ++PK R S
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS 277
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 15/205 (7%)
Query: 353 KLGTGGYGNVYKG-KFPDGRLVAVKVL----EKTSNFSDNFINEVATIGRIHHVNIIHLL 407
K+G G +G VY G L+AVK + +E+ + + H N++
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTI-KEIADEMKVLELLKHPNLVKYY 65
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
G + EY G+L +LL L R+ + L + YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEG--LAYLH---SHG 119
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV--TMTGPRGTIGYIAPEIFMRNL 525
I+H DIKP N+ LD + K+ DFG A N + + + GT Y+APE+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 526 GNPSGKS-DVYSYGMLLLEMIEEKK 549
G G++ D++S G ++LEM K+
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 63/282 (22%), Positives = 129/282 (45%), Gaps = 29/282 (10%)
Query: 342 DIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV 401
+I + + ++KLG G +G V+ + VAVK ++ S + F+ E + + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 61
Query: 402 NIIHLLGFCCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 458
++ L T+ IY E+M GSL D L ++ + P +L++ + +A +
Sbjct: 62 KLVKLHAVV----TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP-KLIDFSAQIAEGMA 116
Query: 459 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 518
++ + +H D++ N+L+ K++DFGLA+ N G + I + AP
Sbjct: 117 FIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAP 172
Query: 519 EIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578
E N G+ + KSDV+S+G+LL+E++ + P + ++I+
Sbjct: 173 EAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---------------EVIRA 215
Query: 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
+ + + ++ + + C + P++RP+ + +L
Sbjct: 216 LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 9e-19
Identities = 71/227 (31%), Positives = 115/227 (50%), Gaps = 36/227 (15%)
Query: 340 YNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRL---VAVKVLEKTSNFSD--NFINEVAT 394
+NDIK F++ +G G +G V K + L A+K +++ ++ D +F E+
Sbjct: 6 WNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 395 IGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPA--------- 444
+ ++ HH NII+LLG C L EY P+G+L D L R+ L PA
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTAS 119
Query: 445 -----RLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499
+LL A VA ++YL + + +H D+ +N+L+ ++ K++DFGL SR
Sbjct: 120 TLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL----SR 172
Query: 500 NRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
+ V V T R + ++A E N + SDV+SYG+LL E++
Sbjct: 173 GQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 72/277 (25%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKT--SNFSDNFINEVATIGRIHHVNIIHLLG 408
E++G G +G V+ G+ D VAVK +T + F+ E + + H NI+ L+G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
C ++ E + G L E L +K L+++ A +EYL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVK--ELIQMVENAAAGMEYLESKH---C 115
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
+H D+ +N L+ K+SDFG+++ T + + + APE N G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL--NYGRY 173
Query: 529 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588
S +SDV+S+G+LL E P S T EA E+ + +
Sbjct: 174 SSESDVWSFGILLWEAFSLGA--VPYANLSNQQTREAI------------EQGVRLPCPE 219
Query: 589 DC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
C + R M C + +P RPS + V + L S
Sbjct: 220 LCPDAVYRLM----ERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 354 LGTGGYGNVYKGKF------PDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNIIH 405
LG G +G VY+G + VAVK L ++ + D +F+ E + + +H NI+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENL----SLKPARLLEIALGVAHAIEYLH 461
L+G + R ++ E M G L L + SL LL A VA +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 462 NGCELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT--IGYI 516
E +H DI +N LL P K++DFG+A+ R+ G R I ++
Sbjct: 134 ---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRASYYRKGGRAMLPIKWM 188
Query: 517 APEIFMRNLGNPSGKSDVYSYGMLLLEM 544
PE F+ G + K+DV+S+G+LL E+
Sbjct: 189 PPEAFLD--GIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 68/276 (24%), Positives = 120/276 (43%), Gaps = 38/276 (13%)
Query: 354 LGTGGYGN--VYKGKFPDGRLVAVK---VLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
LG G +G +Y+ + D LV K + + + +NE+ + + H NII
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
D +T + EY G+L D + R+K L + +L + A+ Y+H + I
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIH---KAGI 122
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKA----HSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
LH DIK N+ L K+ DFG++K +S +VV GT Y++PE+
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV------GTPYYMSPELCQGV 176
Query: 525 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584
N KSD+++ G +L E++ K+ T +N + K++Q
Sbjct: 177 KYN--FKSDIWALGCVLYELLTLKR------TFDATNPLN------LVVKIVQGNYTP-- 220
Query: 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
+ ++I + +Q +P+ RP+ V++
Sbjct: 221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 85/307 (27%), Positives = 144/307 (46%), Gaps = 73/307 (23%)
Query: 350 FKEKLGTGGYGNVY----KG--KFPDGR-----------LVAVKVL--EKTSNFSDNFIN 390
FKEKLG G +G V+ +G KF D LVAVK+L + N ++F+
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 391 EVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREK--------ENLSLK 442
E+ + R+ NII LL C +I EYM NG L LSR + + +++
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 443 PARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN-- 500
+ L+ +A +A ++YL + L +H D+ +N L+ ++T K++DFG+ SRN
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGM----SRNLY 181
Query: 501 ---------RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI---EEK 548
R+V+ I +++ E + LG + SDV+++G+ L E++ +E+
Sbjct: 182 SGDYYRIQGRAVL-------PIRWMSWESIL--LGKFTTASDVWAFGVTLWEILTLCKEQ 232
Query: 549 KHLRPTETTSGSNTTEAYFPD---WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQI 605
+ + ++ NT E +F D +Y L +P + + L C +
Sbjct: 233 PYSQLSDEQVIENTGE-FFRDQGRQVY--LPKPA----------LCPDSLYKLMLSCWRR 279
Query: 606 NPKDRPS 612
N K+RPS
Sbjct: 280 NAKERPS 286
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 357 GGYGNVYKG-KFPDGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLL-GFC 410
G YG V+ K G + A+KV++K N D + E + + ++ L F
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 411 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCELRI 468
L+ EY+P G L LL +L AR + EI L A+EYLH+ I
Sbjct: 64 GK-KNLYLVMEYLPGGDLASLLENV-GSLDEDVARIYIAEIVL----ALEYLHS---NGI 114
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR------GTIGYIAPEIFM 522
+H D+KP N+L+D + K++DFGL+K R + + GT YIAPE+
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI- 173
Query: 523 RNLGNPSGKS-DVYSYGMLLLEMI 545
LG K+ D +S G +L E +
Sbjct: 174 --LGQGHSKTVDWWSLGCILYEFL 195
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 354 LGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDN----------FINEVATIGRIHHVN 402
+G+G +G+VY G G L+AVK +E S + + E+A + + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
I+ LG D + EY+P GS+ LL+ + + + + + YLHN
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHN 124
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR----GTIGYIAP 518
I+H DIK N+L+D K+SDFG++K N G R G++ ++AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 519 EIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 548
E+ + K+D++S G L++EM+ K
Sbjct: 182 EVVKQTSYTR--KADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 85/291 (29%), Positives = 123/291 (42%), Gaps = 44/291 (15%)
Query: 354 LGTGGYGNV----YKGKFPD-GRLVAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIHL 406
LG G +G V Y G +VAVK L E + + E+ + ++H NI+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 407 LGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
G C + + LI EY+P GSL D L + K NL A+LL A + + YLH+
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL----AQLLLFAQQICEGMAYLHSQ- 126
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA----HSRNRSVVTMTGPRGTIGYIAPEI 520
+H D+ +NVLLD D K+ DFGLAKA H R V G Y A E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR--VREDGDSPVFWY-AVEC 181
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEMIEE--------KKHLRPTETTSGSNTTEAYFPDWIY 572
N S SDV+S+G+ L E++ KK G T
Sbjct: 182 LKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV-------- 231
Query: 573 DKLIQ-PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+LI+ E+ + +C I++ C + K RP+ ++ +L
Sbjct: 232 -RLIELLERGMRLPCPKNCPQEVYILMKN-CWETEAKFRPTFRSLIPILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 63/200 (31%), Positives = 107/200 (53%), Gaps = 17/200 (8%)
Query: 354 LGTGGYGNVYKGKF-PDGRLV----AVKVLEKTSNFSDN--FINEVATIGRIHHVNIIHL 406
LG+G +G VYKG + P+G V A+K+L +T+ N F++E + + H +++ L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
LG C T L+ + MP+G L D + K+N+ + LL + +A + YL E
Sbjct: 75 LGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQ--LLLNWCVQIAKGMMYLE---ER 128
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE-IFMRNL 525
R++H D+ +NVL+ K++DFGLA+ + G + I ++A E I R
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 526 GNPSGKSDVYSYGMLLLEMI 545
+ +SDV+SYG+ + E++
Sbjct: 189 ---THQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 17/202 (8%)
Query: 354 LGTGGYGNVYKGKF-PDG----RLVAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIHL 406
LG G +G V ++ P+G VAVK L E N + E+ + ++H NI+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 407 LGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
G C + LI E++P+GSL + L R K ++LK + L+ A+ + ++YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--QQLKYAVQICKGMDYLGS-- 127
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPEIFMR 523
+ +H D+ +NVL++ + K+ DFGL KA ++ T+ + + + APE ++
Sbjct: 128 -RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 524 NLGNPSGKSDVYSYGMLLLEMI 545
+ + SDV+S+G+ L E++
Sbjct: 187 SKFYIA--SDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 78/277 (28%), Positives = 131/277 (47%), Gaps = 32/277 (11%)
Query: 354 LGTGGYGNVYKGKF-PDGR----LVAVKVLEKTSNFSDN--FINEVATIGRIHHVNIIHL 406
LG+G +G VYKG + PDG VA+KVL + ++ N ++E + + + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
LG C ST L+ + MP G L D + K+ + + LL + +A + YL E+
Sbjct: 75 LGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQ--DLLNWCVQIAKGMSYLE---EV 128
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
R++H D+ +NVL+ K++DFGLA+ + + G + I ++A E +
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR-- 186
Query: 527 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586
+ +SDV+SYG+ + E++ T G+ + I D L EK + + +
Sbjct: 187 RFTHQSDVWSYGVTVWELM-----------TFGAKPYDGIPAREIPDLL---EKGERLPQ 232
Query: 587 EDDC-IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
C I MI+V W I+ + RP +V+ S
Sbjct: 233 PPICTIDVYMIMVKCW--MIDSECRPRFRELVDEFSR 267
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 73/273 (26%), Positives = 115/273 (42%), Gaps = 30/273 (10%)
Query: 350 FKEKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHL 406
E +G G VY P+ VA+K LEK D EV + + +H N++
Sbjct: 5 LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH-NGCE 465
G L+ Y+ GSL D++ L A + + V +EYLH NG
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG-- 122
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAK--AHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
+H DIK N+LL D + K++DFG++ A +R+ GT ++APE+ M
Sbjct: 123 --QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV-ME 179
Query: 524 NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583
+ K+D++S+G+ +E+ T S Y P + +Q +
Sbjct: 180 QVHGYDFKADIWSFGITAIELA--------TGAAPYSK----YPPMKVLMLTLQNDPPSL 227
Query: 584 VEEEDDC----IARKMIIVGLWCIQINPKDRPS 612
D RKMI + C+Q +P RP+
Sbjct: 228 ETGADYKKYSKSFRKMISL---CLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLE------KTSNFSDNFINEVATIGRIHHVNIIHL 406
LG G +G VY D GR +AVK + +T + E+ + + H I+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSRE---KENLSLKPARLLEIALGVAHAIEYLHNG 463
G D T ++ EYMP GS+ D L E ++ K R + +EYLH+
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR------QILEGVEYLHSN 123
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT-MTGPRGTIGYIAPEIFM 522
I+H DIK N+L D K+ DFG +K S T M GT +++PE+
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI- 179
Query: 523 RNLGNPSG-KSDVYSYGMLLLEMIEEK 548
G G K+DV+S G ++EM+ EK
Sbjct: 180 --SGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 9e-18
Identities = 77/242 (31%), Positives = 116/242 (47%), Gaps = 62/242 (25%)
Query: 350 FKEKLGTGGYGNVY-----------KGKFP----DGR--LVAVKVL--EKTSNFSDNFIN 390
FKEKLG G +G V+ +FP GR LVAVK+L + N ++F+
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 391 EVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR-------EKENLSLKP 443
EV + R+ NII LLG C D +I EYM NG L LS E N ++ P
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 444 A---------RLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 494
A LL +AL +A ++YL + L +H D+ +N L+ + T K++DFG+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGM- 184
Query: 495 KAHSRN-----------RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLE 543
SRN R+V+ I ++A E + +G + SDV+++G+ L E
Sbjct: 185 ---SRNLYAGDYYRIQGRAVL-------PIRWMAWECIL--MGKFTTASDVWAFGVTLWE 232
Query: 544 MI 545
++
Sbjct: 233 IL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 9e-18
Identities = 73/284 (25%), Positives = 131/284 (46%), Gaps = 34/284 (11%)
Query: 352 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFIN--EVATIGRI-HHVNIIHLL 407
++LG G +G+VY + + G LVA+K ++K + +N EV ++ ++ H NI+ L
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH-NGCEL 466
+ ++EYM G+L L+ K + + I + + ++H +G
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLMKDRKGKP-FSESVIRSIIYQILQGLAHIHKHG--- 119
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
H D+KP+N+L+ K++DFGLA+ R+R T T Y APEI +R+
Sbjct: 120 -FFHRDLKPENLLVSGPEVVKIADFGLAR-EIRSRP--PYTDYVSTRWYRAPEILLRS-T 174
Query: 527 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586
+ S D+++ G ++ E+ LRP GS+ + + I L P K+D+ E
Sbjct: 175 SYSSPVDIWALGCIMAELYT----LRP--LFPGSSEIDQLYK--ICSVLGTPTKQDWPEG 226
Query: 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEM 630
+A K+ + ++ +AS EAI++
Sbjct: 227 YK--LASKLGFRFPQFAPTSLHQ---------LIPNASPEAIDL 259
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLE---KTSNFSDNFINEVATIGRIHHVNIIHLL 407
EK+G G YG VYK + G +VA+K + +T I E++ + ++H NI+ LL
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 408 GFCCDGSTRALIYEYMPNGSLG---DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
+ L++E++ + L D L L + L ++ G+A + H+
Sbjct: 66 DVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----FCHSH- 119
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
R+LH D+KPQN+L++ + K++DFGLA+A V T T T+ Y APEI
Sbjct: 120 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFG--VPVRTYTHEVVTLWYRAPEIL--- 172
Query: 525 LGNP--SGKSDVYSYGMLLLEMIEEK 548
LG S D++S G + EM+ +
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 75/292 (25%), Positives = 128/292 (43%), Gaps = 52/292 (17%)
Query: 347 TNGFK--EKLGTGGYGNVYKGK-FPDGRLVAVKVLE----KTSNFSDNFINEVATIGRIH 399
FK +K+G G + VYK DGR+VA+K ++ + + + E+ + ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 400 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL-EIALGVAHAIE 458
H N+I L + + ++ E G L ++ K+ L P R + + + + A+E
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 459 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN----RSVVTMTGPRGTIG 514
++H RI+H DIKP NV + K+ D GL + S S+V GT
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV------GTPY 171
Query: 515 YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD- 573
Y++PE N N KSD++S G LL EM L+ N +Y
Sbjct: 172 YMSPERIHENGYN--FKSDIWSLGCLLYEMAA----LQSPFYGDKMN---------LYSL 216
Query: 574 --KLIQPE-----KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
K+ + + + + EE D ++R CI +P+ RP ++ V++
Sbjct: 217 CKKIEKCDYPPLPADHYSEELRDLVSR--------CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 72/291 (24%), Positives = 121/291 (41%), Gaps = 52/291 (17%)
Query: 354 LGTGGYGNVYKGKFP------DGRLVAVKVLEKT--SNFSDNFINEVATIGRIHHVNIIH 405
LG G +G V+ K LV VK L+KT N F E+ ++ H N++
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLL--SREKENLS----LKPARLLEIALGVAHAIEY 459
LLG C + +I EY G L L ++ K+ L + + + +A +++
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-------HSRNRSVVTMTGPRGT 512
L N R +H D+ +N L+ KVS L+K RN +
Sbjct: 133 LSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI--------P 181
Query: 513 IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 572
+ ++APE + + S KSDV+S+G+L+ E+ E F
Sbjct: 182 LRWLAPEAVQED--DFSTKSDVWSFGVLMWEVF---------------TQGELPFYGLSD 224
Query: 573 DKLIQPEKEDFVE--EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621
++++ + +E + C +R ++ C +NPKDRPS + +V L
Sbjct: 225 EEVLNRLQAGKLELPVPEGCPSRLYKLM-TRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 33/219 (15%)
Query: 352 EKLGTGGYGNVYKGKF-----PDGRL-VAVKVLEKTSNFSD--NFINEVATIGRI-HHVN 402
+ LG G +G V K + P+ VAVK+L+ + D + ++E+ + I H N
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREK---------------ENLSLKPARLL 447
II+LLG C ++ EY +G+L D L + E L+ K L+
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK--DLV 135
Query: 448 EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVVTM 506
A VA +E+L + + +H D+ +NVL+ D K++DFGLA+ H + T
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
G R + ++APE + + +SDV+S+G+LL E+
Sbjct: 193 NG-RLPVKWMAPEALFDRVY--THQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 8/192 (4%)
Query: 353 KLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD 412
KLG G +G V+ G + VA+K L+ + + F+ E + ++ H ++ L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 413 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLD 472
++ EYM GSL D L E L+ +L+++A +A + Y+ + +H D
Sbjct: 73 EPIY-IVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127
Query: 473 IKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKS 532
++ N+L+ + KV+DFGLA+ N G + I + APE + G + KS
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKS 184
Query: 533 DVYSYGMLLLEM 544
DV+S+G+LL E+
Sbjct: 185 DVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 84/285 (29%), Positives = 133/285 (46%), Gaps = 35/285 (12%)
Query: 343 IKKMTNGFKEK-LGTGGYGNVYKGKF-PDGR----LVAVKVLEKTSNFSDN--FINEVAT 394
I K T K K LG+G +G VYKG + P+G VA+K L + ++ N ++E
Sbjct: 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 395 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVA 454
+ + + ++ LLG C ST LI + MP G L D + K+N+ + LL + +A
Sbjct: 63 MASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQIA 119
Query: 455 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 514
+ YL E R++H D+ +NVL+ K++DFGLAK + G + I
Sbjct: 120 KGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176
Query: 515 YIAPE-IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573
++A E I R + +SDV+SYG+ + E++ T GS + I
Sbjct: 177 WMALESILHRIY---THQSDVWSYGVTVWELM-----------TFGSKPYDGIPASEISS 222
Query: 574 KLIQPEKEDFVEEEDDC-IARKMIIVGLWCIQINPKDRPSMTRVV 617
L EK + + + C I MI+V W I+ RP ++
Sbjct: 223 IL---EKGERLPQPPICTIDVYMIMVKCW--MIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 27/219 (12%)
Query: 355 GTGGYGNVYKGKFPDGRLV-------AVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLL 407
G G +G V + D + + K +EK S N +NE + ++H +++L
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGS--VRNVLNERRILQELNHPFLVNLW 66
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGCE 465
D L+ + + G L LS+ K S + + EI L A+EYLH
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQ-KVKFSEEQVKFWICEIVL----ALEYLH---S 118
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
I+H DIKP N+LLD ++DF +A + + + + GT GY+APE+ R
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLCRQ- 174
Query: 526 GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE 564
S D +S G+ E + K RP S + +
Sbjct: 175 -GYSVAVDWWSLGVTAYECLRGK---RPYRGHSRTIRDQ 209
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 4e-17
Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 353 KLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD 412
KLG G +G V+ G + VA+K L+ + + F+ E + ++ H ++ L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 413 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLD 472
++ E+M GSL D L +E + LK +L+++A +A + Y+ + +H D
Sbjct: 73 EPIY-IVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127
Query: 473 IKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKS 532
++ N+L+ + K++DFGLA+ N G + I + APE + G + KS
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL--YGRFTIKS 184
Query: 533 DVYSYGMLLLEMIEEKK 549
DV+S+G+LL E++ + +
Sbjct: 185 DVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 339 SYNDIKKMTNGFKEKLGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDN-----FINEV 392
S D KK F EK+G G G VY G+ VA+K + N INE+
Sbjct: 13 SVGDPKKKYTRF-EKIGQGASGTVYTAIDVATGQEVAIKQM----NLQQQPKKELIINEI 67
Query: 393 ATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALG 452
+ H NI++ L G ++ EY+ GSL D+++ + ++ +
Sbjct: 68 LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRE 123
Query: 453 VAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL-AKAHSRNRSVVTMTGPRG 511
A+E+LH+ +++H DIK N+LL D + K++DFG A+ TM G
Sbjct: 124 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---G 177
Query: 512 TIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE 546
T ++APE+ R P K D++S G++ +EM+E
Sbjct: 178 TPYWMAPEVVTRKAYGP--KVDIWSLGIMAIEMVE 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 354 LGTGGYGNVYKGKFPD------GRL-VAVKVLEKTSNFSD--NFINEVATIGRIHHVNII 404
LG+G +G VY+G D G + VAVK L K + + F+ E + +H NI+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLS--REKENLSLKPA-----RLLEIALGVAHAI 457
LLG C + +I E M GDLLS R+ P LL+I L VA
Sbjct: 63 KLLGVCLLNEPQYIIMELMEG---GDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 458 EYLHNGCELRILHLDIKPQNVLL-----DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT 512
YL ++ +H D+ +N L+ D D K+ DFGLA+ ++
Sbjct: 120 VYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 513 IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
+ ++APE + +SDV+S+G+L+ E++
Sbjct: 177 VRWMAPESLLDGKFT--TQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 352 EKLGTGGYGNVYKGKFPD-GRLVAVKVL---EKTSNFSDNFINEVATIGRIHHVNIIHLL 407
+G G YG V K + G +VA+K E + + EV + ++ H NI++L
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
L++EY+ +L +LL L R L AI Y H
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL--LQAIAYCH---SHN 120
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
I+H DIKP+N+L+ K+ DFG A+A +R S +T T Y APE+ +G
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP--LTDYVATRWYRAPELL---VG 175
Query: 527 NPS-GKS-DVYSYGMLLLEMI 545
+ + GK DV++ G ++ E++
Sbjct: 176 DTNYGKPVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LE-KTSNFSDNFINEVATIGRIHHVNIIHLL 407
EK+G G YG VYK + G +VA+K LE + I E++ + ++H NI+ LL
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
+ L++E++ + L + L P + + I Y H+ R
Sbjct: 65 DVVHSENKLYLVFEFL-DLDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---R 119
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
+LH D+KPQN+L+D + K++DFGLA+A V T T T+ Y APEI LG+
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL---LGS 174
Query: 528 P--SGKSDVYSYGMLLLEMIEEK 548
S D++S G + EM+ +
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 69/227 (30%), Positives = 107/227 (47%), Gaps = 42/227 (18%)
Query: 350 FKEKLGTGGYGNVY------------KGKFPDG-----RLVAVKVLEK--TSNFSDNFIN 390
F EKLG G +G V+ K + LVAVKVL + N ++F+
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68
Query: 391 EVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR-EKEN-------LSLK 442
EV + R+ NI LLG C +I EYM NG L L + E SL
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 443 PARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNR 501
+ LL +A +A + YL L +H D+ +N L+ ++T K++DFG+++ +S +
Sbjct: 129 FSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185
Query: 502 SVVTMTGPRGT----IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 544
V +G I ++A E + LG + KSDV+++G+ L E+
Sbjct: 186 YRV-----QGRAPLPIRWMAWESVL--LGKFTTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 352 EKLGTGGYGNVYKGKF--PDGRLV--AVKVLEKTSNFSD--NFINEVATIGRIHHVNIIH 405
+G G +G VY G DG+ + AVK L + ++ + F+ E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 406 LLGFCCDGSTRALI-YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
LLG C L+ YM +G L + + E N ++K L+ L VA +EYL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKD--LIGFGLQVAKGMEYL---A 115
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA--HSRNRSVVTMTGPRGTIGYIAPEIFM 522
+ +H D+ +N +LD FT KV+DFGLA+ SV TG + + ++A E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 523 RNLGNPSGKSDVYSYGMLLLEMI 545
+ KSDV+S+G+LL E++
Sbjct: 176 TQ--KFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 70/220 (31%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 338 YSYNDIKKMTNGFKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFS----DNFINEV 392
+S +D +K+ +E +G G +G VY + +VA+K + + S + I EV
Sbjct: 8 FSKDDPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 393 ATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIA-- 450
+ ++ H N I G T L+ EY GS D+L K KP + +EIA
Sbjct: 67 RFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHK-----KPLQEVEIAAI 120
Query: 451 -LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 509
G + YLH+ +H DIK N+LL T K++DFG A S S V
Sbjct: 121 CHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV----- 172
Query: 510 RGTIGYIAPE-IFMRNLGNPSGKSDVYSYGMLLLEMIEEK 548
GT ++APE I + G GK DV+S G+ +E+ E K
Sbjct: 173 -GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 352 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLG 408
+LG G G+V K + + G + A+K + N + E+ I+ G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 409 FCCD--GSTRALIYEYMPNGSLGDLLSREKEN---LSLKPARLLEIALGVAHAIEYLHNG 463
D S+ + EY GSL + + K+ + K L +IA V + YLH
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV--LGKIAESVLKGLSYLH-- 122
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
+I+H DIKP N+LL K+ DFG++ N T T GT Y+APE R
Sbjct: 123 -SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-GELVNSLAGTFT---GTSFYMAPE---R 174
Query: 524 NLGNP-SGKSDVYSYGMLLLEM 544
G P S SDV+S G+ LLE+
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 351 KEKLGTGGYGNVYKGKF----PDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNII 404
+G G +G+VY+G + + VAVK + ++ S F+ E + + H +I+
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
L+G + ++ E P G L L K +L L A L+ + ++ A+ YL +
Sbjct: 71 KLIGVITENPV-WIVMELAPLGELRSYLQVNKYSLDL--ASLILYSYQLSTALAYLES-- 125
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE-IFMR 523
R +H DI +NVL+ K+ DFGL++ + S + + I ++APE I R
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFR 183
Query: 524 NLGNPSGKSDVYSYGMLLLEMI 545
+ SDV+ +G+ + E++
Sbjct: 184 RF---TSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVA---VKVLEKTSNF--SDNFINEVATIGRIHHVNIIHL 406
+++G G +G V G+ G A VK L ++ F+ EV ++H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGC 464
LG C + L+ E+ P G L + L + ++ + L +A VA + +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE---IF 521
+ +H D+ +N L D + K+ D+GLA +T + ++APE I
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 522 MRNL--GNPSGKSDVYSYGMLLLEMIE 546
++L + + KS+++S G+ + E+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 72/227 (31%), Positives = 117/227 (51%), Gaps = 36/227 (15%)
Query: 340 YNDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLV--AVKVLEKTSNFSD--NFINEVAT 394
+ DIK F++ +G G +G V + DG + A+K+L++ ++ +D +F E+
Sbjct: 1 WEDIK-----FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEV 55
Query: 395 IGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPA--------- 444
+ ++ HH NII+LLG C + + EY P G+L D L R+ L PA
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTAS 114
Query: 445 -----RLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499
+LL+ A VA ++YL E + +H D+ +NVL+ + K++DFGL SR
Sbjct: 115 TLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGL----SR 167
Query: 500 NRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
V V T R + ++A E N + KSDV+S+G+LL E++
Sbjct: 168 GEEVYVKKTMGRLPVRWMAIESL--NYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-16
Identities = 89/358 (24%), Positives = 153/358 (42%), Gaps = 38/358 (10%)
Query: 288 MVLVAVALLVFRKRIPSFFKKPFSEERQNIGDGLNVKQFIKTYRSALLSNYSYNDIKKMT 347
+ LVA + R R K+ +E DG QF + S + + + NDI
Sbjct: 642 LALVAFGFVFIRGRNNLELKRVENE------DGTWELQF---FDSKVSKSITINDILSSL 692
Query: 348 NGFKEKLGTGGYGNVYKGKFPDGRL-VAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHL 406
+ + G G YKGK + VK + ++ + I + +G++ H NI+ L
Sbjct: 693 KE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD---MGKLQHPNIVKL 748
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
+G C LI+EY+ +L ++L NLS + R +IA+G+A A+ +LH C
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWE--RRRKIAIGIAKALRFLHCRCSP 802
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
++ ++ P+ +++D P + L + T T + Y+APE R
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPG------LLCTDTKCFISSAYVAPE--TRETK 853
Query: 527 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY-----DKLIQPEKE 581
+ + KSD+Y +G++L+E++ K P + G + + + + Y D I P
Sbjct: 854 DITEKSDIYGFGLILIELLTGKS---PADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR 910
Query: 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKPLFPSP 639
V + I M + L C +P RP V++ L SAS + F S
Sbjct: 911 GDVSVNQNEIVEVMNL-ALHCTATDPTARPCANDVLKTLESASRSSSSCVTGLKFSSL 967
|
Length = 968 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 77/284 (27%), Positives = 134/284 (47%), Gaps = 33/284 (11%)
Query: 350 FKEKLGTGGYGNVYK------GKFPDGRLVAVKVLEKTSNFSDN--FINEVATIGRI-HH 400
F + LG G +G V + K VAVK+L+ T++ S+ ++E+ + + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 401 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 460
NI++LLG C G +I EY G L + L R++E+ L LL + VA + +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFL 157
Query: 461 HN-GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 519
+ C +H D+ +NVLL K+ DFGLA+ + + V R + ++APE
Sbjct: 158 ASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213
Query: 520 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD-KLIQP 578
+ + +SDV+SYG+LL E+ + GSN +P D K +
Sbjct: 214 SIFNCV--YTFESDVWSYGILLWEIF-----------SLGSNP----YPGMPVDSKFYKL 256
Query: 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
KE + + + ++ + C +P RP+ ++V+++
Sbjct: 257 IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 350 FKEKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHL 406
+++G+G YG+VYK + G LVA+KV LE +F E++ + H NI+
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI-IQQEISMLKECRHPNIVAY 65
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL---GVAHAIEYLHNG 463
G ++ EY GSL D+ + LS L+IA + YLH
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSE-----LQIAYVCRETLKGLAYLH-- 118
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLA----KAHSRNRSVVTMTGPRGTIGYIAPE 519
E +H DIK N+LL D K++DFG++ ++ +S + GT ++APE
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI------GTPYWMAPE 171
Query: 520 IFMRNLGNP-SGKSDVYSYGMLLLEMIE 546
+ GK D+++ G+ +E+ E
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAE 199
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
EKLG G Y VYKG+ G +VA+K L+ I E++ + + H NI+ L
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+ L++EYM + L + +L P + + I + H E R+
Sbjct: 66 VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRV 121
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
LH D+KPQN+L++ K++DFGLA+A V T + T+ Y AP++ LG+
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFG--IPVNTFSNEVVTLWYRAPDVL---LGSR 176
Query: 529 --SGKSDVYSYGMLLLEMI 545
S D++S G ++ EMI
Sbjct: 177 TYSTSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 352 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLL 407
EK+G G YG VYKG+ G++VA+K + S I E++ + + H NI+ L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
S LI+E++ + L L + + + + I + H R
Sbjct: 66 DVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRR 121
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
+LH D+KPQN+L+D K++DFGLA+A V T T+ Y APE+ LG+
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFG--IPVRVYTHEVVTLWYRAPEVL---LGS 176
Query: 528 P--SGKSDVYSYGMLLLEMIEEK 548
P S D++S G + EM +K
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 65/201 (32%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 354 LGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHLLG 408
LG GG+G V K R A+K ++K +E + +H I+ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 409 FCCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
D + IY EY G L +L R++ AR IA V A EYLHN
Sbjct: 61 TFKD---KKYIYMLMEYCLGGELWTIL-RDRGLFDEYTARFY-IA-CVVLAFEYLHN--- 111
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
I++ D+KP+N+LLD + K+ DFG AK + T GT Y+APEI L
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC---GTPEYVAPEII---L 165
Query: 526 GNPSGKS-DVYSYGMLLLEMI 545
S D +S G+LL E++
Sbjct: 166 NKGYDFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 15/199 (7%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVK-VLEKTSNFSDNFIN--EVATIGRIHHVNIIHLL 407
K+G G YG VYK + G +VA+K + + + E+ + ++H NII LL
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
L++E+M + L L+ L + + + + + H+
Sbjct: 65 DVFRHKGDLYLVFEFM-DTDLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSH---G 118
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
ILH D+KP+N+L++ + K++DFGLA+ S R T T Y APE+ + + G
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR---PYTHYVVTRWYRAPELLLGDKG 175
Query: 527 NPSGKSDVYSYGMLLLEMI 545
+ D++S G + E++
Sbjct: 176 YSTP-VDIWSVGCIFAELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 71/288 (24%), Positives = 128/288 (44%), Gaps = 49/288 (17%)
Query: 354 LGTGGYGNVYKGK------FPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNIIH 405
LG G +G V K VAVK+L++ ++ S+ + ++E + +++H ++I
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 406 LLGFCCDGSTRALIYEYMPNGSL---------------GDLLSREKENL------SLKPA 444
L G C LI EY GSL G +R L +L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 445 RLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504
L+ A ++ ++YL E++++H D+ +NVL+ K+SDFGL++ S V
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE 564
+ R + ++A E ++ + +SDV+S+G+LL E++ T G N
Sbjct: 185 KRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIV-----------TLGGNPYP 231
Query: 565 AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
P+ +++ L K + E + + +M + L C + P RP+
Sbjct: 232 GIAPERLFNLL----KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPT 275
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 73/212 (34%), Positives = 110/212 (51%), Gaps = 41/212 (19%)
Query: 354 LGTGGYGNVYKGKFPDG----RLVAVKVLEKTS---NFSD--------NFINEVATIGRI 398
LG GGYG V++ + G ++ A+KVL+K + N D N + V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV------ 57
Query: 399 HHVNIIHLL-GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR---LLEIALGVA 454
H I+ L+ F G LI EY+ G L + E+E + ++ L EI+L
Sbjct: 58 KHPFIVDLIYAFQTGGKLY-LILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISL--- 111
Query: 455 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 514
A+E+LH + I++ D+KP+N+LLD K++DFGL K + VT T GTI
Sbjct: 112 -ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFC-GTIE 165
Query: 515 YIAPEIFMRNLGNPSGKS-DVYSYGMLLLEMI 545
Y+APEI MR+ G+ GK+ D +S G L+ +M+
Sbjct: 166 YMAPEILMRS-GH--GKAVDWWSLGALMYDML 194
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-16
Identities = 70/274 (25%), Positives = 120/274 (43%), Gaps = 32/274 (11%)
Query: 353 KLGTGGYGNVYKGKF---PDGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHL 406
+LG+G +G V KG + + VAVK+L+ +N D + E + ++ + I+ +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
+G C + + L+ E G L L + K + + E+ V+ ++YL E
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMGMKYLE---ET 114
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV-TMTGPRGTIGYIAPEIFMRNL 525
+H D+ +NVLL K+SDFGL+KA + + T + + + APE N
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM--NY 172
Query: 526 GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585
S KSDV+S+G+L+ E +P + G+ T+ E + +E
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYG--QKPYKGMKGNEVTQMI------------ESGERME 218
Query: 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619
C +M + C +RP VVE+
Sbjct: 219 CPQRC-PPEMYDLMKLCWTYGVDERPGFA-VVEL 250
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 32/208 (15%)
Query: 354 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSD----NFINEVATIGRI---HHVNIIH 405
+G G YG VYK + GR VA+K + + + + + E+A + ++ H NI+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 406 LLGFC--CDGSTR---ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 460
LL C L++E++ + L LS+ + L P + ++ + +++L
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKP-GLPPETIKDLMRQLLRGVDFL 123
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS----VVTMTGPRGTIGYI 516
H+ RI+H D+KPQN+L+ D K++DFGLA+ +S + VVT+ Y
Sbjct: 124 HSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLW-------YR 173
Query: 517 APEIFMRNLGNPSGKSDVYSYGMLLLEM 544
APE+ +++ D++S G + E+
Sbjct: 174 APEVLLQSSYATP--VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGF 409
E +G G YG VYKG+ G+L A+KV++ T + + E+ + + HH NI G
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 410 CCDGSTRA------LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 463
+ L+ E+ GS+ DL+ K N +LK + I + + +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-TLKEEWIAYICREILRGLSHLH-- 128
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
+ +++H DIK QNVLL + K+ DFG++ +R+V GT ++APE+
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 524 NLGNPSG----KSDVYSYGMLLLEMIE 546
+ NP KSD++S G+ +EM E
Sbjct: 186 D-ENPDATYDFKSDLWSLGITAIEMAE 211
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 70/214 (32%), Positives = 113/214 (52%), Gaps = 25/214 (11%)
Query: 353 KLGTGGYGNVYKGKFPD-GRLVAVKVLE-KTSNFSDNFINEVATIGRIHHVNIIHLLG-F 409
+LG G +G VYK K + G L A KV+E K+ ++++ E+ + +H I+ LLG F
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
DG +I E+ P G++ D + E + L ++ I + A++YLH+ ++I+
Sbjct: 79 YWDGKLWIMI-EFCPGGAV-DAIMLELDR-GLTEPQIQVICRQMLEALQYLHS---MKII 132
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLA----KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
H D+K NVLL D K++DFG++ K R S + GT ++APE+ M
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEVVMCET 186
Query: 526 GNPSG---KSDVYSYGMLLLEM--IEEKKH-LRP 553
+ K+D++S G+ L+EM IE H L P
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 66/213 (30%), Positives = 107/213 (50%), Gaps = 31/213 (14%)
Query: 354 LGTGGYGNVYKGKFPDGRL---VAVKVLEKTSNFSD--NFINEVATIGRI-HHVNIIHLL 407
+G G +G V K + L A+K +++ ++ D +F E+ + ++ HH NII+LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPA--------------RLLEIALGV 453
G C L EY P+G+L D L R+ L PA +LL A V
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 454 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV-VTMTGPRGT 512
A ++YL + + +H D+ +N+L+ ++ K++DFGL SR + V V T R
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL----SRGQEVYVKKTMGRLP 174
Query: 513 IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
+ ++A E N + SDV+SYG+LL E++
Sbjct: 175 VRWMAIESL--NYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 66/226 (29%), Positives = 96/226 (42%), Gaps = 44/226 (19%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLG 408
+G G +G V+ + D G++ A+KVL K+ N + E + I+ L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY 68
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGCEL 466
D L+ EYMP G L +LL R K+ + AR E+ L A++ +H L
Sbjct: 69 SFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVL----ALDSVHK---L 120
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAK----AHSR--------NRSVVTMTGPR---- 510
+H DIKP N+L+D D K++DFGL K A R N R
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 511 -----------GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
GT YIAPE+ + D +S G++L EM+
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGF 409
E +G G YG VYKG+ G+L A+KV++ T + + E+ + + HH NI G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 410 CCDGSTRA------LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 463
S L+ E+ GS+ DL+ K N +LK + I + + +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-ALKEDWIAYICREILRGLAHLHAH 140
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
+++H DIK QNVLL + K+ DFG++ +R+V GT ++APE+
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 524 NLGNPSG----KSDVYSYGMLLLEMIE 546
+ NP +SD++S G+ +EM E
Sbjct: 196 D-ENPDATYDYRSDIWSLGITAIEMAE 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 28/199 (14%)
Query: 357 GGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV-----NIIHLLGFC 410
G +G+VY K G A+KVL+K+ + N + V I + + L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 411 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLH-NGCELR 467
L+ EY+ G L+ + L A+ + E+ LGV E LH G
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQYIAEVVLGV----EDLHQRG---- 117
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
I+H DIKP+N+L+D K++DFGL++ N+ V GT Y+APE + G
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETIL---GV 168
Query: 528 PSGK-SDVYSYGMLLLEMI 545
K SD +S G ++ E +
Sbjct: 169 GDDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 73/298 (24%), Positives = 117/298 (39%), Gaps = 67/298 (22%)
Query: 351 KEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLG 408
E +G G YG VYK + G+LVA+K+++ + + E + + +H NI G
Sbjct: 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 409 F------CCDGSTRALIYEYMPNGSLGDLLSR-EKENLSLKPARLLEIALGVAHAIEYLH 461
+ L+ E GS+ DL+ K+ LK + I + YLH
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA-----KAHSRNRSVVTMTGPRGTIGYI 516
+++H DIK QN+LL + K+ DFG++ RN + GT ++
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-------GTPYWM 180
Query: 517 APEIFMRNLGNPS----GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYF----- 567
APE+ + P +SDV+S G+ +E+ + K L + A F
Sbjct: 181 APEVIACDE-QPDASYDARSDVWSLGITAIELADGKPPL------CDMHPMRALFKIPRN 233
Query: 568 --PDWIYDKLIQPEK-----EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
P L PE DF+ C+ N + RP M ++E
Sbjct: 234 PPP-----TLKSPENWSKKFNDFIS---------------ECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 350 FKEKLGTGGYGNVYKGKF-----PDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVN 402
F E+LG +G +YKG +LVA+K L+ +N F E + + +HH N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLL------------SREKENL--SLKPARLLE 448
I+ LLG +++EY+ G L + L S E + SL L
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 449 IALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508
IA+ +A +EYL + +H D+ +N+L+ K+SD GL++
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 544
I ++ PE M G S SD++S+G++L E+
Sbjct: 186 SLLPIRWMPPEAIM--YGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 76/296 (25%), Positives = 130/296 (43%), Gaps = 55/296 (18%)
Query: 354 LGTGGYGNVYKGKF--PDGRL-VAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLL 407
LG G +G+V +G+ D L VAVK ++ T + ++F++E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 408 GFCCDGSTR------ALIYEYMPNGSLGDLL--SREKENLSLKPARLL-EIALGVAHAIE 458
G C +I +M +G L L SR + P ++L + +A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 459 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-----HSRNRSVVTMTGPRGTI 513
YL + +H D+ +N +L+ + V+DFGL+K + R + M I
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 514 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573
+A ++ + KSDV+S+G+ + E+ + P G +E IYD
Sbjct: 184 ESLADRVY-------TTKSDVWSFGVTMWEIATRGQTPYP-----GVENSE------IYD 225
Query: 574 KLIQPEKEDFVEEEDDCIARKMIIVGLW-----CIQINPKDRPSMTRVVEMLSSAS 624
L Q + +++ DC+ GL+ C +NPKDRPS + L A
Sbjct: 226 YLRQGNR---LKQPPDCLD------GLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 67/208 (32%), Positives = 107/208 (51%), Gaps = 35/208 (16%)
Query: 354 LGTGGYGNVY---KGKFPD-GRLVAVKVLEK-TSNFSDNF--INEVATIGRIHHVNIIHL 406
LG G +G V+ K PD G+L A+KVL+K T D E + ++H I+ L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 407 -LGFCCDGSTRALIYEYMPNGSLGDLLSRE----KENLSLKPARLLEIALGVAHAIEYLH 461
F +G LI +++ G L LS+E +E++ A E+AL + H LH
Sbjct: 64 HYAFQTEGKLY-LILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELALALDH----LH 115
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK----AHSRNRSVVTMTGPRGTIGYIA 517
+ L I++ D+KP+N+LLD + K++DFGL+K + S GT+ Y+A
Sbjct: 116 S---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMA 166
Query: 518 PEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
PE+ R + +D +S+G+L+ EM+
Sbjct: 167 PEVVNRR--GHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 61/224 (27%), Positives = 109/224 (48%), Gaps = 24/224 (10%)
Query: 330 YRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKG-KFPDGRLVAVKVLE-KTSNFSDN 387
+R+AL D + + F K+G G G V GR VAVK ++ + +
Sbjct: 4 FRAALQLVVDPGDPRSYLDNFV-KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL 62
Query: 388 FINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL 447
NEV + H NI+ + G ++ E++ G+L D+++ + + ++
Sbjct: 63 LFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIA 118
Query: 448 EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSV 503
+ L V A+ +LH ++H DIK ++LL D K+SDFG ++K R +S+
Sbjct: 119 TVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL 175
Query: 504 VTMTGPRGTIGYIAPEIFMRNLGNPSG-KSDVYSYGMLLLEMIE 546
V GT ++APE+ R P G + D++S G++++EM++
Sbjct: 176 V------GTPYWMAPEVISR---LPYGTEVDIWSLGIMVIEMVD 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 16/216 (7%)
Query: 334 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKG-KFPDGRLVAVKVLE-KTSNFSDNFINE 391
L S S D KK F EK+G G G VY G+ VA+K + + + INE
Sbjct: 8 LRSIVSVGDPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINE 66
Query: 392 VATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL 451
+ + + NI++ L G ++ EY+ GSL D+++ + ++ +
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCR 122
Query: 452 GVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL-AKAHSRNRSVVTMTGPR 510
A+++LH+ +++H DIK N+LL D + K++DFG A+ TM
Sbjct: 123 ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--- 176
Query: 511 GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE 546
GT ++APE+ R P K D++S G++ +EM+E
Sbjct: 177 GTPYWMAPEVVTRKAYGP--KVDIWSLGIMAIEMVE 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 22/219 (10%)
Query: 334 LLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKG-KFPDGRLVAVKVLE-KTSNFSDNFINE 391
L S S D KK F EK+G G G VY G+ VA++ + + + INE
Sbjct: 9 LRSIVSVGDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 392 VATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL 451
+ + + NI++ L G ++ EY+ GSL D+++ + ++ +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCR 123
Query: 452 GVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMT 507
A+E+LH+ +++H DIK N+LL D + K++DFG + S+ ++V
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--- 177
Query: 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE 546
GT ++APE+ R P K D++S G++ +EMIE
Sbjct: 178 ---GTPYWMAPEVVTRKAYGP--KVDIWSLGIMAIEMIE 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 9e-15
Identities = 64/240 (26%), Positives = 110/240 (45%), Gaps = 49/240 (20%)
Query: 338 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVL--EKTSNFSDNFI 389
Y N+I+ + +G G +G V++ + P +VAVK+L E +++ +F
Sbjct: 2 YPRNNIE-----YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 56
Query: 390 NEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL----SREKENLSLKPAR 445
E A + H NI+ LLG C G L++EYM G L + L R + +LS +
Sbjct: 57 REAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 446 ---------------LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSD 490
L IA VA + YL E + +H D+ +N L+ + K++D
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIAD 173
Query: 491 FGLAKAHSRNRSVVTMTGPRGT------IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 544
FGL+ R++ + + + I ++ PE N + +SDV++YG++L E+
Sbjct: 174 FGLS------RNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 28/206 (13%)
Query: 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNF--INEVATIGRIHHVNIIHLLG 408
EKLG G Y VYKGK +G+LVA+KV+ F I E + + + H NI+ L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLS-REKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
T L++EY+ DL +K L P + + + Y+H +
Sbjct: 71 IIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRY 123
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKA-----HSRNRSVVTMTGPRGTIGYIAPEIFM 522
ILH D+KPQN+L+ K++DFGLA+A H+ + VVT+ Y P++
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLW-------YRPPDVL- 175
Query: 523 RNLGNPSGKS--DVYSYGMLLLEMIE 546
LG+ + D++ G + +EMI+
Sbjct: 176 --LGSTEYSTCLDMWGVGCIFVEMIQ 199
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 353 KLGTGGYGNVY-KGKFPDGRLVAVKVL----EKTSNFSDNFINEVATIGRIHHVNIIHLL 407
++G G +G VY +VAVK + ++T+ + I EV + ++ H N I
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL---GVAHAIEYLHNGC 464
G T L+ EY GS DLL K KP + +EIA G + YLH+
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHSHN 141
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM-R 523
++H DIK N+LL K++DFG A S S V GT ++APE+ +
Sbjct: 142 ---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAM 192
Query: 524 NLGNPSGKSDVYSYGMLLLEMIEEKKHL 551
+ G GK DV+S G+ +E+ E K L
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 351 KEKLGTGGYGNVY--KGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN----II 404
K +G G +G V + K G + A+KV++K+ + ++ I ++ I
Sbjct: 6 KSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIP 64
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHN 462
L D L+ EY P G L LL+R ++ A+ L E+ L AI +H
Sbjct: 65 QLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVL----AIHSVH- 119
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
++ +H DIKP+NVL+D K++DFG A + N+ V + P GT YIAPE+
Sbjct: 120 --QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS-KLPVGTPDYIAPEVLT 176
Query: 523 RNLGNPSGKSDV----YSYGMLLLEMI 545
G+ G V +S G++ EMI
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 79/295 (26%), Positives = 125/295 (42%), Gaps = 58/295 (19%)
Query: 352 EKLGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDNF--INEVATIGRIHHVNIIHLLG 408
EKLG G Y VYKG +G+LVA+KV+ + F I E + + + H NI+ L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
T ++EYM + L + + L RL L + Y+H I
Sbjct: 71 IIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQL--LRGLAYIHGQ---HI 124
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
LH D+KPQN+L+ K++DFGLA+A S T + T+ Y P++ + +
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--TYSSEVVTLWYRPPDVLL-GATDY 181
Query: 529 SGKSDVYSYGMLLLEMIEEKKHLR------------------PTETT-SGSNTTEAYFPD 569
S D++ G + +EM++ + PTE T G + Y P+
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241
Query: 570 W-----------IYDKLIQ-PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
W ++ +L + P+ ED +A +M + + PKDR S
Sbjct: 242 WFLPCKPQQLRVVWKRLSRPPKAED--------LASQM-------LMMFPKDRIS 281
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 1e-14
Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 339 SYNDIKKMTNGFKEKLGTGGYGNVYKGK-FPDGRLVAVKVLE-KTSNFSDNFINEVATIG 396
S D KK + EK+G G G V+ G+ VA+K + + + INE+ +
Sbjct: 13 SIGDPKKKYTRY-EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMK 71
Query: 397 RIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHA 456
+ + NI++ L G ++ EY+ GSL D+++ + A++ + A
Sbjct: 72 ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQA 127
Query: 457 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL-AKAHSRNRSVVTMTGPRGTIGY 515
+E+LH +++H DIK NVLL D + K++DFG A+ TM GT +
Sbjct: 128 LEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYW 181
Query: 516 IAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE 546
+APE+ R P K D++S G++ +EM+E
Sbjct: 182 MAPEVVTRKAYGP--KVDIWSLGIMAIEMVE 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 34/226 (15%)
Query: 343 IKKMTNGFKEKLGTGGYGNVYKGK----FP--DGRLVAVKVL-EKTSNFSDNFINEVATI 395
IK+ K +LG G +G V+ + P D LVAVK L E + + +F E +
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 61
Query: 396 GRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLS---------REKENLSLKP--- 443
+ H +I+ G C +G +++EYM +G L L E+++
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 444 ARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRS 502
++L IA +A + YL L +H D+ +N L+ K+ DFG+++ +S +
Sbjct: 122 GQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 178
Query: 503 VV---TMTGPRGTIGYIAPE-IFMRNLGNPSGKSDVYSYGMLLLEM 544
V TM I ++ PE I R + +SD++S+G++L E+
Sbjct: 179 RVGGRTML----PIRWMPPESILYRKF---TTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 73/222 (32%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 341 NDIKKMTNGFKEKLGTGGYGNVYKGKFPDGR---LVAVKVLEKTSNFSD----NFINEVA 393
D +K+ +E +G G +G VY + D R +VA+K + + S+ + I EV
Sbjct: 21 EDPEKLFTDLRE-IGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK 77
Query: 394 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL-- 451
+ RI H N I G T L+ EY GS DLL K KP + +EIA
Sbjct: 78 FLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAIT 131
Query: 452 -GVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR 510
G + YLH+ ++H DIK N+LL K++DFG A S S V
Sbjct: 132 HGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------ 182
Query: 511 GTIGYIAPEIFM-RNLGNPSGKSDVYSYGMLLLEMIEEKKHL 551
GT ++APE+ + + G GK DV+S G+ +E+ E K L
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 353 KLGTGGYGNVYKGKFPDGRL---VAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIHLL 407
+LG+G +G V KG + + VA+KVL E + D + E + ++ + I+ ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
G C + L+ E G L LS +K+ +++ + ++E+ V+ ++YL
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITV--SNVVELMHQVSMGMKYLE---GKN 115
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM-TGPRGTIGYIAPEIFMRNLG 526
+H D+ +NVLL K+SDFGL+KA + S + + + + APE N
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI--NFR 173
Query: 527 NPSGKSDVYSYGMLLLE 543
S +SDV+SYG+ + E
Sbjct: 174 KFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 351 KEKLGTGGYGNVYKG-KFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHL 406
K+G G +G V+K + D R+ A+K ++ + + I+E + ++ II
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLL-----SREKENLSLKPARLLEIALGVAHAIEYLH 461
D ++ EY NG L LL E+ + ++I LG+AH LH
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR--FFIQILLGLAH----LH 118
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV-TMTGPRGTIGYIAPEI 520
+ +ILH DIK N+ LD K+ D G+AK S N + T+ GT Y++PE+
Sbjct: 119 SK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV---GTPYYLSPEL 172
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEM 544
N KSDV++ G++L E
Sbjct: 173 CEDKPYNE--KSDVWALGVVLYEC 194
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 67/200 (33%), Positives = 99/200 (49%), Gaps = 20/200 (10%)
Query: 354 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 407
LG G +G V + GRL AVKVL+K D+ + T RI +H + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL- 61
Query: 408 GFCCDGSTRALIY--EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
+CC + L + E++ NG GDL+ +++ AR A + A+ +LH +
Sbjct: 62 -YCCFQTPDRLFFVMEFV-NG--GDLMFHIQKSRRFDEARARFYAAEITSALMFLH---D 114
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
I++ D+K NVLLD + K++DFG+ K N T + GT YIAPEI L
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEML 172
Query: 526 GNPSGKSDVYSYGMLLLEMI 545
PS D ++ G+LL EM+
Sbjct: 173 YGPS--VDWWAMGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 352 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI----HHVNIIHL 406
++G GGYG V+ K D G +VA+K ++K+ F N + V T I ++ L
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
L D L EY+P G LL+ LS AR + A ++ LH EL
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLN-NLGVLSEDHARFYMAEMFEA--VDALH---EL 120
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
+H D+KP+N L+D K++DFGL+K + SVV G+ Y+APE+
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV------GSPDYMAPEVL--RG 172
Query: 526 GNPSGKSDVYSYGMLLLEMI 545
D +S G +L E +
Sbjct: 173 KGYDFTVDYWSLGCMLYEFL 192
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 34/213 (15%)
Query: 352 EKLGTGGYGNVYKGKF---PDGRL--------VAVKVLEKTSNFSDNFINEVATIGRIHH 400
E LG G + N+YKG D + V +KVL S F + + ++ H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 401 VNIIHLLGFC-CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY 459
+++ L G C D + ++ EY+ G L L REK N+SL L++A +A A+ Y
Sbjct: 61 KHLVKLYGVCVRDENI--MVEEYVKFGPLDVFLHREKNNVSL--HWKLDVAKQLASALHY 116
Query: 460 LHNGCELRILHLDIKPQNVLL---DPDFTP----KVSDFGLAKAHSRNRSVVTMTGPRGT 512
L + +++H ++ +N+L+ + K+SD G+ +V++
Sbjct: 117 LE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP------ITVLSREERVER 167
Query: 513 IGYIAPEIFMRNLG-NPSGKSDVYSYGMLLLEM 544
I +IAPE +RN + + +D +S+G LLE+
Sbjct: 168 IPWIAPE-CIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 354 LGTGGYGNVY--KGKFPDGRLVAVK---VLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
+G G +G V+ + K D +LV +K V + T + NE + + H NII
Sbjct: 8 VGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+ ++ EY P G+L + + + +L L +L + + A+ ++H I
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHVHTK---LI 122
Query: 469 LHLDIKPQNVLLDPDFTP-KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
LH D+K QN+LLD K+ DFG++K S T+ GT YI+PE+ G
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV---GTPCYISPELCE---GK 176
Query: 528 P-SGKSDVYSYGMLLLEMIEEKK 549
P + KSD+++ G +L E+ K+
Sbjct: 177 PYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 352 EKLGTGGYGNVYKGKFPD-GRLVAVKV-LEKTSNFSDNFI--NEVATIGRIHHVNIIHLL 407
+G G YG V K K + G++VA+K LE + I E+ + ++ H N+++L+
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
L++E++ + L DL EK L +R+ + + IE+ H+
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSH---N 120
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-------GTIGYIAPEI 520
I+H DIKP+N+L+ K+ DFG A+ T+ P T Y APE+
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFAR---------TLAAPGEVYTDYVATRWYRAPEL 171
Query: 521 FMRNLGNPS-GKS-DVYSYGMLLLEMI 545
+G+ G++ D+++ G L+ EM+
Sbjct: 172 L---VGDTKYGRAVDIWAVGCLVTEML 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 31/209 (14%)
Query: 354 LGTGGYGNVY----KGKFPDGRLVAVKVLEKTS-----NFSDNFINEVATIGRIHHVNII 404
LGTG YG V+ G G+L A+KVL+K + +++ E + + +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 405 HLLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLH 461
L + T+ LI +Y+ G L L ++E+ + R+ EI L A+++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFTESEVRVYIAEIVL----ALDHLH 122
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-----GTIGYI 516
+L I++ DIK +N+LLD + ++DFGL+K + R GTI Y+
Sbjct: 123 ---QLGIIYRDIKLENILLDSEGHVVLTDFGLSK------EFLAEEEERAYSFCGTIEYM 173
Query: 517 APEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
APE+ G D +S G+L E++
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 89/319 (27%), Positives = 147/319 (46%), Gaps = 58/319 (18%)
Query: 354 LGTGGYGNVYKGK-------FPDGRL-VAVKVLEKTSNFSD--NFINEVATIGRI-HHVN 402
LG G +G V + + PD + VAVK+L+ + D + I+E+ + I H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREK---------------ENLSLKPARLL 447
II+LLG C +I EY G+L + L + E LS K L+
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD--LV 137
Query: 448 EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVVTM 506
A VA +EYL + R +H D+ +NVL+ D K++DFGLA+ H + T
Sbjct: 138 SCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 507 TGPRGTIGYIAPE-IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEA 565
G R + ++APE +F R + +SDV+S+G+L+ E+ T GS
Sbjct: 195 NG-RLPVKWMAPEALFDRVY---THQSDVWSFGILMWEIF----------TLGGSP---- 236
Query: 566 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE----MLS 621
+P ++L + +E ++ ++ ++ C P RP+ ++VE +L+
Sbjct: 237 -YPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295
Query: 622 SASAEAIE--MPPKPLFPS 638
+ S E ++ MP + PS
Sbjct: 296 AVSEEYLDLSMPFEQYSPS 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 66/220 (30%), Positives = 104/220 (47%), Gaps = 25/220 (11%)
Query: 341 NDIKKMTNGFKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSD----NFINEVATI 395
+D +K+ + +E +G G +G VY + + +VA+K + + S+ + I EV +
Sbjct: 11 DDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 396 GRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL---G 452
++ H N I G T L+ EY GS DLL K KP + +EIA G
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK-----KPLQEVEIAAVTHG 123
Query: 453 VAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT 512
+ YLH+ ++H D+K N+LL K+ DFG A + V GT
Sbjct: 124 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GT 174
Query: 513 IGYIAPEIFM-RNLGNPSGKSDVYSYGMLLLEMIEEKKHL 551
++APE+ + + G GK DV+S G+ +E+ E K L
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 64/226 (28%), Positives = 114/226 (50%), Gaps = 24/226 (10%)
Query: 328 KTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNV-YKGKFPDGRLVAVKVLE-KTSNFS 385
+ +R+AL S D ++ + F K+G G G V + G+ VAVK ++ +
Sbjct: 5 EQFRAALQLVVSPGDPREYLDSFI-KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR 63
Query: 386 DNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR 445
+ NEV + HH N++ + G ++ E++ G+L D+++ + N +
Sbjct: 64 ELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMN----EEQ 119
Query: 446 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNR 501
+ + L V A+ YLHN ++H DIK ++LL D K+SDFG ++K + +
Sbjct: 120 IATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176
Query: 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKS-DVYSYGMLLLEMIE 546
S+V GT ++APE+ R P G D++S G++++EMI+
Sbjct: 177 SLV------GTPYWMAPEVISR---LPYGTEVDIWSLGIMVIEMID 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 57/294 (19%)
Query: 353 KLGTGGYGNVYKGKF-------PDGRLVAVKVLEKTSNFSD--NFINEVATIGRI--HHV 401
+LG G +G VY+G + R VAVK + ++++ + F+NE + + HHV
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR---EKENLSLKPA----RLLEIALGVA 454
+ LLG G ++ E M +G L L E EN +P ++++A +A
Sbjct: 72 --VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 455 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG--T 512
+ YL+ + +H D+ +N ++ DFT K+ DFG+ + + G +G
Sbjct: 130 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLP 184
Query: 513 IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 572
+ ++APE + S SD++S+G++L E+ T+ A P Y
Sbjct: 185 VRWMAPESLKDGVFTTS--SDMWSFGVVLWEI-----------------TSLAEQP---Y 222
Query: 573 DKLIQPEKEDFV------EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
L + FV ++ D+C R ++ + C Q NPK RP+ +V +L
Sbjct: 223 QGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRM-CWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 30/207 (14%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHV---NIIH 405
E +G G YG VY+GK P GR+VA+K++ + D + EVA + ++ NI
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVA-----HAIEYL 460
G G +I EY GS+ L+ K + E + V A++Y+
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLM---------KAGPIAEKYISVIIREVLVALKYI 117
Query: 461 H-NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV-VTMTGPRGTIGYIAP 518
H G ++H DIK N+L+ K+ DFG+A ++N S T GT ++AP
Sbjct: 118 HKVG----VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV---GTPYWMAP 170
Query: 519 EIFMRNLGNPSGKSDVYSYGMLLLEMI 545
E+ + K+D++S G+ + EM
Sbjct: 171 EVITEGKYYDT-KADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 64/204 (31%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 354 LGTGGYGNV----YKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNII 404
LG G +G V KG L AVKVL+K D+ + T R+ H +
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 405 HLLGFCCDGSTRALIY--EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
L C + L + EY+ NG GDL+ + + R A + +++LH
Sbjct: 60 QL--HSCFQTKDRLFFVMEYV-NG--GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH- 113
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
E I++ D+K NVLLD + K++DFG+ K VT + GT YIAPEI
Sbjct: 114 --ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIAPEIL- 168
Query: 523 RNLGNPSGKS-DVYSYGMLLLEMI 545
P G + D ++ G+LL EM+
Sbjct: 169 --SYQPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 352 EKLGTGGYGNVYKGKFPDG---RLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNIIHL 406
+++G G +G V G+ G V VK L +++ + F+ E + H N++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLS--REKENLSLKPARLLEIALGVAHAIEYLHNGC 464
LG C + + L+ E+ P G L L R+ E ++ P L +A +A + +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
+H D+ +N LL D T K+ D+GL+ + VT + +IAPE+
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 525 LGN-----PSGKSDVYSYGMLLLEMIE 546
GN + +S+V+S G+ + E+ E
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFE 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 73/266 (27%), Positives = 119/266 (44%), Gaps = 40/266 (15%)
Query: 373 VAVKVLEKTSNFSD--NFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429
VAVK+L+ + D + I+E+ + I H NII+LLG C +I EY G+L
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112
Query: 430 DLLSREK---------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIK 474
+ L + E LS K L+ A VA +EYL + + +H D+
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKD--LVSCAYQVARGMEYLASK---KCIHRDLA 167
Query: 475 PQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDV 534
+NVL+ D K++DFGLA+ T R + ++APE + + +SDV
Sbjct: 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI--YTHQSDV 225
Query: 535 YSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARK 594
+S+G+LL E+ T GS +P ++L + KE ++ +
Sbjct: 226 WSFGVLLWEIF----------TLGGSP-----YPGVPVEELFKLLKEGHRMDKPSNCTNE 270
Query: 595 MIIVGLWCIQINPKDRPSMTRVVEML 620
+ ++ C P RP+ ++VE L
Sbjct: 271 LYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 26/224 (11%)
Query: 342 DIKKMTNGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTSNFS--DNFINEVA 393
+I T F E+LG +G VYKG + VA+K L+ + + F +E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 394 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL----------SREKENL---S 440
R+ H NI+ LLG ++I+ Y + L + L S + + +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 441 LKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500
L+PA + I +A +E+L + ++H D+ +NVL+ K+SD GL +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 544
M I +++PE M G S SD++SYG++L E+
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 33/212 (15%)
Query: 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVL---EKTSNFSDNFINEVATIGRIHHVNIIHLL 407
EK+G G YG VYK + +A+K + ++ I E++ + + H NI+ L
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 408 GFCCDGSTRALIYEYMPNGSLGDL-LSRE-------KENLSLKPARLLEIALGVAHAIEY 459
L++EY+ DL L + +N L L +I G+A Y
Sbjct: 68 DVVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----Y 117
Query: 460 LHNGCELRILHLDIKPQNVLLD-PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 518
H+ R+LH D+KPQN+L+D K++DFGLA+A V T T T+ Y AP
Sbjct: 118 CHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG--IPVRTFTHEVVTLWYRAP 172
Query: 519 EIFM--RNLGNPSGKSDVYSYGMLLLEMIEEK 548
EI + R+ P D++S G + EM+ +K
Sbjct: 173 EILLGSRHYSTP---VDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLE-KTSNFSDNFINEVATIGRIHHVNIIHLL-GFC 410
LG G +G VYK + + G A K+++ ++ ++F+ E+ + H NI+ L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 411 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 470
+ LI E+ G+L ++ + L ++ + + A+ +LH+ +++H
Sbjct: 73 YENKLWILI-EFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 471 LDIKPQNVLLDPDFTPKVSDFGL-AKAHSRNRSVVTMTGPRGTIGYIAPEIFM--RNLGN 527
D+K N+LL D K++DFG+ AK S + T GT ++APE+ N
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYWMAPEVVACETFKDN 183
Query: 528 P-SGKSDVYSYGMLLLEMIE 546
P K+D++S G+ L+E+ +
Sbjct: 184 PYDYKADIWSLGITLIELAQ 203
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 353 KLGTGGYGNVYKGKFP-DGRLVAVK---VLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
K+G G +G V+K + ++VA+K + + F + E+ + + H N+++L+
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 409 FCCDGST-----RALIYEYMP--NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
C +T + Y L LLS +N+ + + ++ + + + Y+H
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEHDLAGLLS--NKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS------RNRSVVTMTGPRGTIGY 515
+ILH D+K N+L+ D K++DFGLA+A S NR T T+ Y
Sbjct: 137 RN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR----YTNRVVTLWY 189
Query: 516 IAPEIFM--RNLGNPSGKSDVYSYGMLLLEM 544
PE+ + R+ G P D++ G ++ EM
Sbjct: 190 RPPELLLGERDYGPP---IDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-13
Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 25/189 (13%)
Query: 370 GRLVAVKVL-----EKTSNFSDNFINEVATIGRIHHVNIIHLL--GFCCDGSTRALIYEY 422
G VA+K+L E+ + F E A R++H NI+ LL G G A ++EY
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRA-RFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEY 60
Query: 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD- 481
+P +L ++L+ + +L + L V A+ HN I+H D+KPQN+++
Sbjct: 61 VPGRTLREVLAADG---ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQ 114
Query: 482 PDFTP--KVSDFG----LAKAHSRNRSVVTMTGPR-GTIGYIAPEIFMRNLGNPSGKSDV 534
P KV DFG L + + +T T GT Y APE +R + SD+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQ-LRG-EPVTPNSDL 172
Query: 535 YSYGMLLLE 543
Y++G++ LE
Sbjct: 173 YAWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 50/292 (17%)
Query: 354 LGTGGYGNVY--------KGKFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRI-HHVN 402
LG G +G V K K VAVK+L+ + D + ++E+ + I H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREK---------------ENLSLKPARLL 447
II+LLG C ++ EY G+L + L + E L+ K L+
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD--LV 137
Query: 448 EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVVTM 506
A VA +EYL + + +H D+ +NVL+ D K++DFGLA+ H+ + T
Sbjct: 138 SCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAY 566
G R + ++APE + + +SDV+S+G+LL E+ T GS
Sbjct: 195 NG-RLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIF----------TLGGSP----- 236
Query: 567 FPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+P ++L + KE ++ ++ ++ C P RP+ ++VE
Sbjct: 237 YPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 46/189 (24%), Positives = 89/189 (47%), Gaps = 26/189 (13%)
Query: 353 KLGTGGYGNVYKGK---FPDGRLVAVKVLE----KTSNFSDNFINEVATIGRIHHVNIIH 405
+G G YG VYK K DG+ A+K + + + S + E+A + + H N++
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 406 LLGFCCDGSTRA--LIYEYMPNGSLGDLLS-----REKENLSLKPARLLEIALGVAHAIE 458
L+ + + ++ L+++Y + DL R+ + +S+ P+ + + + + +
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 459 YLHNGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLA-KAHSRNRSVVTMTGPRGTI 513
YLH +LH D+KP N+L+ K+ D GLA ++ + + + TI
Sbjct: 123 YLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 514 GYIAPEIFM 522
Y APE+ +
Sbjct: 180 WYRAPELLL 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 67/283 (23%), Positives = 125/283 (44%), Gaps = 41/283 (14%)
Query: 353 KLGTGGYGNVYKG-------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNI 403
+LG G +G VY+G P+ R VA+K + + ++ + F+NE + + + ++
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 404 IHLLGFCCDGSTRALIYEYMPNGSLGDLL----SREKENLSLKP---ARLLEIALGVAHA 456
+ LLG G +I E M G L L + N P +++++A +A
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 457 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG--TIG 514
+ YL+ + +H D+ +N ++ DFT K+ DFG+ + + G +G +
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVR 186
Query: 515 YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 574
+++PE G + SDV+S+G++L E+ + +P + S + DK
Sbjct: 187 WMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAE--QPYQGMSNEQVLRFVMEGGLLDK 242
Query: 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVV 617
D+C ++ + C Q NPK RPS ++
Sbjct: 243 ------------PDNCPDMLFELMRM-CWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 85/314 (27%), Positives = 138/314 (43%), Gaps = 85/314 (27%)
Query: 351 KEKLGTGGYGNVYKGKFPD---GRLVAVK-VLEKTSNFSDN--------FINEVATIGRI 398
+KLG G YG V+K D +VA+K + + N +D F+ E+
Sbjct: 12 LQKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG----- 64
Query: 399 HHVNIIHLLGFCCDGSTRA-------LIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL 451
H NI+ LL +A L++EYM DL + + N+ L+ I
Sbjct: 65 DHPNIVKLLNV-----IKAENDKDIYLVFEYMET----DLHAVIRANI-LEDVHKRYIMY 114
Query: 452 GVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG 511
+ A++Y+H+G ++H D+KP N+LL+ D K++DFGLA RS+ +
Sbjct: 115 QLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLA------RSLSELEENPE 165
Query: 512 ---------TIGYIAPEIFMRNLGNPS-GKS-DVYSYGMLLLEMIEEKKHLRPTETTSGS 560
T Y APEI LG+ K D++S G +L EM+ K L P G+
Sbjct: 166 NPVLTDYVATRWYRAPEIL---LGSTRYTKGVDMWSVGCILGEMLLGKP-LFP-----GT 216
Query: 561 NTTEAYFPDWIYDKLIQ----PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRV 616
+T + + +K+I+ P ED +E A M+ + + R +
Sbjct: 217 STL-----NQL-EKIIEVIGPPSAED-IESIKSPFAATML------DSLPSRPRKPLD-- 261
Query: 617 VEMLSSASAEAIEM 630
E+L AS +A+++
Sbjct: 262 -ELLPKASDDALDL 274
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 25/201 (12%)
Query: 350 FKEKLGTGGYGNVYKG-KFPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHL 406
++E LG G G VYK R++AVKV L+ T ++E+ + + II
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
G + ++ E+M GSL D+ + E++ L IA+ V + YL + L
Sbjct: 65 YGAFFVENRISICTEFMDGGSL-DVYRKIPEHV------LGRIAVAVVKGLTYLWS---L 114
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAK--AHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
+ILH D+KP N+L++ K+ DFG++ +S ++ V GT Y+APE R
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV------GTNAYMAPE---RI 165
Query: 525 LGNPSG-KSDVYSYGMLLLEM 544
G G SDV+S G+ +E+
Sbjct: 166 SGEQYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 21/200 (10%)
Query: 353 KLGTGGYGNVYKGKF-PDGRLVAVKVLE-KTSNFSDNFINEVATIGRIHHVNIIHLLGFC 410
K+G G G V G+LVAVK ++ + + NEV + H N++ +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 411 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 470
G ++ E++ G+L D+++ + N ++ + L V A+ LH ++H
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMN----EEQIAAVCLAVLKALSVLHAQ---GVIH 139
Query: 471 LDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
DIK ++LL D K+SDFG ++K R +S+V GT ++APE+ R
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPELISRLPY 193
Query: 527 NPSGKSDVYSYGMLLLEMIE 546
P + D++S G++++EM++
Sbjct: 194 GP--EVDIWSLGIMVIEMVD 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 353 KLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSN---FSDNFINEVATIGRIH---HVNIIH 405
++G G YG VYK + P G VA+K + +N + + EVA + R+ H NI+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 406 LLGFCCDGSTR-----ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 460
L+ C T L++E++ L L + + ++ +++L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDFL 124
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 520
H C I+H D+KP+N+L+ K++DFGLA+ +S + +T T+ Y APE+
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYRAPEV 178
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEMIEEK 548
+++ + D++S G + EM K
Sbjct: 179 LLQS--TYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 31/217 (14%)
Query: 341 NDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRL--VAVKVLEKTSNFS----DNFINEVAT 394
N +K F LGTG +G V + + VA+K EK+ D+ +E
Sbjct: 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKI 84
Query: 395 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLS----LKPARLLEIA 450
+ I+H ++L G D S L+ E++ G L R K + A+++ I
Sbjct: 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI- 143
Query: 451 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVVTMTGP 509
EYL + L I++ D+KP+N+LLD D K++DFG AK +R ++
Sbjct: 144 ------FEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC----- 189
Query: 510 RGTIGYIAPEIFMRNLGNPSGK-SDVYSYGMLLLEMI 545
GT YIAPEI + N+G+ GK +D ++ G+ + E++
Sbjct: 190 -GTPEYIAPEILL-NVGH--GKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 30/229 (13%)
Query: 343 IKKMTNGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTS-NFSDNFINEVATI 395
IK+ K +LG G +G V+ + D LVAVK L+ S N +F E +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 396 GRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGD----------LLSREKENLSLKPAR 445
+ H +I+ G C +G +++EYM +G L L++ L ++
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 446 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVV 504
+L IA +A + YL +H D+ +N L+ + K+ DFG+++ +S + V
Sbjct: 122 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178
Query: 505 ---TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKH 550
TM I ++ PE M + +SDV+S G++L E+ K
Sbjct: 179 GGHTML----PIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 21/200 (10%)
Query: 353 KLGTGGYGNVYKGKFP-DGRLVAVKVLE-KTSNFSDNFINEVATIGRIHHVNIIHLLGFC 410
K+G G G V + GR VAVK+++ + + NEV + H N++ +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 411 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 470
G ++ E++ G+L D++S+ + L ++ + V A+ YLH+ ++H
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTR----LNEEQIATVCESVLQALCYLHSQ---GVIH 140
Query: 471 LDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
DIK ++LL D K+SDFG ++K + +S+V GT ++APE+ R
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISRTP- 193
Query: 527 NPSGKSDVYSYGMLLLEMIE 546
+ D++S G++++EM++
Sbjct: 194 -YGTEVDIWSLGIMVIEMVD 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 65/243 (26%), Positives = 106/243 (43%), Gaps = 41/243 (16%)
Query: 343 IKKMTNGFKEKLGTGGYGNVYKGK------FPDGRLVAVKVLEKTSNFS--DNFINEVAT 394
IK+ K +LG G +G V+ + D LVAVK L K + +F E
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAEL 60
Query: 395 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSRE-------------KENLSL 441
+ + H +I+ G C DG +++EYM +G L L + L
Sbjct: 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120
Query: 442 KPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRN 500
+++L IA +A + YL +H D+ +N L+ + K+ DFG+++ +S +
Sbjct: 121 GLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
Query: 501 RSVV---TMTGPRGTIGYIAPE-IFMRNLGNPSGKSDVYSYGMLLLEMIEEKK----HLR 552
V TM I ++ PE I R + +SDV+S+G++L E+ K L
Sbjct: 178 YYRVGGHTML----PIRWMPPESIMYRKF---TTESDVWSFGVILWEIFTYGKQPWFQLS 230
Query: 553 PTE 555
TE
Sbjct: 231 NTE 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 69/229 (30%), Positives = 100/229 (43%), Gaps = 48/229 (20%)
Query: 353 KLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDN------FINEVATIGRIHHVNIIH 405
+G GG G VY P R VA+K + + + S+N F+ E + H I+
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIRE--DLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 406 LLGFCCDGSTRALIYEYMP---NGSLGDLLS--REKENLSLKP-------ARLLEIALGV 453
+ C DG +Y MP +L LL +KE+LS K L I +
Sbjct: 67 VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLS-KELAEKTSVGAFLSIFHKI 122
Query: 454 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA-------------KAHSRN 500
IEY+H+ +LH D+KP N+LL + D+G A RN
Sbjct: 123 CATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 501 RSVVTMTGPR---GTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMI 545
+MT P GT Y+APE R LG P S +D+Y+ G++L +M+
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPE---RLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 71/283 (25%), Positives = 126/283 (44%), Gaps = 36/283 (12%)
Query: 354 LGTGGYGNVYKG--KFPDGRL--VAVKVLEKTSNFS---DNFINEVATIGRIHHVNIIHL 406
LG G +G+V + K DG VAVK+L+ S + F+ E A + H N+I L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 407 LGFCCDGSTRA------LIYEYMPNGSLGD--LLSREKEN-LSLKPARLLEIALGVAHAI 457
+G + +I +M +G L L+SR E +L L+ + +A +
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 458 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 517
EYL + +H D+ +N +L+ + T V+DFGL+K + + ++A
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 518 PEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 577
E N+ + SDV+++G+ + E++ R +G +E IY+ LI+
Sbjct: 184 LESLADNV--YTTHSDVWAFGVTMWEIMT-----RGQTPYAGVENSE------IYNYLIK 230
Query: 578 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
+ +++ DC+ ++ C PK RPS + + L
Sbjct: 231 GNR---LKQPPDCLEDVYELM-CQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 32/220 (14%)
Query: 352 EKLGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHL 406
KLG G +G VYK + GR+VA+K + N D F + E+ + ++ H N++ L
Sbjct: 14 GKLGEGTFGEVYKARQIKTGRVVALKKI-LMHNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 407 LGFCCDGS-----TRALIYEYMP--NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY 459
+ + R +Y P + L LL E ++ L +++ L + I Y
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL--ENPSVKLTESQIKCYMLQLLEGINY 130
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI--- 516
LH E ILH DIK N+L+D K++DFGLA+ + G GT Y
Sbjct: 131 LH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187
Query: 517 ------APEIFM--RNLGNPSGKSDVYSYGMLLLEMIEEK 548
PE+ + R D++ G + EM +
Sbjct: 188 VTRWYRPPELLLGERRYTTA---VDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 69/232 (29%), Positives = 99/232 (42%), Gaps = 50/232 (21%)
Query: 352 EKLGTGGYGNVY----KGKFPDGRLVAVKVLEKTSNFSDNFINEVAT----IGRIHHVNI 403
+ LG G G V+ KG G+L A+KVL+K N + V T + + H +
Sbjct: 7 KLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFL 63
Query: 404 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKEN-LSLKPAR--LLEIALGVAHAIEYL 460
L + L+ +Y P G L LL R+ LS + AR E+ L A+EYL
Sbjct: 64 PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL----ALEYL 119
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK----------AHSRNRS-------- 502
H L I++ D+KP+N+LL +SDF L+K R S
Sbjct: 120 HL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 503 ----VVTMTGPR-----GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
R GT YIAPE+ + G+ S D ++ G+LL EM+
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEV-ISGDGHGSA-VDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 77/302 (25%), Positives = 132/302 (43%), Gaps = 50/302 (16%)
Query: 345 KMTNGFKEKLGTGGYGNVY--------KGKFPDGRLVAVKVLEKTSNFSD--NFINEVAT 394
K+T G + LG G +G V K K + VAVK+L+ + D + ++E+
Sbjct: 16 KLTLG--KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 73
Query: 395 IGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREK---------------EN 438
+ I H NII+LLG C +I EY G+L + L + E
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 439 LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498
++ K L+ VA +EYL + +H D+ +NVL+ + K++DFGLA+ +
Sbjct: 134 MTFKD--LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188
Query: 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS 558
T R + ++APE + + +SDV+S+G+L+ E+ T
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIF----------TLG 236
Query: 559 GSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
GS +P ++L + KE ++ ++ ++ C P RP+ ++VE
Sbjct: 237 GSP-----YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291
Query: 619 ML 620
L
Sbjct: 292 DL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 30/228 (13%)
Query: 354 LGTGGYGNVYKGKFPDGR-LVAVKVLEKTSNFS----DNFINEVATIGRIHHVNIIHLLG 408
+GTG +G V+ + A+KV+ + NE + + H II L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
D ++ EY+P G L L R S A + A+EYLH+ I
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFY--ASEIVCALEYLHS---KEI 122
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
++ D+KP+N+LLD + K++DFG AK R+R+ T+ GT Y+APE+ N
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRT-WTLC---GTPEYLAPEVIQSKGHNK 177
Query: 529 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 576
+ D ++ G+L+ EM+ N P IY+K++
Sbjct: 178 A--VDWWALGILIYEMLVGYPPFF------DDN------PFGIYEKIL 211
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 63/247 (25%), Positives = 118/247 (47%), Gaps = 31/247 (12%)
Query: 353 KLGTGGYGNVYKGK--FPDGRLVA---VKVLEKTSNFSDNFINEVATIGRIH---HVNII 404
++G G YG V+K + GR VA V+V + I EVA + + H N++
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 405 HLLGFCC----DGSTR-ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY 459
L C D T+ L++E++ + L L + E + + ++ + +++
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDF 125
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 519
LH+ R++H D+KPQN+L+ K++DFGLA+ +S ++ ++ T+ Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTLWYRAPE 179
Query: 520 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579
+ +++ + + D++S G + EM K R GS+ + I D + P
Sbjct: 180 VLLQS--SYATPVDLWSVGCIFAEMFRRKPLFR------GSSDVDQLGK--ILDVIGLPG 229
Query: 580 KEDFVEE 586
+ED+ +
Sbjct: 230 EEDWPRD 236
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 352 EKLGTGGYGNVYKGKFP-DGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
+KLG G Y VYKG+ G+LVA+K LE I E + + + H NI+ L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL--GVAHAIEYLHNGCEL 466
T L++EY+ + L + LS+ RL L G+A Y H +
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA----YCH---QR 122
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG--TIGYIAPEIFMRN 524
R+LH D+KPQN+L+ K++DFGLA+A +SV + T T+ Y P++
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLARA----KSVPSKTYSNEVVTLWYRPPDVL--- 175
Query: 525 LG--NPSGKSDVYSYGMLLLEMI 545
LG S D++ G + EM
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMA 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|222721 pfam14380, WAK_assoc, Wall-associated receptor kinase C-terminal | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-12
Identities = 30/76 (39%), Positives = 37/76 (48%), Gaps = 11/76 (14%)
Query: 200 PSGCD-SVVVPVSSVTSLYLGADVFDT------LRQGFPLEWPKLD-DCEKCQNRSGRCG 251
GC SVVVPV LGAD+ LR+GF LEW DC +C+ GRCG
Sbjct: 22 SGGCSRSVVVPVLGSA---LGADLGSGDGYEEVLREGFELEWNVDPGDCSECEASGGRCG 78
Query: 252 YNGSLKKITCFCKGGR 267
Y+ + + C C G
Sbjct: 79 YDQTSEFFGCLCPDGP 94
|
This WAK_assoc domain is cysteine-rich and lies C-terminal to the binding domain, GUB_WAK_bind, pfam13947. Length = 94 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 69/244 (28%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 352 EKLGTGGYGNVYKG--KFPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLL 407
+KLG G Y VYKG K D LVA+K LE I EV+ + + H NI+ L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
+ L++EY+ + L L ++++ +L L + Y H +
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQL--LRGLNYCH---RRK 124
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
+LH D+KPQN+L++ K++DFGLA+A S T + T+ Y P+I + + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKS--IPTKTYSNEVVTLWYRPPDILLGST-D 181
Query: 528 PSGKSDVYSYGMLLLEM-----------IEEKKHL------RPTETTSGSNTTEAYFPDW 570
S + D++ G + EM +EE+ H PTE T + F +
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241
Query: 571 IYDK 574
Y K
Sbjct: 242 NYPK 245
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 65/277 (23%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLE----KTSNFSDNFINEVATIGRIHHVNIIH 405
++K+G G + VY+ DG VA+K ++ + + I E+ + +++H N+I
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL-EIALGVAHAIEYLHNGC 464
+ + ++ E G L ++ K+ L P + + + + + A+E++H+
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-- 124
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
R++H DIKP NV + K+ D GL + S + GT Y++PE N
Sbjct: 125 -RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIHEN 181
Query: 525 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW--IYDKLIQPEKED 582
N KSD++S G LL EM + ++ D +Y + E+ D
Sbjct: 182 GYN--FKSDIWSLGCLLYEM---------------AALQSPFYGDKMNLYSLCKKIEQCD 224
Query: 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619
+ D + ++ + CI +P+ RP +T V ++
Sbjct: 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 34/205 (16%)
Query: 353 KLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFIN----EVATIGRIHHVNIIHLL 407
++G+G G VYK P GRL A+KV+ N D E+ + ++H N++
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVI--YGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 408 GFCCDGSTRALIYEYMPNGSL-GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
++ E+M GSL G ++ E+ L ++A + I YLH
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQF--------LADVARQILSGIAYLH---RR 187
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR-----NRSVVTMTGPRGTIGYIAPEIF 521
I+H DIKP N+L++ K++DFG+++ ++ N SV GTI Y++PE
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-------GTIAYMSPERI 240
Query: 522 MRNL--GNPSGKS-DVYSYGMLLLE 543
+L G G + D++S G+ +LE
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 354 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LLGFC 410
+G G +G V K DG+ AVKVL+K + + + N+ H L+G
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 411 CDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
T +Y +Y+ G L L RE+ S R A +A A+ YLH L
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLH---SLN 116
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAK---AHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
I++ D+KP+N+LLD ++DFGL K HS+ S GT Y+APE+ +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-----GTPEYLAPEVLRK- 170
Query: 525 LGNPSGKS-DVYSYGMLLLEMI 545
P ++ D + G +L EM+
Sbjct: 171 --QPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHL 406
++LG G YG+VYK P G +A+K LE + + I E+ + + I+
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 407 LG-FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
G F +G+ + EYM GSL L + + L I V +++L E
Sbjct: 65 YGAFFIEGAVYMCM-EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--E 121
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
I+H D+KP NVL++ + K+ DFG+ S N G Y+APE
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGV----SGNLVASLAKTNIGCQSYMAPERI--KS 175
Query: 526 GNPSG------KSDVYSYGMLLLEM 544
G P+ +SDV+S G+ +LEM
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 16/206 (7%)
Query: 353 KLGTGGYGNVYKGKFPD-GRLVAVKVLE-KTSNFSDNFINEVATIGRIHHVNIIHLL-GF 409
+LG G +G VYK + + G L A KV++ K+ ++++ E+ + H NI+ LL F
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
+ + LI E+ G++ D + E E L ++ + A+ YLH E +I+
Sbjct: 72 YYENNLWILI-EFCAGGAV-DAVMLELER-PLTEPQIRVVCKQTLEALNYLH---ENKII 125
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 529
H D+K N+L D K++DFG++ ++ R++ GT ++APE+ M
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 530 G---KSDVYSYGMLLLEM--IEEKKH 550
K+DV+S G+ L+EM IE H
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHH 209
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 76/257 (29%), Positives = 115/257 (44%), Gaps = 39/257 (15%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVL------EKTSNFSDNFINEVATIGRIHHVNIIHL 406
LG G +G VY D GR +AVK + ++TS + E+ + + H I+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 407 LGFCCDGSTRAL--IYEYMPNGSLGDLLSRE---KENLSLKPARLLEIALGVAHAIEYLH 461
G D + L EYMP GS+ D L EN++ + R +I GV+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR--QILQGVS----YLH 123
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP-----RGTIGYI 516
+ I+H DIK N+L D K+ DFG S+ + M+G GT ++
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGA----SKRIQTICMSGTGIKSVTGTPYWM 176
Query: 517 APEIFMRNLGNPSG-KSDVYSYGMLLLEMIEEKKHLRPTETTS-----GSNTTEAYFPDW 570
+PE+ G G K+DV+S ++EM+ EK E + + T+ PD
Sbjct: 177 SPEVIS---GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG 233
Query: 571 IYDKLIQPEKEDFVEEE 587
+ D K+ FVEE+
Sbjct: 234 VSDACRDFLKQIFVEEK 250
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 14/197 (7%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEK----TSNFSDNFINEVATIGRIHHVNIIHLLG 408
LG GG+G V + G++ A K L+K +NE + ++ I+ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
L+ M G L + E AR + A + +E+LH RI
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEP-GFPEARAIFYAAQIICGLEHLHQ---RRI 116
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
++ D+KP+NVLLD ++SD GLA + + G GT GY+APE+ + +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 529 SGKSDVYSYGMLLLEMI 545
S D ++ G L EMI
Sbjct: 174 S--VDWFALGCTLYEMI 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 74/254 (29%), Positives = 114/254 (44%), Gaps = 42/254 (16%)
Query: 352 EKLGTGGYGNVYKGKFP-DGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
+KLG G Y V+KG+ LVA+K LE I EV+ + + H NI+ L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
L++EY+ + L L +S+ ++ L + Y H + +I
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQL--LRGLSYCH---KRKI 124
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG--TIGYIAPEIFMRNLG 526
LH D+KPQN+L++ K++DFGLA+A +SV T T T+ Y P++ LG
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARA----KSVPTKTYSNEVVTLWYRPPDVL---LG 177
Query: 527 NP--SGKSDVYSYGMLLLEM-----------IEEKKHL------RPTETT-SGSNTTEAY 566
+ S D++ G +L EM ++E+ HL PTE T G + E +
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237
Query: 567 ----FPDWIYDKLI 576
FP + LI
Sbjct: 238 RSYLFPQYRAQPLI 251
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLE------KTSNFSDNFINEVATIGRIHHVNIIHL 406
LG G +G VY D GR +AVK ++ +TS + E+ + + H I+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 407 LGFCCDGSTRAL--IYEYMPNGSLGDLLSRE---KENLSLKPARLLEIALGVAHAIEYLH 461
G D R L E+MP GS+ D L EN++ K R +I GV+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR--QILEGVS----YLH 123
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEI 520
+ I+H DIK N+L D K+ DFG +K + S M GT +++PE+
Sbjct: 124 SN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 521 FMRNLGNPSG-KSDVYSYGMLLLEMIEEK 548
G G K+D++S G ++EM+ EK
Sbjct: 181 IS---GEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 351 KEKLGTGGYGNVYKGK-FPDGRLVAVKVLE----KTSNFSDNFINEVATIGRIHHVNIIH 405
++K+G G + VY+ D + VA+K ++ + + + E+ + +++H N+I
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL-EIALGVAHAIEYLHNGC 464
L + + ++ E G L ++ K+ L P R + + + + A+E++H+
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-- 124
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
R++H DIKP NV + K+ D GL + S + GT Y++PE N
Sbjct: 125 -RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIHEN 181
Query: 525 LGNPSGKSDVYSYGMLLLEM 544
N KSD++S G LL EM
Sbjct: 182 GYN--FKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 52/172 (30%), Positives = 74/172 (43%), Gaps = 60/172 (34%)
Query: 418 LIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCELRILHLDIKP 475
LI EY+P G + LL + K+ + + R + E L AI+ +H +L +H DIKP
Sbjct: 78 LIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETIL----AIDSIH---KLGYIHRDIKP 129
Query: 476 QNVLLDPDFTPKVSDFGL-----------------------------------AKAHS-- 498
N+LLD K+SDFGL KA +
Sbjct: 130 DNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWK 189
Query: 499 RNR-----SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
RNR S V GT YIAPE+F++ N D +S G+++ EM+
Sbjct: 190 RNRRALAYSTV------GTPDYIAPEVFLQTGYNKE--CDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 54/227 (23%), Positives = 95/227 (41%), Gaps = 49/227 (21%)
Query: 352 EKLGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIHHVNII 404
E +G+G YG V G+ VA+K K + D E+ + H NII
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIK---KIPHAFDVPTLAKRTLRELKILRHFKHDNII 67
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLG-------DLLS-------REKENLSLKPAR--LLE 448
+ P G+ DL+ + L+ + R L +
Sbjct: 68 AIRDI------------LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ 115
Query: 449 IALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT--M 506
+ G ++Y+H+ ++H D+KP N+L++ D ++ DFG+A+ S + + M
Sbjct: 116 LLRG----LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 553
T T Y APE+ + +L + D++S G + EM+ ++ L P
Sbjct: 169 TEYVATRWYRAPEL-LLSLPEYTTAIDMWSVGCIFAEML-GRRQLFP 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 22/201 (10%)
Query: 352 EKLGTGGYGNVYKG--KFPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLL 407
EKLG G Y V+KG K + LVA+K LE I EV+ + + H NI+ L
Sbjct: 12 EKLGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCE 465
+ L++EY+ + L + +S+ + L +I G+A Y H
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLA----YCH---R 122
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG--TIGYIAPEIFMR 523
++LH D+KPQN+L++ K++DFGLA+A +SV T T T+ Y P++ +
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARA----KSVPTKTYSNEVVTLWYRPPDVLLG 178
Query: 524 NLGNPSGKSDVYSYGMLLLEM 544
+ S + D++ G + EM
Sbjct: 179 S-SEYSTQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 24/201 (11%)
Query: 352 EKLGTGGYGNVYKG-KFPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
E++G G +G VYKG +VA+K+ LE+ + ++ E+ + + I G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
G+ +I EY+ GS DLL L+ + I + ++YLH+ R
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RK 122
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHS-----RNRSVVTMTGPRGTIGYIAPEIFMR 523
+H DIK NVLL K++DFG+A + RN V GT ++APE+ +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-------GTPFWMAPEVIKQ 175
Query: 524 NLGNPSGKSDVYSYGMLLLEM 544
+ + K+D++S G+ +E+
Sbjct: 176 SAYD--FKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 351 KEKLGTGGYGNV----YKGKFPDGRLVAVKVLEKTSNFS----DNFINEVATIGRIHHVN 402
E LGTG +G V +KG G A+K L+K + E + + + H
Sbjct: 23 GETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYL 460
I++++ D + + E++ G L L R+ A+ E+ L A EYL
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGRFPNDVAKFYHAELVL----AFEYL 134
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 520
H+ I++ D+KP+N+LLD KV+DFG AK +R+ GT Y+APE+
Sbjct: 135 HS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFTLC----GTPEYLAPEV 186
Query: 521 FMRNLGNPSGKS-DVYSYGMLLLEMI 545
+++ G+ GK+ D ++ G+LL E I
Sbjct: 187 -IQSKGH--GKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 80/338 (23%), Positives = 132/338 (39%), Gaps = 83/338 (24%)
Query: 350 FKEKLGTGGYGNVYK------GKFPDGRLVAVKVLEK--TSNFSDNFINEVATIGRI-HH 400
+ LG G +G V + K R VAVK+L++ T++ + E+ + I HH
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 401 VNIIHLLGFCC-DGSTRALIYEYMPNGSLGDLLSREKENLSL------------------ 441
+N+++LLG C G +I EY G+L + L ++E S
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKK 130
Query: 442 ------------------------------KPARLLEIALGVAHAIEY---LHNGCEL-- 466
+ L + L + I Y + G E
Sbjct: 131 QRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA 190
Query: 467 --RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE-IFMR 523
+ +H D+ +N+LL + K+ DFGLA+ ++ V R + ++APE IF +
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK 250
Query: 524 NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583
+SDV+S+G+LL E+ P G E + +L + +
Sbjct: 251 VYTT---QSDVWSFGVLLWEIFSLGASPYP-----GVQIDEEFC-----RRLKEGTRMRA 297
Query: 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621
E I M L C NP+DRP+ + +VE+L
Sbjct: 298 PEYATPEIYSIM----LDCWHNNPEDRPTFSELVEILG 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 354 LGTGGYGNVY---KGKFPD-GRLVAVKVLEKTS-----NFSDNFINEVATIGRIHHVNII 404
LGTG YG V+ K D G+L A+KVL+K + ++ E + + +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 405 HLLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLH 461
L + + LI +Y+ G + L +++N S R EI L A+E+LH
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFSEDEVRFYSGEIIL----ALEHLH 122
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 521
+L I++ DIK +N+LLD + ++DFGL+K T + GTI Y+APEI
Sbjct: 123 ---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-GTIEYMAPEI- 177
Query: 522 MRNLGNPSGKSDVYSYGMLLLEMI 545
+R G D +S G+L+ E++
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN--FINEVATIGR-IHHVNIIHLL 407
E+LG G YG V K + P G ++AVK + T N + + ++ R + +
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
G + E M + SL + + L++ L +IA+ + A+EYLH+ +L
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KL 123
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
++H D+KP NVL++ + K+ DFG++ + + T+ G Y+APE +
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGIS-GYLVDSVAKTIDA--GCKPYMAPE-RINPEL 179
Query: 527 NPSG---KSDVYSYGMLLLEM 544
N G KSDV+S G+ ++E+
Sbjct: 180 NQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 29/205 (14%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVA-TIG------RIHHVNIIH 405
+G G +G VY+ + D R+ A+KVL K + EVA TIG R
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK---EVAHTIGERNILVRTLLDESPF 57
Query: 406 LLGFCCDGSTRA---LIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYL 460
++G T + L+ +YM G L L +E S A+ + E+ L A+E+L
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR-FSEDRAKFYIAELVL----ALEHL 112
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPE 519
H + I++ D+KP+N+LLD + DFGL+KA+ + N++ T GT Y+APE
Sbjct: 113 H---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPE 166
Query: 520 IFMRNLGNPSGKSDVYSYGMLLLEM 544
+ + G + D +S G+L+ EM
Sbjct: 167 VLLDEKGY-TKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 21/201 (10%)
Query: 353 KLGTGGYGNVYKGK-FPDGRLVAVKVLEKT--SNFSDNFINEVATIGRI-HHVNIIHLLG 408
K+G G + V K + G+ A+K ++K S N + E+ + R+ H NI+ L+
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 409 FCCDGSTR--ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH-NGCE 465
D T AL++E M + +L +L+ K L R+ + +++++H NG
Sbjct: 66 VLFDRKTGRLALVFELM-DMNLYELIKGRKRPLP--EKRVKSYMYQLLKSLDHMHRNG-- 120
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
I H DIKP+N+L+ D K++DFG + +S+ T T Y APE + +
Sbjct: 121 --IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKP----PYTEYISTRWYRAPECLLTD 173
Query: 525 LGNPSGKSDVYSYGMLLLEMI 545
G K D+++ G + E++
Sbjct: 174 -GYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 69/273 (25%), Positives = 117/273 (42%), Gaps = 40/273 (14%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLGFC 410
LG G G+V K K P G ++A KV + S+ + E + +H +++ F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRE---LQIMHECRSPYIVSFY 69
Query: 411 CDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
G+ + E+M GSL + K+ + L +IA+ V + YL+N
Sbjct: 70 --GAFLNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYN--V 122
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKA--HSRNRSVVTMTGPRGTIGYIAPEIFMR 523
RI+H DIKP N+L++ K+ DFG++ +S + V GT Y++PE
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV------GTSTYMSPERIQG 176
Query: 524 NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE---- 579
G + KSDV+S G+ ++E+ K + D + + +P
Sbjct: 177 --GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP 234
Query: 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
DF E+ D + C+ +P +RP+
Sbjct: 235 SSDFPEDLRDFVDA--------CLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 352 EKLGTGGYGNVYK-GKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGF 409
E +G G YG VYK DG L AVK+L+ S+ + E + + +H N++ G
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 410 C-----CDGSTRALIYEYMPNGSLGDLLS-REKENLSLKPARLLEIALGVAHAIEYLHNG 463
G L+ E GS+ +L+ L A + I G +++LHN
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN 147
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS-----RNRSVVTMTGPRGTIGYIAP 518
RI+H D+K N+LL + K+ DFG++ + RN SV GT ++AP
Sbjct: 148 ---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-------GTPFWMAP 197
Query: 519 EIF---MRNLGNPSGKSDVYSYGMLLLEM 544
E+ + + + DV+S G+ +E+
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 26/203 (12%)
Query: 354 LGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-------HHVNIIH 405
LG G +G V + L A+K+L+K D+ + R+ + +H
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 406 LLGFCCDGSTRALIY--EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 463
C + L + EY+ NG GDL+ ++ K + A +A + +LH+
Sbjct: 68 ----SCFQTMDRLYFVMEYV-NG--GDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
I++ D+K NV+LD + K++DFG+ K + T T GT YIAPEI
Sbjct: 121 ---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENI-FGGKTTRTFC-GTPDYIAPEII-- 173
Query: 524 NLGNPSGKS-DVYSYGMLLLEMI 545
P GKS D +++G+LL EM+
Sbjct: 174 -AYQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLE------KTSNFSDNFINEVATIGRIHHVNIIHL 406
LG G +G VY D GR +A K ++ +TS E+ + + H I+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 407 LGFCCDGSTRAL--IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
G D + + L EYMP GS+ D L K +L + + + + YLH+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMSYLHSN- 125
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV-VTMTGPR---GTIGYIAPEI 520
I+H DIK N+L D K+ DFG +K R +++ ++ TG R GT +++PE+
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASK---RLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 521 FMRNLGNPSG-KSDVYSYGMLLLEMIEEK 548
G G K+DV+S G ++EM+ EK
Sbjct: 181 IS---GEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 31/209 (14%)
Query: 354 LGTGGYGNVYKGK----FPDGRLVAVKVLEKTS-----NFSDNFINEVATIGRIHHVNII 404
LGTG YG V+ + G+L A+KVL+K + +++ E + I +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 405 HLLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLH 461
L + T+ LI +Y+ G L LS ++E + ++ EI L A+E+LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLS-QRERFKEQEVQIYSGEIVL----ALEHLH 122
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-----GTIGYI 516
+L I++ DIK +N+LLD + ++DFGL+K R GTI Y+
Sbjct: 123 ---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK------EFHEDEVERAYSFCGTIEYM 173
Query: 517 APEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
AP+I G D +S G+L+ E++
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 18/199 (9%)
Query: 354 LGTGGYGNVY----KGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LL 407
LG G +G V KG + A+KVL+K D+ ++ T RI + H L
Sbjct: 3 LGKGSFGKVMLAELKGT---DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH-NGCEL 466
C T+ ++ M + GDL+ + + + R A V A+ +LH +G
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--- 116
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
+++ D+K N+LLD + K++DFG+ K N VT T GT YIAPEI
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQELEY 173
Query: 527 NPSGKSDVYSYGMLLLEMI 545
PS D ++ G+L+ EM+
Sbjct: 174 GPS--VDWWALGVLMYEMM 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 69/278 (24%), Positives = 126/278 (45%), Gaps = 41/278 (14%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFI-------NEVATIGRIHHVNII 404
+K+G G +G +Y K + + + K + + + EV + ++ H NI+
Sbjct: 6 KKIGEGSFGKIYLAK---AKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV 62
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARL---LEIALGVAHAIEYLH 461
+ ++ EY G L ++R++ L + L ++I+LG+ H +H
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKH----IH 118
Query: 462 NGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 520
+ +ILH DIK QN+ L + K+ DFG+A+ N S+ GT Y++PEI
Sbjct: 119 ---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEI 173
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580
N K+D++S G +L E+ K P E G+N + I P
Sbjct: 174 CQNRPYN--NKTDIWSLGCVLYELCTLK---HPFE---GNNLHQLVLK--ICQGYFAPIS 223
Query: 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+F + + +I L+ +++P+DRPS+T +++
Sbjct: 224 PNFSRD------LRSLISQLF--KVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 4e-10
Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 18/198 (9%)
Query: 352 EKLGTGGYGNVYKGKFPDGR---LVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHL 406
EK+G G +G V+KG D R +VA+K+ LE+ + ++ E+ + + +
Sbjct: 10 EKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
G + +I EY+ GS DLL E L ++ I + ++YLH+
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE--- 120
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
+ +H DIK NVLL K++DFG+A + + + GT ++APE+ ++
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAY 178
Query: 527 NPSGKSDVYSYGMLLLEM 544
+ K+D++S G+ +E+
Sbjct: 179 D--SKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 29/202 (14%)
Query: 357 GGYGNVYKGKFPD---GRLVAVKVL---EKTSNFSDNFINEVATIGRIHHVNIIHLLGFC 410
G YG VY+ + D G +VA+K L ++ F + E+ + ++ H NI+ +
Sbjct: 16 GTYGVVYRAR--DKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVV 73
Query: 411 CDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCE 465
GS IY EY+ + L L+ K+ + +L++ GVAH LH +
Sbjct: 74 V-GSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAH----LH---D 124
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
ILH D+K N+LL+ K+ DFGLA+ + T T+ Y APE+ L
Sbjct: 125 NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELL---L 179
Query: 526 GNP--SGKSDVYSYGMLLLEMI 545
G S D++S G + E++
Sbjct: 180 GAKEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 354 LGTGGYGNVY------KGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLL 407
LG GG+G V GK + + K L+K + + E + ++H I+ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-EKRILAKVHSRFIVSL- 58
Query: 408 GFCCDGSTRA---LIYEYMPNGSLG-DLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 463
T+ L+ M G L + + ++EN R + +E+LH
Sbjct: 59 --AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH-- 114
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
+ RI++ D+KP+NVLLD D ++SD GLA +S G GT G++APE+
Sbjct: 115 -QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELL-- 169
Query: 524 NLGNPSGKS-DVYSYGMLLLEMIEEKKHLR 552
G S D ++ G+ L EMI + R
Sbjct: 170 -QGEEYDFSVDYFALGVTLYEMIAARGPFR 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 30/205 (14%)
Query: 354 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 407
LG G +G V+ + + A+K L+K D+ + R+ H + HL
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61
Query: 408 GFCCDGSTRALIY--EYMPNGSLGDLL----SREKENLSLKPARLLEIALGVAHAIEYLH 461
+C + L + EY+ NG GDL+ S K +L EI G +++LH
Sbjct: 62 -YCTFQTKENLFFVMEYL-NG--GDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLH 113
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 521
+ I++ D+K N+LLD D K++DFG+ K + + GT YIAPEI
Sbjct: 114 SK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC--GTPDYIAPEIL 168
Query: 522 MRNLGNPSGKS-DVYSYGMLLLEMI 545
LG S D +S+G+LL EM+
Sbjct: 169 ---LGQKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 48/212 (22%), Positives = 91/212 (42%), Gaps = 38/212 (17%)
Query: 357 GGYGNVYKGKFPDG-----RLVAVKVLEKTSNFS--DNFINEVATIGRIHHVNIIHLLGF 409
G +G ++ G D V VK ++ ++ + E + + H NI+ +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 410 CCDGSTRALI-YEYMPNGSLGDLLSREKE-----NLSLKPARLLEIALGVAHAIEYLHNG 463
C + + Y YM G+L L + + +L +L+ +A+ +A + YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK- 135
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAK----------AHSRNRSVVTMTGPRGTI 513
++H DI +N ++D + K++D L++ + NR V M
Sbjct: 136 --RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM------- 186
Query: 514 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
A E + + + SDV+S+G+LL E++
Sbjct: 187 ---ALESLVNKEYSSA--SDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 18/198 (9%)
Query: 352 EKLGTGGYGNVYKGKFPDGR---LVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHL 406
E++G G +G V+KG D R +VA+K+ LE+ + ++ E+ + + +
Sbjct: 10 ERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
G G+ +I EY+ GS DLL + L EI G ++YLH+ E
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKG----LDYLHS--EK 121
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
+I H DIK NVLL K++DFG+A + + + GT ++APE+ ++
Sbjct: 122 KI-HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAY 178
Query: 527 NPSGKSDVYSYGMLLLEM 544
+ K+D++S G+ +E+
Sbjct: 179 D--SKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 64/199 (32%), Positives = 94/199 (47%), Gaps = 18/199 (9%)
Query: 354 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LLGFC 410
+G G +G V K DG AVKVL+K + N + + N+ H L+G
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 411 CDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
T +Y +Y+ G L L RE+ L + AR A VA AI YLH+ L
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPR-ARFY--AAEVASAIGYLHS---LN 116
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
I++ D+KP+N+LLD ++DFGL K T + GT Y+APE+ +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRK---E 171
Query: 528 PSGKS-DVYSYGMLLLEMI 545
P ++ D + G +L EM+
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 352 EKLGTGGYGNVYKG-KFPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
+++G+G YG+VYK G L AVK+ LE +FS E+ + H NI+ G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS-LIQQEIFMVKECKHCNIVAYFG 73
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+ EY GSL D+ L+ A + L + YLH+ ++
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL---QGLAYLHSKGKM-- 128
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG---YIAPEI-FMRN 524
H DIK N+LL + K++DFG+A + T+ + IG ++APE+ +
Sbjct: 129 -HRDIKGANILLTDNGDVKLADFGVAA-----KITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 525 LGNPSGKSDVYSYGMLLLEMIE 546
G + D+++ G+ +E+ E
Sbjct: 183 NGGYNQLCDIWAVGITAIELAE 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 36/214 (16%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNF-----INEVATIGRIHHVNIIHLL 407
+G+G YG V GR VA+K + F D + E+ + + H NII LL
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNV--FDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 408 GFCCDGSTRA-----LIYEYMPNGSLGDL--LSREKENLSLKPAR--LLEIALGVAHAIE 458
S ++ E M DL + + + L+ + L +I G+
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET----DLHKVIKSPQPLTDDHIQYFLYQILRGLK---- 117
Query: 459 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIA 517
YLH+ ++H D+KP N+L++ + K+ DFGLA+ +T T Y A
Sbjct: 118 YLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174
Query: 518 PEIFMRNLGNPSGKS---DVYSYGMLLLEMIEEK 548
PE+ L + S + D++S G + E++ K
Sbjct: 175 PEL----LLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 352 EKLGTGGYGNV-YKGKFPDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLL 407
+++G+G YG V G VA+K L + + F+ E+ + + H N+I LL
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 408 G-FCCDGSTRAL--IYEYMP--NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
F D S Y MP LG L+ EK L R+ + + ++Y+H
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK----LSEDRIQFLVYQMLKGLKYIHA 136
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
I+H D+KP N+ ++ D K+ DFGLA+ ++ MTG T Y APE+ +
Sbjct: 137 A---GIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVIL 188
Query: 523 RNLGNPSGKSDVYSYGMLLLEMIEEK 548
N + + D++S G ++ EM+ K
Sbjct: 189 -NWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 65/211 (30%), Positives = 92/211 (43%), Gaps = 42/211 (19%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 407
LG G +G V + A+K L+K D+ + R+ H + HL
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61
Query: 408 GFCCDGSTRALIY--EYMPNGSLGDLLS--REKENLSLKPARLL--EIALGVAHAIEYLH 461
FC + L + EY+ NG GDL+ + AR EI G +++LH
Sbjct: 62 -FCTFQTKEHLFFVMEYL-NG--GDLMFHIQSSGRFDEARARFYAAEIICG----LQFLH 113
Query: 462 -NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR------GTIG 514
G I++ D+K NVLLD D K++DFG+ K + M G GT
Sbjct: 114 KKG----IIYRDLKLDNVLLDKDGHIKIADFGMCKEN--------MNGEGKASTFCGTPD 161
Query: 515 YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
YIAPEI N S D +S+G+LL EM+
Sbjct: 162 YIAPEILKGQKYNES--VDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 73/290 (25%), Positives = 121/290 (41%), Gaps = 36/290 (12%)
Query: 354 LGTGGYGNVYKGKF-PDGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLG 408
LG GG+G V + G++ A K LEK +NE + +++ ++ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
L+ M G L + E + R + A + +E LH + RI
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLH---QERI 123
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
++ D+KP+N+LLD ++SD GLA + T+ G GT+GY+APE+ ++N
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEV-VKN-ERY 178
Query: 529 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588
+ D ++ G LL EMI + + + E +L++ +E++ E+
Sbjct: 179 TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---------RLVKEVQEEYSEKFS 229
Query: 589 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKPLFPS 638
AR + C + KD P E L A E+ PLF
Sbjct: 230 PD-ARSL------CKMLLCKD-PK-----ERLGCQGGGAREVKEHPLFKQ 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 39/220 (17%)
Query: 341 NDIKKMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN--FINEVATIGR 397
ND++ + ++G+G G VYK +F G ++AVK + +T N +N + ++ + +
Sbjct: 15 NDLENL-----GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69
Query: 398 IHHV-NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL-EIALGVAH 455
H I+ G+ S + E M L LL R + + P +L ++ + +
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPI---PEDILGKMTVAIVK 125
Query: 456 AIEYL---HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA------KAHSRNRSVVTM 506
A+ YL H ++H D+KP N+LLD K+ DFG++ KA +R+
Sbjct: 126 ALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS------ 174
Query: 507 TGPRGTIGYIAPEIFMRNLGNPSG--KSDVYSYGMLLLEM 544
G Y+APE NP ++DV+S G+ L+E+
Sbjct: 175 ---AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 40/218 (18%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHL-- 406
+G G YG VYK + D G LVA+K + + N + F I E+ + +++H NI++L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 407 --------LGFCCDGSTRALIYEYMPNGSLGDLLSR----EKENLSLKPARLLEIALGVA 454
L F D L++EYM + +G L S ++++ +LLE
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE------ 127
Query: 455 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 514
+ Y H LH DIK N+LL+ K++DFGLA+ ++ S T T+
Sbjct: 128 -GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLW 182
Query: 515 YIAPEIFMRNLGN----PSGKSDVYSYGMLLLEMIEEK 548
Y PE+ LG P+ DV+S G +L E+ +K
Sbjct: 183 YRPPELL---LGEERYGPA--IDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 52/180 (28%), Positives = 78/180 (43%), Gaps = 34/180 (18%)
Query: 457 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 516
++YLH+ ILH DIKP N+L++ + K+ DFGLA+ + S MT T Y
Sbjct: 116 LKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQYYR 171
Query: 517 APEIFMRNLGNP--SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFP----DW 570
APEI M G+ + D++S G + E++ +A P D
Sbjct: 172 APEILM---GSRHYTSAVDIWSVGCIFAELL------------GRRILFQAQSPIQQLDL 216
Query: 571 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEM 630
I D L P E + AR I+ G P PS+ + + S A+ EA+ +
Sbjct: 217 ITDLLGTPSLEAMRSACEG--ARAHILRG-------PHKPPSLPVLYTLSSQATHEAVHL 267
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 45/130 (34%), Positives = 66/130 (50%), Gaps = 11/130 (8%)
Query: 418 LIYEYMPNGSLGDLLSREKENLS--LKPARLLEIALGVAHAIEYLHNGCELRILHLDIKP 475
L+Y M GDL + KE L +++E + +A A++YLH E ILH D+K
Sbjct: 74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKT 130
Query: 476 QNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDV 534
QNV L KV D G+A+ ++ T+ GT Y++PE+F N KSDV
Sbjct: 131 QNVFLTRTNIIKVGDLGIARVLENQCDMASTLI---GTPYYMSPELFSNKPYNY--KSDV 185
Query: 535 YSYGMLLLEM 544
++ G + EM
Sbjct: 186 WALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 352 EKLGTGGYGNVYKGKF---PDGRLVAVKVLEKTSNF--SDNFINEVATIGRIHHVNIIHL 406
+++G G +G V + V VK L+ ++ + F+ + + H NI+
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL-----EIALGVAHAIEYLH 461
LG C + L++EY G L LS+E+ + LL EIA GV H +H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTH----MH 116
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 521
+ LH D+ +N L D T KV D+G+ + + + T + ++APE+
Sbjct: 117 ---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 522 MRNLG-----NPSGKSDVYSYGMLLLEMIE 546
G + S+V++ G+ L E+ E
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELFE 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFIN----EVATIGRIHHV 401
F LG G +G V + L A+K+L+K D+ + E +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 402 NIIHLLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 460
+ L C R + EY+ NG GDL+ ++ K + + A ++ + +L
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYV-NG--GDLMYHIQQVGKFKEPQAVFYAAEISVGLFFL 117
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 520
H I++ D+K NV+LD + K++DFG+ K H + V T T GT YIAPEI
Sbjct: 118 H---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GVTTRTFC-GTPDYIAPEI 172
Query: 521 FMRNLGNPSGKS-DVYSYGMLLLEMI 545
P GKS D ++YG+LL EM+
Sbjct: 173 IAY---QPYGKSVDWWAYGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 338 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSD--NFINEVAT 394
++ D+K + ++G G +G V K G ++AVK + T + + + ++
Sbjct: 1 FTAEDLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV 55
Query: 395 IGRIHH-VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR---EKENLSLKPARLLEIA 450
+ R I+ G + E M + SL D + E + L +IA
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDCWICMELM-DISL-DKFYKYVYEVLKSVIPEEILGKIA 113
Query: 451 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR 510
+ A+ YL EL+I+H D+KP N+LLD + K+ DFG++ + + T
Sbjct: 114 VATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-GQLVDS--IAKTRDA 168
Query: 511 GTIGYIAPEIFMRNLGNPSG-KSDVYSYGMLLLEM 544
G Y+APE + + +SDV+S G+ L E+
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 37/218 (16%)
Query: 352 EKLGTGGYGNVYKGKFPD-GRLVAVKVL---EKTSNFSDNFINEVATIGRIHHVNIIHLL 407
EK+G G YG V+K K + +VA+K + + + + E+ + + H NI+ L
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR------LLEIALGVAHAIEYLH 461
L++EY L + ++ + + ++ G+A H
Sbjct: 66 DVLHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS--H 118
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-----SRNRSVVTMTGPRGTIGYI 516
N +LH D+KPQN+L++ + K++DFGLA+A + VVT+ Y
Sbjct: 119 N-----VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLW-------YR 166
Query: 517 APEIFM-RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 553
P++ L + S D++S G + E+ + L P
Sbjct: 167 PPDVLFGAKLYSTS--IDMWSAGCIFAELANAGRPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 38/216 (17%)
Query: 352 EKL---GTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNI 403
EKL G G YG VY+ + G +VA+K + + N D + E+ + + H NI
Sbjct: 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKV-RMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 404 IHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLS--LKPARLLEIALGVAHAIEY 459
+ L + L+ EY L LL +N+ +++ + L + ++Y
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQ-DLASLL----DNMPTPFSESQVKCLMLQLLRGLQY 123
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-----AHSRNRSVVTMTGPRGTIG 514
LH I+H D+K N+LL K++DFGLA+ A VVT+
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLW------- 173
Query: 515 YIAPEIFMRNLG--NPSGKSDVYSYGMLLLEMIEEK 548
Y APE+ LG + D+++ G +L E++ K
Sbjct: 174 YRAPELL---LGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 53/225 (23%)
Query: 409 FCCDGSTRAL--IYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGC 464
FC + R L + EY+ G LL + L + AR+ E L A+EYLHN
Sbjct: 67 FCSFETKRHLCMVMEYVEGGDCATLL-KNIGALPVDMARMYFAETVL----ALEYLHN-- 119
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-------------G 511
I+H D+KP N+L+ K++DFGL+K + + G G
Sbjct: 120 -YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 512 TIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG-----SNTTEA 565
T YIAPE+ +R G P D ++ G++L E + G +T E
Sbjct: 179 TPEYIAPEVILRQGYGKP---VDWWAMGIILYEFL------------VGCVPFFGDTPEE 223
Query: 566 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDR 610
F I D + PE ++ + + + ++ ++ NP +R
Sbjct: 224 LFGQVISDDIEWPEGDEALPADAQDLISRL-------LRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 18/199 (9%)
Query: 354 LGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LLGFC 410
+G G +G V + + + AVKVL+K + + + + N+ H L+G
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 411 CDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
T +Y +Y+ G L L RE+ L+P R A +A A+ YLH+ L
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRER--CFLEP-RARFYAAEIASALGYLHS---LN 116
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
I++ D+KP+N+LLD ++DFGL K + + T + GT Y+APE+ +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHK---Q 171
Query: 528 PSGKS-DVYSYGMLLLEMI 545
P ++ D + G +L EM+
Sbjct: 172 PYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 56/204 (27%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 354 LGTGGYGNVYKGKF-PDGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLG 408
LG GG+G V + G++ A K LEK +NE + +++ +++L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
L+ M G L N + R L A + +E LH
Sbjct: 68 AYETKDALCLVLTIMNGGDL-KFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENT 123
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
++ D+KP+N+LLD ++SD GLA S+ G GT+GY+APE+
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI---RGRVGTVGYMAPEVLNNQRYTL 180
Query: 529 SGKSDVYSYGMLLLEMIEEKKHLR 552
S D + G L+ EMIE + R
Sbjct: 181 S--PDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 34/204 (16%)
Query: 354 LGTGGYGNVYKGKF-PDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG-- 408
LG G G V K P G ++A K+ LE + I E+ + H N +++G
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVL---HECNSPYIVGFY 65
Query: 409 --FCCDGSTRALIYEYMPNGSLGDLLSREK---ENLSLKPARLLEIALGVAHAIEYLHNG 463
F DG ++ E+M GSL +L + EN+ L +I++ V + YL
Sbjct: 66 GAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPENI------LGKISIAVLRGLTYLRE- 117
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA--HSRNRSVVTMTGPRGTIGYIAPEIF 521
+ +I+H D+KP N+L++ K+ DFG++ S S V GT Y++PE
Sbjct: 118 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE-- 168
Query: 522 MRNLGNP-SGKSDVYSYGMLLLEM 544
R G + +SD++S G+ L+EM
Sbjct: 169 -RLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 38/112 (33%), Positives = 55/112 (49%), Gaps = 26/112 (23%)
Query: 448 EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507
EI G+ LH RI++ D+KP+N+LLD ++SD GLA T+
Sbjct: 110 EITCGLED----LHRE---RIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGE--TIR 159
Query: 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSY-------GMLLLEMIEEKKHLR 552
G GT+GY+APE+ K++ Y++ G L+ EMIE K R
Sbjct: 160 GRVGTVGYMAPEVV---------KNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 51/203 (25%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
+++G+G YG+VYK + G L A+KV LE +F E+ + H NI+ G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDF-AVVQQEIIMMKDCKHSNIVAYFG 73
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+ E+ GSL D+ L +++ ++ + YLH+ ++
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKGKM-- 128
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHS----RNRSVVTMTGPRGTIGYIAPEI-FMR 523
H DIK N+LL + K++DFG++ + + +S + GT ++APE+ +
Sbjct: 129 -HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI------GTPYWMAPEVAAVE 181
Query: 524 NLGNPSGKSDVYSYGMLLLEMIE 546
G + D+++ G+ +E+ E
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAE 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 48/239 (20%), Positives = 100/239 (41%), Gaps = 24/239 (10%)
Query: 349 GFK--EKLGTGGYGNVYKGKFPDGR--LVAVKVLEKTSNFSDNFINEVATIGRIHHVNII 404
G+ + L G G V+ G+ V +K+ +K + + E + ++H ++I
Sbjct: 67 GYTVIKTLTPGSEGRVFVAT-KPGQPDPVVLKIGQKGTT-----LIEAMLLQNVNHPSVI 120
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
+ G+ ++ + + L L++ L + A ++E + + YLH
Sbjct: 121 RMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ--ILEGLRYLH--- 174
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
RI+H D+K +N+ ++ + D G A+ G GT+ APE+ R+
Sbjct: 175 AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLAGTVETNAPEVLARD 231
Query: 525 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG---SNTTEAYFPDWIYDKLIQPEK 580
N K+D++S G++L EM+ + ++ + ++ I + PE+
Sbjct: 232 KYN--SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288
|
Length = 357 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 35/213 (16%)
Query: 352 EKLGTGGYGNVYKGKFPD----GRL----VAVKVLEKT-SNFSDNFINEVATIGRIHHVN 402
E LG G + ++KG + G L V +KVL+K+ N+S++F + + ++ H +
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKE--NLSLKPARLLEIALGVAHAIEYL 460
++ G C G ++ EY+ GSL L + K N+S K LE+A +A A+ +L
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK----LEVAKQLAWALHFL 116
Query: 461 HNGCELRILHLDIKPQNVLL---------DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG 511
+ + H ++ +NVLL +P F K+SD G++ V+
Sbjct: 117 E---DKGLTHGNVCAKNVLLIREEDRKTGNPPFI-KLSDPGISIT------VLPKEILLE 166
Query: 512 TIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 544
I ++ PE + N N S +D +S+G L E+
Sbjct: 167 RIPWVPPEC-IENPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 17/199 (8%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLLGF 409
+G G +G V + G+ VA+K + K T + E+ + + H NII L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISL--- 74
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
D L Y LG L R + L+ + + ++Y+H+ ++
Sbjct: 75 -SDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA---GVV 130
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 529
H D+KP N+L++ + K+ DFGLA+ MTG T Y APEI M
Sbjct: 131 HRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEI-MLTWQKYD 184
Query: 530 GKSDVYSYGMLLLEMIEEK 548
+ D++S G + EM+E K
Sbjct: 185 VEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 26/206 (12%)
Query: 354 LGTGGYGNVYKGKFPDGRL---VAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLL 407
+G+G YG V D + VA+K L + ++ + E+ + + H N+I LL
Sbjct: 23 VGSGAYGQVCSAF--DTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 408 G-FCCDGSTRAL--IYEYMP--NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
F S +Y L +++ +K L + + + ++Y+H+
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK----LSDDHIQFLVYQILRGLKYIHS 136
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
I+H D+KP N+ ++ D K+ DFGLA+ MTG T Y APEI M
Sbjct: 137 A---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI-M 187
Query: 523 RNLGNPSGKSDVYSYGMLLLEMIEEK 548
N + + D++S G ++ E++ K
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 71/305 (23%), Positives = 111/305 (36%), Gaps = 78/305 (25%)
Query: 357 GGYGNVYKGKFPDGRLVAVKV--LEKTSNFSDNFI-NEVATIGRIHHVNIIHLLGFCCDG 413
++ K K P LVAVK L+ S + E+ T ++ H NI+ +
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 414 STRALIYEYMPNGSLGDLLSRE-KENLSLKPARLLEIAL---GVAHAIEYLH-NGCELRI 468
S ++ M GS DLL E L L IA V +A++Y+H G
Sbjct: 72 SELYVVSPLMAYGSCEDLLKTHFPEGLPE-----LAIAFILKDVLNALDYIHSKGF---- 122
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHS----RNRSVVTMTGPRGTIG---YIAPEIF 521
+H +K ++LL D +S GL + S R V P+ ++ +++PE+
Sbjct: 123 IHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 522 MRNLGNPSGKSDVYSYG---------------MLLLEMIEEKKHLR-------------- 552
+NL + KSD+YS G M +M+ EK +R
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK--VRGTVPCLLDKSTYPL 238
Query: 553 -----PTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINP 607
+S + D Y + FVE C+Q +P
Sbjct: 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVEL---------------CLQRDP 283
Query: 608 KDRPS 612
+ RPS
Sbjct: 284 ESRPS 288
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 48/231 (20%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI----HHVNIIHLLG 408
+G G +G V + D G + A+K+L K + + I + ++ +
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
D LI E++P G + LL + K+ L+ + IA V AI+ +H +L
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLLMK-KDTLT-EEETQFYIAETVL-AIDSIH---QLGF 122
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLA----KAH--------------------------- 497
+H DIKP N+LLD K+SDFGL KAH
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 498 ---SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
RNR + + GT YIAPE+FM+ N D +S G+++ EM+
Sbjct: 183 ETWKRNRRQLAFS-TVGTPDYIAPEVFMQTGYNK--LCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 42/132 (31%), Positives = 71/132 (53%), Gaps = 12/132 (9%)
Query: 418 LIYEYMPNGSLGDL----LSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDI 473
LI EY GS GDL R KE+L + + + + A++ +H+ ++H D+
Sbjct: 142 LIMEY---GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDL 195
Query: 474 KPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSD 533
K N+ L P K+ DFG +K +S + S+ + GT Y+APE++ R S K+D
Sbjct: 196 KSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK--RYSKKAD 253
Query: 534 VYSYGMLLLEMI 545
++S G++L E++
Sbjct: 254 MWSLGVILYELL 265
|
Length = 478 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEK---------TSNFSDNFINEVATIGRIHHVNI 403
+G GG+G VY + D G++ A+K L+K T ++ + + + G +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 404 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLH 461
+ D I + M G L LS+ S K R EI LG +E++H
Sbjct: 62 MTYAFHTPD--KLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIILG----LEHMH 114
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 521
N +++ D+KP N+LLD ++SD GLA S+ + ++ GT GY+APE+
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVL 167
Query: 522 MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTET 556
+ S +D +S G +L +++ R +T
Sbjct: 168 QKGTAYDS-SADWFSLGCMLFKLLRGHSPFRQHKT 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 36/215 (16%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDN------FINEVATIGRIHHVN-I 403
EK+G G YG VYK + G+LVA+K KT D + E++ + + I
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 404 IHLLGF--CCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLL-----EIALGV 453
+ LL + + + +Y EY+ + + S + PA+ + ++ GV
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 454 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTP-KVSDFGLAKAHSRNRSVVTMTGPRGT 512
AH H + ++H D+KPQN+L+D K++D GL +A S V + T T
Sbjct: 124 AH----CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS--IPVKSYTHEIVT 174
Query: 513 IGYIAPEIFMRNLGNP--SGKSDVYSYGMLLLEMI 545
+ Y APE+ LG+ S D++S G + EM
Sbjct: 175 LWYRAPEVL---LGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 44/132 (33%), Positives = 68/132 (51%), Gaps = 14/132 (10%)
Query: 418 LIYEYMPNGSLGDLLSREKENLSLKPARL--LEIALGVAHAIEYLHNGCELRILHLDIKP 475
++ EYMP G L +L+S ++ K AR E+ L A++ +H+ + +H D+KP
Sbjct: 120 MVMEYMPGGDLVNLMS--NYDIPEKWARFYTAEVVL----ALDAIHS---MGFIHRDVKP 170
Query: 476 QNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS-GKS-D 533
N+LLD K++DFG N V T GT YI+PE+ G+ G+ D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECD 229
Query: 534 VYSYGMLLLEMI 545
+S G+ L EM+
Sbjct: 230 WWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 67/235 (28%), Positives = 111/235 (47%), Gaps = 25/235 (10%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LLGF- 409
+G G Y V + R+ A+KV++K D I+ V T + H L+G
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 410 -CCDGSTRAL-IYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGCE 465
C +R + EY+ G L + R+++ L + AR EI+L A+ YLH E
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISL----ALNYLH---E 114
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
I++ D+K NVLLD + K++D+G+ K R T + GT YIAPEI
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILR--- 169
Query: 526 GNPSGKS-DVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579
G G S D ++ G+L+ EM+ + P + S+ + D+++ +++ +
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRS---PFDIVGSSDNPDQNTEDYLFQVILEKQ 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 351 KEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNF-----INEVATIGRIHHVNII 404
+G G YG V P G VA+K K S F + E+ + R H NII
Sbjct: 10 LSYIGEGAYGMVCSATHKPTGVKVAIK---KISPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 405 HLLGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAI 457
+L S + ++ E M L L+ ++LS + L +I G+
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGL---- 119
Query: 458 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR-SVVTMTGPRGTIGYI 516
+Y+H+ +LH D+KP N+LL+ + K+ DFGLA+ +T T Y
Sbjct: 120 KYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 517 APEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
APEI M N + D++S G +L EM+
Sbjct: 177 APEI-MLNSKGYTKAIDIWSVGCILAEML 204
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD 412
+G G +G VY+ D VA+K + + + + E+ + ++H+NII L +
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFLKDYYYT 130
Query: 413 GSTRA--------LIYEYMPNGSLGDLLSREKENLSLKPARLLEI-ALGVAHAIEYLHNG 463
+ ++ E++P + + N +L P L+++ + + A+ Y+H+
Sbjct: 131 ECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHAL-PLFLVKLYSYQLCRALAYIHSK 189
Query: 464 CELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
I H D+KPQN+L+DP+ T K+ DFG AK + V+ R Y APE+ M
Sbjct: 190 F---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR---FYRAPEL-M 242
Query: 523 RNLGNPSGKSDVYSYGMLLLEMI 545
N + D++S G ++ EMI
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 34/210 (16%)
Query: 417 ALIYEYMPNGSL-GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKP 475
AL+ +Y G L ++ SR K N + + + + V A+ ++H+ ++H DIK
Sbjct: 115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKS 171
Query: 476 QNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP-SGKSDV 534
N+LL + K+ DFG +K ++ S GT Y+APEI+ R P S K+D+
Sbjct: 172 ANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR---KPYSKKADM 228
Query: 535 YSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI--YDKL---IQPEKEDFVEEEDD 589
+S G+LL E++ K RP + G N E YD L I PE ++ V
Sbjct: 229 FSLGVLLYELLTLK---RPFD---GENMEEVMHKTLAGRYDPLPPSISPEMQEIVTA--- 279
Query: 590 CIARKMIIVGLWCIQINPKDRPSMTRVVEM 619
+ +PK RPS ++++ M
Sbjct: 280 ------------LLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 44/134 (32%), Positives = 71/134 (52%), Gaps = 15/134 (11%)
Query: 418 LIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCELRILHLDIKP 475
L+ +Y G L LLS+ ++ L AR L E+ L AI+ +H +L +H DIKP
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVL----AIDSVH---QLGYVHRDIKP 130
Query: 476 QNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGK---- 531
NVLLD + +++DFG + +V + GT YI+PEI ++ + + G+
Sbjct: 131 DNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPEI-LQAMEDGKGRYGPE 188
Query: 532 SDVYSYGMLLLEMI 545
D +S G+ + EM+
Sbjct: 189 CDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 14/161 (8%)
Query: 391 EVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIA 450
EVA + + H NI+ + ++ +Y G L ++ ++ L ++L+
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVL-FPEDQILDWF 107
Query: 451 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR 510
+ + A++++H + +ILH DIK QN+ L D T K+ DFG+A+ + T+ R
Sbjct: 108 VQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-----TVELAR 159
Query: 511 GTIG---YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 548
IG Y++PEI N KSD+++ G +L EM K
Sbjct: 160 TCIGTPYYLSPEICENRPYN--NKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI----HHVNIIHLLG 408
LG G +G V + G+ A+K+L+K + + + T R+ H + L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+ EY+ G L LSRE+ R + A++YLH+G +I
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KI 116
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
++ D+K +N++LD D K++DFGL K + + TM GT Y+APE+ N
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLE---DND 171
Query: 529 SGKS-DVYSYGMLLLEMI 545
G++ D + G+++ EM+
Sbjct: 172 YGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 18/199 (9%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LLGFC 410
LG G +G V K GR A+K+L+K + + + T R+ N H L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-NSRHPFLTALK 61
Query: 411 CDGSTR---ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
T + EY G L LSRE+ S AR + A++YLH+ E
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFY--GAEIVSALDYLHS--EKN 116
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
+++ D+K +N++LD D K++DFGL K ++ + TM GT Y+APE+ N
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLE---DN 171
Query: 528 PSGKS-DVYSYGMLLLEMI 545
G++ D + G+++ EM+
Sbjct: 172 DYGRAVDWWGLGVVMYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 20/198 (10%)
Query: 353 KLGTGGYGNVYKGKF-PDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG- 408
+LG G G V K + P G ++A K+ LE + I E+ + + I+ G
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
F DG ++ E+M GSL +L KE + L ++++ V + YL + +I
Sbjct: 72 FYSDGEI-SICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLRE--KHQI 125
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKA--HSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
+H D+KP N+L++ K+ DFG++ S S V GT Y++PE
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGT-- 177
Query: 527 NPSGKSDVYSYGMLLLEM 544
+ S +SD++S G+ L+E+
Sbjct: 178 HYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 354 LGTGGYGNVYKGKFPDGR-LVAVKVL---EKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
+G G YG V K + + + +VA+K E+ + + E+ + + NI+ L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
L++EY+ L +LL E+ + P ++ + AI + H I+
Sbjct: 69 FRRRGKLYLVFEYVEKNML-ELL--EEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIV 122
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 529
H DIKP+N+L+ + K+ DFG A+ S S T T Y +PE+ LG P
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEG-SNANYTEYVATRWYRSPELL---LGAPY 178
Query: 530 GKS-DVYSYGMLLLEMIEEKKHLRPTET 556
GK+ D++S G +L E+ + + L P E+
Sbjct: 179 GKAVDMWSVGCILGEL-SDGQPLFPGES 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 6/95 (6%)
Query: 456 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT--MTGPRGTI 513
++Y+H+ +LH D+KP N+L++ D K+ DFGLA+ S N MT T
Sbjct: 117 GLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 514 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 548
Y APEI M + + + DV+S G +L E++ K
Sbjct: 174 WYRAPEI-MLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH----LLG 408
LG G +G V + GR A+K+L K + + + T R+ N H L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-NTRHPFLTALK 61
Query: 409 FCCDGSTR-ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
+ R + EY G L LSRE+ + + AR + A+EYLH+
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFY--GAEIVSALEYLHSR---D 115
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
+++ DIK +N++LD D K++DFGL K + + TM GT Y+APE+ N
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLE---DN 170
Query: 528 PSGKS-DVYSYGMLLLEMI 545
G++ D + G+++ EM+
Sbjct: 171 DYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 354 LGTGGYGNVYKGKFPDG-RLVAVKVLEK--------TSNFSDNFINEVATIGRIHHVNII 404
+G G +G V K R+ A+K+L K T+ F + V G + +
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE--RNVLVNGDCQWITTL 66
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
H F D + L+ +Y G L LLS+ ++ L AR +A + +H+
Sbjct: 67 HY-AFQ-DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMVLAIHSIH 119
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR- 523
+L +H DIKP NVLLD + +++DFG +++ +V + GT YI+PEI
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEILQAM 178
Query: 524 --NLGNPSGKSDVYSYGMLLLEMI 545
+G + D +S G+ + EM+
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 55/161 (34%), Positives = 75/161 (46%), Gaps = 41/161 (25%)
Query: 418 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQN 477
LI E++P G + LL + K+ LS + + IA V AI+ +H +L +H DIKP N
Sbjct: 78 LIMEFLPGGDMMTLLMK-KDTLSEEATQFY-IAETVL-AIDAIH---QLGFIHRDIKPDN 131
Query: 478 VLLDPDFTPKVSDFGLA----KAHS----RNR--------SVVTMTGPR----------- 510
+LLD K+SDFGL KAH RN S M R
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 511 ------GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
GT YIAPE+FM+ N D +S G+++ EM+
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKL--CDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 48/187 (25%), Positives = 87/187 (46%), Gaps = 21/187 (11%)
Query: 435 EKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDPDFTPKVSDFGL 493
E++ L+L LL + VA + +L + C +H D+ +N+LL K+ DFGL
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGL 260
Query: 494 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 553
A+ + + V R + ++APE + + +SDV+SYG+LL E+
Sbjct: 261 ARDIRNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIF-------- 310
Query: 554 TETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSM 613
+ GS+ D + K+I KE + +C +M + C +P RP+
Sbjct: 311 ---SLGSSPYPGMPVDSKFYKMI---KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTF 364
Query: 614 TRVVEML 620
++V+++
Sbjct: 365 KQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 33/207 (15%)
Query: 354 LGTGGYGNVYKGKF-PDGRLVAVKVLEK---------TSNFSDNFINEVATIGRIHHVNI 403
LG G +G V ++ G L A+K L+K S + I E A H +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETA--NSERHPFL 64
Query: 404 IHLLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
++L C + EY G L ++ + S A A V ++YLH
Sbjct: 65 VNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFY--AACVVLGLQYLH- 118
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK---AHSRNRSVVTMTGPRGTIGYIAPE 519
E +I++ D+K N+LLD + K++DFGL K S GT ++APE
Sbjct: 119 --ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-----GTPEFLAPE 171
Query: 520 IFMRNLGNPSGKS-DVYSYGMLLLEMI 545
+ ++ D + G+L+ EM+
Sbjct: 172 VL---TETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 354 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LLGFC 410
+G G +G V K DG+ AVKVL+K + + + N+ H L+G
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 411 CDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
T +Y +++ G L L RE+ S R A +A A+ YLH+ +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHS---IN 116
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
I++ D+KP+N+LLD ++DFGL K T T GT Y+APE+ +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRK---Q 171
Query: 528 PSGKS-DVYSYGMLLLEMI 545
P + D + G +L EM+
Sbjct: 172 PYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 22/201 (10%)
Query: 354 LGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV--NIIHLLGF- 409
+G G Y V + R+ A+KV++K D I+ V T + N L+G
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 410 -CCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGCE 465
C +R + E++ G L + R+++ L + AR EI+L A+ +LH E
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRK-LPEEHARFYSAEISL----ALNFLH---E 114
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
I++ D+K NVLLD + K++D+G+ K R T + GT YIAPEI
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPEILR--- 169
Query: 526 GNPSGKS-DVYSYGMLLLEMI 545
G G S D ++ G+L+ EM+
Sbjct: 170 GEDYGFSVDWWALGVLMFEMM 190
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 22/199 (11%)
Query: 353 KLGTGGYGNVYK-GKFPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG- 408
+LG G G V+K P G ++A K+ LE + I E+ + + I+ G
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL-EIALGVAHAIEYLHNGCELR 467
F DG ++ E+M GSL +L + P ++L ++++ V + YL + +
Sbjct: 72 FYSDGEI-SICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLRE--KHK 124
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKA--HSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
I+H D+KP N+L++ K+ DFG++ S S V GT Y++PE
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGT- 177
Query: 526 GNPSGKSDVYSYGMLLLEM 544
+ S +SD++S G+ L+EM
Sbjct: 178 -HYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 57/272 (20%), Positives = 107/272 (39%), Gaps = 42/272 (15%)
Query: 362 VYKGKFPDGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHVNIIHLLGF---CCDGS 414
+YKG F + + V ++ +K D NE+ + RI NI+ + GF D
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 415 TR-ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDI 473
R +LI EY G L ++L +EK +LS K L++A+ + L+ + ++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEK-DLSFKTK--LDMAIDCCKGLYNLYK--YTNKPYKNL 149
Query: 474 KPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR----GTIGYIAPEIFMRNLGNPS 529
+ L+ ++ K+ GL K ++ P + Y + ++ +
Sbjct: 150 TSVSFLVTENYKLKIICHGLEK---------ILSSPPFKNVNFMVYFSYKMLNDIFSEYT 200
Query: 530 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589
K D+YS G++L E+ K T IYD +I + +
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFENLTTKE------------IYDLIINKNNSLKLPLDCP 248
Query: 590 CIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621
+ ++ C + RP++ ++ LS
Sbjct: 249 LEIKCIVEA---CTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 59/248 (23%), Positives = 88/248 (35%), Gaps = 74/248 (29%)
Query: 354 LGTGGYGNVYKGKFPDGR-LVAVKVLEKTSNFSDNFINEVATIGRIHHVN---------- 402
+G G +G V + D L A+K L K N + A HV
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRN---QAA------HVKAERDILAEAD 59
Query: 403 ---IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALG-VAHAIE 458
++ L D + +Y+P G + LL R L + L + + AIE
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIE 115
Query: 459 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA--------------HSRNRSV- 503
+H + +H DIKP N+L+D D K++DFGL H R S+
Sbjct: 116 SVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 504 ----VTMTGPR----------------------GTIGYIAPEIFMRNLGNPSGKSDVYSY 537
+ GT YIAPE+ +R D +S
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL--CDWWSV 230
Query: 538 GMLLLEMI 545
G++L EM+
Sbjct: 231 GVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 413 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEI---ALGVAHAIEYLHNGCELRIL 469
G L + P+ S +E ++L P + ++ + VA +E+L + +
Sbjct: 140 GQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCI 196
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE-IFMRNLGNP 528
H D+ +N+LL + K+ DFGLA+ ++ V R + ++APE IF +
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY--- 253
Query: 529 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588
+ +SDV+S+G+LL E+ S Y I ++ Q K+
Sbjct: 254 TTQSDVWSFGVLLWEIF--------------SLGASPYPGVQINEEFCQRLKDGTRMRAP 299
Query: 589 DCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
+ ++ + L C Q +PK+RP+ + +VE+L
Sbjct: 300 ENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 37/210 (17%)
Query: 352 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFIN-----EVATIGRIHHVNIIH 405
K+G G YG V+K + + G++VA+K ++ + D I E+ + ++ H N+++
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVN 64
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH-NGC 464
L+ L++EY + L +L EK + + +I A+ + H + C
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG-------TIGYIA 517
+H D+KP+N+L+ K+ DFG A+ +TGP T Y A
Sbjct: 122 ----IHRDVKPENILITKQGQIKLCDFGFAR---------ILTGPGDDYTDYVATRWYRA 168
Query: 518 PEIFMRNL--GNPSGKSDVYSYGMLLLEMI 545
PE+ + + G P DV++ G + E++
Sbjct: 169 PELLVGDTQYGPP---VDVWAIGCVFAELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 41/130 (31%), Positives = 66/130 (50%), Gaps = 10/130 (7%)
Query: 418 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQN 477
++ EYMP G L +L+S ++ K AR V A++ +H+ + +H D+KP N
Sbjct: 120 MVMEYMPGGDLVNLMS--NYDVPEKWARFYTAE--VVLALDAIHS---MGFIHRDVKPDN 172
Query: 478 VLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP--SGKSDVY 535
+LLD K++DFG ++ V T GT YI+PE+ G+ + D +
Sbjct: 173 MLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 536 SYGMLLLEMI 545
S G+ L EM+
Sbjct: 232 SVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 18/221 (8%)
Query: 354 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LLGF- 409
+G G Y V + + ++ A+KV++K D I+ V T + + L+G
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 410 -CCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
C ++R L+ EY+ G L + R+++ L + AR A + A+ +LH E
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRK-LPEEHARFY--AAEICIALNFLH---ERG 116
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
I++ D+K NVLLD D K++D+G+ K T + GT YIAPEI G
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILR---GE 171
Query: 528 PSGKS-DVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYF 567
G S D ++ G+L+ EM+ + NT + F
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF 212
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 39/209 (18%)
Query: 354 LGTGGYGNVY--KGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCC 411
LG G +G V + K G+ A+K+L+K + + EVA H + +L
Sbjct: 3 LGKGTFGKVILVREK-ATGKYYAMKILKKEVIIAKD---EVA-----HTLTESRVLQNTR 53
Query: 412 DGSTRALIY------------EYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAI 457
AL Y EY G L LSRE+ S AR EI A+
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVS----AL 108
Query: 458 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 517
YLH+ +++ D+K +N++LD D K++DFGL K + + TM GT Y+A
Sbjct: 109 GYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLA 163
Query: 518 PEIFMRNLGNPSGKS-DVYSYGMLLLEMI 545
PE+ N G++ D + G+++ EM+
Sbjct: 164 PEVLE---DNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 47/181 (25%), Positives = 89/181 (49%), Gaps = 22/181 (12%)
Query: 373 VAVKVLEKT-SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDL 431
V +KVL+ + + + F + + ++ H+++ + G C GS ++ E++ +G L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106
Query: 432 LSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVL-----LDPDFTP 486
L +EK + A + +A +A A+ YL + ++H ++ +N+L L +P
Sbjct: 107 LRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSP 161
Query: 487 --KVSDFGLA-KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLE 543
K+SD G++ A SR V I +IAPE + + S +D +S+G LLE
Sbjct: 162 FIKLSDPGVSFTALSREERV-------ERIPWIAPEC-VPGGNSLSTAADKWSFGTTLLE 213
Query: 544 M 544
+
Sbjct: 214 I 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 34/213 (15%)
Query: 352 EKLGTGGYGNVYK-GKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGF 409
E +G G YG V+K +G AVK+L+ + + E + + H N++ G
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 410 -----CCDGSTRALIYEYMPNGSLGDL----LSR-EKENLSLKPARLLEIALGVAHAIEY 459
+G L+ E GS+ DL L R E+ + L E +G+ H
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQH---- 139
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-----HSRNRSVVTMTGPRGTIG 514
LH + +H D+K N+LL + K+ DFG++ RN SV GT
Sbjct: 140 LHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-------GTPF 189
Query: 515 YIAPEIFM--RNLGNP-SGKSDVYSYGMLLLEM 544
++APE+ + L + + DV+S G+ +E+
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 350 FKEKLGTGGYGNVY--KGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN----I 403
F LG G +G V + K D L A+K+L+K D+ + R+ ++
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTD-ELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 404 IHLLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
+ L C R + EY+ NG GDL+ + ++ K + A +A + +LH+
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYV-NG--GDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
I++ D+K NV+LD + K++DFG+ K + + VT GT YIAPEI
Sbjct: 120 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIA 174
Query: 523 RNLGNPSGKS-DVYSYGMLLLEMI 545
P GKS D +++G+LL EM+
Sbjct: 175 Y---QPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 64/247 (25%), Positives = 108/247 (43%), Gaps = 28/247 (11%)
Query: 309 PFSEERQNIGDGLN-VKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKF 367
P + +NI + LN ++ ++ R + Y+ +K +G G +G V +
Sbjct: 13 PALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKV--------IGRGAFGEVQLVRH 64
Query: 368 PDGRLV-AVKVLEKTSNF--SDN--FINEVATIGRIHHVNIIHLLGFCC--DGSTRALIY 420
+ V A+K+L K SD+ F E + + ++ L FC D ++
Sbjct: 65 KSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVM 122
Query: 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 480
EYMP G L +L+S E+ L A++ +H+ + ++H D+KP N+LL
Sbjct: 123 EYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL----ALDAIHS---MGLIHRDVKPDNMLL 175
Query: 481 DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP--SGKSDVYSYG 538
D K++DFG V T GT YI+PE+ G+ + D +S G
Sbjct: 176 DKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 539 MLLLEMI 545
+ L EM+
Sbjct: 235 VFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 22/196 (11%)
Query: 358 GYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 417
G + +GK RL+A K ++ S + NE+ +GR++H NI+ + +
Sbjct: 181 GVNSTNQGKPKCERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTY 239
Query: 418 LI--------YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
+I Y +M + + K+ LK R I + A+EY+H+ +++
Sbjct: 240 MITQKYDFDLYSFMYDEAF-----DWKDRPLLKQTR--AIMKQLLCAVEYIHDK---KLI 289
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 529
H DIK +N+ L+ D + DFG A + R G GT+ +PEI +
Sbjct: 290 HRDIKLENIFLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGD--GYC 346
Query: 530 GKSDVYSYGMLLLEMI 545
+D++S G++LL+M+
Sbjct: 347 EITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 33/98 (33%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 448 EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507
+I G+ H LH + I++ D+KP+NVLLD ++SD GLA +++ T
Sbjct: 103 QITCGILH----LH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---T 152
Query: 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
GT GY+APEI S D ++ G + EM+
Sbjct: 153 QRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMV 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 17/147 (11%)
Query: 357 GGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDNFINEVAT----IGRIHHVNIIHLLGFCC 411
G +G VY G K + +L AVKV++K + N +++V + I+HL
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 412 DGSTRALIYEYMPNGSLGDLLSRE---KENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+ L+ EY+ G + LL E +++K + E+AL A++YLH I
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVK--YISEVAL----ALDYLH---RHGI 125
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAK 495
+H D+KP N+L+ + K++DFGL+K
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 54/224 (24%), Positives = 89/224 (39%), Gaps = 38/224 (16%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLE--KTSNFSDNFINEVATIG-------------R 397
LG G YG V K G++VA+K ++ + SN V G
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 398 IHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAI 457
I H NI+ L+ +G L+ + M DL + L +++ I L + + +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA----SDLKKVVDRKIRLTESQVKCILLQILNGL 132
Query: 458 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT------------ 505
LH +H D+ P N+ ++ K++DFGLA+ + T
Sbjct: 133 NVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 506 MTGPRGTIGYIAPEIFMRNLGNPSGKS-DVYSYGMLLLEMIEEK 548
MT T+ Y APE+ M + D++S G + E++ K
Sbjct: 190 MTSKVVTLWYRAPELLMG--AEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 33/95 (34%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 456 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-GTIG 514
I++LH+ I+H D+KP N+++ D T K+ DFGLA R M P T
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA----RTAGTSFMMTPYVVTRY 182
Query: 515 YIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEK 548
Y APE+ LG D++S G ++ EMI
Sbjct: 183 YRAPEVI---LGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 31/86 (36%), Positives = 47/86 (54%), Gaps = 5/86 (5%)
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
RI++ D+KP+N+LLD ++SD GLA T+ G GT+GY+APE+ N
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVI--NNE 176
Query: 527 NPSGKSDVYSYGMLLLEMIEEKKHLR 552
+ D + G L+ EMI+ + R
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIH------HVNIIHL 406
+G G YG V K + VA+K K +N DN I+ T+ I H N+I +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIK---KIANAFDNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 407 LGFCCDGSTRA-----LIYEYMPNGSLGDL--LSREKENLSLKPAR--LLEIALGVAHAI 457
A ++YE M DL + R + LS + L ++ G +
Sbjct: 70 KDIMPPPHREAFNDVYIVYELMDT----DLHQIIRSSQTLSDDHCQYFLYQLLRG----L 121
Query: 458 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 517
+Y+H+ +LH D+KP N+LL+ + K+ DFGLA+ S MT T Y A
Sbjct: 122 KYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF--MTEYVVTRWYRA 176
Query: 518 PEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 548
PE+ + N + DV+S G + E++ K
Sbjct: 177 PELLL-NCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 32/98 (32%), Positives = 56/98 (57%), Gaps = 12/98 (12%)
Query: 448 EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507
EI LG +E++HN +++ D+KP N+LLD ++SD GLA S+ + ++
Sbjct: 105 EIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV- 156
Query: 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
GT GY+APE+ + + S +D +S G +L +++
Sbjct: 157 ---GTHGYMAPEVLQKGVAYDS-SADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 74/300 (24%), Positives = 125/300 (41%), Gaps = 59/300 (19%)
Query: 354 LGTGGYGNVYKG-KFPDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLLGF 409
+G+G YG+V G VA+K L + + F+ E+ + + H N+I LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL-- 80
Query: 410 CCDGSTRALIYEYMPNGSL------GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 463
D T A+ + + L DL LS + L + ++Y+H+
Sbjct: 81 --DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL--VYQMLCGLKYIHSA 136
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
I+H D+KP N+ ++ D K+ DFGLA+ + MTG T Y APE+ +
Sbjct: 137 ---GIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVIL- 187
Query: 524 NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK--- 580
N + + D++S G ++ EM+ K + D++ D+L Q K
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK--------------DYL-DQLTQILKVTG 232
Query: 581 ---EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR--VVEMLSSASAEAIEMPPKPL 635
+FV++ +D A+ I K P R + AS +A+++ K L
Sbjct: 233 VPGPEFVQKLEDKAAKSYI-----------KSLPKYPRKDFSTLFPKASPQAVDLLEKML 281
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 64/257 (24%), Positives = 99/257 (38%), Gaps = 61/257 (23%)
Query: 354 LGTGGYGNV-YKGKFPDGRLVAVKVLEKTSNFSDNFINEVAT----IGRIHHVNIIHLLG 408
LG G +G V K L A+K L K + N + V + + ++ L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALG-VAHAIEYLHNGCELR 467
D + +Y+P G + LL R + + P L + + AIE +H ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVH---KMG 121
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAK--------------AHSRNRSVV--------- 504
+H DIKP N+L+D D K++DFGL +H R S+
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 505 -TMTGPR---------------------GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLL 542
G R GT YIAPE+ +R + D +S G++L
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWSVGVILF 239
Query: 543 EM-IEEKKHLRPTETTS 558
EM + + L PT T +
Sbjct: 240 EMLVGQPPFLAPTPTET 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 16/171 (9%)
Query: 378 LEKTSNFSDNFINEVATIGRIHHVNIIHLL-GFCCDGSTRALIYEYMPNGSLGDLLSREK 436
L K+S+ ++ E + ++ H NI+ F DG ++ EY G L + ++
Sbjct: 35 LPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLY-IVMEYCDGGDLMQKIKLQR 93
Query: 437 ENLSLKPARL---LEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 493
L + L +++ LGV H +H E R+LH DIK +N+ L + K+ DFG
Sbjct: 94 GKLFPEDTILQWFVQMCLGVQH----IH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGS 146
Query: 494 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 544
A+ + + GT Y+ PEI+ N KSD++S G +L E+
Sbjct: 147 ARLLTSPGAYACTY--VGTPYYVPPEIWENMPYN--NKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 351 KEKLGTGGYGNVYKGKFPDGRLVA---VKVLEKTS------NFSDNFINEVATIGRIHHV 401
+++LG G +G VY K D + VA +KVL++ N + E + ++ H
Sbjct: 5 QQRLGKGSFGTVYLVK--DKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR-----LLEIALGVAHA 456
I+ + +I EY L L K +++ LGV
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV--- 119
Query: 457 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 516
Y+H + RILH D+K +N+ L + K+ DFG+++ + + T GT Y+
Sbjct: 120 -HYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTF--TGTPYYM 172
Query: 517 APEIFMRNLGNPSGKSDVYSYGMLLLEM 544
+PE +++ G S KSD++S G +L EM
Sbjct: 173 SPEA-LKHQGYDS-KSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 354 LGTGGYGNVYKGKFPDGRL---VAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLL 407
+G+G YG+V D RL VAVK L + + E+ + + H N+I LL
Sbjct: 23 VGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 408 G-FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
F S Y+ +G L+ + L + + + ++Y+H+
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA--- 137
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
I+H D+KP NV ++ D ++ DFGLA+ MTG T Y APEI M N
Sbjct: 138 GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEI-MLNWM 191
Query: 527 NPSGKSDVYSYGMLLLEMIEEK 548
+ + D++S G ++ E+++ K
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 48/154 (31%), Positives = 72/154 (46%), Gaps = 13/154 (8%)
Query: 393 ATIGR-IHHVNIIHLLG-FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIA 450
A I R I+H +II L G F + T ++ Y DL ++ +L I
Sbjct: 134 AHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-----DLYCYLAAKRNIAICDILAIE 188
Query: 451 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR 510
V AI+YLH RI+H DIK +N+ ++ + DFG A + + G
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 511 GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 544
GTI APE+ R+ P+ D++S G++L EM
Sbjct: 245 GTIATNAPELLARDPYGPA--VDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 78/314 (24%), Positives = 132/314 (42%), Gaps = 49/314 (15%)
Query: 354 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 407
LG G +G V + G AVK L+K D+ + R+ + + HL
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
C T+ ++ M + GDL+ ++ R A + +++LH+
Sbjct: 63 ---CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---G 116
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAH--SRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
I++ D+K NV+LD D K++DFG+ K + NR+ GT YIAPEI
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC----GTPDYIAPEIL---Q 169
Query: 526 GNPSGKS-DVYSYGMLLLEMIEEKKHLR---PTETTSGSNTTEAYFPDWIYDKLIQPEKE 581
G S D +S+G+LL EM+ + E ++P W I E +
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRW-----ITKESK 224
Query: 582 DFVE---EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKPLFPS 638
D +E E D R++ +VG N + P + ++ + E E+ P P
Sbjct: 225 DILEKLFERDP--TRRLGVVG------NIRGHP----FFKTINWTALEKRELDP----PF 268
Query: 639 PPQLQTQNEIISFD 652
P++++ ++ +FD
Sbjct: 269 KPKVKSPSDYSNFD 282
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 354 LGTGGYGNVYKG-KFPDGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLG- 408
+G+G YG+V G VAVK L + + E+ + + H N+I LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
F S Y+ +G L+ + L + + + ++Y+H+ I
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DI 141
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
+H D+KP N+ ++ D K+ DFGLA+ H+ + MTG T Y APEI M N +
Sbjct: 142 IHRDLKPSNLAVNEDCELKILDFGLAR-HTDDE----MTGYVATRWYRAPEI-MLNWMHY 195
Query: 529 SGKSDVYSYGMLLLEMI 545
+ D++S G ++ E++
Sbjct: 196 NQTVDIWSVGCIMAELL 212
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 63/248 (25%), Positives = 110/248 (44%), Gaps = 23/248 (9%)
Query: 353 KLGTGGYGNVYKGKFPDG---RLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
K+G G YG+VYK K DG R A+K +E T S + E+A + + H N+I L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKV 66
Query: 410 CCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARL-----LEIALGVAHAIEYLHN 462
+ R L+++Y + + + KP +L + + I YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 463 GCELRILHLDIKPQNVLL---DPDF-TPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIA 517
+LH D+KP N+L+ P+ K++D G A+ +S + + + T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 518 PEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK--HLRPTETTSGSNTTEAYFPDWIYDKL 575
PE+ + + + D+++ G + E++ + H R E SN D I++ +
Sbjct: 184 PELLL-GARHYTKAIDIWAIGCIFAELLTSEPIFHCR-QEDIKTSNPYHHDQLDRIFNVM 241
Query: 576 IQPEKEDF 583
P +D+
Sbjct: 242 GFPADKDW 249
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 354 LGTGGYGNVYKGKFPDG-RLVAVKVLEK--------TSNFSDNFINEVATIGRIHHVNII 404
+G G +G V K + ++ A+K+L K T+ F + +V G + +
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE--RDVLVNGDNQWITTL 66
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHN 462
H D + L+ +Y G L LLS+ ++ L AR L E+ + AI+ +H
Sbjct: 67 HYA--FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVI----AIDSVH- 119
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
+L +H DIKP N+L+D + +++DFG + +V + GT YI+PEI
Sbjct: 120 --QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQ 176
Query: 523 R---NLGNPSGKSDVYSYGMLLLEMI 545
G + D +S G+ + EM+
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 80/342 (23%), Positives = 135/342 (39%), Gaps = 95/342 (27%)
Query: 354 LGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSDN--FINEVATIGRI-HHVNII 404
LG G +G V + K R VAVK+L++ + S++ ++E+ + I HH+N++
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 405 HLLG--------------FCCDGSTRALIY----EYMP--------------NGSLGDLL 432
+LLG FC G+ + E++P G + + L
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 433 SR------------------------------EKENLSLKPARLLEI---ALGVAHAIEY 459
R E+E+L K L ++ + VA +E+
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 519
L + +H D+ +N+LL + K+ DFGLA+ ++ V R + ++APE
Sbjct: 195 L---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251
Query: 520 -IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578
IF R + +SDV+S+G+LL E+ S Y I ++ +
Sbjct: 252 TIFDRVY---TIQSDVWSFGVLLWEIF--------------SLGASPYPGVKIDEEFCRR 294
Query: 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
KE D +M L C P RP+ + +VE L
Sbjct: 295 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 420 YEYMPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNV 478
Y+ + + +LLS + E L+ LL VA +E+L + +H D+ +NV
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLD--LLSFTYQVARGMEFLASK---NCVHRDLAARNV 268
Query: 479 LLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYG 538
LL K+ DFGLA+ + + V+ + ++APE NL + SDV+SYG
Sbjct: 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL--YTTLSDVWSYG 326
Query: 539 MLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIV 598
+LL E+ P + Y+K+ K + + D +++ +
Sbjct: 327 ILLWEIFSLGGTPYPGMIVDST----------FYNKI----KSGYRMAKPDHATQEVYDI 372
Query: 599 GLWCIQINPKDRPSMTRVVEMLSS 622
+ C P+ RPS + +++ S
Sbjct: 373 MVKCWNSEPEKRPSFLHLSDIVES 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 353 KLGTGGYGNVYKGKFPDG---RLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
K+G G YG+VYK K DG + A+K +E T S + E+A + + H N+I L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKV 66
Query: 410 CCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARL-----LEIALGVAHAIEYLHN 462
S R L+++Y + + + KP +L + + I YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 463 GCELRILHLDIKPQNVLL---DPDF-TPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIA 517
+LH D+KP N+L+ P+ K++D G A+ +S + + + T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 518 PEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
PE+ + + + D+++ G + E++
Sbjct: 184 PELLL-GARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNIIHLLGFCC 411
LG G G V+ D + VAVK + T S + + E+ I R+ H NI+ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 412 DGSTR-----------ALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAI 457
+ +Y EYM L ++L E+ LS + ARL L +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL--EQGPLSEEHARLFMYQL--LRGL 127
Query: 458 EYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAK---AHSRNRSVVTMTGPRGTI 513
+Y+H+ +LH D+KP NV ++ D K+ DFGLA+ H ++ ++ T
Sbjct: 128 KYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG--LVTK 182
Query: 514 GYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 548
Y +P + + N + D+++ G + EM+ K
Sbjct: 183 WYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 75/299 (25%), Positives = 112/299 (37%), Gaps = 92/299 (30%)
Query: 354 LGTGGYGNV-YKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN---------- 402
+G G +G V K G++ A+K L K+ F + ++ HV
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKD---------QLAHVKAERDVLAESD 59
Query: 403 ---IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAI 457
++ L D LI E++P G L +L + + S R + E L AI
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVL----AI 114
Query: 458 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA----KAHSRN------------- 500
E +H +L +H DIKP N+L+D K+SDFGL+ K H
Sbjct: 115 EAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN 171
Query: 501 -----RSVV------TMTGPR-----------------GTIGYIAPEIFMRNLGNPSGKS 532
SV TM+ GT YIAPEIF++ +
Sbjct: 172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQEC 229
Query: 533 DVYSYGMLLLEMI-------EEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584
D +S G ++ E + E H + + T YFPD I+ + E ED +
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETL--YFPDDIH---LSVEAEDLI 283
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 58/244 (23%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 340 YNDIKKMTNGFK--EKLGTGGYGNVYKGK------FPDGRLVAVKVLEKTSNFSDNFINE 391
Y+D + N ++ +K+G G +G V+ K F + ++ + L++ + E
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK--SQLVIE 62
Query: 392 VATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENL-----SLKPARL 446
V + + H NI+ + + + + L Y M GDL SR + ++ +
Sbjct: 63 VNVMRELKHKNIVRYIDRFLNKANQKL-YILMEFCDAGDL-SRNIQKCYKMFGKIEEHAI 120
Query: 447 LEIALGVAHAIEYLHNGCE----LRILHLDIKPQNVLLDPDF-----------------T 485
++I + HA+ Y HN + R+LH D+KPQN+ L
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 486 PKVSDFGLAKAHSRNRSVVTMTGP-RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 544
K+ DFGL S+N + +M GT Y +PE+ + + KSD+++ G ++ E+
Sbjct: 181 AKIGDFGL----SKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
Query: 545 IEEK 548
K
Sbjct: 237 CSGK 240
|
Length = 1021 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 354 LGTGGYGNVYKGKFPDG-RLVAVKVLEKTSNFS----DNFINEVATIGRIHHVNIIHL-L 407
+G G +G V + + D R+ A+K + K S + + E + +++ I+ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
F L+ ++ G L L RE L AR L A +E LH +
Sbjct: 61 SFQSPEKLY-LVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCA--LENLH---KFN 113
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
+++ D+KP+N+LLD + DFGL K + ++ GT Y+APE+ LG+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELL---LGH 168
Query: 528 PSGKS-DVYSYGMLLLEMI 545
K+ D ++ G+LL EM+
Sbjct: 169 GYTKAVDWWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 23/187 (12%)
Query: 371 RLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA------LIYE 421
R VA+K L + + E+ + ++H NII LL + L+ E
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102
Query: 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD 481
M + +L ++ E L R+ + + I++LH+ I+H D+KP N+++
Sbjct: 103 LM-DANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK 153
Query: 482 PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLL 541
D T K+ DFGLA+ + MT T Y APE+ + +G D++S G ++
Sbjct: 154 SDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPEVIL-GMGYKE-NVDIWSVGCIM 208
Query: 542 LEMIEEK 548
EM+ K
Sbjct: 209 GEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 59/243 (24%), Positives = 92/243 (37%), Gaps = 60/243 (24%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVAT----IGRIHHVNIIHLLG 408
LG G +G V + D L A+K L K N + V + + ++ L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALG-VAHAIEYLHNGCELR 467
D + +Y+P G + LL R + + P L + + A+E +H ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVH---KMG 121
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKA--------------HSRNRSV---------- 503
+H DIKP N+L+D D K++DFGL H R S+
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181
Query: 504 VTMTGPR---------------------GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLL 542
G R GT YIAPE+ +R + D +S G++L
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVILY 239
Query: 543 EMI 545
EM+
Sbjct: 240 EML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 54/173 (31%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 353 KLGTGGYGNVY--KGKFPDGRLVAVKVLEKTSNFSDNFINE--VATIGRIHHVNIIHLLG 408
KL G +G V K K P +L K++ K NF N I E V + + + N I L
Sbjct: 23 KLIDGKFGKVSVLKHK-PTQKLFVQKII-KAKNF--NAI-EPMVHQLMK-DNPNFIKLYY 76
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
LI +Y+ +G L DLL +E + LS + I + A+ LH I
Sbjct: 77 SVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKK--IIRQLVEALNDLHKH---NI 130
Query: 469 LHLDIKPQNVLLDPDFTPKV--SDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 519
+H DIK +NVL D ++ D+GL K + T + GT+ Y +PE
Sbjct: 131 IHNDIKLENVLYD-RAKDRIYLCDYGLCK------IIGTPSCYDGTLDYFSPE 176
|
Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 10/92 (10%)
Query: 456 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGY 515
I++LH+ I+H D+KP N+++ D T K+ DFGLA+ N MT T Y
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYY 188
Query: 516 IAPEIFMRNLGNPSGKS-DVYSYGMLLLEMIE 546
APE+ LG ++ D++S G ++ E+++
Sbjct: 189 RAPEVI---LGMGYKENVDIWSVGCIMGELVK 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 446 LLEIALGVAHAIEYL-HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504
LL + VA +++L C +H D+ +NVLL K+ DFGLA+ + + V
Sbjct: 214 LLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269
Query: 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 544
R + ++APE + + +SDV+SYG+LL E+
Sbjct: 270 VKGNARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVK----VLEKTSNFSDNFINEVATIGRIHHVNIIHL 406
E +G G YG V G VA+K V E S+ + + E+ + + H +I+ +
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSD-ATRILREIKLLRLLRHPDIVEI 64
Query: 407 LGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
S R +++E M + DL K N L P + A++Y+H
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEI 520
+ H D+KP+N+L + D K+ DFGLA+ + + + T T Y APE+
Sbjct: 121 TA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEMIEEK 548
+ D++S G + E++ K
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 31/151 (20%), Positives = 55/151 (36%), Gaps = 14/151 (9%)
Query: 351 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNII--HLLG 408
+ L G VY D V +K+ + EVA + + + +L
Sbjct: 3 IKLLKGGLTNRVYLLGTKDEDYV-LKINPSRE-KGADREREVAILQLLARKGLPVPKVLA 60
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
L+ E++ +L ++ EKE+++ + A LL LH L +
Sbjct: 61 SGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAK----------LHQLPLLVL 110
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499
H D+ P N+L+D + D+ A
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 8/93 (8%)
Query: 456 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGY 515
I++LH+ I+H D+KP N+++ D T K+ DFGLA+ + MT T Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 191
Query: 516 IAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 548
APE+ + +G D++S G ++ EMI+
Sbjct: 192 RAPEVIL-GMGYKE-NVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 1e-04
Identities = 18/64 (28%), Positives = 35/64 (54%), Gaps = 7/64 (10%)
Query: 49 KCGNLTFSFPFSSSSTSGYCGL-PNYQITCDSSSV-PKLLLSGRLYQVRNFFSSQDDRLI 106
+CGN++ +PF C P +++TC++++ P+LLL Y+V + S + +
Sbjct: 7 RCGNVSIPYPF---GIGPGCARDPGFELTCNNTTSPPRLLLGNGNYEVLSI--SLANGTV 61
Query: 107 TVVD 110
V+D
Sbjct: 62 RVLD 65
|
This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 52/188 (27%), Positives = 85/188 (45%), Gaps = 18/188 (9%)
Query: 368 PDGRLVAVKV--LEKTSNFSDNFI-NEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424
P G LV V++ LE + + NEV H NI+ GS +I +M
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH-NGCELRILHLDIKPQNVLLDPD 483
GS LL + + A + I G + YLH NG +H +IK ++L+ D
Sbjct: 83 YGSANSLL-KTYFPEGMSEALIGNILFGALRGLNYLHQNGY----IHRNIKASHILISGD 137
Query: 484 FTPKVSDFGLAKAHS--RN--RSVVTMTGPR---GTIGYIAPEIFMRNLGNPSGKSDVYS 536
+S GL+ +S RN ++ V P+ + +++PE+ ++L + KSD+YS
Sbjct: 138 GLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYS 195
Query: 537 YGMLLLEM 544
G+ E+
Sbjct: 196 VGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 26/197 (13%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD 412
L G G V++ PD + V VK S+ ++E + R+ H ++ LL
Sbjct: 177 LTPGSEGCVFESSHPDYPQRVVVKAGWYASS-----VHEARLLRRLSHPAVLALLDVRVV 231
Query: 413 GSTRALIYEYMP--NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILH 470
G L+ +P L L L L A++ +A + AI+Y+H E I+H
Sbjct: 232 GGLTCLV---LPKYRSDLYTYLGARLRPLGL--AQVTAVARQLLSAIDYIH--GE-GIIH 283
Query: 471 LDIKPQNVLLDPDFTPK---VSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
DIK +NVL++ P+ + DFG A + S G GT+ APE+ G+
Sbjct: 284 RDIKTENVLVN---GPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLA---GD 337
Query: 528 PSGKS-DVYSYGMLLLE 543
P S D++S G+++ E
Sbjct: 338 PYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 16/187 (8%)
Query: 368 PDGRLVAVKV--LEKTSNFSDNFIN-EVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424
P G V V+ LE +N F+ E+ +H NI+ + ++ +M
Sbjct: 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF 484
GS DL+ + + + I GV A++Y+H+ + +H +K ++L+ D
Sbjct: 83 YGSAKDLICTHFMD-GMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVD- 137
Query: 485 TPKVSDFGLAKAHSR----NRSVVTMTGPRGTIG---YIAPEIFMRNLGNPSGKSDVYSY 537
KV GL S R V P+ ++ +++PE+ +NL KSD+YS
Sbjct: 138 -GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 538 GMLLLEM 544
G+ E+
Sbjct: 197 GITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 9/122 (7%)
Query: 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDP 482
P + D L E LS L+ + VA+ +E+L + C +H D+ +NVL+
Sbjct: 221 PERTRRDTLINESPALSYMD--LVGFSYQVANGMEFLASKNC----VHRDLAARNVLICE 274
Query: 483 DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLL 542
K+ DFGLA+ R+ + ++ + ++APE NL + SDV+S+G+LL
Sbjct: 275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL--YTTLSDVWSFGILLW 332
Query: 543 EM 544
E+
Sbjct: 333 EI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 35/215 (16%)
Query: 352 EKLGTGGYGNVYKGKFPDGR-------------LVAVKVLEKT-SNFSDNFINEVATIGR 397
E LG G +Y G V +KVL+ + + S F + + +
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 398 IHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAI 457
+ H +I+ L G C ++ E++ G L DL K ++ P + ++A +A A+
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPWK-FKVAKQLASAL 118
Query: 458 EYLHNGCELRILHLDIKPQNVLL-----DPDFTP--KVSDFGLA-KAHSRNRSVVTMTGP 509
YL + ++H ++ +N+LL D + P K+SD G+ SR V
Sbjct: 119 SYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECV------ 169
Query: 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 544
I +IAPE + + N S +D +S+G L E+
Sbjct: 170 -ERIPWIAPEC-VEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 39/138 (28%), Positives = 70/138 (50%), Gaps = 15/138 (10%)
Query: 350 FKEKLGTGGYGNV-----YKGKFPDGRL-VAVKVLEKTSNFSDN--FINEVATIGRI-HH 400
F + LG G +G V Y D + VAVK+L+ +++ ++ ++E+ + + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 401 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKEN-LSLKPARLLEIAL--GVAHAI 457
+NI++LLG C G +I EY G L + L R++++ + K E AL + H
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQR 158
Query: 458 EYLHNGCELRILHLDIKP 475
E C+ ++D+KP
Sbjct: 159 E---MSCDSLNEYMDMKP 173
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 11/100 (11%)
Query: 350 FKEKLGTGGYGNVYK------GKFPDGRLVAVKVLEKTSNFSDN---FINEVATIGRI-H 399
F + LG G +G V + GK + VAVK+L K S +D ++E+ + +
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKML-KASAHTDEREALMSELKILSHLGQ 100
Query: 400 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENL 439
H NI++LLG C G +I EY G L + L ++ E
Sbjct: 101 HKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETF 140
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 41/164 (25%), Positives = 69/164 (42%), Gaps = 33/164 (20%)
Query: 354 LGTGGYGNVY----KGKFPDGRLVAVKV--LEKTSNFSDNF-------INEVATIGRIHH 400
+G GG+G VY K+ LE + + I+++A IH
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH- 78
Query: 401 VNIIHL---LGFCCDGSTRALIY------EYMPNGSLGDLLSREKENLSLKPARLLE-IA 450
NI HL + C R +Y E + + ++ R K K +L++ I
Sbjct: 79 -NIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIM 132
Query: 451 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 494
+ +EY+H E I H DIKP+N+++D + + D+G+A
Sbjct: 133 KDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 667 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| PF14380 | 94 | WAK_assoc: Wall-associated receptor kinase C-termi | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.88 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.86 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.76 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.68 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.67 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.63 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.57 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.5 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.33 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.3 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.18 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.11 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.11 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.09 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.09 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.97 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.94 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.91 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.81 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.8 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.79 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.77 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.76 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.57 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.5 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.41 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.4 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.35 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.32 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.94 | |
| PLN02236 | 344 | choline kinase | 96.82 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.79 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.7 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.51 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.32 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.27 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.24 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.97 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.88 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.83 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.7 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.63 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.55 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.49 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.29 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.69 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.66 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.59 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.37 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.9 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-54 Score=450.16 Aligned_cols=280 Identities=43% Similarity=0.729 Sum_probs=235.0
Q ss_pred cCCCCCHHHHHHHHHHhh--hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcc-hHHHHHHHHHHhhcccceEEeecceE
Q 005953 334 LLSNYSYNDIKKMTNGFK--EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNF-SDNFINEVATIGRIHHVNIIHLLGFC 410 (667)
Q Consensus 334 ~~~~~~~~~l~~~~~~~~--~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~g~~ 410 (667)
....|++.+|+++|++|. .+||+|+||.||+|.+++|+.||||++...... .++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456799999999999998 589999999999999999999999988876654 67799999999999999999999999
Q ss_pred ecCC-eeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEE
Q 005953 411 CDGS-TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 489 (667)
Q Consensus 411 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~ 489 (667)
.+.+ .++||||||++|+|+++|+..... .++|.++++||.++|+||+|||..+.++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999976544 78999999999999999999999988899999999999999999999999
Q ss_pred eCCCccccCC-CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccch
Q 005953 490 DFGLAKAHSR-NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFP 568 (667)
Q Consensus 490 DFGla~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 568 (667)
|||+|+.... ....... . .||.+|+|||++.. +..+.|+|||||||+|+||+||+++.+.... ..+..+.
T Consensus 220 DFGLa~~~~~~~~~~~~~-~-~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~-----~~~~~l~ 290 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTT-V-MGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRP-----RGELSLV 290 (361)
T ss_pred CccCcccCCccccceeee-c-CCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCC-----cccccHH
Confidence 9999977655 3322211 1 79999999999976 5899999999999999999999988875432 1222356
Q ss_pred HHHHHhhcCcccc----cc-c-chhhH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 569 DWIYDKLIQPEKE----DF-V-EEEDD-CIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 569 ~~~~~~~~~~~~~----~~-~-~~~~~-~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
+|....+.+.... .. . ..... ....++..++.+|++.+|++||+|.||+++|+.+
T Consensus 291 ~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 291 EWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 6665544443221 11 1 12121 4677899999999999999999999999999644
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-48 Score=401.67 Aligned_cols=258 Identities=30% Similarity=0.509 Sum_probs=210.5
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcc---hHHHHHHHHHHhhcccceEEeecceEecCC-eeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNF---SDNFINEVATIGRIHHVNIIHLLGFCCDGS-TRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-~~~lV~e~~~~ 425 (667)
+.+.||+|+||+||+|.+.+...||||++...... .++|.+|+.+|.+++|||||+++|+|.+.. ...+|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 34669999999999999955555999999865422 568999999999999999999999999887 79999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eeecCCCCCcEEECCCC-ceEEEeCCCccccCCCCce
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR-ILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~-ivH~Dikp~NIll~~~~-~~ki~DFGla~~~~~~~~~ 503 (667)
|+|.++|+.. ....+++..+++||.|||+||+|||+. + ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 9999999875 355799999999999999999999998 6 99999999999999998 99999999998765432
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
...+...||+.|||||++......++.|+||||||+++|||+||+.||..... ...+............
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----------~~~~~~v~~~~~Rp~~ 267 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----------VQVASAVVVGGLRPPI 267 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----------HHHHHHHHhcCCCCCC
Confidence 23455779999999999984224789999999999999999999999975432 1111111112211111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccccc
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAI 628 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 628 (667)
+......+..++.+||+.||+.||++.+++..|+.+.....
T Consensus 268 ----p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 268 ----PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred ----CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 11246678889999999999999999999999996655443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=397.14 Aligned_cols=256 Identities=28% Similarity=0.474 Sum_probs=214.7
Q ss_pred HHHHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
....+.++||+|.||+||.|+++....||+|.++......++|.+|+++|++|+|+|||+++|+|..++..+||||||++
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 33446789999999999999997777999999998777778999999999999999999999999998899999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.++|... .+..+...+++.++.|||+||+||+++ ++|||||.++||||++++.+||+|||||+....+.. ..
T Consensus 286 GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-~~ 360 (468)
T KOG0197|consen 286 GSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-TA 360 (468)
T ss_pred CcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCce-ee
Confidence 9999999873 245688999999999999999999998 999999999999999999999999999995544433 33
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
..+..-+..|.|||.+.. +.++.|||||||||+||||+| |+.|+.... ...+.+.+.++ .+
T Consensus 361 ~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms------------n~ev~~~le~G----yR 422 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMS------------NEEVLELLERG----YR 422 (468)
T ss_pred cCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCC------------HHHHHHHHhcc----Cc
Confidence 355566889999999975 589999999999999999998 555543322 12233333332 33
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
...+..++..++++|..||+.+|++|||++.+...|++..
T Consensus 423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 3344456778999999999999999999999999998654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=370.17 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=209.1
Q ss_pred CCHHHHHHHHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEccc--CCcchHHHHHHHHHHhhcccceEEeecceEecCC
Q 005953 338 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEK--TSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGS 414 (667)
Q Consensus 338 ~~~~~l~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 414 (667)
.+..||+. .+.||+|..|+|||++++ +++.+|+|++.. +....+++.+|++++++.+||+||.++|.|....
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 44556653 378999999999999996 689999999944 3455678999999999999999999999999988
Q ss_pred e-eEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCC
Q 005953 415 T-RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 493 (667)
Q Consensus 415 ~-~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGl 493 (667)
. ..++||||++|||++++...+ .+++..+-+|+.++++||.|||+. .+||||||||+||||+..|++||+|||.
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccc
Confidence 4 999999999999999997643 489999999999999999999962 3999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHH
Q 005953 494 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573 (667)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 573 (667)
++.+... .....+||..|||||.+.+. .++.++||||||+.++|+.+|+.|+.+.... ... .-....
T Consensus 226 S~~lvnS----~a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-----~~~--~~~Ll~ 292 (364)
T KOG0581|consen 226 SGILVNS----IANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-----YLD--IFELLC 292 (364)
T ss_pred cHHhhhh----hcccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCcCCC-----CCC--HHHHHH
Confidence 9877544 12456799999999999875 8899999999999999999999998654110 001 111233
Q ss_pred hhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.+..+........ ..+.++..++-.||++||.+||++.|++++=
T Consensus 293 ~Iv~~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 293 AIVDEPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred HHhcCCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 3333222222221 3567888999999999999999999999764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=381.86 Aligned_cols=246 Identities=26% Similarity=0.403 Sum_probs=207.3
Q ss_pred HHHhhhhcccCCCeEEEEEEe-CCCcEEEEEEccc----CCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK----TSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~----~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
+|...+.||+|||+.+|.++. ..|+.||+|++.+ .....+...+||++.++|+|||||+++++|++.+..|+|.|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 344567899999999999998 7899999999976 34556789999999999999999999999999999999999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC-
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN- 500 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~- 500 (667)
+|++|+|..++++. ..+++..+..+.+||+.||.|||++ +|+|||||..|+||+++.++||+|||||..+..+
T Consensus 99 LC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 99 LCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred ecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999743 4799999999999999999999998 9999999999999999999999999999988755
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
....+ ..|||.|+|||++.+. ..+..+||||+|||+|-||.|++||+...- ...+.++.....
T Consensus 173 Erk~T---lCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~v------------kety~~Ik~~~Y 235 (592)
T KOG0575|consen 173 ERKKT---LCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTV------------KETYNKIKLNEY 235 (592)
T ss_pred cccce---ecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchH------------HHHHHHHHhcCc
Confidence 33333 4589999999999864 678899999999999999999999975421 112223222111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
..+..++....+|+.++|+.||.+|||+++|+.+=
T Consensus 236 -----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 236 -----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred -----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 11113455677899999999999999999999764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=367.66 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=208.3
Q ss_pred HHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc--------chHHHHHHHHHHhhcccceEEeecceEecCCeeE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN--------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 417 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 417 (667)
.+-+.+.||+|+||.|-+|..+ +|+.||||++.+... ......+|+++|++++|||||++++++......|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 3445688999999999999764 799999999976431 2234579999999999999999999999999999
Q ss_pred EEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC---CceEEEeCCCc
Q 005953 418 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD---FTPKVSDFGLA 494 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~---~~~ki~DFGla 494 (667)
+||||++||+|.+.+.+++ .+.+..-..+++|++.|+.|||+. ||+||||||+|||+..+ ..+||+|||+|
T Consensus 253 mVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchh
Confidence 9999999999999997654 477777788999999999999998 99999999999999665 78999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhhhhhcCCCC-CcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHH
Q 005953 495 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS-GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573 (667)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s-~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 573 (667)
+...... .+....||+.|.|||++......++ .|+|+||+|||||-+++|.+||..... +.-..+
T Consensus 327 K~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~-----------~~sl~e 392 (475)
T KOG0615|consen 327 KVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT-----------DPSLKE 392 (475)
T ss_pred hccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC-----------CccHHH
Confidence 9876433 3456679999999999977544444 489999999999999999999975432 111234
Q ss_pred hhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
++.++.. .+.......+.++..+++.+||..||++|||+.|++++=.
T Consensus 393 QI~~G~y-~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 393 QILKGRY-AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred HHhcCcc-cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 4444433 2233456678889999999999999999999999997654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=356.85 Aligned_cols=194 Identities=29% Similarity=0.518 Sum_probs=172.8
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.++||.|+||+||+|+++ ++..||||.+.+.. ...+....|+.+|+.++|||||++++++.+++..+||||||.+
T Consensus 14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g 93 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG 93 (429)
T ss_pred ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence 3467999999999999985 58999999987653 3456688999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC------CceEEEeCCCccccCC
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD------FTPKVSDFGLAKAHSR 499 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~------~~~ki~DFGla~~~~~ 499 (667)
|+|.+||++.. .+++..+..+..|+|.||++||++ +||||||||+||||+.. -.+||+|||+|+.+..
T Consensus 94 GDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 94 GDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 99999998754 599999999999999999999998 99999999999999764 4689999999999875
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPT 554 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~ 554 (667)
.... ....|++-|||||++.. .+|+.|+|+||+|+||||+++|+.||+..
T Consensus 168 ~~~a---~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 168 GSMA---ETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hhHH---HHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 5433 34569999999999975 48999999999999999999999999754
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=397.93 Aligned_cols=261 Identities=27% Similarity=0.466 Sum_probs=214.1
Q ss_pred HHHHHHHHhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecC
Q 005953 342 DIKKMTNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDG 413 (667)
Q Consensus 342 ~l~~~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~ 413 (667)
++......+.++||+|+||+||+|+.. +...||||.++.... ...+|.+|+++|..++|||||+|+|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 344444457789999999999999763 356899999997653 467999999999999999999999999999
Q ss_pred CeeEEEEEEcCCCCccccccccc-------c----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC
Q 005953 414 STRALIYEYMPNGSLGDLLSREK-------E----NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP 482 (667)
Q Consensus 414 ~~~~lV~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~ 482 (667)
+..++|+|||..|+|.++|.... . +.+++..+.+.||.|||.||+||-++ .+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 99999999999999999996421 1 23388999999999999999999998 9999999999999999
Q ss_pred CCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCC
Q 005953 483 DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSN 561 (667)
Q Consensus 483 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~ 561 (667)
+..|||+||||+|..-..+.........-+++|||||.+.- +.+|.+||||||||||||+++ |+.|+....
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glS------ 710 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLS------ 710 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccc------
Confidence 99999999999997654443322222335789999999975 599999999999999999997 777765432
Q ss_pred CccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 562 TTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
.+.+.+.+.++.. .+.++..+.+++.||..||+.+|++||+++||-..|+..
T Consensus 711 ------n~EVIe~i~~g~l----L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 711 ------NQEVIECIRAGQL----LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred ------hHHHHHHHHcCCc----ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 2334444444433 344455678999999999999999999999999999843
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=343.15 Aligned_cols=255 Identities=23% Similarity=0.375 Sum_probs=207.1
Q ss_pred HHhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecc-eEecC-CeeEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLG-FCCDG-STRALIYE 421 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g-~~~~~-~~~~lV~e 421 (667)
+.+.++||+|.||+|||+.. .+|..||.|.+.-. ....++...|+.+|++|+|||||+.++ -+.++ ..++||||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 45668999999999999975 58999999988633 344567899999999999999999998 34444 44899999
Q ss_pred EcCCCCccccccc-cccCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 422 YMPNGSLGDLLSR-EKENLSLKPARLLEIALGVAHAIEYLHNGCEL-RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 422 ~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~-~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
++..|+|..++++ ++....+++..+++++.|+++||..+|+.... -|+||||||.||+|+.+|.+||+||||++.+..
T Consensus 101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 9999999999975 34456799999999999999999999984221 399999999999999999999999999999877
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
.... .+..+|||.||+||.+... .++.||||||+||++|||..-++||.+..- ..+..++.++.
T Consensus 181 ~~tf--A~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------------~~L~~KI~qgd 244 (375)
T KOG0591|consen 181 KTTF--AHSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDNL------------LSLCKKIEQGD 244 (375)
T ss_pred hhHH--HHhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCcccccH------------HHHHHHHHcCC
Confidence 6543 2567899999999999875 789999999999999999999999975421 12233444432
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
. ..-....++..+.+++..|+..||+.||+.-.++..++
T Consensus 245 ~---~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 245 Y---PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred C---CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 2 22223567889999999999999999998666665554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=352.87 Aligned_cols=265 Identities=22% Similarity=0.346 Sum_probs=208.9
Q ss_pred HHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHH--HHHHHHHHhhcc-cceEEeecceEecCC-eeEEEE
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDN--FINEVATIGRIH-HVNIIHLLGFCCDGS-TRALIY 420 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~--~~~Ei~~l~~l~-h~niv~l~g~~~~~~-~~~lV~ 420 (667)
.+|...++||.|.||+||+|+.. +++.||||.+++.-...++ -++|++.|++|+ ||||++|..++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 35667899999999999999864 6899999999865433333 468999999998 999999999999888 999999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||| ..+|.+++... +..+++..+..|.+||++||+|+|.+ |++|||+||+|||+..+..+||+||||||.....
T Consensus 90 E~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 90 EFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred Hhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccC
Confidence 999 57899999765 56899999999999999999999998 9999999999999999999999999999988665
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC---------CCCCccccchHHH
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS---------GSNTTEAYFPDWI 571 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~~~~ 571 (667)
.. ++..+.|..|+|||++.+. +.|+.+.|||++|||++|+.+-++.|-+..+.+ |....+.+....-
T Consensus 164 pP---YTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 164 PP---YTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred CC---cchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 43 3566789999999999987 789999999999999999999998885543311 1111111111111
Q ss_pred HHhhcCccc----ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 572 YDKLIQPEK----EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 572 ~~~~~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
....+.-.. ...........+.+.++++.+|+++||++|||+.|.+++-
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 111111111 1111122223567888999999999999999999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=362.63 Aligned_cols=256 Identities=26% Similarity=0.430 Sum_probs=205.4
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.++||+|.||+||+|+|.+ .||||+++... ...+.|.+|+..+++.+|.||+-+.|+|..... .+|..+++|-
T Consensus 396 l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGs 472 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGS 472 (678)
T ss_pred ccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCc
Confidence 45889999999999999943 68999998654 456789999999999999999999999988776 9999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|..+||..+ ..++..+.++||.||++||.|||.+ +|||||||..||+|.+++.|||+||||+.....-......
T Consensus 473 SLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~ 547 (678)
T KOG0193|consen 473 SLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL 547 (678)
T ss_pred hhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecccccc
Confidence 9999998654 4588999999999999999999998 9999999999999999999999999999765443322333
Q ss_pred cCCCCCccccchhhhhhh-cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 507 TGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
....|...|||||++... ...+++.+||||||+|+|||++|..|+..... +-+.-.+..+.......
T Consensus 548 ~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~------------dqIifmVGrG~l~pd~s 615 (678)
T KOG0193|consen 548 EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR------------DQIIFMVGRGYLMPDLS 615 (678)
T ss_pred CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh------------hheEEEecccccCccch
Confidence 445689999999999643 34679999999999999999999999973221 00111111221111111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
.......++|.+|+..||..++++||.+.+|+..|++...
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1222346689999999999999999999999999985543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=343.89 Aligned_cols=257 Identities=25% Similarity=0.381 Sum_probs=211.4
Q ss_pred HHhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
|++.++||.|..++||+|+. +.++.||||++..++ ...+.+.+|+..|+.++||||++.+..|..+..+|+||.||.
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa 107 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA 107 (516)
T ss_pred eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence 34568999999999999986 468999999997654 335788999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC-ce
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR-SV 503 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~-~~ 503 (667)
+||+.+++...- ...+++..+..|++++++||.|||++ |.||||||+.||||+++|.+||+|||.+..+.... ..
T Consensus 108 ~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 108 GGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred CCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999997643 34599999999999999999999998 99999999999999999999999999775543322 22
Q ss_pred e-eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc---
Q 005953 504 V-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE--- 579 (667)
Q Consensus 504 ~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 579 (667)
. .+...+||+.|||||+++.+...|+.|+||||||+...||.+|..||....+ ...+...+...-
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-----------mkvLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-----------MKVLLLTLQNDPPTL 252 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-----------HHHHHHHhcCCCCCc
Confidence 2 2256789999999999877777899999999999999999999999975533 111222222111
Q ss_pred -cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 580 -KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 580 -~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
......+......+.+.+++..||+.||++|||+++++.+
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1123345556667789999999999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=332.18 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=198.8
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
..++|+|+||.|||++++ +|+.||||++..++. ..+-.++||++|++++|+|+|.|+.+|.....++||+||++..
T Consensus 7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT 86 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT 86 (396)
T ss_pred hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchH
Confidence 357999999999999986 599999999976653 3456889999999999999999999999999999999999765
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
-|.+ |.+. ...++.+.+.++++|+++|+.|+|++ ++|||||||+||||+.++.+||+|||+|+.+..... .+
T Consensus 87 vL~e-Le~~--p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--~Y 158 (396)
T KOG0593|consen 87 VLHE-LERY--PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD--NY 158 (396)
T ss_pred HHHH-HHhc--cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcc--hh
Confidence 4444 4333 34688999999999999999999998 999999999999999999999999999998874332 23
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh-----------
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL----------- 575 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------- 575 (667)
+..+.|..|.|||++.+. ..+...+||||+||++.||++|.+.|-..... + ..-.+...+
T Consensus 159 TDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi------D--QLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI------D--QLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred hhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchH------H--HHHHHHHHHcccCHHHHHHh
Confidence 566789999999999886 47888999999999999999999876433221 0 000111110
Q ss_pred ---------cCcc--cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 576 ---------IQPE--KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 576 ---------~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.-+. ...........+..-+++++..||+.||++|++-+|++.+
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 0011 1111112223455678999999999999999999999854
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=357.13 Aligned_cols=264 Identities=26% Similarity=0.491 Sum_probs=214.1
Q ss_pred CCCHHHHHHHHHHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCee
Q 005953 337 NYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTR 416 (667)
Q Consensus 337 ~~~~~~l~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 416 (667)
...+++|.+. +.||.|+.|.||+|++ .++.||||+++.-+ ..+|+-|++|+|+||+.+.|+|.....+
T Consensus 120 eiPFe~IsEL-----eWlGSGaQGAVF~Grl-~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 120 EIPFEEISEL-----EWLGSGAQGAVFLGRL-HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred cCCHHHhhhh-----hhhccCcccceeeeec-cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCcee
Confidence 3455565543 7899999999999999 67889999876433 3689999999999999999999999999
Q ss_pred EEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 417 ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 417 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
+|||||++.|-|..+|.... .+....+..|..+||.||.|||.+ .|||||||+-||||..+-.+||+|||-++.
T Consensus 188 CIiMEfCa~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred EEeeeccccccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHh
Confidence 99999999999999997643 688999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhc
Q 005953 497 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 576 (667)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (667)
...... .-.+.||..|||||++... ..++|+|||||||||||||||..|+.+.+... .||. +.
T Consensus 262 ~~~~ST---kMSFaGTVaWMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----------IIwG-VG 324 (904)
T KOG4721|consen 262 LSDKST---KMSFAGTVAWMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----------IIWG-VG 324 (904)
T ss_pred hhhhhh---hhhhhhhHhhhCHHHhhcC--CcccccceehhHHHHHHHHhcCCCccccchhe-----------eEEe-cc
Confidence 765432 3346799999999999874 88999999999999999999999997654310 0111 00
Q ss_pred CcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccccccCCCCCCCCCC
Q 005953 577 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKPLFPS 638 (667)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~~p~~~~ 638 (667)
.. .+....+...++-+.-|+.+||+..|.+||++.+++.+|+-+..+.+.++....+-+
T Consensus 325 sN---sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee~yf~s 383 (904)
T KOG4721|consen 325 SN---SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTEETYFKS 383 (904)
T ss_pred CC---cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHHHHHHH
Confidence 11 111122223455677889999999999999999999999976667666666555433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=341.80 Aligned_cols=236 Identities=26% Similarity=0.387 Sum_probs=196.3
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.++||+|+||+||.++.. +++.+|+|++++.. ...+...+|..+|.+++||+||+++-.|++.+.+|||+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 4588999999999999775 58999999998754 345678899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
||.|..+|+++. .+++..+.-++.+|+.||.|||+. +||||||||+|||||++|+++|+||||++..-.....
T Consensus 109 GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~- 181 (357)
T KOG0598|consen 109 GGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA- 181 (357)
T ss_pred CccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc-
Confidence 999999998754 588999999999999999999998 9999999999999999999999999999865443322
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....||+.|||||++.+. .++..+|.||+|+++|||++|.+||...+. ....+.+......
T Consensus 182 -t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~------------~~~~~~I~~~k~~--- 243 (357)
T KOG0598|consen 182 -TRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDV------------KKMYDKILKGKLP--- 243 (357)
T ss_pred -cccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccH------------HHHHHHHhcCcCC---
Confidence 2346799999999999875 788999999999999999999999976543 1123333333211
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCC
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRP 611 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RP 611 (667)
..+.-......+++...|+.||++|-
T Consensus 244 -~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 -LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 11111345677788889999999995
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=370.88 Aligned_cols=269 Identities=25% Similarity=0.445 Sum_probs=223.2
Q ss_pred CCCCCHHHHHHHHHHhh-----------hhcccCCCeEEEEEEeC----CCcEEEEEEcccC--CcchHHHHHHHHHHhh
Q 005953 335 LSNYSYNDIKKMTNGFK-----------EKLGTGGYGNVYKGKFP----DGRLVAVKVLEKT--SNFSDNFINEVATIGR 397 (667)
Q Consensus 335 ~~~~~~~~l~~~~~~~~-----------~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~ 397 (667)
..+++|+|.-++-.+|. ++||.|.||.|++|+++ ....||||.++.. +....+|+.|..+|.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 45678888777766664 46899999999999885 2457999999875 3556789999999999
Q ss_pred cccceEEeecceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCc
Q 005953 398 IHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQN 477 (667)
Q Consensus 398 l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~N 477 (667)
++||||++|.|+........+|.|||+||+|+.+|..+. ..+++.++..++++||.||.||-+. ++|||||.++|
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARN 761 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARN 761 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhh
Confidence 999999999999999999999999999999999998764 3589999999999999999999987 99999999999
Q ss_pred EEECCCCceEEEeCCCccccCCCC-ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q 005953 478 VLLDPDFTPKVSDFGLAKAHSRNR-SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTE 555 (667)
Q Consensus 478 Ill~~~~~~ki~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~ 555 (667)
||++.+..+||+||||+|.+..+. ...+..+..-+.+|.|||.+.- .++|.+|||||||+|+||.++ |.+|+....
T Consensus 762 ILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmS 839 (996)
T KOG0196|consen 762 ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMS 839 (996)
T ss_pred eeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccc
Confidence 999999999999999999886655 2233345556789999999975 489999999999999999986 777775443
Q ss_pred cCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 556 TTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
. +++++...++.+...+.+.+..|.+||+.|||+|-.+||++.||+.+|.....+
T Consensus 840 N----------------QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 840 N----------------QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred h----------------HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 2 222222333444444556678899999999999999999999999999865544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=346.35 Aligned_cols=252 Identities=28% Similarity=0.412 Sum_probs=201.0
Q ss_pred hhhhcccCCCeEEEEEEeCC-CcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCC--eeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS--TRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--~~~lV~e~~~~ 425 (667)
..+.||+|+||+||++...+ |+..|||.+.... ...+.+.+|+.+|++++|||||+.+|...... ..++.|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 45789999999999998864 8999999887653 22466899999999999999999999755444 68899999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC-CCceEEEeCCCccccCCCC-ce
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSRNR-SV 503 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~-~~~~ki~DFGla~~~~~~~-~~ 503 (667)
|+|.+++.+... .+++..+.++++||++||+|||++ +|+|+||||+||||+. ++.+||+|||+++...... ..
T Consensus 101 GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 101 GSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred CcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 999999987653 699999999999999999999988 9999999999999999 7999999999998766411 11
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
......+||+.|||||++... .....++|||||||++.||+||++||... .....++..........
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----------~~~~~~~~~ig~~~~~P-- 242 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEF----------FEEAEALLLIGREDSLP-- 242 (313)
T ss_pred cccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhh----------cchHHHHHHHhccCCCC--
Confidence 122346799999999999752 23345899999999999999999998642 01122222222222111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
..+..++....+++..|++.+|++||||++++++.-
T Consensus 243 --~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 243 --EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred --CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 223335667788999999999999999999999886
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=342.43 Aligned_cols=265 Identities=26% Similarity=0.378 Sum_probs=200.8
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHh--hcccceEEeecceEecCC----eeEEEEEEc
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIG--RIHHVNIIHLLGFCCDGS----TRALIYEYM 423 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~--~l~h~niv~l~g~~~~~~----~~~lV~e~~ 423 (667)
+.+.+|+|+||.||||++ +++.||||++..... +.|.+|-++.+ .++|+||++++++-..+. .++||+||.
T Consensus 214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~k--qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQEK--QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hHHHhhcCccceeehhhc-cCceeEEEecCHHHH--HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 457899999999999999 569999999986543 45556555554 558999999999876555 789999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCCeeecCCCCCcEEECCCCceEEEeCCCcccc
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG------CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~------~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~ 497 (667)
++|+|.++|..+ .++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||||..+
T Consensus 291 ~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 291 PKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred cCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 999999999765 489999999999999999999953 4678999999999999999999999999999988
Q ss_pred CCCCceeeecCCCCCccccchhhhhhhcCCCC-----CcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCcc------cc
Q 005953 498 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS-----GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE------AY 566 (667)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s-----~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~------~~ 566 (667)
..........+.+||.+|||||++.+.. ++. .+.||||+|.|||||+++-..+++..........+ ..
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgai-nl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAI-NLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhc-ccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 8766665666789999999999997753 333 35799999999999999876665322211111111 11
Q ss_pred chHHHHHhhcCcccccccchhh--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 567 FPDWIYDKLIQPEKEDFVEEED--DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
+. ..++.+...+......... ......+.+.+..||+.||+-|.|+.=|-+++.+.
T Consensus 446 ~e-~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 446 LE-EMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred HH-HHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 11 1111111111111111111 12356788899999999999999999999988754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.95 Aligned_cols=258 Identities=25% Similarity=0.441 Sum_probs=200.0
Q ss_pred HHHhhhhcccCCCeEEEEEEe------CCCcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEecCC-ee
Q 005953 347 TNGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGS-TR 416 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~-~~ 416 (667)
.+.+.++||+|+||.||+|.+ .+++.||||+++... ...+.+.+|+.++.++ +||||+++++++...+ ..
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL 87 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence 345678999999999999974 235689999987543 2345789999999999 8999999999887644 57
Q ss_pred EEEEEEcCCCCcccccccccc-----------------------------------------------------------
Q 005953 417 ALIYEYMPNGSLGDLLSREKE----------------------------------------------------------- 437 (667)
Q Consensus 417 ~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 437 (667)
++||||+++|+|.+++.....
T Consensus 88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (338)
T cd05102 88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW 167 (338)
T ss_pred EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence 899999999999999864211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCCCCCccccc
Q 005953 438 NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 517 (667)
Q Consensus 438 ~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~a 517 (667)
...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++...............++..|+|
T Consensus 168 ~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 168 KSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 13478889999999999999999997 999999999999999999999999999987644332222223446789999
Q ss_pred hhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHH
Q 005953 518 PEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMI 596 (667)
Q Consensus 518 PE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 596 (667)
||++.+. .++.++||||||+++|||++ |+.||..... .......+..+.... ........+.
T Consensus 245 PE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~-----------~~~~~~~~~~~~~~~----~~~~~~~~l~ 307 (338)
T cd05102 245 PESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-----------NEEFCQRLKDGTRMR----APENATPEIY 307 (338)
T ss_pred cHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCc-----------cHHHHHHHhcCCCCC----CCCCCCHHHH
Confidence 9998754 67899999999999999997 9988864321 011112222211111 1122345688
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 597 IVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 597 ~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
+++.+||+.||++|||+.|+++.|+++.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=352.84 Aligned_cols=243 Identities=24% Similarity=0.398 Sum_probs=204.3
Q ss_pred hhcccCCCeEEEEEEe-CCCcEEEEEEcccCCcch-HHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~-~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
++||+|+.|.||.++- .+++.||||++....... +-.++|+.+|+..+|+|||.++..+..++.+++|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 6899999999999975 468899999998776544 55789999999999999999999999899999999999999999
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCC
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 509 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 509 (667)
|++... .+++.++..|.+++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+...... ....
T Consensus 359 DvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K--R~Tm 429 (550)
T KOG0578|consen 359 DVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK--RSTM 429 (550)
T ss_pred hhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc--cccc
Confidence 998654 389999999999999999999998 9999999999999999999999999999888766542 2456
Q ss_pred CCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhH
Q 005953 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589 (667)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (667)
+||+.|||||++.++ .+..|+||||||++++||+-|.+||-.... ..+-+....-.. .......
T Consensus 430 VGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~P---------lrAlyLIa~ng~-----P~lk~~~ 493 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNENP---------LRALYLIATNGT-----PKLKNPE 493 (550)
T ss_pred cCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCCh---------HHHHHHHhhcCC-----CCcCCcc
Confidence 799999999999885 788999999999999999999999854322 011111111111 1122334
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 590 CIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.++..+.+++.+||+.|+++||++.|+|++
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 567789999999999999999999999976
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=345.46 Aligned_cols=260 Identities=28% Similarity=0.422 Sum_probs=205.4
Q ss_pred HhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecC--CeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~ 422 (667)
+-.++||+|.||.||||+. .+|+.||+|+++.+. .......+||.+|++|+||||++|.+...+. ...|||+||
T Consensus 120 eki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeY 199 (560)
T KOG0600|consen 120 EKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEY 199 (560)
T ss_pred HHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEec
Confidence 3457899999999999987 479999999987654 3446778999999999999999999998876 689999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
|+ -+|.-++... ...+++.++..+.+|++.||+|+|.. +|+|||||.+|||||.+|.+||+|||||+++.....
T Consensus 200 Md-hDL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 200 MD-HDLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred cc-chhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 96 4777777553 34699999999999999999999998 999999999999999999999999999998766553
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC---------CCCCccccchHHHHH
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS---------GSNTTEAYFPDWIYD 573 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~~~~~~ 573 (667)
. .++..+-|..|.|||++.+. ..|+.++|+||.||||.||+.|++.+.+..+.. +. ..+.+ |...
T Consensus 274 ~-~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGS-P~e~~---W~~~ 347 (560)
T KOG0600|consen 274 A-PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGS-PTEDY---WPVS 347 (560)
T ss_pred c-ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCC-CChhc---cccc
Confidence 3 35667789999999999987 689999999999999999999999887654321 11 11111 1111
Q ss_pred hhc-----Cccc--ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 574 KLI-----QPEK--EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 574 ~~~-----~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
++. ++.. .....+.........++|+..+|..||++|.|+.++++.=
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se 401 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSE 401 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCc
Confidence 111 1111 1111222334456788899999999999999999988643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=316.35 Aligned_cols=261 Identities=25% Similarity=0.384 Sum_probs=203.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
|.-.++||+|.||.||+|++. +|+.||||+++..+ ......++||+.|+.++|+||+.+++++...+...||+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 344578999999999999874 69999999997653 33467899999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
+ .+|+.++... ...++..++..++.++++|++|||++ .|+||||||.|+|++++|.+||+|||+|+.+......
T Consensus 84 ~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 84 P-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred c-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 4 6899999765 35799999999999999999999998 9999999999999999999999999999998766544
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC--------CCCCcc------ccchH
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS--------GSNTTE------AYFPD 569 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~--------~~~~~~------~~~~~ 569 (667)
.+ ..+-|..|.|||++.+. ..++..+||||.|||+.||+-|.+-|.+...-. .....+ ..+++
T Consensus 158 ~~--~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 158 QT--HQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred cc--cceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 32 23578999999999886 588999999999999999998876654322100 000001 11112
Q ss_pred HHHHh-hcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 570 WIYDK-LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 570 ~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
+..-+ ...+.... .-........+++..|+..||.+|.|++|++++=-
T Consensus 235 Y~~~~~~P~~~~~~----lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNN----LFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred HHHHhcCCCCcccc----ccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 11111 10111111 11123456689999999999999999999997755
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=382.15 Aligned_cols=264 Identities=28% Similarity=0.469 Sum_probs=211.3
Q ss_pred HHHHHhhhhcccCCCeEEEEEEeCC--Cc----EEEEEEcccC--CcchHHHHHHHHHHhhcccceEEeecceEecCCee
Q 005953 345 KMTNGFKEKLGTGGYGNVYKGKFPD--GR----LVAVKVLEKT--SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTR 416 (667)
Q Consensus 345 ~~~~~~~~~LG~G~fg~Vy~~~~~~--~~----~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 416 (667)
...-.+.+.||+|+||.||.|...+ +. .||||.++.. .....+|++|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3333456789999999999998743 43 4899999875 34567899999999999999999999999999999
Q ss_pred EEEEEEcCCCCccccccccc----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCC
Q 005953 417 ALIYEYMPNGSLGDLLSREK----ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG 492 (667)
Q Consensus 417 ~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFG 492 (667)
++++|||++|+|..+|...+ ....++..+++.++.|||+|+.||++. ++|||||.++|+||++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997642 245799999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHH
Q 005953 493 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWI 571 (667)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 571 (667)
||+.+.............-+.+|||||.+.. +.++.|+|||||||++||++| |..|+..... ..+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n------------~~v 913 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN------------FEV 913 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcch------------HHH
Confidence 9996654443322222245689999999987 589999999999999999998 5556543321 112
Q ss_pred HHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccccccC
Q 005953 572 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIE 629 (667)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 629 (667)
...+..+. +.+.+..++..++++|..||+.+|++||++..+++.+..+......
T Consensus 914 ~~~~~~gg----RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 914 LLDVLEGG----RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred HHHHHhCC----ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 22122221 2233344567899999999999999999999999999866654433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=344.65 Aligned_cols=247 Identities=27% Similarity=0.388 Sum_probs=204.5
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEc
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
|.+.||+|+|++|++|+.. .++.+|||++.+.- ...+-...|-..|.+| .||.|++|+-.|.+...+|+|+||.
T Consensus 77 Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A 156 (604)
T KOG0592|consen 77 FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYA 156 (604)
T ss_pred hhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEec
Confidence 7789999999999999875 68999999997642 2334567888899999 7999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
+||+|.++|++.. .+++.-...++.+|+.||+|||+. |||||||||+|||||+|+++||+|||.|+.+......
T Consensus 157 ~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 157 PNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred CCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 9999999998764 589999999999999999999998 9999999999999999999999999999987543222
Q ss_pred ---------ee--ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHH
Q 005953 504 ---------VT--MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 572 (667)
Q Consensus 504 ---------~~--~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 572 (667)
.. ....+||..|.+||+|..+ ..+..+|+|+||||||+|+.|++||.+..+ -.++
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------------yliF 296 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRAANE------------YLIF 296 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCccccH------------HHHH
Confidence 11 1347899999999999874 778899999999999999999999976543 1234
Q ss_pred HhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 573 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
+++++-..+ ......+.+.+|+.+.|..||.+|+|.+||-++.=
T Consensus 297 qkI~~l~y~-----fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 297 QKIQALDYE-----FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred HHHHHhccc-----CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence 444433221 11112345677888899999999999999998874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=357.13 Aligned_cols=252 Identities=29% Similarity=0.444 Sum_probs=201.8
Q ss_pred hhhhcccCCCeEEEEEEeCC--C--cE-EEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFPD--G--RL-VAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~--~--~~-vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
+.++||+|+||.||+|++.. + .. ||||..+.+ .....+|++|.++|++++|||||+++|++.....+++||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 45899999999999998742 2 23 899998852 345678999999999999999999999999999999999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
|+++||+|+++|..... .++..+.++++.+.|+||+|||+. ++|||||.++|+|++.++.+||+||||++.....
T Consensus 241 El~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred EecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 99999999999987643 689999999999999999999998 9999999999999999999999999998765411
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
. .......-+.+|+|||.+.. +.++.++|||||||++||+++ |..|+.+... ..+...+....
T Consensus 316 ~--~~~~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~------------~~v~~kI~~~~ 379 (474)
T KOG0194|consen 316 V--MKKFLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN------------YEVKAKIVKNG 379 (474)
T ss_pred e--eccccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCH------------HHHHHHHHhcC
Confidence 1 11112246789999999976 488999999999999999998 6777654432 12333332211
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
... ..+...+..+..++.+||..+|++||+|.++.+.|+.+..
T Consensus 380 ~r~---~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 380 YRM---PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred ccC---CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 111 1111235567778889999999999999999999985544
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=337.73 Aligned_cols=246 Identities=22% Similarity=0.282 Sum_probs=197.7
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcc----hHHHHHHHHHHhhcccceEEeecceEec----CCeeEEEEEEc
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNF----SDNFINEVATIGRIHHVNIIHLLGFCCD----GSTRALIYEYM 423 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~~~lV~e~~ 423 (667)
..||+|++|.||+|++ +|+.||||+++..... .+.|.+|+.+|++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4689999999999999 7899999999765332 3677899999999999999999999876 34678999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++.... .+++...++++.+++.||.|||+. .+++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 9999999997543 588899999999999999999973 278899999999999999999999999998654322
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
....|+..|+|||++.+....++.++|||||||++|||++|+.||..... ..+...+........
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------------~~~~~~i~~~~~~~~ 242 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------------KEIYDLIINKNNSLK 242 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHhcCCCCC
Confidence 12357899999999976445789999999999999999999999964321 111122211111100
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
.+......+.+++.+||+.||++|||++|+++.|++.
T Consensus 243 ---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 243 ---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred ---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1112355788999999999999999999999999853
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=342.74 Aligned_cols=268 Identities=25% Similarity=0.403 Sum_probs=213.6
Q ss_pred HHHHHHHHHHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeE
Q 005953 340 YNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 417 (667)
Q Consensus 340 ~~~l~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 417 (667)
..|.-+..-.|.++||+|-||.|..+....+..||||+++... ...++|.+|+++|.+++|||||+|+|+|..++.++
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 3444444455789999999999999999778999999998765 34578999999999999999999999999999999
Q ss_pred EEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcccc
Q 005953 418 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~ 497 (667)
+|+|||++|+|.++|.+...+. +.-....+|+.||+.||+||.+. ++|||||.++|+|+|.++++||+|||+++.+
T Consensus 612 mI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccc
Confidence 9999999999999998764332 45667788999999999999997 9999999999999999999999999999976
Q ss_pred CCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh--CCCCCCCCCcCCCCCCccccchHHHHHhh
Q 005953 498 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE--EKKHLRPTETTSGSNTTEAYFPDWIYDKL 575 (667)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (667)
-.+.........+-+++|||+|.+.. +++|.++|||+||+.+||+++ ..+|+...... ...+. ...+
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--------~vven-~~~~ 756 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--------QVVEN-AGEF 756 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--------HHHHh-hhhh
Confidence 65554433334556899999999976 589999999999999999874 56666433210 00000 1111
Q ss_pred cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
............+.-.+..+++++++||..+.++||+++++...|++
T Consensus 757 ~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 757 FRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred cCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 12222222223344456789999999999999999999999999985
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=340.52 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=196.9
Q ss_pred HHhhhhcccCCCeEEEEEEeCC-----------------CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecc
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPD-----------------GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLG 408 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g 408 (667)
+.+.++||+|+||.||++.+.+ +..||+|++.... ....+|.+|++++.+++||||+++++
T Consensus 7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 86 (304)
T cd05096 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG 86 (304)
T ss_pred CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 4456889999999999997532 3479999987643 23457999999999999999999999
Q ss_pred eEecCCeeEEEEEEcCCCCccccccccc----------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecC
Q 005953 409 FCCDGSTRALIYEYMPNGSLGDLLSREK----------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLD 472 (667)
Q Consensus 409 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~D 472 (667)
++.+.+..++||||+++|+|.+++.... ....+++..+++++.|++.||+|||+. +|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~d 163 (304)
T cd05096 87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRD 163 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence 9999999999999999999999885421 113478888999999999999999998 999999
Q ss_pred CCCCcEEECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhC--CCC
Q 005953 473 IKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEE--KKH 550 (667)
Q Consensus 473 ikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg--~~p 550 (667)
|||+|||+++++.+||+|||+++...............++..|+|||++.. +.++.++||||||+++|||+++ ..|
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999986644433222233446889999999865 4688999999999999999974 445
Q ss_pred CCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 551 LRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
+..... ......+........... ........+..+.+++.+||+.+|++|||+.||.+.|+
T Consensus 242 ~~~~~~--------~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTD--------EQVIENAGEFFRDQGRQV-YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCH--------HHHHHHHHHHhhhccccc-cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 543211 011111111111110000 00011123457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=350.36 Aligned_cols=255 Identities=27% Similarity=0.486 Sum_probs=199.0
Q ss_pred HHhhhhcccCCCeEEEEEEe------CCCcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 418 (667)
+.+.++||+|+||.||+|++ .++..||||+++... ...+.+.+|+.++..+ +||||+++++++.++...++
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 45678999999999999974 236689999997543 2345788999999999 89999999999999999999
Q ss_pred EEEEcCCCCcccccccccc-------------------------------------------------------------
Q 005953 419 IYEYMPNGSLGDLLSREKE------------------------------------------------------------- 437 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~------------------------------------------------------------- 437 (667)
||||+++|+|.+++.+...
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 9999999999998864211
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 438 -----------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 438 -----------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
...+++..+.+++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++...........
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 12478889999999999999999987 9999999999999999999999999999876543322222
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
....++..|+|||++.+ ..++.++||||||+++|||++ |..||..... ...+ ...+........
T Consensus 274 ~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-------~~~~----~~~~~~~~~~~~-- 338 (375)
T cd05104 274 GNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-------DSKF----YKMIKEGYRMLS-- 338 (375)
T ss_pred CCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-------hHHH----HHHHHhCccCCC--
Confidence 22345678999999865 377899999999999999998 7777754321 0111 111111111000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
.......+.+++.+||+.||++||++.||++.|++
T Consensus 339 --~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 339 --PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred --CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 11124568899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=345.18 Aligned_cols=257 Identities=28% Similarity=0.465 Sum_probs=214.1
Q ss_pred HHHHHHHHhhhhcccCCCeEEEEEEeCC-CcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 342 DIKKMTNGFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 342 ~l~~~~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
|+++....+.++||.|-||.||.|.|+. .-.||||.++.+....++|+.|..+|+.++|||+|+|+|+|......|||.
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence 4444444467899999999999999975 568999999999888999999999999999999999999999999999999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
|||.+|+|.+||.+.. ...++...++.+|.||+.||+||..+ ++|||||.++|+|+.++..+||+||||++++..+
T Consensus 343 EfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred ecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 9999999999998654 34577788899999999999999987 9999999999999999999999999999998776
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
.... ..+..=++.|.|||.+.-+ .++.|+|||+|||+|||+.| |-.|+-..+ ...++..+.+
T Consensus 419 TYTA-HAGAKFPIKWTAPEsLAyN--tFSiKSDVWAFGVLLWEIATYGMsPYPGid------------lSqVY~LLEk-- 481 (1157)
T KOG4278|consen 419 TYTA-HAGAKFPIKWTAPESLAYN--TFSIKSDVWAFGVLLWEIATYGMSPYPGID------------LSQVYGLLEK-- 481 (1157)
T ss_pred ceec-ccCccCcccccCccccccc--ccccchhhHHHHHHHHHHHhcCCCCCCCcc------------HHHHHHHHhc--
Confidence 5432 3445567899999998654 78999999999999999997 555543221 1122333322
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
+.+.+.+..++.++++||++||+++|.+||++.|+.+.++
T Consensus 482 --gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 482 --GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred --cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 2333444556789999999999999999999999998886
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.82 Aligned_cols=247 Identities=24% Similarity=0.380 Sum_probs=200.7
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----C--cchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----S--NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~--~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV 419 (667)
+.+.+.||+|.||+|+.|... +++.||+|++... . ...+...+|+.++++++ ||||++++.+.......++|
T Consensus 19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~iv 98 (370)
T KOG0583|consen 19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIV 98 (370)
T ss_pred eeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEE
Confidence 345678999999999999774 6899999977653 1 23445668999999998 99999999999999999999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC-CceEEEeCCCccccC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHS 498 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~-~~~ki~DFGla~~~~ 498 (667)
|||+.+|+|.+++... ..+.+..+.+++.|++.|++|+|+. +|+||||||+|||+|.+ +++||+|||++....
T Consensus 99 mEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 99 MEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 9999999999999773 3588899999999999999999998 99999999999999999 999999999999874
Q ss_pred -CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcC
Q 005953 499 -RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 577 (667)
Q Consensus 499 -~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (667)
.+. ......||+.|+|||++.+....-..++||||+||+||-|++|+.||+.... .....++..
T Consensus 173 ~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------------~~l~~ki~~ 237 (370)
T KOG0583|consen 173 GEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------------PNLYRKIRK 237 (370)
T ss_pred CCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------------HHHHHHHhc
Confidence 322 2345679999999999987631336799999999999999999999986322 112222333
Q ss_pred cccccccchhhHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 578 PEKEDFVEEEDDCI-ARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 578 ~~~~~~~~~~~~~~-~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
+...- +... +..+..++.+|++.||.+|+|+.+++++=
T Consensus 238 ~~~~~-----p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~ 276 (370)
T KOG0583|consen 238 GEFKI-----PSYLLSPEARSLIEKMLVPDPSTRITLLEILEHP 276 (370)
T ss_pred CCccC-----CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhCh
Confidence 22211 1111 55778899999999999999999999443
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=346.41 Aligned_cols=257 Identities=25% Similarity=0.449 Sum_probs=199.6
Q ss_pred HHHhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRA 417 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 417 (667)
.+.+.+.||+|+||.||+|+.. ++..||||++.... ...+.+.+|+++++++ +|+||+++++++.+....+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 3446789999999999998742 34589999997543 2345688999999999 8999999999999999999
Q ss_pred EEEEEcCCCCccccccccc-------------------------------------------------------------
Q 005953 418 LIYEYMPNGSLGDLLSREK------------------------------------------------------------- 436 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~------------------------------------------------------------- 436 (667)
+||||+++|+|.+++....
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 9999999999999885321
Q ss_pred ------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCCC
Q 005953 437 ------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR 510 (667)
Q Consensus 437 ------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~ 510 (667)
....+++..+++++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...............
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 012478889999999999999999998 99999999999999999999999999998765433222222334
Q ss_pred CCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhH
Q 005953 511 GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589 (667)
Q Consensus 511 gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (667)
++..|+|||++.+ ..++.++||||||+++|||++ |+.||...... ......+....... ...
T Consensus 276 ~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-----------~~~~~~~~~~~~~~----~~~ 338 (374)
T cd05106 276 LPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-----------SKFYKMVKRGYQMS----RPD 338 (374)
T ss_pred CccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCcccccc-----------HHHHHHHHcccCcc----CCC
Confidence 5678999999865 368899999999999999997 99998643210 00111111110000 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 590 CIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
..+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1245788899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=332.20 Aligned_cols=249 Identities=32% Similarity=0.590 Sum_probs=194.4
Q ss_pred hhhhcccCCCeEEEEEEeC-----CCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-----DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.+.||.|.||.||+|.+. .+..|+||+++.... ..++|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999886 256899999965432 357899999999999999999999999988889999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.++|.... ...+++..+++|+.|+++||+|||+. +++|+||+++|||+++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999998752 34689999999999999999999998 999999999999999999999999999987743333
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
............|+|||.+... .++.++||||||+++|||++ |+.|+.... ...+...+.+....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~~------------~~~~~~~~~~~~~~ 224 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDYD------------NEEIIEKLKQGQRL 224 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTSC------------HHHHHHHHHTTEET
T ss_pred cccccccccccccccccccccc--cccccccccccccccccccccccccccccc------------cccccccccccccc
Confidence 3333445578899999999764 57899999999999999999 667764321 11222333332221
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.. .......+.+++.+||+.+|++||++.++++.|
T Consensus 225 ~~----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 PI----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TS----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ee----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11 112355688899999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=340.24 Aligned_cols=241 Identities=23% Similarity=0.321 Sum_probs=194.5
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.||+|+||.||+++.. +|+.||+|+++... .....+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 68999999987532 23456789999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~ 152 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cc
Confidence 999988653 3588999999999999999999998 999999999999999999999999999975432221 12
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..... .
T Consensus 153 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~------------~~~~~~~~~~~~-----~ 213 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------EKLFELILMEEI-----R 213 (323)
T ss_pred cceecCccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCH------------HHHHHHHHcCCC-----C
Confidence 234589999999998753 678899999999999999999999864321 111111111111 1
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 619 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~ 619 (667)
....+...+.+++.+||+.||++|| ++.+++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1122355678899999999999999 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=335.53 Aligned_cols=244 Identities=29% Similarity=0.420 Sum_probs=204.5
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.+.||+|.||.||||+-+ +.+.||+|.+.+... ..+...+|++++++++|||||.++.+++...+.++|.||+.
T Consensus 5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~ 84 (808)
T KOG0597|consen 5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAV 84 (808)
T ss_pred hHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhh
Confidence 34578999999999999875 589999999976543 34568899999999999999999999999999999999996
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
| +|..+|.+.. .++++.+..|+.++..||.|||+. +|+|||+||+|||++.++.+|++|||+|+.+..+..
T Consensus 85 g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~-- 155 (808)
T KOG0597|consen 85 G-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS-- 155 (808)
T ss_pred h-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCce--
Confidence 5 9999997654 599999999999999999999998 999999999999999999999999999998876543
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
..+...|||-|||||++.+ +.++..+|.||+|||+||+++|++||..... .+.+...+.++..
T Consensus 156 vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si-----------~~Lv~~I~~d~v~---- 218 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSI-----------TQLVKSILKDPVK---- 218 (808)
T ss_pred eeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHH-----------HHHHHHHhcCCCC----
Confidence 3467889999999999985 5889999999999999999999999964321 1112111111111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.+......+..++...|++||.+|.|-.+++.+=
T Consensus 219 --~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 219 --PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred --CcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 1124567788899999999999999999998653
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=338.00 Aligned_cols=241 Identities=24% Similarity=0.333 Sum_probs=194.0
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.||+|+||.||+++.. +|+.||+|+++.. ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999875 6899999998753 223456788999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 152 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence 999888653 2588999999999999999999998 999999999999999999999999999875432221 12
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
....||+.|+|||++.+ +.++.++|||||||++|||++|+.||..... ......+..... .
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------------~~~~~~~~~~~~-~---- 213 (323)
T cd05595 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------ERLFELILMEEI-R---- 213 (323)
T ss_pred ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCH------------HHHHHHHhcCCC-C----
Confidence 33568999999999865 3678999999999999999999999864321 011111111111 0
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 619 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~ 619 (667)
.+..+...+.+++.+||+.||++|| ++.+++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1112345678899999999999998 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=324.55 Aligned_cols=249 Identities=24% Similarity=0.433 Sum_probs=200.9
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
.+.++||+|+||.||++.+.++..+|+|.+.......+++.+|+.++++++||||+++++++.+....++||||+++|+|
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 86 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL 86 (256)
T ss_pred EEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcH
Confidence 34578999999999999998888999999876665567899999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++........ ....
T Consensus 87 ~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~ 160 (256)
T cd05114 87 LNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSG 160 (256)
T ss_pred HHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCC
Confidence 99987543 2588999999999999999999988 9999999999999999999999999999865433222 1223
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 587 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (667)
..++..|+|||++... .++.++||||||+++|||++ |+.||..... .. ....+........
T Consensus 161 ~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----------~~-~~~~i~~~~~~~~---- 222 (256)
T cd05114 161 AKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----------YE-VVEMISRGFRLYR---- 222 (256)
T ss_pred CCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----------HH-HHHHHHCCCCCCC----
Confidence 3456789999998653 67889999999999999999 8888854321 01 1111111111100
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 588 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
+......+.+++.+||+.+|++||++.++++.|.
T Consensus 223 ~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112456889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=329.40 Aligned_cols=248 Identities=24% Similarity=0.337 Sum_probs=197.7
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
..+.||+|+||+||++... +++.||+|.+.... .....+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence 4578999999999999874 68999999986432 223467899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 84 ~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 157 (285)
T cd05631 84 GGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-- 157 (285)
T ss_pred CCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe--
Confidence 999998886432 33588999999999999999999998 999999999999999999999999999987543322
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....||..|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+...+.....
T Consensus 158 -~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~---- 222 (285)
T cd05631 158 -VRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER--------VKREEVDRRVKEDQE---- 222 (285)
T ss_pred -ecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcc--------hhHHHHHHHhhcccc----
Confidence 234568999999999975 37789999999999999999999999754321 011111111111111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEM 619 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~~ 619 (667)
.........+.+++.+||+.||++||+ +++++++
T Consensus 223 -~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 -EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 111223557888999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=326.40 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=204.8
Q ss_pred HHHHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
..+.+.++||+|++|.||+|.+.+++.||+|.++......+++.+|+.++++++|+||+++++++...+..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKY 85 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccC
Confidence 34556789999999999999987788999999987665667899999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++........ .
T Consensus 86 ~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~ 160 (261)
T cd05068 86 GSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-A 160 (261)
T ss_pred CcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-c
Confidence 99999996543 34689999999999999999999987 9999999999999999999999999999876532211 1
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
..+...+..|+|||++.. ..++.++||||||+++|||++ |+.|+..... ..+...+......
T Consensus 161 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------------~~~~~~~~~~~~~--- 223 (261)
T cd05068 161 REGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN------------AEVLQQVDQGYRM--- 223 (261)
T ss_pred cCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH------------HHHHHHHHcCCCC---
Confidence 122334568999998865 367889999999999999999 8888753321 1111121111110
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
.........+.+++.+||+.+|++||+++++++.|++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0111234678889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=306.31 Aligned_cols=238 Identities=28% Similarity=0.387 Sum_probs=198.6
Q ss_pred CCHHHHHHHHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEec
Q 005953 338 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCD 412 (667)
Q Consensus 338 ~~~~~l~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~ 412 (667)
++++|.+ +.+.||.|+||.|..++.+ +|..+|+|++.+.. ...+...+|..+|+.+.||+++++++.+.+
T Consensus 41 ~~l~dfe-----~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFE-----RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhh-----heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 6666543 4578999999999999885 68999999998764 334678899999999999999999999999
Q ss_pred CCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCC
Q 005953 413 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG 492 (667)
Q Consensus 413 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFG 492 (667)
.+..++||||++||.|..+|++.. .+++..+..+|.||+.||+|||+. +|++|||||+|||||.+|.+||+|||
T Consensus 116 ~~~lymvmeyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred CCeEEEEEeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEecc
Confidence 999999999999999999997654 588999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHH
Q 005953 493 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 572 (667)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 572 (667)
+|+..... .. ...|||.|+|||.+... .+..++|.|||||++|||+.|.+||....+ ..++
T Consensus 190 FAK~v~~r--T~---TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~~------------~~iY 250 (355)
T KOG0616|consen 190 FAKRVSGR--TW---TLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDNP------------IQIY 250 (355)
T ss_pred ceEEecCc--EE---EecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCCh------------HHHH
Confidence 99987654 22 24589999999999875 677899999999999999999999975432 3456
Q ss_pred HhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCC
Q 005953 573 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDR 610 (667)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 610 (667)
+++..+...- +.-....+.+|+...|+.|-.+|
T Consensus 251 ~KI~~~~v~f-----P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 251 EKILEGKVKF-----PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHhCcccC-----CcccCHHHHHHHHHHHhhhhHhh
Confidence 6666554421 11123456667777888888888
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=327.69 Aligned_cols=252 Identities=23% Similarity=0.381 Sum_probs=199.5
Q ss_pred HHHhhhhcccCCCeEEEEEEeC----CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
.+.+.+.||+|+||.||+|.+. .+..||+|+++... .....|.+|+..+++++||||+++++++..++..++||
T Consensus 6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 85 (266)
T cd05064 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVT 85 (266)
T ss_pred HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEE
Confidence 3456688999999999999763 35689999988653 33457899999999999999999999999999999999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||.+......
T Consensus 86 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 86 EYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999987542 3588999999999999999999988 9999999999999999999999999987654322
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
... ......++..|+|||.+.+ +.++.++||||||+++||+++ |+.||..... ......+.+..
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~------------~~~~~~~~~~~ 225 (266)
T cd05064 161 AIY-TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSG------------QDVIKAVEDGF 225 (266)
T ss_pred chh-cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCH------------HHHHHHHHCCC
Confidence 211 1122345678999999865 478899999999999999875 9998864321 11111221111
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
.. ......+..+.+++.+||+.+|++||+++|+++.|+.
T Consensus 226 ~~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 226 RL----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred CC----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 11 1122345678889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=324.97 Aligned_cols=252 Identities=24% Similarity=0.408 Sum_probs=203.4
Q ss_pred HHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
+.+.++||+|+||.||+|...++..||+|.+.......+.+.+|+.++++++|+||+++++.+.+.+..+++|||+++|+
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87 (261)
T ss_pred eEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence 34568999999999999998888899999987665556789999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|.+++.... ...+++.+++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++........ ...
T Consensus 88 L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 162 (261)
T cd05072 88 LLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-ARE 162 (261)
T ss_pred HHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee-ccC
Confidence 999997543 34588899999999999999999987 9999999999999999999999999999876543221 123
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
...++..|+|||++.. +.++.++||||||+++|||++ |+.||..... ......+.......
T Consensus 163 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~------------~~~~~~~~~~~~~~---- 224 (261)
T cd05072 163 GAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN------------SDVMSALQRGYRMP---- 224 (261)
T ss_pred CCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCH------------HHHHHHHHcCCCCC----
Confidence 3446778999999865 467889999999999999998 8888753211 01111111111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
....+...+.+++.+||+.+|++||+++++.+.|+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111234568889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.55 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=200.0
Q ss_pred HHhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~l 418 (667)
+.+.++||+|+||.||+|++. .+..||||+++... ...+.+.+|+++++++. ||||+++++++.+....++
T Consensus 39 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (400)
T cd05105 39 LVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYI 118 (400)
T ss_pred eehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEE
Confidence 346689999999999999862 13479999997543 23467999999999996 9999999999999999999
Q ss_pred EEEEcCCCCcccccccccc-------------------------------------------------------------
Q 005953 419 IYEYMPNGSLGDLLSREKE------------------------------------------------------------- 437 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~------------------------------------------------------------- 437 (667)
||||+++|+|.++|+....
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (400)
T cd05105 119 ITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEAS 198 (400)
T ss_pred EEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhh
Confidence 9999999999998864210
Q ss_pred --------------------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCc
Q 005953 438 --------------------------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT 485 (667)
Q Consensus 438 --------------------------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~ 485 (667)
...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCE
Confidence 12478888899999999999999987 9999999999999999999
Q ss_pred eEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCcc
Q 005953 486 PKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTE 564 (667)
Q Consensus 486 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 564 (667)
+||+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |+.|+.....
T Consensus 276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~~~-------- 345 (400)
T cd05105 276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGMIV-------- 345 (400)
T ss_pred EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCcccch--------
Confidence 999999999876443322222334467899999998653 67899999999999999997 8888754321
Q ss_pred ccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 565 AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
.......+...... .........+.+++.+||+.+|++||++.+|.++|+++
T Consensus 346 ---~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 346 ---DSTFYNKIKSGYRM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred ---hHHHHHHHhcCCCC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 01111111111111 11123456788999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=327.66 Aligned_cols=255 Identities=25% Similarity=0.433 Sum_probs=202.8
Q ss_pred HHHHhhhhcccCCCeEEEEEEeCC------CcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeE
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 417 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 417 (667)
.++.+.+.||+|+||.||+|+..+ ++.||||.++.... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 445677899999999999998633 47899999876543 3468999999999999999999999999999999
Q ss_pred EEEEEcCCCCccccccccc-----------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCce
Q 005953 418 LIYEYMPNGSLGDLLSREK-----------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTP 486 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 486 (667)
+||||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999996532 123578899999999999999999988 99999999999999999999
Q ss_pred EEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccc
Q 005953 487 KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEA 565 (667)
Q Consensus 487 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 565 (667)
||+|||+++...............+++.|+|||++.. +.++.++||||||+++|||++ |+.||.....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--------- 230 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--------- 230 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---------
Confidence 9999999976543322211223346789999999875 468889999999999999998 9988754321
Q ss_pred cchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 566 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.. ....+..+.... ........+.+++.+||+.||++||++.||++.|+
T Consensus 231 --~~-~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 231 --EE-VIECITQGRLLQ----RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --HH-HHHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 01 111111111111 11224567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.08 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=199.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCc----EEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGR----LVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
+...+.||+|+||+||+|++. +++ .||+|+++... ...+++.+|+.+++.++||||++++|++... ..++|+
T Consensus 9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~ 87 (316)
T cd05108 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 87 (316)
T ss_pred ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence 344578999999999999864 333 48999987543 3356789999999999999999999999764 578999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||+++|+|.+++.... ..+++..+++++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 88 e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 88 QLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCC
Confidence 9999999999987543 3478889999999999999999998 9999999999999999999999999999877654
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
..........++..|+|||++.+ ..++.++||||||+++|||++ |+.|+..... ..+...+....
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~------------~~~~~~~~~~~ 228 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------------SEISSILEKGE 228 (316)
T ss_pred CcceeccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------------HHHHHHHhCCC
Confidence 44333333445778999999875 377899999999999999998 8888854321 00111111111
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
.... .......+.+++.+||+.+|++||++.+++..|.....+
T Consensus 229 ~~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 229 RLPQ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 1111 111234678899999999999999999999999866544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.90 Aligned_cols=253 Identities=25% Similarity=0.469 Sum_probs=201.8
Q ss_pred HhhhhcccCCCeEEEEEEeCC------CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
.+.+.||+|+||.||+|.... ...||+|.+.... ....+|.+|+..+++++||||+++++++.+....+++|
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence 356889999999999998642 2579999987543 23457899999999999999999999999999999999
Q ss_pred EEcCCCCcccccccccc-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceE
Q 005953 421 EYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPK 487 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 487 (667)
||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEE
Confidence 99999999999865321 14588899999999999999999998 999999999999999999999
Q ss_pred EEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCcccc
Q 005953 488 VSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAY 566 (667)
Q Consensus 488 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 566 (667)
|+|||+++...............+++.|+|||.+.. +.++.++|||||||++|||++ |+.||.....
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---------- 232 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---------- 232 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH----------
Confidence 999999986543332222233456889999999865 367899999999999999998 9988864321
Q ss_pred chHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 567 FPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
..+...+....... ....++..+.+++.+||+.||++||++.||+++|+.
T Consensus 233 --~~~~~~i~~~~~~~----~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 233 --QEVIEMIRSRQLLP----CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHHHHHcCCcCC----CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11222222221111 122345678899999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=324.07 Aligned_cols=252 Identities=30% Similarity=0.473 Sum_probs=202.5
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
.+.++||+|+||.||+|.+. .++.||+|++.......+++.+|++++++++|+||+++++++......++||||+++++
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (263)
T cd05052 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 88 (263)
T ss_pred EEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCc
Confidence 35578999999999999875 58899999988766556789999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|.+++.... ...+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||+++........ ...
T Consensus 89 L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~ 163 (263)
T cd05052 89 LLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHA 163 (263)
T ss_pred HHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee-ccC
Confidence 999986543 34589999999999999999999987 9999999999999999999999999999876543221 112
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
...++..|+|||.+.. ..++.++||||||+++|||++ |..|+..... ......+...... .
T Consensus 164 ~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------------~~~~~~~~~~~~~----~ 225 (263)
T cd05052 164 GAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------------SQVYELLEKGYRM----E 225 (263)
T ss_pred CCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------------HHHHHHHHCCCCC----C
Confidence 2234678999998865 367889999999999999998 8888753221 1111222211111 1
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
.....+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1122356788899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=322.38 Aligned_cols=249 Identities=26% Similarity=0.449 Sum_probs=201.6
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
.+.+.||+|+||+||+|++.++..+|+|.+.......+++.+|+.++++++||||+++++++.+....++||||+++|+|
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 86 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86 (256)
T ss_pred EEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcH
Confidence 45688999999999999987777899999886655567899999999999999999999999998899999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.+++.... ..+++..+++++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++....... .....
T Consensus 87 ~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~ 160 (256)
T cd05113 87 LNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVG 160 (256)
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce-eecCC
Confidence 99986543 2589999999999999999999988 999999999999999999999999999986544322 12233
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 587 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (667)
..++..|+|||++.. +.++.++||||||+++|||++ |+.|+..... ..+...+.........
T Consensus 161 ~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------------~~~~~~~~~~~~~~~~--- 223 (256)
T cd05113 161 SKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN------------SETVEKVSQGLRLYRP--- 223 (256)
T ss_pred CccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCH------------HHHHHHHhcCCCCCCC---
Confidence 446778999999865 367889999999999999998 8888753321 1112222222111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 588 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
......+.+++.+||+.+|++||++.++++.|+
T Consensus 224 -~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 -HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112457889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=330.05 Aligned_cols=243 Identities=24% Similarity=0.357 Sum_probs=201.5
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
.++||+|.||.||||.+. .++.||+|++.... ...++...|+.+|.+++++||.+.+|.+..+..++++|||+.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 378999999999999874 68999999997653 456788999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
+.+.|.... .+++..+.-|.++++.||.|||.+ +.+|||||+.|||+..+|.+|++|||.+..+....... .
T Consensus 98 v~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~ 169 (467)
T KOG0201|consen 98 VLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--K 169 (467)
T ss_pred hhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc--c
Confidence 999996543 347777888999999999999998 99999999999999999999999999998776554332 4
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchh
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 587 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (667)
..+||+.|||||++... .++.|+||||||++.+||.+|.+|+....+. +++-..........
T Consensus 170 tfvGTPfwMAPEVI~~~--~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~PP~L 231 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQS--GYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAPPRL 231 (467)
T ss_pred cccccccccchhhhccc--cccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCCCcc
Confidence 57799999999999853 7889999999999999999999998655431 00000011111111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 588 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.....+.+.+++..||+.||+.||++.+++.+
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22456678899999999999999999999864
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.00 Aligned_cols=242 Identities=23% Similarity=0.330 Sum_probs=194.9
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.||+|+||.||+++.. +++.||+|++... ......+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999875 6899999998753 233457889999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~ 152 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TM 152 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cc
Confidence 999888653 3588999999999999999999998 999999999999999999999999999875432221 12
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..... .
T Consensus 153 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~------------~~~~~~~~~~~~-~---- 213 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------EKLFELILMEDI-K---- 213 (328)
T ss_pred ccccCCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCH------------HHHHHHhccCCc-c----
Confidence 335689999999998753 678899999999999999999999864321 011111111111 0
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 620 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~L 620 (667)
.+..+...+.+++.+||+.||++|| ++.|++++-
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 1112345678899999999999997 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=337.08 Aligned_cols=245 Identities=25% Similarity=0.360 Sum_probs=206.7
Q ss_pred hhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.||+|+.|.|-.|++ .+|+.+|||++.+.. .....+.+||.+|+.++|||++++++++++...+|||.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 457899999999999988 479999999997652 334568899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|.|.++|.+++ .+.+..+.++++||+.|+.|+|.. +|+||||||+|+|||.++++||+|||+|..-..+.-.
T Consensus 96 gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL- 168 (786)
T KOG0588|consen 96 GGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL- 168 (786)
T ss_pred CchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCccc-
Confidence 999999997654 588899999999999999999998 9999999999999999999999999999876554432
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
....|++.|.|||++.+. .....++||||.|||||.||||+.||++... ..+..++..+..+
T Consensus 169 --eTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNi------------r~LLlKV~~G~f~--- 230 (786)
T KOG0588|consen 169 --ETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNI------------RVLLLKVQRGVFE--- 230 (786)
T ss_pred --cccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccH------------HHHHHHHHcCccc---
Confidence 345689999999999886 3457899999999999999999999985432 1223344333321
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.+..++.+..+|+.+|+..||+.|.|++||+++--
T Consensus 231 --MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 231 --MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred --CCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 12445667788999999999999999999998863
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=335.05 Aligned_cols=246 Identities=23% Similarity=0.372 Sum_probs=191.7
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.++||+|+||+||+|++. +++.||||++.... ...+.+.+|++++++++|+||+++++++.+.+..++||||+++|
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 4578999999999999875 68999999986543 23467899999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+.. ...+..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........ .
T Consensus 158 ~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~--~ 225 (353)
T PLN00034 158 SLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--C 225 (353)
T ss_pred cccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc--c
Confidence 986542 345677889999999999999998 9999999999999999999999999999876433211 1
Q ss_pred cCCCCCccccchhhhhhhc---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 507 TGPRGTIGYIAPEIFMRNL---GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~---~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
....||..|+|||++.... ...+.++|||||||++|||++|+.||...... .+.... ..+.....
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--------~~~~~~-~~~~~~~~--- 293 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--------DWASLM-CAICMSQP--- 293 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--------cHHHHH-HHHhccCC---
Confidence 3346899999999874321 23356899999999999999999998632210 011111 11111111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
..........+.+++.+||+.||++||++.|++++-
T Consensus 294 -~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 294 -PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred -CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 111122355788999999999999999999999864
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=312.36 Aligned_cols=256 Identities=26% Similarity=0.358 Sum_probs=199.6
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHHhhcccce-EEeecceEecCC------eeE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVN-IIHLLGFCCDGS------TRA 417 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~------~~~ 417 (667)
...++||+|+||+||+|+.. +|+.||+|+++.... ......+|+.++++++|+| ||+|++++.+.+ .++
T Consensus 14 ~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~ 93 (323)
T KOG0594|consen 14 EKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLY 93 (323)
T ss_pred HHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEE
Confidence 34578999999999999875 689999999976543 4567899999999999999 999999998877 889
Q ss_pred EEEEEcCCCCccccccccccC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 418 LIYEYMPNGSLGDLLSREKEN-LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
+|+||+ .-+|..++...... ..++...+..+.+|+++||+|||++ +|+||||||+||||+++|.+||+|||+|+.
T Consensus 94 lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 94 LVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred EEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHH
Confidence 999999 57899998764422 4577788999999999999999998 999999999999999999999999999997
Q ss_pred cCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhc
Q 005953 497 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 576 (667)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (667)
..-... ..+..++|..|.|||++.+. ..++...||||+|||++||++++..|....+. ....-+++.+.
T Consensus 170 ~~ip~~--~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--------~ql~~If~~lG 238 (323)
T KOG0594|consen 170 FSIPMR--TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--------DQLFRIFRLLG 238 (323)
T ss_pred hcCCcc--cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--------HHHHHHHHHcC
Confidence 653332 24566789999999999886 46899999999999999999998887544321 00111111111
Q ss_pred Cccc---------------------ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 577 QPEK---------------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 577 ~~~~---------------------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.+.. ................+++.+||+.+|.+|.|++.++++
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1100 000000011112367889999999999999999999987
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=325.42 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=196.6
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
..+.||+|+||+||.++-+ +|+.+|+|+++++. ...+....|-.+|...++|+||+|+-.|.+.+.+||||||+|
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 3478999999999999764 69999999999865 345678889999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC-----
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR----- 499 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~----- 499 (667)
||++..+|.+.. .+++..+..++.+++.|++-||+. |+|||||||+|+|||..|++||+||||+.-+..
T Consensus 225 GGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 225 GGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred CccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 999999997654 689999999999999999999998 999999999999999999999999999953211
Q ss_pred ------------------CCc-----eee-----------------ecCCCCCccccchhhhhhhcCCCCCcccHHHHHH
Q 005953 500 ------------------NRS-----VVT-----------------MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGM 539 (667)
Q Consensus 500 ------------------~~~-----~~~-----------------~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGv 539 (667)
+.. ... ....+|||.|||||++.+. .++..+|.|||||
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDWWSLGC 376 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccHHHHHH
Confidence 000 000 0123699999999999986 5788999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCC---HHHH
Q 005953 540 LLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS---MTRV 616 (667)
Q Consensus 540 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt---~~ev 616 (667)
|+||||.|-+||....+ ...+.++..-.. ............+..+++.+|+. ||++|-. ++||
T Consensus 377 ImyEmLvGyPPF~s~tp------------~~T~rkI~nwr~-~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETP------------QETYRKIVNWRE-TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHHhCCCCCCCCCH------------HHHHHHHHHHhh-hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 99999999999976543 222333322111 00111111223567789999999 9999975 6666
Q ss_pred HHHH
Q 005953 617 VEML 620 (667)
Q Consensus 617 l~~L 620 (667)
-++=
T Consensus 443 K~HP 446 (550)
T KOG0605|consen 443 KKHP 446 (550)
T ss_pred hcCC
Confidence 6554
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=320.67 Aligned_cols=249 Identities=28% Similarity=0.468 Sum_probs=200.2
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
.+.+.||+|+||.||+|++.++..+|+|++.......+++.+|++++++++|+||+++++++.+....++|+||+++++|
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL 86 (256)
T ss_pred chhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCH
Confidence 46688999999999999987778899999876555567899999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........ ....
T Consensus 87 ~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 160 (256)
T cd05059 87 LNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQG 160 (256)
T ss_pred HHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc-ccCC
Confidence 99987543 2588999999999999999999998 9999999999999999999999999999765432211 1122
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 587 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (667)
..++..|+|||.+... .++.++||||||+++|||++ |+.||...... .....+..... ...
T Consensus 161 ~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------------~~~~~~~~~~~----~~~ 222 (256)
T cd05059 161 TKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS------------EVVESVSAGYR----LYR 222 (256)
T ss_pred CCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCHH------------HHHHHHHcCCc----CCC
Confidence 3345689999998753 67889999999999999998 78887543210 11111111111 011
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 588 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
....+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1124567889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=329.16 Aligned_cols=243 Identities=24% Similarity=0.285 Sum_probs=197.2
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 83 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV 83 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence 34678999999999999885 68999999986432 23456889999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-- 155 (291)
T cd05612 84 PGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-- 155 (291)
T ss_pred CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--
Confidence 9999999986532 588899999999999999999998 99999999999999999999999999998664322
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
....|++.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 156 ---~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------------~~~~~~i~~~~~~-- 216 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDNP------------FGIYEKILAGKLE-- 216 (291)
T ss_pred ---ccccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCcC--
Confidence 224589999999998764 578899999999999999999999864321 1122222222111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHh
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEMLS 621 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~~L~ 621 (667)
........+.+++.+||+.||.+||+ ++|++++-.
T Consensus 217 ---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 217 ---FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred ---CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 11112446788999999999999995 888887753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=334.55 Aligned_cols=257 Identities=27% Similarity=0.470 Sum_probs=199.4
Q ss_pred HHHhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEec-CCee
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCD-GSTR 416 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~-~~~~ 416 (667)
.+++.+.||+|+||.||+|... +++.||+|+++... ...+.+.+|+.++.++ +|+||+++++++.. +...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 4556789999999999999642 24789999987543 2335678899999999 79999999998865 4568
Q ss_pred EEEEEEcCCCCcccccccccc----------------------------------------------------------C
Q 005953 417 ALIYEYMPNGSLGDLLSREKE----------------------------------------------------------N 438 (667)
Q Consensus 417 ~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------~ 438 (667)
++++||+++|+|.+++..... .
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 899999999999998853211 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCCCCCccccch
Q 005953 439 LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 518 (667)
Q Consensus 439 ~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aP 518 (667)
..+++..+.+++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+.............++..|+||
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 2678999999999999999999988 9999999999999999999999999999876544332222334567889999
Q ss_pred hhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHH
Q 005953 519 EIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMII 597 (667)
Q Consensus 519 E~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 597 (667)
|++.+. .++.++|||||||++|||++ |+.||...... +.....+...... .........+.+
T Consensus 245 E~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-----------~~~~~~~~~~~~~----~~~~~~~~~~~~ 307 (337)
T cd05054 245 ESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-----------EEFCRRLKEGTRM----RAPEYATPEIYS 307 (337)
T ss_pred HHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-----------HHHHHHHhccCCC----CCCccCCHHHHH
Confidence 998764 78899999999999999998 98888543210 0111111111111 111123457889
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 598 VGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 598 l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
++.+||+.+|++||++.||+++|+++
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=326.80 Aligned_cols=263 Identities=22% Similarity=0.298 Sum_probs=194.8
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.++||+|+||+||+|+.. +++.||+|+++... .....+.+|+.++++++||||+++++++.+....++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 345678999999999999875 68899999987542 334577899999999999999999999999999999999996
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 87 -~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 87 -SDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred -cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence 58988886432 3478889999999999999999998 999999999999999999999999999976543221
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCc---cccchHHHHHhhc-----
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT---EAYFPDWIYDKLI----- 576 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~----- 576 (667)
......+++.|+|||++.+. ..++.++||||+||++|||++|+.||............ ....+...+..+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 12334579999999998653 46788999999999999999999998643221000000 0000000000000
Q ss_pred ----Ccccc-cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 577 ----QPEKE-DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 577 ----~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.+... ...............+++.+||+.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 00000011224567889999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=324.24 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=201.0
Q ss_pred HHHhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 418 (667)
.+.+.++||+|+||.||+|++. +++.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4556789999999999999863 257899999975542 23568899999999999999999999999999999
Q ss_pred EEEEcCCCCccccccccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCc
Q 005953 419 IYEYMPNGSLGDLLSREK-------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT 485 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~ 485 (667)
++||+++++|.+++.... ....+++..+.+++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999985321 123478888999999999999999988 9999999999999999999
Q ss_pred eEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCcc
Q 005953 486 PKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTE 564 (667)
Q Consensus 486 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 564 (667)
+||+|||+++...............+++.|+|||.+.. +.++.++||||||+++|||++ |..|+.....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------- 232 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------- 232 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence 99999999987644333222233456789999999865 467889999999999999998 7777653211
Q ss_pred ccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 565 AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
..+.+.+........ ....+..+.+++.+||+.+|++||++++|+..|+
T Consensus 233 ----~~~~~~i~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 233 ----QDVIEMIRNRQVLPC----PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred ----HHHHHHHHcCCcCCC----CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 112222222222111 1223556889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=320.57 Aligned_cols=252 Identities=25% Similarity=0.421 Sum_probs=200.9
Q ss_pred HhhhhcccCCCeEEEEEEeCC----CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.+.+.||+|+||+||+|++.. ...||||++.... ....+|.+|+..+++++||||+++++++.+.+..++||||
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 86 (266)
T cd05033 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEY 86 (266)
T ss_pred eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEc
Confidence 356889999999999998742 4589999987543 3346789999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++++|.+++.... ..+++..+++++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 87 MENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred CCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 99999999997543 2688999999999999999999997 999999999999999999999999999987753222
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
........++..|+|||.+... .++.++||||||+++|||++ |+.|+..... ..+...+......
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~------------~~~~~~~~~~~~~ 227 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSN------------QDVIKAVEDGYRL 227 (266)
T ss_pred ceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCH------------HHHHHHHHcCCCC
Confidence 2222234457889999998753 67889999999999999998 8888743211 1112222221111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
.. ....+..+.+++.+||+.+|++||+++||+++|+++
T Consensus 228 ~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 PP----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 112345788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=324.43 Aligned_cols=252 Identities=26% Similarity=0.439 Sum_probs=198.5
Q ss_pred HhhhhcccCCCeEEEEEEe-----CCCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKF-----PDGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
.+.++||+|+||+||+|++ .+++.||+|.+..... ...++.+|++++++++||||+++++++..+...++|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 87 (283)
T cd05090 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFE 87 (283)
T ss_pred eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEE
Confidence 4568899999999999975 2467899999875432 23578899999999999999999999999999999999
Q ss_pred EcCCCCccccccccc--------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceE
Q 005953 422 YMPNGSLGDLLSREK--------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPK 487 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 487 (667)
|+++|+|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+|
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEE
Confidence 999999999985322 123578899999999999999999988 999999999999999999999
Q ss_pred EEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCcccc
Q 005953 488 VSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAY 566 (667)
Q Consensus 488 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 566 (667)
|+|||+++...............++..|+|||++.+ +.++.++||||||+++|||++ |..||.....
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---------- 232 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---------- 232 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----------
Confidence 999999987644332222233446778999999865 367899999999999999998 8888753211
Q ss_pred chHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 567 FPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
..+...+....... ....+...+.+++.+||+.+|++||++.+++++|+
T Consensus 233 --~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 233 --QEVIEMVRKRQLLP----CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred --HHHHHHHHcCCcCC----CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 11122222111111 11123456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=302.35 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=199.0
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHHhhcccceEEeecceEec--CCeeEEEEEEcC
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRALIYEYMP 424 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~ 424 (667)
.++|++|.||.||+|+++ +++.||+|+++.+.. ..-.-++||.+|.+++|||||.+-.+..- -+..|+||||++
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 368999999999999985 689999999987653 22357899999999999999999887764 357999999995
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
-+|..++..-+ ..+...++..+..|+++|++|||.+ .|+|||||++|+|+++.|.+||+||||||.+.....
T Consensus 161 -hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k-- 232 (419)
T KOG0663|consen 161 -HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK-- 232 (419)
T ss_pred -hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCcc--
Confidence 58888887654 4588888899999999999999998 999999999999999999999999999998876543
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc------
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP------ 578 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 578 (667)
.++..+-|..|.|||++.+. ..++...|+||+|||+.||+++++.|.+..+. ...+.++..+..+
T Consensus 233 ~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~--------dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI--------DQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred cCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchH--------HHHHHHHHHhCCCccccCC
Confidence 34566679999999999886 68899999999999999999999888654331 1111111111111
Q ss_pred --------------cc--ccccchhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 579 --------------EK--EDFVEEEDDC-IARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 579 --------------~~--~~~~~~~~~~-~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.. .......... +.+.-.+++...|..||.+|-|++|.|++=-
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 00 0001111111 3456778888999999999999999987654
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=319.13 Aligned_cols=251 Identities=29% Similarity=0.466 Sum_probs=204.8
Q ss_pred HHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCc-chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN-FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.+.++||+|+||.||+|.+.+++.+|+|++..... ....+.+|+.++++++|+||+++++++.+....++||||+++|
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG 87 (261)
T ss_pred HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence 456789999999999999998899999999986654 4677899999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++......... .
T Consensus 88 ~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~ 161 (261)
T cd05148 88 SLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--S 161 (261)
T ss_pred CHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc--c
Confidence 9999997643 34689999999999999999999987 9999999999999999999999999999776443222 1
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
....++..|+|||.+.+ +.++.++||||||+++++|++ |+.|+..... ......+......
T Consensus 162 ~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~------------~~~~~~~~~~~~~---- 223 (261)
T cd05148 162 SDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN------------HEVYDQITAGYRM---- 223 (261)
T ss_pred cCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH------------HHHHHHHHhCCcC----
Confidence 23446788999999865 367889999999999999998 7888854321 1111122111111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
.........+.+++.+||+.+|++|||+.++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1112234568899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=330.79 Aligned_cols=260 Identities=21% Similarity=0.315 Sum_probs=198.9
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.++||+|+||.||+++.. ++..+|+|++.... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (331)
T ss_pred ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence 344578999999999999886 58899999987543 234679999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|+|.+++.... .+++..+..++.|++.||+|||+. .+|+||||||+|||+++++.+||+|||+++......
T Consensus 87 ~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 158 (331)
T cd06649 87 GGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (331)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence 999999986533 588999999999999999999974 269999999999999999999999999997654322
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC-----CC--ccc------------
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS-----NT--TEA------------ 565 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~-----~~--~~~------------ 565 (667)
.....|++.|+|||++.+. .++.++|||||||++|||++|+.||......... .. ...
T Consensus 159 -~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred -cccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 1234589999999998754 6789999999999999999999998543210000 00 000
Q ss_pred -----------cch----HHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 566 -----------YFP----DWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 566 -----------~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
..+ ....+.+..... .......+...+.+++.+||+.||++|||++|++++.-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPP---PKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCC---cCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 000 000000000000 00001124567889999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=323.06 Aligned_cols=253 Identities=23% Similarity=0.395 Sum_probs=196.8
Q ss_pred HHhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 419 (667)
+.+.++||+|+||.||+|.+. .+..||+|++.... ....++.+|+.++++++|+||+++++++.++...++|
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 87 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence 445688999999999999753 25679999986543 2345788999999999999999999999999999999
Q ss_pred EEEcCCCCcccccccccc-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCC
Q 005953 420 YEYMPNGSLGDLLSREKE-------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG 492 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFG 492 (667)
|||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg 164 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG 164 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCC
Confidence 999999999999865321 23467888999999999999999987 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHH
Q 005953 493 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWI 571 (667)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 571 (667)
+++...............++..|+|||++.+ +.++.++||||||+++|||++ |..|+..... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~------------~~~ 230 (277)
T cd05062 165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN------------EQV 230 (277)
T ss_pred CccccCCcceeecCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------------HHH
Confidence 9976543332221122345788999999875 467899999999999999999 6777743211 111
Q ss_pred HHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 572 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
............ .......+.+++.+||+.+|++|||+.|++++|+
T Consensus 231 ~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 231 LRFVMEGGLLDK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHcCCcCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111111111111 1123456888999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=328.60 Aligned_cols=258 Identities=24% Similarity=0.419 Sum_probs=209.7
Q ss_pred HHHHHHHHhhhhcccCCCeEEEEEEeCC---C--cEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCC
Q 005953 342 DIKKMTNGFKEKLGTGGYGNVYKGKFPD---G--RLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS 414 (667)
Q Consensus 342 ~l~~~~~~~~~~LG~G~fg~Vy~~~~~~---~--~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 414 (667)
+|.+....+.++||+|-||.||+|.+.+ | -.||||.-+.+. ...+.|+.|..+|++++||||++|+|+|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 4455555567899999999999998743 3 358899887643 446789999999999999999999999975 5
Q ss_pred eeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCc
Q 005953 415 TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 494 (667)
Q Consensus 415 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla 494 (667)
..++|||.++-|.|+.+|.+++ ..++...+..+++||..+|+|||+. .+|||||..+|||+...-.+||+||||+
T Consensus 464 P~WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence 7899999999999999998764 3588889999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHH
Q 005953 495 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYD 573 (667)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 573 (667)
+.+..+.... .+...-++.|||||.+. +..++.++|||-|||.+||+++ |.+||......+ +..
T Consensus 539 R~~ed~~yYk-aS~~kLPIKWmaPESIN--fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD------------VI~ 603 (974)
T KOG4257|consen 539 RYLEDDAYYK-ASRGKLPIKWMAPESIN--FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD------------VIG 603 (974)
T ss_pred hhccccchhh-ccccccceeecCccccc--hhcccchhhHHHHHHHHHHHHHhcCCccccccccc------------eEE
Confidence 9887665432 23445688999999884 3578999999999999999986 889997643210 111
Q ss_pred hhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
++.+ +.+...++.++..++.++.+||+.+|.+||+++|+...|++..
T Consensus 604 ~iEn----GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 604 HIEN----GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred EecC----CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 2222 2223334456778999999999999999999999998886443
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=329.18 Aligned_cols=239 Identities=22% Similarity=0.308 Sum_probs=192.2
Q ss_pred cccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 354 LGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 354 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
||+|+||.||+++.. +++.||+|++... ......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999885 5889999998643 23346788999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 152 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNT 152 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccc
Confidence 9998653 2588999999999999999999998 999999999999999999999999999976433221 1233
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (667)
..||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..... ...
T Consensus 153 ~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~------------~~~~~~~~~~~~-----~~~ 213 (312)
T cd05585 153 FCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENV------------NEMYRKILQEPL-----RFP 213 (312)
T ss_pred ccCCcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCH------------HHHHHHHHcCCC-----CCC
Confidence 5689999999999763 678999999999999999999999864321 111222222111 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 005953 589 DCIARKMIIVGLWCIQINPKDRPS---MTRVVEM 619 (667)
Q Consensus 589 ~~~~~~l~~l~~~cl~~~P~~RPt---~~evl~~ 619 (667)
..+...+.+++.+||+.||++||+ +.|++.+
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 223456788999999999999975 6666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=318.14 Aligned_cols=256 Identities=25% Similarity=0.438 Sum_probs=205.3
Q ss_pred HHHHHHHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 343 IKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 343 l~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+...++++.++||+|+||.||+|..++++.||+|.+.......+++.+|+.++++++|+||+++++++. ....++++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 344566778999999999999999888999999999877666788999999999999999999999864 4578999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.+++.... +..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999986543 34688999999999999999999987 999999999999999999999999999977653322
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
. ......++..|+|||++.. +.++.++||||||++++||++ |+.||..... ......+......
T Consensus 158 ~-~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------------~~~~~~~~~~~~~ 222 (260)
T cd05067 158 T-AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN------------PEVIQNLERGYRM 222 (260)
T ss_pred c-cccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCCh------------HHHHHHHHcCCCC
Confidence 1 1123346788999999865 367889999999999999999 9988864321 0111111111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
. ........+.+++.+||+.+|++||+++++++.|+.
T Consensus 223 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 P----RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1 111234578899999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=323.85 Aligned_cols=256 Identities=24% Similarity=0.410 Sum_probs=201.8
Q ss_pred HHhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
+.+.+.||+|+||+||++... ++..+|+|.+.... ...+.+.+|++++++++||||+++++++......++||
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 86 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 345678999999999999752 34678999987654 33567999999999999999999999999999999999
Q ss_pred EEcCCCCccccccccc----------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEe
Q 005953 421 EYMPNGSLGDLLSREK----------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSD 490 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~D 490 (667)
||+++++|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEecc
Confidence 9999999999986432 123589999999999999999999988 999999999999999999999999
Q ss_pred CCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchH
Q 005953 491 FGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPD 569 (667)
Q Consensus 491 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 569 (667)
||+++...............++..|+|||++.. ..++.++||||||++++||++ |+.||..... .
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~------------~ 229 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------------N 229 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------------H
Confidence 999986644332222223345788999999865 367889999999999999998 8888753321 1
Q ss_pred HHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 570 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
.....+........ .......+.+++.+||+.+|.+|||+.|+++.|+.+.
T Consensus 230 ~~~~~i~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 230 EVIECITQGRVLQR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHHHHHcCCcCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 11122222211111 1123456889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=317.65 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=198.1
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---------------cchHHHHHHHHHHhhcccceEEeecceEe
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---------------NFSDNFINEVATIGRIHHVNIIHLLGFCC 411 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~ 411 (667)
|.+.+.||+|.||.|-+|+.. +++.||||++.+.+ ...+...+||.+|++++|||||+|+.+..
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 345678999999999999875 69999999986432 12357889999999999999999999887
Q ss_pred cC--CeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEE
Q 005953 412 DG--STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 489 (667)
Q Consensus 412 ~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~ 489 (667)
+. +..|||+||+..|.+...--. ...+.+.++++++.++..||+|||.+ +||||||||+|+||+++|++||+
T Consensus 179 DP~s~~~YlVley~s~G~v~w~p~d---~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWCPPD---KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred CcccCceEEEEEeccCCccccCCCC---cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEee
Confidence 64 579999999998877554321 22389999999999999999999998 99999999999999999999999
Q ss_pred eCCCccccCCCC---ceeeecCCCCCccccchhhhhhhc--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCcc
Q 005953 490 DFGLAKAHSRNR---SVVTMTGPRGTIGYIAPEIFMRNL--GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE 564 (667)
Q Consensus 490 DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~ 564 (667)
|||.+-...... .........|||.|+|||...... ...+.+.||||+||.||-|+.|+.||-+...
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-------- 324 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-------- 324 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--------
Confidence 999987663221 111223467999999999987632 2346788999999999999999999964322
Q ss_pred ccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 565 AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
...++++...... -....++.+.+.+|++++|++||++|.+..+|..+..
T Consensus 325 ----~~l~~KIvn~pL~---fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 325 ----LELFDKIVNDPLE---FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred ----HHHHHHHhcCccc---CCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 2233343332221 1112244667888999999999999999999998886
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=318.43 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=201.7
Q ss_pred HHHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
.+.+.++||+|+||+||+|++.+...||+|+++......+++.+|++++++++|+||+++++.+. ....++||||+++|
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKG 85 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCC
Confidence 35567899999999999999877778999999876555678999999999999999999999874 45689999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++........ ..
T Consensus 86 ~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~ 160 (262)
T cd05071 86 SLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-AR 160 (262)
T ss_pred cHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc-cc
Confidence 9999997543 34578999999999999999999997 9999999999999999999999999999866543321 11
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
....++..|+|||++.+ +.++.++||||||+++|||++ |+.||..... ......+......
T Consensus 161 ~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~------------~~~~~~~~~~~~~---- 222 (262)
T cd05071 161 QGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------------REVLDQVERGYRM---- 222 (262)
T ss_pred cCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh------------HHHHHHHhcCCCC----
Confidence 23346778999998865 367899999999999999999 7777753321 1111222111110
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
.........+.+++.+||+.+|++||++.++++.|++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11123456788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.12 Aligned_cols=252 Identities=25% Similarity=0.431 Sum_probs=201.1
Q ss_pred HHHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
.+.+.++||+|+||.||+|...++..+|+|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||++++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKG 85 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCC
Confidence 34567899999999999999888888999999876655678999999999999999999999875 45688999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++.... ...+++..+..++.+++.||+|||+. +++|+||||+||++++++.+||+|||++.......... .
T Consensus 86 ~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~ 160 (260)
T cd05070 86 SLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-R 160 (260)
T ss_pred cHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc-c
Confidence 9999987533 34588999999999999999999998 99999999999999999999999999998764432211 1
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
....++..|+|||.+.. +.++.++||||||+++|||++ |+.||..... ......+......
T Consensus 161 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------------~~~~~~~~~~~~~---- 222 (260)
T cd05070 161 QGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------------REVLEQVERGYRM---- 222 (260)
T ss_pred cCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------------HHHHHHHHcCCCC----
Confidence 22335678999998865 467889999999999999999 8888753221 0111112111110
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
+........+.+++.+||+.+|++|||+.++++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112234578899999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=316.56 Aligned_cols=247 Identities=25% Similarity=0.417 Sum_probs=194.7
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
++||+|+||.||+|++. +++.||+|...... .....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999885 68999999876432 3346789999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99986432 3578999999999999999999988 999999999999999999999999999876543221111111
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 587 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (667)
...+..|+|||.+.. +.++.++||||||+++|||++ |..|+..... ......+...... ..
T Consensus 156 ~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~------------~~~~~~~~~~~~~----~~ 217 (252)
T cd05084 156 KQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSN------------QQTREAIEQGVRL----PC 217 (252)
T ss_pred CCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCH------------HHHHHHHHcCCCC----CC
Confidence 223567999999865 367889999999999999998 7777753221 0111111111110 11
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 588 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
....+..+.+++.+||+.+|++|||+.+|+++|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1223557888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=329.91 Aligned_cols=242 Identities=25% Similarity=0.327 Sum_probs=196.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 100 (329)
T PTZ00263 21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100 (329)
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence 45688999999999999985 58999999986532 33467889999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 101 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 173 (329)
T PTZ00263 101 VGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF- 173 (329)
T ss_pred CCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc-
Confidence 999999998653 2578888999999999999999998 999999999999999999999999999987643321
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
...||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+...... .
T Consensus 174 ----~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~------------~~~~~~i~~~~~~-~ 234 (329)
T PTZ00263 174 ----TLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------------FRIYEKILAGRLK-F 234 (329)
T ss_pred ----eecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCCH------------HHHHHHHhcCCcC-C
Confidence 23589999999999764 568899999999999999999999854321 1112222222111 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEML 620 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~~L 620 (667)
+..+...+.+++.+||+.||++||+ +++++.+-
T Consensus 235 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 235 ----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred ----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 1113456788999999999999996 78888663
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=335.69 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=199.0
Q ss_pred HHhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~l 418 (667)
..+.++||+|+||.||+|++. .++.||||+++... ...+.+.+|+++|.++. ||||+++++++......++
T Consensus 39 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~i 118 (401)
T cd05107 39 LVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYI 118 (401)
T ss_pred eehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEE
Confidence 345689999999999999863 24689999997643 22357889999999997 9999999999999999999
Q ss_pred EEEEcCCCCcccccccccc-------------------------------------------------------------
Q 005953 419 IYEYMPNGSLGDLLSREKE------------------------------------------------------------- 437 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~------------------------------------------------------------- 437 (667)
|+||+++|+|.+++++...
T Consensus 119 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (401)
T cd05107 119 ITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGT 198 (401)
T ss_pred EEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhh
Confidence 9999999999999864321
Q ss_pred ----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC
Q 005953 438 ----------------------------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD 483 (667)
Q Consensus 438 ----------------------------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~ 483 (667)
...+++..+++++.|++.||+|||+. +++||||||+|||++++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~ 275 (401)
T cd05107 199 VKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEG 275 (401)
T ss_pred hhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCC
Confidence 12467788899999999999999987 99999999999999999
Q ss_pred CceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCC
Q 005953 484 FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNT 562 (667)
Q Consensus 484 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 562 (667)
+.+||+|||+++...............++..|+|||.+.. ..++.++||||||+++|||++ |+.|+.....
T Consensus 276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~------ 347 (401)
T cd05107 276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELPM------ 347 (401)
T ss_pred CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc------
Confidence 9999999999986543322222223346789999999875 367889999999999999998 7888743211
Q ss_pred ccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 563 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
.......+..+... ..+......+.+++.+||+.+|++||+++||++.|+++
T Consensus 348 -----~~~~~~~~~~~~~~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 348 -----NEQFYNAIKRGYRM----AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred -----hHHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111111111110 01112345788999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=323.65 Aligned_cols=255 Identities=24% Similarity=0.426 Sum_probs=201.9
Q ss_pred hhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCCc-chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN-FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.+.||+|+||.||+|+.. ++..+++|.+..... ..+.+.+|++.+++++|+||+++++++.+....++||||
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (291)
T cd05094 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEY 88 (291)
T ss_pred EeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEec
Confidence 4578999999999999752 355789999876543 346789999999999999999999999999999999999
Q ss_pred cCCCCccccccccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEE
Q 005953 423 MPNGSLGDLLSREK-------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 489 (667)
Q Consensus 423 ~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~ 489 (667)
+++++|.+++.... ....+++..+++++.|++.||+|||++ +|+||||||+|||+++++.+||+
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEEC
Confidence 99999999986532 123588999999999999999999988 99999999999999999999999
Q ss_pred eCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccch
Q 005953 490 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFP 568 (667)
Q Consensus 490 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 568 (667)
|||+++...............++..|+|||.+... .++.++||||||+++|||++ |+.|+.....
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~------------ 231 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSN------------ 231 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------------
Confidence 99999766443322222334568899999998753 67889999999999999998 8988754321
Q ss_pred HHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 569 DWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
....+.+....... .....+..+.+++.+||+.+|++||++.+|+++|+++..
T Consensus 232 ~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 232 TEVIECITQGRVLE----RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHHHHhCCCCCC----CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11111222211111 111234568899999999999999999999999996643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=346.21 Aligned_cols=251 Identities=21% Similarity=0.290 Sum_probs=199.1
Q ss_pred HHhhhhcccCCCeEEEEEEeC-C-CcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-D-GRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.+.||+|+||.||+|... + ++.||+|.+.... .....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 445688999999999999764 3 6788888765443 334567889999999999999999999999999999999999
Q ss_pred CCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 425 NGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 425 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
+|+|.++|.+. .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988643 2344688999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+...+..+.....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------------~~~~~~~~~~~~~~~ 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQ------------REIMQQVLYGKYDPF 291 (478)
T ss_pred ccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCCCCC
Confidence 22234568999999999875 3678999999999999999999999854321 111222222111111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
...+...+.+++.+||+.+|++||++.+++.+
T Consensus 292 ----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 292 ----PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ----CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11234568889999999999999999998753
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=332.81 Aligned_cols=247 Identities=22% Similarity=0.279 Sum_probs=198.7
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.++||+|+||.||+|++. +++.||||+++... ...+.+.+|++++.+++||||+++++++.+....++||||+
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV 83 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence 34578999999999999986 58999999987532 23457889999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 84 PGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 999999999653 2588999999999999999999998 999999999999999999999999999976543
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc---c
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE---K 580 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 580 (667)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.... .
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~------------~~~~~~i~~~~~~~~ 218 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTP------------NETWENLKYWKETLQ 218 (333)
T ss_pred -ccCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCH------------HHHHHHHHhcccccc
Confidence 12345689999999999764 778999999999999999999999864321 00111111000 0
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
..........+...+.+++.+||+.+|++||++++++++-
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 0000100123456788899999999999999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=316.22 Aligned_cols=255 Identities=22% Similarity=0.371 Sum_probs=190.3
Q ss_pred hhcccCCCeEEEEEEeCC---CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 352 EKLGTGGYGNVYKGKFPD---GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
++||+|+||+||+|+..+ ...+|+|.+.... .....+.+|+..++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 4578889876543 23457889999999999999999999999999999999999999
Q ss_pred Ccccccccccc--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 427 SLGDLLSREKE--NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 427 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|.+++..... ....++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999975432 23356788899999999999999998 99999999999999999999999999987654333222
Q ss_pred eecCCCCCccccchhhhhhh-----cCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 505 TMTGPRGTIGYIAPEIFMRN-----LGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-----~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
......++..|+|||++... ....+.++||||||+++|||++ |+.|+..... .+.....+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----------~~~~~~~~~~~ 226 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-----------EQVLKQVVREQ 226 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-----------HHHHHHHhhcc
Confidence 22334467889999998542 1355789999999999999999 6677643221 01111111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
................+.+++..|| .||++|||++||++.|.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 227 DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1110111111233456667888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=311.64 Aligned_cols=262 Identities=23% Similarity=0.289 Sum_probs=201.4
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEccc---CCcchHHHHHHHHHHhhcccceEEeecceEec-----CCeeEEEEE
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLLGFCCD-----GSTRALIYE 421 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-----~~~~~lV~e 421 (667)
.+.||+|+||.|.++..+ +|+.||||++.. .....++..+|+++|+.++|+||+.+.+++.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 367999999999999885 689999998873 23446788999999999999999999998765 357899999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
+| ..+|..+++... .++...+.-+.+|+++||.|+|+. +|+||||||.|+|++.+..+||+|||+|+......
T Consensus 107 lM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred HH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99 678988886543 489999999999999999999998 99999999999999999999999999999886543
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC---ccccchHHHHHhhc--
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWIYDKLI-- 576 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~-- 576 (667)
....++..+.|..|.|||++... ..++.+.||||.|||+.||++|++-|-+.+....-.. .-....+.....+.
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred cccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 33445778889999999999654 6889999999999999999999998865433110000 00000011111111
Q ss_pred ------C--cccc-cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 577 ------Q--PEKE-DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 577 ------~--~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
. +... ..............++++.+||..||.+|+|++|.+++-
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 0 0000 000111123345678899999999999999999999765
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=331.28 Aligned_cols=242 Identities=24% Similarity=0.336 Sum_probs=193.4
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.||+|+||.||+++.. +++.||+|++... ......+.+|++++..++||||+++++++.+....++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999874 6899999998753 223456788999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
+|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-- 152 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-- 152 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--
Confidence 999888653 258899999999999999999996 5 9999999999999999999999999998754322211
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~------------~~~~~~i~~~~~-~~-- 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------EKLFELILMEEI-RF-- 215 (325)
T ss_pred cccccCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCH------------HHHHHHHhcCCC-CC--
Confidence 1234589999999998653 678899999999999999999999854321 011111111111 00
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 620 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~L 620 (667)
...+...+.+++.+||+.||++|+ ++.+++++-
T Consensus 216 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 216 --PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 112345678899999999999996 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.27 Aligned_cols=251 Identities=23% Similarity=0.292 Sum_probs=196.4
Q ss_pred HhhhhcccCCCeEEEEEEe----CCCcEEEEEEcccC-----CcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEE
Q 005953 349 GFKEKLGTGGYGNVYKGKF----PDGRLVAVKVLEKT-----SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~-----~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 418 (667)
.+.++||+|+||+||+++. .+++.||+|++... ....+.+.+|+.++.++ +|+||+++++++.+....++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 3568899999999999975 35789999998642 22345678899999999 59999999999999999999
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 83 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 83 ILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999998653 3588999999999999999999988 99999999999999999999999999998654
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
...... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||...... .....+...+...
T Consensus 157 ~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~~~~~~~~~ 226 (332)
T cd05614 157 SEEKER-TYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGER--------NTQSEVSRRILKC 226 (332)
T ss_pred ccCCCc-cccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCC--------CCHHHHHHHHhcC
Confidence 332221 1234689999999998753 34678999999999999999999998643221 0111122222211
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 620 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~L 620 (667)
.. . ....+...+.+++.+||+.||++|| ++++++++-
T Consensus 227 ~~-~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 227 DP-P----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred CC-C----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 11 1 1112345678899999999999999 788888663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=321.71 Aligned_cols=258 Identities=22% Similarity=0.365 Sum_probs=203.5
Q ss_pred HHHHhhhhcccCCCeEEEEEEeCC-----CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEec-CCeeE
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFPD-----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCD-GSTRA 417 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~ 417 (667)
..+.+.+.||+|+||.||+|.+.+ +..|++|++.... ...+.+.+|+.++++++|+||+++++++.+ +...+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 344566889999999999998865 6889999987543 334678899999999999999999998876 46789
Q ss_pred EEEEEcCCCCccccccccccC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCC
Q 005953 418 LIYEYMPNGSLGDLLSREKEN-----LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG 492 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFG 492 (667)
+++||+++|+|.+++...... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCC
Confidence 999999999999998654322 4689999999999999999999987 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHH
Q 005953 493 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWI 571 (667)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 571 (667)
+++.+.............++..|+|||++... .++.++||||||+++||+++ |+.|+..... ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------------~~~ 228 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDP------------FEM 228 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCH------------HHH
Confidence 99876544333222334467889999998653 67899999999999999999 9998854321 001
Q ss_pred HHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 572 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
...+....... ........+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 229 ~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 229 AAYLKDGYRLA----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred HHHHHcCCCCC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11111111100 11123456889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=324.83 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=194.6
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.||+|+||+||+++.. +++.||+|+++... ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36899999999999875 58899999987532 2335677899888877 799999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~-- 152 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-- 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc--
Confidence 9998888643 3588999999999999999999998 9999999999999999999999999999754322211
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|+|||++.+. .++.++||||||+++|||++|+.||....... ........++...+......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~~~~~~~~~~i~~~~~~---- 223 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD---NPDQNTEDYLFQVILEKQIR---- 223 (329)
T ss_pred cccccCCccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCccCCCcC---CcccccHHHHHHHHhcCCCC----
Confidence 1234589999999999764 67889999999999999999999996432211 11111223333333322111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPS------MTRVVEM 619 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt------~~evl~~ 619 (667)
.+......+.+++.+||+.||++||+ +.+++++
T Consensus 224 -~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 -IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred -CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11123456778999999999999998 5677655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=324.77 Aligned_cols=242 Identities=28% Similarity=0.388 Sum_probs=193.5
Q ss_pred hhcccCCCeEEEEEEe----CCCcEEEEEEcccCC-----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 352 EKLGTGGYGNVYKGKF----PDGRLVAVKVLEKTS-----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
++||+|+||.||+++. .+++.||+|+++... .....+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999976 357899999987532 2234678899999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.+++.+.. .+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999886532 477888899999999999999998 999999999999999999999999999875432222
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
. .....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ......+......
T Consensus 156 ~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~~------------~~~~~~~~~~~~~- 218 (323)
T cd05584 156 V--THTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAENR------------KKTIDKILKGKLN- 218 (323)
T ss_pred c--ccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCCH------------HHHHHHHHcCCCC-
Confidence 1 1234689999999998764 568899999999999999999999864321 1112222222111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 620 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~L 620 (667)
. .......+.+++.+||+.+|++|| ++.+++++-
T Consensus 219 ~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 219 L----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred C----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 1 112345678899999999999999 888888753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=315.32 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=191.2
Q ss_pred hhcccCCCeEEEEEEeCC---CcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 352 EKLGTGGYGNVYKGKFPD---GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.||+|+||.||+|++.+ +..+|+|.++.... ....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 45799998876542 3357889999999999999999999999999999999999999
Q ss_pred Cccccccccc--cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 427 SLGDLLSREK--ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 427 sL~~~l~~~~--~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|.+++.... .....++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 223567778889999999999999987 99999999999999999999999999997654333222
Q ss_pred eecCCCCCccccchhhhhhhcC-----CCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLG-----NPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~-----~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
......++..|+|||++....+ .++.++||||||+++|||++ |+.||...... + ..... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~------~--~~~~~---~~~~ 226 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE------Q--VLTYT---VREQ 226 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH------H--HHHHH---hhcc
Confidence 2233457889999999864311 35789999999999999996 99888543210 0 00000 0000
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
................+.+++..|| .+|++|||++||+..|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 227 QLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0000000001112345677888898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=300.47 Aligned_cols=262 Identities=24% Similarity=0.316 Sum_probs=205.7
Q ss_pred HHHhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCC-----eeEEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS-----TRALI 419 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-----~~~lV 419 (667)
+|++.++||+|||+-||.++. .+++.+|+|++.-.. +..+..++|++..++++||||++++++...+. ..||+
T Consensus 22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll 101 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL 101 (302)
T ss_pred eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence 345678999999999999984 578999999887655 56678999999999999999999999876544 48999
Q ss_pred EEEcCCCCccccccccc-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 420 YEYMPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
++|...|||.+.+...+ ++..+++.+++.|+.++++||++||.. .+++.||||||.|||+.+++.++|.|||.+....
T Consensus 102 ~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~ 180 (302)
T KOG2345|consen 102 LPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAP 180 (302)
T ss_pred eehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccc
Confidence 99999999999998643 345799999999999999999999987 4569999999999999999999999999987543
Q ss_pred CCC-------ceeeecCCCCCccccchhhhhhhc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHH
Q 005953 499 RNR-------SVVTMTGPRGTIGYIAPEIFMRNL-GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW 570 (667)
Q Consensus 499 ~~~-------~~~~~~~~~gt~~y~aPE~~~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 570 (667)
-.- ..........|.-|.|||++.-.. ...++++|||||||+||+|+.|..||+..-...++......-+
T Consensus 181 i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~-- 258 (302)
T KOG2345|consen 181 IQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNA-- 258 (302)
T ss_pred eEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecc--
Confidence 110 001112345789999999985432 3568999999999999999999999975433111111000000
Q ss_pred HHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 571 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
++.. .....+++.+.+++.+||+.||.+||++.+++..++.
T Consensus 259 ---q~s~--------P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 259 ---QISI--------PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ---cccc--------CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 0101 1112267889999999999999999999999999974
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.05 Aligned_cols=237 Identities=22% Similarity=0.361 Sum_probs=195.9
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.|.++||+|.||+|+++.++ +++.+|||++++.. ...+..+.|-+++... +||.|++++..+.+.++.++||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 35689999999999999886 58899999999864 3456677888888877 599999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+.||++..+.+.. .+++.++.-+|..|+.||.|||++ +||+||||.+|||||.+|.+||+||||++.......
T Consensus 451 ~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 451 VAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred cCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence 9999965555433 489999999999999999999998 999999999999999999999999999987542222
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
......||+.|||||++... .|+..+|.|||||+|||||.|..||.+.++ +.+++.+...+..
T Consensus 524 --~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE------------ee~FdsI~~d~~~- 586 (694)
T KOG0694|consen 524 --RTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDE------------EEVFDSIVNDEVR- 586 (694)
T ss_pred --ccccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCH------------HHHHHHHhcCCCC-
Confidence 22456799999999999874 889999999999999999999999975543 2233333332221
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSM 613 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 613 (667)
.+..++++.+.++.++|..+|++|.-+
T Consensus 587 ----yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 ----YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CCCcccHHHHHHHHHHhccCcccccCC
Confidence 122346678889999999999999865
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=327.89 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=209.3
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCe-eEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGST-RALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~-~~lV~e~ 422 (667)
|...+.+|+|+||.++..+++ ++..+++|.+.... ...+....|+.++++++|||||.+.+.+.+++. .+|||+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 445688999999999999875 57789999987543 344578899999999999999999999999888 9999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
++||+|.+.|.+.+ +..++++++.+|+.|++.|+.|||++ +|+|||||+.||+++.++.+||.|||+|+.+..+..
T Consensus 86 ~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred cCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 99999999998765 56799999999999999999999987 999999999999999999999999999999887653
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
.. ....||+.||.||.+.+. .+..|+|||||||++|||++-+++|...+.. .+..++....
T Consensus 162 ~a--~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------------~Li~ki~~~~--- 222 (426)
T KOG0589|consen 162 LA--STVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------------ELILKINRGL--- 222 (426)
T ss_pred hh--heecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccchH------------HHHHHHhhcc---
Confidence 32 346799999999999875 7889999999999999999999998765431 1122222222
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
....+..+...+..++..|++.+|+.||++.++|.+-
T Consensus 223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 2222334567888899999999999999999999763
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.91 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=195.1
Q ss_pred hhhhcccCCCeEEEEEEeCC-Cc--EEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecC------CeeE
Q 005953 350 FKEKLGTGGYGNVYKGKFPD-GR--LVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRA 417 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~~ 417 (667)
+.++||+|+||.||+|++.+ ++ .||+|.++... ...+.+.+|++++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 45789999999999998854 33 68999887542 3356788999999999999999999987532 2468
Q ss_pred EEEEEcCCCCcccccccc---ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCc
Q 005953 418 LIYEYMPNGSLGDLLSRE---KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 494 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla 494 (667)
+++||+++|+|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 999999999999887432 1234588999999999999999999987 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHH
Q 005953 495 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYD 573 (667)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 573 (667)
+...............+++.|+|||.+... .++.++||||||+++|||++ |+.||..... ..+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~------------~~~~~ 225 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVEN------------SEIYD 225 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCH------------HHHHH
Confidence 876543322211223467789999998753 67889999999999999999 7777753211 11222
Q ss_pred hhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
.+........ .......+.+++.+||+.+|++|||+.++++.|+++
T Consensus 226 ~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 226 YLRQGNRLKQ----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHcCCCCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2222211111 112345688999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.06 Aligned_cols=254 Identities=24% Similarity=0.422 Sum_probs=199.7
Q ss_pred hhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
+.+.||+|+||.||+|+.. ....+++|.+..... ..+++.+|+.++++++||||+++++.+...+..++|+|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 4578999999999999763 235789998875432 34578899999999999999999999999999999999
Q ss_pred EcCCCCccccccccc---------------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE
Q 005953 422 YMPNGSLGDLLSREK---------------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 480 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll 480 (667)
|+++|+|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+|||+
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEE
Confidence 999999999885421 123578999999999999999999987 99999999999999
Q ss_pred CCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCC
Q 005953 481 DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSG 559 (667)
Q Consensus 481 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~ 559 (667)
++++.+||+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |+.|+.....
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--- 235 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--- 235 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCCH---
Confidence 99999999999999865433322222334467789999988653 67899999999999999998 8888753221
Q ss_pred CCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 560 SNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
..+++.+....... ........+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 236 ---------~~~~~~~~~~~~~~----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 236 ---------ERLFNLLKTGYRME----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ---------HHHHHHHhCCCCCC----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11222222111111 11223457889999999999999999999999999653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=331.02 Aligned_cols=249 Identities=29% Similarity=0.454 Sum_probs=206.5
Q ss_pred hhhhcccCCCeEEEEEEeC--CCc--EEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 350 FKEKLGTGGYGNVYKGKFP--DGR--LVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~--~~~--~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
+.|+||+|.||.|++|.|+ +|+ .||||.++.... ..++|++|+.+|.+|+|+|+++|||+..+ ....+|+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 5689999999999999985 344 689999987653 56899999999999999999999999987 7788999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
+.|||.+.|+.. ....+-...+..++.|||.||.||.++ ++|||||..+|+||...-.+||+||||.+-+......
T Consensus 193 plGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 193 PLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred ccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999873 345677888999999999999999998 9999999999999999999999999999998877766
Q ss_pred eeecCC-CCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 504 VTMTGP-RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 504 ~~~~~~-~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
..+... .-...|.|||.+.. ..++.++|||+|||.+|||+| |..||-.... ..|.+.+.+
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------------~qIL~~iD~---- 330 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------------IQILKNIDA---- 330 (1039)
T ss_pred eEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCH------------HHHHHhccc----
Confidence 666543 35779999999975 489999999999999999998 4556543321 223333332
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
..........++.++++++.||..+|++|||+..|.+.+-
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 2233334456889999999999999999999999985553
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=314.62 Aligned_cols=251 Identities=24% Similarity=0.420 Sum_probs=200.0
Q ss_pred HHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
+.+.++||+|++|.||+|.+.++..+|+|.+.......+.+.+|+.++++++|+|++++++++. ....++||||+++|+
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 86 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGS 86 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCC
Confidence 4556889999999999999877778999998766655678999999999999999999999875 456889999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++........ ...
T Consensus 87 L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~ 161 (260)
T cd05069 87 LLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQ 161 (260)
T ss_pred HHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccC
Confidence 999997543 34578999999999999999999987 9999999999999999999999999999766433221 112
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
...++..|+|||.+.. +..+.++||||||+++|||++ |+.|+..... ......+...... .
T Consensus 162 ~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------------~~~~~~~~~~~~~----~ 223 (260)
T cd05069 162 GAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVN------------REVLEQVERGYRM----P 223 (260)
T ss_pred CCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCC----C
Confidence 3346778999998865 367889999999999999999 8888754321 0111111111110 1
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
.....+..+.+++.+||+.+|++||++++|++.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112345678899999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=325.09 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=195.5
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999875 58899999997532 2345678899999998 699999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--T 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC--c
Confidence 9999888643 3589999999999999999999998 999999999999999999999999999875322111 1
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||+...... ........+..+.+...... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~-~-- 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD---NPDQNTEDYLFQVILEKQIR-I-- 224 (329)
T ss_pred cccccCCccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccccccc---cccccchHHHHHHHHcCCCC-C--
Confidence 1234589999999999763 67889999999999999999999996432211 01111223333333322111 1
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPS------MTRVVEM 619 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt------~~evl~~ 619 (667)
+..+...+.+++.+||+.||++||+ +.+++++
T Consensus 225 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 --PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1123456788999999999999997 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=327.17 Aligned_cols=197 Identities=24% Similarity=0.384 Sum_probs=169.2
Q ss_pred HHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
..+.+.++||+|+||.||++.+. ++..+|+|++.... ...+.+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 34556789999999999999886 58889999887542 2346789999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.+++.... .+++..+..++.+++.||+|||+. .+|+|+||||+|||+++++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 85 MDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 99999999996532 478899999999999999999963 269999999999999999999999999997653321
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 553 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~ 553 (667)
.....|+..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ---cccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1234589999999998753 678899999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.72 Aligned_cols=262 Identities=20% Similarity=0.282 Sum_probs=196.0
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.+.||+|+||+||++++. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07848 4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE 83 (287)
T ss_pred eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence 35678999999999999986 58899999987542 334678899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
++++..+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 156 (287)
T cd07848 84 KNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA- 156 (287)
T ss_pred CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-
Confidence 8877655432 23588999999999999999999988 9999999999999999999999999999876433221
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC---CccccchHHHHHh-hcCccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN---TTEAYFPDWIYDK-LIQPEK 580 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~---~~~~~~~~~~~~~-~~~~~~ 580 (667)
......|++.|+|||++.+. .++.++|||||||++|||++|+.||.......... ......+...... ...+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 12334589999999999764 67889999999999999999999986532110000 0000000000000 000000
Q ss_pred -----cc------ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 581 -----ED------FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 581 -----~~------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.. ............+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 0000111245678999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=344.92 Aligned_cols=251 Identities=25% Similarity=0.324 Sum_probs=198.0
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCC--------e
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS--------T 415 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--------~ 415 (667)
|.+.++||+|+||+||+|+.. +++.||||++.... .....+.+|+..+..++|+|+++++..+.... .
T Consensus 34 Y~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~ 113 (496)
T PTZ00283 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLM 113 (496)
T ss_pred EEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceE
Confidence 345688999999999999864 68999999986543 23456889999999999999999988765432 3
Q ss_pred eEEEEEEcCCCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCc
Q 005953 416 RALIYEYMPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 494 (667)
Q Consensus 416 ~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla 494 (667)
.++||||+++|+|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 114 i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred EEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 67999999999999998643 2345689999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHh
Q 005953 495 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 574 (667)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 574 (667)
+...............||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ..+...
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------------~~~~~~ 256 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENM------------EEVMHK 256 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------------HHHHHH
Confidence 876443222222345689999999999763 688999999999999999999999864321 111222
Q ss_pred hcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
........ ....+...+.+++.+||+.+|++||++.+++++
T Consensus 257 ~~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGRYDP----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCCCCC----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 22221111 112235678899999999999999999999875
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=314.83 Aligned_cols=255 Identities=23% Similarity=0.369 Sum_probs=202.6
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||.||+|+.. +++.||||.+.... .....+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence 35678999999999999875 68999999875422 23456889999999999999999999999999999999999
Q ss_pred CCCCccccccccc-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 424 PNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 424 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
++|+|.+++.... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 9999999886422 234578899999999999999999988 999999999999999999999999999987654322
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
. .....|++.|+|||.+.+. .++.++||||||+++|||++|+.|+...... ... +...+......
T Consensus 162 ~--~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---------~~~-~~~~~~~~~~~- 226 (267)
T cd08228 162 A--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------LFS-LCQKIEQCDYP- 226 (267)
T ss_pred H--HhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCcccccc---------HHH-HHHHHhcCCCC-
Confidence 1 1234578999999998754 6788999999999999999999998543210 011 11222111111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
..........+.+++.+||+.+|++||++.+|++.|++.
T Consensus 227 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 --PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111223456788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=330.13 Aligned_cols=263 Identities=19% Similarity=0.302 Sum_probs=193.2
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecC-----CeeEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG-----STRALI 419 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~~~lV 419 (667)
.+.++||+|+||.||+|+.. +++.||||++.... .....+.+|++++++++||||+++++++... ...++|
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv 82 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 82 (338)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence 45688999999999999875 68999999986432 2345688999999999999999999988643 247999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||+. ++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 83 FELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 99994 7888888643 3588999999999999999999998 999999999999999999999999999986533
Q ss_pred CCc-eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC----CccccchHHHHHh
Q 005953 500 NRS-VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN----TTEAYFPDWIYDK 574 (667)
Q Consensus 500 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~----~~~~~~~~~~~~~ 574 (667)
... ........||+.|+|||++.+....++.++|||||||++|||++|+.||.......... ........+ ...
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~ 234 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET-ISR 234 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH-HHH
Confidence 221 11223456899999999986533467889999999999999999999986432100000 000000000 000
Q ss_pred hcCc-----------ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 575 LIQP-----------EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 575 ~~~~-----------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
+... ................+.+++.+||+.||++|||++|++++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 00000000001123567889999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.91 Aligned_cols=264 Identities=26% Similarity=0.373 Sum_probs=194.0
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.++||+|+||+||+|+.. +++.||||++.... .....+.+|+.++++++||||+++++++.+....++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 345688999999999999986 68999999987543 233567899999999999999999999999999999999995
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 87 -~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 158 (303)
T cd07869 87 -TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-- 158 (303)
T ss_pred -cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--
Confidence 6787777543 23578889999999999999999998 999999999999999999999999999875432221
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC---------CCccccchHHHHHhh
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS---------NTTEAYFPDWIYDKL 575 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~ 575 (667)
......+++.|+|||++.+. ..++.++|||||||++|||++|+.||......... ......++.......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 12345679999999998654 35788999999999999999999999653210000 000000000000000
Q ss_pred cCccc-ccccchhhH------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 576 IQPEK-EDFVEEEDD------CIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 576 ~~~~~-~~~~~~~~~------~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
..+.. ......... .....+.+++.+||+.||++|||+.|++++=
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~ 289 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCc
Confidence 00000 000000000 1124577899999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=332.52 Aligned_cols=250 Identities=26% Similarity=0.342 Sum_probs=199.7
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||+||+|+.. +++.||||++.... .....+.+|++++..++|+||+++++++.+++..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (350)
T cd05573 4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM 83 (350)
T ss_pred eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence 35678999999999999985 68999999987532 34467889999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC--
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR-- 501 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~-- 501 (667)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 84 PGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999999999764 3588999999999999999999997 99999999999999999999999999998664432
Q ss_pred -------------------------ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCc
Q 005953 502 -------------------------SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTET 556 (667)
Q Consensus 502 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~ 556 (667)
.........||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00112335689999999999764 778999999999999999999999864321
Q ss_pred CCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHH
Q 005953 557 TSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS-MTRVVEML 620 (667)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-~~evl~~L 620 (667)
......+...... ........+...+.+++.+||+ +|++||+ ++|++++-
T Consensus 236 ------------~~~~~~i~~~~~~-~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 236 ------------QETYNKIINWKES-LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred ------------HHHHHHHhccCCc-ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 1111222210000 0000011145677889999998 9999999 99999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=331.45 Aligned_cols=259 Identities=22% Similarity=0.268 Sum_probs=194.0
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
|.+.++||+|+||.||++... +++.||+|... .+.+.+|++++++++||||+++++++..+...++|+|++ .+
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~ 167 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KT 167 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CC
Confidence 456688999999999999875 68999999754 245689999999999999999999999999999999999 47
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 168 ~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~ 240 (391)
T PHA03212 168 DLYCYLAAK---RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKY 240 (391)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-ccc
Confidence 888887543 3578999999999999999999998 999999999999999999999999999975432211 112
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccch------------------
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFP------------------ 568 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~------------------ 568 (667)
....||+.|+|||++.+. .++.++|||||||++|||++|+.|+.......+.......+.
T Consensus 241 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 241 YGWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 345689999999998763 678999999999999999999988753321111000000000
Q ss_pred ---HHHHHhhcC-cccc---cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 569 ---DWIYDKLIQ-PEKE---DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 569 ---~~~~~~~~~-~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
...+..... .... .............+.+++.+||+.||++|||++|++++=-
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 000000000 0000 0001112234567889999999999999999999996543
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=329.54 Aligned_cols=251 Identities=25% Similarity=0.290 Sum_probs=198.3
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.++||+|+||+||+++.. +++.||+|+++... ...+.+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ 83 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence 35678999999999999875 68999999987542 23456888999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++.+.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 84 PGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 9999999997642 3588999999999999999999998 9999999999999999999999999999876544332
Q ss_pred eeecCCCCCccccchhhhhhh----cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRN----LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~----~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
......||+.|+|||++... ...++.++|||||||++|||++|+.||..... ......+....
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------------~~~~~~i~~~~ 225 (330)
T cd05601 159 -NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------------AKTYNNIMNFQ 225 (330)
T ss_pred -eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------------HHHHHHHHcCC
Confidence 22335689999999998632 23567899999999999999999999864321 01112221111
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
... .......+...+.+++..||+ +|++||++.+++.+
T Consensus 226 ~~~-~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 226 RFL-KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred Ccc-CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 100 001111234567788899998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=317.15 Aligned_cols=246 Identities=24% Similarity=0.325 Sum_probs=195.0
Q ss_pred cccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 354 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 354 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
||+|+||+||++... +++.||+|.+.... ...+.+..|++++++++|+||+++.+++.+....++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 68899999986532 2235678899999999999999999999999999999999999999
Q ss_pred ccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 429 GDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 429 ~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
.+++... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++........ ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 9887542 2344689999999999999999999998 9999999999999999999999999999766443321 23
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchh
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 587 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (667)
...||+.|+|||++.+. .++.++||||||+++|||++|+.||...... . ....+...+..... ..
T Consensus 156 ~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~----~~~~~~~~~~~~~~-----~~ 220 (280)
T cd05608 156 GYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEK----V----ENKELKQRILNDSV-----TY 220 (280)
T ss_pred ccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcc----h----hHHHHHHhhcccCC-----CC
Confidence 45689999999999763 6788999999999999999999998653221 0 01111111111111 11
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005953 588 DDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 619 (667)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~ 619 (667)
...++..+.+++.+||+.||++|| ++++++++
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 123456788899999999999999 77888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.99 Aligned_cols=254 Identities=26% Similarity=0.434 Sum_probs=199.8
Q ss_pred HhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV 419 (667)
.+.+.||+|+||.||++... ....+|+|++.... ....++.+|++++.++ +|+||+++++++..++..+++
T Consensus 15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li 94 (293)
T cd05053 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV 94 (293)
T ss_pred EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence 34578999999999999864 23689999987543 2335688999999999 799999999999999999999
Q ss_pred EEEcCCCCcccccccc-------------ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCce
Q 005953 420 YEYMPNGSLGDLLSRE-------------KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTP 486 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 486 (667)
|||+++|+|.+++... .....+++..+++++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeE
Confidence 9999999999998642 1234688999999999999999999987 99999999999999999999
Q ss_pred EEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccc
Q 005953 487 KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEA 565 (667)
Q Consensus 487 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 565 (667)
||+|||+++...............++..|+|||++.. ..++.++||||||+++|||++ |..|+.....
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------- 240 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--------- 240 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCH---------
Confidence 9999999987654433222233445778999998865 367889999999999999997 8887743221
Q ss_pred cchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 566 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
....+.+....... ........+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 241 ---~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 241 ---EELFKLLKEGYRME----KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HHHHHHHHcCCcCC----CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11112222211111 1112245788899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=322.48 Aligned_cols=241 Identities=25% Similarity=0.333 Sum_probs=192.2
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.||+|+||+||+|+.. +++.||||++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999885 5889999998753 23345678899988877 699999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~ 152 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--T 152 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--c
Confidence 9999988654 2588999999999999999999988 999999999999999999999999999875432221 1
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~------------~~~~~~i~~~~~~---- 214 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENE------------DDLFEAILNDEVV---- 214 (320)
T ss_pred ccccccCccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCH------------HHHHHHHhcCCCC----
Confidence 2334689999999998753 678899999999999999999999964321 1112222221111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSM------TRVVEM 619 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~------~evl~~ 619 (667)
....+...+.+++.+||+.||++||++ ++++.+
T Consensus 215 -~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 215 -YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 011234567889999999999999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.58 Aligned_cols=243 Identities=26% Similarity=0.335 Sum_probs=196.9
Q ss_pred HHhhhhcccCCCeEEEEEEeCC--CcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPD--GRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
+.+.+.||+|+||.||+|++.+ +..||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 4456889999999999998643 468999998643 2334678899999999999999999999999999999999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 112 y~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~ 185 (340)
T PTZ00426 112 FVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185 (340)
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence 999999999996543 588999999999999999999998 99999999999999999999999999998764322
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+......
T Consensus 186 -----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------------~~~~~~i~~~~~~ 246 (340)
T PTZ00426 186 -----YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANEP------------LLIYQKILEGIIY 246 (340)
T ss_pred -----ceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCCH------------HHHHHHHhcCCCC
Confidence 234589999999999753 678899999999999999999999964321 1122233222111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 620 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~L 620 (667)
. +......+.+++.+||+.+|++|+ ++++++++-
T Consensus 247 -~----p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 247 -F----PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred -C----CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 0 111234567899999999999995 899998873
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.12 Aligned_cols=251 Identities=26% Similarity=0.434 Sum_probs=194.3
Q ss_pred hhhhcccCCCeEEEEEEeC-CCc----EEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGR----LVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.+.||+|+||+||+|++. +++ .+++|.+.... ....++..|+..+++++||||+++++++. +...++++||
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~ 89 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQL 89 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEe
Confidence 4578999999999999874 344 47888875433 23357788888999999999999999875 4567899999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.+++.... ..+++..+..|+.|++.||+|||+. +++||||||+|||+++++.+||+|||+++.......
T Consensus 90 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 90 SPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred CCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 99999999997543 3588999999999999999999987 999999999999999999999999999987654433
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
........++..|+|||.+.. +.++.++||||||+++|||++ |+.|+..... ..+.+.+......
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------------~~~~~~~~~~~~~ 230 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP------------HEVPDLLEKGERL 230 (279)
T ss_pred ccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH------------HHHHHHHHCCCcC
Confidence 333334557889999999865 367899999999999999998 8888754321 1111111111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
.... .....+.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus 231 ~~~~----~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 231 AQPQ----ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1000 12335677899999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.64 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=193.9
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.++||+|+||+||+++.. +++.||||++.... .....+.+|+.++..++||||+++++++.++...++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence 4578999999999999885 58999999987532 334567889999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 85 ~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 85 GGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999986532 589999999999999999999998 99999999999999999999999999987543211100
Q ss_pred ------------------------------------eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCC
Q 005953 505 ------------------------------------TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 548 (667)
Q Consensus 505 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~ 548 (667)
......||+.|+|||++.+. .++.++|||||||++|||++|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHHhhcCC
Confidence 00123589999999998753 6789999999999999999999
Q ss_pred CCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHH
Q 005953 549 KHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS---MTRVVEML 620 (667)
Q Consensus 549 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt---~~evl~~L 620 (667)
.||..... ......+...... ........+...+.+++.+|+. +|.+|++ +.|++++-
T Consensus 237 ~Pf~~~~~------------~~~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 237 PPFCSDNP------------QETYRKIINWKET-LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred CCCCCCCH------------HHHHHHHHcCCCc-cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 99964321 0011111111110 0000011234466778888886 9999998 99988753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=293.83 Aligned_cols=244 Identities=26% Similarity=0.381 Sum_probs=202.7
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.||+|.||.||.|+.+ ++-.||+|++.++. ....++.+|+++-+.|+||||+++++++.+....||++||.+
T Consensus 26 igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~ 105 (281)
T KOG0580|consen 26 IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAP 105 (281)
T ss_pred ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecC
Confidence 5688999999999999875 57899999997754 445688999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|+|...|.... ...+++.....+..|+|.||.|+|.. +||||||||+|+|++.++.+||+|||-+.....+. ..
T Consensus 106 ~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k-R~ 180 (281)
T KOG0580|consen 106 RGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK-RK 180 (281)
T ss_pred CchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCCC-ce
Confidence 999999997433 44688889999999999999999987 99999999999999999999999999887654322 22
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
...||..|.+||...+. ..+.++|+|++|++.+|++.|.+||..... ...+.++.+....
T Consensus 181 ---tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes~~~------------~etYkrI~k~~~~--- 240 (281)
T KOG0580|consen 181 ---TLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFESQSH------------SETYKRIRKVDLK--- 240 (281)
T ss_pred ---eeecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhhhhh------------HHHHHHHHHcccc---
Confidence 24489999999998764 678899999999999999999999964321 1223333322211
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.+..+.....+++.+|+..+|.+|.+..|++++=
T Consensus 241 --~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 241 --FPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred --CCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 1133456778899999999999999999999864
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=321.55 Aligned_cols=262 Identities=26% Similarity=0.410 Sum_probs=196.3
Q ss_pred HHHHhhhhcccCCCeEEEEEEeCC---------------CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecc
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFPD---------------GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLG 408 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~~---------------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g 408 (667)
..+.+.++||+|+||.||+++..+ ...||+|++.... ...+.|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 345567899999999999987632 2358999987542 23457899999999999999999999
Q ss_pred eEecCCeeEEEEEEcCCCCccccccccc---------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEE
Q 005953 409 FCCDGSTRALIYEYMPNGSLGDLLSREK---------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVL 479 (667)
Q Consensus 409 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIl 479 (667)
++......++||||+++++|.+++.... ....+++..++.++.|++.||+|||+. +++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 9999999999999999999999986432 112468889999999999999999998 9999999999999
Q ss_pred ECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh--CCCCCCCCCcC
Q 005953 480 LDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE--EKKHLRPTETT 557 (667)
Q Consensus 480 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt--g~~p~~~~~~~ 557 (667)
+++++.+||+|||+++...............++..|+|||.+.. +.++.++||||||++++||++ |..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-
Confidence 99999999999999976543332222223345789999998865 468899999999999999998 4445543211
Q ss_pred CCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 558 SGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
+ .....+.... ...............+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 239 ------~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 ------E-QVIENTGEFF-RNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ------H-HHHHHHHHhh-hhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 0 0000000000 000000000011123457899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.84 Aligned_cols=262 Identities=24% Similarity=0.391 Sum_probs=190.0
Q ss_pred HHhhhhcccCCCeEEEEEEeC--CCcEEEEEEcccCC---cchHHHHHHHHHHhhc---ccceEEeecceEec-----CC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP--DGRLVAVKVLEKTS---NFSDNFINEVATIGRI---HHVNIIHLLGFCCD-----GS 414 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~-----~~ 414 (667)
|.+.+.||+|+||+||+|+.. +++.||+|+++... .....+.+|+.+++++ +||||+++++++.. ..
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 345688999999999999873 47889999886432 2334567788777766 69999999998852 45
Q ss_pred eeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCc
Q 005953 415 TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 494 (667)
Q Consensus 415 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla 494 (667)
..++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 6899999995 68998886543 33588999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC--------CCcccc
Q 005953 495 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEAY 566 (667)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~ 566 (667)
+...... ......||+.|+|||.+... .++.++|||||||++|||++|+.||......... ......
T Consensus 158 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 158 RIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred EeccCCc---ccccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 8654332 12344589999999998653 6788999999999999999999998654221000 000000
Q ss_pred chHHH--HHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 567 FPDWI--YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 567 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
++... .......................+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00000 000000000000001111234567889999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=316.66 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=197.2
Q ss_pred hhhhcccCCCeEEEEEEeCC----CcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCe------e
Q 005953 350 FKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGST------R 416 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~------~ 416 (667)
+.+.||+|+||.||+|++.. +..||+|+++... ...+.+.+|++.++.++|+||+++++++.+... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 45789999999999998742 3679999987543 234578999999999999999999998876554 7
Q ss_pred EEEEEEcCCCCccccccccc---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCC
Q 005953 417 ALIYEYMPNGSLGDLLSREK---ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 493 (667)
Q Consensus 417 ~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGl 493 (667)
++++||+++|+|..++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence 89999999999999985432 234689999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHH
Q 005953 494 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIY 572 (667)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 572 (667)
++...............++..|+|||.+.. ..++.++||||||+++|||++ |..|+..... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~------------~~~~ 225 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN------------HEIY 225 (273)
T ss_pred eeeccccccccccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCH------------HHHH
Confidence 987644332211122335678999999865 367889999999999999999 7787753221 1112
Q ss_pred HhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 573 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
+.+..+..... .......+.+++.+||+.||++||++.|+++.|+++
T Consensus 226 ~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 226 DYLRHGNRLKQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHcCCCCCC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 22222211111 122355788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=332.21 Aligned_cols=250 Identities=23% Similarity=0.271 Sum_probs=190.6
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.++||+|+||+||+|+.. +++.||||++.... ...+.+.+|++++++++|+||+++++++.+....++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 4578999999999999875 58899999987532 234578899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce-
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV- 503 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~- 503 (667)
+|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 85 gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 85 GGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999986543 478888999999999999999998 9999999999999999999999999998643210000
Q ss_pred --------------------------------------------eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHH
Q 005953 504 --------------------------------------------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGM 539 (667)
Q Consensus 504 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGv 539 (667)
.......||+.|+|||++.+. .++.++|||||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlG~ 236 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccceeehhh
Confidence 001124689999999998764 6788999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHH--hcccCCCCCCCHHHHH
Q 005953 540 LLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLW--CIQINPKDRPSMTRVV 617 (667)
Q Consensus 540 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~P~~RPt~~evl 617 (667)
++|||++|+.||...... .....+....... .......+...+.+++.+ |+..+|..||++.|++
T Consensus 237 il~elltG~~Pf~~~~~~------------~~~~~i~~~~~~~-~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPT------------ETQLKVINWENTL-HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHH------------HHHHHHHcccccc-CCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 999999999999653220 0111111100000 000011123455566655 5566777799999999
Q ss_pred HHH
Q 005953 618 EML 620 (667)
Q Consensus 618 ~~L 620 (667)
++-
T Consensus 304 ~hp 306 (381)
T cd05626 304 AHP 306 (381)
T ss_pred cCc
Confidence 874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.81 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=197.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
+..++||+|+||+||++... +++.||+|++.... .....+.+|+.++++++|+||+++++.+.+++..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEecc
Confidence 34578999999999999875 68999999986532 22345788999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05605 83 NGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET- 157 (285)
T ss_pred CCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence 9999998886432 34589999999999999999999998 999999999999999999999999999987543322
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
.....|++.|+|||++.+ ..++.++||||||+++|||++|+.||...... .....+...+....
T Consensus 158 --~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~---- 221 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK--------VKREEVERRVKEDQ---- 221 (285)
T ss_pred --cccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchh--------hHHHHHHHHhhhcc----
Confidence 123468999999999865 36788999999999999999999999643210 00011111111111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 619 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~ 619 (667)
......+...+.+++.+||+.||++|| ++++++++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111223456788899999999999999 88898766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=309.72 Aligned_cols=266 Identities=24% Similarity=0.382 Sum_probs=196.6
Q ss_pred HHHHHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHh--hcccceEEeecceEecCC----eeEE
Q 005953 345 KMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIG--RIHHVNIIHLLGFCCDGS----TRAL 418 (667)
Q Consensus 345 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~--~l~h~niv~l~g~~~~~~----~~~l 418 (667)
..+..+.+.||+|.||.||+|+| .|+.||||++...++ +.+.+|.++.+ .|+|+||+.+++.-..++ .++|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecccch--hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 33445668899999999999999 789999999987654 44555555555 459999999998755443 6789
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHc-----CCCCCeeecCCCCCcEEECCCCceEEEeCCC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN-----GCELRILHLDIKPQNVLLDPDFTPKVSDFGL 493 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-----~~~~~ivH~Dikp~NIll~~~~~~ki~DFGl 493 (667)
|.+|.++|||.|+|.+. .++.+..++++..+|.||++||. +.+|.|.|||||++|||+..++...|+|+||
T Consensus 287 vTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 99999999999999874 58999999999999999999994 3468999999999999999999999999999
Q ss_pred ccccCCCCcee--eecCCCCCccccchhhhhhhcC--CC--CCcccHHHHHHHHHHHHhC----------CCCCCCCCcC
Q 005953 494 AKAHSRNRSVV--TMTGPRGTIGYIAPEIFMRNLG--NP--SGKSDVYSYGMLLLEMIEE----------KKHLRPTETT 557 (667)
Q Consensus 494 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~--~~--s~k~DvwSlGvvl~elltg----------~~p~~~~~~~ 557 (667)
|.....+.... .....+||.+|||||++..... .+ -..+||||||+|+||+..+ +.||.+..+.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 98876654332 2234679999999999965321 11 2358999999999999743 2344433221
Q ss_pred CCCCCccccchHHHHHhhcCcccccc--cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 558 SGSNTTEAYFPDWIYDKLIQPEKEDF--VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
+..+.++ .+.+-....... ..-......+.+.++|..||..||.-|-|+=.+-..|.++.
T Consensus 443 ------DPs~eeM-rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 443 ------DPSFEEM-RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred ------CCCHHHH-hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 1112211 111111111111 11122345778999999999999999999999988887553
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=317.86 Aligned_cols=262 Identities=26% Similarity=0.376 Sum_probs=197.1
Q ss_pred HhhhhcccCCCeEEEEEEe-----CCCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecC--CeeEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKF-----PDGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALI 419 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV 419 (667)
.+.+.||+|+||+||+++. .+++.||+|++..... ....+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 4568899999999988753 3578899999876432 456788999999999999999999988653 457899
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 87 ~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999998643 489999999999999999999988 999999999999999999999999999987654
Q ss_pred CCceee-ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC---CCccccchHHHHHhh
Q 005953 500 NRSVVT-MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS---NTTEAYFPDWIYDKL 575 (667)
Q Consensus 500 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~ 575 (667)
...... .....++..|+|||.+.. +.++.++||||||+++|||++|+.|+......... ............+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 332111 112235677999998865 36788999999999999999999987543211000 000000000001111
Q ss_pred cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
..... ..........+.+++.+||+.+|++|||++++++.|+++
T Consensus 238 ~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 238 ERGMR----LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hcCCC----CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11100 011122346788999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=315.72 Aligned_cols=247 Identities=23% Similarity=0.307 Sum_probs=193.7
Q ss_pred cccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 354 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 354 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
||+|+||+||+++.. +|+.+|+|++.... .....+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 58999999986432 2234566799999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 98886433 34588999999999999999999987 999999999999999999999999999977654322 133
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (667)
..|+..|+|||++... .++.++|||||||++|||++|+.||...... .....+.......... ...
T Consensus 154 ~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~----~~~ 219 (277)
T cd05607 154 RAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--------VAKEELKRRTLEDEVK----FEH 219 (277)
T ss_pred cCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcch--------hhHHHHHHHhhccccc----ccc
Confidence 4589999999998764 5889999999999999999999998643210 0011111111111111 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 589 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 589 ~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
..+...+.+++.+||+.||++||++.|+++.+.
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 124557889999999999999999977664443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=321.37 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=200.0
Q ss_pred HHhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 418 (667)
..+.+.||+|+||.||+++.. .+..||||+++... ...+.+.+|+++++++ +|+||+++++++...+..++
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence 445688999999999999742 34579999987543 2345789999999999 79999999999999999999
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
||||+++|+|.+++.... ...+++.++..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||+++...
T Consensus 117 v~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred EEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 999999999999997543 23489999999999999999999987 99999999999999999999999999998765
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcC
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 577 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (667)
............++..|+|||.+... .++.++||||||+++|||++ |+.|+..... .......+..
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~~~~~-----------~~~~~~~~~~ 259 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMPV-----------DSKFYKLIKE 259 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-----------hHHHHHHHHc
Confidence 44332222234467889999998653 67889999999999999998 8888754321 0111111111
Q ss_pred cccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 578 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 578 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
+.... ........+.+++.+||+.+|++|||+.|+++.|++
T Consensus 260 ~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 260 GYRMA----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CCcCC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 11111 111224578889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.34 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=200.2
Q ss_pred HHHHhhhhcccCCCeEEEEEEeC--------CCcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEecCC
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFP--------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGS 414 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~ 414 (667)
..+.+.+.||+|+||.||+++.. +...+|+|.+.... ....++.+|+++++++ +|+||+++++++.+..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 34556789999999999999752 23579999997543 3345788999999999 7999999999999999
Q ss_pred eeEEEEEEcCCCCcccccccccc-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC
Q 005953 415 TRALIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD 481 (667)
Q Consensus 415 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~ 481 (667)
..++||||+++|+|.+++..... ...+++..+++++.|++.||+|||+. +++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 99999999999999999975321 13588899999999999999999987 999999999999999
Q ss_pred CCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCC
Q 005953 482 PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGS 560 (667)
Q Consensus 482 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~ 560 (667)
+++.+||+|||+++...............++..|+|||.+.+ ..++.++||||||+++|||++ |+.|+.....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---- 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH----
Confidence 999999999999976543221111122334578999999865 367889999999999999998 7777743211
Q ss_pred CCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 561 NTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
..+...+..... .+........+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 249 --------~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 249 --------EELFKLLKEGHR----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred --------HHHHHHHHcCCC----CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 111122211111 1111223457888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=309.11 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=205.8
Q ss_pred HHHHHhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCCc----chHHHHHHHHHHhhcccceEEeecceEecCCeeEEE
Q 005953 345 KMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 345 ~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 419 (667)
+.++++.+.||+|.||.|-+|.. ..|+.||||.++++.- ..-.+.+||++|+.|+||||+.++.+|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45667889999999999999976 5799999999987642 223578999999999999999999999999999999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||..+|.|.||+.+.. .+++.....+++||..|+.|+|.+ +++|||||.+|||||+|+++||+||||+..+..
T Consensus 132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999998754 599999999999999999999998 999999999999999999999999999988876
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
+... +...|++-|.+||.+.+. ..-...+|-|||||+||-|+.|.-||++.+.. . +..++..+.
T Consensus 206 ~kfL---qTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-----------~-lvrQIs~Ga 269 (668)
T KOG0611|consen 206 KKFL---QTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-----------R-LVRQISRGA 269 (668)
T ss_pred ccHH---HHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchHH-----------H-HHHHhhccc
Confidence 5543 446689999999999765 23367899999999999999999999865431 1 112222221
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.... + .+....-++.|||..||++|.|+.+|..+-.
T Consensus 270 YrEP--~----~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 270 YREP--E----TPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ccCC--C----CCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1111 1 1223455889999999999999999998764
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=312.03 Aligned_cols=245 Identities=25% Similarity=0.425 Sum_probs=194.1
Q ss_pred hcccCCCeEEEEEEeC---CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 353 KLGTGGYGNVYKGKFP---DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+||+|+||.||+|.++ ++..+|+|+++... ...+++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 57889999987543 23467899999999999999999999875 45778999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee-
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT- 505 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~- 505 (667)
+|.+++... ..+++..+.+++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 999998653 2588999999999999999999987 999999999999999999999999999987654433221
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....++..|+|||.+.. +.++.++||||||+++|||++ |+.||..... ..+...+........
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------------~~~~~~i~~~~~~~~- 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG------------NEVTQMIESGERMEC- 219 (257)
T ss_pred cCCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHCCCCCCC-
Confidence 122334679999998864 367889999999999999998 8988864321 011122222111111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
....+..+.+++.+||+.||++||++.+|.+.|+.
T Consensus 220 ---~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 ---PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ---CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11235578899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=318.70 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=198.9
Q ss_pred HHhhhhcccCCCeEEEEEEeCC-----------------CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecc
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPD-----------------GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLG 408 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g 408 (667)
+.+.++||+|+||.||++++.+ +..||+|++.... ...+++.+|++++++++||||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (296)
T cd05051 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG 86 (296)
T ss_pred CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 3456899999999999997642 2468999987653 33567899999999999999999999
Q ss_pred eEecCCeeEEEEEEcCCCCccccccccc--------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE
Q 005953 409 FCCDGSTRALIYEYMPNGSLGDLLSREK--------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 480 (667)
Q Consensus 409 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll 480 (667)
++..+...++|+||+++++|.+++.+.. ....+++..++.++.|++.||+|||+. +++|+||||+||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili 163 (296)
T cd05051 87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhceee
Confidence 9999999999999999999999986532 123589999999999999999999988 99999999999999
Q ss_pred CCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh--CCCCCCCCCcCC
Q 005953 481 DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE--EKKHLRPTETTS 558 (667)
Q Consensus 481 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt--g~~p~~~~~~~~ 558 (667)
++++.++|+|||+++...............++..|+|||.+.+ +.++.++||||||+++|||++ |..|+.....
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-- 239 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence 9999999999999976544332222234456789999999875 367899999999999999998 5556532211
Q ss_pred CCCCccccchHHHHHhhcCc---ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 559 GSNTTEAYFPDWIYDKLIQP---EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
..+....... .............+..+.+++.+||+.+|++|||+.||++.|+
T Consensus 240 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 ----------QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ----------HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111111 0000001111223467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=317.17 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=196.1
Q ss_pred hhhhcccCCCeEEEEEEeCC------CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
+.+.||+|+||.||+|.+.+ +..||+|...... .....|.+|+.++++++|+||+++++++.+....++|||
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 89 (277)
T cd05036 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLE 89 (277)
T ss_pred eeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEe
Confidence 45789999999999998753 5678999886543 234578999999999999999999999999999999999
Q ss_pred EcCCCCcccccccccc----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC---ceEEEeCCCc
Q 005953 422 YMPNGSLGDLLSREKE----NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF---TPKVSDFGLA 494 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~---~~ki~DFGla 494 (667)
|+++++|.+++..... ...+++..+++++.||+.||+|||+. +++|+||||+||+++.++ .+||+|||++
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCccc
Confidence 9999999999975431 23589999999999999999999998 999999999999998764 5999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHH
Q 005953 495 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYD 573 (667)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 573 (667)
+................+..|+|||++.+ +.++.++|||||||++|||++ |+.||..... ..+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~------------~~~~~ 232 (277)
T cd05036 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN------------QEVME 232 (277)
T ss_pred cccCCccceecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------------HHHHH
Confidence 87643322211122234578999999865 368999999999999999997 8888754321 01111
Q ss_pred hhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.+....... .....+..+.+++.+||+.+|++||++.+|+++|+
T Consensus 233 ~~~~~~~~~----~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 FVTGGGRLD----PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHcCCcCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111111 11223457888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=317.82 Aligned_cols=254 Identities=24% Similarity=0.404 Sum_probs=199.6
Q ss_pred HHHhhhhcccCCCeEEEEEEeCC------CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 418 (667)
.+.+.+.||+|+||.||+|...+ +..||+|.+.... .....+.+|+.+++.++|+||+++++++......++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 86 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV 86 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence 34456889999999999998742 3689999987543 234578899999999999999999999999999999
Q ss_pred EEEEcCCCCcccccccccc-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeC
Q 005953 419 IYEYMPNGSLGDLLSREKE-------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDF 491 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DF 491 (667)
||||+++|+|.+++..... ...+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+||
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCc
Confidence 9999999999999965321 23478899999999999999999987 9999999999999999999999999
Q ss_pred CCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHH
Q 005953 492 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDW 570 (667)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 570 (667)
|+++...............++..|+|||.+.. +.++.++||||||+++|||++ |+.|+..... ..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------------~~ 229 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------------EE 229 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCH------------HH
Confidence 99986544332211223346789999999865 367889999999999999998 8888753221 11
Q ss_pred HHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 571 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
....+......... ......+.+++.+||+.+|++|||+.++++.|+
T Consensus 230 ~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 230 VLKFVIDGGHLDLP----ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHhcCCCCCCC----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11122221111111 112567889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=313.34 Aligned_cols=253 Identities=24% Similarity=0.442 Sum_probs=203.5
Q ss_pred HHHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
.+.+.++||+|+||.||+|.+++++.||||.+.......+++.+|+.++++++|+||+++++++.+....++||||++++
T Consensus 7 ~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 86 (261)
T cd05034 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKG 86 (261)
T ss_pred heeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCC
Confidence 34456889999999999999888889999999876666788999999999999999999999999888999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++.... ...+++..+..++.+++.|++|||+. +++|+||||+||++++++.+||+|||+++........ ..
T Consensus 87 ~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~ 161 (261)
T cd05034 87 SLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-AR 161 (261)
T ss_pred CHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh-hh
Confidence 9999997643 34589999999999999999999988 9999999999999999999999999999866432211 11
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
....++..|+|||.+.+. ..+.++||||||++++||++ |+.||..... ......+........
T Consensus 162 ~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------------~~~~~~~~~~~~~~~-- 225 (261)
T cd05034 162 EGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTN------------REVLEQVERGYRMPR-- 225 (261)
T ss_pred hccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCCCC--
Confidence 223356789999998753 67889999999999999998 8888853221 111112211111000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
....+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 226 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 --PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11124578889999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.10 Aligned_cols=252 Identities=23% Similarity=0.404 Sum_probs=198.1
Q ss_pred HhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
.+.++||+|+||.||++... ++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.+....++++|
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 35689999999999999642 35689999887544 335679999999999999999999999999999999999
Q ss_pred EcCCCCcccccccccc------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEE
Q 005953 422 YMPNGSLGDLLSREKE------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 489 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~ 489 (667)
|+++|+|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEEC
Confidence 9999999999865321 13588999999999999999999988 99999999999999999999999
Q ss_pred eCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccch
Q 005953 490 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFP 568 (667)
Q Consensus 490 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 568 (667)
|||+++...............+++.|+|||++.+. .++.++||||||+++|||++ |+.||..... .
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----------~ 231 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-----------T 231 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCccCCH-----------H
Confidence 99999765433222212223357889999998754 67899999999999999998 8888753321 0
Q ss_pred HHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 569 DWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
. ............ ....++..+.+++.+||+.||++||++.||++.|+
T Consensus 232 ~-~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 E-AIECITQGRELE----RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-HHHHHHcCccCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1 111111111111 11123456789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=321.98 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=201.6
Q ss_pred HHHHHhhhhcccCCCeEEEEEEeC--------CCcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEecC
Q 005953 345 KMTNGFKEKLGTGGYGNVYKGKFP--------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDG 413 (667)
Q Consensus 345 ~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~ 413 (667)
...+.+.+.||+|+||.||+|+.. ++..||+|.+.... ...+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 334456688999999999999741 24579999987542 3346789999999999 899999999999999
Q ss_pred CeeEEEEEEcCCCCcccccccccc-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE
Q 005953 414 STRALIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 480 (667)
Q Consensus 414 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll 480 (667)
...++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 999999999999999999975321 23578889999999999999999998 99999999999999
Q ss_pred CCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCC
Q 005953 481 DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSG 559 (667)
Q Consensus 481 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~ 559 (667)
++++.+||+|||+++...............++..|+|||++.+. .++.++||||||+++|||++ |..|+....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 99999999999999876543332222334467889999998653 67889999999999999998 677664321
Q ss_pred CCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 560 SNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
...+...+....... ........+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 245 --------~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 245 --------VEELFKLLKEGHRMD----KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred --------HHHHHHHHHcCCcCC----CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 111222222211111 11123567888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=328.14 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=196.5
Q ss_pred HHHhhhhcccCCCeEEEEEEe------CCCcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEecC-Cee
Q 005953 347 TNGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDG-STR 416 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~-~~~ 416 (667)
.+.+.++||+|+||.||+|.+ .+++.||||+++... ...+.+.+|+.++.++ +|+||+++++++... ...
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 87 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence 456778999999999999974 347899999997543 2345788999999999 689999999988654 467
Q ss_pred EEEEEEcCCCCcccccccccc-----------------------------------------------------------
Q 005953 417 ALIYEYMPNGSLGDLLSREKE----------------------------------------------------------- 437 (667)
Q Consensus 417 ~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 437 (667)
++||||+++|+|.+++.....
T Consensus 88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (343)
T cd05103 88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE 167 (343)
T ss_pred EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence 899999999999998864210
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCCCCC
Q 005953 438 -----NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT 512 (667)
Q Consensus 438 -----~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt 512 (667)
...+++..+.+++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++...............++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 12367888899999999999999988 9999999999999999999999999999865433222222233467
Q ss_pred ccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHH
Q 005953 513 IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCI 591 (667)
Q Consensus 513 ~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (667)
..|+|||.+... .++.++||||||+++|||++ |..|+..... .......+........ ....
T Consensus 245 ~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~----~~~~ 307 (343)
T cd05103 245 LKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-----------DEEFCRRLKEGTRMRA----PDYT 307 (343)
T ss_pred cceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCccc-----------cHHHHHHHhccCCCCC----CCCC
Confidence 789999998653 67889999999999999997 8888753221 0111111111111111 1112
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 592 ARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 592 ~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
...+.+++.+||+.+|++|||+.||+++|+.+
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 34688899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=325.60 Aligned_cols=243 Identities=23% Similarity=0.362 Sum_probs=190.8
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHH---hhcccceEEeecceEecCCeeEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATI---GRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l---~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
+.+.||+|+||.||+|.+. +++.||||+++... ...+.+.+|++++ ++++||||+++++++.+++..++|||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E 82 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME 82 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence 4578999999999999875 68999999987532 2334566666554 56689999999999999999999999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|..++... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 83 YAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred CCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 99999998887542 489999999999999999999998 99999999999999999999999999987543222
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
. ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~------------~~~~~~i~~~~~~ 219 (324)
T cd05589 156 D--RTSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDE------------EEVFDSIVNDEVR 219 (324)
T ss_pred C--cccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCCC
Confidence 1 12335689999999998753 678899999999999999999999864321 1111122111110
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 620 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~L 620 (667)
....+...+.+++.+||+.||++|| ++.+++++-
T Consensus 220 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 220 -----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred -----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 1112345678899999999999999 577777654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=322.47 Aligned_cols=236 Identities=26% Similarity=0.353 Sum_probs=186.3
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHH-HHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVA-TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.||+|+||+||+|+.. +|+.||+|++.... ....++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999985 68999999986532 22345556655 56778999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--T 152 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--c
Confidence 9999988653 3588899999999999999999998 999999999999999999999999999875432221 1
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ....+.+...... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~------------~~~~~~i~~~~~~-~-- 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------------AEMYDNILNKPLR-L-- 215 (323)
T ss_pred cccccCChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCH------------HHHHHHHHcCCCC-C--
Confidence 2334589999999998753 678899999999999999999999864321 1112222221111 1
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMT 614 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 614 (667)
...+...+.+++.+||+.||++||++.
T Consensus 216 --~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 --KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 112245678899999999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=313.81 Aligned_cols=251 Identities=26% Similarity=0.372 Sum_probs=196.5
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEecC------CeeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDG------STRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~------~~~~lV 419 (667)
+.+.+.||+|+||.||+|... +++.||+|++........++.+|+.+++++ +|+||+++++++... ...++|
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 345678999999999999875 588999999977666667889999999999 699999999998753 457899
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 88 MEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 99999999999987533 34688999999999999999999998 999999999999999999999999999976543
Q ss_pred CCceeeecCCCCCccccchhhhhhh---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhc
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 576 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (667)
... ......|+..|+|||++... ...++.++|||||||++|||++|+.|+...... ... ....
T Consensus 164 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----------~~~--~~~~ 229 (272)
T cd06637 164 TVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----------RAL--FLIP 229 (272)
T ss_pred ccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----------HHH--HHHh
Confidence 221 12334588999999998632 235678999999999999999999998543210 000 0001
Q ss_pred CcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 577 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
...... .........+.+++.+||+.+|++|||+.|++++
T Consensus 230 ~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 230 RNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred cCCCCC---CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 100000 0111234568899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=323.25 Aligned_cols=241 Identities=23% Similarity=0.326 Sum_probs=192.8
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.||+|+||+||++++. +++.||+|+++.. ....+.+.+|++++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999886 5789999998753 23345677899999888 699999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-- 152 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--
Confidence 9999888654 2589999999999999999999988 9999999999999999999999999998753222211
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....|++.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+......
T Consensus 153 ~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~~~~------------~~~~~~i~~~~~~---- 214 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEGDDE------------DELFQSILEDEVR---- 214 (318)
T ss_pred ccceecCccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCCCCH------------HHHHHHHHcCCCC----
Confidence 1234589999999999763 678899999999999999999999864321 1111122111110
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSM-----TRVVEM 619 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~-----~evl~~ 619 (667)
....+...+.+++.+||+.||++||++ .+++++
T Consensus 215 -~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 -YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 111234567889999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=366.41 Aligned_cols=261 Identities=26% Similarity=0.440 Sum_probs=199.5
Q ss_pred CCHHHHHHHHHHhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCee
Q 005953 338 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTR 416 (667)
Q Consensus 338 ~~~~~l~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 416 (667)
++++++.+.. ...+.||+|+||.||+|+. .+++.||||++...... ..+|++.+++++|||||+++|+|.+....
T Consensus 683 ~~~~~~~~~~-~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 683 ITINDILSSL-KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hhHHHHHhhC-CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence 4445544332 2345799999999999987 47899999998754432 23568899999999999999999999999
Q ss_pred EEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 417 ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 417 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
++||||+++|+|.++++. ++|.++.+|+.|+++||+|||..+.++|+||||||+||+++.++.+++. ||.+..
T Consensus 759 ~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred EEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 999999999999999952 7899999999999999999997767799999999999999999988875 666544
Q ss_pred cCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh-
Q 005953 497 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL- 575 (667)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 575 (667)
.... ....+|+.|+|||++.. ..++.|+|||||||++|||++|+.|++..... ......|.....
T Consensus 832 ~~~~------~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~------~~~~~~~~~~~~~ 897 (968)
T PLN00113 832 LCTD------TKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFGV------HGSIVEWARYCYS 897 (968)
T ss_pred cccC------CCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccCC------CCcHHHHHHHhcC
Confidence 3221 12357899999999875 47899999999999999999999998543211 111222322111
Q ss_pred -------cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 576 -------IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 576 -------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
.++..... .........++.+++.+||+.+|++||||+||+++|++..
T Consensus 898 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 898 DCHLDMWIDPSIRGD-VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred ccchhheeCccccCC-CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 11111111 1112334557889999999999999999999999999653
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=316.51 Aligned_cols=264 Identities=24% Similarity=0.414 Sum_probs=196.2
Q ss_pred HhhhhcccCCCeEEEEEEeC-----CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEec--CCeeEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-----DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRALIY 420 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~ 420 (667)
.+.+.||+|+||+||++..+ +++.||+|.+.... ...+.+.+|++++++++||||+++++++.. ....++|+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 34578999999999999752 57899999987654 334678999999999999999999998754 34688999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 87 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 87 EYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 9999999999986542 3588999999999999999999988 9999999999999999999999999999876543
Q ss_pred Cceeee-cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCcc----ccchHHHHHhh
Q 005953 501 RSVVTM-TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE----AYFPDWIYDKL 575 (667)
Q Consensus 501 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~----~~~~~~~~~~~ 575 (667)
...... ....++..|+|||.+.+ +.++.++||||||+++|||++|..+.............. ........+.+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 322111 11224556999999865 367889999999999999999876653221110000000 00001111111
Q ss_pred cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
..... ..........+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 240 ~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGR----LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCc----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11111 011122345788999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=324.84 Aligned_cols=244 Identities=22% Similarity=0.315 Sum_probs=192.5
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.+.+.||+|+||+||+|+.. +++.||+|++.... ...+.+..|..++..+ +|++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 34678999999999999876 57899999987532 2234567788888877 589999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 83 VNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 99999998886532 488999999999999999999998 999999999999999999999999999975432221
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~------------~~~~~~i~~~~~~- 219 (323)
T cd05616 157 --TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------------DELFQSIMEHNVA- 219 (323)
T ss_pred --ccccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCCC-
Confidence 12345689999999999763 678999999999999999999999964321 1111222211110
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSM-----TRVVEM 619 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~-----~evl~~ 619 (667)
.+......+.+++.+||+.+|++|++. .+++++
T Consensus 220 ----~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 220 ----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ----CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 111235577889999999999999974 666544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=310.22 Aligned_cols=249 Identities=31% Similarity=0.534 Sum_probs=203.1
Q ss_pred hhcccCCCeEEEEEEeCC----CcEEEEEEcccCCcc--hHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTSNF--SDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~--~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.||+|+||.||+|.... +..|++|++...... .+.+.+|++.+++++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998853 788999999865433 57889999999999999999999999999999999999999
Q ss_pred CCcccccccccc------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 426 GSLGDLLSREKE------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 426 gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
++|.+++..... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999976421 25689999999999999999999997 999999999999999999999999999987765
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
...........++..|+|||.+... .++.++||||||++++||++ |+.|+..... ..+.+.+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------~~~~~~~~~~ 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------------EEVLEYLRKG 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCH------------HHHHHHHHcC
Confidence 4322223345578999999998764 67889999999999999999 5888864321 1122222222
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
... .....+...+.+++.+||+.+|++|||+.|++++|+
T Consensus 224 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 YRL----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCC----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111 111223567889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=315.91 Aligned_cols=254 Identities=27% Similarity=0.434 Sum_probs=197.9
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCc----EEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGR----LVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
.+.++||+|+||+||+|++. +++ .||+|+++... ...+++.+|+.+++.++|+||+++++++.. ...++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~ 88 (279)
T cd05109 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQ 88 (279)
T ss_pred eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEE
Confidence 34588999999999999863 444 48999987543 334678899999999999999999999875 45789999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 89 ~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 89 LMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred cCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 999999999986542 3588999999999999999999998 99999999999999999999999999998775443
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
.........++..|+|||.+.+ ..++.++||||||+++|||++ |..|+..... ..+...+.....
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------------~~~~~~~~~~~~ 229 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA------------REIPDLLEKGER 229 (279)
T ss_pred ceeecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------------HHHHHHHHCCCc
Confidence 3322233445788999999865 367889999999999999998 8888754321 001111111111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
... .......+.+++.+||+.||++||++.++++.|+.....
T Consensus 230 ~~~----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 230 LPQ----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 111 112345678899999999999999999999999865443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=321.51 Aligned_cols=240 Identities=23% Similarity=0.338 Sum_probs=188.5
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.||+|+||.||+|+.. +++.||+|+++... ...+.+..|..++... +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999885 58899999987532 2334566677777654 799999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~ 152 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--K 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--c
Confidence 9999988653 2588999999999999999999998 999999999999999999999999999976433221 1
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~~------------~~~~~~i~~~~~----- 213 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDE------------DELFDSILNDRP----- 213 (316)
T ss_pred cccccCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHcCCC-----
Confidence 2334589999999998754 678899999999999999999999864321 111112211111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMT-RVVE 618 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-evl~ 618 (667)
..+..+...+.+++.+||+.+|++||++. ++++
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 01112345677899999999999999875 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=337.21 Aligned_cols=251 Identities=27% Similarity=0.472 Sum_probs=209.2
Q ss_pred hhhcccCCCeEEEEEEe-CCC----cEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 351 KEKLGTGGYGNVYKGKF-PDG----RLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~-~~~----~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.++||+|+||+||||.| +.| -+||+|++.... ...+++++|+-+|.+++||||++|+|+|.... +.||.+||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 47899999999999987 333 479999987654 34689999999999999999999999998765 88999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
|.|+|.|+++.++. .+..+..+.|..|||+||.|||.+ .++||||.++||||.+-..+||.|||+++....+...
T Consensus 780 P~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred ccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999987543 577888999999999999999987 9999999999999999999999999999999888776
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
....+..-.+.|||=|.+.. ..++.++|||||||.+||++| |.+|++.... +.|.+.+.++..
T Consensus 855 y~~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~------------~eI~dlle~geR-- 918 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA------------EEIPDLLEKGER-- 918 (1177)
T ss_pred ccccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCH------------HHhhHHHhcccc--
Confidence 66566666889999999876 488999999999999999998 7777765432 233444444433
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
...+......++.++.+||..|++.||+++++.+.+.+...
T Consensus 919 --LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 919 --LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred --CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 22233345678889999999999999999999988875444
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=322.52 Aligned_cols=242 Identities=23% Similarity=0.312 Sum_probs=193.2
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
++||+|+||.||+|+.. +++.||+|++... ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999885 5789999998753 23345677899988876 799999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-- 152 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT-- 152 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcc--
Confidence 9999888653 3588899999999999999999998 9999999999999999999999999998754322221
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ......+......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~------------~~~~~~i~~~~~~---- 214 (321)
T cd05591 153 TTTFCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNE------------DDLFESILHDDVL---- 214 (321)
T ss_pred ccccccCccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCH------------HHHHHHHHcCCCC----
Confidence 2345689999999998753 678899999999999999999999964321 1112222221110
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRP-------SMTRVVEML 620 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RP-------t~~evl~~L 620 (667)
.+......+.+++.+||+.||++|| ++.+++++-
T Consensus 215 -~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 215 -YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 0111345678899999999999999 888888663
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=317.07 Aligned_cols=256 Identities=23% Similarity=0.401 Sum_probs=197.8
Q ss_pred HHHhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 418 (667)
.+.+.++||+|+||.||+|..+ .+..||+|.+..... ....+.+|+..+++++|+||+++++++.+....++
T Consensus 7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (288)
T cd05061 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV 86 (288)
T ss_pred HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 3455689999999999999753 245899998875442 23468899999999999999999999999999999
Q ss_pred EEEEcCCCCcccccccccc-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeC
Q 005953 419 IYEYMPNGSLGDLLSREKE-------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDF 491 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DF 491 (667)
||||+++|+|.+++..... ....++..+.+++.|++.||.|||++ +|+||||||+|||+++++.+||+||
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Df 163 (288)
T cd05061 87 VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDF 163 (288)
T ss_pred EEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcC
Confidence 9999999999999964221 23456778899999999999999988 9999999999999999999999999
Q ss_pred CCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHH
Q 005953 492 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDW 570 (667)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 570 (667)
|+++...............++..|+|||.+.. +.++.++||||||+++|||++ |+.|+..... ..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------------~~ 229 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------------EQ 229 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------------HH
Confidence 99986543322211122335778999999875 367889999999999999998 6777753221 11
Q ss_pred HHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 571 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
+...+........ .......+.+++.+||+.+|++|||+.++++.|+..
T Consensus 230 ~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 230 VLKFVMDGGYLDQ----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHHHcCCCCCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1122222111111 112245788999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=310.60 Aligned_cols=246 Identities=30% Similarity=0.489 Sum_probs=200.7
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
.+.+.||.|+||.||+|.. .++.||+|.+.......+++.+|+.++++++|+||+++++++.+....++||||+++++|
T Consensus 9 ~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 87 (256)
T cd05039 9 KLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL 87 (256)
T ss_pred cceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcH
Confidence 4568899999999999988 588999999987665567899999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++....... .
T Consensus 88 ~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~ 158 (256)
T cd05039 88 VDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----S 158 (256)
T ss_pred HHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-----c
Confidence 99986543 23589999999999999999999998 999999999999999999999999999987633221 2
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 587 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (667)
...+..|+|||.+.. +.++.++||||||+++|||++ |+.|+..... ..+...+...... ..
T Consensus 159 ~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------~~~~~~~~~~~~~----~~ 220 (256)
T cd05039 159 GKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------------KDVVPHVEKGYRM----EA 220 (256)
T ss_pred CCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH------------HHHHHHHhcCCCC----CC
Confidence 335678999999865 467889999999999999997 8888753321 1111121111111 11
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 588 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
....+..+.+++.+||+.+|++||++.|++++|+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 12235678899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=309.81 Aligned_cols=247 Identities=28% Similarity=0.451 Sum_probs=195.2
Q ss_pred hhcccCCCeEEEEEEeCC----CcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
++||+|+||.||+|++.. +..+|+|.+..... ..+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997632 26899999886654 4567999999999999999999999875 5568999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++.... .+++..+..++.|++.||+|||.. +++|+||||+|||+++++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999997543 588999999999999999999987 999999999999999999999999999987644332211
Q ss_pred -ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 506 -MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 506 -~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
.....++..|+|||.+.. +.++.++||||||+++|||++ |+.||..... ..+...+......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~------------~~~~~~~~~~~~~-- 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG------------AEVIAMLESGERL-- 217 (257)
T ss_pred cccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCH------------HHHHHHHHcCCcC--
Confidence 122234578999998865 468889999999999999998 8988854321 0011111111111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
......+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11122345788999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.40 Aligned_cols=255 Identities=24% Similarity=0.391 Sum_probs=202.9
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||.||+|... +++.||+|.++... ...+.+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (267)
T cd08224 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecC
Confidence 45688999999999999986 78999999886422 23567899999999999999999999999999999999999
Q ss_pred CCCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 424 PNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 424 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
++|+|.+++... .....+++.++..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||+++.......
T Consensus 85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 85 DAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999998642 2234588999999999999999999998 999999999999999999999999999876543321
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
. .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... ... ..+.+.......
T Consensus 162 ~--~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------~~~-~~~~~~~~~~~~ 227 (267)
T cd08224 162 A--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------LYS-LCKKIEKCDYPP 227 (267)
T ss_pred c--cceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccCCcc---------HHH-HHhhhhcCCCCC
Confidence 1 1234578899999998653 6788999999999999999999998543210 000 111111111111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
.........+.+++.+||+.+|++|||+.+|+++|+++
T Consensus 228 ---~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 ---LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11123455788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=310.68 Aligned_cols=249 Identities=25% Similarity=0.483 Sum_probs=199.9
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
.+.+.||+|+||.||+|.+.+++.+|+|.+........++.+|++++++++|||++++++++......++|+||+++++|
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 86 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL 86 (256)
T ss_pred EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcH
Confidence 35688999999999999987788999999887665567899999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.+++.... ..+++..+..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||+++........ ....
T Consensus 87 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~ 160 (256)
T cd05112 87 SDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTG 160 (256)
T ss_pred HHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCC
Confidence 99986543 2478899999999999999999988 9999999999999999999999999998765432211 1123
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 587 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (667)
..++.+|+|||.+.. +.++.++||||||+++|||++ |+.|+..... ....+.+....... .
T Consensus 161 ~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------------~~~~~~~~~~~~~~----~ 222 (256)
T cd05112 161 TKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------------SEVVETINAGFRLY----K 222 (256)
T ss_pred CccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------------HHHHHHHhCCCCCC----C
Confidence 335678999999865 367889999999999999998 8888754321 11111221111100 0
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 588 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.......+.+++.+||+.+|++||++.|++++|.
T Consensus 223 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1112457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=310.80 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=189.5
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCC-----eeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGS-----TRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-----~~~lV~e~~~~ 425 (667)
+++|.|+||.||+|+.. +++.||||+.-.+.... -+|+++|+++.|||||+|.-++.... ...|||||||.
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~ 106 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE 106 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH
Confidence 68999999999999885 47899999876554322 27999999999999999998886432 23489999974
Q ss_pred CCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC-CceEEEeCCCccccCCCCce
Q 005953 426 GSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 426 gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~-~~~ki~DFGla~~~~~~~~~ 503 (667)
+|.++++.. ..+..++...+.-+.+||.+||+|||+. +|+||||||+|+|+|.+ |.+||+|||.|+.+..+...
T Consensus 107 -tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn 182 (364)
T KOG0658|consen 107 -TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN 182 (364)
T ss_pred -HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence 788888642 2234577777788999999999999997 99999999999999987 99999999999988766654
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc--
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE-- 581 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 581 (667)
... .-|..|+|||++.+. ..++.+.||||.|||+.||+-|++-|.+.... .....+.+.+..+..+
T Consensus 183 iSY---icSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--------dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 183 ISY---ICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--------DQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eeE---EEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHH--------HHHHHHHHHhCCCCHHHH
Confidence 332 348899999999986 68999999999999999999999888653321 1111111111111100
Q ss_pred -----------------ccc-chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 582 -----------------DFV-EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 582 -----------------~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
... .-.......+.++++.++|+.+|.+|.++.|++.+
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 000 00122335678899999999999999999999854
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=310.50 Aligned_cols=246 Identities=24% Similarity=0.359 Sum_probs=200.1
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.||+|++|.||+|+.. +++.|++|.+... ....+++.+|++++++++||||+++++++.+....++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08529 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN 83 (256)
T ss_pred EeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence 4578999999999999885 6899999988643 23456789999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++.... ...+++..++.++.+++.||.|||+. +++|+||||+||++++++.+||+|||+++........
T Consensus 84 ~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-- 157 (256)
T cd08529 84 GDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-- 157 (256)
T ss_pred CcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch--
Confidence 99999997642 34688999999999999999999987 9999999999999999999999999999876543322
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....|++.|+|||++... .++.++||||||+++|||++|+.||..... ..............
T Consensus 158 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~~--- 220 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDANNQ------------GALILKIIRGVFPP--- 220 (256)
T ss_pred hhccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHcCCCCC---
Confidence 1234578999999998753 678899999999999999999999864321 11112222211111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
....+...+.+++.+||+.+|++||++.+++++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 -VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.28 Aligned_cols=256 Identities=23% Similarity=0.370 Sum_probs=202.7
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.+.+.||+|+||.||++... +++.+|||.+.... ....++.+|+.+++.++|+||+++++++.+++..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 345688999999999999864 78999999876432 2346788999999999999999999999999999999999
Q ss_pred cCCCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 423 MPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 423 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
+++++|.+++... .....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 9999999998642 2234689999999999999999999988 99999999999999999999999999987664433
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
.. .....|+..|+|||.+... .++.++||||||+++|||++|..|+...... . ......+......
T Consensus 161 ~~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---------~-~~~~~~~~~~~~~ 226 (267)
T cd08229 161 TA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---------L-YSLCKKIEQCDYP 226 (267)
T ss_pred cc--cccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcccccch---------H-HHHhhhhhcCCCC
Confidence 21 1234588999999998653 6788999999999999999999998543210 0 0011111111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
..........+.+++.+||+.+|++||||.+|++.+++.
T Consensus 227 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 ---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111123456788999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=314.81 Aligned_cols=263 Identities=25% Similarity=0.362 Sum_probs=196.9
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.||+|++|.||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.++...++|+||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (285)
T cd07861 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS- 82 (285)
T ss_pred EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence 4578999999999999885 68999999986532 234678899999999999999999999999999999999996
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++........+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++........ .
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~ 157 (285)
T cd07861 83 MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--V 157 (285)
T ss_pred CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--c
Confidence 68888887654445789999999999999999999988 999999999999999999999999999976543321 1
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCC--------CCCccccchHH----HHH
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG--------SNTTEAYFPDW----IYD 573 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~~~----~~~ 573 (667)
.....+++.|+|||.+.+. ..++.++||||||+++|||++|+.||........ .......++.+ .+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred ccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2334578999999998654 3568899999999999999999999864321000 00000000000 000
Q ss_pred hhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.................+..++.+++.+||+.||++|||+.+|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000011111245677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.10 Aligned_cols=244 Identities=22% Similarity=0.306 Sum_probs=192.2
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhccc-ceEEeecceEecCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHH-VNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.+.+.||+|+||.||+|+.. +++.||||++... ....+.+..|++++..++| ++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 35688999999999999875 4789999998753 2334668889999999975 5688999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 83 VNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 9999999988653 2578899999999999999999998 999999999999999999999999999875322211
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+......
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~------------~~~~~~i~~~~~~- 219 (324)
T cd05587 157 --TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------------DELFQSIMEHNVS- 219 (324)
T ss_pred --ceeeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCH------------HHHHHHHHcCCCC-
Confidence 12234589999999999753 678899999999999999999999864321 1111222211110
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSM-----TRVVEM 619 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~-----~evl~~ 619 (667)
....+...+.+++.+||+.||++|++. ++++++
T Consensus 220 ----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 220 ----YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111234567889999999999999976 666654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=323.96 Aligned_cols=263 Identities=25% Similarity=0.407 Sum_probs=203.5
Q ss_pred HHHHHHHHhhhhcccCCCeEEEEEEeC--------CCcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceE
Q 005953 342 DIKKMTNGFKEKLGTGGYGNVYKGKFP--------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFC 410 (667)
Q Consensus 342 ~l~~~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~ 410 (667)
++...++.+.+.||+|+||.||++... .+..||+|.++... ...+++.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 344445667789999999999999752 12368999887543 3346789999999999 799999999999
Q ss_pred ecCCeeEEEEEEcCCCCccccccccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCc
Q 005953 411 CDGSTRALIYEYMPNGSLGDLLSREK-------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQN 477 (667)
Q Consensus 411 ~~~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~N 477 (667)
.+....++++||+++|+|.+++.+.. ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 99999999999999999999986532 123578899999999999999999987 99999999999
Q ss_pred EEECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCc
Q 005953 478 VLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTET 556 (667)
Q Consensus 478 Ill~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~ 556 (667)
||+++++.+||+|||+++...............++..|+|||++.+. .++.++||||||+++|||++ |+.|+.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999866443222222233456789999998653 67889999999999999998 7777743221
Q ss_pred CCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 557 TSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
......+........ .......+.+++.+||+.+|++||++.|+++.|++...
T Consensus 243 ------------~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 ------------EELFKLLKEGHRMDK----PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ------------HHHHHHHHcCCCCCC----CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 111122211111111 11234578889999999999999999999999996654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=311.77 Aligned_cols=253 Identities=23% Similarity=0.431 Sum_probs=201.8
Q ss_pred HHHHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
..+.+.++||+|+||.||++.+.++..+|+|.+.......+.+.+|++++++++|+||+++++++.+ ...+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 3445678999999999999998778889999988665556789999999999999999999999887 778999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......... .
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~ 159 (260)
T cd05073 85 GSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-A 159 (260)
T ss_pred CcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-c
Confidence 99999997543 34578889999999999999999987 9999999999999999999999999999765433221 1
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....++..|+|||++.. +.++.++||||||++++||++ |+.||..... . .....+......
T Consensus 160 ~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----------~-~~~~~~~~~~~~--- 222 (260)
T cd05073 160 REGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----------P-EVIRALERGYRM--- 222 (260)
T ss_pred ccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCH-----------H-HHHHHHhCCCCC---
Confidence 223345678999999865 367889999999999999998 8888753321 0 011111111110
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
+........+.+++.+||+.+|++||++.++++.|+.
T Consensus 223 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112234578899999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=321.19 Aligned_cols=254 Identities=22% Similarity=0.240 Sum_probs=192.6
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||+||+++.. +++.||+|++... ....+.+.+|+.++..++|+||+++++++.++...++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY 83 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence 35688999999999999875 5899999998642 223456888999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++.+. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 84 ~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 84 VGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred CCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999999999653 23588899999999999999999998 9999999999999999999999999998765433221
Q ss_pred eeecCCCCCccccchhhhhhh---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
. .....||+.|+|||++... .+.++.++|||||||++|||++|+.||..... .+ ....+.....
T Consensus 159 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-----------~~-~~~~i~~~~~ 225 (331)
T cd05597 159 Q-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----------VE-TYGKIMNHKE 225 (331)
T ss_pred c-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-----------HH-HHHHHHcCCC
Confidence 1 1223589999999998642 23567899999999999999999999864321 01 1111111111
Q ss_pred ccccchhhHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHH
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQI--NPKDRPSMTRVVEML 620 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~--~P~~RPt~~evl~~L 620 (667)
..........+...+.+++.+|+.. ++..||++.+++++-
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 226 HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 0000111112344566677776654 444488999999884
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=309.20 Aligned_cols=247 Identities=30% Similarity=0.469 Sum_probs=196.9
Q ss_pred hhcccCCCeEEEEEEeCC--C--cEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFPD--G--RLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
++||+|++|.||+|.+.+ + ..||||.+..... ..+++.+|+..+++++||||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998743 3 3689999986543 45689999999999999999999999988 889999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++..... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999976432 4689999999999999999999988 999999999999999999999999999987654332211
Q ss_pred e-cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhc-Cccccc
Q 005953 506 M-TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLI-QPEKED 582 (667)
Q Consensus 506 ~-~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 582 (667)
. ....++..|+|||.+... .++.++||||||+++|||++ |+.|+..... .+ +...+. ......
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------~~-~~~~~~~~~~~~~ 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-----------SQ-ILKKIDKEGERLE 221 (257)
T ss_pred cccCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----------HH-HHHHHHhcCCcCC
Confidence 1 234578899999988653 67889999999999999998 9998853321 01 111111 111100
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.....+..+.+++.+||+.+|++||++.++++.|.
T Consensus 222 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 ----RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11123457888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.36 Aligned_cols=246 Identities=26% Similarity=0.427 Sum_probs=195.9
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
++||+|+||.||+|...+++.+|+|++..... ....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988889999999875432 2356889999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCC
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 509 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 509 (667)
+++.... ..+++..++.++.+++.+|.|||+. +++|+||||+||++++++.+||+|||++.......... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~ 154 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK 154 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence 9886532 3578999999999999999999987 99999999999999999999999999987543322111 1122
Q ss_pred CCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhh
Q 005953 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588 (667)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (667)
.++..|+|||++.. +.++.++||||||+++|||++ |..||..... ......+....... ..
T Consensus 155 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~------------~~~~~~~~~~~~~~----~~ 216 (250)
T cd05085 155 QIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTN------------QQAREQVEKGYRMS----CP 216 (250)
T ss_pred CCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH------------HHHHHHHHcCCCCC----CC
Confidence 34678999999865 467889999999999999998 8888754321 11111111111111 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 589 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 589 ~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
......+.+++.+||+.+|++||++.|+++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 123467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=316.50 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=196.0
Q ss_pred HHhhhhcccCCCeEEEEEEeC-----------------CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecc
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-----------------DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLG 408 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-----------------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g 408 (667)
+.+.++||+|+||.||++... ++..||+|++.... ...+++.+|+.++++++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 346688999999999998542 23468999987543 23467899999999999999999999
Q ss_pred eEecCCeeEEEEEEcCCCCcccccccccc--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE
Q 005953 409 FCCDGSTRALIYEYMPNGSLGDLLSREKE--------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 480 (667)
Q Consensus 409 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll 480 (667)
++......++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+. +++|+||||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili 163 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEE
Confidence 99999999999999999999999865321 13477889999999999999999998 99999999999999
Q ss_pred CCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh--CCCCCCCCCcCC
Q 005953 481 DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE--EKKHLRPTETTS 558 (667)
Q Consensus 481 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt--g~~p~~~~~~~~ 558 (667)
++++.+||+|||+++.+.............++..|+|||.... +.++.++||||||+++|||++ |..|+......
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 9999999999999986644332211122345678999998765 468899999999999999998 56666433210
Q ss_pred CCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 559 GSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
. ................ ...........+.+++.+||+.||++||++.||++.|+
T Consensus 241 ------~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 ------Q-VIENTGEFFRDQGRQV-YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ------H-HHHHHHHHHhhccccc-cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 0000000000000000 00111123457889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=316.58 Aligned_cols=252 Identities=26% Similarity=0.458 Sum_probs=197.0
Q ss_pred HhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
.+.+.||+|+||.||+++.. ++..||+|++.... ...+++.+|+.++++++||||+++++++.++...++|+
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (288)
T cd05050 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF 87 (288)
T ss_pred eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEE
Confidence 34578999999999999863 46789999987543 23467899999999999999999999999999999999
Q ss_pred EEcCCCCccccccccc-------------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC
Q 005953 421 EYMPNGSLGDLLSREK-------------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD 481 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~ 481 (667)
||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+||+++
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~ 164 (288)
T cd05050 88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVG 164 (288)
T ss_pred ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEec
Confidence 9999999999986421 113478889999999999999999987 999999999999999
Q ss_pred CCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCC
Q 005953 482 PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGS 560 (667)
Q Consensus 482 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~ 560 (667)
+++.+||+|||+++................+..|+|||.+.+. .++.++|||||||++|||++ |..|+.....
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~~~~p~~~~~~---- 238 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYYGMAH---- 238 (288)
T ss_pred CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 9999999999998765433221111223346789999998653 67889999999999999997 7777643221
Q ss_pred CCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 561 NTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
..+...+........ .......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 239 --------~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 --------EEVIYYVRDGNVLSC----PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred --------HHHHHHHhcCCCCCC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 111122222211111 1123457889999999999999999999999997
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=311.12 Aligned_cols=253 Identities=22% Similarity=0.312 Sum_probs=197.4
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.++||+|+||.||+|+.. +++.||+|++.... .....+.+|+.++++++||||+++++++...+..++|+||+++
T Consensus 11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~ 90 (267)
T cd06646 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG 90 (267)
T ss_pred cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence 445688999999999999974 68899999987543 3345678999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....... .
T Consensus 91 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~ 162 (267)
T cd06646 91 GSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--K 162 (267)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc--c
Confidence 9999988643 3578999999999999999999988 999999999999999999999999999986543221 1
Q ss_pred ecCCCCCccccchhhhhhh-cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....|+..|+|||.+... ...++.++||||||+++|||++|+.|+........ . ..+.........
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~------~------~~~~~~~~~~~~ 230 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------L------FLMSKSNFQPPK 230 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh------h------eeeecCCCCCCC
Confidence 1234578999999988532 23567899999999999999999998854321100 0 000000000000
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
......+...+.+++.+||+.+|++||++++++++|
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 001112345788999999999999999999999765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=308.02 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=193.3
Q ss_pred hcccCCCeEEEEEEeC---CCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 353 KLGTGGYGNVYKGKFP---DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++++++|+||+++++++. ....++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 356799999876532 3467899999999999999999999885 457899999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee-ee
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV-TM 506 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~-~~ 506 (667)
|.+++.... ..+++..+++++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++......... ..
T Consensus 81 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999986432 3589999999999999999999987 99999999999999999999999999998654433221 12
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
....++..|+|||.+.. ..++.++||||||+++|||++ |+.||..... ..+...+.......
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------------~~~~~~~~~~~~~~--- 218 (257)
T cd05115 156 SAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG------------PEVMSFIEQGKRLD--- 218 (257)
T ss_pred CCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH------------HHHHHHHHCCCCCC---
Confidence 22334678999999865 367889999999999999996 9988864321 11112222211111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
.+......+.+++.+||+.+|++||++.+|.+.|+.
T Consensus 219 -~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 219 -CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 111234577889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=328.97 Aligned_cols=253 Identities=23% Similarity=0.270 Sum_probs=199.2
Q ss_pred HHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
.+.+.++||+|+||.||+++.. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence 3455688999999999999885 58899999986432 233457889999999999999999999999999999999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 124 y~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 124 YMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred CCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999998643 377888899999999999999998 99999999999999999999999999998764332
Q ss_pred ceeeecCCCCCccccchhhhhhhc--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNL--GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
.. ......||+.|+|||++.... ..++.++|||||||++|||++|+.||..... ......+....
T Consensus 197 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------------~~~~~~i~~~~ 263 (370)
T cd05596 197 MV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------------VGTYSKIMDHK 263 (370)
T ss_pred cc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------------HHHHHHHHcCC
Confidence 21 123456899999999986531 3478899999999999999999999864321 11122222211
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKD--RPSMTRVVEML 620 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~~L 620 (667)
.... ......++..+.+++.+||+.+|++ ||++.|++++-
T Consensus 264 ~~~~-~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 264 NSLT-FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CcCC-CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 1100 0111123567788999999999987 99999998874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=323.14 Aligned_cols=240 Identities=22% Similarity=0.310 Sum_probs=189.7
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
++||+|+||.||+|++. +|+.||+|+++.. ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999886 5889999998753 22345567788888765 899999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--R 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--c
Confidence 9999988653 3578899999999999999999998 999999999999999999999999999875322221 1
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+.+.+..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~------------~~~~~~~~~~~~-~~-- 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDE------------DELFESIRVDTP-HY-- 215 (316)
T ss_pred eeccCCCcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCC-CC--
Confidence 2345689999999999764 678899999999999999999999864321 111222211111 00
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMT-RVVE 618 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-evl~ 618 (667)
...+...+.+++.+||+.||++||++. ++++
T Consensus 216 --~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 216 --PRWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred --CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 112345678899999999999999984 6653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=322.22 Aligned_cols=240 Identities=22% Similarity=0.324 Sum_probs=189.5
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.||+|+||+||+|+.. +++.||||+++.. ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999885 5789999998754 23345567788888765 899999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-- 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc--
Confidence 9999998653 3578899999999999999999998 9999999999999999999999999998754322211
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+..... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~------------~~~~~~i~~~~~-~--- 214 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDE------------EELFQSIRMDNP-C--- 214 (316)
T ss_pred eeeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCC-C---
Confidence 1234589999999998753 678999999999999999999999864321 111111111110 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMT-RVVE 618 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-evl~ 618 (667)
.+..+...+.+++.+||+.||++||++. ++++
T Consensus 215 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 215 -YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 0112345677899999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.26 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=194.1
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
..||+|+||.||+|++. +++.||+|.+.... ...+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 47999999999999875 57889999887654 34567899999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC-CCceEEEeCCCccccCCCCceeeecC
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~-~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
+++.........++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++......... ...
T Consensus 94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~--~~~ 168 (268)
T cd06624 94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--TET 168 (268)
T ss_pred HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc--ccc
Confidence 9997543222237888899999999999999987 9999999999999976 679999999998765432221 123
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (667)
..|+..|+|||++......++.++||||||+++|||++|+.|+...... . ...+........ ...+
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~-----~-----~~~~~~~~~~~~----~~~~ 234 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP-----Q-----AAMFKVGMFKIH----PEIP 234 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh-----h-----hhHhhhhhhccC----CCCC
Confidence 3578999999998654335788999999999999999999998543210 0 000000000000 1111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 589 DCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 589 ~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
......+.+++.+||+.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 2234568889999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.39 Aligned_cols=237 Identities=24% Similarity=0.338 Sum_probs=189.9
Q ss_pred hhcccCCCeEEEEEEe----CCCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 352 EKLGTGGYGNVYKGKF----PDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.||+|+||.||+++. .+|+.||+|++.... .....+.+|++++++++||||+++++++.+....++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 358899999987532 233457789999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|+|.+++.+. ..+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~- 154 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK- 154 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc-
Confidence 99999988653 3589999999999999999999998 9999999999999999999999999999765433221
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....|++.|+|||.+.+. .++.++||||||+++|||++|+.||..... ......+......
T Consensus 155 -~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~------------~~~~~~i~~~~~~--- 216 (318)
T cd05582 155 -AYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDR------------KETMTMILKAKLG--- 216 (318)
T ss_pred -eecccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCH------------HHHHHHHHcCCCC---
Confidence 1235689999999998753 668899999999999999999999864321 1111222111111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTR 615 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e 615 (667)
.+..+...+.+++.+||+.||++||++.+
T Consensus 217 --~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 --MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11123456788999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.07 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=196.2
Q ss_pred HHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
.+.+.++||+|+||.||+++.. +++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence 3455688999999999999985 58899999986421 233567899999999999999999999999999999999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 124 y~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 124 YMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred CCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 99999999998643 478889999999999999999998 99999999999999999999999999998764332
Q ss_pred ceeeecCCCCCccccchhhhhhhc--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNL--GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
. .......||+.|+|||++.+.. +.++.++|||||||++|||++|+.||..... ......+....
T Consensus 197 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------------~~~~~~i~~~~ 263 (370)
T cd05621 197 M-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------------VGTYSKIMDHK 263 (370)
T ss_pred c-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCC
Confidence 2 1223456999999999997542 2368899999999999999999999964321 01112222211
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHHH
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPK--DRPSMTRVVEML 620 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~--~RPt~~evl~~L 620 (667)
.. ........+...+.+++..|++.++. .||++.|++++-
T Consensus 264 ~~-~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 264 NS-LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred cc-cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 11 00111122355677788888875554 388999999884
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.92 Aligned_cols=245 Identities=29% Similarity=0.472 Sum_probs=194.7
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEe-cCCeeEEEEEEcCCCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCC-DGSTRALIYEYMPNGS 427 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~-~~~~~~lV~e~~~~gs 427 (667)
.+.+.||+|+||.||++.. .+..||+|.++... ..+.+.+|+.++++++|+|++++++++. +++..++|+||+++++
T Consensus 9 ~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 86 (256)
T cd05082 9 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86 (256)
T ss_pred eeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCc
Confidence 4568899999999999987 57889999987543 3567999999999999999999999764 4567899999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++...... .
T Consensus 87 L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~ 157 (256)
T cd05082 87 LVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D 157 (256)
T ss_pred HHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-----C
Confidence 999987543 33588999999999999999999988 99999999999999999999999999987653322 1
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
...++..|+|||++.. ..++.++||||||+++|||++ |+.|+..... .. +...+...... .
T Consensus 158 ~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----------~~-~~~~~~~~~~~----~ 219 (256)
T cd05082 158 TGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------KD-VVPRVEKGYKM----D 219 (256)
T ss_pred CCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----------HH-HHHHHhcCCCC----C
Confidence 2234678999999865 367889999999999999997 8888753211 11 11111111111 1
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
.....+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 112235678889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=311.58 Aligned_cols=251 Identities=25% Similarity=0.425 Sum_probs=197.9
Q ss_pred hhhhcccCCCeEEEEEEeC-CC---cEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DG---RLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~---~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
..+.||+|+||.||+|+.. ++ ..+|+|.+.... ...+++.+|++++++++|+|++++++++.+.+..++||||+
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcC
Confidence 4578999999999999875 23 379999987543 33467899999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 89 ENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 9999999986532 3588999999999999999999988 9999999999999999999999999999866433221
Q ss_pred e-eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 504 V-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 504 ~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
. .......+..|+|||++.. +.++.++||||||+++|||++ |+.|+..... ......+......
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------------~~~~~~i~~~~~~ 229 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------------HEVMKAINDGFRL 229 (268)
T ss_pred ceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------------HHHHHHHhcCCCC
Confidence 1 1122234568999999865 367889999999999999997 9999853321 1111222111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
.. .......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 230 ~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 PA----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 112345788999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.70 Aligned_cols=197 Identities=26% Similarity=0.368 Sum_probs=168.2
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.++||+|+||+||+++.. +++.||+|++.... .....+.+|+.++.+++|+||+++++.+.+....++||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 4578999999999999875 58999999987532 233567889999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce-
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV- 503 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~- 503 (667)
+|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 85 gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 85 GGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 99999999753 3588999999999999999999998 9999999999999999999999999999754321100
Q ss_pred --------------------------------eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCC
Q 005953 504 --------------------------------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHL 551 (667)
Q Consensus 504 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~ 551 (667)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHhCCCCC
Confidence 001234699999999999764 6788999999999999999999999
Q ss_pred CCC
Q 005953 552 RPT 554 (667)
Q Consensus 552 ~~~ 554 (667)
...
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.69 Aligned_cols=265 Identities=23% Similarity=0.389 Sum_probs=200.1
Q ss_pred HHHhhhhcccCCCeEEEEEEe-----CCCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecC--CeeE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKF-----PDGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRA 417 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~ 417 (667)
++...++||+|+||.||++++ .+++.||+|.++... ...+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 445568899999999999975 247889999987543 3346789999999999999999999998775 5688
Q ss_pred EEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcccc
Q 005953 418 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~ 497 (667)
+||||+++++|.+++.+.. ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 85 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 9999999999999986532 3588999999999999999999988 9999999999999999999999999999876
Q ss_pred CCCCcee-eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC----CCCCccccchHHHH
Q 005953 498 SRNRSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS----GSNTTEAYFPDWIY 572 (667)
Q Consensus 498 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~ 572 (667)
....... ......++..|+|||++.+ ..++.++||||||+++|||++++.|........ +....+... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 236 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV-TRLV 236 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH-HHHH
Confidence 5433221 1123456778999999865 367889999999999999999876543211100 000011111 1111
Q ss_pred HhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 573 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
..+....... ....+...+.+++.+||+.+|++||++.++++.|+++
T Consensus 237 ~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLP----RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCC----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111111111 1122456789999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=319.35 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=198.7
Q ss_pred HhhhhcccCCCeEEEEEEeC--------CCcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP--------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRA 417 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 417 (667)
.+.++||+|+||.||+++.. ....+|+|+++... ....++.+|+.+++++ +||||+++++++.+....+
T Consensus 15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (314)
T cd05099 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLY 94 (314)
T ss_pred eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceE
Confidence 35688999999999999752 24579999987543 2345788999999999 6999999999999999999
Q ss_pred EEEEEcCCCCccccccccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC
Q 005953 418 LIYEYMPNGSLGDLLSREK-------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF 484 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~ 484 (667)
+|+||+++|+|.+++.... ....+++..+.+++.|++.||+|||++ +++||||||+|||+++++
T Consensus 95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDN 171 (314)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCC
Confidence 9999999999999996532 123588999999999999999999987 999999999999999999
Q ss_pred ceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCc
Q 005953 485 TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTT 563 (667)
Q Consensus 485 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~ 563 (667)
.+||+|||+++...............++..|+|||.+.+ +.++.++||||||+++|||++ |+.||.....
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~------- 242 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV------- 242 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-------
Confidence 999999999986643222111122234568999999865 467889999999999999999 7877743211
Q ss_pred cccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 564 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
..+...+....... ........+.+++.+||+.+|++|||+.|+++.|++...
T Consensus 243 -----~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 243 -----EELFKLLREGHRMD----KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -----HHHHHHHHcCCCCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11122222211111 111234567789999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=316.54 Aligned_cols=198 Identities=25% Similarity=0.395 Sum_probs=161.5
Q ss_pred hhhcccCCCeEEEEEEeC---CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEec--CCeeEEEEEEcCC
Q 005953 351 KEKLGTGGYGNVYKGKFP---DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRALIYEYMPN 425 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~ 425 (667)
.++||+|+||+||+|+.. +++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...++|+||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 368999999999999864 46789999987543 24567899999999999999999998854 456789999985
Q ss_pred CCcccccccc------ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE----CCCCceEEEeCCCcc
Q 005953 426 GSLGDLLSRE------KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAK 495 (667)
Q Consensus 426 gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll----~~~~~~ki~DFGla~ 495 (667)
++|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 5887776432 1223588999999999999999999998 99999999999999 456899999999998
Q ss_pred ccCCCCce-eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 005953 496 AHSRNRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPT 554 (667)
Q Consensus 496 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~ 554 (667)
........ .......||+.|+|||++.+. ..++.++||||+||++|||++|++||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 76543221 122345689999999998754 35788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.44 Aligned_cols=248 Identities=27% Similarity=0.469 Sum_probs=192.5
Q ss_pred hhcccCCCeEEEEEEeCC-Cc--EEEEEEcccC--CcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFPD-GR--LVAVKVLEKT--SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~-~~--~vavK~l~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.||+|+||.||+|++.+ +. .+++|.++.. ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998853 43 5788888753 23446788999999999 799999999999999999999999999
Q ss_pred CCccccccccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCC
Q 005953 426 GSLGDLLSREK-------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG 492 (667)
Q Consensus 426 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFG 492 (667)
|+|.+++.... ....+++..+..++.|++.||+|||+. +++|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 123478999999999999999999987 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHH
Q 005953 493 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWI 571 (667)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 571 (667)
+++...... .......+..|+|||++.. ..++.++||||||+++|||++ |+.||..... .. .
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----------~~-~ 220 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----------AE-L 220 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----------HH-H
Confidence 986332111 1111234678999999865 367889999999999999997 8888854321 01 1
Q ss_pred HHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 572 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
...+....... ........+.+++.+||+.+|.+|||+.+++..|+++
T Consensus 221 ~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 221 YEKLPQGYRLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred HHHHhCCCCCC----CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 11121111111 1112345688999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.37 Aligned_cols=249 Identities=27% Similarity=0.458 Sum_probs=195.7
Q ss_pred hhcccCCCeEEEEEEeCC-------CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 352 EKLGTGGYGNVYKGKFPD-------GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.||+|+||.||+|+..+ ++.+|+|.+.... ....++.+|+.++++++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998742 2579999886543 3456789999999999999999999999999999999999
Q ss_pred cCCCCccccccccc----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC-----ceEEEeCCC
Q 005953 423 MPNGSLGDLLSREK----ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-----TPKVSDFGL 493 (667)
Q Consensus 423 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~-----~~ki~DFGl 493 (667)
+++|+|.+++.... ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996532 223578899999999999999999987 999999999999999887 899999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHH
Q 005953 494 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIY 572 (667)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 572 (667)
++...............++..|+|||++.+ +.++.++||||||+++|||++ |+.|+..... .. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-----------~~-~~ 223 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----------QE-VL 223 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCH-----------HH-HH
Confidence 976543322221122345789999999875 467899999999999999998 8888753221 00 11
Q ss_pred HhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 573 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
..+..... .......+..+.+++.+||+.+|++||++.++++.|+
T Consensus 224 ~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 224 QHVTAGGR----LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHhcCCc----cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11111110 0111234567889999999999999999999999987
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=331.39 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=190.9
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
+.++||+|+||.||++.+. .++.||||... ...+.+|++++++++|+|||++++++..++..++|||++ .++|
T Consensus 173 i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L 246 (461)
T PHA03211 173 IHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDL 246 (461)
T ss_pred EEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCH
Confidence 4578999999999999886 47899999633 234678999999999999999999999999999999999 5788
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.+++.... ..+++..++.|+.|+++||+|||+. +|+||||||+||||+.++.+||+|||+++.............
T Consensus 247 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 321 (461)
T PHA03211 247 YTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321 (461)
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence 88875432 3689999999999999999999998 999999999999999999999999999987643322222234
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc--------
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK-------- 580 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 580 (667)
..||..|+|||++.+. .++.++|||||||++|||++|..++........ ...+...+...+.....
T Consensus 322 ~~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~----~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 322 IAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE----RRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cCCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCcccCCcccc----cCCcHHHHHHHHHhhccccccCCCC
Confidence 5689999999999764 678999999999999999998876533221110 11111111111110000
Q ss_pred ------------------ccccc---hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 581 ------------------EDFVE---EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 581 ------------------~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
..... .........+.+++.+||+.||++|||+.|++++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 0001223467789999999999999999999976
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=319.32 Aligned_cols=253 Identities=21% Similarity=0.228 Sum_probs=193.3
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.++||+|+||+||+++.+ +++.+|+|++.+.. .....+.+|+.++..++|+||+++++++.+....++||||+
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~ 83 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY 83 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence 34578999999999999986 47889999986422 23345788999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++.+.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 84 VGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred CCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999997532 3588889999999999999999998 9999999999999999999999999999765433222
Q ss_pred eeecCCCCCccccchhhhhhh---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
......||+.|+|||++... .+.++.++|||||||++|||++|+.||..... ......+.....
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------------~~~~~~i~~~~~ 225 (332)
T cd05623 159 -QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------------VETYGKIMNHKE 225 (332)
T ss_pred -eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------------HHHHHHHhCCCc
Confidence 12334689999999998631 23578899999999999999999999864321 011122221111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPK--DRPSMTRVVEM 619 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~--~RPt~~evl~~ 619 (667)
..........+...+.+++.+|+..+++ .|+++.|++++
T Consensus 226 ~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1111111122345677778887755444 47899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.27 Aligned_cols=248 Identities=22% Similarity=0.296 Sum_probs=193.9
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.||+|+||+||+++.. +++.||+|+++... ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999875 57899999997542 2345678899999888 699999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT-- 152 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc--
Confidence 9999888643 3589999999999999999999998 9999999999999999999999999998753222111
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ......++...+......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~---- 221 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNP-----DMNTEDYLFQVILEKPIR---- 221 (327)
T ss_pred eecccCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCc-----ccccHHHHHHHHHhCCCC----
Confidence 1234589999999998753 67889999999999999999999996432211 111122333333221111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSM------TRVVEM 619 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~------~evl~~ 619 (667)
.+......+.+++.+||+.||++|+++ .+++++
T Consensus 222 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 222 -IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 111234567789999999999999984 577655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=308.78 Aligned_cols=254 Identities=22% Similarity=0.378 Sum_probs=187.1
Q ss_pred hhcccCCCeEEEEEEeCCC---cEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 352 EKLGTGGYGNVYKGKFPDG---RLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~---~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
++||+|+||+||+|...++ ..+++|.+.... ...+.+.+|+..++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976433 356677766443 34568999999999999999999999999999999999999999
Q ss_pred Ccccccccccc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 427 SLGDLLSREKE-NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 427 sL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
+|.+++.+... ....++..+..++.|+++||+|||+. +++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976432 23467777889999999999999987 999999999999999999999999999864322221111
Q ss_pred ecCCCCCccccchhhhhhhc-----CCCCCcccHHHHHHHHHHHHhC-CCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 506 MTGPRGTIGYIAPEIFMRNL-----GNPSGKSDVYSYGMLLLEMIEE-KKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~-----~~~s~k~DvwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
.....++..|+|||++.... ..++.++||||||+++|||+++ ..|+..... ......+....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------------~~~~~~~~~~~ 225 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------------REVLNHVIKDQ 225 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHhhc
Confidence 23345788999999985321 2347799999999999999975 556643221 11111111111
Q ss_pred ccc-ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 580 KED-FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 580 ~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
... ........+...+.+++..|| .+|++||++++|++.|.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 226 QVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 100 001111123456777888899 57999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.98 Aligned_cols=236 Identities=25% Similarity=0.342 Sum_probs=184.7
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHH-HHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVA-TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
++||+|+||+||+|+.. +++.||+|++.... ....++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999885 58999999986432 22345556654 57888999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... ..+.+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T 152 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence 9998888643 3578888999999999999999987 999999999999999999999999999875322221 1
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ....+.+...... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~~~~~i~~~~~~-~-- 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------------SQMYDNILHKPLQ-L-- 215 (321)
T ss_pred cccccCCcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCCH------------HHHHHHHhcCCCC-C--
Confidence 2334589999999998653 678899999999999999999999864321 1111222211110 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMT 614 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 614 (667)
.......+.+++.+||+.+|.+||++.
T Consensus 216 --~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 --PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111244678899999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.86 Aligned_cols=252 Identities=27% Similarity=0.456 Sum_probs=195.1
Q ss_pred HhhhhcccCCCeEEEEEEeCC-C--cEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFPD-G--RLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~-~--~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.+.+.||+|+||.||+|...+ + ..+++|.++... ...+.+.+|+.++.++ +||||+++++++.+....++|+||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 356789999999999998753 3 357888887432 3346789999999999 799999999999999999999999
Q ss_pred cCCCCccccccccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEE
Q 005953 423 MPNGSLGDLLSREK-------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 489 (667)
Q Consensus 423 ~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~ 489 (667)
+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEEC
Confidence 99999999986432 113588899999999999999999987 99999999999999999999999
Q ss_pred eCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccch
Q 005953 490 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFP 568 (667)
Q Consensus 490 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 568 (667)
|||++....... .......+..|+|||++... .++.++|||||||++|||++ |+.||.....
T Consensus 162 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~------------ 224 (297)
T cd05089 162 DFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC------------ 224 (297)
T ss_pred CcCCCcccccee---ccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------------
Confidence 999986432111 11122235679999988653 67889999999999999997 9888854321
Q ss_pred HHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 569 DWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
..+...+....... ....+...+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 225 ~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 225 AELYEKLPQGYRME----KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HHHHHHHhcCCCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11112222111111 11123456888999999999999999999999998554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=306.32 Aligned_cols=240 Identities=22% Similarity=0.371 Sum_probs=186.3
Q ss_pred hhcccCCCeEEEEEEeCC-------------CcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeE
Q 005953 352 EKLGTGGYGNVYKGKFPD-------------GRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 417 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 417 (667)
+.||+|+||.||+|++.+ ...|++|++.... .....|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998632 2258899876543 33457888999999999999999999999999999
Q ss_pred EEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCc-------eEEEe
Q 005953 418 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT-------PKVSD 490 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~-------~ki~D 490 (667)
+||||+++|+|..++.... ..+++..+++++.|+++||+|||+. +|+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999998886532 3588999999999999999999987 9999999999999987664 89999
Q ss_pred CCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHH-hCCCCCCCCCcCCCCCCccccchH
Q 005953 491 FGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI-EEKKHLRPTETTSGSNTTEAYFPD 569 (667)
Q Consensus 491 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~ 569 (667)
||++...... ....++..|+|||.+... ..++.++||||||+++|||+ +|+.|+...... .
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----------~ 217 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-----------E 217 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-----------H
Confidence 9998655322 223468899999988643 46788999999999999998 577766432110 0
Q ss_pred HHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 570 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.......... .... ....+.+++.+||+.||++||++.++++.|+
T Consensus 218 --~~~~~~~~~~-~~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 218 --KERFYEGQCM-LVTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred --HHHHHhcCcc-CCCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0011111110 0011 1346788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=311.94 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=197.5
Q ss_pred HHhhhhcccCCCeEEEEEEeCC-C---cEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPD-G---RLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
+.+.+.||+|+||.||+|.+.. + ..||||++.... ...++|.+|+.++++++||||+++++++.++...++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 3456889999999999998742 3 369999987542 334689999999999999999999999999999999999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 86 FMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred cCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999986542 3588999999999999999999987 99999999999999999999999999987654332
Q ss_pred ceeeecC---CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcC
Q 005953 502 SVVTMTG---PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 577 (667)
Q Consensus 502 ~~~~~~~---~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (667)
....... ...+..|+|||.+.. +.++.++||||||+++|||++ |+.||..... ..+...+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~------------~~~~~~i~~ 226 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSN------------QDVINAIEQ 226 (269)
T ss_pred cccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCH------------HHHHHHHHc
Confidence 2211111 112457999999865 467889999999999999986 8888854321 011111111
Q ss_pred cccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 578 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 578 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
.... ......+..+.+++.+||+.+|++||++.+|+..|+.+
T Consensus 227 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 DYRL----PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCcC----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 01112345678899999999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=343.74 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=197.3
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.++||+|+||.||+|++. +++.||+|++.... ...+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~ 84 (932)
T PRK13184 5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI 84 (932)
T ss_pred EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcC
Confidence 34578999999999999885 58999999987532 23467999999999999999999999999999999999999
Q ss_pred CCCCccccccccc--------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 424 PNGSLGDLLSREK--------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 424 ~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
++|+|.+++.... .....++..+++++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcce
Confidence 9999999986421 123456778899999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCce----------------eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCC
Q 005953 496 AHSRNRSV----------------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG 559 (667)
Q Consensus 496 ~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~ 559 (667)
........ .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-- 237 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKGR-- 237 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcchh--
Confidence 66211100 001124589999999998764 6789999999999999999999998643210
Q ss_pred CCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhc
Q 005953 560 SNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP-SMTRVVEMLSSA 623 (667)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~evl~~L~~~ 623 (667)
.... ...+..+... .....++..+.+++.+||+.||++|| +++++++.|+..
T Consensus 238 ----ki~~----~~~i~~P~~~----~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 238 ----KISY----RDVILSPIEV----APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred ----hhhh----hhhccChhhc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0000 0111111100 01123455678899999999999996 677787877754
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=307.52 Aligned_cols=250 Identities=27% Similarity=0.449 Sum_probs=190.7
Q ss_pred hhcccCCCeEEEEEEeC----CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEe-cCCeeEEEEEEcC
Q 005953 352 EKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCC-DGSTRALIYEYMP 424 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~-~~~~~~lV~e~~~ 424 (667)
+.||+|+||.||+|++. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++. .+...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999863 24579999986432 33567889999999999999999999876 4556889999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce-
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV- 503 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~- 503 (667)
+|+|.+++.+.. ...++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 999999997542 2467788899999999999999987 9999999999999999999999999999765432211
Q ss_pred -eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCC-CCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 504 -VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK-HLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 504 -~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
.......++..|+|||.+.. ..++.++||||||+++|||++|+. |+..... .. ....+......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----------~~-~~~~~~~~~~~ 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-----------FD-ITVYLLQGRRL 221 (262)
T ss_pred ecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-----------HH-HHHHHhcCCCC
Confidence 11123446778999999865 367889999999999999999654 4432111 01 11112111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
.. ....+..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 222 ~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 LQ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 11 1122457889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.04 Aligned_cols=264 Identities=21% Similarity=0.303 Sum_probs=195.2
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.+.++||+|+||+||+|+.. +++.||+|+++... .....+.+|+.++++++||||+++++++..++..++||||++
T Consensus 9 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 87 (309)
T cd07872 9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD- 87 (309)
T ss_pred EEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-
Confidence 34578999999999999875 57899999987543 234567899999999999999999999999999999999996
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 88 ~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 160 (309)
T cd07872 88 KDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT-- 160 (309)
T ss_pred CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCccc--
Confidence 47887775432 3478889999999999999999998 9999999999999999999999999999765433221
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCc---cccchHHHHHhhcC-----
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT---EAYFPDWIYDKLIQ----- 577 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~----- 577 (667)
.....+++.|+|||.+.+. ..++.++||||||+++|||++|+.||............ ........+..+..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred cccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1234578999999998654 46788999999999999999999998654321000000 00000000000000
Q ss_pred ----ccc-ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 578 ----PEK-EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 578 ----~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
+.. ..........+...+.+++.+||+.||++|||+.|++++--
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 000 00000011123456788999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=303.82 Aligned_cols=247 Identities=28% Similarity=0.473 Sum_probs=196.4
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
++||+|+||.||++.+.+++.||+|.+..... ....+.+|++++++++|+||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987799999999876543 3467899999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCC
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 509 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 509 (667)
+++.... ..+++..++.++.+++.||+|||+. +++||||||+||+++.++.+||+|||+++..............
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9986542 2578899999999999999999988 9999999999999999999999999999765432221111122
Q ss_pred CCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhh
Q 005953 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588 (667)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (667)
.++..|+|||.+.+ +.++.++||||||++++||++ |..|+..... ......+...... ...
T Consensus 156 ~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~------------~~~~~~~~~~~~~----~~~ 217 (251)
T cd05041 156 QIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSN------------QQTRERIESGYRM----PAP 217 (251)
T ss_pred cceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCH------------HHHHHHHhcCCCC----CCC
Confidence 34667999999865 367889999999999999999 7777743321 0011111111000 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 589 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 589 ~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
...+..+.+++.+||+.+|++|||+.||++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 223457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=317.21 Aligned_cols=266 Identities=18% Similarity=0.252 Sum_probs=194.3
Q ss_pred hhhhcccC--CCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 350 FKEKLGTG--GYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 350 ~~~~LG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
+.++||+| +||+||+++.. +|+.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999874 68999999987543 23345778999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999996532 23488999999999999999999988 9999999999999999999999999865433211110
Q ss_pred ee-----ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCC-------CCC--cc-ccc-
Q 005953 504 VT-----MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG-------SNT--TE-AYF- 567 (667)
Q Consensus 504 ~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~-------~~~--~~-~~~- 567 (667)
.. .....++..|+|||++.+....++.++|||||||++|||++|+.||........ ... .+ ...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 00 012246778999999976434678999999999999999999999964321100 000 00 000
Q ss_pred hHHHHHh---------hcCc---------ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 568 PDWIYDK---------LIQP---------EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 568 ~~~~~~~---------~~~~---------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
+...... .... ............+...+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000000 0000 00000011122345678899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=303.91 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=199.5
Q ss_pred HHhhhhcccCCCeEEEEEEeCC-CcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.+.++||+|+||.||+|+..+ ++.+++|.+..... .+++.+|++++++++|+||+++++++.+....++++||++++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 83 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG 83 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence 3456789999999999999864 78999999876544 678999999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++......... .
T Consensus 84 ~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~--~ 156 (256)
T cd06612 84 SVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--R 156 (256)
T ss_pred cHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCccc--c
Confidence 999998643 24689999999999999999999988 9999999999999999999999999999876543321 1
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
....++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... ... .... .......
T Consensus 157 ~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~----------~~~--~~~~--~~~~~~~ 220 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMR----------AIF--MIPN--KPPPTLS 220 (256)
T ss_pred ccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhh----------hhh--hhcc--CCCCCCC
Confidence 223478899999998654 67889999999999999999999986432210 000 0000 0000111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
....+...+.+++.+||+.+|++|||+.|++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 122345678889999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=311.80 Aligned_cols=264 Identities=26% Similarity=0.447 Sum_probs=202.1
Q ss_pred HHhhhhcccCCCeEEEEEEeC-----CCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEec--CCeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-----DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~l 418 (667)
+.+.+.||+|+||.||+|+++ +++.+|||++..... ..+.|.+|++.+++++|+||+++++++.. +...++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 345688999999999999864 367999999986654 36789999999999999999999999887 557899
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 999999999999997543 2589999999999999999999987 99999999999999999999999999998776
Q ss_pred CCCceeee-cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC----CCccccchHHHHH
Q 005953 499 RNRSVVTM-TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS----NTTEAYFPDWIYD 573 (667)
Q Consensus 499 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~----~~~~~~~~~~~~~ 573 (667)
........ ....++..|+|||.+... .++.++||||||+++|||++|+.|+......... ......... +.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 237 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR-LLE 237 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH-HHH
Confidence 43322211 123456679999988653 6788999999999999999999887543221100 000001111 111
Q ss_pred hhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
.+..... ..........+.+++.+||+.+|++||||.||+++|+.+
T Consensus 238 ~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGER----LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCc----CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111 111122345788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.00 Aligned_cols=248 Identities=27% Similarity=0.350 Sum_probs=195.9
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC------cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
..+.||+|++|.||++... +++.+|+|.+.... ...+.+.+|++++++++||||+++++++.+....++|+||
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 4578999999999999874 68999999886432 1235688999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++.......
T Consensus 86 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 86 MPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred CCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 9999999988653 2478889999999999999999988 999999999999999999999999999976543221
Q ss_pred eee-ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 503 VVT-MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 503 ~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
... .....++..|+|||++.+. .++.++||||||+++|||++|+.||..... ..............
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~~~~~~~~~~~ 226 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEA-----------MAAIFKIATQPTNP 226 (263)
T ss_pred ccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccch-----------HHHHHHHhccCCCC
Confidence 111 1234578899999999764 578899999999999999999999854321 01111111111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.........+.+++.+||+.+|++|||+.|++++.
T Consensus 227 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 227 ----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred ----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 11122355678899999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.75 Aligned_cols=249 Identities=23% Similarity=0.297 Sum_probs=191.3
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.++||+|+||+||+++.. +++.||||++.... ...+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 4578999999999999875 68999999986532 234568889999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce-
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV- 503 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~- 503 (667)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 85 gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 85 GGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 99999998653 3578889999999999999999998 9999999999999999999999999999643211000
Q ss_pred --------------------------------------------eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHH
Q 005953 504 --------------------------------------------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGM 539 (667)
Q Consensus 504 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGv 539 (667)
.......||+.|+|||++.+. .++.++|||||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGv 236 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceeeEecch
Confidence 000123589999999998764 6789999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCC---CCHHHH
Q 005953 540 LLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDR---PSMTRV 616 (667)
Q Consensus 540 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---Pt~~ev 616 (667)
++|||++|+.||..... ......+......... .....+...+.+++.+||+ +|.+| +++.|+
T Consensus 237 il~elltG~~Pf~~~~~------------~~~~~~i~~~~~~~~~-p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 237 IMFECLIGWPPFCSENS------------HETYRKIINWRETLYF-PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhcCCCCCCCCCH------------HHHHHHHHccCCccCC-CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 99999999999864321 0111111111000000 0011234567788888997 67765 599999
Q ss_pred HHHH
Q 005953 617 VEML 620 (667)
Q Consensus 617 l~~L 620 (667)
+.+-
T Consensus 303 l~hp 306 (377)
T cd05629 303 KSHP 306 (377)
T ss_pred hcCC
Confidence 9874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=330.39 Aligned_cols=264 Identities=22% Similarity=0.270 Sum_probs=206.0
Q ss_pred hhhhcccCCCeEEEEEEeCCC-cEEEEEEcccC-CcchHHHHHHHHHHhhcc-cceEEeecceE-ec------CCeeEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFPDG-RLVAVKVLEKT-SNFSDNFINEVATIGRIH-HVNIIHLLGFC-CD------GSTRALI 419 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~-~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~-~~------~~~~~lV 419 (667)
+.+.|.+|||+.||.|.+..+ ..+|+|++-.. +...+...+||++|++|+ |+|||.+++.. .. .-+.+|+
T Consensus 41 V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL 120 (738)
T KOG1989|consen 41 VEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL 120 (738)
T ss_pred EEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence 457899999999999998765 99999987644 445578899999999996 99999999932 21 1256799
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
||||.+|+|-|+++...... +++..+++|+.++++|+++||.. .++|||||||-+||||+.++..||||||.|.-...
T Consensus 121 mEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~ 198 (738)
T KOG1989|consen 121 MEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL 198 (738)
T ss_pred hhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence 99999999999998655443 99999999999999999999986 77899999999999999999999999999864322
Q ss_pred CC-ceeee------cCCCCCccccchhhhhhh-cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHH
Q 005953 500 NR-SVVTM------TGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI 571 (667)
Q Consensus 500 ~~-~~~~~------~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 571 (667)
.. ..... -...-|+-|+|||++.-. ...+++|+|||+|||+||-|+....||+.....
T Consensus 199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------------- 264 (738)
T KOG1989|consen 199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------------- 264 (738)
T ss_pred CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--------------
Confidence 22 11000 011258999999998532 136799999999999999999999999765321
Q ss_pred HHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccccccCCCCCC
Q 005953 572 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKP 634 (667)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~~p 634 (667)
.++.+.. .-.....+...|.+||..||+.||++||++.||++.+.++......++..+
T Consensus 265 --aIlng~Y---~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 265 --AILNGNY---SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred --eEEeccc---cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 1111111 111124578899999999999999999999999999987766555544444
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=315.28 Aligned_cols=238 Identities=22% Similarity=0.322 Sum_probs=188.9
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
++.+.||+|+||+||+++.. +++.||+|++.... ...+.+..|..++..+. |++|+++++++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 45678999999999999875 68999999987532 23456778999988885 67888899999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 83 VNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 9999999988653 3588999999999999999999998 999999999999999999999999999875433221
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~------------~~~~~~i~~~~~~- 219 (323)
T cd05615 157 --TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE------------DELFQSIMEHNVS- 219 (323)
T ss_pred --cccCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCCC-
Confidence 11234589999999998753 678899999999999999999999864321 1112222221111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSM 613 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 613 (667)
........+.+++.+||+.+|++|++.
T Consensus 220 ----~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 ----YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111234567889999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=299.70 Aligned_cols=247 Identities=23% Similarity=0.351 Sum_probs=203.6
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
+.++||+|.||+|||+.++ .|+.||||.+.... ..+++..|+.+|++...|++|+++|.+.....+++|||||..|++
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 4589999999999999885 69999999987654 367899999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.|++... ++++.++.+..+++..++||+|||.. .-||||||+.||||+.+|.+||+|||.|-.+..--. ....
T Consensus 116 SDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--KRNT 188 (502)
T KOG0574|consen 116 SDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--KRNT 188 (502)
T ss_pred HHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH--hhCc
Confidence 9999754 45799999999999999999999987 889999999999999999999999999976543221 1234
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (667)
..||+.|||||++..- .+..++||||||+...||..|++|+.+..+-. ....-+......-..+
T Consensus 189 VIGTPFWMAPEVI~EI--GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR--------------AIFMIPT~PPPTF~KP 252 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEI--GYDTKADIWSLGITAIEMAEGRPPYSDIHPMR--------------AIFMIPTKPPPTFKKP 252 (502)
T ss_pred cccCcccccHHHHHHh--ccchhhhHhhhcchhhhhhcCCCCcccccccc--------------eeEeccCCCCCCCCCh
Confidence 6799999999999864 56779999999999999999999997654310 0011111111111223
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 589 DCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 589 ~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
...+..+.+++..||-.+|++|-|+.+++++-
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 34566888999999999999999999998764
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=310.40 Aligned_cols=262 Identities=23% Similarity=0.324 Sum_probs=201.9
Q ss_pred HHHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 345 KMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 345 ~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
...+++.++||+|+||+||++... +++.||+|++.... ...+.+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 344566789999999999999875 58899999876542 335678999999999999999999999999999999999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++++|.+++... ..+++..+..++.+++.||.|||+. .+++|+||||+||++++++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 84 FMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred cCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999988653 2588999999999999999999962 279999999999999999999999999986543221
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
. ....|+..|+|||++.+ +.++.++|||||||++|||++|+.||..................+.. ........
T Consensus 159 ~----~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (284)
T cd06620 159 A----DTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ-QIVQEPPP 231 (284)
T ss_pred c----CccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH-HHhhccCC
Confidence 1 23458999999999865 37788999999999999999999999754321110000011111111 11111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.. ........+.+++.+||+.||++|||+.|++++..
T Consensus 232 ~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 232 RL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 11 11124557888999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=306.73 Aligned_cols=246 Identities=20% Similarity=0.291 Sum_probs=197.8
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.++||+|+||.||+++.. +++.+|+|.++... ...+.+.+|+.++++++|+||+++++.+.++...++||||+++|
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 83 (255)
T cd08219 4 VLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG 83 (255)
T ss_pred EEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence 4678999999999999875 68899999886432 34567889999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++.... ...+++..++.++.|++.||.|||+. +|+|+||||+||++++++.++|+|||+++........ .
T Consensus 84 ~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~ 157 (255)
T cd08219 84 DLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY--A 157 (255)
T ss_pred cHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc--c
Confidence 9999886432 34578999999999999999999998 9999999999999999999999999999766443221 1
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
....|++.|+|||++.+. ..+.++||||||+++|+|++|+.||..... ... ...+.......
T Consensus 158 ~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----------~~~-~~~~~~~~~~~---- 219 (255)
T cd08219 158 CTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSW-----------KNL-ILKVCQGSYKP---- 219 (255)
T ss_pred ccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCH-----------HHH-HHHHhcCCCCC----
Confidence 234588999999998653 678899999999999999999999864321 111 11111111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
....+...+.+++.+||+.||++||++.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=328.17 Aligned_cols=261 Identities=22% Similarity=0.324 Sum_probs=194.0
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCC-----eeEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS-----TRALIY 420 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-----~~~lV~ 420 (667)
..++||+|+||+||++... +++.||||++.... ...+++.+|+++++.++|+||+++++++.... ..++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 3578999999999999874 68999999986532 23467889999999999999999999998776 789999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||+. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 84 ELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred eccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9996 6777776442 3589999999999999999999998 9999999999999999999999999999865433
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC---------CCCCccccc--hH
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS---------GSNTTEAYF--PD 569 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~---------~~~~~~~~~--~~ 569 (667)
... ......+++.|+|||++.+. ..++.++|||||||++|||++|+.||....... +....+... ..
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 157 ESK-HMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred ccc-cCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 221 22344678999999998764 356889999999999999999999996543210 000000000 00
Q ss_pred HHHHhhcCc-cccccc---chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 570 WIYDKLIQP-EKEDFV---EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 570 ~~~~~~~~~-~~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.....+... ...... ..........+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000001000 000000 00011124567889999999999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=317.37 Aligned_cols=239 Identities=24% Similarity=0.327 Sum_probs=186.0
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHH-HHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVA-TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.||+|+||+||+++.. +++.||+|++.... ....++..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46899999999999885 57899999986532 22234455544 56778999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... ..+.+..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~ 152 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T 152 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence 9999988653 2477888889999999999999998 999999999999999999999999999975432221 1
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~~~~~i~~~~~~---- 214 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------------AEMYDNILNKPLQ---- 214 (325)
T ss_pred cccccCCccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCH------------HHHHHHHHhCCcC----
Confidence 2334689999999998763 678899999999999999999999864321 0111121111110
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVV 617 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl 617 (667)
....+...+.+++.+||+.+|.+||++.+.+
T Consensus 215 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 215 -LKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 0112345678899999999999999887433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=313.77 Aligned_cols=256 Identities=24% Similarity=0.330 Sum_probs=203.5
Q ss_pred HHHHHHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccC---CcchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEE
Q 005953 344 KKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKT---SNFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 344 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV 419 (667)
+...|...++||.||.+.||++...+.+.+|+|++... ....+-|.+|+..|.+|+ |.+||+|++|-..++.+|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 33445567899999999999999988889998876543 345678999999999995 99999999999999999999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||= ..+|..+|.+.... ...| .+..+..|++.++.++|.+ +|||.||||.|+|+-. |.+||+|||+|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 9986 67999999875432 2333 6788999999999999999 9999999999999864 6999999999999988
Q ss_pred CCceeeecCCCCCccccchhhhhhhcC---------CCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHH
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLG---------NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW 570 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~---------~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 570 (667)
+.........+||+.||+||.+..+.. ..+.++||||+|||||+|+.|+.||..... .|
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------------~~ 579 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------------QI 579 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------------HH
Confidence 887777778899999999999954322 257899999999999999999999864321 11
Q ss_pred -HHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 571 -IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 571 -~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
....+.++..+-...+-.. ...++++|..||++||.+|||..|||++=
T Consensus 580 aKl~aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhp 628 (677)
T KOG0596|consen 580 AKLHAITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQHP 628 (677)
T ss_pred HHHHhhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCc
Confidence 1223333322211111111 12388999999999999999999999653
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.47 Aligned_cols=253 Identities=27% Similarity=0.465 Sum_probs=194.9
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCc--EEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGR--LVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~--~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.+.+.||+|+||.||+|.+. ++. .+|+|.++... .....+.+|++++.++ +|+||+++++++.+++..++|+||
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 89 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence 35688999999999999874 344 46777766432 3345788999999999 899999999999999999999999
Q ss_pred cCCCCccccccccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEE
Q 005953 423 MPNGSLGDLLSREK-------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 489 (667)
Q Consensus 423 ~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~ 489 (667)
+++|+|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeC
Confidence 99999999996432 123578999999999999999999987 99999999999999999999999
Q ss_pred eCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccch
Q 005953 490 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFP 568 (667)
Q Consensus 490 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 568 (667)
|||+++...... ......++..|+|||++... .++.++||||||+++|||+| |..||.....
T Consensus 167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~------------ 229 (303)
T cd05088 167 DFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------------ 229 (303)
T ss_pred ccccCcccchhh---hcccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCCh------------
Confidence 999986432111 11122346789999988653 57889999999999999998 8888853321
Q ss_pred HHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 569 DWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
......+....... ........+.+++.+||+.+|++||++.+++..|+++..
T Consensus 230 ~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 230 AELYEKLPQGYRLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HHHHHHHhcCCcCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01111111111100 111124567889999999999999999999999985543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=312.31 Aligned_cols=247 Identities=23% Similarity=0.368 Sum_probs=197.4
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.++||+|+||.||+|+.. +++.||+|.+.... ...+.+.+|+.+++.++|+||+++++.+..+...++||||+++
T Consensus 22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~ 101 (296)
T cd06654 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (296)
T ss_pred eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence 345578999999999999864 68899999887543 3346788999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++... .+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.........
T Consensus 102 ~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 172 (296)
T cd06654 102 GSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172 (296)
T ss_pred CCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc--
Confidence 9999998542 478899999999999999999998 9999999999999999999999999998765433221
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....|++.|+|||.+.+ ...+.++|||||||++|||++|+.||...... ............ . .
T Consensus 173 ~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-----------~~~~~~~~~~~~-~--~ 236 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----------RALYLIATNGTP-E--L 236 (296)
T ss_pred cCcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-----------HhHHHHhcCCCC-C--C
Confidence 123457899999999875 36788999999999999999999998643220 000111111100 0 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.....+...+.+++.+||+.+|++||++.|++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1122345678889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=322.28 Aligned_cols=247 Identities=25% Similarity=0.367 Sum_probs=201.9
Q ss_pred hcccCCCeEEEEEEeCC-CcEEEEEEcccC-CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCccc
Q 005953 353 KLGTGGYGNVYKGKFPD-GRLVAVKVLEKT-SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGD 430 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 430 (667)
+||+|.||+||.|++.+ ...+|||-+... ....+-...||.+.++++|.|||+.+|.+.+++..-+.||-+|||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999854 567899988654 3445668899999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC-CCCceEEEeCCCccccCCCCceeeecCC
Q 005953 431 LLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSDFGLAKAHSRNRSVVTMTGP 509 (667)
Q Consensus 431 ~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~-~~~~~ki~DFGla~~~~~~~~~~~~~~~ 509 (667)
+|.....+..-++..+-.+.+||++||.|||.. .|||||||-+||||+ -.|.+||+|||-++.+..-.... ...
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T--ETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT--ETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccc--ccc
Confidence 998766555568899999999999999999998 999999999999995 57999999999998775433221 235
Q ss_pred CCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhH
Q 005953 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589 (667)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (667)
.||..|||||++......+..++|||||||.+.||.|||+||.....+ .+.+ .+-..-....+.+.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---------qAAM-----FkVGmyKvHP~iPe 802 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---------QAAM-----FKVGMYKVHPPIPE 802 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---------hHhh-----hhhcceecCCCCcH
Confidence 589999999999877778899999999999999999999999644321 0111 01011111223344
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005953 590 CIARKMIIVGLWCIQINPKDRPSMTRVVE 618 (667)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 618 (667)
.+..+...++++|+.++|.+||+++++++
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 56778888999999999999999999984
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=322.42 Aligned_cols=255 Identities=22% Similarity=0.279 Sum_probs=197.2
Q ss_pred HHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
..+.+.+.||+|+||.||+++.. +++.+|+|++.... ...+.+.+|+.+++.++||||+++++.+.++...++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 34556688999999999999886 58899999986422 23355788999999999999999999999999999999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 123 Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 123 EYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred cCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 999999999998643 378888899999999999999998 9999999999999999999999999999876533
Q ss_pred CceeeecCCCCCccccchhhhhhhc--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNL--GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
... ......||+.|+|||++.... +.++.++|||||||++|||++|+.||..... ......+...
T Consensus 196 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------------~~~~~~i~~~ 262 (371)
T cd05622 196 GMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------------VGTYSKIMNH 262 (371)
T ss_pred Ccc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------------HHHHHHHHcC
Confidence 221 123456899999999997532 2378899999999999999999999964321 0112222221
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHh
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKD--RPSMTRVVEMLS 621 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~~L~ 621 (667)
..... ......+...+.+++.+||+.++.+ ||++.|++++.-
T Consensus 263 ~~~~~-~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 263 KNSLT-FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred CCccc-CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 11100 0111234556778889999844433 789999998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=308.08 Aligned_cols=251 Identities=25% Similarity=0.445 Sum_probs=198.2
Q ss_pred HhhhhcccCCCeEEEEEEeC----CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.+.+.||+|+||.||+|++. .+..+|+|.++... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (267)
T cd05066 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY 86 (267)
T ss_pred EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 45688999999999999863 23479999987543 2346789999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 87 MENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 99999999997543 3578999999999999999999987 999999999999999999999999999987654332
Q ss_pred ee-eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 503 VV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 503 ~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
.. ......++..|+|||++... .++.++||||||+++||+++ |+.||...... .....+.+...
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~------------~~~~~~~~~~~ 227 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ------------DVIKAIEEGYR 227 (267)
T ss_pred eeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCHH------------HHHHHHhCCCc
Confidence 21 11223346789999999753 67889999999999999886 99887543210 01111111111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
. ......+..+.+++.+||+.+|++||+|.++++.|++
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 228 L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0 1111234577889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=327.66 Aligned_cols=249 Identities=23% Similarity=0.297 Sum_probs=190.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.++||+|+||+||+++.. +++.||||++.... .....+.+|++++++++|+||+++++.+.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence 34678999999999999875 58999999986532 23456889999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC--
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR-- 501 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~-- 501 (667)
++|+|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 84 PGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999996532 578888899999999999999998 99999999999999999999999999975321000
Q ss_pred ---------------------------------------ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHH
Q 005953 502 ---------------------------------------SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLL 542 (667)
Q Consensus 502 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ 542 (667)
.........||+.|+|||++.+. .++.++|||||||++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvily 235 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeeccceee
Confidence 00001234689999999999764 6788999999999999
Q ss_pred HHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 005953 543 EMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP---SMTRVVEM 619 (667)
Q Consensus 543 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP---t~~evl~~ 619 (667)
||++|+.||...... . ....+...... ........+...+.+++.+|+ .+|++|+ ++.|++.+
T Consensus 236 ell~G~~Pf~~~~~~-----------~-~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPA-----------E-TQLKVINWETT-LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHH-----------H-HHHHHhccCcc-ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999654320 0 01111110000 000001112345566777765 4999999 89999977
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=308.32 Aligned_cols=246 Identities=23% Similarity=0.341 Sum_probs=197.1
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+...+.||+|+||.||+|.+. +++.||+|.+.... ...+.+.+|++++++++||||+++++++..+...++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 445578999999999999875 57899999987443 334678899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.+++.. ..+++..+..++.|+++|++|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06642 86 GGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchh-
Confidence 9999998854 2578899999999999999999987 9999999999999999999999999999766433211
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....|+..|+|||.+.+. .++.++||||||+++|||++|+.|+...... .....+.....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------------~~~~~~~~~~~---- 218 (277)
T cd06642 158 -RNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPM------------RVLFLIPKNSP---- 218 (277)
T ss_pred -hhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchh------------hHHhhhhcCCC----
Confidence 1224578899999998754 6788999999999999999999987543210 00001111111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
..........+.+++.+||+.+|++||++.+++.+-
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 111122355688999999999999999999999854
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=311.07 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=195.9
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
..+.||+|+||+||++... +++.||+|.+.... ...+.+.+|+.++++++|+|++++++.+.+++..++||||++
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence 3478999999999999875 68899999886542 123457789999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 84 g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 157 (285)
T cd05630 84 GGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 157 (285)
T ss_pred CCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--
Confidence 999999886433 34588999999999999999999987 999999999999999999999999999976543322
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....|+..|+|||++.+ ..++.++||||||+++|||++|+.||...... . ...............
T Consensus 158 -~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~----~-----~~~~~~~~~~~~~~~-- 223 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----I-----KREEVERLVKEVQEE-- 223 (285)
T ss_pred -ccCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCcc----c-----hHHHHHhhhhhhhhh--
Confidence 123468999999999875 36788999999999999999999999653210 0 000011111110000
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~~L 620 (667)
........+.+++.+||+.||++||| ++|++++-
T Consensus 224 --~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 224 --YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred --cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 11123456788999999999999999 88988743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=317.56 Aligned_cols=253 Identities=23% Similarity=0.238 Sum_probs=193.6
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.++||+|+||+||+++.. +++.||+|++.... .....+.+|+.++..++|+||+++++++.+.+..++||||+
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~ 83 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY 83 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 35678999999999999885 58899999986532 23345788999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++.+.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 84 VGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999997532 3578889999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeecCCCCCccccchhhhhhh---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
. .....||+.|+|||++.+. .+.++.++||||||+++|||++|+.||..... ......+.....
T Consensus 159 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------------~~~~~~i~~~~~ 225 (331)
T cd05624 159 Q-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------------VETYGKIMNHEE 225 (331)
T ss_pred e-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------------HHHHHHHHcCCC
Confidence 1 1234689999999998642 13567899999999999999999999864321 011112211111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKD--RPSMTRVVEM 619 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~~ 619 (667)
..........+...+.+++.+|++.++++ |+++++++++
T Consensus 226 ~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 226 RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00011111123456777888888865544 4688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=309.91 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=200.8
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCc----EEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGR----LVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
+.+.+.||+|+||.||+|.+. +|+ .+|+|.+..... ...++.+|+..+++++|+||+++++++.. ...++|+
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence 345688999999999999874 233 689998876543 34678899999999999999999999987 7889999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.....
T Consensus 88 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 88 QLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred ecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 9999999999997643 2489999999999999999999997 9999999999999999999999999999876544
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
..........++..|+|||.+.. +.++.++||||||+++|||++ |+.|+..... ..+...+....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------------~~~~~~~~~~~ 228 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------------VEIPDLLEKGE 228 (279)
T ss_pred ccceecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------------HHHHHHHhCCC
Confidence 43333233335678999998864 467889999999999999998 9998854321 11122222221
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
...... .....+.+++.+||..+|++||++.++++.|++...+
T Consensus 229 ~~~~~~----~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 229 RLPQPP----ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 111111 1234577889999999999999999999999976443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=291.56 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=204.3
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-----c----chHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEE
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-----N----FSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~----~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV 419 (667)
++.||.|..++|-+...+ +|+..|+|++.... . ..+.-..|+.+|+++ .||+|+.+.++++.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 467999999999998764 67888988875321 1 224566899999999 599999999999999999999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
+|.|+.|.|.|+|... ..+++....+|.+|+.+|+.|||.. +||||||||+|||+|++.++||+|||+|..+.+
T Consensus 102 Fdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCC
Confidence 9999999999999764 3689999999999999999999998 999999999999999999999999999999887
Q ss_pred CCceeeecCCCCCccccchhhhhh----hcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMR----NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (667)
+... ....|||+|+|||.+.- +...++..+|+|+.||++|-|+.|.+||.... +.++-.+
T Consensus 176 GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------------QmlMLR~ 239 (411)
T KOG0599|consen 176 GEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------------QMLMLRM 239 (411)
T ss_pred chhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------------HHHHHHH
Confidence 7654 45669999999998732 22456889999999999999999999986432 1122222
Q ss_pred cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
....+-.+..++..+++....+++.+||+.||++|.|++|++++=
T Consensus 240 ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 240 IMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred HHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 222222344566677888899999999999999999999999753
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=333.01 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=188.0
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecC--------CeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDG--------STRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--------~~~~l 418 (667)
+.+.++||+|+||.||+|... +++.||||++..... ...+|+.++++++||||+++++++... ...++
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 445688999999999999875 688999998865432 345799999999999999999876432 24678
Q ss_pred EEEEcCCCCccccccc-cccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC-ceEEEeCCCccc
Q 005953 419 IYEYMPNGSLGDLLSR-EKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKA 496 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~-~~ki~DFGla~~ 496 (667)
||||++ ++|.+++.. ......+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+|+.
T Consensus 145 vmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 145 VMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 999997 567776653 22345688999999999999999999998 999999999999998664 799999999987
Q ss_pred cCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhc
Q 005953 497 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 576 (667)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (667)
....... ....||+.|+|||++.+. ..++.++|||||||++|||++|++||....... .+. .+...+.
T Consensus 221 ~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-------~~~-~i~~~~~ 288 (440)
T PTZ00036 221 LLAGQRS---VSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-------QLV-RIIQVLG 288 (440)
T ss_pred ccCCCCc---ccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-------HHH-HHHHHhC
Confidence 6543322 234579999999998654 367899999999999999999999986532210 000 0000000
Q ss_pred Cc----------c-----ccc-----ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 577 QP----------E-----KED-----FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 577 ~~----------~-----~~~-----~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.+ . ... .....+...+..+.+++.+||+.||++|||+.|++++-
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 00 0 000 00000112345788999999999999999999999654
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=302.89 Aligned_cols=240 Identities=24% Similarity=0.384 Sum_probs=188.9
Q ss_pred hhcccCCCeEEEEEEeCCCc-----------EEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 352 EKLGTGGYGNVYKGKFPDGR-----------LVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
+.||+|+||.||+|.+.+.. .|++|++.........+.+|+.++++++||||+++++++.. ...++|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999885432 57888877655446789999999999999999999999988 7789999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC-------ceEEEeCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-------TPKVSDFGL 493 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~-------~~ki~DFGl 493 (667)
||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 80 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 80 EYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999976432 588999999999999999999987 999999999999999888 799999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhC-CCCCCCCCcCCCCCCccccchHHHH
Q 005953 494 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEE-KKHLRPTETTSGSNTTEAYFPDWIY 572 (667)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~ 572 (667)
+...... ....++..|+|||++......++.++||||||+++|||++| ..|+...... ....+
T Consensus 155 a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--------~~~~~-- 218 (259)
T cd05037 155 PITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--------EKERF-- 218 (259)
T ss_pred ccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--------hHHHH--
Confidence 9765431 12336778999999875434678899999999999999995 5555433210 00000
Q ss_pred HhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 573 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
........ ... ...+.+++.+||+.+|++|||+.++++.|+
T Consensus 219 --~~~~~~~~-~~~-----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 --YQDQHRLP-MPD-----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --HhcCCCCC-CCC-----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000000 000 157888999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=306.54 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=197.5
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+++.++||+|+||.||+|... ++..+++|.+.... ...+.+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 345678999999999999886 47888999886543 3456788999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++.+.. ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~ 159 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 159 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc--c
Confidence 99998876532 3589999999999999999999998 999999999999999999999999999876533221 1
Q ss_pred ecCCCCCccccchhhhhh---hcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 506 MTGPRGTIGYIAPEIFMR---NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~---~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
.....++..|+|||++.. ....++.++|||||||++|||++|+.|+..... ..............
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------------~~~~~~~~~~~~~~ 227 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------------MRVLLKIAKSEPPT 227 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------------HHHHHHHhhcCCCC
Confidence 233458999999999852 123567899999999999999999998854321 00011111111100
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
. .....+...+.+++.+||+.+|++||++.+++++--
T Consensus 228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 228 L--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 0 111223457889999999999999999999886543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=314.97 Aligned_cols=197 Identities=25% Similarity=0.397 Sum_probs=160.5
Q ss_pred hhcccCCCeEEEEEEeC---CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEec--CCeeEEEEEEcCCC
Q 005953 352 EKLGTGGYGNVYKGKFP---DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRALIYEYMPNG 426 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~g 426 (667)
.+||+|+||+||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||++ +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence 57999999999999874 35789999887543 23567899999999999999999998854 457889999985 5
Q ss_pred Ccccccccc------ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE----CCCCceEEEeCCCccc
Q 005953 427 SLGDLLSRE------KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKA 496 (667)
Q Consensus 427 sL~~~l~~~------~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll----~~~~~~ki~DFGla~~ 496 (667)
+|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 777776421 1233588999999999999999999998 99999999999999 5668999999999987
Q ss_pred cCCCCce-eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 005953 497 HSRNRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPT 554 (667)
Q Consensus 497 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~ 554 (667)
....... .......||+.|+|||++.+. ..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 6543221 122345689999999998653 35788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.93 Aligned_cols=248 Identities=23% Similarity=0.276 Sum_probs=188.9
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.++||+|+||+||+|+.. +++.||+|++.... .....+.+|+.++++++|+||+++++.+.++...++||||++
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 4578999999999999875 68899999987532 234578899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc--
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS-- 502 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~-- 502 (667)
+|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 85 GGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 99999998654 2478888999999999999999998 999999999999999999999999999753311000
Q ss_pred -------------------------------------------eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHH
Q 005953 503 -------------------------------------------VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGM 539 (667)
Q Consensus 503 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGv 539 (667)
........||+.|+|||++.+. .++.++|||||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGv 236 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeEEechH
Confidence 0001124689999999999764 6788999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCC---HHHH
Q 005953 540 LLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS---MTRV 616 (667)
Q Consensus 540 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt---~~ev 616 (667)
++|||++|+.||..... ......+...... ........+...+.+++.+++ .+|++|++ +.|+
T Consensus 237 il~elltG~~Pf~~~~~------------~~~~~~i~~~~~~-~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTP------------LETQMKVINWQTS-LHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCH------------HHHHHHHHccCCC-cCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 99999999999964321 0011111111000 000011122345556666655 49999997 8888
Q ss_pred HHH
Q 005953 617 VEM 619 (667)
Q Consensus 617 l~~ 619 (667)
+++
T Consensus 303 ~~h 305 (382)
T cd05625 303 KAH 305 (382)
T ss_pred hcC
Confidence 765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=314.64 Aligned_cols=249 Identities=25% Similarity=0.346 Sum_probs=208.4
Q ss_pred HHHhhhhcccCCCeEEEEEEeCC-CcEEEEEEcccCCc----chHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSN----FSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~ 420 (667)
.|.+.++||+|.||.||+++.+. |+.+|+|++.+... ..+.+.+|+.+|+++. |||||.+.+.+++....++||
T Consensus 36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm 115 (382)
T KOG0032|consen 36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM 115 (382)
T ss_pred cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence 34566899999999999998864 99999999976542 3468899999999998 999999999999999999999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC----CceEEEeCCCccc
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD----FTPKVSDFGLAKA 496 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~----~~~ki~DFGla~~ 496 (667)
|++.||.|.+.+... .+++..+..++.|++.++.|||+. +|+||||||+|+|+... +.+|++|||++..
T Consensus 116 EL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 116 ELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999765 289999999999999999999997 99999999999999543 5799999999998
Q ss_pred cCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhc
Q 005953 497 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 576 (667)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (667)
..... ......||+.|+|||++... .++.++||||+||++|.|++|.+||...... .....+.
T Consensus 189 ~~~~~---~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~------------~~~~~i~ 251 (382)
T KOG0032|consen 189 IKPGE---RLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETEF------------EIFLAIL 251 (382)
T ss_pred ccCCc---eEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCChh------------HHHHHHH
Confidence 87632 34567799999999999753 7889999999999999999999999765421 1122333
Q ss_pred CcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 577 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.+.. .+..+....+...+.+++..++..||..|+|+.+++++-
T Consensus 252 ~~~~-~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 252 RGDF-DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred cCCC-CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 3322 233344455677888999999999999999999999963
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=306.45 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=194.3
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.+.+.||+|+||.||+|++. +++.||+|++.... ...+++.+|++++++++||||+++++++...+..++|+||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 35678999999999999874 68899999986542 3346788999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++.......
T Consensus 84 ~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---- 149 (279)
T cd06619 84 GSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---- 149 (279)
T ss_pred CChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----
Confidence 9986542 367888899999999999999988 99999999999999999999999999997654322
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....|+..|+|||++.+. .++.++||||||+++|||++|+.||........ .. ........+.........
T Consensus 150 ~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~- 221 (279)
T cd06619 150 AKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQG----SL-MPLQLLQCIVDEDPPVLP- 221 (279)
T ss_pred ccCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhccccc----cc-chHHHHHHHhccCCCCCC-
Confidence 1334689999999998764 678899999999999999999999865322110 00 111111111111111110
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.......+.+++.+||+.+|++||+++|++++-
T Consensus 222 --~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 222 --VGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred --CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 111345678899999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=310.55 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=195.9
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
..+.||+|+||+||+|++. +++.||+|.+.... .....+.+|++++++++|+|++++.+.+.+++..++||||++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 3478999999999999885 68899999986543 223457889999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 157 (285)
T cd05632 84 GGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-- 157 (285)
T ss_pred CccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--
Confidence 999998886543 33689999999999999999999987 999999999999999999999999999976543221
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....|+..|+|||++.+ ..++.++|+||||+++|||++|+.||...... .....+...+......
T Consensus 158 -~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~--------~~~~~~~~~~~~~~~~--- 223 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK--------VKREEVDRRVLETEEV--- 223 (285)
T ss_pred -ccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHhhhccccc---
Confidence 123458999999999865 36788999999999999999999998643210 0011111111111111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEM 619 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~~ 619 (667)
........+.+++..||+.||++||+ +.+++.+
T Consensus 224 --~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 --YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11123456788999999999999999 7777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=339.98 Aligned_cols=254 Identities=21% Similarity=0.353 Sum_probs=196.0
Q ss_pred HHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEec--CCeeEEEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRALIY 420 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~ 420 (667)
.+.+.++||+|+||+||++++. +++.||+|++.... .....+..|+.++++++|||||++++++.+ ....+|||
T Consensus 14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVM 93 (1021)
T PTZ00266 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM 93 (1021)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEE
Confidence 3456689999999999999885 57889999987532 334678999999999999999999998854 35689999
Q ss_pred EEcCCCCccccccccc-cCCCCCHHHHHHHHHHHHHHHHHHHcCCC----CCeeecCCCCCcEEECC-------------
Q 005953 421 EYMPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCE----LRILHLDIKPQNVLLDP------------- 482 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~yLH~~~~----~~ivH~Dikp~NIll~~------------- 482 (667)
||+++|+|.++|.... ....+++..++.|+.||+.||+|||+... .+||||||||+||||+.
T Consensus 94 EY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~ 173 (1021)
T PTZ00266 94 EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173 (1021)
T ss_pred eCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccc
Confidence 9999999999997532 23468999999999999999999998521 35999999999999964
Q ss_pred ----CCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC
Q 005953 483 ----DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS 558 (667)
Q Consensus 483 ----~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~ 558 (667)
...+||+|||+++....... .....||+.|+|||++......++.++||||||||||||++|+.||.....
T Consensus 174 n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~-- 248 (1021)
T PTZ00266 174 NLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN-- 248 (1021)
T ss_pred ccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc--
Confidence 23589999999987643322 133468999999999876545678999999999999999999999864321
Q ss_pred CCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 559 GSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
+.. +...+....... .......+.+|+.+||+.+|++||++.|++.+
T Consensus 249 --------~~q-li~~lk~~p~lp-----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 249 --------FSQ-LISELKRGPDLP-----IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred --------HHH-HHHHHhcCCCCC-----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 111 111221111100 11124568889999999999999999999943
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.38 Aligned_cols=239 Identities=24% Similarity=0.297 Sum_probs=186.9
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHH-HHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVA-TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.||+|+||+||+|+.. +|+.||+|++.... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999875 68999999986532 23345566665 46778999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 152 (325)
T cd05604 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--T 152 (325)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--C
Confidence 9998888643 3588999999999999999999988 999999999999999999999999999875432211 1
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+....... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~------------~~~~~~~~~~~~~~-~- 216 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------------AEMYDNILHKPLVL-R- 216 (325)
T ss_pred cccccCChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCH------------HHHHHHHHcCCccC-C-
Confidence 2334689999999998763 678899999999999999999999864321 11122222211110 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVV 617 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl 617 (667)
......+.+++.+||+.+|++||++.+.+
T Consensus 217 ---~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 217 ---PGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred ---CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 11244677899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=308.86 Aligned_cols=252 Identities=21% Similarity=0.353 Sum_probs=195.1
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEe-----cCCeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCC-----DGSTRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~-----~~~~~~lV~e~ 422 (667)
+.+.||+|+||.||+++.. +++.+|+|++........++.+|+.+++++ +|+||+++++++. .+...++||||
T Consensus 22 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 101 (286)
T cd06638 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101 (286)
T ss_pred eeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence 4578999999999999875 588999999876555556788999999999 6999999999874 34568999999
Q ss_pred cCCCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 423 MPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 423 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
+++++|.+++... .....+++..+..++.|+++||.|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 178 (286)
T cd06638 102 CNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178 (286)
T ss_pred cCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecccCC
Confidence 9999999987642 2234688899999999999999999987 99999999999999999999999999998664332
Q ss_pred ceeeecCCCCCccccchhhhhhh---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
.. .....|++.|+|||++... ...++.++|||||||++|||++|+.|+...... .. +. .....
T Consensus 179 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----------~~-~~-~~~~~ 244 (286)
T cd06638 179 LR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----------RA-LF-KIPRN 244 (286)
T ss_pred Cc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh----------HH-Hh-hcccc
Confidence 11 1234589999999998532 134688999999999999999999998643220 00 00 11111
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
..... .........+.+++.+||+.+|++|||+.|+++++
T Consensus 245 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 245 PPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00000 00111244688899999999999999999999865
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=305.26 Aligned_cols=251 Identities=25% Similarity=0.440 Sum_probs=197.3
Q ss_pred HhhhhcccCCCeEEEEEEeCC--CcEEEEEEcccCC-----------cchHHHHHHHHHHhh-cccceEEeecceEecCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFPD--GRLVAVKVLEKTS-----------NFSDNFINEVATIGR-IHHVNIIHLLGFCCDGS 414 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~~-----------~~~~~~~~Ei~~l~~-l~h~niv~l~g~~~~~~ 414 (667)
.+.+.||+|+||.||+|.+.. ++.+|+|.+.... ....++.+|+.++.+ ++||||+++++++.+++
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 345789999999999999864 6889999875321 223457789988875 69999999999999999
Q ss_pred eeEEEEEEcCCCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCC
Q 005953 415 TRALIYEYMPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 493 (667)
Q Consensus 415 ~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGl 493 (667)
..++||||+++++|.+++... .....+++..+++++.|++.||.|||+. .+++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999988542 2244689999999999999999999962 2899999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHH
Q 005953 494 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573 (667)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 573 (667)
+....... ......|+..|+|||.+.+ +.++.++||||||+++|||++|+.|+..... .. ...
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----------~~-~~~ 223 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----------LS-LAT 223 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCH-----------HH-HHH
Confidence 98765433 2234568999999999975 4678999999999999999999999854321 00 111
Q ss_pred hhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.+........ ........+.+++.+||+.||++||++.|+.++|+
T Consensus 224 ~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 224 KIVEAVYEPL---PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHhhccCCcC---CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111111110 11123457888999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.89 Aligned_cols=252 Identities=31% Similarity=0.497 Sum_probs=196.5
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchH---HHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSD---NFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~---~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
++.+.||+|+||+||+++.. +++.+|+|++........ ...+|+.++++++||||+++++++.+....++||||++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 35688999999999999986 467899999987764333 34569999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.+++.. ...+++..+..++.|+++||++||+. +++|+||||+||++++++.++|+|||.+....... .
T Consensus 82 ~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--~ 153 (260)
T PF00069_consen 82 GGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--E 153 (260)
T ss_dssp TEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--S
T ss_pred cccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--c
Confidence 9999999973 23589999999999999999999998 99999999999999999999999999997642221 2
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
......++..|+|||++... ...+.++||||+|+++|+|++|+.|+..... . ...................
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-------~-~~~~~~~~~~~~~~~~~~~ 224 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQG-KKYTRKSDIWSLGIILYELLTGKLPFEESNS-------D-DQLEIIEKILKRPLPSSSQ 224 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTT-SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-------H-HHHHHHHHHHHTHHHHHTT
T ss_pred cccccccccccccccccccc-ccccccccccccccccccccccccccccccc-------h-hhhhhhhhccccccccccc
Confidence 23456689999999998722 4778999999999999999999998864310 0 0000111111110000000
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
. .......+.+++.+||+.||++||++.+++++
T Consensus 225 ~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 Q--SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp S--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred c--cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00012678899999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.21 Aligned_cols=252 Identities=21% Similarity=0.301 Sum_probs=196.0
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.++||+|+||.||+|+.. +++.||+|+++... .....+.+|+.+++.++||||+++++.+...+..++|+||+++
T Consensus 11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 90 (267)
T cd06645 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG 90 (267)
T ss_pred HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence 446688999999999999875 58899999987553 3345678899999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++... ..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........ .
T Consensus 91 ~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~ 162 (267)
T cd06645 91 GSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--K 162 (267)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--c
Confidence 9999998643 2588999999999999999999998 999999999999999999999999999876543221 1
Q ss_pred ecCCCCCccccchhhhhh-hcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....|+..|+|||++.. ..+.++.++|||||||++|||++|+.|+...... . .+.............
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~------~-----~~~~~~~~~~~~~~~ 231 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM------R-----ALFLMTKSNFQPPKL 231 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch------h-----hHHhhhccCCCCCcc
Confidence 234468999999999742 1245788999999999999999999988543210 0 000000000000000
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.....+...+.+++.+||+.+|++||++++|+++
T Consensus 232 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 -KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0001134467889999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=290.12 Aligned_cols=248 Identities=22% Similarity=0.353 Sum_probs=202.7
Q ss_pred HHhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 348 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
+.+.++||+|.|+.||+... ++|+.+|+|++... ....++..+|+.+-+.|+|||||+|.....+....|+|+|+|
T Consensus 13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m 92 (355)
T KOG0033|consen 13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 92 (355)
T ss_pred hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence 45668899999999999865 46888999887543 345678899999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC---CCceEEEeCCCccccCCC
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~---~~~~ki~DFGla~~~~~~ 500 (667)
.|++|..-|.+. ...++..+-....||+++|.|+|.+ +|||||+||+|+||.. .--+||+|||+|..+..+
T Consensus 93 ~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 93 TGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred cchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 999996655432 2477888889999999999999998 9999999999999943 456999999999988733
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
. ...+..|||+|||||++.+. .++..+|||+-|||||-|+.|..||.+... .-+++.+.++..
T Consensus 167 ~---~~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~~~~------------~rlye~I~~g~y 229 (355)
T KOG0033|consen 167 E---AWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQ------------HRLYEQIKAGAY 229 (355)
T ss_pred c---ccccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCCccH------------HHHHHHHhcccc
Confidence 2 23677899999999999875 788899999999999999999999976432 224455554433
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
+ ........+.+...+++.+||..||.+|.|+.|.|.+
T Consensus 230 d-~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 230 D-YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred C-CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 2 1222344556678889999999999999999998854
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=305.08 Aligned_cols=252 Identities=26% Similarity=0.405 Sum_probs=196.4
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc-----------chHHHHHHHHHHhhcccceEEeecceEecCCeeEE
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN-----------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-----------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 418 (667)
.+.||+|+||.||+|... +++.||+|.++.... ..+.+.+|+.++++++|+|++++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 468999999999999864 689999998753210 12457889999999999999999999999999999
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
|+||+++++|.+++.+. ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 86 FLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred EEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 99999999999998654 3588899999999999999999987 99999999999999999999999999997654
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
............|+..|+|||.+......++.++||||||+++|||++|+.|+..... .....+.....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----------~~~~~~~~~~~ 228 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----------IAAMFKLGNKR 228 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----------HHHHHHhhccc
Confidence 3322222233458899999999876433478899999999999999999999853221 00111111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
............+...+.+++.+||+.+|++||++.+|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111111122345678889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=305.95 Aligned_cols=239 Identities=24% Similarity=0.409 Sum_probs=185.2
Q ss_pred hcccCCCeEEEEEEeCC-------------------------CcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEee
Q 005953 353 KLGTGGYGNVYKGKFPD-------------------------GRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHL 406 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l 406 (667)
.||+|+||.||+|.+.. ...|++|++.... ....+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997521 1358899886543 234578889999999999999999
Q ss_pred cceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC--
Q 005953 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-- 484 (667)
Q Consensus 407 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~-- 484 (667)
++++.+....++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999886532 3578889999999999999999987 999999999999997643
Q ss_pred -----ceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHH-hCCCCCCCCCcCC
Q 005953 485 -----TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI-EEKKHLRPTETTS 558 (667)
Q Consensus 485 -----~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ell-tg~~p~~~~~~~~ 558 (667)
.+|++|||++...... ....++..|+|||.+.+. ..++.++||||||+++|||+ +|+.|+......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~- 228 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTPS- 228 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccChH-
Confidence 4899999988644322 122467889999988654 46789999999999999995 688887543210
Q ss_pred CCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 559 GSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
. .. ..... . . .... .....+.+++.+||+.+|++|||+.++++.|+
T Consensus 229 ---~----~~-~~~~~---~-~-~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 ---E----KE-RFYEK---K-H-RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---H----HH-HHHHh---c-c-CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 00 11110 0 0 0000 11246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.18 Aligned_cols=246 Identities=21% Similarity=0.329 Sum_probs=198.4
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+...++||+|+||.||+|++. +++.||+|++.... ...+.+.+|+.++++++|+||+++++++.++...++||||++
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCC
Confidence 344578999999999999875 58899999987543 345678899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|+|.+++... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 86 ~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06640 86 GGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCccc-
Confidence 99999988542 478889999999999999999987 9999999999999999999999999999766443211
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....++..|+|||++.+. .++.++||||||+++|||++|+.|+...... .....+... ..
T Consensus 158 -~~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------------~~~~~~~~~----~~ 218 (277)
T cd06640 158 -RNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPM------------RVLFLIPKN----NP 218 (277)
T ss_pred -cccccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcChH------------hHhhhhhcC----CC
Confidence 1234578899999998653 6788999999999999999999998643221 000011111 11
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
..........+.+++.+||+.+|++||++.+++.+-
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 122233566788999999999999999999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=307.51 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=198.7
Q ss_pred HHHHhhhhcccCCCeEEEEEEeCC----CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEE
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 419 (667)
..+.+.++||+|+||.||+|.+.+ ...||||...... ...+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 334466899999999999998643 3468999887543 334679999999999999999999998875 457899
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||+++|+|.+++.... ..+++..++.++.+++.||+|||+. +++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999996543 2589999999999999999999987 999999999999999999999999999987654
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
..... .....++..|+|||.+.. ..++.++||||||+++|||++ |+.||...... . ....+...
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----------~-~~~~~~~~ 224 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-----------D-VIGRIENG 224 (270)
T ss_pred cccee-cCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-----------H-HHHHHHcC
Confidence 42221 123335678999998865 367889999999999999996 99988643220 0 01111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
..... ....+..+.+++.+||..+|++|||+.++++.|+++..
T Consensus 225 ~~~~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 225 ERLPM----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CcCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11111 11234578889999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=304.48 Aligned_cols=247 Identities=28% Similarity=0.451 Sum_probs=194.7
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC-------cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
..+.||+|+||+||+|...+++.+|+|.+.... .....+.+|++++++++|+||+++++++.+....++|+||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 457899999999999998889999999886432 1224688899999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++++|.+++.+.. .+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 84 VPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999996532 478899999999999999999987 999999999999999999999999999876532111
Q ss_pred ----eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 503 ----VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 503 ----~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
........|+..|+|||++.+. .++.++||||||+++|||++|+.||...... ... . .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----------~~~-~-~~~~~ 223 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDRL----------AAM-F-YIGAH 223 (265)
T ss_pred cccccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCChH----------HHH-H-Hhhhc
Confidence 1111234588999999998753 6788999999999999999999998643210 000 0 00000
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 618 (667)
..........+...+.+++.+||+.+|++||++.|++.
T Consensus 224 --~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 --RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00011112234567888999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.53 Aligned_cols=241 Identities=26% Similarity=0.322 Sum_probs=187.6
Q ss_pred cccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhc---ccceEEeecceEecCCeeEEEEEEcCC
Q 005953 354 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI---HHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 354 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
||+|+||+||+|+.. +++.||||++.... .....+..|..++.+. +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 58999999986432 2233456677777665 699999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... ..+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-- 152 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-- 152 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--
Confidence 9999888653 3588999999999999999999998 9999999999999999999999999998754332211
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|+|||++.+. ..++.++|||||||++|||++|+.||..... ......+...... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~------------~~~~~~i~~~~~~-~~- 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------------QQMYRNIAFGKVR-FP- 217 (330)
T ss_pred ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCH------------HHHHHHHHcCCCC-CC-
Confidence 2334689999999998653 3568899999999999999999999864321 1112222211111 00
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRP----SMTRVVEM 619 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RP----t~~evl~~ 619 (667)
...+...+.+++.+||+.||++|| ++.+++++
T Consensus 218 --~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 --KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred --CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 112345677899999999999998 57777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.38 Aligned_cols=244 Identities=23% Similarity=0.372 Sum_probs=201.8
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEc-----ccCCcchHHHHHHHHHHhhcccceEEeecceEecCCe--eEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVL-----EKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGST--RALIYE 421 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l-----~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~--~~lV~e 421 (667)
|.++||+|+|-+||||.+. +|..||--.+ .......+.|..|+.+|+.|+|+||++++.++.+... ..+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 5578999999999999885 4777773322 2233445889999999999999999999999987655 778999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC-CceEEEeCCCccccCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~-~~~ki~DFGla~~~~~~ 500 (667)
.|..|+|..|+.+.+ .++...+.+|++||++||.|||++ .++|||||||-+||+|+.+ |.|||+|.|||......
T Consensus 124 L~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999997654 488889999999999999999997 8899999999999999765 89999999999987655
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
.. ....|||.|||||++.. .|.+.+||||||+.++||+|+..|+..-. -+.-|+.++..+.+
T Consensus 200 ~a----ksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----------n~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 200 HA----KSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECT-----------NPAQIYKKVTSGIK 261 (632)
T ss_pred cc----ceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhC-----------CHHHHHHHHHcCCC
Confidence 43 33679999999999873 78899999999999999999999986432 24567888887776
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
........ -.++.+++.+||.. .++|||+.|+|..
T Consensus 262 P~sl~kV~---dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 262 PAALSKVK---DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHhhccC---CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 54332222 23567789999999 9999999999954
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=312.50 Aligned_cols=253 Identities=27% Similarity=0.462 Sum_probs=195.2
Q ss_pred hhhhcccCCCeEEEEEEeC-CCc----EEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGR----LVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
..+.||+|+||.||+|.+. +++ .||+|.+..... ...++.+|+.++++++||||+++++++... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 3478999999999999863 343 578898875432 234688999999999999999999998754 56799999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.......
T Consensus 90 ~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 90 MPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred cCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccc
Confidence 99999999986542 3578899999999999999999988 999999999999999999999999999987654333
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
........++..|+|||.+.. ..++.++||||||+++|||++ |+.|+..... .....++ ......
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--------~~~~~~~----~~~~~~ 230 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--------REIPDLL----EKGERL 230 (303)
T ss_pred ccccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH----HCCCCC
Confidence 222233446789999999865 367889999999999999997 8888753211 0011111 111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
.. .......+.+++..||..+|++||++.++++.|+++..+
T Consensus 231 ~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 PQ----PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 10 111234678899999999999999999999999865433
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=320.94 Aligned_cols=259 Identities=23% Similarity=0.297 Sum_probs=189.6
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecCC------eeEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGS------TRAL 418 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------~~~l 418 (667)
.+.+.||+|+||.||+++.. +|+.||+|++... ......+.+|+.+++.++||||+++++++.... ..++
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 103 (359)
T cd07876 24 QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL 103 (359)
T ss_pred EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEE
Confidence 34578999999999999875 5899999998653 233467889999999999999999999886543 5799
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 104 v~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 104 VMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred EEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 9999964 56555532 377888999999999999999998 99999999999999999999999999997643
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCC--------CCCcccc---c
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG--------SNTTEAY---F 567 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~--------~~~~~~~---~ 567 (667)
.... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||........ ....... .
T Consensus 175 ~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 175 TNFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred cCcc---CCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 3221 2334689999999999753 678899999999999999999999975421000 0000000 0
Q ss_pred hHHHHHhhc-Cccccc-------------ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 568 PDWIYDKLI-QPEKED-------------FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 568 ~~~~~~~~~-~~~~~~-------------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
...+..... .+.... ............+.+++.+||+.||++|||+.|++++-.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 000000000 000000 000011112356788999999999999999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=311.92 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=195.3
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.+.++||+|+||.||+|+.. +++.||+|.++... .....+.+|+.++++++||||+++++++.+....++|+||++
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~- 87 (301)
T cd07873 9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 87 (301)
T ss_pred EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-
Confidence 45578999999999999875 58899999986442 334567899999999999999999999999999999999996
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++.... ..+++..+..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||+++........
T Consensus 88 ~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-- 160 (301)
T cd07873 88 KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-- 160 (301)
T ss_pred cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--
Confidence 68888886532 3578899999999999999999998 9999999999999999999999999999765432211
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC--------CCccccchHHHHHhhc-
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEAYFPDWIYDKLI- 576 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~- 576 (667)
.....+++.|+|||.+.+. ..++.++||||||+++|||++|+.||......... ......++.+......
T Consensus 161 ~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred ccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 1234568999999998654 35788999999999999999999998643220000 0000000000000000
Q ss_pred Cccccccc----chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 577 QPEKEDFV----EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 577 ~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
........ ......+...+.+++.+||+.||.+|||++|++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00000000 001112345678899999999999999999999743
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=323.04 Aligned_cols=261 Identities=21% Similarity=0.252 Sum_probs=194.2
Q ss_pred HHHhhhhcccCCCeEEEEEEeC---CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP---DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.++||+|+||.||++... .++.||+|.+... +.+.+|++++++++||||+++++++......++|||++
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 168 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY 168 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence 4556789999999999999753 3578999988653 24568999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
. ++|.+++.. ...+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 169 ~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 169 K-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 4 688888733 24689999999999999999999998 9999999999999999999999999999766543332
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCc----------cccchH----
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT----------EAYFPD---- 569 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~----------~~~~~~---- 569 (667)
.......||+.|+|||++... .++.++|||||||++|||++|+.||............ ...++.
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 223345689999999998753 6788999999999999999999998654321000000 000000
Q ss_pred ---HHHHhhcCccccccc-chh--hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 570 ---WIYDKLIQPEKEDFV-EEE--DDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 570 ---~~~~~~~~~~~~~~~-~~~--~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.....+......... ... .......+.+++.+||+.||++|||+.|++.+=
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 000000000000000 000 011234677889999999999999999999764
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=306.43 Aligned_cols=251 Identities=27% Similarity=0.374 Sum_probs=195.2
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEec------CCeeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCD------GSTRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~------~~~~~lV 419 (667)
+.+.++||+|+||+||+|++. +++.+|+|++........++..|+.+++++ +|+||+++++++.. ....+++
T Consensus 18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 97 (282)
T cd06636 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLV 97 (282)
T ss_pred hhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEE
Confidence 345578999999999999884 588999999877655567788999999999 69999999998853 4578999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++.....
T Consensus 98 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 98 MEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 99999999999986543 34578888999999999999999998 999999999999999999999999999876532
Q ss_pred CCceeeecCCCCCccccchhhhhhh---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhc
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 576 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (667)
... ......|+..|+|||.+... ...++.++||||||+++|||++|+.||...... ... ..+.
T Consensus 174 ~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~------~~~------~~~~ 239 (282)
T cd06636 174 TVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM------RAL------FLIP 239 (282)
T ss_pred ccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH------hhh------hhHh
Confidence 211 11234588999999998531 235678999999999999999999998543210 000 0011
Q ss_pred CcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 577 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
...... .....+...+.+++.+||+.||++||++.|++++
T Consensus 240 ~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 240 RNPPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hCCCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 110100 1112245678899999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=316.66 Aligned_cols=241 Identities=27% Similarity=0.394 Sum_probs=195.8
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.||.|+||.||-|++. +.+.||||++.-+. ..-.+++.|+..|.+++|||++.+-|++......+|||||| -|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence 57999999999999874 68899999986443 22357999999999999999999999999999999999999 67
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
|-.|++.-. .+++.+..+..|..+.+.||+|||++ +.||||||+.||||++.|.|||+|||.|....+..
T Consensus 111 SAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn----- 180 (948)
T KOG0577|consen 111 SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN----- 180 (948)
T ss_pred cHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh-----
Confidence 888888543 24688899999999999999999998 99999999999999999999999999998766543
Q ss_pred cCCCCCccccchhhhhh-hcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 507 TGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.++|||.|||||++.. ..|.|+.|+||||||+...||.-.++|+-.... ... .-.+.+.......
T Consensus 181 -sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-----------MSA-LYHIAQNesPtLq- 246 (948)
T KOG0577|consen 181 -SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSA-LYHIAQNESPTLQ- 246 (948)
T ss_pred -cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-----------HHH-HHHHHhcCCCCCC-
Confidence 3569999999999853 347899999999999999999999988754322 000 1111122111111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
....+..+..++-.||+.-|.+|||.++++.+
T Consensus 247 --s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 --SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred --CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 23345677888899999999999999998865
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=301.95 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=200.4
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.+.||+|+||.||.++.. +++.+++|.+... ....+++.+|++++++++|+||+++++++.+....+++|||++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 45688999999999999874 5889999987643 2345678899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|+|.+++.+.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++.......
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-- 156 (256)
T cd08221 83 GGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-- 156 (256)
T ss_pred CCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc--
Confidence 999999997643 34688999999999999999999987 999999999999999999999999999987644332
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
......+++.|+|||.+.+. ..+.++||||||+++|||++|+.|+..... ......+..+....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------------~~~~~~~~~~~~~~-- 220 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNP------------LNLVVKIVQGNYTP-- 220 (256)
T ss_pred cccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHcCCCCC--
Confidence 12334589999999998754 578899999999999999999998854321 11111222211111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
........+.+++.+||+.+|++||++.++++++
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1123456788899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.70 Aligned_cols=247 Identities=24% Similarity=0.356 Sum_probs=199.1
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.+.||.|++|.||+|+.. +++.||+|++.... .....+.+|++++++++|+||+++++++.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 345688999999999999875 58899999987543 334678899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++.......
T Consensus 83 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 153 (274)
T cd06609 83 GGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-- 153 (274)
T ss_pred CCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc--
Confidence 99999998653 588999999999999999999987 999999999999999999999999999987754321
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
......+++.|+|||++.+. .++.++||||||+++|||++|+.|+...... .....+.........
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------------~~~~~~~~~~~~~~~ 219 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHPM------------RVLFLIPKNNPPSLE 219 (274)
T ss_pred ccccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCchH------------HHHHHhhhcCCCCCc
Confidence 12334578899999999764 5889999999999999999999998643210 011111111111111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
. ..+...+.+++.+||+.+|++|||+++++++-
T Consensus 220 ~---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 220 G---NKFSKPFKDFVSLCLNKDPKERPSAKELLKHK 252 (274)
T ss_pred c---cccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence 0 11355688899999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=311.51 Aligned_cols=258 Identities=21% Similarity=0.298 Sum_probs=195.8
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.++||+|+||.||++++. ++..+|+|.+.... ....++.+|++++++++||||+++++++.+++..++|+||++++
T Consensus 5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~ 84 (308)
T cd06615 5 KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 84 (308)
T ss_pred EEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence 4578999999999999875 57889999886542 23456889999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++... ..+++..+..++.|+++||+|||+. .+++|+||||+|||+++++.+||+|||++....... .
T Consensus 85 ~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~ 155 (308)
T cd06615 85 SLDQVLKKA---GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----A 155 (308)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc----c
Confidence 999999654 3578899999999999999999972 289999999999999999999999999987653321 1
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCcccc---ch---------------
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAY---FP--------------- 568 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~---~~--------------- 568 (667)
....|+..|+|||.+.+. .++.++||||||+++|||++|+.|+............... ..
T Consensus 156 ~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 156 NSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 234578999999998653 6788999999999999999999998533211000000000 00
Q ss_pred ------HHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 569 ------DWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 569 ------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
....+.+...... ......+...+.+++.+||+.+|++|||+.||+++.-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPP---KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred cchhhHHHHHHHHhcCCCc---cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0000000000000 0001123456889999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=319.29 Aligned_cols=259 Identities=23% Similarity=0.280 Sum_probs=189.8
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecC------CeeE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRA 417 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~~ 417 (667)
+.+.+.||+|+||.||++... .++.||||++... ....+.+.+|+.+++.++||||+++++++... ...+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence 345578999999999999875 5889999998753 23346788999999999999999999987543 3579
Q ss_pred EEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcccc
Q 005953 418 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~ 497 (667)
+||||++ ++|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 106 lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 106 IVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred EEEeCCC-CCHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 9999996 467666632 378889999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC----CCccccchHH---
Q 005953 498 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS----NTTEAYFPDW--- 570 (667)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~----~~~~~~~~~~--- 570 (667)
..... .....||..|+|||++.+. .++.++|||||||++|||++|+.||......... .......+.+
T Consensus 177 ~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 177 GTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred CCCCc---ccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 43221 2345689999999999763 6788999999999999999999999643221000 0000000000
Q ss_pred ----HHHhhc-Cccccc-------------ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 571 ----IYDKLI-QPEKED-------------FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 571 ----~~~~~~-~~~~~~-------------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
+..... .+.... ............+.+++.+||+.||++|||+.|++++-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 000000 000000 00000111234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=308.36 Aligned_cols=261 Identities=26% Similarity=0.400 Sum_probs=189.3
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhc---ccceEEeecceEec-----CCee
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRI---HHVNIIHLLGFCCD-----GSTR 416 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~-----~~~~ 416 (667)
.+.+.||+|+||+||+|+.. +++.||+|.++... .....+.+|+.+++++ +||||+++++++.. ....
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~ 82 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82 (288)
T ss_pred eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence 34578999999999999875 68999999987532 2234566787777766 69999999998864 2457
Q ss_pred EEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 417 ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 417 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
++|+||++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 83 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 83 TLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 89999997 58888886543 23589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCc-----cccchHHH
Q 005953 497 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT-----EAYFPDWI 571 (667)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~-----~~~~~~~~ 571 (667)
...... .....|+..|+|||++.+. .++.++|||||||++|||++|++||............ ......|.
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 158 YSCQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred ccCccc---CCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 643322 1334578999999998753 6789999999999999999999998543211000000 00000000
Q ss_pred HHh-h----cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 572 YDK-L----IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 572 ~~~-~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
... . ...............+...+.+++.+||+.||++|||+.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 0 00000000011112345567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.28 Aligned_cols=247 Identities=23% Similarity=0.365 Sum_probs=196.9
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.++||+|+||.||+|+.. +++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++..+...++||||+++
T Consensus 21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (297)
T cd06656 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100 (297)
T ss_pred ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCC
Confidence 345688999999999999874 68999999987543 3346688999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 101 ~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-- 171 (297)
T cd06656 101 GSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171 (297)
T ss_pred CCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC--
Confidence 9999988542 478889999999999999999988 9999999999999999999999999999765443221
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ..+. ...... ...
T Consensus 172 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~------~~~~------~~~~~~--~~~ 235 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYL------IATNGT--PEL 235 (297)
T ss_pred cCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch------heee------eccCCC--CCC
Confidence 123457889999999875 367889999999999999999999996533210 0000 000000 000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.....+...+.+++.+||+.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122334567889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=301.11 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=201.7
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.+.+.||.|+||+||+|... ++..+|+|++.... ...+.+.+|++.++.++|+|++++++.+...+..++|+|++++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG 83 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence 45678999999999999874 68899999986543 3457789999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee-
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV- 504 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~- 504 (667)
++|.+++........+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++..........
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 84 GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred CcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 99999997643334689999999999999999999988 99999999999999999999999999997665433221
Q ss_pred -eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 505 -TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 505 -~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
......|+..|+|||.+... ...+.++||||||+++|||++|+.|+...... .. ............
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~~-----~~~~~~~~~~~~ 227 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPM-------KV-----LMLTLQNDPPSL 227 (267)
T ss_pred cccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChh-------hh-----HHHHhcCCCCCc
Confidence 11233578999999998754 36788999999999999999999998643221 00 111111111111
Q ss_pred cc-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 584 VE-EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 584 ~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.. .....+...+.+++.+||+.||++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 10 1112345678899999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.74 Aligned_cols=240 Identities=24% Similarity=0.378 Sum_probs=186.7
Q ss_pred hhcccCCCeEEEEEEeCC--------CcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 352 EKLGTGGYGNVYKGKFPD--------GRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.||+|+||+||+|.... ...||+|.+.... ...+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997642 2348888876543 3346788999999999999999999999998999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCc--------eEEEeCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT--------PKVSDFGLA 494 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~--------~ki~DFGla 494 (667)
+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999997543 2578999999999999999999988 9999999999999987765 699999998
Q ss_pred cccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCC-CCCCCCCcCCCCCCccccchHHHHH
Q 005953 495 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK-KHLRPTETTSGSNTTEAYFPDWIYD 573 (667)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 573 (667)
...... ....++..|+|||++.+. ..++.++||||||+++|||++|. .|+..... . .. .
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~----------~-~~-~- 215 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDS----------Q-KK-L- 215 (258)
T ss_pred cccCCc------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccH----------H-HH-H-
Confidence 655332 123468899999998753 35688999999999999999995 44432211 0 00 0
Q ss_pred hhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
...... .... .....++.+++.+||+.+|++|||++++++.|+
T Consensus 216 ~~~~~~-~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 216 QFYEDR-HQLP----APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHcc-ccCC----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000000 0000 112346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.28 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=199.1
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+++.+.||+|+||.||++++. +++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..++|+||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 456789999999999999986 68999999886532 234678999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|..++........+++..+..++.+++.||.|||+. .+|+|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 158 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA-- 158 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc--
Confidence 999999887643334689999999999999999999962 2899999999999999999999999999876533221
Q ss_pred eecCCCCCccccchhhhhhhc----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNL----GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~----~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
....++..|+|||.+.+.. ..++.++|||||||++|||++|+.||...... ..+ .....+.....
T Consensus 159 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~--~~~~~~~~~~~ 227 (286)
T cd06622 159 --KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-------NIF--AQLSAIVDGDP 227 (286)
T ss_pred --ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-------hHH--HHHHHHhhcCC
Confidence 2345788999999985431 23578999999999999999999998543210 000 01111111111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
. .....+...+.+++.+||+.+|++||++.+++.+-
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 228 P----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred C----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 1 11222456788899999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.02 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=195.5
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEec-CCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD-GSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~lV~e~~ 423 (667)
.+.+.||+|++|.||+++.. +++.||+|.+.... ...+.+.+|++++++++|+|++++++.+.. ....++||||+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence 45688999999999999875 57899999986532 334578899999999999999999988764 44678999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++++|.+++.... ...+++.++..++.+++.|++|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 83 EGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 9999999987533 34589999999999999999999988 9999999999999999999999999999866433221
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
.....+++.|+|||++.+. .++.++||||||++++||++|+.|+..... ..... .+......
T Consensus 159 --~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----------~~~~~-~~~~~~~~-- 220 (257)
T cd08223 159 --ASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDM-----------NSLVY-RIIEGKLP-- 220 (257)
T ss_pred --cccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----------HHHHH-HHHhcCCC--
Confidence 1234578999999998763 678899999999999999999998853321 11111 11111111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.........+.+++.+||+.+|++||++.+++++
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=305.62 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=196.9
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+++.++||+|+||.||+|+.. +++.|++|++.... ...+.+.+|+.++++++|+||+++++.+..++..++||||+++
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG 93 (292)
T ss_pred hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence 456688999999999999885 48899999987654 3456788999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|..++.+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 94 ~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--~ 166 (292)
T cd06644 94 GAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ--R 166 (292)
T ss_pred CcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc--c
Confidence 99988875432 3588999999999999999999987 999999999999999999999999999875432211 1
Q ss_pred ecCCCCCccccchhhhhhh---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
.....++..|+|||++... ...++.++|||||||++|||++|+.|+..... ..............
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------------~~~~~~~~~~~~~~ 234 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------------MRVLLKIAKSEPPT 234 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------------HHHHHHHhcCCCcc
Confidence 1234578899999998532 13467899999999999999999998854321 01111111111111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
. .....+...+.+++.+||+.+|++||++.|++++
T Consensus 235 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 235 L--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred C--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 1112234567889999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=303.93 Aligned_cols=251 Identities=21% Similarity=0.361 Sum_probs=198.8
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.++||+|+||.||+|++. +++.+|+|++.... ...+.+.+|++++++++|+||+++++.+.++...++||||+++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 456788999999999999885 58899999987543 3446789999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++.........
T Consensus 87 ~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-- 159 (280)
T cd06611 87 GALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK-- 159 (280)
T ss_pred CcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccc--
Confidence 99999986532 3588999999999999999999998 9999999999999999999999999998765432221
Q ss_pred ecCCCCCccccchhhhhhh---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
.....+++.|+|||.+... ...++.++||||||+++|||++|+.|+...... . ....+.......
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----------~-~~~~~~~~~~~~ 227 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----------R-VLLKILKSEPPT 227 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----------H-HHHHHhcCCCCC
Confidence 1234578999999998532 134677999999999999999999998643210 0 111111111111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
. .....+...+.+++.+||+.+|++||++.+++++
T Consensus 228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 228 L--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred c--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 1112234567889999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=301.47 Aligned_cols=244 Identities=29% Similarity=0.480 Sum_probs=194.4
Q ss_pred HHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
+.+.+.||+|+||.||+++. +++.||+|.++... ..+.+.+|+.++++++|||++++++++... ..++||||+++|+
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~ 84 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN 84 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence 34568899999999999986 67889999986543 346789999999999999999999998654 5799999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...... .
T Consensus 85 L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~ 155 (254)
T cd05083 85 LVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----D 155 (254)
T ss_pred HHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-----C
Confidence 999997543 34588999999999999999999987 99999999999999999999999999987543221 2
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
....+..|+|||.+.. +.++.++||||||+++|||++ |+.||..... ......+...... .
T Consensus 156 ~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------------~~~~~~~~~~~~~----~ 217 (254)
T cd05083 156 NSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------------KEVKECVEKGYRM----E 217 (254)
T ss_pred CCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------------HHHHHHHhCCCCC----C
Confidence 2234678999998865 467889999999999999997 8888754321 0111111111111 1
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
....++..+.+++.+||+.+|++||++.++++.|+
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 11234567889999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=301.74 Aligned_cols=245 Identities=27% Similarity=0.399 Sum_probs=196.2
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC------cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
..+.||+|+||.||+|... +++.|++|.+.... ...+.+.+|+.++++++|+||+++++++.++...++|+||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 4578999999999999886 78999999886533 2346788999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++++|.+++.+. ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 84 VPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 9999999998653 2478999999999999999999988 99999999999999999999999999987654433
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
......|+..|+|||.+... ..++.++|+||||+++|||++|+.||..... ..............
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-----------~~~~~~~~~~~~~~- 221 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEG-----------VAAVFKIGRSKELP- 221 (258)
T ss_pred --cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----------HHHHHHHHhcccCC-
Confidence 12334578999999998654 2378899999999999999999999864321 01111111101111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.....+...+.+++.+||+.+|++||++.+++.+
T Consensus 222 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 222 ---PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ---CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1112234567889999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=318.26 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=189.9
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.||+|+||+||+++.. +++.||+|++... ......+.+|+.++.+++|+||+++++.+.+.+..++||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 4578999999999999875 5899999998643 2334567889999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce-
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV- 503 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~- 503 (667)
+|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 85 gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 85 GGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 99999998653 3588999999999999999999998 9999999999999999999999999998754321100
Q ss_pred --------------------------------eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCC
Q 005953 504 --------------------------------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHL 551 (667)
Q Consensus 504 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~ 551 (667)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeecccCCCCC
Confidence 001134689999999998764 6788999999999999999999999
Q ss_pred CCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 005953 552 RPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS---MTRVVEM 619 (667)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt---~~evl~~ 619 (667)
..... ......+........... .......+.+++.+++ .+|++|++ +.|++++
T Consensus 237 ~~~~~------------~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETP------------QETYRKVMNWKETLVFPP-EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCH------------HHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 64322 111222221111000000 0012345666777766 49999985 6677665
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=308.01 Aligned_cols=262 Identities=22% Similarity=0.357 Sum_probs=196.2
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.++||+|+||.||+|++. +++.||+|++.... ...+.+.+|+.++++++|+|++++++++......++||||++
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 83 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD 83 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence 34578999999999999986 58999999886432 234568899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|..++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~- 156 (286)
T cd07847 84 HTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD- 156 (286)
T ss_pred ccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCccc-
Confidence 98888776442 3589999999999999999999997 9999999999999999999999999999876543321
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCc----cccchHH--HH------
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT----EAYFPDW--IY------ 572 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~----~~~~~~~--~~------ 572 (667)
.....++..|+|||.+.+. ..++.++||||||+++|||++|+.||............ ....... ++
T Consensus 157 -~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 157 -YTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -ccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 1234578899999998653 35688999999999999999999998643221000000 0000000 00
Q ss_pred HhhcCcccc--cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 573 DKLIQPEKE--DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 573 ~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.....+... .........+...+.+++.+||+.+|++||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000 00001112335678899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=319.44 Aligned_cols=258 Identities=24% Similarity=0.286 Sum_probs=189.2
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecC------CeeEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRAL 418 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~~l 418 (667)
.+.+.||+|+||.||++... .++.||||++.... ...+.+.+|+.+++.++||||+++++++... ...++
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 99 (355)
T cd07874 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL 99 (355)
T ss_pred eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEE
Confidence 34578999999999999874 58899999987532 2346788999999999999999999988643 35789
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
||||++ ++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 100 v~e~~~-~~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 100 VMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred Ehhhhc-ccHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 999996 466666532 378889999999999999999998 99999999999999999999999999998654
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC----CccccchH-----
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN----TTEAYFPD----- 569 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~----~~~~~~~~----- 569 (667)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... ......+.
T Consensus 171 ~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 171 TSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred Cccc---cCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 3221 2334689999999998754 67889999999999999999999986432100000 00000000
Q ss_pred --HHHHhhcC-cccc-------------cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 570 --WIYDKLIQ-PEKE-------------DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 570 --~~~~~~~~-~~~~-------------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.+...... +... .............+.+++.+||+.||++|||+.|++++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 00000000 0000 000001112245678999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=301.51 Aligned_cols=246 Identities=26% Similarity=0.359 Sum_probs=188.5
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC------cchHHHHHHHHHHhhcccceEEeecceEec--CCeeEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS------NFSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRALIY 420 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~ 420 (667)
..+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+ ....++++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 3578999999999999875 58899999886432 223568889999999999999999998875 35678999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||+++++|.+++.... .+++...+.++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 86 EYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999986532 478889999999999999999987 9999999999999999999999999999765432
Q ss_pred Cce-eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 501 RSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 501 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+........
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----------~~~~~~~~~~~~ 226 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----------MAAIFKIATQPT 226 (266)
T ss_pred cccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccch-----------HHHHHHHhcCCC
Confidence 111 11123457899999999865 3678899999999999999999999864321 111111111111
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
. ........+.+..++ +||..+|++||+++||+++
T Consensus 227 ~----~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 N----PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred C----CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 1 111122334455555 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=318.61 Aligned_cols=195 Identities=26% Similarity=0.370 Sum_probs=170.6
Q ss_pred HHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcc-c-----ceEEeecceEecCCeeEEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-H-----VNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h-----~niv~l~g~~~~~~~~~lV 419 (667)
+|.+.+.||+|.||.|.|+.+. +++.||||+++.......+...|+.+|..|+ | -|+|++++++...++.+||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 4566789999999999999774 6999999999998888888899999999997 4 4899999999999999999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC--CceEEEeCCCcccc
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD--FTPKVSDFGLAKAH 497 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~--~~~ki~DFGla~~~ 497 (667)
+|.+ ..+|.++|+.++ ...++...+..|+.||+.||.+||.. +|||+||||+||||.+- ..+||+|||.|...
T Consensus 267 fELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999 679999998765 45699999999999999999999988 99999999999999654 47999999999866
Q ss_pred CCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 005953 498 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 553 (667)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~ 553 (667)
..... ...-+..|+|||++.+. .++.+.||||||||++||++|.+.|.+
T Consensus 342 ~q~vy-----tYiQSRfYRAPEVILGl--pY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 342 SQRVY-----TYIQSRFYRAPEVILGL--PYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred CCcce-----eeeeccccccchhhccC--CCCCccceeehhhhHHhHhcCccccCC
Confidence 54332 22347899999999984 889999999999999999999776643
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.88 Aligned_cols=251 Identities=26% Similarity=0.433 Sum_probs=196.1
Q ss_pred hhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
..+.||+|+||+||+|+.. +.+.|++|.+..... ..+++.+|++++++++|+||+++++++.+....++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence 3467999999999999864 346799998876543 35689999999999999999999999999899999999
Q ss_pred EcCCCCccccccccccC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 422 YMPNGSLGDLLSREKEN------LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
|+++|+|.+++...... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccccc
Confidence 99999999999754322 2589999999999999999999988 99999999999999999999999999987
Q ss_pred ccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHh
Q 005953 496 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDK 574 (667)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 574 (667)
....... .......++..|+|||.+.+. ..+.++||||||++++||++ |..||..... .. +...
T Consensus 166 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-----------~~-~~~~ 230 (275)
T cd05046 166 DVYNSEY-YKLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-----------EE-VLNR 230 (275)
T ss_pred ccCcccc-cccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccch-----------HH-HHHH
Confidence 5432221 122334467889999988653 57789999999999999998 6777743211 01 1111
Q ss_pred hcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
......... ........+.+++.+||+.+|++||++.|++..|+
T Consensus 231 ~~~~~~~~~---~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLELP---VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111111000 01123457888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=301.48 Aligned_cols=247 Identities=25% Similarity=0.389 Sum_probs=196.9
Q ss_pred HhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccC--CcchHHHHHHHHHHhhcc---cceEEeecceEecCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKT--SNFSDNFINEVATIGRIH---HVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.+.+.||+|+||.||+|.+ .+++.||+|.+... ....+++.+|+.++++++ |||++++++++.++...++||||
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83 (277)
T ss_pred hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence 3457899999999999987 46899999998653 234567889999999997 99999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++++|.+++... .+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 84 AEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred CCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 9999999988543 588999999999999999999987 999999999999999999999999999987654432
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
. .....|+..|+|||.+... ..++.++||||||+++|||++|+.|+...... ..+ ..+.......
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----------~~~-~~~~~~~~~~ 221 (277)
T cd06917 157 K--RSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----------RAM-MLIPKSKPPR 221 (277)
T ss_pred c--cccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChh-----------hhh-hccccCCCCC
Confidence 1 2334588999999998643 35688999999999999999999998643221 000 0000100011
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
... ......+.+++.+||+.||++||++.|++.+-
T Consensus 222 ~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 222 LED---NGYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred CCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 111 11345788899999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=299.08 Aligned_cols=248 Identities=30% Similarity=0.537 Sum_probs=198.2
Q ss_pred hhhhcccCCCeEEEEEEeCC-----CcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFPD-----GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.+.||.|+||.||++++.+ +..||+|++..... ..+.+..|+..+++++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45789999999999998853 38899999976543 467899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++.......
T Consensus 83 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 83 MEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred cCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 999999999875432 2289999999999999999999998 999999999999999999999999999987654422
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
... ....++..|+|||.+.. ..++.++||||+|++++||++ |+.|+..... ..+..........
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------------~~~~~~~~~~~~~ 223 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------------EEVLEYLKKGYRL 223 (258)
T ss_pred ccc-ccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHhcCCCC
Confidence 211 12347889999999854 477899999999999999998 6777653211 1111122221111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.. ....+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 224 ~~----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PK----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11 112456788899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=308.84 Aligned_cols=249 Identities=24% Similarity=0.320 Sum_probs=196.1
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc----chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.||+|+||+||++... +++.||+|.+..... ..+.+.+|++++++++|+||+++++.+.+....++||||+.
T Consensus 5 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (316)
T cd05574 5 KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCP 84 (316)
T ss_pred EeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecC
Confidence 4578999999999999886 489999999876432 34568899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.+++.+.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..........
T Consensus 85 ~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 85 GGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred CCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999987532 34689999999999999999999987 99999999999999999999999999987543221110
Q ss_pred ---------------------------eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcC
Q 005953 505 ---------------------------TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETT 557 (667)
Q Consensus 505 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~ 557 (667)
......|+..|+|||++.+. .++.++||||||+++|||++|+.||......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 01123578899999999754 6788999999999999999999998643220
Q ss_pred CCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 005953 558 SGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS----MTRVVEM 619 (667)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt----~~evl~~ 619 (667)
. ....+...... ......+...+.+++.+||+.+|++||+ ++|++.+
T Consensus 239 -------~-----~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 -------E-----TFSNILKKEVT---FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred -------H-----HHHHHhcCCcc---CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 0 01111111100 0111114567889999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.49 Aligned_cols=246 Identities=28% Similarity=0.445 Sum_probs=194.4
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc----------chHHHHHHHHHHhhcccceEEeecceEecCCeeEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 418 (667)
+.+.||+|++|.||+|... +++.+|+|.+..... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence 4578999999999999874 588999998864321 12467889999999999999999999999999999
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 84 FLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999653 3578889999999999999999987 99999999999999999999999999998765
Q ss_pred CCCcee----eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHh
Q 005953 499 RNRSVV----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 574 (667)
Q Consensus 499 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 574 (667)
...... ......|+..|+|||.+.+. .++.++||||||+++|||++|+.||...... ..+. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----------~~~~-~ 223 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----------QAIF-K 223 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----------HHHH-H
Confidence 321111 11123478899999998753 6788999999999999999999998643210 0111 1
Q ss_pred hcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
...... ..........+.+++.+||+.+|++||++.|++++
T Consensus 224 ~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 224 IGENAS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HhccCC----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 111111 11112345678889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.54 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=196.8
Q ss_pred HhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 349 GFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
.+.++||.|+||.||+|.. .+++.||+|.+.... ...+.+.+|+..++.++|+|++++++++......++|+||++++
T Consensus 22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 101 (296)
T cd06655 22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG 101 (296)
T ss_pred EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence 3457899999999999986 468999999886543 34567889999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++... .+++.++..++.+++.||+|||+. +++|+||||+||++++++.+||+|||++......... .
T Consensus 102 ~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~ 172 (296)
T cd06655 102 SLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--R 172 (296)
T ss_pred cHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc--C
Confidence 999988543 478999999999999999999998 9999999999999999999999999998765443221 1
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ... . .+....... ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~----------~~~-~-~~~~~~~~~--~~ 236 (296)
T cd06655 173 STMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----------RAL-Y-LIATNGTPE--LQ 236 (296)
T ss_pred CCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------HHH-H-HHHhcCCcc--cC
Confidence 234578999999998753 6788999999999999999999998653220 000 0 010000000 01
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
....+...+.+++.+||+.+|++||++.+++.+=
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 1122345677899999999999999999998553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.27 Aligned_cols=253 Identities=24% Similarity=0.387 Sum_probs=194.5
Q ss_pred hhhhcccCCCeEEEEEEeC----CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCC------ee
Q 005953 350 FKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS------TR 416 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------~~ 416 (667)
+.+.||+|+||+||+|.+. +++.||||++.... ...+++.+|++++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4578999999999999863 36889999987543 23467889999999999999999999886532 24
Q ss_pred EEEEEEcCCCCcccccccc---ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCC
Q 005953 417 ALIYEYMPNGSLGDLLSRE---KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 493 (667)
Q Consensus 417 ~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGl 493 (667)
++++||+++|+|.+++... .....+++..+.+++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence 7889999999999887532 1223578899999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHH
Q 005953 494 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIY 572 (667)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 572 (667)
++...............++..|++||.+... .++.++||||||+++|||++ |+.|+..... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~~~~~------------~~~~ 225 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN------------SEIY 225 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCCCCCH------------HHHH
Confidence 9876443322222233456789999998653 67889999999999999999 7777753321 0111
Q ss_pred HhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 573 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
..+........ .......+.+++.+||+.+|++||++.++++.|+++
T Consensus 226 ~~~~~~~~~~~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 226 NYLIKGNRLKQ----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHcCCcCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111111110 112345788999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=317.83 Aligned_cols=188 Identities=23% Similarity=0.378 Sum_probs=159.5
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.+.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++|+||+++++++.+....++|+|++ .+
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~ 141 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SS 141 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CC
Confidence 455688999999999999885 4788999985433 2357999999999999999999999999999999999 57
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++... ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 142 ~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---~ 213 (357)
T PHA03209 142 DLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA---F 213 (357)
T ss_pred cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcc---c
Confidence 888887643 24589999999999999999999998 999999999999999999999999999975432221 1
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCC
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHL 551 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~ 551 (667)
....||..|+|||++.+. .++.++|||||||++|||+++..++
T Consensus 214 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 214 LGLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCcc
Confidence 335589999999998764 6789999999999999999876654
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=298.32 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=199.1
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
.+.+.||+|+||.||+|... +++.+++|++.... ...+.+.+|++++++++||||+++++++.++...+++|||++++
T Consensus 6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~ 85 (262)
T cd06613 6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85 (262)
T ss_pred EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence 35578999999999999875 57889999987643 34578899999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........ ..
T Consensus 86 ~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~ 158 (262)
T cd06613 86 SLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KR 158 (262)
T ss_pred cHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh--cc
Confidence 9999886542 3588999999999999999999988 999999999999999999999999999976543221 11
Q ss_pred cCCCCCccccchhhhhhh-cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 507 TGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
....++..|+|||.+... ...++.++||||||+++|||++|+.|+...... . . .. ............
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~------~----~-~~-~~~~~~~~~~~~ 226 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM------R----A-LF-LISKSNFPPPKL 226 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH------H----H-HH-HHHhccCCCccc
Confidence 334578899999998642 125678999999999999999999998643210 0 0 00 011110011111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.....+...+.+++.+||+.+|++|||+.+|+.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1223456678999999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=299.62 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=198.2
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.++||+|+||.||+++.. +++.||+|.+... ....+++.+|+.++++++|+||+++++++.+.+..++|+||++
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE 82 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence 34678999999999999875 6889999998643 2334678999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.+++.... ...+++..+++++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 83 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~- 157 (256)
T cd08218 83 GGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL- 157 (256)
T ss_pred CCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-
Confidence 999999886532 33578899999999999999999987 9999999999999999999999999999765443221
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....|++.|+|||++.+. ..+.++||||||++++||++|+.|+..... ... ...+..+...
T Consensus 158 -~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----------~~~-~~~~~~~~~~--- 219 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----------KNL-VLKIIRGSYP--- 219 (256)
T ss_pred -hhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCCH-----------HHH-HHHHhcCCCC---
Confidence 1223478899999998653 678899999999999999999998854321 111 1122222111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.........+.+++.+||+.+|++||++.+|+++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 -PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1122335678899999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=301.47 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=198.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEecCC------eeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGS------TRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~------~~~lV 419 (667)
+.+.+.||+|++|.||+|+.. +++.+++|++.......+++.+|+.+++++ +|+||+++++++.+.. ..++|
T Consensus 8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv 87 (275)
T cd06608 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV 87 (275)
T ss_pred eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence 345688999999999999985 578999999887766667899999999999 6999999999997644 48999
Q ss_pred EEEcCCCCccccccccc-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 420 YEYMPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
|||+++++|.+++.... .+..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 88 MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred EEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 99999999999986532 235689999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCceeeecCCCCCccccchhhhhhh---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (667)
..... .....|+..|+|||++... ...++.++||||||++++||++|+.||...... .... .+
T Consensus 165 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----------~~~~-~~ 230 (275)
T cd06608 165 STLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-----------RALF-KI 230 (275)
T ss_pred cchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-----------HHHH-Hh
Confidence 32221 1234588999999988542 134678999999999999999999998643210 0011 11
Q ss_pred cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
....... ........+.+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 PRNPPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hccCCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111 11122345678899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=303.30 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=195.1
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEecC-----CeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDG-----STRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~-----~~~~lV~e~ 422 (667)
+.+.||+|+||.||++... +++.+|+|++.........+.+|+.++.++ +|||++++++++... ...++|+||
T Consensus 26 ~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey 105 (291)
T cd06639 26 IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL 105 (291)
T ss_pred EEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence 4578999999999999884 688999999876655567788999999999 799999999998753 358999999
Q ss_pred cCCCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 423 MPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 423 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
+++|+|.++++.. .....+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 106 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 182 (291)
T cd06639 106 CNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182 (291)
T ss_pred CCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhccccc
Confidence 9999999988642 2234688999999999999999999988 99999999999999999999999999988654332
Q ss_pred ceeeecCCCCCccccchhhhhhhc---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNL---GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
.. .....|+..|+|||.+.... ..++.++|||||||++|||++|+.|+...... ..+. .+...
T Consensus 183 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-----------~~~~-~~~~~ 248 (291)
T cd06639 183 LR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-----------KTLF-KIPRN 248 (291)
T ss_pred cc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-----------HHHH-HHhcC
Confidence 21 12345789999999985421 13578999999999999999999998643210 0011 11111
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
..... .........+.+++.+||+.+|++||++.|++++
T Consensus 249 ~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 249 PPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111 0111234568899999999999999999999865
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=306.16 Aligned_cols=261 Identities=25% Similarity=0.362 Sum_probs=195.7
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc------chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.+.||+|+||.||+|... +++.||||.+..... ....+..|++++++++|+||+++++++.+....++||||
T Consensus 4 ~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (298)
T cd07841 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEF 83 (298)
T ss_pred eeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcc
Confidence 4578999999999999875 689999999875432 234577899999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+ +|+|.+++.... ..+++..+..++.|+++||+|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 84 ~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 84 M-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred c-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 9 999999996543 3589999999999999999999998 999999999999999999999999999987654322
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC----Cccccch-HHHHH-hhc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN----TTEAYFP-DWIYD-KLI 576 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~----~~~~~~~-~~~~~-~~~ 576 (667)
. .....+++.|+|||.+.+. ..++.++||||||++++||++|.+++.......... ....... .|... .+.
T Consensus 158 ~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 158 K--MTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred c--ccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 1 1233467889999988543 456889999999999999999977765332100000 0000000 00000 000
Q ss_pred Cccc-----ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 577 QPEK-----EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 577 ~~~~-----~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.... ..............+.+++.+||+.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 000011112335678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=298.82 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=199.0
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.+.+.||+|+||.||++.+. +++.+|+|++.... ...+++.+|++++++++||||+++++.+......++++||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 35678999999999999886 58999999987653 3446789999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
++|.+++.... ..+++..+..++.|++.||+|||+ . +++|+||||+||++++++.+||+|||.+.........
T Consensus 84 ~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 84 GSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred CcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 99999987543 468889999999999999999998 6 9999999999999999999999999998765432211
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
...++..|+|||.+.+. .++.++||||||+++|+|++|+.|+...... .+ .... ..+...........
T Consensus 158 ---~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~-~~~~-~~~~~~~~~~~~~~ 225 (265)
T cd06605 158 ---TFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDP-----PD-GIFE-LLQYIVNEPPPRLP 225 (265)
T ss_pred ---cccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCccccc-----cc-cHHH-HHHHHhcCCCCCCC
Confidence 14578899999998764 7788999999999999999999998654220 00 0111 11222111111111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
...+...+.+++.+||..+|++|||+.+++.+
T Consensus 226 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 226 ---SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11145678899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=326.55 Aligned_cols=259 Identities=16% Similarity=0.271 Sum_probs=185.7
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhccc------ceEEeecceEecC-CeeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHH------VNIIHLLGFCCDG-STRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h------~niv~l~g~~~~~-~~~~lV 419 (667)
+.+.++||+|+||+||+|.+. .++.||||+++......+++..|+.++++++| .+++++++++... ...++|
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv 210 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIV 210 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEE
Confidence 345678999999999999875 58899999997654445566778888877765 4588899888764 468899
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC---------------
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF--------------- 484 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~--------------- 484 (667)
||++ +++|.+++.+. ..+++..+..|+.||+.||+|||+. .+|+||||||+|||++.++
T Consensus 211 ~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 211 MPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred Eecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 9988 78888888653 3588999999999999999999962 2899999999999998765
Q ss_pred -ceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC-
Q 005953 485 -TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT- 562 (667)
Q Consensus 485 -~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~- 562 (667)
.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........
T Consensus 285 ~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 285 CRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred ceEEECCCCccccCccc-----cccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 4999999988643222 2345689999999999764 688899999999999999999999965332100000
Q ss_pred --ccccch-HHH-----------HHhhcC--cccc--------cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005953 563 --TEAYFP-DWI-----------YDKLIQ--PEKE--------DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618 (667)
Q Consensus 563 --~~~~~~-~~~-----------~~~~~~--~~~~--------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 618 (667)
....++ .|. +..... +... .............+.+|+.+||+.||++|||++|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 000000 010 000000 0000 0000000011345779999999999999999999997
Q ss_pred H
Q 005953 619 M 619 (667)
Q Consensus 619 ~ 619 (667)
+
T Consensus 438 H 438 (467)
T PTZ00284 438 H 438 (467)
T ss_pred C
Confidence 4
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.42 Aligned_cols=262 Identities=23% Similarity=0.370 Sum_probs=196.2
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
++.++||+|+||.||+|.++ +++.||+|++.... ...+.+.+|++++++++||||+++++++.++...++|+||++
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence 35588999999999999986 58999999986533 234578899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 84 ~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~- 156 (286)
T cd07846 84 HTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV- 156 (286)
T ss_pred ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc-
Confidence 99988876543 2489999999999999999999987 9999999999999999999999999999866443321
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC---ccccchHHH---------H
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWI---------Y 572 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~---------~ 572 (667)
.....++..|+|||++.+. ..++.++||||||+++|||++|++|+........... ....+.... .
T Consensus 157 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 157 -YTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred -cCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 2334578999999998653 3567899999999999999999988853321000000 000000000 0
Q ss_pred HhhcCccccc--ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 573 DKLIQPEKED--FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 573 ~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.....+.... ........+...+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000 0001112345678899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=304.69 Aligned_cols=260 Identities=20% Similarity=0.297 Sum_probs=193.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.++||+|+||.||+|+.. +|+.||+|++.... .....+.+|++++++++|+||+++++++.+....++|+||++
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 34578999999999999885 68999999986532 233567889999999999999999999999999999999996
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
++|.+++... ...+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 83 -~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~- 155 (284)
T cd07839 83 -QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC- 155 (284)
T ss_pred -CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-
Confidence 5787777543 23589999999999999999999998 9999999999999999999999999999865433221
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccc------cchHHHHHhh---
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEA------YFPDWIYDKL--- 575 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~------~~~~~~~~~~--- 575 (667)
.....++..|+|||++.+. ..++.++||||||+++|||++|+.|+....... ..... ......+..+
T Consensus 156 -~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred -cCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhc
Confidence 2334578999999998653 356889999999999999999998864332110 00000 0000000000
Q ss_pred cCcc-ccccc-----chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 576 IQPE-KEDFV-----EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 576 ~~~~-~~~~~-----~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.... ..... .+....+...+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000 00000 01112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=313.04 Aligned_cols=258 Identities=21% Similarity=0.269 Sum_probs=189.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecC------CeeE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRA 417 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~~ 417 (667)
+...+.||+|+||+||+|... +++.||||++.... ...+.+.+|+.++++++||||+++++++... ...+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07878 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY 96 (343)
T ss_pred hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence 344578999999999999874 68899999987542 2345678999999999999999999987543 3568
Q ss_pred EEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcccc
Q 005953 418 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~ 497 (667)
+++|++ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 97 ~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 97 LVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred EEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceec
Confidence 999988 7899887753 2488999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCc---cccchHHHHHh
Q 005953 498 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT---EAYFPDWIYDK 574 (667)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~ 574 (667)
... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||............ ...........
T Consensus 169 ~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 169 DDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred CCC-----cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 432 2334689999999998653 36788999999999999999999998643210000000 00000000000
Q ss_pred hcCcc-------cccccc----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 575 LIQPE-------KEDFVE----EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 575 ~~~~~-------~~~~~~----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
+.... ...... .........+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 000000 0001122357789999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=304.62 Aligned_cols=244 Identities=23% Similarity=0.365 Sum_probs=194.5
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
.+||+|+||.||++... +++.||+|++.... ...+.+.+|+.+++.++||||+++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 47999999999999875 68999999986533 33467889999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCC
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 509 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 509 (667)
+++.. ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......... ....
T Consensus 107 ~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~ 177 (297)
T cd06659 107 DIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSL 177 (297)
T ss_pred HHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccce
Confidence 87744 2478999999999999999999988 9999999999999999999999999998765433221 1234
Q ss_pred CCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhH
Q 005953 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589 (667)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (667)
.|+..|+|||++.+. .++.++||||||+++|||++|+.||...... .....+....... .....
T Consensus 178 ~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------------~~~~~~~~~~~~~--~~~~~ 241 (297)
T cd06659 178 VGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV------------QAMKRLRDSPPPK--LKNAH 241 (297)
T ss_pred ecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------------HHHHHHhccCCCC--ccccC
Confidence 578999999998753 6788999999999999999999998643210 0011111110000 01111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 590 CIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.....+.+++.+||+.+|++||++++++++-
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 2345678899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=299.06 Aligned_cols=245 Identities=22% Similarity=0.341 Sum_probs=196.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.++||+|+||.||+|... +++.||+|++.... ...+.+.+|+..+++++||||+++++++.++...++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 445678999999999999874 68899999876443 334678899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.+++... .+++..+..++.+++.|+.|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 86 ~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06641 86 GGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhh-
Confidence 99999988542 478999999999999999999987 9999999999999999999999999998765433211
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....++..|+|||.+.. ..++.++||||||+++|||++|+.|+..... ......+......
T Consensus 158 -~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~--- 219 (277)
T cd06641 158 -RNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHP------------MKVLFLIPKNNPP--- 219 (277)
T ss_pred -hccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccch------------HHHHHHHhcCCCC---
Confidence 123457889999999865 3678899999999999999999998853221 0111111111111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.....+...+.+++.+||+.+|++||++.+++.+
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 -TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1112345668889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=292.44 Aligned_cols=249 Identities=23% Similarity=0.316 Sum_probs=198.5
Q ss_pred hhhhcccCCCeEEEEEEeCC-CcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.++||.|.-|+||++.+.+ +...|+|++.+.. ....+...|-++|+.++||.++.|++.++.....+||||||+
T Consensus 81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp 160 (459)
T KOG0610|consen 81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP 160 (459)
T ss_pred HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence 45789999999999999864 5899999997653 234567789999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC-----
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR----- 499 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~----- 499 (667)
||+|..++++.. +..+++..+..+|.+++-||+|||-. |||.|||||+||||.++|++.|+||.|+.....
T Consensus 161 GGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 161 GGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred CccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 999999887654 55799999999999999999999987 999999999999999999999999999853210
Q ss_pred ----------------------------CCce---------------------eeecCCCCCccccchhhhhhhcCCCCC
Q 005953 500 ----------------------------NRSV---------------------VTMTGPRGTIGYIAPEIFMRNLGNPSG 530 (667)
Q Consensus 500 ----------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~ 530 (667)
.... ......+||-.|+|||++.+. ..+.
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~--GHgs 314 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE--GHGS 314 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC--CCCc
Confidence 0000 001134699999999999886 5678
Q ss_pred cccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCC
Q 005953 531 KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDR 610 (667)
Q Consensus 531 k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 610 (667)
++|.|+|||++|||+.|+.||.+... +.-+...+ .++.. + .....+.....+|+.+.|.+||++|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~-------~~Tl~NIv----~~~l~--F--p~~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNN-------KETLRNIV----GQPLK--F--PEEPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCc-------hhhHHHHh----cCCCc--C--CCCCcchhHHHHHHHHHhccChhhh
Confidence 99999999999999999999976543 11122221 11111 1 1111345678889999999999999
Q ss_pred CC----HHHHHHH
Q 005953 611 PS----MTRVVEM 619 (667)
Q Consensus 611 Pt----~~evl~~ 619 (667)
-. ++||-++
T Consensus 380 lg~~rGA~eIK~H 392 (459)
T KOG0610|consen 380 LGSKRGAAEIKRH 392 (459)
T ss_pred hccccchHHhhcC
Confidence 98 7777655
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=297.90 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=197.3
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEec--CCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~ 422 (667)
.+.+.||.|+||.||++... +++.+|+|++.... ...+.+.+|++++++++|+||+++++++.. +...+++|||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence 34578999999999999874 68899999986532 334568899999999999999999998764 4567899999
Q ss_pred cCCCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 423 MPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGC--ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 423 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~--~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
+++++|.+++... .....+++..++.++.|++.||+|||..+ ..+++|+||||+||++++++.+||+|||++.....
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 9999999999653 22356899999999999999999999321 23999999999999999999999999999987654
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
.... .....+++.|+|||.+... ..+.++||||||+++|+|++|+.|+..... ....+.+....
T Consensus 163 ~~~~--~~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------------~~~~~~~~~~~ 226 (265)
T cd08217 163 DSSF--AKTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARNQ------------LQLASKIKEGK 226 (265)
T ss_pred Cccc--ccccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccCcCH------------HHHHHHHhcCC
Confidence 4321 1334689999999998653 578899999999999999999999864321 11112222211
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.. .........+.+++.+||+.+|++||++.+|+++
T Consensus 227 ~~----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 FR----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CC----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11 1122345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=303.66 Aligned_cols=243 Identities=23% Similarity=0.363 Sum_probs=193.0
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
.+||+|+||.||++... +++.||||.+.... ...+.+.+|+..+++++|+||+++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 56999999999999875 58899999986543 33467889999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCC
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 509 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 509 (667)
+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......... ....
T Consensus 108 ~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~ 178 (292)
T cd06658 108 DIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSL 178 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--Ccee
Confidence 988542 478899999999999999999998 9999999999999999999999999998765432221 1224
Q ss_pred CCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhH
Q 005953 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589 (667)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (667)
.|+..|+|||.+.+. .++.++||||||+++|||++|+.|+...... .....+........ ....
T Consensus 179 ~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------------~~~~~~~~~~~~~~--~~~~ 242 (292)
T cd06658 179 VGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL------------QAMRRIRDNLPPRV--KDSH 242 (292)
T ss_pred ecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------------HHHHHHHhcCCCcc--cccc
Confidence 578999999998653 6788999999999999999999998543210 00111111000000 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 590 CIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.+...+.+++.+||+.+|++|||++|++++
T Consensus 243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 234467788999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=297.13 Aligned_cols=246 Identities=24% Similarity=0.387 Sum_probs=195.9
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.+.||+|+||.||++... +++.+|+|.+.... ...+.+.+|++++++++||||+++++.+..++..++|+||++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP 82 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence 35678999999999999874 68899999986542 335678899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC-CceEEEeCCCccccCCCCce
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~-~~~ki~DFGla~~~~~~~~~ 503 (667)
+++|.+++.... ...+++..+..++.+++.||+|||+. +++|+||+|+||+++++ +.+||+|||++.........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (256)
T cd08220 83 GGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA 158 (256)
T ss_pred CCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence 999999997543 34588999999999999999999998 99999999999999855 56899999999876543321
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
....++..|+|||.+.+. ..+.++||||||+++|+|++|+.|+..... ..... .........
T Consensus 159 ---~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----------~~~~~-~~~~~~~~~- 220 (256)
T cd08220 159 ---YTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANL-----------PALVL-KIMSGTFAP- 220 (256)
T ss_pred ---cccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCch-----------HHHHH-HHHhcCCCC-
Confidence 224578899999998753 678899999999999999999998854321 11111 111111111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
........+.+++.+||+.+|++|||+.|++.+
T Consensus 221 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 ---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111235578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=300.98 Aligned_cols=261 Identities=24% Similarity=0.340 Sum_probs=191.9
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.+.+.||+|++|.||+|+.. +++.||+|.+.... .....+.+|++++++++|+||+++++++.++...++||||++
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 86 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD- 86 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-
Confidence 34578999999999999885 68999999986543 223567889999999999999999999999999999999997
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++.+.. ..+++..+..++.|+++||.|||+. +|+|+||||+||++++++.+||+|||+++....... .
T Consensus 87 ~~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~ 159 (291)
T cd07844 87 TDLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--T 159 (291)
T ss_pred CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc--c
Confidence 58998886543 2588999999999999999999988 999999999999999999999999999875432211 1
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC-----CccccchHHHHHhhcCc-c
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN-----TTEAYFPDWIYDKLIQP-E 579 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~-~ 579 (667)
.....++..|+|||++.+. ..++.++||||||+++|||++|+.||.......... ..... ....+...... .
T Consensus 160 ~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTP-TEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCC-Chhhhhhhhhccc
Confidence 1223468899999998653 357889999999999999999999985432100000 00000 00000000000 0
Q ss_pred ----ccccc-ch----hhHHH--HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 580 ----KEDFV-EE----EDDCI--ARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 580 ----~~~~~-~~----~~~~~--~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
..... .. ..... ...+.+++.+||+.+|++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000 00 00011 2567789999999999999999998853
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=297.04 Aligned_cols=246 Identities=25% Similarity=0.319 Sum_probs=189.6
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC------cchHHHHHHHHHHhhcccceEEeecceEecC--CeeEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS------NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIY 420 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 420 (667)
+.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+. ...++|+
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 3578999999999999875 58999999875321 1235688899999999999999999988764 4678999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||+++++|.+++.+.. .+++....+++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 86 EHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 9999999999986432 478888999999999999999988 9999999999999999999999999999765422
Q ss_pred Cce-eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 501 RSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 501 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
... .......|+..|+|||.+.+. .++.++||||||+++|||++|+.||..... ...+......+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----------~~~~~~~~~~~~ 226 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----------MAAIFKIATQPT 226 (265)
T ss_pred cccccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccch-----------HHHHHHHhcCCC
Confidence 111 112234588999999998653 678899999999999999999999853211 001111111111
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
. ..........+.+++.+|+. +|++||+++|++++
T Consensus 227 ~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 N----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred C----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1 11122345567778888885 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=302.01 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=197.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.+.||+|+||.||+|++. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.++...++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~- 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM- 81 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence 45678999999999999875 68999999987543 33467899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.+++.... ..+++..++.++.|+++||+|||+. +++|+||||+||++++++.++|+|||++........ .
T Consensus 82 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 82 PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 999999986543 4589999999999999999999998 999999999999999999999999999987654432 1
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh---------
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL--------- 575 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 575 (667)
......|+..|+|||.+.+. ..++.++||||+|++++||++|++++...... .....+...+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDI--------EQLAIVFRTLGTPNEETWP 226 (286)
T ss_pred ccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH--------HHHHHHHHHcCCCChHHHh
Confidence 12335689999999988653 35688999999999999999997776432210 0000000000
Q ss_pred -----------cCccccc-ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 576 -----------IQPEKED-FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 576 -----------~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
....... ............+.+++.+||+.+|++||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 0000111234688899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=301.54 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=193.4
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
..+.||+|++|.||+|+.. +++.||||++.... ...+.+.+|++++++++||||+++++++.++...++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence 3578999999999999875 68999999886543 233578899999999999999999999999999999999995
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++........
T Consensus 83 ~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~-- 156 (284)
T cd07860 83 QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-- 156 (284)
T ss_pred cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--
Confidence 68888886543 34689999999999999999999987 9999999999999999999999999998765433221
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCc---cccchHHHHHhhc------
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT---EAYFPDWIYDKLI------ 576 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~------ 576 (667)
.....++..|+|||.+.+. ..++.++||||||+++|||+||+.||............ ........+....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred cccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 1233468899999988653 34678999999999999999999998543210000000 0000000000000
Q ss_pred ---CcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 577 ---QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 577 ---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
..............+...+.+++.+||+.||++|||+++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000001111234567789999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=303.54 Aligned_cols=247 Identities=28% Similarity=0.387 Sum_probs=194.3
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+...++||+|+||+||+|+.. +++.||+|++.... ...+++.+|++++++++||||+++++++.+....++|+||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 445678999999999999875 68999999886432 2235688999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
++ |+|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 97 ~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~- 169 (307)
T cd06607 97 CL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN- 169 (307)
T ss_pred hC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCCC-
Confidence 96 67777765432 3589999999999999999999987 99999999999999999999999999987654322
Q ss_pred eeeecCCCCCccccchhhhhh-hcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
...++..|+|||++.. ..+.++.++||||||+++|||++|+.|+...... ..... +......
T Consensus 170 -----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----------~~~~~-~~~~~~~ 232 (307)
T cd06607 170 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------SALYH-IAQNDSP 232 (307)
T ss_pred -----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----------HHHHH-HhcCCCC
Confidence 2347889999998743 1246788999999999999999999998543210 00111 1111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
. .........+.+++.+||+.+|++||++.+++.+.-
T Consensus 233 ~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 233 T---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred C---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 1 111224567889999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.30 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=200.4
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
.+.+.||+|++|.||+|.++ +++.+++|++.......+.+.+|++.+++++|+|++++++.+......++|+||+++++
T Consensus 22 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 101 (286)
T cd06614 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS 101 (286)
T ss_pred hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCc
Confidence 34578999999999999986 68899999998665556778999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|.+++.... ..+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.+||+|||++......... ..
T Consensus 102 L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~ 174 (286)
T cd06614 102 LTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--RN 174 (286)
T ss_pred HHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh--hc
Confidence 999997643 3689999999999999999999987 9999999999999999999999999998765433221 12
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchh
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 587 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (667)
...++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... .. ........... ...
T Consensus 175 ~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-----------~~-~~~~~~~~~~~--~~~ 238 (286)
T cd06614 175 SVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----------RA-LFLITTKGIPP--LKN 238 (286)
T ss_pred cccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----------HH-HHHHHhcCCCC--Ccc
Confidence 33478899999998653 6788999999999999999999998543210 00 01111111100 111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 588 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
...+...+.+++.+||+.+|.+||++.+++++.-
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 1224567889999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=297.59 Aligned_cols=257 Identities=26% Similarity=0.346 Sum_probs=196.4
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecC--CeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~ 424 (667)
+.++||.|++|.||++... +++.+|+|.+..... ...++.+|++++++++||||+++++++.+. ...++||||++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 3578999999999999985 588999999875432 456789999999999999999999988653 46899999999
Q ss_pred CCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 425 NGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 425 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
+++|.+++... .....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 160 (287)
T cd06621 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA- 160 (287)
T ss_pred CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc-
Confidence 99999987642 2234588899999999999999999998 999999999999999999999999999876543221
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .........++... ........
T Consensus 161 ---~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~ 231 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP---PLGPIELLSYIVNM-PNPELKDE 231 (287)
T ss_pred ---ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCC---CCChHHHHHHHhcC-CchhhccC
Confidence 12346889999999865 36788999999999999999999998754221 00011111111110 00000000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
..........+.+++.+||+.+|++|||+.|++++-
T Consensus 232 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 232 -PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred -CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 111112356788999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=300.73 Aligned_cols=262 Identities=24% Similarity=0.342 Sum_probs=195.0
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.++||.|++|.||+|... +|+.||+|++.... ...+.+.+|++.+++++|+|++++++++.++...+++|||+ +
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~ 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-D 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-C
Confidence 4578999999999999875 69999999987543 23357889999999999999999999999999999999999 4
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++.... ...+++..++.++.|+++||+|||+. +++|+||+|+||++++++.+||+|||+++........
T Consensus 82 ~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-- 155 (283)
T cd07835 82 LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-- 155 (283)
T ss_pred cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--
Confidence 78999886543 24589999999999999999999987 9999999999999999999999999999765433221
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC---ccccchHHHHHhhcC-----
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWIYDKLIQ----- 577 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~----- 577 (667)
.....++..|+|||++.+. ..++.++||||||+++|||++|+.||........... .........+.....
T Consensus 156 ~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred cCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 2233568899999988653 3568899999999999999999999854321000000 000000000000000
Q ss_pred ----cccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 578 ----PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 578 ----~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.............+...+.+++.+||+.+|++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000011112234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=299.36 Aligned_cols=248 Identities=24% Similarity=0.380 Sum_probs=197.4
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.+.||+|+||.||++... +++.||+|.+.... ...+.+.+|+.++++++||||+++++.+...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 100 (293)
T cd06647 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100 (293)
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCC
Confidence 345678999999999999864 67899999986433 3456789999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++.+. .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 101 ~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-- 171 (293)
T cd06647 101 GSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171 (293)
T ss_pred CcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc--
Confidence 9999998643 378889999999999999999988 9999999999999999999999999998765443321
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....+++.|+|||.+.. +.++.++||||||+++|||++|+.||....... ... .+....... .
T Consensus 172 ~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~------~~~------~~~~~~~~~--~ 235 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALY------LIATNGTPE--L 235 (293)
T ss_pred cccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh------hee------ehhcCCCCC--C
Confidence 123457889999999865 367889999999999999999999996543210 000 000000000 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.....+...+.+++.+||+.+|++||++.+++.+-
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 11223455688899999999999999999999773
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=301.31 Aligned_cols=247 Identities=28% Similarity=0.385 Sum_probs=194.8
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+...+.||+|+||.||+|+.. +++.||+|++.... ....++.+|++++++++|+|++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 334578999999999999875 68899999986432 2235788999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
++ |+|.+++... ...+++..+..++.+++.||.|||+. +|+|+||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 96 5787777543 23589999999999999999999988 9999999999999999999999999998754432
Q ss_pred eeeecCCCCCccccchhhhhh-hcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
....|+..|+|||++.. ..+.++.++||||||+++|||++|+.|+..... ... ...+......
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----------~~~-~~~~~~~~~~ 242 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSA-LYHIAQNESP 242 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-----------HHH-HHHHHhccCC
Confidence 22347889999999753 224678899999999999999999998754321 000 1111111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
. .........+.+++.+||+.+|++||++.++++++.
T Consensus 243 ~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 243 T---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred C---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 1 111223456888999999999999999999999876
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=295.11 Aligned_cols=247 Identities=26% Similarity=0.407 Sum_probs=200.5
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.+.||+|++|.||+++.. +++.|++|++.... ...+.+.+|+..+.+++|+||+++++++......++|+||++++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06623 5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG 84 (264)
T ss_pred eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence 4578999999999999886 48999999987654 34578999999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
+|.+++... ..+++..++.++.|+++||+|||+ . +++|+||+|+||+++.++.++|+|||++..........
T Consensus 85 ~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~- 157 (264)
T cd06623 85 SLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC- 157 (264)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-
Confidence 999999754 358999999999999999999998 7 99999999999999999999999999998765433221
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
....++..|+|||.+... .++.++||||||+++|||++|+.|+..... ..+.+. ...+.......
T Consensus 158 -~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--------~~~~~~-~~~~~~~~~~~--- 222 (264)
T cd06623 158 -NTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQ--------PSFFEL-MQAICDGPPPS--- 222 (264)
T ss_pred -cceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccccc--------cCHHHH-HHHHhcCCCCC---
Confidence 233478899999998653 778899999999999999999999865431 011111 11111111111
Q ss_pred hhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 586 EEDDC-IARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 586 ~~~~~-~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.... ++..+.+++.+||+.+|++||++.|++++
T Consensus 223 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 -LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111 45678899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.51 Aligned_cols=250 Identities=25% Similarity=0.415 Sum_probs=197.4
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
..+.||+|+||.||+|... +++.|++|.+..... ..+.+.+|+.++++++|+||+++++.+.+.+..++|+||+++
T Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06626 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSG 83 (264)
T ss_pred eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCC
Confidence 4578999999999999875 689999999876543 456789999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++... ..+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++...........
T Consensus 84 ~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 84 GTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred CcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 9999998653 2478889999999999999999998 999999999999999999999999999987654332211
Q ss_pred --ecCCCCCccccchhhhhhhc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 506 --MTGPRGTIGYIAPEIFMRNL-GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 506 --~~~~~gt~~y~aPE~~~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
.....++..|+|||++.... ...+.++||||||+++|||++|+.||...... . ..... +.......
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---------~-~~~~~-~~~~~~~~ 226 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---------F-QIMFH-VGAGHKPP 226 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---------H-HHHHH-HhcCCCCC
Confidence 12345789999999987542 23788999999999999999999998643210 0 00111 11111111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 618 (667)
. .....+...+.+++.+||+.+|++||++.|++.
T Consensus 227 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 I--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred C--CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1 111123556778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=295.93 Aligned_cols=246 Identities=23% Similarity=0.390 Sum_probs=196.2
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.||+|+||.||+|... +|..+|+|.+... ....+.+.+|+.++++++|+||+++++.+.+....++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (257)
T cd08225 4 IIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG 83 (257)
T ss_pred EEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCC
Confidence 4578999999999999886 5889999998653 23446788999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC-ceEEEeCCCccccCCCCcee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~-~~ki~DFGla~~~~~~~~~~ 504 (667)
++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++ .+||+|||.+.........
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~- 158 (257)
T cd08225 84 GDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL- 158 (257)
T ss_pred CcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCccc-
Confidence 99999987543 33578999999999999999999988 999999999999998885 4699999999776543221
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....|++.|+|||++... .++.++||||||+++|||++|+.|+..... ..++.... ......
T Consensus 159 -~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~-~~~~~~-- 221 (257)
T cd08225 159 -AYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----------HQLVLKIC-QGYFAP-- 221 (257)
T ss_pred -ccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHHHHh-cccCCC--
Confidence 1234588999999988653 678899999999999999999999854321 11222111 111111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
........+.+++.+||+.+|++|||+.|++.+
T Consensus 222 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 --ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111234568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.72 Aligned_cols=260 Identities=27% Similarity=0.394 Sum_probs=196.3
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.++||+|++|.||+|+.. +|+.||||+++... ...+.+.+|+.++++++|+||+++++++.+.+..++||||++ +
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 82 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-K 82 (284)
T ss_pred EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-c
Confidence 4578999999999999985 58899999987543 234677899999999999999999999999999999999997 5
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++........+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++....... ..
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~ 157 (284)
T cd07836 83 DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TF 157 (284)
T ss_pred cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--cc
Confidence 8888886544345689999999999999999999987 999999999999999999999999999976543221 11
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccc------hHHHHHhhcCc-c
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYF------PDWIYDKLIQP-E 579 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~-~ 579 (667)
....++..|++||.+.+. ..++.++||||||+++|||++|+.||....... .....+ ....+..+... .
T Consensus 158 ~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED---QLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhHHHHhcCch
Confidence 234468899999998654 356889999999999999999999986543210 000000 00000000000 0
Q ss_pred -cccc-------cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 580 -KEDF-------VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 580 -~~~~-------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.... ...........+.+++.+||+.||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 001112235678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.74 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=191.1
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHH-HhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVAT-IGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~-l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.||+|+||.||++++. +|+.||+|+++... ....++..|+.. ++.++||||+++++++..+...+++|||++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~- 83 (283)
T cd06617 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD- 83 (283)
T ss_pred EEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-
Confidence 4578999999999999885 68999999987643 233456667765 555689999999999999999999999995
Q ss_pred CCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 426 GSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 426 gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
|+|.+++... .....+++..++.++.|++.||+|||++ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-- 159 (283)
T cd06617 84 TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA-- 159 (283)
T ss_pred ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccccc--
Confidence 7888887642 2235689999999999999999999973 3899999999999999999999999999986543221
Q ss_pred eecCCCCCccccchhhhhhhc--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNL--GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~--~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
.+...++..|+|||.+.+.. ..++.++|+||||+++|||++|+.|+..... .+. .+... .......
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------~~~-~~~~~-~~~~~~~ 227 (283)
T cd06617 160 -KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT---------PFQ-QLKQV-VEEPSPQ 227 (283)
T ss_pred -cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc---------CHH-HHHHH-HhcCCCC
Confidence 12345788999999886421 3457899999999999999999999853221 001 11111 1111111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
. ....++..+.+++.+||+.+|++||++.+++++
T Consensus 228 ~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 228 L---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred C---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 112245678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=294.57 Aligned_cols=249 Identities=26% Similarity=0.456 Sum_probs=195.3
Q ss_pred hhhcccCCCeEEEEEEe-CCCcEEEEEEcccCC-------cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 351 KEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.+.||+|++|.||+|+. .+++.||+|++.... ...+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 46799999999999987 468999999986433 1246788999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC-ceEEEeCCCccccCCCC
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~-~~ki~DFGla~~~~~~~ 501 (667)
+++++|.+++.+. ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 85 MAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred cCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 9999999998653 2578999999999999999999998 999999999999998775 59999999997765432
Q ss_pred cee--eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 502 SVV--TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 502 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
... ......++..|+|||.+.+. .++.++||||+|++++||++|+.|+...... .....+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~-- 226 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--------NHLALIFKIASA-- 226 (268)
T ss_pred ccCCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCc--------chHHHHHHHhcc--
Confidence 111 11223578899999998653 6788999999999999999999998533210 001111111111
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.............+.+++.+||+.+|++||++.|++.+
T Consensus 227 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 227 --TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred --CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 11112223456678889999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=325.91 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=187.5
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccC--CcchHHHHHHHHHHhhcccceEEeecceEec----------------
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT--SNFSDNFINEVATIGRIHHVNIIHLLGFCCD---------------- 412 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~---------------- 412 (667)
+.||+||||.|||++.+ ||+.+|||++... ........+|+..|++|+|||||+++..+.+
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 57999999999999987 8999999998765 3445678899999999999999998732210
Q ss_pred --------------------------------------------------------------------------------
Q 005953 413 -------------------------------------------------------------------------------- 412 (667)
Q Consensus 413 -------------------------------------------------------------------------------- 412 (667)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ---------------C--------CeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCee
Q 005953 413 ---------------G--------STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469 (667)
Q Consensus 413 ---------------~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iv 469 (667)
. ..+||=||||+..+|++++.++.... .....++++++|++||+|+|+. +||
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~---giI 719 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQ---GII 719 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhC---cee
Confidence 0 13467789998888888887654221 4667899999999999999998 999
Q ss_pred ecCCCCCcEEECCCCceEEEeCCCccccC----------------CCCceeeecCCCCCccccchhhhhhhcC-CCCCcc
Q 005953 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHS----------------RNRSVVTMTGPRGTIGYIAPEIFMRNLG-NPSGKS 532 (667)
Q Consensus 470 H~Dikp~NIll~~~~~~ki~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~s~k~ 532 (667)
||||||.||+||++..|||+|||+|.... ........++.+||.-|+|||++.+... .++.|+
T Consensus 720 HRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~Ki 799 (1351)
T KOG1035|consen 720 HRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKI 799 (1351)
T ss_pred eccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchh
Confidence 99999999999999999999999998621 1112224567889999999999976522 689999
Q ss_pred cHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCC
Q 005953 533 DVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612 (667)
Q Consensus 533 DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt 612 (667)
|+||+|||++||+. ||....+ ...+...+.++..+.. ..........-.+++.|+++.||.+|||
T Consensus 800 DmYSLGIVlFEM~y---PF~TsME-----------Ra~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 800 DMYSLGIVLFEMLY---PFGTSME-----------RASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred hhHHHHHHHHHHhc---cCCchHH-----------HHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCCccCCC
Confidence 99999999999983 4433221 1223444444443322 1112222344567899999999999999
Q ss_pred HHHHHH
Q 005953 613 MTRVVE 618 (667)
Q Consensus 613 ~~evl~ 618 (667)
+.|+|.
T Consensus 865 A~eLL~ 870 (1351)
T KOG1035|consen 865 ATELLN 870 (1351)
T ss_pred HHHHhh
Confidence 999874
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.75 Aligned_cols=263 Identities=21% Similarity=0.280 Sum_probs=194.4
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecC--CeeEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIYE 421 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV~e 421 (667)
+.+.+.||+|+||.||+|++. +++.+|+|.++... .....+.+|+.++++++||||+++++++... ...++|+|
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 345688999999999999986 58899999987543 2234678899999999999999999998877 88999999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 87 ~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 87 YVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred hcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 996 58988886543 2589999999999999999999988 99999999999999999999999999998765432
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC----Cccccch-HHHHH-hh
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN----TTEAYFP-DWIYD-KL 575 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~----~~~~~~~-~~~~~-~~ 575 (667)
.. .....+++.|+|||.+.+. ...+.++|+||||+++|||++|+.||.......... ....... .|... .+
T Consensus 161 ~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 161 KP--YTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred cc--cccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 11 1334578899999998654 346889999999999999999999986432100000 0000000 00000 00
Q ss_pred cCcc--------cccccchhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 576 IQPE--------KEDFVEEEDDC-IARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 576 ~~~~--------~~~~~~~~~~~-~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.... ........... +...+.+++.+||+.+|++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 00000000111 35668889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=295.79 Aligned_cols=243 Identities=23% Similarity=0.313 Sum_probs=186.8
Q ss_pred hcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhh---cccceEEeecceEecCCeeEEEEEEcC
Q 005953 353 KLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGR---IHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~---l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.||+|+||.||+++.. +++.+|+|.+.... .....+.+|..+++. .+|+||+.+++++.+.+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 58999999886542 112334455544443 469999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||++........
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 99999988653 3589999999999999999999998 999999999999999999999999999875543221
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
....|+..|+|||.+... ..++.++||||||++++||++|+.||...... . ...+...... . .
T Consensus 153 --~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~-----~~~~~~~~~~-~----~ 215 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----D-----KHEIDRMTLT-V----N 215 (279)
T ss_pred --cCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc----C-----HHHHHHHhhc-C----C
Confidence 234589999999988643 35788999999999999999999998643221 0 0111111100 0 0
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~L 620 (667)
..........+.+++.+||+.||++|| +++|++++-
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 011223456788899999999999999 699998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.03 Aligned_cols=250 Identities=22% Similarity=0.276 Sum_probs=193.6
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.||+|+||.||++... .++.||+|.+.... ...+.+.+|+++++.++||||+++++.+..+...++||||++
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (305)
T cd05609 5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVE 84 (305)
T ss_pred EeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 4578999999999999885 57899999987543 234568899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC---
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR--- 501 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~--- 501 (667)
+++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 85 g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 85 GGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 99999999653 2588899999999999999999988 99999999999999999999999999987421110
Q ss_pred ----------ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHH
Q 005953 502 ----------SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI 571 (667)
Q Consensus 502 ----------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 571 (667)
.........++..|+|||.+... .++.++|+||||+++|||++|+.||..... ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~~------------~~~ 224 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTP------------EEL 224 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------HHH
Confidence 00011123478899999998653 678999999999999999999999853211 111
Q ss_pred HHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 572 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
........... .......+..+.+++.+||+.+|++||++.++.+.|+
T Consensus 225 ~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 225 FGQVISDDIEW--PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHHHHhcccCC--CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 11111111000 0011124556889999999999999999766666665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.52 Aligned_cols=263 Identities=21% Similarity=0.348 Sum_probs=194.4
Q ss_pred HhhhhcccCCCeEEEEEEeC---CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecC--CeeEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP---DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALI 419 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV 419 (667)
.+.++||+|+||.||+|+.. +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 34578999999999999885 47899999987632 3346778999999999999999999999988 789999
Q ss_pred EEEcCCCCccccccccc--cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC----CCceEEEeCCC
Q 005953 420 YEYMPNGSLGDLLSREK--ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP----DFTPKVSDFGL 493 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~----~~~~ki~DFGl 493 (667)
|||++ ++|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 83 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 83 FDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 99996 46777664322 223688999999999999999999988 9999999999999999 89999999999
Q ss_pred ccccCCCCc-eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchH---
Q 005953 494 AKAHSRNRS-VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPD--- 569 (667)
Q Consensus 494 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--- 569 (667)
++....... ........++..|+|||++.+. ..++.++||||||++++||++|+.||........ ....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~ 234 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIK---KSNPFQRDQL 234 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCccccc---ccchhHHHHH
Confidence 987643322 1122334578999999988653 3568899999999999999999999975433210 0000000
Q ss_pred -HHHHhhcC--------------------cc-ccccc-chhhH------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 570 -WIYDKLIQ--------------------PE-KEDFV-EEEDD------CIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 570 -~~~~~~~~--------------------~~-~~~~~-~~~~~------~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.+...+.. .. ..... ..... .....+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000 00 00000 00000 234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=296.83 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=192.1
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.++||+|+||.||+++.. +++.||+|.+.... .....+.+|+.++.++. |+||+++++++......+++|||+.
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~- 86 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD- 86 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-
Confidence 3478999999999999875 58999999987543 33457889999999996 9999999999999899999999985
Q ss_pred CCccccccc--cccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 426 GSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 426 gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
+++.++... ......+++..+.+++.+++.||+|||+. .+++||||||+||+++.++.+||+|||+++........
T Consensus 87 ~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 164 (288)
T cd06616 87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164 (288)
T ss_pred CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence 566554321 11234689999999999999999999963 38999999999999999999999999999765433221
Q ss_pred eeecCCCCCccccchhhhhhhc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNL-GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
....|+..|+|||++.... ..++.++||||||+++|||++|+.||..... ....+ ..........
T Consensus 165 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~~~~~-~~~~~~~~~~ 230 (288)
T cd06616 165 ---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----------VFDQL-TQVVKGDPPI 230 (288)
T ss_pred ---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----------HHHHH-hhhcCCCCCc
Confidence 2235789999999986531 2578899999999999999999999853321 00111 1111111111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
........+...+.+++.+||+.+|++|||+++|+++
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111112345678899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=285.22 Aligned_cols=269 Identities=22% Similarity=0.309 Sum_probs=201.2
Q ss_pred HHhhhhcccCCCeEEEEEEeC---C--CcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEec-CCeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP---D--GRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD-GSTRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~---~--~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~l 418 (667)
++...+||+|.||.||||.-+ + ...+|+|.++.++ .......+|+.+++.++||||+.|..++.+ +...++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 345678999999999999543 2 2378999998653 345678999999999999999999999887 778999
Q ss_pred EEEEcCCCCccccccc--cccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC----CceEEEeCC
Q 005953 419 IYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD----FTPKVSDFG 492 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~----~~~ki~DFG 492 (667)
++||.+ -+|..+|+. ......++...+..|++||+.|+.|||++ -|+||||||.|||+..+ |.|||+|||
T Consensus 106 ~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 106 LFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred Eehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeeccc
Confidence 999995 578888753 33346799999999999999999999998 89999999999999777 899999999
Q ss_pred CccccCCCCcee-eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC-CccccchHH
Q 005953 493 LAKAHSRNRSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN-TTEAYFPDW 570 (667)
Q Consensus 493 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~ 570 (667)
+++.+...-... .....+-|+.|.|||++.+. .++|.+.|||+.|||+.||+|-++.|....+..... .......+-
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999876543332 33445579999999999987 689999999999999999999998886543321111 111111122
Q ss_pred HHHhhcCccccc----------------cc----chh-hHH-------HHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 571 IYDKLIQPEKED----------------FV----EEE-DDC-------IARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 571 ~~~~~~~~~~~~----------------~~----~~~-~~~-------~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
+++.+..+.... +. ... ... -.....+++..+|+.||.+|.|+++.+++.-
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 222222221100 00 000 000 0123678889999999999999999998775
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=295.24 Aligned_cols=243 Identities=22% Similarity=0.351 Sum_probs=194.4
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
++||+|++|.||++... +++.+++|++.... ...+.+.+|+.++++++|+||+++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 68999999999999874 68899999886543 33456889999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCC
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 509 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 509 (667)
+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++......... ....
T Consensus 105 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~ 175 (285)
T cd06648 105 DIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSL 175 (285)
T ss_pred HHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--cccc
Confidence 99865 2478899999999999999999998 9999999999999999999999999988765433221 1234
Q ss_pred CCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhH
Q 005953 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589 (667)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (667)
.|+..|+|||.+.+. .++.++||||||+++|||++|+.|+..... ......+........ ....
T Consensus 176 ~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------------~~~~~~~~~~~~~~~--~~~~ 239 (285)
T cd06648 176 VGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------------LQAMKRIRDNLPPKL--KNLH 239 (285)
T ss_pred cCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCCH------------HHHHHHHHhcCCCCC--cccc
Confidence 588999999998653 678899999999999999999999854221 001111111111010 1111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 590 CIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.+...+.+++.+||+.+|++||++.+++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 234578899999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=289.00 Aligned_cols=246 Identities=27% Similarity=0.447 Sum_probs=198.7
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc-chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN-FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
..+.||+|++|.||++... +++.+++|++..... ..+.+.+|++.+++++|+|++++++++......++++||+++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 3578999999999999986 688999999976553 56789999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|.+++.... ..+++..+..++.|++++|+|||+. +++|+||+|+||++++++.++|+|||.+........ ..
T Consensus 84 L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~ 155 (253)
T cd05122 84 LKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RN 155 (253)
T ss_pred HHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---cc
Confidence 999986642 4689999999999999999999997 999999999999999999999999999987655432 12
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchh
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 587 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (667)
...++..|+|||.+... ..+.++||||||+++++|++|+.|+..... ........ ....... ..
T Consensus 156 ~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~-~~~~~~~--~~ 219 (253)
T cd05122 156 TMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELPP-----------MKALFKIA-TNGPPGL--RN 219 (253)
T ss_pred ceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCch-----------HHHHHHHH-hcCCCCc--Cc
Confidence 34578999999998764 578899999999999999999998864321 01111111 0000011 01
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 588 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
...+...+.+++.+||+.||++|||+.|++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11124578889999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=299.45 Aligned_cols=265 Identities=20% Similarity=0.252 Sum_probs=194.5
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.+.+|.|+++.||+++. +++.||||++... ....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 345566666666666665 7899999998754 234567999999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce---
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV--- 503 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~--- 503 (667)
+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+.........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999997543 23588899999999999999999998 9999999999999999999999999988654322110
Q ss_pred --eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC---------CC-ccccchHHH
Q 005953 504 --VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS---------NT-TEAYFPDWI 571 (667)
Q Consensus 504 --~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~---------~~-~~~~~~~~~ 571 (667)
.......++..|+|||++......++.++||||||+++|||++|+.||......... .. .....+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY- 239 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh-
Confidence 111233467899999998764345788999999999999999999999754221000 00 00000000
Q ss_pred HHhhcC-------cc-cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 572 YDKLIQ-------PE-KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 572 ~~~~~~-------~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
...... .. ...............+.+++.+||+.||++|||+++++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 000000 00 00001111223456788899999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=310.09 Aligned_cols=199 Identities=31% Similarity=0.530 Sum_probs=175.4
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCC------eeEEEEE
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS------TRALIYE 421 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------~~~lV~e 421 (667)
.+.||+||||.||+|+++ .|+.||||.++... ...+...+|+++|++++|+|||+++++-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 478999999999999975 69999999998743 45678899999999999999999999766544 5679999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC--CCC--ceEEEeCCCcccc
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD--PDF--TPKVSDFGLAKAH 497 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~--~~~--~~ki~DFGla~~~ 497 (667)
||++|||+.+|.+......+++..++.++.++..||.|||.+ +|+||||||.||++- ++| .-||+|||.|+.+
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 999999999999877778899999999999999999999988 999999999999983 333 4799999999998
Q ss_pred CCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCc
Q 005953 498 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTET 556 (667)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~ 556 (667)
..+. ..+...||..|++||++.+. +.++..+|.|||||++||.+||..||.+...
T Consensus 175 ~d~s---~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 175 DDNS---LFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred CCCC---eeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 7766 34667899999999999863 5788999999999999999999999987644
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=299.99 Aligned_cols=265 Identities=22% Similarity=0.305 Sum_probs=193.6
Q ss_pred hhcccC--CCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTG--GYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
++||+| +||+||++++. +|+.||+|++.... ...+.+.+|+.+++.++||||+++++++..+...++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999875 69999999987543 2246788899999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee-
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV- 504 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~- 504 (667)
++|.+++.+.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999987643 23588999999999999999999987 99999999999999999999999998654332211110
Q ss_pred -ee---cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC----------CCccccchH-
Q 005953 505 -TM---TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS----------NTTEAYFPD- 569 (667)
Q Consensus 505 -~~---~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~----------~~~~~~~~~- 569 (667)
.. ....++..|+|||++.+....++.++||||||+++|||++|+.||......... ......++.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 00 011246679999999765456788999999999999999999998653211000 000000000
Q ss_pred ---H----------HHHhhcC-----c-ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 570 ---W----------IYDKLIQ-----P-EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 570 ---~----------~~~~~~~-----~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
+ +.+.... . ................+.+++.+||+.||++|||+.|++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0 0000000 0 000011122234567889999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=296.76 Aligned_cols=258 Identities=21% Similarity=0.303 Sum_probs=191.8
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcc-cceEEeecceEecC--CeeEEEEEEc
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIH-HVNIIHLLGFCCDG--STRALIYEYM 423 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~--~~~~lV~e~~ 423 (667)
+.++||+|+||.||+|+.. +++.||+|+++... .......+|+..+.++. |+|++++++++.+. +..++|+||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 4578999999999999875 68899999987542 22334568999999995 99999999999987 8899999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
+ |+|.+.+.... ..+++..+..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++........
T Consensus 83 ~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 83 D-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred C-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 6 67877775432 3589999999999999999999998 9999999999999999 99999999999876433221
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC----CccccchHHHHHhhcCcc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN----TTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 579 (667)
....++..|+|||.+... +..+.++|||||||++|||++|+.||.......... ........+ ........
T Consensus 156 ---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 230 (282)
T cd07831 156 ---TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKSR 230 (282)
T ss_pred ---CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhcccc
Confidence 223478899999987543 456889999999999999999999986432210000 000000111 11111100
Q ss_pred cccc---------cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 580 KEDF---------VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 580 ~~~~---------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.... .......++..+.+++.+||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 001112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=289.78 Aligned_cols=247 Identities=27% Similarity=0.392 Sum_probs=199.9
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecC--CeeEEEEEEcC
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIYEYMP 424 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~~ 424 (667)
.+.||+|++|.||+|... +++.|++|++.... ...+.+.+|+..+++++|+||+++++.+.+. ...++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 467999999999999986 68999999987654 3457889999999999999999999999988 88999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.+++.... .+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.+||+|||.+..........
T Consensus 85 ~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 85 GGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 999999987543 689999999999999999999997 99999999999999999999999999998776543211
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
......++..|+|||.+... ..+.++||||||+++++|++|+.|+..... ...... .+..... .
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------~~~~~~-~~~~~~~---~ 222 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELGN----------PMAALY-KIGSSGE---P 222 (260)
T ss_pred cccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCc----------hHHHHH-hccccCC---C
Confidence 12334578999999998764 578899999999999999999999865431 011111 1111111 1
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
..........+.+++.+|++.+|++||++.|++.+
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11122235678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=295.56 Aligned_cols=244 Identities=24% Similarity=0.325 Sum_probs=197.4
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||.|+||.||+++.. +++.||+|++.... ...+.+.+|++++++++||||+++++.+.++...++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 35678999999999999986 58999999987532 34578899999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
.+++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 155 (258)
T cd05578 83 LGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL- 155 (258)
T ss_pred CCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-
Confidence 999999998654 3688999999999999999999988 999999999999999999999999999887654321
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
.....|+..|+|||.+... ..+.++|+||||+++|+|++|+.|+...... ...+.........
T Consensus 156 --~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~~~~~~---- 218 (258)
T cd05578 156 --TTSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---------IRDQIRAKQETAD---- 218 (258)
T ss_pred --ccccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCcc---------HHHHHHHHhcccc----
Confidence 2345578999999998764 5788999999999999999999998654320 1112222211111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSM--TRVV 617 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~--~evl 617 (667)
..........+.+++.+||+.+|.+||++ +|++
T Consensus 219 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 -VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11112234678899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.27 Aligned_cols=241 Identities=27% Similarity=0.384 Sum_probs=195.5
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||.||++.+. +++.+|+|++.... ...+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV 83 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence 35678999999999999885 58999999986532 33467889999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++......
T Consensus 84 ~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~-- 155 (290)
T cd05580 84 PGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-- 155 (290)
T ss_pred CCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC--
Confidence 999999998654 3588999999999999999999997 99999999999999999999999999998765431
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
....+++.|+|||.+... ..+.++||||||+++|||++|+.||..... ......+......
T Consensus 156 ---~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~-- 216 (290)
T cd05580 156 ---YTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNP------------IQIYEKILEGKVR-- 216 (290)
T ss_pred ---CCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHhcCCcc--
Confidence 233578999999998653 678899999999999999999999864321 1112222211111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 619 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~ 619 (667)
........+.+++.+||+.+|++|+ +++|++++
T Consensus 217 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 217 ---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 1111245678899999999999999 77777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=325.84 Aligned_cols=254 Identities=26% Similarity=0.441 Sum_probs=202.1
Q ss_pred hhhhcccCCCeEEEEEEeC----C----CcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP----D----GRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~----~----~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 418 (667)
+.+.||+|+||.|++|... . ...||||+++... ...+.+..|+++|+.+ +|+||+.++|+|.+++..++
T Consensus 300 ~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~ 379 (609)
T KOG0200|consen 300 LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYV 379 (609)
T ss_pred ccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEE
Confidence 4568999999999999753 1 4579999998654 3457899999999999 69999999999999999999
Q ss_pred EEEEcCCCCccccccccc-----cC--------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCc
Q 005953 419 IYEYMPNGSLGDLLSREK-----EN--------LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT 485 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~ 485 (667)
|.||+..|+|.++|...+ .. ..+....++.++.|||.|++||++. ++|||||.++|||+.++..
T Consensus 380 v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 380 IVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKV 456 (609)
T ss_pred EEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCE
Confidence 999999999999997654 00 2388899999999999999999998 9999999999999999999
Q ss_pred eEEEeCCCccccCCCCceeee-cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCc
Q 005953 486 PKVSDFGLAKAHSRNRSVVTM-TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTT 563 (667)
Q Consensus 486 ~ki~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~ 563 (667)
+||+|||+|+........... ....-+..|||||.+.. ..++.|+|||||||+||||+| |..|+...
T Consensus 457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~--------- 525 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGI--------- 525 (609)
T ss_pred EEEccccceeccCCCCceEecCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCC---------
Confidence 999999999977665544321 11113667999999986 488999999999999999998 44454321
Q ss_pred cccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 564 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
.....+.+.+.++.. .+.+.....+++++|..||+.+|++||++.++++.++..
T Consensus 526 --~~~~~l~~~l~~G~r----~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 526 --PPTEELLEFLKEGNR----MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred --CcHHHHHHHHhcCCC----CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 111222333333322 222223366889999999999999999999999999863
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=298.84 Aligned_cols=263 Identities=22% Similarity=0.322 Sum_probs=195.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
++.++||+|+||.||+|.+. +++.||+|+++.. ....+.+.+|++++++++|+||+++++++.+++..++|+||++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 83 (288)
T cd07833 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE 83 (288)
T ss_pred eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCC
Confidence 45678999999999999886 5889999998753 2334678999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
++.+..++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 84 ~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~- 156 (288)
T cd07833 84 RTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS- 156 (288)
T ss_pred CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-
Confidence 87776655432 3488999999999999999999998 9999999999999999999999999999876554321
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC----ccccchHHHHHhhcCccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT----TEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 580 (667)
......++..|+|||++... ..++.++||||||+++|||++|+.|+........... .....+............
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred cccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 12334578899999998754 2678899999999999999999998864321000000 000000000000000000
Q ss_pred c-----cc-c-----chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 581 E-----DF-V-----EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 581 ~-----~~-~-----~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
. .. . ......+...+.+++.+||+.+|++||++++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 00 0 00111235778999999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.96 Aligned_cols=249 Identities=22% Similarity=0.358 Sum_probs=198.5
Q ss_pred hhhhcccCCCeEEEEEEeCC-CcEEEEEEcccC-CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 350 FKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKT-SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
+...||.|+||.||||..++ +-..|-|++... ....++|+-||++|....||+||+|++.+...+.++++.|||.||-
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGA 115 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGA 115 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCch
Confidence 35679999999999998865 445667888654 3556889999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
.+.++-.. +..+++.++.-+.++++.||.|||+. +|||||||+.|||++-+|.++|+|||.+...... .....
T Consensus 116 VDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qkRD 188 (1187)
T KOG0579|consen 116 VDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQKRD 188 (1187)
T ss_pred HhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH--Hhhhc
Confidence 99888654 34699999999999999999999998 9999999999999999999999999987543221 12234
Q ss_pred CCCCCccccchhhhhhh---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 508 GPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
...|||.|||||+.+-. ...|+.++||||||+.|.||..+.+|.....+ --+.-++.+.....+
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------------MRVllKiaKSePPTL- 255 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------------MRVLLKIAKSEPPTL- 255 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------------HHHHHHHhhcCCCcc-
Confidence 57799999999997421 24678899999999999999998887643321 112222322222221
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
..+......+.+++.+||..||..||++.+++++
T Consensus 256 -lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 256 -LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2233456788899999999999999999998864
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=289.25 Aligned_cols=241 Identities=26% Similarity=0.355 Sum_probs=192.7
Q ss_pred cccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 354 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 354 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
||.|++|.||+++.. +++.+|+|++.... ...+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999985 48899999986543 3346789999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.+++.+.. .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~~ 151 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWT 151 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---ccc
Confidence 99997543 488899999999999999999997 999999999999999999999999999987654321 122
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (667)
..++..|+|||.+... .++.++|+||||+++|||++|+.|+...... +................ +
T Consensus 152 ~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------~~~~~~~~~~~~~~~~~---~ 216 (262)
T cd05572 152 FCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDED----------PMEIYNDILKGNGKLEF---P 216 (262)
T ss_pred ccCCcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----------HHHHHHHHhccCCCCCC---C
Confidence 3578899999998653 6788999999999999999999998654310 11112222211111111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 005953 589 DCIARKMIIVGLWCIQINPKDRPS-----MTRVVE 618 (667)
Q Consensus 589 ~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 618 (667)
......+.+++.+||+.+|++||+ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 112557889999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=294.89 Aligned_cols=244 Identities=26% Similarity=0.334 Sum_probs=191.6
Q ss_pred cccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 354 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 354 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
||+|+||+||++... +|+.+|+|++.... .....+.+|++++++++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999864 68999999986432 2234577899999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++........ ...
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~ 153 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKG 153 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---ccc
Confidence 99987543 24689999999999999999999998 999999999999999999999999999876543221 123
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (667)
..++..|+|||++.+. .++.++||||||+++++|++|+.||...... .....+....... . ....
T Consensus 154 ~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~-~----~~~~ 218 (277)
T cd05577 154 RAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKEK--------VEKEELKRRTLEM-A----VEYP 218 (277)
T ss_pred ccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCccc--------ccHHHHHhccccc-c----ccCC
Confidence 4578899999998754 5788999999999999999999998654321 0011111111110 0 0111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005953 589 DCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 619 (667)
Q Consensus 589 ~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~ 619 (667)
......+.+++.+||+.+|++|| ++.+++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 12355778899999999999999 66667653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=293.74 Aligned_cols=245 Identities=23% Similarity=0.346 Sum_probs=201.5
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.||+|.|+.|-.|++- +|+.||||++.+.+ .....+..|++.|+.++|||||+||.+......+|||+|.-.+
T Consensus 22 LekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~ 101 (864)
T KOG4717|consen 22 LEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDG 101 (864)
T ss_pred hhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCC
Confidence 4467999999999999764 89999999998764 2335688999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC-CCCceEEEeCCCccccCCCCcee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~-~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
|+|.|||-... ..+.+....+++.||+.|+.|+|+. .+|||||||+||.+- .-|-+||.|||++..+.++...
T Consensus 102 GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL- 175 (864)
T KOG4717|consen 102 GDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL- 175 (864)
T ss_pred chHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcchh-
Confidence 99999996543 3588999999999999999999987 999999999999875 4588999999999888777654
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
+...|+..|-|||.+.+.. .-.+++||||||||||.|++|+.||+..... ...-.+++-.
T Consensus 176 --~TsCGSLAYSAPEILLGDs-YDAPAVDiWSLGVILyMLVCGq~PFqeANDS------------ETLTmImDCK----- 235 (864)
T KOG4717|consen 176 --TTSCGSLAYSAPEILLGDS-YDAPAVDIWSLGVILYMLVCGQPPFQEANDS------------ETLTMIMDCK----- 235 (864)
T ss_pred --hcccchhhccCchhhhcCc-cCCcchhhhHHHHHHHHHHhCCCccccccch------------hhhhhhhccc-----
Confidence 4456899999999998862 3357899999999999999999999754321 0011111111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
...+..+..+..+++..||..||.+|.+.+|++..-
T Consensus 236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTS 271 (864)
T ss_pred ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccc
Confidence 122334567788899999999999999999998653
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=295.83 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=195.5
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecC--CeeEEEEEEc
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIYEYM 423 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~ 423 (667)
+.++||+|+||.||+|+.. +++.+|+|++.... .....+.+|++++++++|+|++++++++.+. ...++|+||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 4578999999999999886 48899999997652 3346788999999999999999999999988 8899999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
+ ++|.+++.... ..+++..++.++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 83 ~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 83 D-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred c-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 7 58888886542 3689999999999999999999987 9999999999999999999999999999876544321
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC--------CccccchHH----H
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN--------TTEAYFPDW----I 571 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~--------~~~~~~~~~----~ 571 (667)
..+...++..|+|||.+.+. ..++.++||||||+++|||++|+.|+.......... .....++.+ .
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 157 -DYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred -cccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 12334568899999987653 357889999999999999999999986433210000 000000000 0
Q ss_pred HHhhcCccc-ccccchhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 572 YDKLIQPEK-EDFVEEEDDC-IARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 572 ~~~~~~~~~-~~~~~~~~~~-~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
......... .....+.... ++..+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000 0000011111 25678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=297.14 Aligned_cols=261 Identities=26% Similarity=0.357 Sum_probs=189.2
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++++++|+||+++++++.++...++|+||+. +
T Consensus 9 ~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~ 87 (291)
T cd07870 9 NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-T 87 (291)
T ss_pred EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-C
Confidence 4578999999999999875 68899999986543 233467899999999999999999999999999999999995 6
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++.... ..+.+..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++........ .
T Consensus 88 ~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~ 160 (291)
T cd07870 88 DLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--Y 160 (291)
T ss_pred CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--C
Confidence 7776664332 3477888899999999999999998 9999999999999999999999999999764332211 1
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC---------CCccccchHHH-----H
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS---------NTTEAYFPDWI-----Y 572 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~---------~~~~~~~~~~~-----~ 572 (667)
....++..|+|||++.+. ..++.++||||||+++|||++|+.||......... ......++... .
T Consensus 161 ~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 233468999999998643 35678999999999999999999998654321000 00000000000 0
Q ss_pred HhhcCcccccccchhh--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 573 DKLIQPEKEDFVEEED--DCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 573 ~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
................ ......+.+++.+|++.||++|||+.|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000000000 0013467789999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=296.78 Aligned_cols=255 Identities=22% Similarity=0.332 Sum_probs=191.4
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcc-cceEEeecceEecCCe-----eEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGST-----RALI 419 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~-----~~lV 419 (667)
..+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+.++++++ |+||+++++++..... .++|
T Consensus 5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 4578999999999999875 68999999876542 23467889999999995 6999999999887665 8999
Q ss_pred EEEcCCCCcccccccccc--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC-CCceEEEeCCCccc
Q 005953 420 YEYMPNGSLGDLLSREKE--NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKA 496 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~-~~~~ki~DFGla~~ 496 (667)
|||+++ +|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++.
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 999975 88888764321 34689999999999999999999988 9999999999999998 89999999999976
Q ss_pred cCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhc
Q 005953 497 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 576 (667)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (667)
....... .....+++.|+|||.+.+. ..++.++||||||+++|||++|+.||...... .... .+...+.
T Consensus 161 ~~~~~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~------~~~~--~~~~~~~ 229 (295)
T cd07837 161 FSIPVKS--YTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL------QQLL--HIFKLLG 229 (295)
T ss_pred cCCCccc--cCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH------HHHH--HHHHHhC
Confidence 5432221 1233468899999998653 35788999999999999999999988643210 0000 0000000
Q ss_pred Ccc-------------------cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 577 QPE-------------------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 577 ~~~-------------------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.+. ...........+...+.+++.+||+.||++||++.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 0000001112345678899999999999999999998854
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=295.67 Aligned_cols=261 Identities=24% Similarity=0.359 Sum_probs=191.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.++||+|++|+||+|+.. +++.||+|.+.... ...+.+.+|++++++++|+||+++++++.++...++||||++
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD 84 (294)
T ss_pred EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence 34578999999999999885 68899999986542 234678899999999999999999999999999999999995
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC-CCceEEEeCCCccccCCCCce
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~-~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|.+++.... ....++..+..++.|++.||+|||+. +++|+||+|+||++++ ++.+||+|||++........
T Consensus 85 -~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~- 158 (294)
T PLN00009 85 -LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR- 158 (294)
T ss_pred -ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence 57877775432 33467888899999999999999988 9999999999999985 56799999999976543221
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC--------CCccc------cchH
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEA------YFPD 569 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~--------~~~~~------~~~~ 569 (667)
......+++.|+|||++.+. ..++.++||||||+++|||++|+.||......... ..... ..++
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 159 -TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred -ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 11334578899999998653 45788999999999999999999998643210000 00000 0000
Q ss_pred HHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 570 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
+... ...................+.+++.+||+.+|++||++.+++++
T Consensus 237 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 237 YKSA--FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhh--cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00000000000112234568889999999999999999999864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=301.80 Aligned_cols=262 Identities=26% Similarity=0.350 Sum_probs=193.3
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHHhhc-ccceEEeecceEecC--CeeEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDG--STRALIY 420 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~--~~~~lV~ 420 (667)
+.+.+.||+|+||.||+|.+. +++.+|+|++... ......+.+|+.+++++ +|+||+++++++... ...++||
T Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07852 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF 88 (337)
T ss_pred HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence 445688999999999999875 5889999988542 22345677899999999 999999999988643 4689999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||++ ++|.+++... .+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.....
T Consensus 89 e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 89 EYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred cccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9996 6888887543 578889999999999999999987 9999999999999999999999999999866433
Q ss_pred Cce---eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC--------CCccc----
Q 005953 501 RSV---VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEA---- 565 (667)
Q Consensus 501 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~--------~~~~~---- 565 (667)
... .......|+..|+|||.+.+. ...+.++||||||+++|||++|+.||......... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred cccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 112334588999999988654 46788999999999999999999998543211000 00000
Q ss_pred ---cchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 566 ---YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 566 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.........+...... ........+...+.+++.+||+.+|++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRK-PLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHhhhHHHhhhhccccccc-chhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000000 0011111245678899999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=291.79 Aligned_cols=245 Identities=27% Similarity=0.405 Sum_probs=194.7
Q ss_pred cccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 354 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 354 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
||+|+||.||+++.. +++.+++|++.... ...+.+.+|++++++++|+||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 48999999987543 2346788999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc------
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS------ 502 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~------ 502 (667)
.+++.+.. .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997543 589999999999999999999987 999999999999999999999999999876543321
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
........++..|+|||.+... ..+.++||||||+++|||++|+.|+..... ......+......
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~- 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGETP------------EEIFQNILNGKIE- 219 (265)
T ss_pred cccccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHhcCCcC-
Confidence 0112334578899999998764 578899999999999999999999864321 1111222211111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
. .........+.+++.+||+.+|++|||+.++.+.|+
T Consensus 220 ~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 W--PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred C--CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 001112567889999999999999999977766665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=297.07 Aligned_cols=247 Identities=27% Similarity=0.391 Sum_probs=193.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+...+.||+|+||.||+|+.. +++.+|+|.+.... ...+++.+|+++++.++|+|++++++++......++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 334578999999999999975 57899999886421 2345688999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+. |+|.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 97 ~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 97 CL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred cC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 96 68877775432 3478999999999999999999987 9999999999999999999999999998765432
Q ss_pred eeeecCCCCCccccchhhhhh-hcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
....++..|+|||.+.. ..+..+.++||||||+++|||++|+.|+..... ..... .+......
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~~-~~~~~~~~ 232 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALY-HIAQNESP 232 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-----------HHHHH-HHhhcCCC
Confidence 22347889999999853 124578899999999999999999998754321 00111 11111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
..........+.+++.+||+.+|++||++.+++++..
T Consensus 233 ---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 233 ---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 1111234566888999999999999999999998765
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=277.39 Aligned_cols=271 Identities=24% Similarity=0.369 Sum_probs=211.3
Q ss_pred CHHHHHHHHHHhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCCc-chHHHHHHHHHHhhcc-cceEEeecceEecCCe
Q 005953 339 SYNDIKKMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSN-FSDNFINEVATIGRIH-HVNIIHLLGFCCDGST 415 (667)
Q Consensus 339 ~~~~l~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~ 415 (667)
+++|+-+.| .+.||+|+|+.|-.++. .+|..+|||++.+... ...+..+|++++.+.+ |+||++|+.++++++.
T Consensus 74 ~F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 355666665 47899999999998864 6899999999988764 3467899999999995 9999999999999999
Q ss_pred eEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC---ceEEEeCC
Q 005953 416 RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF---TPKVSDFG 492 (667)
Q Consensus 416 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~---~~ki~DFG 492 (667)
.|||||-|.||+|..+|++.+ .+++..+.++.++|+.||.|||.+ +|.|||+||+|||-.+-. -+||+||.
T Consensus 151 FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred EEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccc
Confidence 999999999999999997654 589999999999999999999998 999999999999996554 48999999
Q ss_pred CccccCCCC-----ceeeecCCCCCccccchhhhh---hhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCc-CCCCCCc
Q 005953 493 LAKAHSRNR-----SVVTMTGPRGTIGYIAPEIFM---RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTET-TSGSNTT 563 (667)
Q Consensus 493 la~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~---~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~-~~~~~~~ 563 (667)
|..-+.... .......+.|+..|||||+.. +....++.++|.||||||||-||+|-+||...-. ..+....
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 986432211 112345678999999999873 3334668899999999999999999999976432 2222222
Q ss_pred ccc--chHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 564 EAY--FPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 564 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
+.- -...+++.+.++.. .+.......++....+++...+-.++.+|-++.+++.+
T Consensus 305 e~Cr~CQ~~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CccHHHHHHHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 211 12234444444433 23344455667777888888889999999999999874
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=302.31 Aligned_cols=265 Identities=22% Similarity=0.297 Sum_probs=192.9
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC--CcchHHHHHHHHHHhhcccceEEeecceEecC-----CeeEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT--SNFSDNFINEVATIGRIHHVNIIHLLGFCCDG-----STRALIY 420 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~~~lV~ 420 (667)
.+.++||+|+||.||+|+.. +|+.||+|++... ......+.+|+.++++++|+||+++++++... ...++|+
T Consensus 8 ~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 87 (336)
T cd07849 8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQ 87 (336)
T ss_pred EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEe
Confidence 34578999999999999874 6899999998643 23446788999999999999999999987654 3579999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||++ ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 88 ELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred hhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 9996 577776643 2588999999999999999999998 9999999999999999999999999999765432
Q ss_pred Ccee-eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC----ccccchHHHHHhh
Q 005953 501 RSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT----TEAYFPDWIYDKL 575 (667)
Q Consensus 501 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 575 (667)
.... ......|+..|+|||.+.+. ..++.++||||||+++|||++|+.||........... ......+. ...+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 237 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED-LNCI 237 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH-HHHh
Confidence 2211 11234578999999987543 3578899999999999999999999854321000000 00000000 0000
Q ss_pred cCcc---------cccc--cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhc
Q 005953 576 IQPE---------KEDF--VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM--LSSA 623 (667)
Q Consensus 576 ~~~~---------~~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~--L~~~ 623 (667)
.... .... ...........+.+++.+||+.+|++|||+.|++++ ++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000 0000 000111235678899999999999999999999988 5533
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=295.43 Aligned_cols=264 Identities=25% Similarity=0.379 Sum_probs=192.1
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCC---------
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS--------- 414 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--------- 414 (667)
+.+.+.||+|+||.||+|+.+ +++.||+|+++... .....+.+|++++++++||||+++++++.+..
T Consensus 9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 88 (302)
T cd07864 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDK 88 (302)
T ss_pred hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccC
Confidence 345688999999999999985 58899999987542 23356788999999999999999999987654
Q ss_pred -eeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCC
Q 005953 415 -TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 493 (667)
Q Consensus 415 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGl 493 (667)
..++|+||+++ ++.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+
T Consensus 89 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 89 GAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred CcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccc
Confidence 78999999975 676666543 23589999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC--------CCccc
Q 005953 494 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEA 565 (667)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~--------~~~~~ 565 (667)
+......... ......++..|+|||.+.+. ...+.++||||||+++|||++|+.||......... .....
T Consensus 163 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 163 ARLYNSEESR-PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccCCccc-ccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 9876543321 11223457889999988643 35688999999999999999999998643210000 00000
Q ss_pred cchHHHHHhh---cCccc--ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 566 YFPDWIYDKL---IQPEK--EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 566 ~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.+++...... .+... ...........+..+.+++.+||+.+|++||++.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000000 00000 000001111235678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=293.39 Aligned_cols=243 Identities=23% Similarity=0.362 Sum_probs=192.8
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
.+||+|+||.||++... +++.||+|++.... ...+.+.+|+.++++++|+|++++++.+..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 67999999999999884 68999999886433 33457889999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCC
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 509 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 509 (667)
+++... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......... ....
T Consensus 106 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 176 (292)
T cd06657 106 DIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSL 176 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccc--cccc
Confidence 987532 478899999999999999999998 9999999999999999999999999998765433211 1234
Q ss_pred CCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhH
Q 005953 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589 (667)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (667)
.|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .....+.... ..... ...
T Consensus 177 ~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--------~~~~~~~~~~-~~~~~-----~~~ 240 (292)
T cd06657 177 VGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDNL-PPKLK-----NLH 240 (292)
T ss_pred ccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhhC-CcccC-----Ccc
Confidence 57899999998865 36788999999999999999999998543210 0001111111 00000 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 590 CIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.+...+.+++.+||+.+|.+||++.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 234567789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=288.78 Aligned_cols=245 Identities=27% Similarity=0.406 Sum_probs=198.5
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.++||+|+||.||+++.. +++.+|+|.+.... ....++.+|++++++++|+||+++++++.+....++|+||+++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd08530 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPF 83 (256)
T ss_pred EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCC
Confidence 4578999999999999875 68899999987532 3345788999999999999999999999999999999999999
Q ss_pred CCccccccccc-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 426 GSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 426 gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
++|.+++.+.. ....+++..++.++.+++.||+|||+. +++|+||+|+||++++++.+||+|||+++......
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~--- 157 (256)
T cd08530 84 GDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--- 157 (256)
T ss_pred CCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC---
Confidence 99999986522 235689999999999999999999988 99999999999999999999999999998765441
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....++..|+|||.+.+. .++.++|+||||+++|||++|+.|+..... .............
T Consensus 158 -~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~--- 219 (256)
T cd08530 158 -AKTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSM------------QDLRYKVQRGKYP--- 219 (256)
T ss_pred -cccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHhcCCCC---
Confidence 1234578999999998653 678899999999999999999999864321 0111111111111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.........+.+++.+||+.+|++||++.|++++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 -PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1122445678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=316.67 Aligned_cols=267 Identities=19% Similarity=0.268 Sum_probs=182.6
Q ss_pred HHHhhhhcccCCCeEEEEEEeCC--CcEEEEE------------------EcccCCcchHHHHHHHHHHhhcccceEEee
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFPD--GRLVAVK------------------VLEKTSNFSDNFINEVATIGRIHHVNIIHL 406 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l 406 (667)
.|.+.++||+|+||+||++.+.. +..+++| .+.........+.+|+.+|++++|+||+++
T Consensus 149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 228 (501)
T PHA03210 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI 228 (501)
T ss_pred ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence 34566899999999999987532 2222222 122222334568899999999999999999
Q ss_pred cceEecCCeeEEEEEEcCCCCccccccccc--cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC
Q 005953 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREK--ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF 484 (667)
Q Consensus 407 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~ 484 (667)
++++.+....++|+|++ .++|.+++.... .........+..|+.|++.||+|||+. +|+||||||+|||++.++
T Consensus 229 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 229 EEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304 (501)
T ss_pred eEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence 99999999999999998 467777664321 112234566788999999999999998 999999999999999999
Q ss_pred ceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCC-CCCCcCCCC---
Q 005953 485 TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHL-RPTETTSGS--- 560 (667)
Q Consensus 485 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~-~~~~~~~~~--- 560 (667)
.+||+|||+++.+....... .....||..|+|||++.+. .++.++|||||||++|||++|+.++ .........
T Consensus 305 ~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999998765433221 2335689999999999764 6789999999999999999987543 221110000
Q ss_pred ------CCccccch---HHHHHhhcCcccccccch---h--hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 561 ------NTTEAYFP---DWIYDKLIQPEKEDFVEE---E--DDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 561 ------~~~~~~~~---~~~~~~~~~~~~~~~~~~---~--~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
......++ ..+++.+........... . .......+.+++.+||+.||++|||+.|++++-
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 00000000 011111110000000000 0 001223567788899999999999999999763
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=294.22 Aligned_cols=251 Identities=23% Similarity=0.400 Sum_probs=192.2
Q ss_pred HhhhhcccCCCeEEEEEEeCC-CcEEEEEEcccCC--cchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTS--NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.++||+|+||.||+|++.+ ++.||||+++... ....++..|+.++.+.. |+||+++++++.+....++||||++
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 356899999999999999864 8999999987543 23456777888777775 9999999999999999999999984
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
++|.+++.... ..+++..+..++.|++.||+|||+. .+|+||||+|+||++++++.+||+|||++.........
T Consensus 98 -~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~- 171 (296)
T cd06618 98 -TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171 (296)
T ss_pred -cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc-
Confidence 57777665432 3688999999999999999999962 28999999999999999999999999998765433221
Q ss_pred eecCCCCCccccchhhhhhhc--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNL--GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~--~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
....++..|+|||.+.+.. +.++.++||||||+++|||++|+.||...... + + ............
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------~-~-~~~~~~~~~~~~ 238 (296)
T cd06618 172 --TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---------F-E-VLTKILQEEPPS 238 (296)
T ss_pred --cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---------H-H-HHHHHhcCCCCC
Confidence 2334788999999986542 34788999999999999999999998542110 0 1 111111111111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
... ...+...+.+++.+||+.||++||++.+++++-
T Consensus 239 ~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 239 LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 100 112345788999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=296.22 Aligned_cols=263 Identities=22% Similarity=0.351 Sum_probs=192.7
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecC--CeeEEEEEEc
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIYEYM 423 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~ 423 (667)
+.+.||+|+||.||+|+.. +|+.||+|++.... .....+.+|+.++++++|+||+++++++... +..++||||+
T Consensus 11 ~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (309)
T cd07845 11 KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC 90 (309)
T ss_pred EeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecC
Confidence 4578999999999999885 58999999986432 2234567899999999999999999998755 4689999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
. ++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 91 ~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 164 (309)
T cd07845 91 E-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164 (309)
T ss_pred C-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence 6 58888876532 4589999999999999999999998 9999999999999999999999999999876543221
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC--------CCccccchHHHH---
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEAYFPDWIY--- 572 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~--- 572 (667)
.....++..|+|||.+.+. ..++.++||||||+++|||++|+.||......... ......++....
T Consensus 165 --~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 165 --MTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred --CCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 1233457889999998653 35788999999999999999999998643221000 000000000000
Q ss_pred -HhhcCc-ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 573 -DKLIQP-EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 573 -~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
...... ..............+.+.+++.+||+.||++|||++|++++--
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 000000 0000000111123567788999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=293.47 Aligned_cols=261 Identities=23% Similarity=0.365 Sum_probs=193.9
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc--chHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN--FSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.||+|++|+||+|+.. +++.|+||++..... ......+|+..+++++ |+||+++++++.+++..++||||+ +
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 81 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E 81 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence 4578999999999999986 478999999875432 2234567999999998 999999999999999999999999 8
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||+++........
T Consensus 82 ~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 155 (283)
T cd07830 82 GNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-- 155 (283)
T ss_pred CCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc--
Confidence 89998886543 34689999999999999999999998 9999999999999999999999999999866443221
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCC--------CCCccccchHHH-HHhhc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG--------SNTTEAYFPDWI-YDKLI 576 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~-~~~~~ 576 (667)
....++..|+|||.+.+. ..++.++|+||||+++|||++|+.||........ .......+.... .....
T Consensus 156 -~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 156 -TDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred -CCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 234478899999988654 4578899999999999999999988854321100 000000000000 00000
Q ss_pred Ccccccc----cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 577 QPEKEDF----VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 577 ~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
....... ...........+.+++.+||+.+|++|||++|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 000001113578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=295.60 Aligned_cols=265 Identities=22% Similarity=0.370 Sum_probs=189.3
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCC--------e
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS--------T 415 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--------~ 415 (667)
+.+.++||+|+||.||+|+.. +++.||||++.... .....+.+|++++++++||||+++++++.... .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 345578999999999999875 68999999886432 22345678999999999999999999987654 4
Q ss_pred eEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 416 RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 416 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
.++||||+. ++|.+++... ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++.
T Consensus 94 ~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 94 FYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred EEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 599999995 5787777543 23589999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCce--eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC--------CCccc
Q 005953 496 AHSRNRSV--VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NTTEA 565 (667)
Q Consensus 496 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~--------~~~~~ 565 (667)
........ .......++..|+|||.+.+. ..++.++||||||+++|||++|+.|+......... .....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 66432211 112234578899999988653 34678999999999999999999988643210000 00000
Q ss_pred cchHH----HHHhhcCcccc-cccchh--hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 566 YFPDW----IYDKLIQPEKE-DFVEEE--DDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 566 ~~~~~----~~~~~~~~~~~-~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.++.. .+..+..+... ...... .......+.+++.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000 00000000000 000000 00012456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=287.45 Aligned_cols=247 Identities=26% Similarity=0.323 Sum_probs=192.0
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC------CcchHHHHHHHHHHhhcccceEEeecceEecC--CeeEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT------SNFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALI 419 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV 419 (667)
.+.+.||+|+||.||+|... +++.||+|.+... ......+.+|++++++++|+||+++++++.+. ...+++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 34678999999999999875 5899999987532 12335788999999999999999999998764 468899
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
+||+++++|.+++.... .+++..+.+++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 85 ~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 85 VEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 99999999999986432 478888999999999999999988 999999999999999999999999999986532
Q ss_pred CCc-eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 500 NRS-VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 500 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
... ........++..|+|||++.+. .++.++||||||+++|||++|+.||..... ...+.+....+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~~ 225 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEA-----------MAAIFKIATQP 225 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCH-----------HHHHHHHHcCC
Confidence 111 1111234588999999998753 678899999999999999999999864321 11111111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.. ...+..+.+.+.+++.+||+ +|..||++.+++.+
T Consensus 226 ~~----~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 TK----PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CC----CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11 11223345678889999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=290.96 Aligned_cols=252 Identities=22% Similarity=0.287 Sum_probs=196.0
Q ss_pred hhhhcccCCCeEEEEEEe----CCCcEEEEEEcccCC-----cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEE
Q 005953 350 FKEKLGTGGYGNVYKGKF----PDGRLVAVKVLEKTS-----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV 419 (667)
+.+.||+|+||.||+++. .+++.||||+++... ...+.+.+|+.++.++ +|+||+++++.+..+...++|
T Consensus 4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 457899999999999975 257889999987432 2345688999999999 599999999999999999999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||+++|+|.+++... ..+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 84 LDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 9999999999988643 3588899999999999999999987 999999999999999999999999999876544
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
..... .....|+..|+|||.+.+.....+.++||||||+++|||++|+.|+...... .....+........
T Consensus 158 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~~~~~~~~~~ 228 (288)
T cd05583 158 EEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--------NSQSEISRRILKSK 228 (288)
T ss_pred ccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--------chHHHHHHHHHccC
Confidence 32211 1234578999999998654334688999999999999999999998532210 00111111111111
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
. .........+.+++.+||+.+|++|||+.++.+.|+
T Consensus 229 ~-----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 229 P-----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred C-----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 1 111123456788999999999999999988888776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=293.28 Aligned_cols=242 Identities=28% Similarity=0.421 Sum_probs=189.8
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.++||+|+||+||+|+.. +++.|++|++.... ...+.+.+|++++++++|||++++++++.+....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 367999999999999875 68899999986432 223568899999999999999999999999999999999995
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++.... ..+++..+..++.|++.+|+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 105 ~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~----- 174 (313)
T cd06633 105 GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----- 174 (313)
T ss_pred CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-----
Confidence 67777775432 3588999999999999999999988 9999999999999999999999999998643321
Q ss_pred ecCCCCCccccchhhhhhh-cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
....|+..|+|||++... .+.++.++||||||+++|||++|+.|+...... ....... ......
T Consensus 175 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-----------~~~~~~~-~~~~~~-- 239 (313)
T cd06633 175 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------SALYHIA-QNDSPT-- 239 (313)
T ss_pred -CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHH-hcCCCC--
Confidence 234578899999998531 246788999999999999999999988543210 0111111 110100
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.....+...+.+++.+||+.+|++||++.+++.+
T Consensus 240 -~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 -LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111234467889999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.32 Aligned_cols=258 Identities=23% Similarity=0.291 Sum_probs=189.9
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecC------CeeEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRAL 418 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~~l 418 (667)
...+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|+.++++++|+||+++++++... ...++
T Consensus 19 ~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 98 (353)
T cd07850 19 QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL 98 (353)
T ss_pred EEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEE
Confidence 34578999999999999875 6899999998643 23345678899999999999999999988643 35799
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
||||+. ++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 99 v~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 99 VMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred EEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 999995 588777743 278889999999999999999998 99999999999999999999999999998664
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC----CCccccchHH----
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS----NTTEAYFPDW---- 570 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~----~~~~~~~~~~---- 570 (667)
.... .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..... .........+
T Consensus 170 ~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 170 TSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred CCCC---CCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 3322 1234578999999998763 6789999999999999999999998643210000 0000000000
Q ss_pred ---HHHhhcC-ccc--------------ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 571 ---IYDKLIQ-PEK--------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 571 ---~~~~~~~-~~~--------------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
....... +.. ..............+.+++.+||+.||++|||+.|++++=
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 0000000 000 0000000123355678999999999999999999999663
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=288.99 Aligned_cols=281 Identities=24% Similarity=0.334 Sum_probs=212.8
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
-++||+||||.||-.... +|+.+|.|.+.+.. ....-.++|-.+|.+++.+.||.+--.+++.+.++||+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 368999999999998764 69999999886542 2234578899999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.-+|.+.. +..+++.+++.+|.+|+.||++||+. .||.||+||+|||||+.|+++|+|.|||..+......
T Consensus 270 GDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~-- 343 (591)
T KOG0986|consen 270 GDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI-- 343 (591)
T ss_pred CceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc--
Confidence 99999998755 35799999999999999999999998 9999999999999999999999999999988776643
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
++.+||.+|||||++.+. .++...|.|||||+||||+.|+.||....+ ..-.+.+...+.....
T Consensus 344 -~~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke--------Kvk~eEvdrr~~~~~~----- 407 (591)
T KOG0986|consen 344 -RGRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKE--------KVKREEVDRRTLEDPE----- 407 (591)
T ss_pred -ccccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhh--------hhhHHHHHHHHhcchh-----
Confidence 455799999999999875 588899999999999999999999964432 1111122222222111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHh--hcc--ccccCCCCCCCCCCCCCC--CCcccccccCC
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEMLS--SAS--AEAIEMPPKPLFPSPPQL--QTQNEIISFDS 653 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~~L~--~~~--~~~~~~~~~p~~~~~~~~--~~~~~~~~~~~ 653 (667)
+..+..+++...+....|+.||++|.. +++|-++=- .+. .-...|-++|+.|.|... .+.+.|..++.
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs~ 486 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFST 486 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhhccc
Confidence 112334556667777889999999963 445554321 000 112334555666655543 22344444443
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=288.36 Aligned_cols=243 Identities=24% Similarity=0.310 Sum_probs=186.4
Q ss_pred hcccCCCeEEEEEEeC-CCcEEEEEEcccCCc----chHHHHHHHH---HHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 353 KLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----FSDNFINEVA---TIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~---~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.||+|+||.||++... +++.||+|.+..... ....+..|.. .++...||||+++++++.+.+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 588999999865421 1123444444 3444579999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 99999888643 3589999999999999999999987 999999999999999999999999999876543221
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
....|+..|+|||.+.+. ..++.++||||+|+++|||++|+.||....... . .......... ..
T Consensus 153 --~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-----~----~~~~~~~~~~-~~--- 216 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----K----HEIDRMTLTM-AV--- 216 (278)
T ss_pred --cCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-----h----HHHHHHhhcc-CC---
Confidence 234589999999998643 257889999999999999999999986542210 0 0111111100 00
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~L 620 (667)
......+..+.+++.+||+.+|++|| ++.+++++-
T Consensus 217 -~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 217 -ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 11112356788899999999999999 999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=289.27 Aligned_cols=261 Identities=21% Similarity=0.324 Sum_probs=197.3
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
..+.||+|++|.||+++.. +++.+++|.+..... ....+.+|+.++++++|+||+++++++..+...++|+||++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD- 81 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC-
Confidence 3577999999999999885 688999999865432 34678899999999999999999999999999999999996
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||.+........ .
T Consensus 82 ~~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~ 154 (283)
T cd05118 82 TDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--P 154 (283)
T ss_pred CCHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--c
Confidence 48888876532 4689999999999999999999998 999999999999999999999999999987655431 1
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCC-----------CCCccccchHHHHHh
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG-----------SNTTEAYFPDWIYDK 574 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~-----------~~~~~~~~~~~~~~~ 574 (667)
.....++..|+|||.+.+. ...+.++||||||+++|+|++|+.||........ .......+..+....
T Consensus 155 ~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred ccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 2334578899999998653 3678899999999999999999988854321000 000000000000000
Q ss_pred hcC-ccc-ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 575 LIQ-PEK-EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 575 ~~~-~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
... +.. ..............+.+++.+||+.||.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 000 000111223456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=285.85 Aligned_cols=243 Identities=24% Similarity=0.328 Sum_probs=187.0
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc----chHHHHHHHHHH-hhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----FSDNFINEVATI-GRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l-~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.||+|+||.||+|+.. +++.||+|++..... ....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999875 589999999875431 123345555544 445899999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 150 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----- 150 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence 9999998653 2578899999999999999999998 9999999999999999999999999998754331
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
....++..|+|||.+.+. .++.++||||||+++|||++|..|+..... ......+...... ...
T Consensus 151 -~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~-~~~ 214 (260)
T cd05611 151 -KKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETP------------DAVFDNILSRRIN-WPE 214 (260)
T ss_pred -ccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHhcccC-CCC
Confidence 223478899999998764 478899999999999999999999854321 0111111111100 011
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.....+...+.+++.+||+.+|++||++.++.+.|+
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 111134567889999999999999998766655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.27 Aligned_cols=256 Identities=18% Similarity=0.229 Sum_probs=178.7
Q ss_pred HHhhhhcccCCCeEEEEEEeCC----CcEEEEEEcccCCcch------------HHHHHHHHHHhhcccceEEeecceEe
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTSNFS------------DNFINEVATIGRIHHVNIIHLLGFCC 411 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~------------~~~~~Ei~~l~~l~h~niv~l~g~~~ 411 (667)
+.+.++||+|+||+||+|...+ +..+|+|+........ .....+...+..+.|+|++++++++.
T Consensus 14 y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 93 (294)
T PHA02882 14 WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGS 93 (294)
T ss_pred eEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeee
Confidence 4456889999999999998754 4566777643322110 11233445566678999999998765
Q ss_pred cCC----eeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceE
Q 005953 412 DGS----TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPK 487 (667)
Q Consensus 412 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 487 (667)
... ..++++|++. .++.+.+... ...++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 94 FKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred EecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEE
Confidence 443 3456777663 4565655432 2356788899999999999999987 999999999999999999999
Q ss_pred EEeCCCccccCCCCcee-----eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC
Q 005953 488 VSDFGLAKAHSRNRSVV-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT 562 (667)
Q Consensus 488 i~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~ 562 (667)
|+|||+|+......... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ..
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~~ 242 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--NL 242 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCccccch--HH
Confidence 99999998664322111 11234589999999998754 67999999999999999999999997542110 00
Q ss_pred ccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 563 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
....-.+ ....+..+... .....+.+.+++..||+.+|++||+++++++.|+
T Consensus 243 ~~~~~~~-~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCD-FIKRLHEGKIK------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHH-HHHHhhhhhhc------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0000001 11222221111 1112467889999999999999999999998763
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=290.08 Aligned_cols=250 Identities=24% Similarity=0.311 Sum_probs=193.8
Q ss_pred hhhhcccCCCeEEEEEEe----CCCcEEEEEEcccCC-----cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEE
Q 005953 350 FKEKLGTGGYGNVYKGKF----PDGRLVAVKVLEKTS-----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV 419 (667)
+.+.||+|+||.||+++. .+|+.||+|++.... ...+.+.+|+.+++++ +|+||+++++.+..+...++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 457899999999999986 368899999987532 2346688899999999 599999999999999999999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
+||+++++|.+++... ..+++..+..++.|+++||+|||+. +++||||+|+|||+++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 84 LDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 9999999999998653 3578899999999999999999987 999999999999999999999999999986543
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
.... ......|+..|+|||.+.......+.++||||||+++|||++|+.|+..... .... ..+...+....
T Consensus 158 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-------~~~~-~~~~~~~~~~~ 228 (290)
T cd05613 158 DEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-------KNSQ-AEISRRILKSE 228 (290)
T ss_pred cccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-------cccH-HHHHHHhhccC
Confidence 3211 1123457899999999875434567899999999999999999999853211 0001 11111211111
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 619 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~ 619 (667)
.. ....+...+.+++.+||+.+|++|| ++++++.+
T Consensus 229 ~~-----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 PP-----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CC-----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 10 1112345678899999999999997 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.00 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=192.7
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcc---------------hHHHHHHHHHHhhcccceEEeecceEecCC
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNF---------------SDNFINEVATIGRIHHVNIIHLLGFCCDGS 414 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---------------~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 414 (667)
.+.||+|+||+||+|... +++.||||++...... ...+.+|++++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467999999999999875 6899999998653221 125789999999999999999999999999
Q ss_pred eeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCc
Q 005953 415 TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 494 (667)
Q Consensus 415 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla 494 (667)
..++||||++ |+|.+++... ..+++.....++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccce
Confidence 9999999996 6898888643 3588999999999999999999987 9999999999999999999999999999
Q ss_pred cccCCCC------------ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCC---
Q 005953 495 KAHSRNR------------SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG--- 559 (667)
Q Consensus 495 ~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~--- 559 (667)
+...... .........++..|+|||.+.+. ..++.++||||||+++|||++|+.|+........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 7654111 01111233468899999998653 3568899999999999999999999864422000
Q ss_pred -----CCCccccchHHHHHhhcCccc---ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 560 -----SNTTEAYFPDWIYDKLIQPEK---EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 560 -----~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.......++.........+.. ..............+.+++.+||+.+|++||+++|++.+--
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 000000000000000000000 00000111122456889999999999999999999997654
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=284.69 Aligned_cols=244 Identities=23% Similarity=0.406 Sum_probs=197.7
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.+.||+|++|.||+++.. +++.|++|.+.... ...+.+.+|++++++++|+|++++++++.+.+..++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence 34678999999999999875 57899999987654 345678999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 83 NGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 99999998654 3589999999999999999999988 9999999999999999999999999999876544321
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....++..|+|||.+.+. ..+.++||||+|+++|+|++|+.|+..... ... ... .......
T Consensus 156 -~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----------~~~-~~~-~~~~~~~--- 217 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNP----------MAA-LFR-IVQDDHP--- 217 (254)
T ss_pred -ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccH----------HHH-HHH-HhccCCC---
Confidence 1234578999999998654 478899999999999999999998854321 010 111 1111111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 618 (667)
.....+...+.+++.+||+.+|++||++.+++.
T Consensus 218 -~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 -PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111223557788999999999999999999885
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=271.31 Aligned_cols=250 Identities=23% Similarity=0.367 Sum_probs=196.8
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+...||.|..|+||+.++. .|..+|||.+.... ...++++..+.++.+-+ .|+||+.+|+|..+....+.||.| .
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence 3467999999999999885 58999999997654 34567888888777765 899999999999999999999998 4
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
.-++.+|.+.. .++++..+-++...+.+||.||..+ .+|+|||+||+|||+|+.|++|++|||++-.+-....+
T Consensus 175 ~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 175 TCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred HHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence 45666666543 3588888889999999999999875 39999999999999999999999999999766544332
Q ss_pred ecCCCCCccccchhhhhhh-cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
+...|-+.|||||.+.-+ ...++-++||||||+.|+||.||+.||...... | .+..++.+.+.....
T Consensus 249 -trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---------F--e~ltkvln~ePP~L~ 316 (391)
T KOG0983|consen 249 -TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---------F--EVLTKVLNEEPPLLP 316 (391)
T ss_pred -ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---------H--HHHHHHHhcCCCCCC
Confidence 445688999999998654 346788999999999999999999999764331 1 123333332222111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.....+..+.++...||+.|+.+||...+++++=
T Consensus 317 --~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 317 --GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred --cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 1122567788899999999999999999998763
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=329.62 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=197.3
Q ss_pred hhcccCCCeEEEEEEe-CCCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
.+||.|.||.||.|.. ++|+..|+|-++-.. ...+...+|+.++..++|||+|+.+|+-.+.+..+|.||||.+|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 4699999999999976 469999999876543 334567899999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce--ee
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV--VT 505 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~--~~ 505 (667)
|.+++.... -.++.....+..|++.|++|||++ +||||||||.||+|+.+|.+|++|||.|+.+...... ..
T Consensus 1321 La~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1321 LASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 999996543 356666677889999999999998 9999999999999999999999999999887654211 12
Q ss_pred ecCCCCCccccchhhhhhhc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNL-GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
..+..||+.|||||++.+.. .....+.||||+|||++||+||++||...+. .+. ++-++..+..
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---------e~a--IMy~V~~gh~---- 1459 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---------EWA--IMYHVAAGHK---- 1459 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---------hhH--HHhHHhccCC----
Confidence 23567999999999997643 2335689999999999999999999964432 111 1112222211
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
++.+..++..-.+++.+||+.||++|-++.|++++=
T Consensus 1460 Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1460 PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 122233667778899999999999999998888764
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=296.90 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=187.4
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecC------CeeEEEE
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRALIY 420 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~~lV~ 420 (667)
.+.||+|+||.||+|+.. +++.||||++... ......+.+|+.++++++|+||+++++++... ...++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 468999999999999874 6899999998653 22345688999999999999999999988754 2468999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||+. .+|.+++ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 100 e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~ 170 (342)
T cd07879 100 PYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE 170 (342)
T ss_pred cccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence 9995 4666554 22478899999999999999999998 9999999999999999999999999999765332
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC----CccccchHHHHHhhc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN----TTEAYFPDWIYDKLI 576 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~ 576 (667)
. ....++..|+|||.+.+. ..++.++||||||+++|||++|+.||.......... ......+.+ .+.+.
T Consensus 171 ~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 243 (342)
T cd07879 171 M-----TGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF-VQKLE 243 (342)
T ss_pred C-----CCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH-HHHhc
Confidence 1 234568899999998653 357889999999999999999999996532100000 000000000 00000
Q ss_pred Ccc-------cccccc----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhc
Q 005953 577 QPE-------KEDFVE----EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM--LSSA 623 (667)
Q Consensus 577 ~~~-------~~~~~~----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~--L~~~ 623 (667)
... ...... .........+.+++.+||+.||++||++.|++.+ ++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000 000000 0001124567899999999999999999999966 6644
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=287.11 Aligned_cols=252 Identities=26% Similarity=0.412 Sum_probs=191.4
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhc---ccceEEeecceEecCCe-----eE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRI---HHVNIIHLLGFCCDGST-----RA 417 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~~~~-----~~ 417 (667)
+.++||+|+||.||+|++. +++.||+|+++... .....+.+|+.+++++ +|+|++++++++.+... .+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 4578999999999999986 48999999987432 2234567788877666 59999999999988776 89
Q ss_pred EEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcccc
Q 005953 418 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~ 497 (667)
++|||++ ++|.+++.... ...+++..++.++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++...
T Consensus 83 l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 83 LVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 9999996 58988886543 23589999999999999999999998 9999999999999999999999999999776
Q ss_pred CCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhc-
Q 005953 498 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI- 576 (667)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 576 (667)
...... ....++..|+|||++.+. .++.++||||||+++|||++|+.|+...... ..... +.+...
T Consensus 158 ~~~~~~---~~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-------~~~~~-~~~~~~~ 224 (287)
T cd07838 158 SFEMAL---TSVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFRGTSEA-------DQLDK-IFDVIGL 224 (287)
T ss_pred cCCccc---ccccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCcccCCChH-------HHHHH-HHHHcCC
Confidence 443221 223468899999998764 6788999999999999999999888643221 00000 000000
Q ss_pred -----------------CcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 577 -----------------QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 577 -----------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
..................+.+++.+||+.||++||++.|++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 225 PSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000001111223445678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=284.24 Aligned_cols=247 Identities=25% Similarity=0.428 Sum_probs=199.2
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.||.|+||.||++... +++.+|+|++.... ...+.+.+|++.+++++|+|++++++.+..+...++|+||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83 (258)
T ss_pred EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence 4578999999999999985 58899999987643 3456788999999999999999999999999999999999999
Q ss_pred CCccccccccc-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 426 GSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 426 gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
++|.+++.+.. ....+++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||++.........
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~- 159 (258)
T cd08215 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL- 159 (258)
T ss_pred CcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcce-
Confidence 99999997532 235689999999999999999999998 9999999999999999999999999999876544311
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....|++.|+|||.+... ..+.++||||+|+++++|++|+.|+..... ..+............
T Consensus 160 -~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~~~- 223 (258)
T cd08215 160 -AKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEGENL------------LELALKILKGQYPPI- 223 (258)
T ss_pred -ecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCCCcH------------HHHHHHHhcCCCCCC-
Confidence 1234578899999988654 678899999999999999999998854321 111122222111111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.......+.+++.+||+.+|++|||+.|++++
T Consensus 224 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 ---PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11234578889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=296.78 Aligned_cols=260 Identities=22% Similarity=0.320 Sum_probs=192.0
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecC-----CeeEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDG-----STRALIY 420 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~~~lV~ 420 (667)
..+.||+|+||+||+|+.. +++.||||.+... ......+.+|+.++++++|+||+++++++... ...++|+
T Consensus 9 ~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07858 9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88 (337)
T ss_pred EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence 3578999999999999874 6899999998653 23345678899999999999999999988654 3479999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||+. ++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 89 e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 89 ELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred eCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 9995 7888887543 3589999999999999999999988 9999999999999999999999999999866443
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC---------CCCCcc--ccchH
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS---------GSNTTE--AYFPD 569 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~---------~~~~~~--~~~~~ 569 (667)
.. ......++..|+|||.+... ..++.++||||||+++|||++|+.||....... +....+ .....
T Consensus 162 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 162 GD--FMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred cc--cccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 21 12234578899999998653 357889999999999999999999985432100 000000 00000
Q ss_pred HHHHhhcC--ccc-ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 570 WIYDKLIQ--PEK-EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 570 ~~~~~~~~--~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.......+ +.. ..........+...+.+++.+||+.+|++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000 000 000011112345678899999999999999999999988
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=296.80 Aligned_cols=264 Identities=20% Similarity=0.320 Sum_probs=194.8
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEec----CCeeEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD----GSTRALIYE 421 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~~~lV~e 421 (667)
+.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.. ....++|+|
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 9 PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence 4578999999999999875 58999999987542 334677889999999999999999998753 346899999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+. |+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 89 ~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 89 LME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred hhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 995 6898888653 2489999999999999999999988 99999999999999999999999999997654322
Q ss_pred ce--eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC---------CCCCcc---ccc
Q 005953 502 SV--VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS---------GSNTTE---AYF 567 (667)
Q Consensus 502 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~---------~~~~~~---~~~ 567 (667)
.. .......|+..|+|||.+.+. ..++.++||||||+++|||++|+.||....... +....+ ...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred cCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 11 111234688999999998653 357889999999999999999999996543210 000000 000
Q ss_pred hHHHHHhhcC-cccccc-cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 568 PDWIYDKLIQ-PEKEDF-VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 568 ~~~~~~~~~~-~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
...+...... +..... ...........+.+++.+||+.+|++||++.+++.+--
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 0000000000 000000 01111224567899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=286.06 Aligned_cols=247 Identities=22% Similarity=0.313 Sum_probs=191.1
Q ss_pred HhhhhcccCCCeEEEEEEeCC-CcEEEEEEcccC------CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKT------SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
.+.++||+|+||.||++++.. +..+++|+++.. .....++..|+.++++++||||+++++++.+....++|+|
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE 82 (260)
T ss_pred eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence 456889999999999998753 445566665431 1233457789999999999999999999999999999999
Q ss_pred EcCCCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 422 YMPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 422 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
|+++++|.+++... .....+++..++.++.|++.||+|||+. +++|+||+|+||++++ +.+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 83 YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred eCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 99999999988642 2245689999999999999999999987 9999999999999975 56999999999766433
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
... .....|+..|+|||.+.. ..++.++|+||||+++|+|++|+.|+..... ............
T Consensus 159 ~~~--~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------------~~~~~~~~~~~~ 222 (260)
T cd08222 159 CDL--ATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------------LSVVLRIVEGPT 222 (260)
T ss_pred ccc--ccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccH------------HHHHHHHHcCCC
Confidence 221 123457889999998864 3677899999999999999999998853211 111112211111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
. .....+...+.+++.+||+.+|++||++.|++++
T Consensus 223 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 P----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred C----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1 1123445678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=279.55 Aligned_cols=256 Identities=21% Similarity=0.357 Sum_probs=208.1
Q ss_pred hhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecC-CeeEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDG-STRALIY 420 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-~~~~lV~ 420 (667)
....+-+|.||.||+|.|. +.+.|.||.++.... ....++.|.-.+..+.|||+..+.+++.+. ..++.+|
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 3456899999999999663 345678888876654 345788999999999999999999998754 5788999
Q ss_pred EEcCCCCcccccc-----ccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 421 EYMPNGSLGDLLS-----REKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 421 e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
.++.-|+|..+|. .......++..++..++.|++.|++|||++ +|||.||.++|.+||+..++||+|=.++|
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhcc
Confidence 9999999999997 333345688889999999999999999998 99999999999999999999999999999
Q ss_pred ccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHh
Q 005953 496 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDK 574 (667)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 574 (667)
.+.+.+.+....+...+..||+||.+..+ .++.++|||||||++|||+| |+.|+...++ +.+..
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~PyaeIDP-------------fEm~~ 509 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPYAEIDP-------------FEMEH 509 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCccccCH-------------HHHHH
Confidence 98887776665666789999999999875 88999999999999999998 6667643332 11222
Q ss_pred hcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
+++. +.+...+.+.+.++..+|.-||+..|++||+++|++.-|.+...+
T Consensus 510 ylkd---GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 510 YLKD---GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHhc---cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 2221 122223334567889999999999999999999999999876544
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=272.45 Aligned_cols=236 Identities=25% Similarity=0.337 Sum_probs=192.0
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.|.++||+|.||.|-.++-+ .++.+|+|++++.. .....-+.|-++|+..+||.+..|--.+.....+++||||.
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEc
Confidence 36789999999999999875 69999999998764 23345677899999999999999998899999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
.||.|.-+|++.+ .+++.+...+..+|..||.|||++ +||.||||.+|.|||.+|++||+||||++.--....
T Consensus 251 nGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~- 323 (516)
T KOG0690|consen 251 NGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD- 323 (516)
T ss_pred cCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccccc-
Confidence 9999999998754 588888899999999999999998 999999999999999999999999999986433322
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
++....|||.|+|||++..+ .+..++|.|.+|||+|||++|+.||...+. +..|.-.....+.-
T Consensus 324 -t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh-------~kLFeLIl~ed~kF------ 387 (516)
T KOG0690|consen 324 -TTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-------EKLFELILMEDLKF------ 387 (516)
T ss_pred -eeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccch-------hHHHHHHHhhhccC------
Confidence 33557799999999999875 889999999999999999999999975432 12222222222211
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCC
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRP 611 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP 611 (667)
+..+..+...++.-.|..||.+|.
T Consensus 388 ----Pr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 388 ----PRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ----CccCCHHHHHHHHHHhhcChHhhc
Confidence 122334455667778899999995
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=295.32 Aligned_cols=276 Identities=21% Similarity=0.323 Sum_probs=203.1
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCC-----eeEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS-----TRALI 419 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-----~~~lV 419 (667)
.+.+.||.|++|.||+|+.. +++.||+|++.... ...+.+.+|+.+++.++|+||+++++++.... ..++|
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 35678999999999999985 48999999987542 34567899999999999999999999988765 78999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||++ ++|.+++.+.. .+++..+..++.+++.||+|||+. +|+|+||||+|||++.++.++|+|||++.....
T Consensus 83 ~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 83 TELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred ecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99997 58888886532 689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCce-eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC---------CCCC-------
Q 005953 500 NRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS---------GSNT------- 562 (667)
Q Consensus 500 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~---------~~~~------- 562 (667)
.... .......++..|+|||.+.+. ..++.++||||||+++|+|++|+.||....... +...
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred cccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 3210 112334578899999998764 267889999999999999999999986543210 0000
Q ss_pred ccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhhccccccCCCCCC
Q 005953 563 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM--LSSASAEAIEMPPKP 634 (667)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~--L~~~~~~~~~~~~~p 634 (667)
.......++.. . ..................+.+++.+||+.+|++||++++++.+ +++...+..+.++..
T Consensus 235 ~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~ 306 (330)
T cd07834 235 TSEKARNYLKS-L-PKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKP 306 (330)
T ss_pred cccchhhHHhh-c-ccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCC
Confidence 00000000000 0 0000000001111235678899999999999999999999986 554444444444433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=287.21 Aligned_cols=261 Identities=27% Similarity=0.349 Sum_probs=196.4
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.||+|++|.||+|+.. +++.+|+|++... ....+.+.+|+.++++++|+|++++++++.+....++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 3467999999999999986 4899999998764 3344678899999999999999999999999999999999997
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++.+.. ..+++..+..++.+++.||+|||+. +|+|+||+|+||++++++.+||+|||+++....... .
T Consensus 82 ~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~ 154 (282)
T cd07829 82 MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T 154 (282)
T ss_pred cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence 68999997642 3589999999999999999999998 999999999999999999999999999987654332 1
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCc---cccchHHHHHhhcCc----
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT---EAYFPDWIYDKLIQP---- 578 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~---- 578 (667)
.....++..|+|||.+... ..++.++||||||+++|||++|+.||............ ........+......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred cCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 2233457889999998654 36788999999999999999999888543210000000 000000000000000
Q ss_pred -ccc----cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 579 -EKE----DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 579 -~~~----~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
... .............+.+++.+||+.+|++||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000 00001111235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=289.31 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=196.1
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.+.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|++++++++ |+||+++++++..++..++||||
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY 83 (280)
T ss_pred eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence 34578999999999999885 68999999987532 33467889999999998 99999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++++|.+++.+.. .+++..+..|+.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 84 APNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999996543 589999999999999999999988 999999999999999999999999999976543321
Q ss_pred e------------------eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCcc
Q 005953 503 V------------------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE 564 (667)
Q Consensus 503 ~------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~ 564 (667)
. .......++..|+|||.+... .++.++||||||++++|+++|+.|+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------- 227 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSNE-------- 227 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCccH--------
Confidence 1 111234578999999988653 678899999999999999999999864321
Q ss_pred ccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 005953 565 AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSM----TRVVEM 619 (667)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~----~evl~~ 619 (667)
............ .....+...+.+++.+||+.+|++||++ ++++.+
T Consensus 228 ----~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 ----YLTFQKILKLEY-----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred ----HHHHHHHHhcCC-----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 011111111110 1111235578899999999999999999 776643
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=290.94 Aligned_cols=264 Identities=24% Similarity=0.370 Sum_probs=188.9
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCC--------ee
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS--------TR 416 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--------~~ 416 (667)
.+.++||+|+||.||+|+.. +++.+|+|++.... .....+.+|++++++++|+||+++++++.+.. ..
T Consensus 11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 90 (311)
T cd07866 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV 90 (311)
T ss_pred EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence 34578999999999999875 58899999886432 22346789999999999999999999875433 46
Q ss_pred EEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 417 ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 417 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
++|+||+. ++|.+.+... ...+++..+..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||+++.
T Consensus 91 ~lv~~~~~-~~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 91 YMVTPYMD-HDLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred EEEEecCC-cCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 89999996 4676666543 23589999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCcee---------eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCC--------
Q 005953 497 HSRNRSVV---------TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG-------- 559 (667)
Q Consensus 497 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~-------- 559 (667)
........ ..+...+++.|+|||.+.+. ..++.++||||||+++|||++|+.||........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 54322111 11234568889999998653 3578899999999999999999999864322100
Q ss_pred CCCccccchHHHHHhhc-----CcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 560 SNTTEAYFPDWIYDKLI-----QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 560 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
........+.|...... ..................+.+++.+||+.+|++|||+.|++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000000000000000 0000000000111223578899999999999999999998853
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=281.01 Aligned_cols=234 Identities=24% Similarity=0.283 Sum_probs=181.2
Q ss_pred cccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCCCCcccc
Q 005953 354 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDL 431 (667)
Q Consensus 354 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 431 (667)
||+|+||.||++..+ +++.+|+|++....... .|+.....+ +|+||+++++.+...+..++||||+++|+|.++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~ 99 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL 99 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence 699999999999874 68889999986543211 122222222 699999999999999999999999999999999
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC-ceEEEeCCCccccCCCCceeeecCCC
Q 005953 432 LSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNRSVVTMTGPR 510 (667)
Q Consensus 432 l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~-~~ki~DFGla~~~~~~~~~~~~~~~~ 510 (667)
+.... .+++..+..++.|+++||+|||+. +++||||||+||+++.++ .++|+|||+++...... ...
T Consensus 100 l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~------~~~ 167 (267)
T PHA03390 100 LKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS------CYD 167 (267)
T ss_pred HHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc------cCC
Confidence 96543 689999999999999999999998 999999999999999998 99999999987654322 234
Q ss_pred CCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHH
Q 005953 511 GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDC 590 (667)
Q Consensus 511 gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 590 (667)
++..|+|||++.+. .++.++||||||+++|||++|+.||...... ......+.. .. .... .....
T Consensus 168 ~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~-~~~~-----~~~~~ 232 (267)
T PHA03390 168 GTLDYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDEDE------ELDLESLLK-RQ-QKKL-----PFIKN 232 (267)
T ss_pred CCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCcc------hhhHHHHHH-hh-cccC-----Ccccc
Confidence 78999999999753 6788999999999999999999998633211 111111111 11 1100 11123
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 005953 591 IARKMIIVGLWCIQINPKDRPS-MTRVVE 618 (667)
Q Consensus 591 ~~~~l~~l~~~cl~~~P~~RPt-~~evl~ 618 (667)
....+.+++.+||+.+|++||+ ++|+++
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 233 VSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 4567889999999999999995 688875
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=293.33 Aligned_cols=245 Identities=22% Similarity=0.349 Sum_probs=198.7
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.||+|.|+.|..|++. ++..||||.+.++.. ....+.+|+++|+.++|||||+++.+......+|+||||..+
T Consensus 60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence 4578999999999999875 689999999987642 234588999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|.+.++|..... ..+..+..++.|+.++++|||++ .|+|||||++||||+.+.++||+|||++..+......
T Consensus 140 ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l-- 211 (596)
T KOG0586|consen 140 GELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML-- 211 (596)
T ss_pred chhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccccc--
Confidence 999999987542 45577888999999999999998 9999999999999999999999999999888754432
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
....|++.|.|||++.+. ....+++|+||+|++||-|+.|..||++..-.. ...+.+.+... .
T Consensus 212 -qt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~------------Lr~rvl~gk~r--I- 274 (596)
T KOG0586|consen 212 -QTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE------------LRPRVLRGKYR--I- 274 (596)
T ss_pred -cccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCccccc------------ccchheeeeec--c-
Confidence 446689999999999886 466889999999999999999999998653210 01111111110 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
+.-+.....+++.++|-.+|.+|++++++.+.-.
T Consensus 275 --p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 275 --PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred --cceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 0111234456777888999999999999987654
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=268.19 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=207.2
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEec----CCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCD----GSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~----~~~~~lV~e~~~~ 425 (667)
++||-|-.|.|-....+ +++..|+|++..+. ...+|+++.-.. .|||||.+++++.. ...+.+|||.|+|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG 143 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG 143 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence 78999999999999775 68999999998654 345788877666 59999999998764 3467899999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC---CCceEEEeCCCccccCCCCc
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~---~~~~ki~DFGla~~~~~~~~ 502 (667)
|.|.+.++... ...+++.++..|..||+.|+.|||+. +|.||||||+|+|... |-.+||+|||+|+......
T Consensus 144 GeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~- 218 (400)
T KOG0604|consen 144 GELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG- 218 (400)
T ss_pred hHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCCc-
Confidence 99999997654 45699999999999999999999998 9999999999999954 5679999999998765433
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
.+..+.-|+.|.|||++... .++...|+||+||++|-|++|-+||...... ....-...++..+. -.
T Consensus 219 --~L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~hg~--------aispgMk~rI~~gq-y~ 285 (400)
T KOG0604|consen 219 --DLMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKRRIRTGQ-YE 285 (400)
T ss_pred --cccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccCCc--------cCChhHHhHhhccC-cc
Confidence 33456679999999999765 6777899999999999999999999754431 11111223333322 24
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccccccCCCCCCCC
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKPLF 636 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~~p~~ 636 (667)
+..++..++++...+++..+|..+|++|.|++|++++=. ..+....|..|..
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw--i~~~~~vp~tpl~ 337 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW--INQYEAVPQTPLS 337 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch--hcccccCCCCCch
Confidence 556777888999999999999999999999999998765 2333444444443
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=292.62 Aligned_cols=262 Identities=20% Similarity=0.267 Sum_probs=188.1
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecC-------------
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDG------------- 413 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------------- 413 (667)
.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++...
T Consensus 8 ~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (342)
T cd07854 8 MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTE 87 (342)
T ss_pred EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccc
Confidence 34578999999999999875 58899999886543 3446788999999999999999999876543
Q ss_pred -CeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC-CCCceEEEeC
Q 005953 414 -STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSDF 491 (667)
Q Consensus 414 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~-~~~~~ki~DF 491 (667)
...++|+||++ ++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++ +++.+||+||
T Consensus 88 ~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 88 LNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCc
Confidence 35789999996 5888777532 478999999999999999999988 999999999999997 4567999999
Q ss_pred CCccccCCCCcee-eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC---------C
Q 005953 492 GLAKAHSRNRSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS---------N 561 (667)
Q Consensus 492 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~---------~ 561 (667)
|+++......... ......++..|+|||.+... ..++.++|||||||++|||++|+.||......... .
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9997654322111 11223478899999987543 35788999999999999999999999643210000 0
Q ss_pred C--ccccchHHHHHhhcCccc--ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 562 T--TEAYFPDWIYDKLIQPEK--EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 562 ~--~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
. ....+............. ..............+.+++.+||+.||++|||+.|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0 000000000000000000 000001111234578889999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=288.62 Aligned_cols=263 Identities=23% Similarity=0.285 Sum_probs=188.3
Q ss_pred HhhhhcccCCCeEEEEEEeC-C--CcEEEEEEcccCC---cchHHHHHHHHHHhhc-ccceEEeecceEecC----CeeE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-D--GRLVAVKVLEKTS---NFSDNFINEVATIGRI-HHVNIIHLLGFCCDG----STRA 417 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~--~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~----~~~~ 417 (667)
.+.+.||+|+||.||+++.. . +..||+|++.... ...+.+.+|+.+++++ +||||+++++.+... ...+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 34578999999999999875 3 7789999986432 2345788999999999 599999999875432 4577
Q ss_pred EEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcccc
Q 005953 418 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~ 497 (667)
+++||+. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 83 ~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 83 LYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 8889885 6888888543 3588999999999999999999988 9999999999999999999999999999865
Q ss_pred CCCCce--eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC---ccccchHHHH
Q 005953 498 SRNRSV--VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWIY 572 (667)
Q Consensus 498 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~ 572 (667)
...... .......|+..|+|||++.+. ..++.++||||||+++|+|++|+.||........... .-...+....
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 432211 112334689999999988653 3578899999999999999999999865321000000 0000000000
Q ss_pred HhhcCc-----------ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 573 DKLIQP-----------EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 573 ~~~~~~-----------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
..+... ................+.+++.+||+.||++|||+.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 00000000011124578899999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=278.89 Aligned_cols=260 Identities=22% Similarity=0.336 Sum_probs=198.1
Q ss_pred HHHHHHHhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCCcc--------hHHHHHHHHHHhhcccceEEeecceEec-
Q 005953 343 IKKMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNF--------SDNFINEVATIGRIHHVNIIHLLGFCCD- 412 (667)
Q Consensus 343 l~~~~~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--------~~~~~~Ei~~l~~l~h~niv~l~g~~~~- 412 (667)
+...+|-+.+.||+|||+.||||.+ ...+.||||+-...+.+ .+...+|..+.+.|.||.||++++++.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3344555678899999999999965 56889999987544332 3457889999999999999999999874
Q ss_pred CCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC---CCCceEEE
Q 005953 413 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD---PDFTPKVS 489 (667)
Q Consensus 413 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~---~~~~~ki~ 489 (667)
....+-|+||++|.+|+-+|.+.+ .+++..+..|+.||+.||.||... +++|||-||||.||||- ..|.+||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 557889999999999999997654 588999999999999999999986 78999999999999994 45889999
Q ss_pred eCCCccccCCCCce----e-eecCCCCCccccchhhhhhh--cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC
Q 005953 490 DFGLAKAHSRNRSV----V-TMTGPRGTIGYIAPEIFMRN--LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT 562 (667)
Q Consensus 490 DFGla~~~~~~~~~----~-~~~~~~gt~~y~aPE~~~~~--~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~ 562 (667)
||||++.+..+... . ......||..|++||.+.-. ...++.|+||||+|||+|..+.|++||.......
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---- 691 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---- 691 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH----
Confidence 99999988655432 1 12345699999999988543 3467899999999999999999999997653310
Q ss_pred ccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005953 563 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVV 617 (667)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl 617 (667)
+. +. ...+++... ..-.....+..+...++.+||++.-++|....++.
T Consensus 692 -dI-Lq---eNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 692 -DI-LQ---ENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -HH-Hh---hhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 00 00 001111110 00111123345667799999999999998776665
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=276.45 Aligned_cols=235 Identities=31% Similarity=0.405 Sum_probs=190.1
Q ss_pred cccCCCeEEEEEEeC-CCcEEEEEEcccCCc----chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 354 LGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 354 LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
||+|+||.||+++.. +++.+|+|++..... ..+.+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999886 588999999875432 345788999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNT 152 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccC
Confidence 99996543 588999999999999999999987 999999999999999999999999999977644321 1233
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (667)
..++..|+|||.+.+. ..+.++|+||||+++|||++|+.||..... ......+..... ...
T Consensus 153 ~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------------~~~~~~~~~~~~-----~~~ 213 (250)
T cd05123 153 FCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------------KEIYEKILKDPL-----RFP 213 (250)
T ss_pred CcCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHhcCCC-----CCC
Confidence 4578899999998754 578899999999999999999999854321 111122222111 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005953 589 DCIARKMIIVGLWCIQINPKDRPSMTR 615 (667)
Q Consensus 589 ~~~~~~l~~l~~~cl~~~P~~RPt~~e 615 (667)
......+.+++.+||+.||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 112457788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=289.60 Aligned_cols=256 Identities=22% Similarity=0.296 Sum_probs=189.2
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCC------eeEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS------TRALI 419 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------~~~lV 419 (667)
+.+.||+|+||.||++... +++.||||++.... ...+.+.+|+.++++++|+||+++++++.... ..++|
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07880 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98 (343)
T ss_pred EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence 4578999999999999864 68999999986432 22356889999999999999999999887553 35899
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 99 ~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 99 MPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred EecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 9999 7799888754 2488999999999999999999998 999999999999999999999999999976543
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC---CccccchHHHHHhhc
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN---TTEAYFPDWIYDKLI 576 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~ 576 (667)
.. ....+++.|+|||.+.+. ..++.++|+||||+++|+|++|+.||.......... ......+......+.
T Consensus 171 ~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 171 EM-----TGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred Cc-----cccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 21 234578899999998653 357889999999999999999999986432100000 000000000001110
Q ss_pred Cccc-----------ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 577 QPEK-----------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 577 ~~~~-----------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.... ..............+.+++.+|++.||++|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000001111234568899999999999999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=288.05 Aligned_cols=256 Identities=20% Similarity=0.275 Sum_probs=187.3
Q ss_pred hhhcccCCCeEEEEEEe-CCCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecC------CeeEEEE
Q 005953 351 KEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRALIY 420 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~~lV~ 420 (667)
.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.++++++|+||+++++++... ...++++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 46799999999999986 468899999987532 2245688999999999999999999987643 3467888
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
+++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 102 ~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~ 173 (345)
T cd07877 102 HLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173 (345)
T ss_pred hhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccccccc
Confidence 877 78998877542 488999999999999999999998 9999999999999999999999999998765322
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC---ccccchHHHHHhhcC
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWIYDKLIQ 577 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 577 (667)
.....++..|+|||.+.+. ..++.++||||||+++|||++|+.||........... .....+......+..
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 174 -----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred -----ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 1234578999999998653 3578899999999999999999999854321000000 000000011111100
Q ss_pred cc-----------cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 578 PE-----------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 578 ~~-----------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.. ...............+.+++.+||+.||++||++.+++++=
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 00 00000000001244678999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.72 Aligned_cols=256 Identities=22% Similarity=0.310 Sum_probs=190.8
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCe------eEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGST------RALI 419 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~------~~lV 419 (667)
+.+.||+|++|.||+|+.. +++.||+|++.... ...+.+.+|+.++++++|+|++++++++...+. .++|
T Consensus 19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98 (343)
T ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence 4578999999999999985 58899999986532 234567889999999999999999998766554 8999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 99 ~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 99 THLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred EecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 9998 6799888864 2589999999999999999999997 999999999999999999999999999986643
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC---ccccchHHHHHhhc
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWIYDKLI 576 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~ 576 (667)
. .....++..|+|||.+... ...+.++||||||+++|||++|+.||........... .....++.....+.
T Consensus 171 ~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 171 E-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred c-----ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 3 1334578899999998653 3568899999999999999999999854321000000 00000000001000
Q ss_pred Cc--------cc---ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 577 QP--------EK---EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 577 ~~--------~~---~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.. .. ..............+.+++.+||+.+|++|||+.||+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00 00 000001111235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=285.82 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=188.9
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEec-CCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCD-GSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~lV~e~~~ 424 (667)
+.+.||+|+||.||+++.. +++.||+|++... ....+.+.+|++++++++||||+++++++.. ....++|+||+
T Consensus 14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~- 92 (328)
T cd07856 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92 (328)
T ss_pred EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-
Confidence 4578999999999999875 6899999987542 2334678899999999999999999998865 56789999998
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.+++... .+++..+..++.|+++||+|||+. +|+|+||+|+||++++++.+||+|||+++......
T Consensus 93 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~--- 162 (328)
T cd07856 93 GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM--- 162 (328)
T ss_pred ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCCc---
Confidence 57888887532 477888889999999999999998 99999999999999999999999999987543221
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC---ccccchHHHHHhhcCcc--
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWIYDKLIQPE-- 579 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~-- 579 (667)
....++..|+|||.+... ..++.++||||||+++|||++|+.||........... .-...+..+........
T Consensus 163 --~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 163 --TGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred --CCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 233568899999987542 3678899999999999999999998854321000000 00000000000000000
Q ss_pred -------c-cc-ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 580 -------K-ED-FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 580 -------~-~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
. .. ...+....+...+.+++.+||+.+|++||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00 0001111234678899999999999999999999866
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=270.73 Aligned_cols=264 Identities=24% Similarity=0.346 Sum_probs=201.9
Q ss_pred CCCCCHHHHHHHHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceE
Q 005953 335 LSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFC 410 (667)
Q Consensus 335 ~~~~~~~~l~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~ 410 (667)
...|+-.+|+.. ..||.|+||+|+|-.++ .|+.+|||+++... ...++++.|.+...+- +.||||+++|.+
T Consensus 58 ~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 58 LHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred ccccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 455666666554 57999999999999875 69999999998654 4557788999876665 689999999999
Q ss_pred ecCCeeEEEEEEcCCCCccccccc--cccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEE
Q 005953 411 CDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKV 488 (667)
Q Consensus 411 ~~~~~~~lV~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki 488 (667)
-..+..++-||.| ..||+.+... ......+++.-+-+|......||.||... .+|||||+||+|||||..|.+||
T Consensus 133 F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKL 209 (361)
T KOG1006|consen 133 FSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKL 209 (361)
T ss_pred hcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEee
Confidence 9889999999999 5777766543 22345688888889999999999999874 58999999999999999999999
Q ss_pred EeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccch
Q 005953 489 SDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFP 568 (667)
Q Consensus 489 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 568 (667)
+|||++-.+...-. .+.-.|-..|||||.+......++-+|||||||+.|+|+.||+.|+..... .|.
T Consensus 210 CDFGIcGqLv~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---------vfe 277 (361)
T KOG1006|consen 210 CDFGICGQLVDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---------VFE 277 (361)
T ss_pred ecccchHhHHHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---------HHH
Confidence 99999876543221 234557889999999987655588899999999999999999999864321 222
Q ss_pred HHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 569 DWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
+.-.-...++.. -........++..+..++..|+.+|-.+||...++.++
T Consensus 278 ql~~Vv~gdpp~-l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 278 QLCQVVIGDPPI-LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHHHcCCCCe-ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 211111111111 11112223456788899999999999999999988754
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=294.24 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=205.9
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEec-----CCeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCD-----GSTRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~-----~~~~~lV~e~ 422 (667)
|.+.||.|.+|.||+++.. +++.+|+|++.......++...|.++++.. +|||++.++|++.. ++.++|||||
T Consensus 23 i~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf 102 (953)
T KOG0587|consen 23 IIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEF 102 (953)
T ss_pred EEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence 5688999999999999874 799999999998888888899999999998 69999999998863 5689999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
|.+||.-|+++.-. +..+.|+.+.-|++++++||.+||.+ .++|||||-.|||++.++.||+.|||.+..+.....
T Consensus 103 C~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g 178 (953)
T KOG0587|consen 103 CGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG 178 (953)
T ss_pred cCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeecccc
Confidence 99999999998766 66799999999999999999999998 999999999999999999999999999976643322
Q ss_pred eeeecCCCCCccccchhhhhhh---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
......||+.|||||++.-+ ...++.++|+||||++..||--|.+|+-+..+. .....-+.
T Consensus 179 --rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------------raLF~IpR 242 (953)
T KOG0587|consen 179 --RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------------RALFLIPR 242 (953)
T ss_pred --cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------------hhhccCCC
Confidence 22345799999999998532 235677899999999999999999998765441 00111111
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
........+..-.+++.+++..||..|-++||++.+++++
T Consensus 243 NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 243 NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1122222344567899999999999999999999998854
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=242.26 Aligned_cols=193 Identities=25% Similarity=0.441 Sum_probs=165.4
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
++||+|.||+||||+.. .++.||+|.++.++ ......++|+-+++.++|.|||++++....+....+|+||+ ..+
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqd 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQD 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHH
Confidence 78999999999999875 58999999987543 34567899999999999999999999999999999999999 456
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|..+...- +..++.+.+..+..|+++||.|.|++ ++.|||+||+|.||+.+|++|++|||+++-+.-.... +.
T Consensus 87 lkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc--ys 159 (292)
T KOG0662|consen 87 LKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC--YS 159 (292)
T ss_pred HHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe--ee
Confidence 66665433 34689999999999999999999998 9999999999999999999999999999977654332 23
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 553 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~ 553 (667)
..+-|..|.+|.++.+. ..++...|+||-||++.|+....+|.-+
T Consensus 160 aevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred ceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 45569999999999876 5788899999999999999976555543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=288.40 Aligned_cols=239 Identities=23% Similarity=0.331 Sum_probs=194.0
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+...+|.|+|+.|-++... +++..+||++.+.. .+-.+|+.++.+. +||||+++.+.+.++...|+|||.+.+
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g 400 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG 400 (612)
T ss_pred hccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence 345677999999999998764 68889999998763 2334678777666 699999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE-CCCCceEEEeCCCccccCCCCcee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL-DPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll-~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
|-+.+.+.... .....+..|+.+|+.++.|||.+ +||||||||+|||+ ++.++++|+|||.++....+
T Consensus 401 ~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 401 GELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred cHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence 88777765443 22267778999999999999998 99999999999999 68899999999999887665
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
...+.-|..|.|||++.. ..+++++|+||||++||+||+|+.|+...... ..+...+..+...
T Consensus 470 -~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----------~ei~~~i~~~~~s--- 532 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----------IEIHTRIQMPKFS--- 532 (612)
T ss_pred -hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCch-----------HHHHHhhcCCccc---
Confidence 233445889999999984 48899999999999999999999999654321 3344444443222
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
..++....+++.+||+.||.+||+|.++..+=-
T Consensus 533 ----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w 565 (612)
T KOG0603|consen 533 ----ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPW 565 (612)
T ss_pred ----cccCHHHHHHHHHhccCChhhCcChhhhccCcc
Confidence 455677888999999999999999999987654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=307.09 Aligned_cols=140 Identities=29% Similarity=0.456 Sum_probs=125.9
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.++||+|+||+||+|.+. +++.||||+++... .....+.+|+.++..++|+||+++++++......++||||++
T Consensus 8 i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~ 87 (669)
T cd05610 8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLI 87 (669)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCC
Confidence 4578999999999999986 68999999987543 223578899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
+++|.+++.... .+++..++.|+.||+.||+|||.. +|+||||||+||||+.++.+||+|||+++
T Consensus 88 g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 88 GGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999986532 478889999999999999999997 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=270.13 Aligned_cols=220 Identities=19% Similarity=0.182 Sum_probs=174.2
Q ss_pred CCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCcccccccc
Q 005953 357 GGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSRE 435 (667)
Q Consensus 357 G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~ 435 (667)
|.+|.||++++. +++.+|+|++.... .+.+|...+....||||+++++++.+....++||||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 889999999885 68999999987643 2334555556667999999999999999999999999999999998653
Q ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCCCCCccc
Q 005953 436 KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGY 515 (667)
Q Consensus 436 ~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y 515 (667)
. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||++....... ....++..|
T Consensus 80 ~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y 148 (237)
T cd05576 80 L---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY 148 (237)
T ss_pred c---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence 2 488999999999999999999987 99999999999999999999999999886554321 233457789
Q ss_pred cchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHH
Q 005953 516 IAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKM 595 (667)
Q Consensus 516 ~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 595 (667)
+|||.+.. +.++.++||||+|+++|||++|+.++...... . ..... ...+..+...+
T Consensus 149 ~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----~-------------~~~~~----~~~~~~~~~~~ 205 (237)
T cd05576 149 CAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSG----I-------------NTHTT----LNIPEWVSEEA 205 (237)
T ss_pred cCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchh----c-------------ccccc----cCCcccCCHHH
Confidence 99998854 36788999999999999999999876432110 0 00000 00111234567
Q ss_pred HHHHHHhcccCCCCCCCHH
Q 005953 596 IIVGLWCIQINPKDRPSMT 614 (667)
Q Consensus 596 ~~l~~~cl~~~P~~RPt~~ 614 (667)
.+++.+||+.||++||++.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 8899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=300.16 Aligned_cols=255 Identities=22% Similarity=0.251 Sum_probs=204.4
Q ss_pred HHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
..+.+.++||+|+||.|..++++ .++++|.|++.+- .....-|..|-.+|..-+.+-|+.++-.|.+...+|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 33456789999999999999986 5899999999863 233456888889999889999999999999999999999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
|||+||+|-.++.... .+++..+..++..|..||.-||+- |+|||||||+|||||..|++||+|||.+-.+..+
T Consensus 155 dY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred ecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999999997654 588888899999999999999987 9999999999999999999999999999887766
Q ss_pred CceeeecCCCCCccccchhhhhhhc---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcC
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNL---GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 577 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (667)
... .....+|||.|++||++.... +.++..+|.||+||++|||+.|..||....- ...+.++..
T Consensus 229 G~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------------veTY~KIm~ 295 (1317)
T KOG0612|consen 229 GTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------------VETYGKIMN 295 (1317)
T ss_pred CcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------------HHHHHHHhc
Confidence 544 346678999999999996432 5678899999999999999999999964321 112334443
Q ss_pred cccccccchhhHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHHh
Q 005953 578 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS---MTRVVEMLS 621 (667)
Q Consensus 578 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt---~~evl~~L~ 621 (667)
....-..+ ....++....+++.+.+. +|+.|.. ++++-.+--
T Consensus 296 hk~~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpF 340 (1317)
T KOG0612|consen 296 HKESLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPF 340 (1317)
T ss_pred hhhhcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcc
Confidence 32211111 122356667777776665 7888887 888887764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=263.93 Aligned_cols=237 Identities=28% Similarity=0.423 Sum_probs=191.0
Q ss_pred CCeEEEEEEeC-CCcEEEEEEcccCCcc--hHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCccccccc
Q 005953 358 GYGNVYKGKFP-DGRLVAVKVLEKTSNF--SDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR 434 (667)
Q Consensus 358 ~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 434 (667)
+||.||+|+.. +++.+|+|++...... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 4899999998765432 57899999999999999999999999999999999999999999999865
Q ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCCCCCcc
Q 005953 435 EKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 514 (667)
Q Consensus 435 ~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~ 514 (667)
.. .+++..++.++.++++++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 43 288999999999999999999998 99999999999999999999999999998765542 1234457889
Q ss_pred ccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHH
Q 005953 515 YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARK 594 (667)
Q Consensus 515 y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (667)
|++||.+.. ...+.++||||||+++++|++|+.|+..... ...+.+.+....... ......+...
T Consensus 152 ~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-----------~~~~~~~~~~~~~~~--~~~~~~~~~~ 216 (244)
T smart00220 152 YMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-----------LLELFKKIGKPKPPF--PPPEWKISPE 216 (244)
T ss_pred CCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----------HHHHHHHHhccCCCC--ccccccCCHH
Confidence 999999874 3678899999999999999999988854211 111122222211111 0100113567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 005953 595 MIIVGLWCIQINPKDRPSMTRVVE 618 (667)
Q Consensus 595 l~~l~~~cl~~~P~~RPt~~evl~ 618 (667)
+.+++.+||+.+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=276.42 Aligned_cols=242 Identities=27% Similarity=0.383 Sum_probs=192.2
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
+.||.|-||+||-|++. +|+.||||++.+.+ .......+|+.+|++++||.||.+.-.|++.+..++|||.+ +|+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence 68999999999999884 79999999987643 44577889999999999999999999999999999999999 555
Q ss_pred ccccc-cccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC---CceEEEeCCCccccCCCCce
Q 005953 428 LGDLL-SREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD---FTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 428 L~~~l-~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~---~~~ki~DFGla~~~~~~~~~ 503 (667)
+.++| ..++ ..+++.....++.||+.||.|||.+ +|+|+||||+||||.+. -++||+|||+|+.+......
T Consensus 649 MLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMILSSEK--GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 55544 4443 3578887788899999999999988 99999999999999654 47999999999998765432
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
...+||+.|+|||++.++ .+...-|+||.|||+|--++|.-||..... +.+++..... -.
T Consensus 724 ---rsVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--------------IndQIQNAaF-My 783 (888)
T KOG4236|consen 724 ---RSVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNEDED--------------INDQIQNAAF-MY 783 (888)
T ss_pred ---hhhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCccc--------------hhHHhhcccc-cc
Confidence 456799999999999875 566778999999999999999999964322 1122211111 11
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
......++....++++...||..-.+|-|.++-+.+
T Consensus 784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 223344566677888888888888899888876644
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=257.94 Aligned_cols=262 Identities=23% Similarity=0.394 Sum_probs=193.3
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEccc---CCcchHHHHHHHHHHhhcccceEEeecceEecC--------CeeEE
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLLGFCCDG--------STRAL 418 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--------~~~~l 418 (667)
..++|+|.||.||+|+.. +|+.||+|++-. ........++|+++|..++|+|++.++..|... ...|+
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 367999999999999875 478899987644 234456789999999999999999999988642 35899
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
|+++++ .+|.-+|.... ..++...+.++..++..||.|+|+. .|+|||+||.|+||+.++.+||+|||+++.+.
T Consensus 102 Vf~~ce-hDLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 102 VFDFCE-HDLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred eHHHhh-hhHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 999995 57888886542 3578888999999999999999998 99999999999999999999999999998765
Q ss_pred CCCce--eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC---------CCCCccccc
Q 005953 499 RNRSV--VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS---------GSNTTEAYF 567 (667)
Q Consensus 499 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~---------~~~~~~~~~ 567 (667)
..... ..++..+-|..|++||.+.+. ..++.+.|||.-|||+.||++|.+.++...+.. ++..-+ .+
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke-vW 253 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE-VW 253 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc-cC
Confidence 43322 223455569999999999886 588999999999999999999998776543310 111101 11
Q ss_pred hH----HHHHhhcCc-ccccccchhhHHHH------HHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 568 PD----WIYDKLIQP-EKEDFVEEEDDCIA------RKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 568 ~~----~~~~~~~~~-~~~~~~~~~~~~~~------~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
+. .+++.+..+ ...... ....+.. ....+++..++..||.+|+++++++.+--
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~-rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQK-RKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred CCcccchHHHhccCCCCCcchh-hhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 11 012222111 000000 0001111 25667888899999999999999998764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=284.86 Aligned_cols=262 Identities=20% Similarity=0.231 Sum_probs=177.0
Q ss_pred hhhhcccCCCeEEEEEEe-----------------CCCcEEEEEEcccCCc-chH--------------HHHHHHHHHhh
Q 005953 350 FKEKLGTGGYGNVYKGKF-----------------PDGRLVAVKVLEKTSN-FSD--------------NFINEVATIGR 397 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~-~~~--------------~~~~Ei~~l~~ 397 (667)
+.++||+|+||+||+|.+ .+++.||||++..... ..+ .+..|+.++.+
T Consensus 149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 457899999999999964 2356899999865432 122 23457777888
Q ss_pred cccceE-----EeecceEec--------CCeeEEEEEEcCCCCcccccccccc---------------------CCCCCH
Q 005953 398 IHHVNI-----IHLLGFCCD--------GSTRALIYEYMPNGSLGDLLSREKE---------------------NLSLKP 443 (667)
Q Consensus 398 l~h~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~ 443 (667)
++|.++ ++++++|.. ....+|||||+++|+|.++++.... ...+++
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 876654 677787753 3568999999999999999874211 123567
Q ss_pred HHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhh
Q 005953 444 ARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523 (667)
Q Consensus 444 ~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 523 (667)
..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......... .....+++.|+|||.+..
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEELVM 384 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhhhcC
Confidence 78899999999999999987 99999999999999999999999999997654332211 112235789999998853
Q ss_pred hc--------------------CCCCCcccHHHHHHHHHHHHhCCC-CCCCCCcCCCC-CCccccchHHHHHhhcCcccc
Q 005953 524 NL--------------------GNPSGKSDVYSYGMLLLEMIEEKK-HLRPTETTSGS-NTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 524 ~~--------------------~~~s~k~DvwSlGvvl~elltg~~-p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 581 (667)
.. .....+.||||+||+++||++|.. |+.....-... .........|. .......
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~~~~~~- 461 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MYKGQKY- 461 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hhcccCC-
Confidence 21 111235799999999999999875 55322110000 00001111111 1111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINP---KDRPSMTRVVEML 620 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P---~~RPt~~evl~~L 620 (667)
.. ...+.......+++.++|..+| .+|+|++|+++|-
T Consensus 462 ~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 462 DF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred Cc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 11 1122235567788888998766 6899999999763
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=293.87 Aligned_cols=262 Identities=20% Similarity=0.235 Sum_probs=164.1
Q ss_pred HhhhhcccCCCeEEEEEEeC-C----CcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecce------EecCCeeE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-D----GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF------CCDGSTRA 417 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~----~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~------~~~~~~~~ 417 (667)
.+.++||+|+||.||+|++. + +..||||++..... .+.+..| .+....+.+++.++.. ...+...+
T Consensus 135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (566)
T PLN03225 135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW 211 (566)
T ss_pred EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence 35688999999999999885 4 68999998764332 1111111 1111122222222211 24566789
Q ss_pred EEEEEcCCCCccccccccccC-----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE
Q 005953 418 LIYEYMPNGSLGDLLSREKEN-----------------LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 480 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll 480 (667)
+|+||+++++|.+++...... .......+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NILl 288 (566)
T PLN03225 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIF 288 (566)
T ss_pred EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEEE
Confidence 999999999999988643211 1112344568999999999999988 99999999999999
Q ss_pred CC-CCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcC--------------------CCCCcccHHHHHH
Q 005953 481 DP-DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG--------------------NPSGKSDVYSYGM 539 (667)
Q Consensus 481 ~~-~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--------------------~~s~k~DvwSlGv 539 (667)
++ ++.+||+|||+|+.+....... .....+++.|+|||.+..... .++.++|||||||
T Consensus 289 ~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 289 SEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred eCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 86 5899999999998664332221 133468999999997643211 2345679999999
Q ss_pred HHHHHHhCCCCCCCCCcCCC--CCCccccchHHHHHhhcCcccccc-c--chhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005953 540 LLLEMIEEKKHLRPTETTSG--SNTTEAYFPDWIYDKLIQPEKEDF-V--EEEDDCIARKMIIVGLWCIQINPKDRPSMT 614 (667)
Q Consensus 540 vl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 614 (667)
+||||+++..+.+....... .......+..| ........... . .+..+...+...+++.+||+.||++|||++
T Consensus 368 iL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~ 445 (566)
T PLN03225 368 IFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAW--RKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK 445 (566)
T ss_pred HHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHH--HHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHH
Confidence 99999987654332100000 00000011111 11111110000 0 000001122445799999999999999999
Q ss_pred HHHHH
Q 005953 615 RVVEM 619 (667)
Q Consensus 615 evl~~ 619 (667)
|++++
T Consensus 446 e~L~H 450 (566)
T PLN03225 446 AALAH 450 (566)
T ss_pred HHhCC
Confidence 99986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=288.12 Aligned_cols=241 Identities=27% Similarity=0.386 Sum_probs=185.4
Q ss_pred hhcccCCCeE-EEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 352 EKLGTGGYGN-VYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 352 ~~LG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
+.+|.|.-|+ ||+|.+ +|+.||||++-..- .+...+|+..|+.- +|||||++++.-.+....|+..|.| .-+|+
T Consensus 515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~ 590 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQ 590 (903)
T ss_pred HHcccCCCCcEEEEEee-CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHH
Confidence 6789999986 699999 88999999886432 34567899999988 5999999999888899999999999 67999
Q ss_pred cccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC---C--CceEEEeCCCccccCCCCce
Q 005953 430 DLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---D--FTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 430 ~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~---~--~~~ki~DFGla~~~~~~~~~ 503 (667)
|++... ...........+.+..|++.||++||+. +||||||||+||||+. + ..++|+|||+++.+..+...
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 999763 1111111144577899999999999997 9999999999999965 2 57999999999998776654
Q ss_pred ee-ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhC-CCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 504 VT-MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEE-KKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 504 ~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
.. ..+..||-+|+|||.+... ..+.++||||+|||+|+.++| .+||...-.. ...+..+...
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--------------~~NIl~~~~~ 731 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--------------QANILTGNYT 731 (903)
T ss_pred hhcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHh--------------hhhhhcCccc
Confidence 32 3567799999999999765 445689999999999999987 7888654221 0112222221
Q ss_pred cc-cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005953 582 DF-VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618 (667)
Q Consensus 582 ~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 618 (667)
-. .....++ ...+++.+|++++|..||++.+|+.
T Consensus 732 L~~L~~~~d~---eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 732 LVHLEPLPDC---EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eeeeccCchH---HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11 1111112 5677899999999999999999984
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=263.75 Aligned_cols=271 Identities=20% Similarity=0.288 Sum_probs=202.9
Q ss_pred CCCHHHHHHHHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcc-c-c----eEEeecce
Q 005953 337 NYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-H-V----NIIHLLGF 409 (667)
Q Consensus 337 ~~~~~~l~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h-~----niv~l~g~ 409 (667)
.|...|....++.+.+.+|+|.||.|-...+. .+..||||+++.-..-.+..+-|+++|.++. + | -+|++.++
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 34555655666667789999999999999774 4789999999987776777888999999994 2 2 47888889
Q ss_pred EecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC-------
Q 005953 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP------- 482 (667)
Q Consensus 410 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~------- 482 (667)
+...++.++|+|.+ |-|+.++|..+. ..+++...+..|++|++++++|||+. +++|-||||+|||+.+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEe
Confidence 99999999999999 679999997654 45788999999999999999999998 9999999999999832
Q ss_pred -------------CCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCC
Q 005953 483 -------------DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK 549 (667)
Q Consensus 483 -------------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~ 549 (667)
+..+||+|||.|+....... ..+.|..|.|||++.+- .++..+||||+||||.|+.+|..
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs-----~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS-----TIVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCcc-----eeeeccccCCchheecc--CcCCccCceeeeeEEEEeeccce
Confidence 34589999999987655442 23468899999999875 78899999999999999999998
Q ss_pred CCCCCCcCC---CCCCccccchHHHHHhh-----------cCcc---------------cccccchhhHHHHHHHHHHHH
Q 005953 550 HLRPTETTS---GSNTTEAYFPDWIYDKL-----------IQPE---------------KEDFVEEEDDCIARKMIIVGL 600 (667)
Q Consensus 550 p~~~~~~~~---~~~~~~~~~~~~~~~~~-----------~~~~---------------~~~~~~~~~~~~~~~l~~l~~ 600 (667)
.|+.-+... .-...-..+|.....+. .-++ .........+.....+.+|+.
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 886443110 00000001111111111 0000 000001112233557999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 005953 601 WCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 601 ~cl~~~P~~RPt~~evl~~ 619 (667)
.||..||.+|+|+.|++.+
T Consensus 388 ~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHccCccccccHHHHhcC
Confidence 9999999999999999865
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=263.64 Aligned_cols=242 Identities=23% Similarity=0.319 Sum_probs=191.8
Q ss_pred HHHHHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcc----hHHHHHHHHHHhhc-ccceEEeecceEecCCee
Q 005953 343 IKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNF----SDNFINEVATIGRI-HHVNIIHLLGFCCDGSTR 416 (667)
Q Consensus 343 l~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~ 416 (667)
++....+|..+||+|+||.|.+|.-+ +.+.+|||+++++.-. .+--+.|-++|..- +-|.+++++.++.+-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 44445678899999999999999765 4788999999876422 22345566777666 468999999999999999
Q ss_pred EEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 417 ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 417 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
|+||||+.||+|--++++.. .+.+..+..+|.+||-||-+||++ +||.||||.+||+||.+|++||+|||+++.
T Consensus 426 yFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999998887654 477788899999999999999998 999999999999999999999999999986
Q ss_pred cCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhc
Q 005953 497 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 576 (667)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (667)
---+. .+.....||+.|+|||.+.- ..++..+|.|||||+||||+.|++||+..++ +.+++.+.
T Consensus 500 ni~~~--~TTkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE------------~elF~aI~ 563 (683)
T KOG0696|consen 500 NIFDG--VTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------------DELFQAIM 563 (683)
T ss_pred cccCC--cceeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCH------------HHHHHHHH
Confidence 43222 22345679999999999875 3778889999999999999999999987654 22233333
Q ss_pred CcccccccchhhHHHHHHHHHHHHHhcccCCCCCC
Q 005953 577 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP 611 (667)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 611 (667)
+... ..+...+++...+....|...|.+|.
T Consensus 564 ehnv-----syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 564 EHNV-----SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HccC-----cCcccccHHHHHHHHHHhhcCCcccc
Confidence 2221 12233466677788888999999985
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=269.07 Aligned_cols=253 Identities=24% Similarity=0.311 Sum_probs=206.5
Q ss_pred CCHHHHHHHHHHhhhhcccCCCeEEEEEEeCCCc-EEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEec
Q 005953 338 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGR-LVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCD 412 (667)
Q Consensus 338 ~~~~~l~~~~~~~~~~LG~G~fg~Vy~~~~~~~~-~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~ 412 (667)
..+.+++.. ..||-||||.|-..+.+... ..|+|++++.. ...+....|-.+|...+.|.||++|..+.+
T Consensus 417 v~l~dl~~i-----aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 417 VKLSDLKRI-----ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred cchhhhhhh-----hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence 445555433 46999999999999885433 48899887643 345678889999999999999999999999
Q ss_pred CCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCC
Q 005953 413 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG 492 (667)
Q Consensus 413 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFG 492 (667)
....|++||-|-||.|..+|.... .++......++..+.+|++|||++ +||.|||||+|.+||.+|.+||.|||
T Consensus 492 ~kyvYmLmEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred chhhhhhHHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehh
Confidence 999999999999999999997644 578888889999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHH
Q 005953 493 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 572 (667)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 572 (667)
+|+.+..+....+ ..||+.|.|||.+... ..+.++|.||||++++||++|++||+..++ -..+
T Consensus 566 FAKki~~g~KTwT---FcGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~dp------------mktY 628 (732)
T KOG0614|consen 566 FAKKIGSGRKTWT---FCGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGVDP------------MKTY 628 (732)
T ss_pred hHHHhccCCceee---ecCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCCch------------HHHH
Confidence 9999988776655 4589999999999875 557789999999999999999999986653 1223
Q ss_pred HhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHh
Q 005953 573 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEMLS 621 (667)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~~L~ 621 (667)
..++++... .+.+..+.+...+++.+....+|.+|.. +.++-++-.
T Consensus 629 n~ILkGid~---i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 629 NLILKGIDK---IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred HHHHhhhhh---hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 444444332 1233456677788888888999999975 777776653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=236.70 Aligned_cols=199 Identities=30% Similarity=0.406 Sum_probs=165.7
Q ss_pred hhhcccCCCeEEEEEEe-CCCcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 351 KEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
.+.||+|++|.|-+-++ .+|...|+|.+...- +..++.++|+.+..+. ..|.+|+++|........++.||.| ..
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DT 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hh
Confidence 46899999999998877 479999999997653 4456788999877766 6999999999988889999999999 57
Q ss_pred Cccccccc-cccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 427 SLGDLLSR-EKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 427 sL~~~l~~-~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
||+.+-.+ ...+..+++..+-+||..+.+||.|||++ ..+||||+||+||||+.+|++||+|||++-.+...-..
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk-- 205 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK-- 205 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH--
Confidence 88776653 33456789999999999999999999986 69999999999999999999999999999766433221
Q ss_pred ecCCCCCccccchhhhhhhc--CCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 005953 506 MTGPRGTIGYIAPEIFMRNL--GNPSGKSDVYSYGMLLLEMIEEKKHLRPTE 555 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~--~~~s~k~DvwSlGvvl~elltg~~p~~~~~ 555 (667)
+...|-..|||||.+.... ..++-|+||||||+.+.||.+++.|++...
T Consensus 206 -t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 206 -TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred -HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 2244778899999986432 357889999999999999999999986543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-32 Score=255.26 Aligned_cols=253 Identities=23% Similarity=0.379 Sum_probs=190.6
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecC-----CeeEEEEEE
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG-----STRALIYEY 422 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e~ 422 (667)
+-||-|+||.||..+++ +|+.||+|++..-- ...+.+.+|+++|.-++|.|++..+++..-. .+.|+|.|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 56999999999999885 79999999886532 3357889999999999999999998876543 256788888
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
| ..+|..+|.. +..++...+.-+++||++||.|||+. +|.||||||.|.|++.|-.+||+|||+|+.-..+..
T Consensus 139 m-QSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 139 M-QSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred H-Hhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 8 4577777754 34688888888999999999999998 999999999999999999999999999997665544
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc---
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE--- 579 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 579 (667)
. .++..+-|..|.|||.+++. ..++.+.||||.|||+.||+.++..|+...+. ...+.+.+.+..+.
T Consensus 212 ~-hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi--------qQL~lItdLLGTPs~Ea 281 (449)
T KOG0664|consen 212 L-NMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPI--------EQLQMIIDLLGTPSQEA 281 (449)
T ss_pred h-hhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChH--------HHHHHHHHHhCCCcHHH
Confidence 3 35556678999999999987 68999999999999999999888777643321 11111111111111
Q ss_pred ---------------------cccccc-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 580 ---------------------KEDFVE-EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 580 ---------------------~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
...... ............+...++..||++|.+.++.+.++.
T Consensus 282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 000000 000111223455677789999999999999988775
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=241.51 Aligned_cols=243 Identities=21% Similarity=0.301 Sum_probs=190.0
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEc
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
+..+||+|+|+.|-.++++ +.+.+|+|++++.- +..+=...|-.+..+. +||.+|.++.++.+...+++|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 4578999999999999885 57899999987642 2233355676777766 6999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|--++++.+ .++++.+..+..+|..||.|||++ +||.||||.+|+|||..|++|++|+|+.+.--.+...
T Consensus 334 ~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~gd~ 407 (593)
T KOG0695|consen 334 NGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT 407 (593)
T ss_pred cCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence 9999988886643 589999999999999999999998 9999999999999999999999999999865433322
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
.....|||.|+|||.+.+. .+...+|.|+|||+++||+.|+.||+-.... ..+..-.+++++.++..+..-
T Consensus 408 --tstfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdivgm~----n~d~ntedylfqvilekqiri- 478 (593)
T KOG0695|consen 408 --TSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIVGMD----NPDMNTEDYLFQVILEKQIRI- 478 (593)
T ss_pred --cccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCcceecCC----CcccchhHHHHHHHhhhcccc-
Confidence 2446799999999999875 7788899999999999999999999754332 222233344444444332211
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCC
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRP 611 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP 611 (667)
+...+-+...++..-|++||.+|.
T Consensus 479 ----prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 ----PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ----cceeehhhHHHHHHhhcCCcHHhc
Confidence 111233445567778899999985
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-28 Score=234.39 Aligned_cols=211 Identities=35% Similarity=0.625 Sum_probs=182.9
Q ss_pred cccCCCeEEEEEEeCC-CcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCccc
Q 005953 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGD 430 (667)
Q Consensus 354 LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 430 (667)
||+|.+|.||++...+ ++.+++|++..... ..+.+.+|++.+++++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 89999999887654 25789999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC-CCceEEEeCCCccccCCCCceeeecCC
Q 005953 431 LLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSRNRSVVTMTGP 509 (667)
Q Consensus 431 ~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~-~~~~ki~DFGla~~~~~~~~~~~~~~~ 509 (667)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 986542 3588999999999999999999998 9999999999999999 89999999999987654421 12234
Q ss_pred CCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhH
Q 005953 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589 (667)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (667)
.+...|++||.+... ...+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 478899999988653 2667899999999999998
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 590 CIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3677889999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=230.67 Aligned_cols=258 Identities=21% Similarity=0.326 Sum_probs=191.6
Q ss_pred HHhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHHhhcc-cceEEeecceEecC--CeeEEEEEEc
Q 005953 348 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGFCCDG--STRALIYEYM 423 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~--~~~~lV~e~~ 423 (667)
+++.+++|+|.|+.||.|.. .+.+.++||+++..+ .+.+.+|+.+|..|. ||||++|++...+. ..+.||+||+
T Consensus 40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v 117 (338)
T KOG0668|consen 40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYV 117 (338)
T ss_pred HHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhh
Confidence 45668999999999999974 578899999998654 467889999999997 99999999998865 4678999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC-CceEEEeCCCccccCCCCc
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~-~~~ki~DFGla~~~~~~~~ 502 (667)
.+.+...+.. .++...+..+..+++.||.|+|+. ||.|||+||.|++||.. ..++|+|+|||.+..+...
T Consensus 118 ~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 118 NNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred ccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence 8877665542 366777889999999999999998 99999999999999875 5699999999998876654
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC----------CCccccc-----
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS----------NTTEAYF----- 567 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~----------~~~~~~~----- 567 (667)
.. ..+.+..|.-||++..- ..++..-|+|||||+|.+|+..+.||-.+....++ .....+.
T Consensus 189 Yn---VRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 189 YN---VRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred ee---eeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 43 23357788999998653 46677889999999999999999999665432111 0000000
Q ss_pred --hHHHHHhhcCccc---ccccchhh-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 568 --PDWIYDKLIQPEK---EDFVEEED-DCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 568 --~~~~~~~~~~~~~---~~~~~~~~-~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
+....+.+..... ..+...+. .-...+.++++-..|..|-++|||++|.+++=
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 0000000000000 11111111 12236788899999999999999999988653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=251.52 Aligned_cols=155 Identities=24% Similarity=0.408 Sum_probs=131.8
Q ss_pred HHHHHHHhhcccCCCCCHHHHHH-HHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcc-
Q 005953 323 VKQFIKTYRSALLSNYSYNDIKK-MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH- 399 (667)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~- 399 (667)
.++-.+.|+.+.+....+.|+-+ .+|-+.++||-|.|++||++.+. +.+.||+|+.+....-.+..+.||++|++++
T Consensus 54 eqE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~ 133 (590)
T KOG1290|consen 54 EQEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVRE 133 (590)
T ss_pred cccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHh
Confidence 34445677777888888888777 77878899999999999999874 6889999999987777788899999999994
Q ss_pred ----c---ceEEeecceEec----CCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 005953 400 ----H---VNIIHLLGFCCD----GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468 (667)
Q Consensus 400 ----h---~niv~l~g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~i 468 (667)
| ..||+|++.|.. +.+.++|+|++ |.+|..+|.... ...++...+.+|++||+.||.|||..| +|
T Consensus 134 ~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gI 209 (590)
T KOG1290|consen 134 GDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GI 209 (590)
T ss_pred cCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--Cc
Confidence 2 479999999874 56899999999 788888887543 346889999999999999999999986 99
Q ss_pred eecCCCCCcEEEC
Q 005953 469 LHLDIKPQNVLLD 481 (667)
Q Consensus 469 vH~Dikp~NIll~ 481 (667)
||-||||+|||+.
T Consensus 210 IHTDlKPENvLl~ 222 (590)
T KOG1290|consen 210 IHTDLKPENVLLC 222 (590)
T ss_pred cccCCCcceeeee
Confidence 9999999999983
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=257.45 Aligned_cols=197 Identities=26% Similarity=0.375 Sum_probs=164.3
Q ss_pred hhcccCCCeEEEEEEe-CCCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+-||-|+||+|.++.- ++...+|.|.+++.. ........|-.+|.....+-||+|+-.|.+++.+|+||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 4599999999999954 457789999998754 23345678889999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC--------
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS-------- 498 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~-------- 498 (667)
++-.+|.+.. -+.+..+..++.++..|+++.|.- |+|||||||+|||||.+|++||+||||+.-+.
T Consensus 715 DmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 715 DMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred cHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 9999997653 477777888899999999999986 99999999999999999999999999985221
Q ss_pred -CC-------------------------------CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh
Q 005953 499 -RN-------------------------------RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE 546 (667)
Q Consensus 499 -~~-------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt 546 (667)
.+ .........+||+.|+|||++.+. .++.-+|.||.||||+||+.
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHHHHhh
Confidence 00 000111234699999999999875 66778999999999999999
Q ss_pred CCCCCCCCCc
Q 005953 547 EKKHLRPTET 556 (667)
Q Consensus 547 g~~p~~~~~~ 556 (667)
|+.||-....
T Consensus 867 g~~pf~~~tp 876 (1034)
T KOG0608|consen 867 GQPPFLADTP 876 (1034)
T ss_pred CCCCccCCCC
Confidence 9999965543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=253.16 Aligned_cols=191 Identities=26% Similarity=0.350 Sum_probs=163.2
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchH---------HHHHHHHHHhhcc---cceEEeecceEecCCeeE
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSD---------NFINEVATIGRIH---HVNIIHLLGFCCDGSTRA 417 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~---------~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~ 417 (667)
.+.+|+|+||.|+.+.++ +...|+||.+.+.+-..+ ..-.||.+|..++ |+||++++++|++++..|
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 468999999999999986 467899999987653333 2446999999997 999999999999999999
Q ss_pred EEEEEcC-CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 418 LIYEYMP-NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 418 lV~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
|++|-.. +.+|.++|..+. .+++....-|++|++.|+++||+. +|||||||-+|+.++.+|-+||+|||.|..
T Consensus 646 l~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred EEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhh
Confidence 9999754 559999997654 588999999999999999999998 999999999999999999999999999977
Q ss_pred cCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 005953 497 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLR 552 (667)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~ 552 (667)
...+. +...+||..|.|||++.++ ......-|||++|++||-++....|+.
T Consensus 720 ~ksgp----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 720 TKSGP----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hcCCC----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence 65443 3446799999999999876 344667899999999999988777764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-28 Score=251.11 Aligned_cols=275 Identities=20% Similarity=0.287 Sum_probs=212.8
Q ss_pred CCCCCHHHHHHHHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcc------cceEEeec
Q 005953 335 LSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH------HVNIIHLL 407 (667)
Q Consensus 335 ~~~~~~~~l~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~------h~niv~l~ 407 (667)
+..+.+.|+....|.+.-..|+|-|++|.+|++. .|..||||++...+...+.=+.|+++|++|+ ..|.++|+
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 4456778888888888888999999999999885 4889999999998877788889999999995 35889999
Q ss_pred ceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC-Cce
Q 005953 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTP 486 (667)
Q Consensus 408 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~-~~~ 486 (667)
..|...++++||+|-+ ..+|.++|.....+..+....+..++.|+.-||..|... +|+|.||||.|||++++ ..+
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence 9999999999999988 679999999887788899999999999999999999987 99999999999999876 679
Q ss_pred EEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC--------
Q 005953 487 KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS-------- 558 (667)
Q Consensus 487 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~-------- 558 (667)
||||||.|.......- +...-+..|.|||.+.+- .++...|+||.||.||||.||+..|.+.....
T Consensus 577 KLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~ 650 (752)
T KOG0670|consen 577 KLCDFGSASFASENEI----TPYLVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL 650 (752)
T ss_pred eeccCccccccccccc----cHHHHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence 9999999977655432 222236689999999875 67778999999999999999998774332110
Q ss_pred -CC---------CCccccchHH---HH---Hh-----------hcCccc--------ccccchhhHHHHHHHHHHHHHhc
Q 005953 559 -GS---------NTTEAYFPDW---IY---DK-----------LIQPEK--------EDFVEEEDDCIARKMIIVGLWCI 603 (667)
Q Consensus 559 -~~---------~~~~~~~~~~---~~---~~-----------~~~~~~--------~~~~~~~~~~~~~~l~~l~~~cl 603 (667)
+. ...+..|..- ++ +. ..++.. .............++.+|+-.|+
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml 730 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML 730 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence 00 0000111000 00 00 001100 00122334566788999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 005953 604 QINPKDRPSMTRVVEM 619 (667)
Q Consensus 604 ~~~P~~RPt~~evl~~ 619 (667)
..||++|.|..+.|.+
T Consensus 731 ~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 731 ILDPEKRITVNQALKH 746 (752)
T ss_pred ccChhhcCCHHHHhcC
Confidence 9999999999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-28 Score=254.03 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=194.0
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
+.+++|.|.||.|||+++. .++.+|||+++... ....-...|+-+++..+|||||.++|.+......++.|||+.+|+
T Consensus 19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs 98 (829)
T KOG0576|consen 19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS 98 (829)
T ss_pred heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence 4578999999999999985 68999999998764 334556789999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|++.-+-.. .+++.++..+.++..+||+|||+. +-+|||||-.|||+++.|.+|++|||.+..+..- .....
T Consensus 99 lQdiy~~Tg---plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~Krk 170 (829)
T KOG0576|consen 99 LQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAKRK 170 (829)
T ss_pred ccceeeecc---cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh--hhhhh
Confidence 999887543 689999999999999999999987 8899999999999999999999999998765432 22234
Q ss_pred CCCCCccccchhhhh-hhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 508 GPRGTIGYIAPEIFM-RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~-~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
...||+.|||||+.. ...+.+..++|||+.|+...|+---++|..+... .... -.+.+.........
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-----------mr~l-~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-----------MRAL-FLMTKSGFQPPTLK 238 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-----------HHHH-HHhhccCCCCCccc
Confidence 567999999999873 2336788899999999999998655554322211 0000 01111111111122
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 618 (667)
......+.+.+++..|+..+|++||+++.++.
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 22334567888999999999999999988764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=226.44 Aligned_cols=197 Identities=32% Similarity=0.517 Sum_probs=168.5
Q ss_pred hhhhcccCCCeEEEEEEeCC-CcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 350 FKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.+.||+|++|+||++...+ ++.+|+|.+..... ..+.+.+|++.+++++|+|++++++++......++++||++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45789999999999999865 88999999986543 4678899999999999999999999999989999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++..... .+++..+..++.+++.++.+||+. +++|+||+|.||+++.++.++|+|||++......... ..
T Consensus 83 ~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~ 156 (225)
T smart00221 83 DLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL 156 (225)
T ss_pred CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence 99999875431 178899999999999999999998 9999999999999999999999999999877554300 11
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 553 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~ 553 (667)
....++..|++||.+. ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2234678899999984 334677799999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=231.11 Aligned_cols=255 Identities=23% Similarity=0.294 Sum_probs=184.7
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecC------CeeEEEEE
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRALIYE 421 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~~lV~e 421 (667)
+.+|.|+- .|-.+.+. .++.||+|++... ....++..+|...+..++|+|+++++.++.-. ...|+|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 45677776 55555443 5889999987543 23346778999999999999999999988743 36789999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
+| .++|...++. .++-.++..|.+|++.|+.|||+. +|+||||||+||++..+..+||.|||+|+.-...
T Consensus 102 ~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 102 LM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred hh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 99 6788888863 367788999999999999999998 9999999999999999999999999999865443
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCC--------CCCccccchH---H
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG--------SNTTEAYFPD---W 570 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~~---~ 570 (667)
..++..+.|..|.|||++.+. .+.+.+||||+||++.||++|+-.|.+...-.. ......+..+ -
T Consensus 172 --~~mtpyVvtRyyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred --cccCchhheeeccCchheecc--CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 234666789999999999886 488999999999999999999877753321100 0000000000 0
Q ss_pred H--------------HHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 571 I--------------YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 571 ~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
. +.++.....-....+....-+....+++.+||-.||++|-+++++|++=-
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY 312 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence 0 00000000000001111122445677899999999999999999998754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-27 Score=222.61 Aligned_cols=263 Identities=23% Similarity=0.395 Sum_probs=198.3
Q ss_pred ccCCCCCHHHHHHHHHHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecce
Q 005953 333 ALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGF 409 (667)
Q Consensus 333 ~~~~~~~~~~l~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~ 409 (667)
+.+.+|+-.+.... ++..+|.+...|..|+|+|+. ..+++|++... ....++|..|.-.|+-+.||||++++|.
T Consensus 179 atlsr~~gid~~~l--nl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlga 255 (448)
T KOG0195|consen 179 ATLSRYTGIDVSSL--NLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGA 255 (448)
T ss_pred cccccccCcchhhh--hhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhh
Confidence 34445544444332 466789999999999999954 44556776543 3456789999999999999999999999
Q ss_pred EecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEE
Q 005953 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 489 (667)
Q Consensus 410 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~ 489 (667)
|....++.++..||+.|||..+|+... +..++..++.+++.++|+|++|||+. ++-|...-|.++.++||++.+++|+
T Consensus 256 cnsppnlv~isq~mp~gslynvlhe~t-~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 256 CNSPPNLVIISQYMPFGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred ccCCCCceEeeeeccchHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee
Confidence 999999999999999999999998754 45678889999999999999999986 5556667899999999999998885
Q ss_pred eCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccch
Q 005953 490 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFP 568 (667)
Q Consensus 490 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 568 (667)
.+-+++.. ...+..-.+.||+||.+++..... -.++|+|||++++|||.|..-||.....-
T Consensus 334 -mad~kfsf------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm----------- 395 (448)
T KOG0195|consen 334 -MADTKFSF------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM----------- 395 (448)
T ss_pred -cccceeee------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch-----------
Confidence 11111111 112233478999999998753333 34689999999999999999998654321
Q ss_pred HHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 569 DWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
+--.+-..+......+..+++.+.+++.-|+..||.+||.+..++-.|+.
T Consensus 396 ----ecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 396 ----ECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred ----hhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 00011112233333444567889999999999999999999999998874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-26 Score=215.11 Aligned_cols=252 Identities=17% Similarity=0.290 Sum_probs=183.3
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecc-eEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLG-FCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g-~~~~~~~~~lV~e~~~ 424 (667)
+++.+.||+|.||.+-++.+. ....+++|.+.......++|.+|..-=-.| .|.||+.-+. .+...+...+++||+|
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP 105 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP 105 (378)
T ss_pred hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence 455688999999999999986 478899999988888889999999765555 5899998776 4566677789999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE-C-CCCceEEEeCCCccccCCCCc
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL-D-PDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll-~-~~~~~ki~DFGla~~~~~~~~ 502 (667)
.|+|.+-+.. ..+.+....+++.|++.|+.|||++ ++||||||.+|||| + +..++||+|||+.+....-..
T Consensus 106 ~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 106 RGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred cchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 9999887754 3477888899999999999999998 99999999999999 3 345899999999876543221
Q ss_pred eeeecCCCCCccccchhhhhhh---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
...-+..|.|||+.... .....+.+|||.||+|++..+||+.|++.... .+..+..| .+..+..
T Consensus 179 -----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~------~d~~Y~~~--~~w~~rk 245 (378)
T KOG1345|consen 179 -----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI------MDKPYWEW--EQWLKRK 245 (378)
T ss_pred -----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc------cCchHHHH--HHHhccc
Confidence 12246679999987432 11335568999999999999999999973321 11222222 2222222
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.... ...-.....++..+..+-+..++++|=-..++-.+.
T Consensus 246 ~~~~-P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 246 NPAL-PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred CccC-chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 1111 111112344566677788899999995555555444
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-26 Score=228.22 Aligned_cols=260 Identities=24% Similarity=0.372 Sum_probs=190.0
Q ss_pred hhhhcccCCCeEEEEEEeC----CCcEEEEEEcccCCcchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
..++||+|.|++||++.+. ..+.||+|.+..... .....+|+++|..+. +.||+++.+++..++...+|+||++
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 3578999999999999763 467899999876543 456889999999995 9999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC-CceEEEeCCCccccCCC---
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRN--- 500 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~-~~~ki~DFGla~~~~~~--- 500 (667)
...-.+++.. ++...+..+++.+..||+++|.. |||||||||.|+|.+.. +.-.|.|||||......
T Consensus 119 H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 119 HDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred ccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence 9888887743 56788899999999999999998 99999999999999765 67889999999621000
Q ss_pred ---------------------------------------CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHH
Q 005953 501 ---------------------------------------RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLL 541 (667)
Q Consensus 501 ---------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl 541 (667)
..........||+||.|||++.+- +..+.++||||-|||+
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceeecccee
Confidence 000011123599999999999875 6778999999999999
Q ss_pred HHHHhCCCCCCCCCcCC----------------------CC--CCccccch--HHH---HHhhc-Ccccc-----cccch
Q 005953 542 LEMIEEKKHLRPTETTS----------------------GS--NTTEAYFP--DWI---YDKLI-QPEKE-----DFVEE 586 (667)
Q Consensus 542 ~elltg~~p~~~~~~~~----------------------~~--~~~~~~~~--~~~---~~~~~-~~~~~-----~~~~~ 586 (667)
+.+++++.||-...... +. .+....++ ..+ ++.+. ..... -....
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 99999999984321110 10 00000000 000 01110 00000 01111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
..+.....+++++.+|+..||.+|.|+++.|.+-
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 1223344788999999999999999999998653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-26 Score=264.35 Aligned_cols=198 Identities=19% Similarity=0.245 Sum_probs=137.4
Q ss_pred hccc-ceEEeecceE-------ecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 005953 397 RIHH-VNIIHLLGFC-------CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468 (667)
Q Consensus 397 ~l~h-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~i 468 (667)
.++| .||+++++++ .+....++++|++ +++|.++|... ...+++..++.++.||++||+|||++ +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 4456 6888888877 2334667888988 67999999653 23589999999999999999999988 99
Q ss_pred eecCCCCCcEEECC-------------------CCceEEEeCCCccccCCCCc--------------eeeecCCCCCccc
Q 005953 469 LHLDIKPQNVLLDP-------------------DFTPKVSDFGLAKAHSRNRS--------------VVTMTGPRGTIGY 515 (667)
Q Consensus 469 vH~Dikp~NIll~~-------------------~~~~ki~DFGla~~~~~~~~--------------~~~~~~~~gt~~y 515 (667)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566666666653211000 0001123578899
Q ss_pred cchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHH
Q 005953 516 IAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKM 595 (667)
Q Consensus 516 ~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 595 (667)
||||++.+. .++.++|||||||+||||++|..|+..... .+.. +......+ .........
T Consensus 182 ~APE~~~~~--~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---------~~~~-~~~~~~~~--------~~~~~~~~~ 241 (793)
T PLN00181 182 TSPEEDNGS--SSNCASDVYRLGVLLFELFCPVSSREEKSR---------TMSS-LRHRVLPP--------QILLNWPKE 241 (793)
T ss_pred EChhhhccC--CCCchhhhhhHHHHHHHHhhCCCchhhHHH---------HHHH-HHHhhcCh--------hhhhcCHHH
Confidence 999998764 678999999999999999998776532110 0000 11111110 000112345
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 596 IIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 596 ~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
..++.+||+.+|.+||+|.|++++-
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhch
Confidence 5788899999999999999998653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=207.19 Aligned_cols=167 Identities=19% Similarity=0.245 Sum_probs=124.3
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|||.+++... +..+++..++.|+.|+++||+|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 7889988653 23599999999999999999999987 4 999999999999999 99987654322
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
..||+.|||||++.+. .++.++|||||||++|||++|+.|+..... ....+... ........... .
T Consensus 64 ---~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~------~~~~~~~~-~~~~~~~~~~~--~ 129 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEERE------LSAILEIL-LNGMPADDPRD--R 129 (176)
T ss_pred ---CCCcccccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccch------hcHHHHHH-HHHhccCCccc--c
Confidence 2578999999999764 678899999999999999999999854321 01111111 11111110000 0
Q ss_pred hhhHHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 586 EEDDCIAR--KMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 586 ~~~~~~~~--~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
........ .+.+++.+||+.+|++||++.|+++++...
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11222333 689999999999999999999999999744
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=216.54 Aligned_cols=158 Identities=21% Similarity=0.213 Sum_probs=123.4
Q ss_pred HhhhhcccCCCeEEEEEEeC--CCcEEEEEEcccC------CcchHHHHHHHHHHhhcccceEEe-ecceEecCCeeEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP--DGRLVAVKVLEKT------SNFSDNFINEVATIGRIHHVNIIH-LLGFCCDGSTRALI 419 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~------~~~~~~~~~Ei~~l~~l~h~niv~-l~g~~~~~~~~~lV 419 (667)
.+.+.||+|+||+||+|.+. +++.||||++... ....+.|.+|+++|++++|+|+++ ++. .+..++|
T Consensus 21 ~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LV 96 (365)
T PRK09188 21 VETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLV 96 (365)
T ss_pred eEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEE
Confidence 45678999999999999874 5788899986532 112456899999999999999985 443 2467999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCC-CCCcEEECCCCceEEEeCCCccccC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDI-KPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Di-kp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
|||+++++|... .. .. ...++.+++++|+|||+. +|+|||| ||+|||++.++.+||+|||+|+.+.
T Consensus 97 mE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 97 RGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred EEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 999999999632 11 11 146788999999999998 9999999 9999999999999999999998775
Q ss_pred CCCceee------ecCCCCCccccchhhhhh
Q 005953 499 RNRSVVT------MTGPRGTIGYIAPEIFMR 523 (667)
Q Consensus 499 ~~~~~~~------~~~~~gt~~y~aPE~~~~ 523 (667)
....... .+...+++.|+|||.+..
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 4432111 134567889999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=203.48 Aligned_cols=260 Identities=21% Similarity=0.274 Sum_probs=188.2
Q ss_pred HHhhhhcccCCCeEEEEEEeCCC--cEEEEEEcccCCcc-hHHHHHHHHHHhhccc----ceEEeecceE-ecCCeeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPDG--RLVAVKVLEKTSNF-SDNFINEVATIGRIHH----VNIIHLLGFC-CDGSTRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~-~~~~~~Ei~~l~~l~h----~niv~l~g~~-~~~~~~~lV 419 (667)
+.+.++||+|+||.||++..... ..+|+|+....... ...+..|+.++..+.. .++..+++.. ......++|
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV 99 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV 99 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence 34568999999999999987543 57889987654322 2267788888888863 5778888877 477788999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC-----CceEEEeCCCc
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-----FTPKVSDFGLA 494 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~-----~~~ki~DFGla 494 (667)
|+.+ |.+|.++..... ...++..+.++|+.|++.+|++||+. +++||||||.|+++... ..+.|.|||++
T Consensus 100 M~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 100 MSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred Eecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 9988 889999886554 56799999999999999999999998 99999999999999765 46999999999
Q ss_pred c--ccCCCCce----e-e-ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCcccc
Q 005953 495 K--AHSRNRSV----V-T-MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAY 566 (667)
Q Consensus 495 ~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 566 (667)
+ ........ . . ....+||.+|.++....+. ..+.+.|+||++.++.|++.|..|+....... ....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~----~~~~ 248 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWEALEMTD----LKSK 248 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCccccccc----hHHH
Confidence 8 33222211 0 1 1345699999999988764 78899999999999999999998885443210 0000
Q ss_pred chHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 567 FPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
+......... .. ........+.++...+-..+..++|....+...|++....
T Consensus 249 ~~~~~~~~~~----~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 249 FEKDPRKLLT----DR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHHHhhhhcc----cc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 1100000000 00 0111233455555555568999999999999998765444
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-20 Score=194.99 Aligned_cols=261 Identities=30% Similarity=0.433 Sum_probs=192.7
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCc----chHHHHHHHHHHhhcccc-eEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHV-NIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~h~-niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.||.|+||.||++... ..+++|.+..... ....+.+|+..+..+.|+ +++++.+.+......+++++++.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 4567999999999999986 8889999876532 356899999999999988 79999999977777899999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC-ceEEEeCCCccccCCCCce
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~-~~ki~DFGla~~~~~~~~~ 503 (667)
++++.+++........+.......+..|++.++.|+|+. +++|||+||+||+++..+ .++++|||+++........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999996665432113588889999999999999999998 899999999999999998 7999999999865543322
Q ss_pred e----eecCCCCCccccchhhhhhhc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 504 V----TMTGPRGTIGYIAPEIFMRNL-GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 504 ~----~~~~~~gt~~y~aPE~~~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
. ......|+..|+|||.+.... ...+...|+||+|++++++++|..|+...... .........+.......
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELPTPS 234 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcCCcc
Confidence 1 234567899999999997631 36778999999999999999999986443210 00000111111111000
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
................+.+++..++..+|..|.++.+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000001223467778888999999999999887764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.9e-21 Score=182.14 Aligned_cols=137 Identities=19% Similarity=0.246 Sum_probs=106.9
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCc---c-------hHH-----------------HHHHHHHHhhcccceEE
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN---F-------SDN-----------------FINEVATIGRIHHVNII 404 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~-------~~~-----------------~~~Ei~~l~~l~h~niv 404 (667)
+.||+|+||.||+|...+|+.||||+++.... . ... ..+|++.+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 57999999999999988899999999875421 1 111 23499999999877764
Q ss_pred eecceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeeecCCCCCcEEECCC
Q 005953 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL-HNGCELRILHLDIKPQNVLLDPD 483 (667)
Q Consensus 405 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yL-H~~~~~~ivH~Dikp~NIll~~~ 483 (667)
....+.. ...++||||++++++...+.. ...+++..+.+++.|++.+|.|| |+. +|+||||||+|||++ +
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 3332222 233899999988877654322 23578899999999999999999 677 999999999999998 4
Q ss_pred CceEEEeCCCcccc
Q 005953 484 FTPKVSDFGLAKAH 497 (667)
Q Consensus 484 ~~~ki~DFGla~~~ 497 (667)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=218.02 Aligned_cols=251 Identities=22% Similarity=0.276 Sum_probs=185.4
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEcc----cCCcc---hHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLE----KTSNF---SDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~----~~~~~---~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
...+|.|++|.|+..... ..+..+.|... ..... ...+..|+.+-..++|+|++..+..+.+....+-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 367999999988877543 33334444332 21111 12256688888889999999988888777777667999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++ +|..++.+. ..+....+..+..|+..|++|||+. +|.|||+|++|++++.++.+||+|||.+..+..+..
T Consensus 403 ~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 403 CPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred ccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 999 999988654 2477788889999999999999998 999999999999999999999999999987765544
Q ss_pred e--eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhc-Ccc
Q 005953 503 V--VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI-QPE 579 (667)
Q Consensus 503 ~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 579 (667)
. ....+..|+..|+|||++.+.. .-....||||.|+++..|++|+.||........ .+. ..... ...
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~-ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~------~~~---~~~~~~~~~ 545 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKE-YDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN------SFK---TNNYSDQRN 545 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccc-cCcchhhhhhccceEEEEecCCCcccccccccc------chh---hhccccccc
Confidence 3 4456788999999999998752 224568999999999999999999865432111 000 00000 001
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 618 (667)
...........++.+...++.++|+.+|.+|-|+++|++
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 111222334456677888999999999999999999985
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.5e-20 Score=179.63 Aligned_cols=253 Identities=18% Similarity=0.266 Sum_probs=186.9
Q ss_pred HHhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.++||+|.||.++.|+. -+++.||||.-... ...-++..|....+.|. .+.|...+-+..++..-.||+|.+ |
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEecccc-CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 45679999999999999975 47999999975433 33456778888888885 689999988888888899999999 8
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC-----CCceEEEeCCCccccCCC
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-----DFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~-----~~~~ki~DFGla~~~~~~ 500 (667)
-||+|+..-.. ..++..++.-||.|++.-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+.+...
T Consensus 108 PSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 108 PSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred cCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 89999887543 3588999999999999999999998 9999999999999954 346999999999987654
Q ss_pred Ccee-----eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh
Q 005953 501 RSVV-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575 (667)
Q Consensus 501 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (667)
.... ......||.+||+--...+. ..+.+.|.=|||-|++..|-|..||+...... ...-++++
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t---------nK~kYeKI 251 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKADT---------NKEKYEKI 251 (449)
T ss_pred cccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccccCcc---------hHHHHHHh
Confidence 4332 22345699999998776664 66889999999999999999999998764421 11123344
Q ss_pred cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005953 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618 (667)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 618 (667)
.+........+.....+.++..-+.-.-..+-.+-|..+-+..
T Consensus 252 Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~ 294 (449)
T KOG1165|consen 252 GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRK 294 (449)
T ss_pred ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 4333322222222333444444444444556666676544433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=175.39 Aligned_cols=200 Identities=24% Similarity=0.327 Sum_probs=161.6
Q ss_pred HHhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHHhhccc-ceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH-VNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.++||.|+||.+|.|.. .+|+.||||+-..... .-+...|..+...+++ ..|..+..+..+...-.+|||.+ |
T Consensus 17 y~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-G 94 (341)
T KOG1163|consen 17 YKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-G 94 (341)
T ss_pred eEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-C
Confidence 44668999999999999975 6899999998654432 3467789999999975 67777888888888899999999 8
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC---CCceEEEeCCCccccCCCCc
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~---~~~~ki~DFGla~~~~~~~~ 502 (667)
-||+++.+-.. ..++..+++-.|-|++.-++|+|.+ ++|||||||+|+|..- ...+.++|||||+.+.....
T Consensus 95 PsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 95 PSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred ccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 89999987543 2478889999999999999999998 9999999999999954 35799999999987644332
Q ss_pred ee-----eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCc
Q 005953 503 VV-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTET 556 (667)
Q Consensus 503 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~ 556 (667)
.. .-....||.+|.+--...+. ..+.+.|+=|+|.+|....-|..||+....
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 21 11345689999987665543 557889999999999999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.4e-20 Score=176.84 Aligned_cols=139 Identities=19% Similarity=0.217 Sum_probs=109.5
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcc---------------------------hHHHHHHHHHHhhcccceEE
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNF---------------------------SDNFINEVATIGRIHHVNII 404 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------------------------~~~~~~Ei~~l~~l~h~niv 404 (667)
+.||+|++|+||+|+..+|+.||||+++..... ...+..|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 579999999999999878999999998754210 11235789999999998875
Q ss_pred eecceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCcEEECCC
Q 005953 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDPD 483 (667)
Q Consensus 405 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivH~Dikp~NIll~~~ 483 (667)
....+... ..+|||||++++++...... ...++.....+++.+++.++.+||+ . +|+||||||+|||++ +
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 44433322 34899999988865443211 1246788899999999999999998 7 999999999999999 8
Q ss_pred CceEEEeCCCccccCC
Q 005953 484 FTPKVSDFGLAKAHSR 499 (667)
Q Consensus 484 ~~~ki~DFGla~~~~~ 499 (667)
+.++|+|||+++....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.7e-20 Score=159.34 Aligned_cols=102 Identities=31% Similarity=0.528 Sum_probs=80.6
Q ss_pred CCCCCCccCCccccCCCCCCCCCCCCCC-CCceeeccCC-CCCcEEecCceEEEEEEeecCCceEEEEEecccccccCCC
Q 005953 43 EDCSPFKCGNLTFSFPFSSSSTSGYCGL-PNYQITCDSS-SVPKLLLSGRLYQVRNFFSSQDDRLITVVDTQLIKDLSSG 120 (667)
Q Consensus 43 ~~C~~~~CG~~~I~yPF~~~~~~~~Cg~-~~f~l~C~~~-~~~~l~~~~~~~~V~~I~~~~~~~~~~v~d~~~~~~~~~~ 120 (667)
++| |.+|||++|+||||++ ++|++ |+|+|+|+++ ++++|.+.+++|+|++|+|+ +++++|.++... .
T Consensus 2 ~~C-~~~CGnv~IpYPFgi~---~~C~~~~~F~L~C~~~~~~~~l~l~~~~~~V~~I~~~--~~~i~v~~~~~~-----~ 70 (106)
T PF13947_consen 2 PGC-PSSCGNVSIPYPFGIG---PGCGRDPGFELTCNNNTSPPKLLLSSGNYEVLSISYE--NGTIRVSDPISS-----N 70 (106)
T ss_pred CCC-CCccCCEeecCCCccC---CCCCCCCCcEEECCCCCCCceeEecCCcEEEEEEecC--CCEEEEEecccc-----c
Confidence 579 7999999999999998 79999 9999999987 45688888999999999999 999999998754 3
Q ss_pred CCCCc-ccccccccCCCcCceecCCCCceEEEEcCCC
Q 005953 121 SCESL-YNLSVAINSYSIGSLTLPSGNLNLTFFKCPR 156 (667)
Q Consensus 121 ~c~~~-~n~~~~~~~~~~~pf~~s~~~~~~t~~~C~~ 156 (667)
|+... .........+ ..||.+++.+|.++++||++
T Consensus 71 ~~~~~~~~~~~~~~~~-~~~~~~s~~~N~~~~~GC~t 106 (106)
T PF13947_consen 71 CYSSSSSNSSNSNLSL-NGPFFFSSSSNKFTVVGCNT 106 (106)
T ss_pred eecCCCCcccccEEee-cCCceEccCCcEEEEECCCC
Confidence 33333 1111101112 33888888899999999984
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.9e-20 Score=196.37 Aligned_cols=218 Identities=24% Similarity=0.421 Sum_probs=162.8
Q ss_pred HhhcccceEEeecceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe-eecCC
Q 005953 395 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI-LHLDI 473 (667)
Q Consensus 395 l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~i-vH~Di 473 (667)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+... ...+++.-...+.++++.||+|||+. +| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 46788999999999999999999999999999999999763 34688888999999999999999986 44 99999
Q ss_pred CCCcEEECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhc--CC---CCCcccHHHHHHHHHHHHhCC
Q 005953 474 KPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL--GN---PSGKSDVYSYGMLLLEMIEEK 548 (667)
Q Consensus 474 kp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~---~s~k~DvwSlGvvl~elltg~ 548 (667)
++.|.++|..+.+||+|||+.................-..-|.|||.+.... .. .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987664311111111122356799999997631 11 467899999999999999999
Q ss_pred CCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchh--hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 549 KHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE--DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 549 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
.||....... . ++.+...+.+.......... ..+....+..++..||..+|++||+++++-..++....
T Consensus 156 ~~~~~~~~~~------~--~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 156 GPFDLRNLVE------D--PDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred CccccccccC------C--hHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9997543211 1 12222222221111111111 11334478889999999999999999999999885444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4e-20 Score=179.62 Aligned_cols=167 Identities=15% Similarity=0.169 Sum_probs=127.0
Q ss_pred HHHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchH----H------HHHHHHHHhhcccceEEeecceEecC---
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSD----N------FINEVATIGRIHHVNIIHLLGFCCDG--- 413 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~----~------~~~Ei~~l~~l~h~niv~l~g~~~~~--- 413 (667)
.++..+.||.|+||.||.... +++.+|||++.......+ . +.+|+..+.+++|++|..+..++...
T Consensus 32 ~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~ 110 (232)
T PRK10359 32 NIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERK 110 (232)
T ss_pred ceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccc
Confidence 344567899999999999765 577899999975432222 2 57999999999999999998876533
Q ss_pred -----CeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEE
Q 005953 414 -----STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKV 488 (667)
Q Consensus 414 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki 488 (667)
...+|||||++|.+|.++.. +++ ....+++.++..+|+. +++|||+||+||++++++ ++|
T Consensus 111 ~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 111 TLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred cccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEE
Confidence 35889999999999988731 222 2456899999999998 999999999999999988 999
Q ss_pred EeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHH
Q 005953 489 SDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI 545 (667)
Q Consensus 489 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ell 545 (667)
+|||..+....+... ..++... .+..++|+||||+.+.-+.
T Consensus 176 iDfg~~~~~~e~~a~--------------d~~vler--~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAK--------------DRIDLER--HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhH--------------HHHHHHh--HhcccccccceeEeehHHH
Confidence 999988655322211 0022222 3446899999999988764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=208.61 Aligned_cols=248 Identities=22% Similarity=0.237 Sum_probs=178.0
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC--cchHHHHHHHHH--HhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS--NFSDNFINEVAT--IGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~Ei~~--l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.||.+.|=.|.+|+++.|. |+||++-+.. -..+.|.++++- ...++|||.+++.-+-....-.|||-+|. .
T Consensus 27 ~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv-k 104 (1431)
T KOG1240|consen 27 YVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV-K 104 (1431)
T ss_pred eecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH-h
Confidence 4578999999999999997777 8899986543 223445444433 44458999999988877778888999998 5
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcccc--CCCC--
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH--SRNR-- 501 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~--~~~~-- 501 (667)
-+|.|.|.... -+...+...|+.|++.||.-+|.. +|.|||||.+||||+.-+-+.|+||..-+.. +.+.
T Consensus 105 hnLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 105 HNLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred hhhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 68999886543 466677788999999999999998 9999999999999999999999999866532 2211
Q ss_pred -ceeeecCCCCCccccchhhhhhhc---------CCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHH
Q 005953 502 -SVVTMTGPRGTIGYIAPEIFMRNL---------GNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDW 570 (667)
Q Consensus 502 -~~~~~~~~~gt~~y~aPE~~~~~~---------~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 570 (667)
....+...+.-..|+|||.+.... ...+++-||||+|||++||++ |+++|....-... .....+.++.
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aY-r~~~~~~~e~ 257 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAY-RSGNADDPEQ 257 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhH-hccCccCHHH
Confidence 112223334456899999985532 125678899999999999997 4666643211000 0001222222
Q ss_pred HHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 571 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
+.+++.+ ..+.++++.|++.||++|-++++.|+.-.
T Consensus 258 ~Le~Ied---------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 258 LLEKIED---------------VSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HHHhCcC---------------ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 2222221 24667889999999999999999998744
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-19 Score=168.89 Aligned_cols=184 Identities=16% Similarity=0.127 Sum_probs=138.7
Q ss_pred hhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchH-----HHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEEcC
Q 005953 351 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSD-----NFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~-----~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
...|++|+||+||.+.. +++.++.+.+.......+ .+.+|+++|+++. |+++++++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 36799999999997766 788888888776654333 5789999999995 5788888875 34699999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCC-CCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDI-KPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Di-kp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
|.+|.+.+.. ....++.|++++|.++|+. +|+|||| ||.|||++.++.++|+|||+|.........
T Consensus 82 G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 82 GAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred CccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 9888654311 1135778999999999998 9999999 799999999999999999999865433311
Q ss_pred ----e--e-----ecCCCCCccccchhhhhhhcCCCC-CcccHHHHHHHHHHHHhCCCCCCC
Q 005953 504 ----V--T-----MTGPRGTIGYIAPEIFMRNLGNPS-GKSDVYSYGMLLLEMIEEKKHLRP 553 (667)
Q Consensus 504 ----~--~-----~~~~~gt~~y~aPE~~~~~~~~~s-~k~DvwSlGvvl~elltg~~p~~~ 553 (667)
. . ..-...++.|++|+.-.-- ...+ .+.+.++-|.-+|.++|++.+...
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0 0012367888999865322 1222 356889999999999999877643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-19 Score=191.15 Aligned_cols=231 Identities=26% Similarity=0.300 Sum_probs=176.2
Q ss_pred hcccCCCeEEEEEE----eCCCcEEEEEEcccCCc---chHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEEcC
Q 005953 353 KLGTGGYGNVYKGK----FPDGRLVAVKVLEKTSN---FSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~----~~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+|+|.||.|+..+ .+.|..+|.|++++... .......|-.++..++ ||.+|++.-.+......+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999763 23477889998875431 1124556778888886 9999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|.|...+.... ..++.....+...++-+++++|+. +|+|||+|++||+++.+|.+|+.|||+++..-.....
T Consensus 81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999988886543 466777778888999999999988 9999999999999999999999999999876443322
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.||..|||||.+. .....+|-||||++.+||+||-.||.. .+...+.+.+.
T Consensus 154 -----cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~----------------~~~~~Il~~~~---- 204 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG----------------DTMKRILKAEL---- 204 (612)
T ss_pred -----ccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch----------------HHHHHHhhhcc----
Confidence 5899999999986 235689999999999999999998864 12223322211
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCH--HHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSM--TRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~--~evl~~L 620 (667)
..+.........++..+...+|.+|--. ..+.+.+
T Consensus 205 -~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 205 -EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred -CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 1122334455566677888899998754 3444444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-18 Score=174.01 Aligned_cols=230 Identities=22% Similarity=0.280 Sum_probs=144.9
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcc----------cceEEeecceE-----
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIH----------HVNIIHLLGFC----- 410 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~----------h~niv~l~g~~----- 410 (667)
.+.||.|+++.||.+++. +++.+|||+..... ...+++.+|.-....+. |-.++..++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 367999999999999996 48999999975433 23456666665554432 21222222211
Q ss_pred ----ecC---C-----eeEEEEEEcCCCCccccccc---c-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCC
Q 005953 411 ----CDG---S-----TRALIYEYMPNGSLGDLLSR---E-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIK 474 (667)
Q Consensus 411 ----~~~---~-----~~~lV~e~~~~gsL~~~l~~---~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dik 474 (667)
... + +.+++|+-+ .++|.+++.. . .....+....++.+..|+++.+++||+. +++|+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 111 1 235677777 6788887643 1 1112234455567779999999999998 99999999
Q ss_pred CCcEEECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhc------CCCCCcccHHHHHHHHHHHHhCC
Q 005953 475 PQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL------GNPSGKSDVYSYGMLLLEMIEEK 548 (667)
Q Consensus 475 p~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~s~k~DvwSlGvvl~elltg~ 548 (667)
|+|++++.+|.++|+||+....... ... . ...+..|.+||...... -.++.+.|.|++|+++|.|.+|+
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~---~~~-~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGT---RYR-C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTE---EEE-G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCc---eee-c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 9999999999999999987654432 111 1 33467899999875531 24578899999999999999999
Q ss_pred CCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCC
Q 005953 549 KHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDR 610 (667)
Q Consensus 549 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 610 (667)
.|+....... ...+ ...... .+++.+..++..+|+.||++|
T Consensus 248 lPf~~~~~~~--------~~~~------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEA--------DPEW------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGS--------TSGG------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccc--------cccc------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9997553311 1111 111222 567788899999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.4e-18 Score=163.39 Aligned_cols=131 Identities=20% Similarity=0.318 Sum_probs=103.0
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccC-CcchHHHHHHHHHHhhc-----ccceEEeecceEecCC---e-eEEEE
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT-SNFSDNFINEVATIGRI-----HHVNIIHLLGFCCDGS---T-RALIY 420 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l-----~h~niv~l~g~~~~~~---~-~~lV~ 420 (667)
+.||+|+||.||. ++ ++.. +||++... ....+.+.+|+.+++.+ .||||++++|++.++. . ..+|+
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred ceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 6799999999996 43 3444 79987654 23456799999999999 5799999999998874 3 33789
Q ss_pred EE--cCCCCccccccccccCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCeeecCCCCCcEEECC----CCceEEEeCCC
Q 005953 421 EY--MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAI-EYLHNGCELRILHLDIKPQNVLLDP----DFTPKVSDFGL 493 (667)
Q Consensus 421 e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl-~yLH~~~~~~ivH~Dikp~NIll~~----~~~~ki~DFGl 493 (667)
|| .++|+|.+++.+. .+++. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+||+.
T Consensus 85 e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 99 5579999999653 24444 35677888777 999998 9999999999999974 34899999554
Q ss_pred c
Q 005953 494 A 494 (667)
Q Consensus 494 a 494 (667)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 4
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-17 Score=164.64 Aligned_cols=139 Identities=16% Similarity=0.191 Sum_probs=108.0
Q ss_pred HhhhhcccCCCeEEEEEE--eCCCcEEEEEEcccCCc-------------------------chHHHHHHHHHHhhcccc
Q 005953 349 GFKEKLGTGGYGNVYKGK--FPDGRLVAVKVLEKTSN-------------------------FSDNFINEVATIGRIHHV 401 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~-------------------------~~~~~~~Ei~~l~~l~h~ 401 (667)
.+.+.||+|+||.||+|. ..+|+.||+|++..... ....+.+|+..+.++.+.
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~ 110 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA 110 (237)
T ss_pred HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 355789999999999998 45899999999864321 012356899999999753
Q ss_pred --eEEeecceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eeecCCCCCcE
Q 005953 402 --NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR-ILHLDIKPQNV 478 (667)
Q Consensus 402 --niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~-ivH~Dikp~NI 478 (667)
.+.+++++ ...++||||+++++|...+... ..........++.|++.++++||+. + ++||||||+||
T Consensus 111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NI 180 (237)
T smart00090 111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNI 180 (237)
T ss_pred CCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhE
Confidence 23344432 2358999999998887765322 2355666789999999999999998 8 99999999999
Q ss_pred EECCCCceEEEeCCCccccC
Q 005953 479 LLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 479 ll~~~~~~ki~DFGla~~~~ 498 (667)
+++ ++.++|+|||.+....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.6e-17 Score=188.24 Aligned_cols=195 Identities=23% Similarity=0.280 Sum_probs=154.2
Q ss_pred HHHHHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcc---cceEEeecceEecCCeeEEEEE
Q 005953 345 KMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH---HVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 345 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~lV~e 421 (667)
...+.+.+.||+|+||+||+|...+|+.||+|+-+....+ +|.-=.+++.||+ -+-|.++.....-.+..+||+|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE 774 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence 3334455789999999999999988999999997665432 2322233444444 2345555555566778899999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC-------CCCceEEEeCCCc
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-------PDFTPKVSDFGLA 494 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~-------~~~~~ki~DFGla 494 (667)
|.+.|+|.++++. ....+|..++.++.|+++.++.||.. +|||+||||+|+||. ++.-++|+|||-+
T Consensus 775 y~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 775 YSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 9999999999983 45689999999999999999999998 999999999999993 2346999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCC
Q 005953 495 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK 549 (667)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~ 549 (667)
-.+..-.....+.+..+|-.+--+|...+. .++.+.|-|.|+.+++-||.|+.
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHHH
Confidence 765433333455677789999999998764 88999999999999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.9e-17 Score=161.38 Aligned_cols=133 Identities=21% Similarity=0.303 Sum_probs=112.7
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCc---------chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN---------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.||+|++|.||+|.+ +|..|++|+...... ....+.+|+.++..++|+++.....++.+....++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5689999999999988 677899997653221 123578899999999999988777777777888999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
++|++|.+++.... + .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999885432 2 7789999999999999998 999999999999999 78999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.5e-17 Score=159.00 Aligned_cols=136 Identities=19% Similarity=0.196 Sum_probs=107.6
Q ss_pred HHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCc-----------------------chHHHHHHHHHHhhcccce--
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN-----------------------FSDNFINEVATIGRIHHVN-- 402 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----------------------~~~~~~~Ei~~l~~l~h~n-- 402 (667)
+.+.+.||+|+||.||++...+|+.||||++..... ....+..|+..+.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 445688999999999999988899999998654321 0123567899999998774
Q ss_pred EEeecceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC
Q 005953 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP 482 (667)
Q Consensus 403 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~ 482 (667)
++..++ ....++||||+++++|.++... .....++.+++.++.++|+. +++||||||+||++++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDD 160 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcC
Confidence 444433 2455899999999998776431 23457889999999999997 9999999999999999
Q ss_pred CCceEEEeCCCccccCC
Q 005953 483 DFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 483 ~~~~ki~DFGla~~~~~ 499 (667)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.7e-17 Score=157.71 Aligned_cols=129 Identities=22% Similarity=0.360 Sum_probs=105.8
Q ss_pred hcccCCCeEEEEEEeCCCcEEEEEEcccCC----c-----chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 353 KLGTGGYGNVYKGKFPDGRLVAVKVLEKTS----N-----FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~-----~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.||+|+||.||+|.+ ++..|++|+..... . ...++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999996 67889999864321 1 1245778999999999887655555556667779999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
++++|.+++..... .++.+++.+|.+||+. +++|+|++|+||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988754210 7899999999999998 999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.3e-18 Score=177.31 Aligned_cols=174 Identities=22% Similarity=0.331 Sum_probs=130.8
Q ss_pred eeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCc
Q 005953 415 TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 494 (667)
Q Consensus 415 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla 494 (667)
.+|+.|+++...+|.++|.+.......++.....++.|++.|+.| + +.+|+|+||.||+...+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999876666778888999999999999999 4 8999999999999999999999999999
Q ss_pred cccCCCC----ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchH
Q 005953 495 KAHSRNR----SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPD 569 (667)
Q Consensus 495 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 569 (667)
....... ....++...||..||+||.+.++ .++.|+||||||+||+||+. =...+...
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~~f~T~~er~--------------- 466 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLIQFSTQFERI--------------- 466 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHHHhccHHHHH---------------
Confidence 8765554 22345667899999999999875 88999999999999999986 11111100
Q ss_pred HHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005953 570 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR 615 (667)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e 615 (667)
-....+.++..+. ....+++ .-+.++.+++.+.|.+||++.+
T Consensus 467 ~t~~d~r~g~ip~---~~~~d~p-~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 467 ATLTDIRDGIIPP---EFLQDYP-EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred HhhhhhhcCCCCh---HHhhcCc-HHHHHHHHhcCCCcccCchHHH
Confidence 0111222222211 1111111 2345888999999999995443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-16 Score=158.38 Aligned_cols=200 Identities=20% Similarity=0.202 Sum_probs=136.8
Q ss_pred ccceEEeecceEec---------------------------CCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHH
Q 005953 399 HHVNIIHLLGFCCD---------------------------GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL 451 (667)
Q Consensus 399 ~h~niv~l~g~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 451 (667)
+|||||++.++|.+ +..+|+||.-+ .-+|..++... ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC----CCchHHHHHHHH
Confidence 59999999987653 34678888876 45788887543 355666777899
Q ss_pred HHHHHHHHHHcCCCCCeeecCCCCCcEEE--CCCC--ceEEEeCCCccccCCCC----ceeeecCCCCCccccchhhhhh
Q 005953 452 GVAHAIEYLHNGCELRILHLDIKPQNVLL--DPDF--TPKVSDFGLAKAHSRNR----SVVTMTGPRGTIGYIAPEIFMR 523 (667)
Q Consensus 452 ~i~~gl~yLH~~~~~~ivH~Dikp~NIll--~~~~--~~ki~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~ 523 (667)
|+++|+.|||.+ +|.|||+|++|||| |+|+ .+.|+|||.+---.... .........|...-||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999998 99999999999999 5554 47899999763211100 0011123347788999999865
Q ss_pred hcCCC----CCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHH
Q 005953 524 NLGNP----SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVG 599 (667)
Q Consensus 524 ~~~~~----s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 599 (667)
..|.. -.|+|.|+.|.+.||+++...||....+ ..+..-- +.+.+.. ..+..+...+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--------m~L~~r~---Yqe~qLP----alp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--------MLLDTRT---YQESQLP----ALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccch--------heechhh---hhhhhCC----CCcccCChHHHHHH
Confidence 44432 4589999999999999999999975221 1111111 1111111 11222344566788
Q ss_pred HHhcccCCCCCCCHHHHHHHHh
Q 005953 600 LWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 600 ~~cl~~~P~~RPt~~evl~~L~ 621 (667)
...|+.||.+|++..=....|+
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 8889999999998776665554
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=178.18 Aligned_cols=131 Identities=21% Similarity=0.320 Sum_probs=107.7
Q ss_pred hhhcccCCCeEEEEEEeCCCcEEEEEE-cccC-C-------cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 351 KEKLGTGGYGNVYKGKFPDGRLVAVKV-LEKT-S-------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~~~~~vavK~-l~~~-~-------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
.++||+|+||+||+|.+.+.. +++|+ +.+. . ...+.+.+|++++++++|++++....++.+....++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 478999999999999985444 33333 2211 1 112468899999999999999888878877778899999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcccc
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~ 497 (667)
|+++++|.+++. ....++.+++++|.+||+. +++||||||+|||+ +++.++|+|||+++..
T Consensus 417 ~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 417 YIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999998874 3467899999999999998 99999999999999 6789999999998653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.9e-16 Score=150.23 Aligned_cols=135 Identities=20% Similarity=0.254 Sum_probs=97.9
Q ss_pred hhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcch---HHH----------------------HHHHHHHhhcccce--E
Q 005953 351 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFS---DNF----------------------INEVATIGRIHHVN--I 403 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~---~~~----------------------~~Ei~~l~~l~h~n--i 403 (667)
.+.||+|+||+||+|...+++.||||++....... ..+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987543211 111 24555666664332 3
Q ss_pred EeecceEecCCeeEEEEEEcCCCCcccc-ccccccCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCcEEEC
Q 005953 404 IHLLGFCCDGSTRALIYEYMPNGSLGDL-LSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLD 481 (667)
Q Consensus 404 v~l~g~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivH~Dikp~NIll~ 481 (667)
.+.+++ ...++||||++++++... +.... .. .....++.+++.++.++|. . +|+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 333332 246899999998654322 21111 11 5677899999999999998 6 999999999999999
Q ss_pred CCCceEEEeCCCccccC
Q 005953 482 PDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 482 ~~~~~ki~DFGla~~~~ 498 (667)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.4e-15 Score=137.71 Aligned_cols=133 Identities=20% Similarity=0.201 Sum_probs=114.0
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhccc--ceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH--VNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
+.||+|.++.||+++..+ ..+++|....... ...+.+|+..+..++| .++++++++....+..++++||++++.+.
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 579999999999999854 7899999876544 5678999999999976 58889988888778899999999887776
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
.+ +......++.++++++++||.....+++|+|++|+||++++.+.++++|||.++.
T Consensus 82 ~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 54 4556678899999999999986445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-14 Score=144.07 Aligned_cols=133 Identities=17% Similarity=0.223 Sum_probs=103.6
Q ss_pred hhcc-cCCCeEEEEEEeCCCcEEEEEEcccCC--------------cchHHHHHHHHHHhhcccceE--EeecceEecCC
Q 005953 352 EKLG-TGGYGNVYKGKFPDGRLVAVKVLEKTS--------------NFSDNFINEVATIGRIHHVNI--IHLLGFCCDGS 414 (667)
Q Consensus 352 ~~LG-~G~fg~Vy~~~~~~~~~vavK~l~~~~--------------~~~~~~~~Ei~~l~~l~h~ni--v~l~g~~~~~~ 414 (667)
..|| .||.|+||+.+. ++..++||...... .....+.+|++++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4688 999999999988 46778888774311 122467889999999998774 66776644322
Q ss_pred ----eeEEEEEEcCC-CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEE
Q 005953 415 ----TRALIYEYMPN-GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 489 (667)
Q Consensus 415 ----~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~ 489 (667)
..++|+|++++ .+|.+++... .++.. .+.+++.+|.+||+. +|+|+||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 6898887542 24443 356899999999998 99999999999999999999999
Q ss_pred eCCCccc
Q 005953 490 DFGLAKA 496 (667)
Q Consensus 490 DFGla~~ 496 (667)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4e-15 Score=165.68 Aligned_cols=211 Identities=25% Similarity=0.353 Sum_probs=137.5
Q ss_pred hhhcccCCCeEEEEEEeCC-CcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 351 KEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
++.+..|+||.||..+++. .+..|.|+-+. .- +++- ++.....|.+| |+-.
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNkq-~l----ilRn--ilt~a~npfvv---------------------gDc~ 139 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NL----ILRN--ILTFAGNPFVV---------------------GDCA 139 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhccccc-ch----hhhc--cccccCCccee---------------------chhh
Confidence 4678999999999998863 66778754322 11 1110 22222333333 4444
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce------
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV------ 503 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~------ 503 (667)
..+.... .++.. ++.+++|||+. +|+|||+||+|.+|+.-|++|+.|||+++........
T Consensus 140 tllk~~g---~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~ 205 (1205)
T KOG0606|consen 140 TLLKNIG---PLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGH 205 (1205)
T ss_pred hhcccCC---CCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcc
Confidence 4443221 22222 27789999987 9999999999999999999999999999753111000
Q ss_pred -------eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhc
Q 005953 504 -------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 576 (667)
Q Consensus 504 -------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (667)
..-....||+.|+|||++.+. .|...+|.|++|+|+||.+-|..||....+ +..|...+.+.+.
T Consensus 206 I~k~t~Ef~dKqvcgTPeyiaPeVilrq--gygkpvdwwamGiIlyeFLVgcvpffGdtp-------eelfg~visd~i~ 276 (1205)
T KOG0606|consen 206 IEKDTHEFQDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTP-------EELFGQVISDDIE 276 (1205)
T ss_pred hHHHHHHhhhccccCCccccChhhhhhh--ccCCCccHHHHHHHHHHHheeeeeccCCCH-------HHHHhhhhhhhcc
Confidence 011235699999999999875 677889999999999999999999875432 1222222222222
Q ss_pred CcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 577 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
-+ +.+.....+..+++.+.|+.+|..|--....+++
T Consensus 277 wp-------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ev 312 (1205)
T KOG0606|consen 277 WP-------EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEV 312 (1205)
T ss_pred cc-------ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhh
Confidence 11 1223345567778888999999999643344433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.8e-16 Score=172.02 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=184.7
Q ss_pred hhhhcccCCCeEEEEEEeC--CCcEEEEEEcccCC---cchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEEc
Q 005953 350 FKEKLGTGGYGNVYKGKFP--DGRLVAVKVLEKTS---NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
+.+-||+|+|+.|-..... ....+|+|.+.... ...+....|..+-+.+. |.|++++++...+.+..+++.+|.
T Consensus 24 ~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s 103 (601)
T KOG0590|consen 24 LSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYS 103 (601)
T ss_pred ccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcc
Confidence 4456999999999988764 35566777665443 22334445778878886 999999999999999999999999
Q ss_pred CCCCcccccc-ccccCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeeecCCCCCcEEECCCC-ceEEEeCCCccccCC-
Q 005953 424 PNGSLGDLLS-REKENLSLKPARLLEIALGVAHAIEYLH-NGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSR- 499 (667)
Q Consensus 424 ~~gsL~~~l~-~~~~~~~l~~~~~~~i~~~i~~gl~yLH-~~~~~~ivH~Dikp~NIll~~~~-~~ki~DFGla~~~~~- 499 (667)
.++++.+-+. ... ...+....-.++.|+..++.|+| .. ++.|+||||+|.+++..+ ..|++|||+|..+..
T Consensus 104 ~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 104 DGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 9999999883 322 13445556678999999999999 66 999999999999999999 999999999988776
Q ss_pred CCceeeecCCCC-CccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 500 NRSVVTMTGPRG-TIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 500 ~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
...........| ++.|+|||...+. .......|+||.|+++.-+++|..|++...... ..+..|.-..
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~------~~~~~~~~~~---- 247 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD------GRYSSWKSNK---- 247 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCcccccccc------ccceeecccc----
Confidence 444444455667 9999999999774 345678999999999999999999886544321 1222222111
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVV 617 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl 617 (667)
................++...++..+|..|.+.+++.
T Consensus 248 --~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 --GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred --cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 0001111222344556677778889999999887765
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.4e-13 Score=145.99 Aligned_cols=140 Identities=21% Similarity=0.268 Sum_probs=99.4
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcc-----------------------------------------hHHHHH
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNF-----------------------------------------SDNFIN 390 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------------------------------------~~~~~~ 390 (667)
+.||.|++|+||+|++++|+.||||+.+..... .-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 359999999999999999999999997543100 002455
Q ss_pred HHHHHhhcc----cceEEeecceE-ecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHH-HHHHHHcCC
Q 005953 391 EVATIGRIH----HVNIIHLLGFC-CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAH-AIEYLHNGC 464 (667)
Q Consensus 391 Ei~~l~~l~----h~niv~l~g~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-gl~yLH~~~ 464 (667)
|...+.+++ |.+-+.+-.++ ...+..+|||||++|++|.++...... ..+ ..+++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhC-
Confidence 666666553 22223322222 234567999999999999987653211 122 3456666665 46778877
Q ss_pred CCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 465 ~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
+++|+|+||.||+++++++++++|||++..+..
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999976653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.8e-13 Score=132.00 Aligned_cols=207 Identities=21% Similarity=0.282 Sum_probs=138.6
Q ss_pred HHHhhcccceEEeecceEecC-----CeeEEEEEEcCCCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 005953 393 ATIGRIHHVNIIHLLGFCCDG-----STRALIYEYMPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCEL 466 (667)
Q Consensus 393 ~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~ 466 (667)
..|-++-|.|||+++.|+.+. ....++.|||..|+|..+|++- .....+......+|..||..||.|||+ +.+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 445566799999999998754 3467899999999999999863 234467777888999999999999998 488
Q ss_pred CeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc--eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHH
Q 005953 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS--VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 544 (667)
Q Consensus 467 ~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~el 544 (667)
.|+|+++.-+-|++..++-+||.--.-......-.. ........+-++|.|||+=.. .+.+.++|||+||+-.+||
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEM 275 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc--cccccchhhhhhhHHHHHH
Confidence 999999999999999999999842211111000000 001112346789999996432 3567789999999999999
Q ss_pred HhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 545 IEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 545 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.-+....... ...+..+........+...+.. ..++..|++..|..||+|.+++.+.-
T Consensus 276 ailEiq~tns--------eS~~~~ee~ia~~i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 276 AILEIQSTNS--------ESKVEVEENIANVIIGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred HHheeccCCC--------cceeehhhhhhhheeeccCccc-----------cCcCcccccCCCCCCcchhhhhcCce
Confidence 8765321111 1111111111111111111111 12456699999999999999987653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-12 Score=139.53 Aligned_cols=252 Identities=21% Similarity=0.185 Sum_probs=181.2
Q ss_pred HHHHHHHHhhhhccc--CCCeEEEEEEe---CCCcEEEEEEcccC---CcchHHHHHHHHHHhhcc-cceEEeecceEec
Q 005953 342 DIKKMTNGFKEKLGT--GGYGNVYKGKF---PDGRLVAVKVLEKT---SNFSDNFINEVATIGRIH-HVNIIHLLGFCCD 412 (667)
Q Consensus 342 ~l~~~~~~~~~~LG~--G~fg~Vy~~~~---~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~ 412 (667)
+....+.++.+.+|. |.+|.||.+.. .++..+|+|.-+.. ......-.+|+...++++ |+|.++.+..+..
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 334444456678999 99999999987 35788999874322 122334467888888884 9999999999999
Q ss_pred CCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCeeecCCCCCcEEECCC-CceE
Q 005953 413 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAH----AIEYLHNGCELRILHLDIKPQNVLLDPD-FTPK 487 (667)
Q Consensus 413 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----gl~yLH~~~~~~ivH~Dikp~NIll~~~-~~~k 487 (667)
++..++-.|.+ +.+|..+.+... ..++...++.+..+..+ ||.++|+. +++|-|+||.||++..+ ...+
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred CCcceeeeccc-cchhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceee
Confidence 99999999988 578877776532 34667777888888888 99999998 99999999999999999 8899
Q ss_pred EEeCCCccccCCCCceee---ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCcc
Q 005953 488 VSDFGLAKAHSRNRSVVT---MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE 564 (667)
Q Consensus 488 i~DFGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~ 564 (667)
++|||+...+........ .....|...|++||++.+ .++.+.|+|++|.+++|..++-......-
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~--------- 331 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGK--------- 331 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCC---------
Confidence 999999988766542211 122357889999999864 67889999999999999998876554321
Q ss_pred ccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005953 565 AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618 (667)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 618 (667)
+..|. .+..... ..+.......++..+..++++.+|-.|++.+.+..
T Consensus 332 --~~~W~--~~r~~~i---p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 332 --NSSWS--QLRQGYI---PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --CCCcc--ccccccC---chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111 1111000 01111111233444778899999999999877654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.1e-12 Score=119.99 Aligned_cols=130 Identities=23% Similarity=0.179 Sum_probs=96.9
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEE-eecceEecCCeeEEEEEEcCCCCccc
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNII-HLLGFCCDGSTRALIYEYMPNGSLGD 430 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~gsL~~ 430 (667)
+.|+.|.++.||+++. +++.+++|+..........+.+|+..++.+.+.+++ +++.+. ....++||||+++.++.+
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 5688999999999997 477899999765543334567899999998765544 444433 334689999999988765
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 431 LLSREKENLSLKPARLLEIALGVAHAIEYLHNGC--ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 431 ~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~--~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
.. . ....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 30 0 11245678999999999872 22369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.4e-12 Score=139.68 Aligned_cols=138 Identities=19% Similarity=0.255 Sum_probs=89.8
Q ss_pred hhcccCCCeEEEEEEeCC-CcEEEEEEcccCCc-------------------------------c----hH------HHH
Q 005953 352 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSN-------------------------------F----SD------NFI 389 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~-------------------------------~----~~------~~~ 389 (667)
+.||.|++|+||+|++++ |+.||||+.+.... . .+ +|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999987 99999999864310 0 01 234
Q ss_pred HHHHHHhhcc----cceEEeecceEe-cCCeeEEEEEEcCCCCccccccccccCC---CCCHHHHHHHHHHHHHHHHHHH
Q 005953 390 NEVATIGRIH----HVNIIHLLGFCC-DGSTRALIYEYMPNGSLGDLLSREKENL---SLKPARLLEIALGVAHAIEYLH 461 (667)
Q Consensus 390 ~Ei~~l~~l~----h~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~---~l~~~~~~~i~~~i~~gl~yLH 461 (667)
+|+..+.+++ +.+.+.+-.++. ..+..+|||||++|+.+.++-.-...+. .+....+..++.|+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 4555555553 333333323222 2456789999999999987532111111 122222233333332
Q ss_pred cCCCCCeeecCCCCCcEEECCCC----ceEEEeCCCccccCC
Q 005953 462 NGCELRILHLDIKPQNVLLDPDF----TPKVSDFGLAKAHSR 499 (667)
Q Consensus 462 ~~~~~~ivH~Dikp~NIll~~~~----~~ki~DFGla~~~~~ 499 (667)
.. +++|+|+||.||+++.++ ++++.|||++..+..
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33 999999999999999988 999999999976654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.8e-10 Score=113.75 Aligned_cols=141 Identities=23% Similarity=0.261 Sum_probs=110.5
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCc--chHHHHHHHHHHhhccc--ceEEeecceEecC---CeeEEEEEEcC
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN--FSDNFINEVATIGRIHH--VNIIHLLGFCCDG---STRALIYEYMP 424 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~---~~~~lV~e~~~ 424 (667)
+.|+.|..+.||++...+|+.+++|+...... ....+.+|+++++.+++ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987778899999765443 35678899999999965 4456677766553 25689999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC---------------------------------------- 464 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~---------------------------------------- 464 (667)
+.++.+.+.. ..+++.+...++.++++.|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988876632 24677778888888999998888521
Q ss_pred -------------CCCeeecCCCCCcEEECC--CCceEEEeCCCccc
Q 005953 465 -------------ELRILHLDIKPQNVLLDP--DFTPKVSDFGLAKA 496 (667)
Q Consensus 465 -------------~~~ivH~Dikp~NIll~~--~~~~ki~DFGla~~ 496 (667)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.9e-10 Score=108.43 Aligned_cols=135 Identities=16% Similarity=0.182 Sum_probs=97.7
Q ss_pred hhcccCCCeEEEEEEeCC-------CcEEEEEEcccCC-----------------------cchHHH----HHHHHHHhh
Q 005953 352 EKLGTGGYGNVYKGKFPD-------GRLVAVKVLEKTS-----------------------NFSDNF----INEVATIGR 397 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~-----------------------~~~~~~----~~Ei~~l~~ 397 (667)
..||.|.-+.||.|...+ +..+|||+.+... ...+.+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 4799999864210 001122 279999999
Q ss_pred ccc--ceEEeecceEecCCeeEEEEEEcCCCCccc-cccccccCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeeecCC
Q 005953 398 IHH--VNIIHLLGFCCDGSTRALIYEYMPNGSLGD-LLSREKENLSLKPARLLEIALGVAHAIEYL-HNGCELRILHLDI 473 (667)
Q Consensus 398 l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~gl~yL-H~~~~~~ivH~Di 473 (667)
+.. -++.+++++ ..-+|||||+.++.+.. .+.. ..++......+..+++.+|..| |.. +++|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 953 455666653 46689999997654422 2221 1244556677889999999999 777 9999999
Q ss_pred CCCcEEECCCCceEEEeCCCccccC
Q 005953 474 KPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 474 kp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
++.|||++ ++.+.|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999886554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.6e-09 Score=116.98 Aligned_cols=165 Identities=17% Similarity=0.193 Sum_probs=123.0
Q ss_pred eCCCcEEEEEEcccCCc-chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHH
Q 005953 367 FPDGRLVAVKVLEKTSN-FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR 445 (667)
Q Consensus 367 ~~~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~ 445 (667)
..++.+|.|.+.+.... ......+-++.|+.++||||++++...+..+..|||.|-+. .|..++.+. ....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHHH
Confidence 34688888888776544 23456778899999999999999999999999999999873 456666442 2445
Q ss_pred HHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhc
Q 005953 446 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525 (667)
Q Consensus 446 ~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 525 (667)
..-.+.||+.||.|||+. .+++|++|...-|++++.|+-||++|.++.....-... .....--..|..|+.+...
T Consensus 106 v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s- 180 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPS- 180 (690)
T ss_pred HHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCcc-
Confidence 566789999999999965 38999999999999999999999999987544322210 0111112346677755322
Q ss_pred CCCCCcccHHHHHHHHHHHHhC
Q 005953 526 GNPSGKSDVYSYGMLLLEMIEE 547 (667)
Q Consensus 526 ~~~s~k~DvwSlGvvl~elltg 547 (667)
.-..|.|.||++++|++.|
T Consensus 181 ---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 ---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ---ccchhhhhHHHHHHHHhCc
Confidence 1246999999999999998
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.3e-10 Score=101.49 Aligned_cols=130 Identities=20% Similarity=0.272 Sum_probs=98.4
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEc-ccCCc--------chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVL-EKTSN--------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l-~~~~~--------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.+++|+-+.+|.+.+. |..+++|.- .+.-. ......+|..++.+++--.|...+=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999874 444666643 22211 123567899999998755444444456677888999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
++|-.|.+.+... ...++..+-.-+.-||.+ +|+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998998888653 245667777788899998 999999999999998765 99999999864
|
|
| >PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.1e-10 Score=95.10 Aligned_cols=68 Identities=37% Similarity=0.850 Sum_probs=57.3
Q ss_pred CCCCCcE-EEEeCcCcccc---cccccHHHHHhcCcceecCC-CCCCchhccCCCeeecCCCCCcEEEEecCC
Q 005953 199 APSGCDS-VVVPVSSVTSL---YLGADVFDTLRQGFPLEWPK-LDDCEKCQNRSGRCGYNGSLKKITCFCKGG 266 (667)
Q Consensus 199 ~~~~C~~-~~vp~~~~~~~---~~~~~~~~~l~~gf~L~W~~-~~~C~~C~~~~g~C~~~~~~~~~~C~C~~g 266 (667)
+...|+. +.||+...... .+..+|.++|++||+|+|.+ ...|.+|+.++|+|+++.+...+.|+|++|
T Consensus 21 ~~~~C~~~v~vPV~~~~~~~~~~~~~~~~~~L~~GF~L~w~~~~~~C~~C~~SgG~Cgy~~~~~~f~C~C~dg 93 (94)
T PF14380_consen 21 LAGSCQKSVVVPVLGSAVDSIDGSSGNYEEVLKKGFELEWNADSGDCRECEASGGRCGYDSNSEQFTCFCSDG 93 (94)
T ss_pred cCCcCCEEEEEEECchhhhccccchhHHHHHHhcCcEEEEeCCCCcCcChhcCCCEeCCCCCCceEEEECCCC
Confidence 6789987 67998775321 35678999999999999984 569999999999999999888899999986
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.2e-09 Score=98.16 Aligned_cols=140 Identities=24% Similarity=0.326 Sum_probs=102.5
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEc-ccCC--------cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVL-EKTS--------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l-~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
..+-+|+-+.|+++.+ .|+...||.- .+.- -..++..+|++.|.+++--.|.-..-++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 5688999999999999 6776666643 2211 1234677899999998754444444456677777899999
Q ss_pred cCC-CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC---ceEEEeCCCccc
Q 005953 423 MPN-GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF---TPKVSDFGLAKA 496 (667)
Q Consensus 423 ~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~---~~ki~DFGla~~ 496 (667)
+++ -++.+++...-.. ..........+..|-+.+.-||.+ .|+|+||..+||+|..++ .+.++|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 976 3778887654322 233334478888999999999998 999999999999996554 358999999854
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.9e-10 Score=121.54 Aligned_cols=239 Identities=18% Similarity=0.186 Sum_probs=167.0
Q ss_pred hhhcccCCCeEEEEEEeC--CCcEEEEEEcccCCcc-hH--HHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcC
Q 005953 351 KEKLGTGGYGNVYKGKFP--DGRLVAVKVLEKTSNF-SD--NFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~~-~~--~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
...||.|.|+.|++...+ ++..+++|.+...... .+ .-+.|+.+...+ .|.++++....+......|+=-||++
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 467999999999998643 5788999987654321 11 234566666666 48999998888888888899999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC-CceEEEeCCCccccCCCCce
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~-~~~ki~DFGla~~~~~~~~~ 503 (667)
++++...+. ....+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.+..+.-..
T Consensus 350 ~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-- 421 (524)
T KOG0601|consen 350 GGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-- 421 (524)
T ss_pred CcchhhhhH---HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceec--
Confidence 998877662 233577888899999999999999976 99999999999999876 889999999986432111
Q ss_pred eeecCCCCCcccc-chhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 504 VTMTGPRGTIGYI-APEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 504 ~~~~~~~gt~~y~-aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
.......+++ .+|.+... ..+-.+.|++|||.-+.|.+++..-...... | ..+..+....
T Consensus 422 ---~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------------~--~~i~~~~~p~ 482 (524)
T KOG0601|consen 422 ---GVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------------S--LTIRSGDTPN 482 (524)
T ss_pred ---ccccccccccccchhhccc-cccccccccccccccccccccCcccCccccc-------------c--eeeecccccC
Confidence 1112344555 35555544 4667799999999999999988653322111 0 1111111111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
... ....+..++..++..++..||.+.++..+.+
T Consensus 483 ~~~-----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 483 LPG-----LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred CCc-----hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 111 1133444556688899999999988877665
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.88 E-value=5e-08 Score=102.29 Aligned_cols=169 Identities=18% Similarity=0.272 Sum_probs=129.4
Q ss_pred CCeEEEEEEeC-CCcEEEEEEcccCCc-chHHHHHHHHHHhhcccceEEeecceEec----CCeeEEEEEEcCC-CCccc
Q 005953 358 GYGNVYKGKFP-DGRLVAVKVLEKTSN-FSDNFINEVATIGRIHHVNIIHLLGFCCD----GSTRALIYEYMPN-GSLGD 430 (667)
Q Consensus 358 ~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~~~lV~e~~~~-gsL~~ 430 (667)
--.+.||+... ||..+++|++...+. .......-+++++++.|.|+|++..++.. +..+++||+|.|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34678999764 899999999944332 12233456889999999999999998873 4568899999986 57877
Q ss_pred cccccc------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 431 LLSREK------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 431 ~l~~~~------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
+-.... .+...++..+|.++.|+..||.++|+. |+.-+-|.+++||++.+.+++|+.-|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 653321 234578899999999999999999998 98889999999999999999999988876665
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCC
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKH 550 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p 550 (667)
.+.. |-+.. -.+-|.=.||.+++.|.||...
T Consensus 445 ~d~~----------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT----------------EPLES-----QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC----------------cchhH-----HhhhhHHHHHHHHHHHhhcccc
Confidence 4431 11111 1256888999999999999654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.1e-08 Score=97.23 Aligned_cols=125 Identities=26% Similarity=0.365 Sum_probs=81.3
Q ss_pred EEEEEEeCCCcEEEEEEcccCC--------------c-------------chHHHHHHHHHHhhcccc--eEEeecceEe
Q 005953 361 NVYKGKFPDGRLVAVKVLEKTS--------------N-------------FSDNFINEVATIGRIHHV--NIIHLLGFCC 411 (667)
Q Consensus 361 ~Vy~~~~~~~~~vavK~l~~~~--------------~-------------~~~~~~~Ei~~l~~l~h~--niv~l~g~~~ 411 (667)
.||.|...+|..+|||+.+... . ......+|.+.|.++..- ++.+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899999899999999964210 0 012356799999999754 556666442
Q ss_pred cCCeeEEEEEEcC--CCCccccccccccCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCCeeecCCCCCcEEECCCCceEE
Q 005953 412 DGSTRALIYEYMP--NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY-LHNGCELRILHLDIKPQNVLLDPDFTPKV 488 (667)
Q Consensus 412 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~y-LH~~~~~~ivH~Dikp~NIll~~~~~~ki 488 (667)
.-.|||||++ +..+..+.... ++......++.+++..+.. +|.. +|+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 3479999998 54444433222 1123445677777775555 5677 99999999999999988 9999
Q ss_pred EeCCCccccC
Q 005953 489 SDFGLAKAHS 498 (667)
Q Consensus 489 ~DFGla~~~~ 498 (667)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.6e-08 Score=100.49 Aligned_cols=139 Identities=20% Similarity=0.101 Sum_probs=99.5
Q ss_pred hcccCCCeEEEEEEeCCCcEEEEEEcccCCc------------chHHHHHHHHHHhhcccc--eEEeecceEec-----C
Q 005953 353 KLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN------------FSDNFINEVATIGRIHHV--NIIHLLGFCCD-----G 413 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------~~~~~~~Ei~~l~~l~h~--niv~l~g~~~~-----~ 413 (667)
.+-+-....|.+..+ +|+.+.||....... ....+.+|...+.++... ..++++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 343333345777777 678899997643221 111478999999888533 33344555543 2
Q ss_pred CeeEEEEEEcCCC-CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC-------CCc
Q 005953 414 STRALIYEYMPNG-SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-------DFT 485 (667)
Q Consensus 414 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~-------~~~ 485 (667)
...+||+|++++. +|.+++.... ....+......++.+++..+.-||.. +|+|+|++++|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 3578999999876 8999885322 12355667778999999999999998 9999999999999975 478
Q ss_pred eEEEeCCCccc
Q 005953 486 PKVSDFGLAKA 496 (667)
Q Consensus 486 ~ki~DFGla~~ 496 (667)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998753
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.8e-07 Score=95.78 Aligned_cols=265 Identities=15% Similarity=0.136 Sum_probs=156.9
Q ss_pred hhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEe--------ecceEecCCeeEEEEE
Q 005953 351 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIH--------LLGFCCDGSTRALIYE 421 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~--------l~g~~~~~~~~~lV~e 421 (667)
...||+|+-+.+|..---.+ -| -|+........+ ...+..|.+. .||-+-. |+|-- .+...-++|.
T Consensus 16 gr~LgqGgea~ly~l~e~~d-~V-AKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD-QV-AKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGR-RGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchhhc-hh-heeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCC-ccceeEEecc
Confidence 46799999999996432112 22 244433321111 1223344444 4553332 11110 1222557777
Q ss_pred EcCCC-Ccccccc---ccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcccc
Q 005953 422 YMPNG-SLGDLLS---REKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 422 ~~~~g-sL~~~l~---~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~ 497 (667)
.+++. -+.++++ +...-...+|.-+++.++.++.+.+-||.+ |.+-+|++++|+|+.+++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence 77654 2333332 223344689999999999999999999998 9999999999999999999999986543322
Q ss_pred CCCCceeeecCCCCCccccchhhhh-hhc--CCCCCcccHHHHHHHHHHHHhC-CCCCCCCCcCCC-CCCccccchHH--
Q 005953 498 SRNRSVVTMTGPRGTIGYIAPEIFM-RNL--GNPSGKSDVYSYGMLLLEMIEE-KKHLRPTETTSG-SNTTEAYFPDW-- 570 (667)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~--~~~s~k~DvwSlGvvl~elltg-~~p~~~~~~~~~-~~~~~~~~~~~-- 570 (667)
. ....+...+|...|.+||.-. ..+ ..-+...|-|.|||++++++.| ++||........ ....+......
T Consensus 168 ~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 168 A---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred c---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 2 222346788999999999764 111 1236678999999999999887 889876432110 11111111110
Q ss_pred HHH-hhcCcccccccchhhHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHhhcccc
Q 005953 571 IYD-KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQI--NPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 571 ~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--~P~~RPt~~evl~~L~~~~~~ 626 (667)
.+. +-..+...........-+...+..+..+|+.. ++.-|||++-.+..|.++..+
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 000 11111111111112223344566677778775 356899999988888755443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.1e-09 Score=120.86 Aligned_cols=241 Identities=17% Similarity=0.207 Sum_probs=154.5
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcc----hHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNF----SDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+-+-.|.++.++.++-. .|...+.|+....... .+....+-.++-..+||-++...--+......+||++|..++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 45778888888877543 3444444544332211 112222222222234566666555555677889999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC--------
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS-------- 498 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~-------- 498 (667)
+|...|+... ..+.+-.......+..+++|||.. .+.|+|++|.|+|+..++..+++|||......
T Consensus 890 ~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 890 DLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred CchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence 9999887643 244444455666788899999986 69999999999999999999999998443210
Q ss_pred -------------CCCce--------eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcC
Q 005953 499 -------------RNRSV--------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETT 557 (667)
Q Consensus 499 -------------~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~ 557 (667)
..... .......||+.|.+||.+.+. .....+|.|++|++++|.++|..||......
T Consensus 964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred ccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 00000 011234689999999998775 4556889999999999999999998754331
Q ss_pred CCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 005953 558 SGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMT 614 (667)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 614 (667)
-+.+.+...... .............+++...+..+|.+|-.|.
T Consensus 1042 ------------~~f~ni~~~~~~--~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 ------------QIFENILNRDIP--WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ------------hhhhccccCCCC--CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 122222222111 1111112233445566667788899987765
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=6.5e-08 Score=105.52 Aligned_cols=141 Identities=19% Similarity=0.250 Sum_probs=93.3
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCc-------------------------------chH----------HHHH
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN-------------------------------FSD----------NFIN 390 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-------------------------------~~~----------~~~~ 390 (667)
+-|+.++-|+||+|++++|+.||||+.+..-. ..+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 35889999999999999999999999642210 001 2345
Q ss_pred HHHHHhhcc-----cceEEeecceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 005953 391 EVATIGRIH-----HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465 (667)
Q Consensus 391 Ei~~l~~l~-----h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~ 465 (667)
|...+.+++ .+++.-..=++.-.+...|+|||++|..+.+...-.. ...+...+.....++.--.-+-|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f~~q~~~d---- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAFLRQLLRD---- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHHHHHHHhc----
Confidence 555555553 2333222223334567889999999999988853322 23443333333222222222223
Q ss_pred CCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 466 ~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
+++|.|.+|.||+++.++++.+.|||+...+..
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999876554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.9e-07 Score=91.17 Aligned_cols=134 Identities=23% Similarity=0.239 Sum_probs=94.7
Q ss_pred HHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC-------------------c----chHHHHHHHHHHhhcccc--e
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-------------------N----FSDNFINEVATIGRIHHV--N 402 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-------------------~----~~~~~~~Ei~~l~~l~h~--n 402 (667)
+.+.++||-|.-+.||.|..+.|..+|||.-+... . ......+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 44568899999999999999999999999753210 0 112456899999999643 6
Q ss_pred EEeecceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC
Q 005953 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP 482 (667)
Q Consensus 403 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~ 482 (667)
|.+.+++ +.-.+||||+++-.|...- ++....-.|+..|++-+.-+-.. |+||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 6666643 4567999999886655432 12222333444444444444344 9999999999999999
Q ss_pred CCceEEEeCCCccc
Q 005953 483 DFTPKVSDFGLAKA 496 (667)
Q Consensus 483 ~~~~ki~DFGla~~ 496 (667)
+|.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999975543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.3e-07 Score=86.23 Aligned_cols=136 Identities=16% Similarity=0.121 Sum_probs=102.0
Q ss_pred ccCCCeEEEEEEeCCCcEEEEEEcccC-------CcchHHHHHHHHHHhhccc--ceEEeecceEe-cC----CeeEEEE
Q 005953 355 GTGGYGNVYKGKFPDGRLVAVKVLEKT-------SNFSDNFINEVATIGRIHH--VNIIHLLGFCC-DG----STRALIY 420 (667)
Q Consensus 355 G~G~fg~Vy~~~~~~~~~vavK~l~~~-------~~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~-~~----~~~~lV~ 420 (667)
|+||-+.|++-.+ +|+.+-+|.-... ......|.+|+..|.++.. -.+.+++ ++. .. -..+||+
T Consensus 27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 6799999999887 4557889986521 1234689999999999953 3344544 332 11 2357999
Q ss_pred EEcCC-CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCc--eEEEeCCCccc
Q 005953 421 EYMPN-GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT--PKVSDFGLAKA 496 (667)
Q Consensus 421 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~--~ki~DFGla~~ 496 (667)
|-+++ -+|.+++.... -...+......++.+++..++-||+. ++.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98864 48888875432 22456777789999999999999998 9999999999999986666 99999986653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3e-07 Score=99.91 Aligned_cols=140 Identities=22% Similarity=0.302 Sum_probs=94.5
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCc--------------------------------------chHHHHHHHH
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN--------------------------------------FSDNFINEVA 393 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------------------------------------~~~~~~~Ei~ 393 (667)
+-||.-..|+||+|++++|+.||||+-+..-. ..-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 46999999999999999999999999532210 0113555665
Q ss_pred HHhhc----ccce------EEeecceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 005953 394 TIGRI----HHVN------IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 463 (667)
Q Consensus 394 ~l~~l----~h~n------iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~ 463 (667)
...++ .|-+ |.+++ +.-.....|+||||+|..+.|+-.-.. ..++...+..-+.++..-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~~qIf~~-- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYLEQIFKT-- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHHHHHHhc--
Confidence 44444 3444 33333 223457899999999998888754222 23566655444444333333333
Q ss_pred CCCCeeecCCCCCcEEECC----CCceEEEeCCCccccCCC
Q 005953 464 CELRILHLDIKPQNVLLDP----DFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 464 ~~~~ivH~Dikp~NIll~~----~~~~ki~DFGla~~~~~~ 500 (667)
|++|+|-+|.||+++. ++++.+-|||+.......
T Consensus 321 ---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 321 ---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred ---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 8999999999999984 678999999998776543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.1e-08 Score=107.57 Aligned_cols=153 Identities=14% Similarity=0.249 Sum_probs=100.2
Q ss_pred HHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce--eeec-----CCCCCccccchhhhh
Q 005953 450 ALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV--VTMT-----GPRGTIGYIAPEIFM 522 (667)
Q Consensus 450 ~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~--~~~~-----~~~gt~~y~aPE~~~ 522 (667)
+.+++.|+.|+|+. .++||++|.|++|.++.++..||+.|+.+......... ...+ -..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34455999999986 69999999999999999999999999988654331110 0000 112467899999997
Q ss_pred hhcCCCCCcccHHHHHHHHHHHHhCCCC-CCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHH
Q 005953 523 RNLGNPSGKSDVYSYGMLLLEMIEEKKH-LRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLW 601 (667)
Q Consensus 523 ~~~~~~s~k~DvwSlGvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 601 (667)
.. ..+.++|+||+|++++-+..|.++ +...... .... ......... .......++.++.+-+.+
T Consensus 183 ~~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~~~-----~~~~~~~~~---~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 183 GT--TNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-----LSYS-----FSRNLLNAG---AFGYSNNLPSELRESLKK 247 (700)
T ss_pred cc--cccccccceeeeeEEEEEecCCcchhhccCCc-----chhh-----hhhcccccc---cccccccCcHHHHHHHHH
Confidence 63 667899999999999999954443 3322110 0000 011111000 001113345567777788
Q ss_pred hcccCCCCCCCHHHHHHH
Q 005953 602 CIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 602 cl~~~P~~RPt~~evl~~ 619 (667)
++..++..||++.++...
T Consensus 248 ~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred HhcCCcccCcchhhhhcc
Confidence 899999999988776543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=8e-07 Score=86.65 Aligned_cols=106 Identities=25% Similarity=0.359 Sum_probs=83.4
Q ss_pred HHHHHHHHHHhhcc--cceEEeecceEecCC----eeEEEEEEcCCC-CccccccccccCCCCCHHHHHHHHHHHHHHHH
Q 005953 386 DNFINEVATIGRIH--HVNIIHLLGFCCDGS----TRALIYEYMPNG-SLGDLLSREKENLSLKPARLLEIALGVAHAIE 458 (667)
Q Consensus 386 ~~~~~Ei~~l~~l~--h~niv~l~g~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~ 458 (667)
....+|...+.++. .-.+.+.+++..... ..+||+|++++. +|.+++..... .+......++.++++.++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence 46788888888885 334555666655432 457999999874 89998865322 556677889999999999
Q ss_pred HHHcCCCCCeeecCCCCCcEEECCCC---ceEEEeCCCcccc
Q 005953 459 YLHNGCELRILHLDIKPQNVLLDPDF---TPKVSDFGLAKAH 497 (667)
Q Consensus 459 yLH~~~~~~ivH~Dikp~NIll~~~~---~~ki~DFGla~~~ 497 (667)
-||.. +|+|+|+++.|||++.+. .+.++||+.++..
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99998 999999999999998887 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.33 E-value=7.4e-06 Score=80.96 Aligned_cols=138 Identities=17% Similarity=0.176 Sum_probs=84.4
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccce--EEeecceEecCCeeEEEEEEcCCCC-c
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN--IIHLLGFCCDGSTRALIYEYMPNGS-L 428 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~~~~~~~~~lV~e~~~~gs-L 428 (667)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 56899999999984 24456788876533 3456789999999986433 4667777777777889999998863 2
Q ss_pred cccc---------------------cccccCCCCCHHHH-HHHHH----------HHH-HHHHHHHcC-CCCCeeecCCC
Q 005953 429 GDLL---------------------SREKENLSLKPARL-LEIAL----------GVA-HAIEYLHNG-CELRILHLDIK 474 (667)
Q Consensus 429 ~~~l---------------------~~~~~~~~l~~~~~-~~i~~----------~i~-~gl~yLH~~-~~~~ivH~Dik 474 (667)
...+ |.... ........ ..+.. .+. ....+|... ....++|+|+.
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2111 11000 00111000 00000 000 112222211 13467899999
Q ss_pred CCcEEECCCCceEEEeCCCcc
Q 005953 475 PQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 475 p~NIll~~~~~~ki~DFGla~ 495 (667)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.30 E-value=8.2e-06 Score=79.23 Aligned_cols=134 Identities=22% Similarity=0.291 Sum_probs=91.9
Q ss_pred hcccCCCeEEEEEEeCCCcEEEEEEcccCCcchH--------------------H-----HHHHHHHHhhcc--cceEEe
Q 005953 353 KLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSD--------------------N-----FINEVATIGRIH--HVNIIH 405 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~--------------------~-----~~~Ei~~l~~l~--h~niv~ 405 (667)
.|+.|.-+.||+|...++..+|||+.+......+ + ..+|+..|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 5788889999999988899999999754321110 0 235777777763 334444
Q ss_pred ecceEecCCeeEEEEEEcCCCC-ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCcEEECCC
Q 005953 406 LLGFCCDGSTRALIYEYMPNGS-LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDPD 483 (667)
Q Consensus 406 l~g~~~~~~~~~lV~e~~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivH~Dikp~NIll~~~ 483 (667)
.+++. .-.|||||+.... -.-.|.. ..+.......+..++++.+.-|-. . ++||+||..=|||+. +
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a---~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEA---GLVHGDLSEYNILVH-D 202 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhc---CcccccchhhheEEE-C
Confidence 44433 3469999996431 1112211 123333566777788888888876 4 999999999999999 8
Q ss_pred CceEEEeCCCccccC
Q 005953 484 FTPKVSDFGLAKAHS 498 (667)
Q Consensus 484 ~~~ki~DFGla~~~~ 498 (667)
+.+.|+|||-|....
T Consensus 203 ~~p~iID~~QaV~~~ 217 (268)
T COG1718 203 GEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEECccccccC
Confidence 899999999886554
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.6e-05 Score=79.72 Aligned_cols=139 Identities=15% Similarity=0.160 Sum_probs=85.7
Q ss_pred cccCCC-eEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEEcCCCCcccc
Q 005953 354 LGTGGY-GNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDL 431 (667)
Q Consensus 354 LG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~ 431 (667)
|-.|.. ..||+.... +..+.||+..... ..+..+|+++++.+. +--+.+++++....+..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444555 889999774 4778889876543 345678999988884 44455677777666678999999998877644
Q ss_pred c-------------------ccccc-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHcC----CC
Q 005953 432 L-------------------SREKE-NLSLKP--ARLLEIAL--------------------GVAHAIEYLHNG----CE 465 (667)
Q Consensus 432 l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------~i~~gl~yLH~~----~~ 465 (667)
. |.... ...... ........ .+...+..|-.. ..
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 11000 001110 00000000 011112222111 23
Q ss_pred CCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 466 ~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 468999999999999998888999998763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.11 E-value=3.3e-05 Score=74.34 Aligned_cols=128 Identities=17% Similarity=0.204 Sum_probs=79.9
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHH----------HHHHHHHHhhccc---ceEEeecceEe-----cC
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDN----------FINEVATIGRIHH---VNIIHLLGFCC-----DG 413 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~----------~~~Ei~~l~~l~h---~niv~l~g~~~-----~~ 413 (667)
+++-......|.+-.. +|+.+++|..+......++ ..+++..+.+++. -....++.+.. ..
T Consensus 37 kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~ 115 (229)
T PF06176_consen 37 KVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYT 115 (229)
T ss_pred EeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccce
Confidence 3344444444555444 6788888987654322221 2334444444432 12222222222 22
Q ss_pred CeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCC
Q 005953 414 STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 493 (667)
Q Consensus 414 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGl 493 (667)
...+++|||++|..|.++.. +++ .++..+.+++.-||.. |++|+|.+|.|++++++ .++++||+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~iID~~~ 180 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIRIIDTQG 180 (229)
T ss_pred eEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEEEEECcc
Confidence 45568999999988877642 222 2455677889999998 99999999999999865 499999986
Q ss_pred cc
Q 005953 494 AK 495 (667)
Q Consensus 494 a~ 495 (667)
.+
T Consensus 181 k~ 182 (229)
T PF06176_consen 181 KR 182 (229)
T ss_pred cc
Confidence 54
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.1e-05 Score=77.94 Aligned_cols=142 Identities=20% Similarity=0.249 Sum_probs=84.2
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccc--eEEeecceEec---CCeeEEEEEEcCCC
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV--NIIHLLGFCCD---GSTRALIYEYMPNG 426 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~g~~~~---~~~~~lV~e~~~~g 426 (667)
+.|+.|..+.||+....+ +.+++|..... .......+|..+++.+... .+.+++..... ....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 568899999999999966 68999987655 4456788899998888532 34566654432 33568999999988
Q ss_pred Cccc----------------ccc---ccc-cCCCCCHHH---------HHHH------------HHHHHH-HHHHHHc--
Q 005953 427 SLGD----------------LLS---REK-ENLSLKPAR---------LLEI------------ALGVAH-AIEYLHN-- 462 (667)
Q Consensus 427 sL~~----------------~l~---~~~-~~~~l~~~~---------~~~i------------~~~i~~-gl~yLH~-- 462 (667)
.+.. .+. +.. ......... .... ...+.+ .++.++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8777 111 110 001111100 0000 111222 2333332
Q ss_pred --CCCCCeeecCCCCCcEEEC-CCCceEEEeCCCcc
Q 005953 463 --GCELRILHLDIKPQNVLLD-PDFTPKVSDFGLAK 495 (667)
Q Consensus 463 --~~~~~ivH~Dikp~NIll~-~~~~~ki~DFGla~ 495 (667)
.....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1345799999999999999 66777899998663
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.4e-05 Score=76.35 Aligned_cols=105 Identities=24% Similarity=0.216 Sum_probs=83.0
Q ss_pred HHHHHHHhhccc-ceEEeecceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 005953 389 INEVATIGRIHH-VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467 (667)
Q Consensus 389 ~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ 467 (667)
.+|.-+++.+++ +++++++|+| ..++|.||.+.+++...-..-..-...+|..+.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888975 6999999999 34679999987766532111111234789999999999999999999864446
Q ss_pred eeecCCCCCcEEECCCCceEEEeCCCcccc
Q 005953 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 468 ivH~Dikp~NIll~~~~~~ki~DFGla~~~ 497 (667)
+.-.|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 778999999999999999999999977544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=8.8e-07 Score=95.38 Aligned_cols=182 Identities=16% Similarity=0.140 Sum_probs=129.9
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccce-EEeecceEecCCeeEEEEEEcCCC-Ccc
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN-IIHLLGFCCDGSTRALIYEYMPNG-SLG 429 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~~~~lV~e~~~~g-sL~ 429 (667)
+.+++|++++++|.+....+...++.+... ....-++++|.+++||| .+..++-+......++++++...+ +-.
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 556789999999998755555556665543 33456889999999999 666665555566778899999776 222
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCC
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 509 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 509 (667)
..... ....+...+...+.+.-++++++||+. .-+|+| ||+..+ +..|..||+....+.+.. .....
T Consensus 324 ~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~ 390 (829)
T KOG0576|consen 324 LEMTV--SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTA 390 (829)
T ss_pred ccCCh--hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---ccccC
Confidence 22211 112244445556677778899999975 458888 777665 688999999987766543 22445
Q ss_pred CCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 005953 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLR 552 (667)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~ 552 (667)
.+++.|+|||+...+ .+..+.|+|++|+-..+|--|-+|-.
T Consensus 391 ~~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQEN--TIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCchhhccc--ccccCCCccCCCcchhhcCCCCCCCC
Confidence 689999999998764 67788999999988888877766653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00012 Score=75.60 Aligned_cols=75 Identities=12% Similarity=0.106 Sum_probs=56.4
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhccc---ceEEeecceEecC---CeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH---VNIIHLLGFCCDG---STRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h---~niv~l~g~~~~~---~~~~lV~e~~~~ 425 (667)
+.||.|..+.||+....+++ +.+|..+. ......+.+|.+.|+.+.. ..+.++++++... +..+||||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 56999999999999875664 66677433 2234688899999998852 4677888877543 568999999998
Q ss_pred CCc
Q 005953 426 GSL 428 (667)
Q Consensus 426 gsL 428 (667)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00012 Score=86.55 Aligned_cols=145 Identities=16% Similarity=0.249 Sum_probs=91.0
Q ss_pred hhcccCCCeEEEEEEeCCC---cEEEEEEcccCC--cchHHHHHHHHHHhhcc-cceE--EeecceEecC---CeeEEEE
Q 005953 352 EKLGTGGYGNVYKGKFPDG---RLVAVKVLEKTS--NFSDNFINEVATIGRIH-HVNI--IHLLGFCCDG---STRALIY 420 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~---~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~-h~ni--v~l~g~~~~~---~~~~lV~ 420 (667)
+.++.|.+..+|+....++ ..+++|+..... .....+.+|+++|+.+. |.++ .+++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 5689999999999887553 356777754332 23357889999999995 6654 7777877664 4678999
Q ss_pred EEcCCCCcccc-----------------------ccccccC--------CCCC--HHHHHHHHH---------------H
Q 005953 421 EYMPNGSLGDL-----------------------LSREKEN--------LSLK--PARLLEIAL---------------G 452 (667)
Q Consensus 421 e~~~~gsL~~~-----------------------l~~~~~~--------~~l~--~~~~~~i~~---------------~ 452 (667)
||+++..+.+. ||..... .... ..++..+.. .
T Consensus 124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~ 203 (822)
T PLN02876 124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK 203 (822)
T ss_pred EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence 99987654321 1110000 0000 111211111 1
Q ss_pred HHHHHHHHHcCCC--------CCeeecCCCCCcEEECCC-C-ceEEEeCCCccc
Q 005953 453 VAHAIEYLHNGCE--------LRILHLDIKPQNVLLDPD-F-TPKVSDFGLAKA 496 (667)
Q Consensus 453 i~~gl~yLH~~~~--------~~ivH~Dikp~NIll~~~-~-~~ki~DFGla~~ 496 (667)
+.+.+.+|..+.. +.++|+|+++.||+++.+ . .+-|.||+++..
T Consensus 204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 2334566744321 359999999999999753 3 367999999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.91 E-value=8.9e-05 Score=68.21 Aligned_cols=129 Identities=23% Similarity=0.254 Sum_probs=85.7
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEe-ecceEecCCeeEEEEEEcCCCCc
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH-LLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~-l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
..+.|++|++|.||+|.+ .|..+|+|+-+.+. ....+..|.++|..+.-.++-+ ++.|- ...+.|||+.|-.|
T Consensus 26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds-~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRRDS-PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeec-cCceEEEEEecCCc-chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcch
Confidence 347899999999999999 55688999866544 3567889999999887555443 33332 22345999988777
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCC-CCcEEECCCCceEEEeCCCcccc
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIK-PQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dik-p~NIll~~~~~~ki~DFGla~~~ 497 (667)
.+.-... +..++ ..+++.---|-.. +|-|+.|. |..++|-.++.+.|+||.-|+..
T Consensus 100 ~~~~~~~------~rk~l----~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 100 GKLEIGG------DRKHL----LRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhcc------cHHHH----HHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 6654321 22333 3344443334443 88898885 44444545559999999988743
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00018 Score=71.79 Aligned_cols=74 Identities=15% Similarity=0.243 Sum_probs=45.8
Q ss_pred hhcccCCCe-EEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccc---eEEeecceEecC---CeeEEEEEEcC
Q 005953 352 EKLGTGGYG-NVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV---NIIHLLGFCCDG---STRALIYEYMP 424 (667)
Q Consensus 352 ~~LG~G~fg-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~g~~~~~---~~~~lV~e~~~ 424 (667)
+.++.|+.. .||+. +..+++|.... ......+.+|.+.+..+... .+.++++..... ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 346767766 58975 23467787554 22345788999999887521 233334333222 23578999999
Q ss_pred CCCccc
Q 005953 425 NGSLGD 430 (667)
Q Consensus 425 ~gsL~~ 430 (667)
|.++.+
T Consensus 78 G~~l~~ 83 (235)
T cd05155 78 GETATA 83 (235)
T ss_pred CCCCCc
Confidence 988754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00023 Score=70.83 Aligned_cols=74 Identities=18% Similarity=0.207 Sum_probs=48.8
Q ss_pred hhcccCCCeEEEEEEeCC--CcEEEEEEcccCCcchHHHHHHHHHHhhcccce-EEeecceEecCCeeEEEEEEcCCCCc
Q 005953 352 EKLGTGGYGNVYKGKFPD--GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN-IIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
+.|..|-...+|+....+ ++.+++|+........-+..+|+.+++.+.... .+++++... ..+||||++|.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 457778889999998764 678889977643322223357888888885322 334444332 2479999998776
Q ss_pred c
Q 005953 429 G 429 (667)
Q Consensus 429 ~ 429 (667)
.
T Consensus 80 ~ 80 (235)
T cd05157 80 E 80 (235)
T ss_pred C
Confidence 3
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00021 Score=68.03 Aligned_cols=124 Identities=27% Similarity=0.449 Sum_probs=88.9
Q ss_pred HHHHhhhhcccCCC-eEEEEEEeCCCcEEEEEEccc-----C-------C----------cchHHHHHHHHHHhhcc---
Q 005953 346 MTNGFKEKLGTGGY-GNVYKGKFPDGRLVAVKVLEK-----T-------S----------NFSDNFINEVATIGRIH--- 399 (667)
Q Consensus 346 ~~~~~~~~LG~G~f-g~Vy~~~~~~~~~vavK~l~~-----~-------~----------~~~~~~~~Ei~~l~~l~--- 399 (667)
...+|.+.||.|.- |.|||++. +|+.+|+|+++. . . ...+.|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 34457789999999 99999999 788999999321 0 0 11235788998888884
Q ss_pred cceE--EeecceEecC------------------CeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHH
Q 005953 400 HVNI--IHLLGFCCDG------------------STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY 459 (667)
Q Consensus 400 h~ni--v~l~g~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~y 459 (667)
+.++ |+.+||..-. ..+.||.||++... .+.. +-+.+|.+-+..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 4456 8999987421 12457888775432 1232 334567777889
Q ss_pred HHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCc
Q 005953 460 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 494 (667)
Q Consensus 460 LH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla 494 (667)
+|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 9988 9999999999986 4589999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.77 E-value=7.1e-05 Score=86.34 Aligned_cols=199 Identities=17% Similarity=0.180 Sum_probs=135.7
Q ss_pred HHHHHHHHhhcccceEEeecceEecCCeeE----EEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 005953 388 FINEVATIGRIHHVNIIHLLGFCCDGSTRA----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 463 (667)
Q Consensus 388 ~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~----lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~ 463 (667)
..-|+..+.++.|+|++.++.|-.+....- +..|++..-++...+.... .++....+.+..+..+||+|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHHh
Confidence 445777888899999999998887654433 3456777777777775533 577888888999999999999987
Q ss_pred CCCCeeecCCCCC---cEEECCCCceEEE--eCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHH
Q 005953 464 CELRILHLDIKPQ---NVLLDPDFTPKVS--DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYG 538 (667)
Q Consensus 464 ~~~~ivH~Dikp~---NIll~~~~~~ki~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlG 538 (667)
...|.-+..+ +-..+.++.+.++ ||+.++........ ....-+..|.|||....+....+.+.|+|.+|
T Consensus 306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred ---ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence 5555544444 4555667778877 99988766543322 11223667889998876655555667999999
Q ss_pred HHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005953 539 MLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618 (667)
Q Consensus 539 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 618 (667)
..+..+..|..+-..... ...++. ... ...+.+....|+..++++|+++.+++.
T Consensus 380 ll~~~~~~~~~i~~~~~~---------------~~~~l~----~~~-------~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV---------------PVSLLD----VLS-------TSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCcccccccc---------------hhhhhc----ccc-------chhhhhhhhhhcchhhhhccchhhhhh
Confidence 999999877654211100 000000 000 003445667799999999999999998
Q ss_pred HHh
Q 005953 619 MLS 621 (667)
Q Consensus 619 ~L~ 621 (667)
+.-
T Consensus 434 ~~f 436 (1351)
T KOG1035|consen 434 HPF 436 (1351)
T ss_pred chh
Confidence 875
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00039 Score=66.79 Aligned_cols=129 Identities=21% Similarity=0.347 Sum_probs=90.3
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCC-----------------cchHHHHHHHHHHhhcc------cceEEeecc
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-----------------NFSDNFINEVATIGRIH------HVNIIHLLG 408 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----------------~~~~~~~~Ei~~l~~l~------h~niv~l~g 408 (667)
..||+|+.-.||. +++.....||+..... ...+++.+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4689999999995 3445556788876544 23466778887666665 789999999
Q ss_pred eEecCCeeEEEEEEcCC--C----CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC
Q 005953 409 FCCDGSTRALIYEYMPN--G----SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP 482 (667)
Q Consensus 409 ~~~~~~~~~lV~e~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~ 482 (667)
+..++...-+|+|.+.+ | +|.+++.+. .++. ...+. +-+-..||-.+ +|+.+|++|+||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~~~~---L~~f~~~l~~~---~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-ELRQA---LDEFKRYLLDH---HIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HHHHH---HHHHHHHHHHc---CCeecCCCcccEEEEe
Confidence 99999999999998753 3 456666332 3444 33333 33445667666 8999999999999943
Q ss_pred C---C-ceEEEe-CCC
Q 005953 483 D---F-TPKVSD-FGL 493 (667)
Q Consensus 483 ~---~-~~ki~D-FGl 493 (667)
. . .+.|+| ||-
T Consensus 154 ~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGE 169 (199)
T ss_pred cCCCceEEEEEeCCCC
Confidence 2 2 577776 553
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00058 Score=69.00 Aligned_cols=137 Identities=14% Similarity=0.134 Sum_probs=79.2
Q ss_pred hcccCCCeEEEEEEeCCCcEEEEEEcccCCcch-HHHHHHHHHHhhcccceE-EeecceEecCCeeEEEEEEcCCCCccc
Q 005953 353 KLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEYMPNGSLGD 430 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~ 430 (667)
.+..|-.+.+|+... +++.+++|+........ -+..+|.++++.+....+ .++++... .++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 356688889999884 56778888765433221 245789999988853322 33333321 368999999877643
Q ss_pred c-----------------ccccc-cCCCCCHH-HHHHHHHHH---------HHHHHHHHcC-----CCCCeeecCCCCCc
Q 005953 431 L-----------------LSREK-ENLSLKPA-RLLEIALGV---------AHAIEYLHNG-----CELRILHLDIKPQN 477 (667)
Q Consensus 431 ~-----------------l~~~~-~~~~l~~~-~~~~i~~~i---------~~gl~yLH~~-----~~~~ivH~Dikp~N 477 (667)
- ||... ....++.. .+..+..++ .+.+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 2 11111 01112221 111111111 1112222211 12468999999999
Q ss_pred EEECCCCceEEEeCCCcc
Q 005953 478 VLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 478 Ill~~~~~~ki~DFGla~ 495 (667)
|++++++ ++|+||..|.
T Consensus 158 il~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEEeCCC-CEEEeccccC
Confidence 9999877 7899998774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00083 Score=71.54 Aligned_cols=74 Identities=15% Similarity=0.137 Sum_probs=53.6
Q ss_pred hhcccCCCeEEEEEEeCCC-cEEEEEEcccC--------CcchHHHHHHHHHHhhcc---cceEEeecceEecCCeeEEE
Q 005953 352 EKLGTGGYGNVYKGKFPDG-RLVAVKVLEKT--------SNFSDNFINEVATIGRIH---HVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~-~~vavK~l~~~--------~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~lV 419 (667)
+.||.|.+..||++...+| +.|+||.-... ....+.+..|.+.|..+. -.++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5789999999999999776 58999984311 123456778888888863 2456667655 44667899
Q ss_pred EEEcCCCC
Q 005953 420 YEYMPNGS 427 (667)
Q Consensus 420 ~e~~~~gs 427 (667)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998743
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0039 Score=65.22 Aligned_cols=141 Identities=13% Similarity=0.114 Sum_probs=77.9
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccc--eEEeecc------eEecCCeeEEEEEEc
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV--NIIHLLG------FCCDGSTRALIYEYM 423 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~g------~~~~~~~~~lV~e~~ 423 (667)
+.|+.|...++|+....+| .+++|+.. ....+....|+.++..|... .+.+.+. +....+..++++||+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 4567787789999987555 57888876 22234444566666666321 1223221 112345678999999
Q ss_pred CCCCcccc-----------c---cccccC--------CCCCH-HHHHH------------HH-HHHHHHHHHHHcC----
Q 005953 424 PNGSLGDL-----------L---SREKEN--------LSLKP-ARLLE------------IA-LGVAHAIEYLHNG---- 463 (667)
Q Consensus 424 ~~gsL~~~-----------l---~~~~~~--------~~l~~-~~~~~------------i~-~~i~~gl~yLH~~---- 463 (667)
+|..+... | |..... ..+.+ ..... .. ..+...++.+...
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 88754211 1 110000 01111 11111 11 1111222333211
Q ss_pred CCCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 464 ~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
...+++|+|+++.||+++.+...-|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 24589999999999999977666899999763
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00096 Score=69.21 Aligned_cols=140 Identities=24% Similarity=0.256 Sum_probs=83.7
Q ss_pred hhcccCCCeEEEEEEeCC-------CcEEEEEEcccCCcchHHHHHHHHHHhhcccce-EEeecceEecCCeeEEEEEEc
Q 005953 352 EKLGTGGYGNVYKGKFPD-------GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN-IIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~~~~lV~e~~ 423 (667)
+.|..|-...||+....+ ++.+++|+.........+..+|.+++..+.... ..++++++.. .+|+||+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 345667777999998754 578899997665433345678888888885322 2344544432 3589999
Q ss_pred CCCCcccc-----------------ccccccCC------CC--CHHHHHH--------------------------HHHH
Q 005953 424 PNGSLGDL-----------------LSREKENL------SL--KPARLLE--------------------------IALG 452 (667)
Q Consensus 424 ~~gsL~~~-----------------l~~~~~~~------~l--~~~~~~~--------------------------i~~~ 452 (667)
+|.++... +|+..... .. -+..+.+ +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88776431 11111010 00 0111111 1112
Q ss_pred HHHHHHHHHc------CCCCCeeecCCCCCcEEECCC----CceEEEeCCCcc
Q 005953 453 VAHAIEYLHN------GCELRILHLDIKPQNVLLDPD----FTPKVSDFGLAK 495 (667)
Q Consensus 453 i~~gl~yLH~------~~~~~ivH~Dikp~NIll~~~----~~~ki~DFGla~ 495 (667)
+..-+..|.. .....++|+|+.+.||+++++ +.++++||..|.
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 2223334432 234578999999999999885 889999998774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0049 Score=64.09 Aligned_cols=142 Identities=18% Similarity=0.170 Sum_probs=82.4
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccc--eEEeecceE------ecCCeeEEEEEEc
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV--NIIHLLGFC------CDGSTRALIYEYM 423 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~g~~------~~~~~~~lV~e~~ 423 (667)
+.++.|....+|+....+| .+++|+..... ..++...|++++..|... .+.+++... ...+..++++||+
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 4567777789999876555 46678765432 234556777777777422 234444321 1245678999999
Q ss_pred CCCCcccc--------------ccccccCC---------CCCHHHHH------------HHHHHHHHHHHHHHc----CC
Q 005953 424 PNGSLGDL--------------LSREKENL---------SLKPARLL------------EIALGVAHAIEYLHN----GC 464 (667)
Q Consensus 424 ~~gsL~~~--------------l~~~~~~~---------~l~~~~~~------------~i~~~i~~gl~yLH~----~~ 464 (667)
+|..+... +|...... ...|.... .....+.+.++++.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 88655311 11100000 01111100 011123344555542 23
Q ss_pred CCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 465 ~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
..+++|+|+++.||++++++.+.|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 4689999999999999988877899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0023 Score=66.11 Aligned_cols=141 Identities=18% Similarity=0.117 Sum_probs=85.2
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccc--eEEeecce------EecCCeeEEEEEEc
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV--NIIHLLGF------CCDGSTRALIYEYM 423 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~g~------~~~~~~~~lV~e~~ 423 (667)
+.|..|....+|+....+ ..+++|+... ...+....|++++..+.+. .+.+++.. ....+..++|++|+
T Consensus 20 ~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 20 EGISAGIENTNYFVTTDS-GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred ecccCccccceEEEEeCC-CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 467778888999987644 4688898765 2345667788888888532 24444431 12344668999999
Q ss_pred CCCCcccc----c----------cccccC--------CCCCHHHHH----------HHHHHHHHHHHHHHc----CCCCC
Q 005953 424 PNGSLGDL----L----------SREKEN--------LSLKPARLL----------EIALGVAHAIEYLHN----GCELR 467 (667)
Q Consensus 424 ~~gsL~~~----l----------~~~~~~--------~~l~~~~~~----------~i~~~i~~gl~yLH~----~~~~~ 467 (667)
+|..+... . |..... ....|.... .....+...+.++.. ....+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 98776430 0 100000 011111110 011123334445443 12347
Q ss_pred eeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 468 ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
++|+|+.|.||+++++..+.|+||+.+.
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhc
Confidence 9999999999999998778999998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0032 Score=64.37 Aligned_cols=72 Identities=19% Similarity=0.293 Sum_probs=48.2
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcc---cceEEeecceEecCCeeEEEEEEcCCC
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH---HVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.++.|....+|+.+ .+++.+.||+-. ......|..|.+-|+.|. --.+.+++++....+..+||+||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 468889999999988 578889999876 333457888998888884 345778888887777889999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.011 Score=62.56 Aligned_cols=139 Identities=20% Similarity=0.237 Sum_probs=80.5
Q ss_pred hcccCCCeEEEEEEeCC-----CcEEEEEEcccCCcchHHHHHHHHHHhhcccceE-EeecceEecCCeeEEEEEEcCCC
Q 005953 353 KLGTGGYGNVYKGKFPD-----GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~g 426 (667)
.|-.|-.-.+|+....+ ++.|++|+........-+-.+|..+++.+..-++ .++++.+..+ .|.||+++.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 45567888999987642 3678899876543322223678888888853333 2445555332 589999877
Q ss_pred Ccccc-----------------ccccc--cCC-CCCHHHHHHHHHHH-----------------HHHHHHH----Hc-CC
Q 005953 427 SLGDL-----------------LSREK--ENL-SLKPARLLEIALGV-----------------AHAIEYL----HN-GC 464 (667)
Q Consensus 427 sL~~~-----------------l~~~~--~~~-~l~~~~~~~i~~~i-----------------~~gl~yL----H~-~~ 464 (667)
+|..- +|+.. ... ..-+.++.++..++ ...+..| .. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 76421 11111 001 11122332332111 1112222 21 22
Q ss_pred CCCeeecCCCCCcEEECC-CCceEEEeCCCcc
Q 005953 465 ELRILHLDIKPQNVLLDP-DFTPKVSDFGLAK 495 (667)
Q Consensus 465 ~~~ivH~Dikp~NIll~~-~~~~ki~DFGla~ 495 (667)
...++|+|+++.|||+++ ++.++++||..+.
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 347899999999999986 4789999998774
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.011 Score=60.29 Aligned_cols=69 Identities=14% Similarity=0.149 Sum_probs=40.2
Q ss_pred ccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcc-c-ce-EEeecceEecCCeeEEEEEEcCCCCc
Q 005953 355 GTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH-H-VN-IIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 355 G~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h-~n-iv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
++|-...|+.....+|+..++|.-+.. .......+|.++|+.+. | +- +.+++ +. ....++|++++|..+
T Consensus 20 ~~g~~~~v~~i~~~~g~~~VlR~p~~~-~~~~~l~rE~~vL~~L~~~l~vpvP~~~--~~--~~~~~~y~~i~G~p~ 91 (276)
T cd05152 20 ESGLDFQVVFAKDTDGVPWVLRIPRRP-DVSERAAAEKRVLALVRKHLPVQVPDWR--VH--TPELIAYPKLPGVPA 91 (276)
T ss_pred CCcceeEEEEEEcCCCCeEEEEecCCH-HHHHHHHHHHHHHHHHHhcCCCCCCcee--ee--cCceEEEeccCCCcc
Confidence 444445666665556888888887532 23456789999999885 3 21 11111 11 123567777766544
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.003 Score=63.73 Aligned_cols=135 Identities=16% Similarity=0.180 Sum_probs=92.5
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC-----------------cc------hHHHHHHHHHHhhcc-cc-eE
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-----------------NF------SDNFINEVATIGRIH-HV-NI 403 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----------------~~------~~~~~~Ei~~l~~l~-h~-ni 403 (667)
.+.+.||-|.-+-+|.+...+|+..++|.-+... .. .-...+|+..|+.|. |- -+
T Consensus 95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV 174 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV 174 (465)
T ss_pred hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence 4568899999999999999899999998642110 00 113457888888884 32 33
Q ss_pred EeecceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC
Q 005953 404 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD 483 (667)
Q Consensus 404 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~ 483 (667)
.+.++ .+.-++|||++.+-.|...-+- .+..++.. .+..-+.-|-.+ |+||+|..-=||+++++
T Consensus 175 PkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~---~lm~~Iv~la~~---GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 175 PKPID----HNRHCVVMELVDGYPLRQVRHV------EDPPTLYD---DLMGLIVRLANH---GLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCccc----ccceeeHHHhhcccceeeeeec------CChHHHHH---HHHHHHHHHHHc---CceecccchheeEEecC
Confidence 44443 3456789999988777665432 22333333 233334455555 99999999999999999
Q ss_pred CceEEEeCCCccccCC
Q 005953 484 FTPKVSDFGLAKAHSR 499 (667)
Q Consensus 484 ~~~ki~DFGla~~~~~ 499 (667)
..++++||--....+.
T Consensus 239 ~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 239 DKIVVIDFPQMVSTSH 254 (465)
T ss_pred CCEEEeechHhhccCC
Confidence 9999999986544433
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.036 Score=57.17 Aligned_cols=133 Identities=20% Similarity=0.284 Sum_probs=81.1
Q ss_pred CCCeEEEEEEeCCCcEEEEEEcc--cCCcchHHHHHHHHHHhhccc--ceEEeecceEecCC--eeEEEEEEcCCCCccc
Q 005953 357 GGYGNVYKGKFPDGRLVAVKVLE--KTSNFSDNFINEVATIGRIHH--VNIIHLLGFCCDGS--TRALIYEYMPNGSLGD 430 (667)
Q Consensus 357 G~fg~Vy~~~~~~~~~vavK~l~--~~~~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~ 430 (667)
|..-.+|....+ ++.+++.+-. .......+..+|+.+|+.+.- .-+...++.|.++. ..+.||+|++|..+.+
T Consensus 36 G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~ 114 (321)
T COG3173 36 GWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS 114 (321)
T ss_pred CcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC
Confidence 333445555543 7777777221 112334556678888887742 23445667777666 7799999998855444
Q ss_pred cccccccCCCCCHHHHHHHH-HHHHHHHHHHH------------------------------------------------
Q 005953 431 LLSREKENLSLKPARLLEIA-LGVAHAIEYLH------------------------------------------------ 461 (667)
Q Consensus 431 ~l~~~~~~~~l~~~~~~~i~-~~i~~gl~yLH------------------------------------------------ 461 (667)
.+.... .. .+++ ..+++.|+-||
T Consensus 115 ~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 115 ALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred cCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 332211 00 1111 13444444444
Q ss_pred --cCC-----CCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 462 --NGC-----ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 462 --~~~-----~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
.+. ...++|+|+.+.|++++.+..+-|.||+++..-.
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 221 2468999999999999999889999999987543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.052 Score=56.53 Aligned_cols=139 Identities=22% Similarity=0.257 Sum_probs=84.1
Q ss_pred cccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcc-c--ce---EEeecc----eEecCCeeEEEEEEc
Q 005953 354 LGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH-H--VN---IIHLLG----FCCDGSTRALIYEYM 423 (667)
Q Consensus 354 LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h--~n---iv~l~g----~~~~~~~~~lV~e~~ 423 (667)
|.+ .-..||+....+|+. ++|+.+.. ....+...|+..|..+. + +- +..+=| ....+...+-|++|+
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 556789998877777 88988876 55677778888888884 2 21 222212 111123677899999
Q ss_pred CCCCccc-cc--------------ccccc---------CCCCCHH----H---------HHHHHHHHHHHHHHHHcC---
Q 005953 424 PNGSLGD-LL--------------SREKE---------NLSLKPA----R---------LLEIALGVAHAIEYLHNG--- 463 (667)
Q Consensus 424 ~~gsL~~-~l--------------~~~~~---------~~~l~~~----~---------~~~i~~~i~~gl~yLH~~--- 463 (667)
+|..+.. .. |.... .....|. . ......++...+..+.+.
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 9988873 11 10000 0112222 0 011233344444444432
Q ss_pred -CCCC---eeecCCCCCcEEECCCCc-eEEEeCCCcc
Q 005953 464 -CELR---ILHLDIKPQNVLLDPDFT-PKVSDFGLAK 495 (667)
Q Consensus 464 -~~~~---ivH~Dikp~NIll~~~~~-~ki~DFGla~ 495 (667)
.... +||+|+.|.||+++.+.. +.++|||-+.
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1123 999999999999999885 8999999763
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.084 Score=55.29 Aligned_cols=72 Identities=17% Similarity=0.129 Sum_probs=47.0
Q ss_pred CCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhccc--ceEEeec---c--eEecCCeeEEEEEEcCCCCc
Q 005953 357 GGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH--VNIIHLL---G--FCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 357 G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~---g--~~~~~~~~~lV~e~~~~gsL 428 (667)
+.-..||+...+++..+++|+.+.......+...|++.+..|.. -.++... | ....++..+.|+++++|...
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 34567999988788889999886544445667788888877732 1122212 2 12234567789999987654
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.054 Score=57.70 Aligned_cols=71 Identities=11% Similarity=0.080 Sum_probs=48.8
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEccc-----CC---cchHHHHHHHHHHhhcc---cceEEeecceEecCCeeEEEE
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEK-----TS---NFSDNFINEVATIGRIH---HVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~-----~~---~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~lV~ 420 (667)
+.||.|....||+.... ++.++||.-.. .. ...++-..|.+.|+.+. ..++.+++.++. +..+++|
T Consensus 38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 57899999999998874 55688997641 11 12334445666666653 246777887776 4567889
Q ss_pred EEcCC
Q 005953 421 EYMPN 425 (667)
Q Consensus 421 e~~~~ 425 (667)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.044 Score=56.60 Aligned_cols=141 Identities=19% Similarity=0.268 Sum_probs=94.1
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCc----------------------chHH-----HHHHHHHHhhcccceEE
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN----------------------FSDN-----FINEVATIGRIHHVNII 404 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----------------------~~~~-----~~~Ei~~l~~l~h~niv 404 (667)
..|..|.-+.||.+.-.+|+.+|||+.+.+-- ..+. ...|++-|.+++...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 46889999999999999999999999643210 0011 23577788887643322
Q ss_pred eecceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC
Q 005953 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF 484 (667)
Q Consensus 405 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~ 484 (667)
-.--+.. ..-.|||+|+.... +-.-......++...+...-.+++.-+.-|-+.| ++||.||.-=|+|+. +|
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-dG 301 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-DG 301 (520)
T ss_pred CCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-CC
Confidence 1111111 23468999995321 1111112345777778888888888888887654 899999999999986 46
Q ss_pred ceEEEeCCCccccCCC
Q 005953 485 TPKVSDFGLAKAHSRN 500 (667)
Q Consensus 485 ~~ki~DFGla~~~~~~ 500 (667)
.+.|+|-+-+.....+
T Consensus 302 ~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 302 KLYIIDVSQSVEHDHP 317 (520)
T ss_pred EEEEEEccccccCCCh
Confidence 8999999987655443
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.0018 Score=76.90 Aligned_cols=158 Identities=11% Similarity=-0.012 Sum_probs=105.7
Q ss_pred HHHHHHhhcccceEEeecceEe--cCCeeEEEEEEcCCCCcccccccccc-CCCCCHHHHHHHHHHHHHHHHHHHcCCC-
Q 005953 390 NEVATIGRIHHVNIIHLLGFCC--DGSTRALIYEYMPNGSLGDLLSREKE-NLSLKPARLLEIALGVAHAIEYLHNGCE- 465 (667)
Q Consensus 390 ~Ei~~l~~l~h~niv~l~g~~~--~~~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~gl~yLH~~~~- 465 (667)
.|...++...|+++.....-.. +....+.+++|+..|.+.+.|-.... ...++..-+...-.+......-.|+..+
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 3444555667888776554332 23456788999999999998864322 2233333332222222444455454322
Q ss_pred -CCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHH
Q 005953 466 -LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEM 544 (667)
Q Consensus 466 -~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~el 544 (667)
.-.+|+++|+-|.+|..+..+|+.++|+.+...+.... .....+++.|++|+....- .++.++|+|..|+-+++.
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF--FGLELCSPIYVLQLIKNEI--KFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchHhh--hhhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHHHHHH
Confidence 24689999999999999999999999999844333222 2334578899999987654 667789999999999998
Q ss_pred HhCCCCC
Q 005953 545 IEEKKHL 551 (667)
Q Consensus 545 ltg~~p~ 551 (667)
--|..++
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 7665544
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.061 Score=56.50 Aligned_cols=141 Identities=15% Similarity=0.196 Sum_probs=78.7
Q ss_pred hhcccCCCeEEEEEEeCC----CcEEEEEEcccCCcchHHHHHHHHHHhhcccceE-EeecceEecCCeeEEEEEEcCCC
Q 005953 352 EKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.|..|-...+|+....+ +..|++|+........-+-.+|..+++.+..-++ .++++++..+ +|.+|+++.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 345557778899887543 2378899876543322234578888888864433 3455554322 589999776
Q ss_pred Cccc--c-----c----------cccc-c-CC-CCCHHHHHHHHHHH----------------------HHHHHHHHc--
Q 005953 427 SLGD--L-----L----------SREK-E-NL-SLKPARLLEIALGV----------------------AHAIEYLHN-- 462 (667)
Q Consensus 427 sL~~--~-----l----------~~~~-~-~~-~l~~~~~~~i~~~i----------------------~~gl~yLH~-- 462 (667)
+|.. + + |... . .. ..-+..+.++..++ .+-+..+..
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 6522 1 1 1111 0 00 11122222222111 111111111
Q ss_pred ---CCCCCeeecCCCCCcEEECC-CCceEEEeCCCccc
Q 005953 463 ---GCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKA 496 (667)
Q Consensus 463 ---~~~~~ivH~Dikp~NIll~~-~~~~ki~DFGla~~ 496 (667)
....-..|.|+.+.|||+++ ++.++++||..|..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11234799999999999975 57899999998743
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.099 Score=54.77 Aligned_cols=72 Identities=17% Similarity=0.114 Sum_probs=47.6
Q ss_pred hcccCCCeEEEEEEeCCC-cEEEEEEccc-----C---CcchHHHHHHHHHHhhcc--cc-eEEeecceEecCCeeEEEE
Q 005953 353 KLGTGGYGNVYKGKFPDG-RLVAVKVLEK-----T---SNFSDNFINEVATIGRIH--HV-NIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~~~~~-~~vavK~l~~-----~---~~~~~~~~~Ei~~l~~l~--h~-niv~l~g~~~~~~~~~lV~ 420 (667)
.||.|...-||++..++| +.|+||.-.. . .-..++..-|.+.|+... -| .+.+++ ..+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 579999999999998654 6899997431 1 122345566777776663 24 344444 33556677999
Q ss_pred EEcCCC
Q 005953 421 EYMPNG 426 (667)
Q Consensus 421 e~~~~g 426 (667)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.026 Score=55.13 Aligned_cols=122 Identities=17% Similarity=0.183 Sum_probs=59.8
Q ss_pred CcEEEEEEcccCCcchHHHHHHHHHHhhcccceE-EeecceEecCCeeEEEEEEcCCCCccc--cc--------------
Q 005953 370 GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEYMPNGSLGD--LL-------------- 432 (667)
Q Consensus 370 ~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~--~l-------------- 432 (667)
++.|+||+........-+-..|..+++.+....+ .++++.+.++ .|+||+++.+|.. +-
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~ 77 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK 77 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence 4678888887765555566788888888864333 4455544322 5779997666522 11
Q ss_pred -ccccc----CCCCCHHHHHHH----------------------HHHHHHHHHHHHc-----CCCCCeeecCCCCCcEEE
Q 005953 433 -SREKE----NLSLKPARLLEI----------------------ALGVAHAIEYLHN-----GCELRILHLDIKPQNVLL 480 (667)
Q Consensus 433 -~~~~~----~~~l~~~~~~~i----------------------~~~i~~gl~yLH~-----~~~~~ivH~Dikp~NIll 480 (667)
|.... ....-+..+.++ ...+..-+..+.. .....+.|.|+.+.|||+
T Consensus 78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~ 157 (211)
T PF01633_consen 78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI 157 (211)
T ss_dssp HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence 10000 000011111111 0111112222221 112367899999999999
Q ss_pred -CCCCceEEEeCCCcc
Q 005953 481 -DPDFTPKVSDFGLAK 495 (667)
Q Consensus 481 -~~~~~~ki~DFGla~ 495 (667)
+.++.++++||..|.
T Consensus 158 ~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 158 NNKDGEVKLIDFEYAG 173 (211)
T ss_dssp TSSSSCEEE--GTT-E
T ss_pred ccCCCeEEEecHHHHh
Confidence 888999999998774
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.12 Score=53.60 Aligned_cols=30 Identities=27% Similarity=0.238 Sum_probs=25.7
Q ss_pred CCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 465 ~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
..+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 358999999999999987 678999998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.1 Score=54.24 Aligned_cols=32 Identities=16% Similarity=0.116 Sum_probs=28.2
Q ss_pred CCCeeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 465 ~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
..+++|+|+.++|||+++++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999999999999987743
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.11 Score=50.04 Aligned_cols=152 Identities=17% Similarity=0.178 Sum_probs=92.3
Q ss_pred CCCeEEEEEEeCCCcEEEEEEcccCC-c-chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCccccccc
Q 005953 357 GGYGNVYKGKFPDGRLVAVKVLEKTS-N-FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR 434 (667)
Q Consensus 357 G~fg~Vy~~~~~~~~~vavK~l~~~~-~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 434 (667)
|+-++.-+++-+-|. ..+|++.... . ...-|.++.+++.+++ .|+++.. ..+-..-++.|++..-
T Consensus 73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~-------- 139 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKI-------- 139 (308)
T ss_pred CCceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCc--------
Confidence 444566666553343 4556555443 2 3456778888888875 3555552 1233455888888321
Q ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCCCCCcc
Q 005953 435 EKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 514 (667)
Q Consensus 435 ~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~ 514 (667)
.... ..+..-=+..|.-.|+. +.+.+|+|-.|+||+-|..|.+||.|-+..- +. +..
T Consensus 140 -------~i~~-~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~------------~V~ 196 (308)
T PF07387_consen 140 -------KINF-SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--EN------------QVN 196 (308)
T ss_pred -------ccch-hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh--hh------------eee
Confidence 1111 12222224678888965 5699999999999999999999999987432 11 122
Q ss_pred ccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCC
Q 005953 515 YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK 549 (667)
Q Consensus 515 y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~ 549 (667)
|.--|+ ...|.++.+=+|=.-++++....+
T Consensus 197 ~vN~~Y-----~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 197 MVNIEY-----ESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred EEeeec-----cccChHHHHHHHHHHHHHHHHHHh
Confidence 332121 245677888888888888875443
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.15 Score=49.33 Aligned_cols=75 Identities=16% Similarity=0.298 Sum_probs=52.7
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcc---cceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH---HVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
+++..|.--.-|...+ +...+.||+-.. ....-|.+|+.-|..+. .-++.+++.+-.+....|||+||++-|.+
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~--~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQR--EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecch--hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 3455555455565554 567888997443 23456788887776664 45677888888888999999999998777
Q ss_pred c
Q 005953 429 G 429 (667)
Q Consensus 429 ~ 429 (667)
.
T Consensus 99 d 99 (286)
T COG3001 99 D 99 (286)
T ss_pred C
Confidence 5
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.66 E-value=0.43 Score=57.76 Aligned_cols=141 Identities=18% Similarity=0.178 Sum_probs=78.5
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcc-------cceEEeec-ce----Eec-CC--ee
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH-------HVNIIHLL-GF----CCD-GS--TR 416 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-------h~niv~l~-g~----~~~-~~--~~ 416 (667)
+.|+ |..-.+|+.+..+|+.+++|+.+... .......|.+.|..|. -|.+++-. |- ... .+ ..
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 3464 45688899988788889999988643 2334445555665552 23334322 11 111 12 45
Q ss_pred EEEEEEcCCCCcccccc-----------------cc----c---cCCCCCHHH-----------------HHHHHHHHHH
Q 005953 417 ALIYEYMPNGSLGDLLS-----------------RE----K---ENLSLKPAR-----------------LLEIALGVAH 455 (667)
Q Consensus 417 ~lV~e~~~~gsL~~~l~-----------------~~----~---~~~~l~~~~-----------------~~~i~~~i~~ 455 (667)
+-+++|++|..+.+... .. . ....+.|.. ...++.++.+
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 67899999877755110 00 0 001122211 1122222222
Q ss_pred HHH-----HHHcCCCCCeeecCCCCCcEEECCCC--ceE-EEeCCCcc
Q 005953 456 AIE-----YLHNGCELRILHLDIKPQNVLLDPDF--TPK-VSDFGLAK 495 (667)
Q Consensus 456 gl~-----yLH~~~~~~ivH~Dikp~NIll~~~~--~~k-i~DFGla~ 495 (667)
... .|. ....++||+|+++.|||++.+. ++. |+|||-+.
T Consensus 189 ~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 189 RFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 221 122 2245899999999999999875 454 99999874
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.59 E-value=0.12 Score=53.39 Aligned_cols=104 Identities=13% Similarity=0.196 Sum_probs=69.6
Q ss_pred CeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCC
Q 005953 414 STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 493 (667)
Q Consensus 414 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGl 493 (667)
...|++|++- |++|... ....+++.+.|+++.+.-+.-+... .+.=|||+.-.||||+ +|++-|+||-+
T Consensus 299 ~y~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 299 LYLYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred eEEEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeee
Confidence 3455666665 4444322 1345788889999988888877754 6889999999999999 99999999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHH
Q 005953 494 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYG 538 (667)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlG 538 (667)
+|.- .+...... .+.-.|-.+.+ .-+.+-|||-+-
T Consensus 368 sRl~-~~q~~isy------~rldhp~lF~G---~dd~QFeIYrlM 402 (488)
T COG5072 368 SRLS-YSQGIISY------NRLDHPDLFNG---VDDYQFEIYRLM 402 (488)
T ss_pred eecc-cCCceeec------cccCchhhhcC---ccceeeeHHHHH
Confidence 9843 33322221 12334555543 235567888643
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.37 E-value=0.37 Score=51.47 Aligned_cols=74 Identities=19% Similarity=0.254 Sum_probs=44.8
Q ss_pred hhcccCCCeEEEEEEeCCC--c-----EEEEEEcccCCcchHHHHHHHHHHhhcccceE-EeecceEecCCeeEEEEEEc
Q 005953 352 EKLGTGGYGNVYKGKFPDG--R-----LVAVKVLEKTSNFSDNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~--~-----~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~ 423 (667)
+.|..|-...+|++...++ . .|.+++........-+-.+|+++++.+...++ .++++.+.. .+|+||+
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efI 131 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWV 131 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEe
Confidence 3455688899999976433 2 24444432222222233578999999864433 445555532 5999999
Q ss_pred CCCCcc
Q 005953 424 PNGSLG 429 (667)
Q Consensus 424 ~~gsL~ 429 (667)
+|.+|.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 987764
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.90 E-value=0.071 Score=57.35 Aligned_cols=71 Identities=18% Similarity=0.207 Sum_probs=47.0
Q ss_pred EEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCC-eeEEEEEEcCCCCcccccccc
Q 005953 362 VYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGS-TRALIYEYMPNGSLGDLLSRE 435 (667)
Q Consensus 362 Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~ 435 (667)
.+.|+..+|+.. ..-+... .....++....+++.+.|+|+...+.+..... ...+|+|++ +.||+|++...
T Consensus 5 ~~~a~~~~~~~c-~nglplt-~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLPLT-PNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred EEehhcCCCccc-cCCCcCC-CcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 345555455433 2222222 22456777888999999999999888776443 466789998 78999988643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 667 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-43 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-33 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-32 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-31 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-24 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-24 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-24 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-24 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-24 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-24 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-23 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-23 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-23 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-23 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-23 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-23 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-23 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-23 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-23 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-23 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-23 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-23 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-23 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-23 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-23 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-23 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-22 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-21 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-21 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-20 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-20 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-20 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-20 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 8e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 9e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-04 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 316 bits (813), Expect = e-103
Identities = 110/300 (36%), Positives = 158/300 (52%), Gaps = 26/300 (8%)
Query: 338 YSYNDIKKMTNGFKE--KLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN--FSDNFINEVA 393
+S +++ ++ F LG GG+G VYKG+ DG LVAVK L++ F EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 394 TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGD-LLSREKENLSLK-PARLLEIAL 451
I H N++ L GFC + R L+Y YM NGS+ L R + L P R IAL
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ-RIAL 138
Query: 452 GVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRG 511
G A + YLH+ C+ +I+H D+K N+LLD +F V DFGLAK + VT T RG
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRG 197
Query: 512 TIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI 571
TIG+IAPE G S K+DV+ YG++LLE+I + R + +N + DW+
Sbjct: 198 TIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQ---RAFDLARLANDDDVMLLDWV 252
Query: 572 --------YDKLIQPE-KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+ L+ + + ++ +EE ++I V L C Q +P +RP M+ VV ML
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEE----VEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 8e-89
Identities = 99/315 (31%), Positives = 145/315 (46%), Gaps = 44/315 (13%)
Query: 335 LSNYSYNDIKKMTNGFKE--------KLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSD 386
++S+ ++K +TN F E K+G GG+G VYKG + VAVK L + +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 387 N-----FINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSL 441
F E+ + + H N++ LLGF DG L+Y YMPNGSL D LS L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 442 K-PARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSR 499
R +IA G A+ I +LH +H DIK N+LLD FT K+SDFGLA+ +
Sbjct: 131 SWHMR-CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG 559
++V+T + GT Y+APE +R G + KSD+YS+G++LLE+I +
Sbjct: 187 AQTVMT-SRIVGTTAYMAPE-ALR--GEITPKSDIYSFGVVLLEIITGLPAVDEHR---- 238
Query: 560 SNTTEAYFPDWI---------YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDR 610
D + I + D M V C+ R
Sbjct: 239 ---EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS----VEAMYSVASQCLHEKKNKR 291
Query: 611 PSMTRVVEMLSSASA 625
P + +V ++L +A
Sbjct: 292 PDIKKVQQLLQEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 4e-86
Identities = 94/296 (31%), Positives = 154/296 (52%), Gaps = 21/296 (7%)
Query: 338 YSYNDIKKMTNGFKEK--LGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDN-FINEVAT 394
D+++ TN F K +G G +G VYKG DG VA+K S+ F E+ T
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 395 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGD-LLSREKENLSLK-PARLLEIALG 452
+ H +++ L+GFC + + LIY+YM NG+L L + +S+ R LEI +G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR-LEICIG 147
Query: 453 VAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVVTMTGPRG 511
A + YLH I+H D+K N+LLD +F PK++DFG++K +++ ++ T +G
Sbjct: 148 AARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS-TVVKG 203
Query: 512 TIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE---AYFP 568
T+GYI PE F++ G + KSDVYS+G++L E++ + + + N E
Sbjct: 204 TLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 569 DWIYDKLIQPE-KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623
+ ++++ P + E RK + C+ ++ +DRPSM V+ L A
Sbjct: 262 NGQLEQIVDPNLADKIRPES----LRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 2e-70
Identities = 71/311 (22%), Positives = 123/311 (39%), Gaps = 31/311 (9%)
Query: 336 SNYSYNDIKKMTNGFK--EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVA 393
+ ++ + + E G +G V+K + VAVK+ S EV
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVY 70
Query: 394 TIGRIHHVNIIHLLGFCCDGSTRA----LIYEYMPNGSLGDLLSREKENLSLKPARLLEI 449
++ + H NI+ +G G++ LI + GSL D L + L I
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHI 126
Query: 450 ALGVAHAIEYLH-------NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502
A +A + YLH +G + I H DIK +NVLL + T ++DFGLA +S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 503 VVTMTGPRGTIGYIAPEIFMRNLGNP---SGKSDVYSYGMLLLEMI--------EEKKHL 551
G GT Y+APE+ + + D+Y+ G++L E+ +++
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 552 RPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP 611
P E G + + + + K +P D+ ++ + C + + R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHA--GMAMLCETIEECWDHDAEARL 304
Query: 612 SMTRVVEMLSS 622
S V E ++
Sbjct: 305 SAGCVGERITQ 315
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 3e-64
Identities = 79/351 (22%), Positives = 135/351 (38%), Gaps = 80/351 (22%)
Query: 340 YNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH 399
Y +I+ +E +G G +G V K K+ + VA+K + ++ + FI E+ + R++
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKW-RAKDVAIKQI-ESESERKAFIVELRQLSRVN 59
Query: 400 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY 459
H NI+ L G C + L+ EY GSL ++L + A + L + + Y
Sbjct: 60 HPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFT-PKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 518
LH+ ++H D+KP N+LL T K+ DFG A MT +G+ ++AP
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAP 172
Query: 519 EIFMRNLGNP-SGKSDVYSYGMLLLEMIEEK------------------KHLRPTETTSG 559
E+F G+ S K DV+S+G++L E+I + RP
Sbjct: 173 EVFE---GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP----- 224
Query: 560 SNTTEAYFPDWI---YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRV 616
+ + L+ C W +P RPSM +
Sbjct: 225 -------LIKNLPKPIESLMT-----------RC----------W--SKDPSQRPSMEEI 254
Query: 617 VEMLSSASAEAIEMPPKPLFPSPPQLQTQNE-----IISFDSITSELPLQH 662
V++++ +P L + + F + H
Sbjct: 255 VKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEFYRLWSVDH 305
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 4e-64
Identities = 80/316 (25%), Positives = 132/316 (41%), Gaps = 71/316 (22%)
Query: 340 YNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEK---TSNFSDNFINEVATIG 396
+ D+ KEK+G G +G V++ ++ G VAVK+L + + + F+ EVA +
Sbjct: 36 WCDLN-----IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 397 RIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHA 456
R+ H NI+ +G +++ EY+ GSL LL + L R L +A VA
Sbjct: 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 457 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 516
+ YLHN I+H ++K N+L+D +T KV DFGL++ + ++ GT ++
Sbjct: 150 MNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWM 206
Query: 517 APEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEK-----------------KHLRPTETTS 558
APE+ P + KSDVYS+G++L E+ + K R
Sbjct: 207 APEVLR---DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE---- 259
Query: 559 GSNTTEAYFPDWI---YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR 615
P + +I+ C P RPS
Sbjct: 260 --------IPRNLNPQVAAIIE-----------------------GCWTNEPWKRPSFAT 288
Query: 616 VVEMLSSASAEAIEMP 631
++++L A+ P
Sbjct: 289 IMDLLRPLIKSAVPPP 304
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-59
Identities = 69/297 (23%), Positives = 132/297 (44%), Gaps = 42/297 (14%)
Query: 340 YNDIKKMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN--------FIN 390
N+I+ +++++G GG+G V+KG+ D +VA+K L + + F
Sbjct: 18 DNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 391 EVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIA 450
EV + ++H NI+ L G + ++ E++P G L L + + L +
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWS--VKLRLM 128
Query: 451 LGVAHAIEYLHNGCELRILHLDIKPQNVLLD-----PDFTPKVSDFGLAKAHSRNRSVVT 505
L +A IEY+ N I+H D++ N+ L KV+DFGL++ +
Sbjct: 129 LDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----S 182
Query: 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEA 565
++G G ++APE + + K+D YS+ M+L ++ + P + + +
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE---GPFD---EYSYGKI 236
Query: 566 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
F + I ++ ++P E+ + + C +PK RP + +V+ LS
Sbjct: 237 KFINMIREEGLRPT---IPEDCPPRLRNVI----ELCWSGDPKKRPHFSYIVKELSE 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 4e-59
Identities = 81/326 (24%), Positives = 128/326 (39%), Gaps = 44/326 (13%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINE--VATIGRIHHVNIIHLL 407
E +G G YG VYKG D R VAVKV + NFINE + + + H NI +
Sbjct: 17 LLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFI 73
Query: 408 GFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
+ L+ EY PNGSL LS + +A V + YLH
Sbjct: 74 VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHT 129
Query: 463 ------GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV------VTMTGPR 510
+ I H D+ +NVL+ D T +SDFGL+ + NR V
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 511 GTIGYIAPEIF-----MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS------- 558
GTI Y+APE+ +R+ + + D+Y+ G++ E+ L P E+
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249
Query: 559 ---GSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR 615
G++ T + + +P+ + +E + R + C + + R +
Sbjct: 250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAV-RSLKETIEDCWDQDAEARLTAQX 308
Query: 616 VVEMLSSASAEAIEMPPKPLFPSPPQ 641
E ++ I K + P+
Sbjct: 309 AEERMA--ELMMIWERNKSVSPTAHH 332
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-58
Identities = 64/307 (20%), Positives = 117/307 (38%), Gaps = 76/307 (24%)
Query: 340 YNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVL---EKTSNFSDNFINEVATIG 396
+ + F KL G ++KG++ G + VKVL + ++ S +F E +
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 397 RIHHVNIIHLLGFCCDGSTR--ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVA 454
H N++ +LG C LI +MP GSL ++L E N + ++ ++ AL +A
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMA 121
Query: 455 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 514
+ +LH E I + ++V++D D T ++S + G
Sbjct: 122 RGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPA 173
Query: 515 YIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEK-----------------KHLRPTET 556
++APE + + +D++S+ +LL E++ + + LRPT
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT-- 231
Query: 557 TSGSNTTEAYFPDWI---YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSM 613
P I KL++ C+ +P RP
Sbjct: 232 ----------IPPGISPHVSKLMK-----------------------ICMNEDPAKRPKF 258
Query: 614 TRVVEML 620
+V +L
Sbjct: 259 DMIVPIL 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-57
Identities = 77/317 (24%), Positives = 124/317 (39%), Gaps = 86/317 (27%)
Query: 340 YNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVL-----EKTSNFSDNFINEVAT 394
+ ++ +E +G GG+G VY+ + G VAVK E S +N E
Sbjct: 6 FAELT-----LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 395 IGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVA 454
+ H NII L G C L+ E+ G L +LS ++ + P L+ A+ +A
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIA 115
Query: 455 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTP--------KVSDFGLAKAHSRNRSVVTM 506
+ YLH+ + I+H D+K N+L+ K++DFGLA+ R T
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT----TK 171
Query: 507 TGPRGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEK----------------- 548
G ++APE+ + S SDV+SYG+LL E++ +
Sbjct: 172 MSAAGAYAWMAPEVIR---ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM 228
Query: 549 KHLRPTETTSGSNTTEAYFPDWI---YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQI 605
L P + KL++ DC W
Sbjct: 229 NKLALP------------IPSTCPEPFAKLME-----------DC----------W--NP 253
Query: 606 NPKDRPSMTRVVEMLSS 622
+P RPS T +++ L++
Sbjct: 254 DPHSRPSFTNILDQLTT 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-57
Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 29/284 (10%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHL 406
+++G+G +G VYKGK+ G VAVK+L T F NEV + + HVNI+
Sbjct: 28 VGQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
+G A++ ++ SL L + +K +L++IA A ++YLH
Sbjct: 86 MG-YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMK--KLIDIARQTARGMDYLHA---K 139
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
I+H D+K N+ L D T K+ DFGLA SR G+I ++APE+
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 527 NP-SGKSDVYSYGMLLLEMIEEK---KHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582
NP S +SDVY++G++L E++ + ++ + + + P+
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM----------VGRGSLSPDLSK 249
Query: 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626
+ R M C++ +RPS R++ + + E
Sbjct: 250 VRSNCPKRMKRLM----AECLKKKRDERPSFPRILAEIEELARE 289
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-54
Identities = 63/330 (19%), Positives = 121/330 (36%), Gaps = 80/330 (24%)
Query: 340 YNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEK---TSNFSDNFINEVATIG 396
+ ++ E +G G +G VY G++ G VA+++++ + F EV
Sbjct: 32 FEQLE-----IGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYR 84
Query: 397 RIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHA 456
+ H N++ +G C A+I +L ++ K L + + +IA +
Sbjct: 85 QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVN--KTRQIAQEIVKG 142
Query: 457 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR---NRSVVTMTGPRGTI 513
+ YLH ILH D+K +NV D + ++DFGL R + G +
Sbjct: 143 MGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 514 GYIAPEIFMRNLGNPSG-------KSDVYSYGMLLLEMIEEK----------------KH 550
++APEI + + SDV++ G + E+ +
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258
Query: 551 LRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDR 610
++P + G I D ++ +C ++R
Sbjct: 259 MKPNLSQIG-------MGKEISD-ILL-----------------------FCWAFEQEER 287
Query: 611 PSMTRVVEMLSSASAEAIEMPPKPLFPSPP 640
P+ T++++ML ++P + S P
Sbjct: 288 PTFTKLMDMLE-------KLPKRNRRLSHP 310
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-53
Identities = 67/325 (20%), Positives = 115/325 (35%), Gaps = 66/325 (20%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNIIHLL 407
E LG G +G K G ++ +K L + + F+ EV + + H N++ +
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
G I EY+ G+L ++ + + A +A + YLH +
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWS--QRVSFAKDIASGMAYLH---SMN 128
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAK------------AHSRNRSVVTMTGPRGTIGY 515
I+H D+ N L+ + V+DFGLA+ + G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 516 IAPEIFMRNLGNPSG-KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 574
+APE+ G K DV+S+G++L E+I PD++
Sbjct: 189 MAPEMIN---GRSYDEKVDVFSFGIVLCEII----------------GRVNADPDYL--- 226
Query: 575 LIQPEKEDFVEEED---------DC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
P DF +C + C ++P+ RPS ++ L
Sbjct: 227 ---PRTMDFGLNVRGFLDRYCPPNCPPSFFPIT----VRCCDLDPEKRPSFVKLEHWL-- 277
Query: 623 ASAEAIEMPPKPLFPSPPQLQTQNE 647
E + M P PQL+ +
Sbjct: 278 ---ETLRMHLAGHLPLGPQLEQLDR 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-51
Identities = 69/295 (23%), Positives = 121/295 (41%), Gaps = 29/295 (9%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
+++G G YG V+ GK+ G VAVKV T S E+ + H NI+ +
Sbjct: 41 MVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 410 CCDGSTR----ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH---- 461
G+ LI +Y NGSL D L L +L++A + +LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 462 -NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT--MTGPRGTIGYIAP 518
+ I H D+K +N+L+ + T ++D GLA + + V GT Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 519 EIFMRNLGNPSG----KSDVYSYGMLLLEMI-------EEKKHLRPTETTSGSNTTEAYF 567
E+ +L +D+YS+G++L E+ +++ P S+ +
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 568 PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+ + K ++P + ++ ++ C NP R + RV + L+
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMT--ECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-51
Identities = 65/304 (21%), Positives = 126/304 (41%), Gaps = 30/304 (9%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
+E +G G +G V++GK+ G VAVK+ S E+ + H NI+ +
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 410 CCDGSTRA----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH---- 461
+ L+ +Y +GSL D L+R + ++++AL A + +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 160
Query: 462 -NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT--MTGPRGTIGYIAP 518
+ I H D+K +N+L+ + T ++D GLA H + GT Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 519 EIFMRNLGNPSG----KSDVYSYGMLLLEMI-------EEKKHLRPTETTSGSNTTEAYF 567
E+ ++ ++D+Y+ G++ E+ + + P S+ +
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280
Query: 568 PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS-ASAE 626
+ ++ ++P + + + I+ C N R + R+ + LS + E
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMR--ECWYANGAARLTALRIKKTLSQLSQQE 338
Query: 627 AIEM 630
I+M
Sbjct: 339 GIKM 342
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-50
Identities = 68/304 (22%), Positives = 113/304 (37%), Gaps = 47/304 (15%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
E +G G YG V++G + G VAVK+ S E+ + H NI+ +
Sbjct: 12 LLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 410 CCDGSTRA----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH---- 461
+ LI Y GSL D L L L I L +A + +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 462 -NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA--KAHSRNRSVVTMTGPRGTIGYIAP 518
+ I H D+K +N+L+ + ++D GLA + S N+ V GT Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 519 EIFMRNLGNPSG----KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 574
E+ + + D++++G++L E+ R + + F D +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV------ARRMVSNGIVEDYKPPFYDVVP-- 238
Query: 575 LIQPEKEDFVE---------------EEDDCIAR-KMIIVGLWCIQINPKDRPSMTRVVE 618
P ED + D + ++ W NP R + R+ +
Sbjct: 239 -NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECW--YQNPSARLTALRIKK 295
Query: 619 MLSS 622
L+
Sbjct: 296 TLTK 299
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 72/292 (24%), Positives = 118/292 (40%), Gaps = 53/292 (18%)
Query: 350 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
LG G +G V K + D R A+K + T ++EV + ++H ++
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 409 FCCDGS----------TRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAH 455
+ ++ ++ EY NG+L DL+ ENL+ + + +
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRLFRQILE 127
Query: 456 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT---------- 505
A+ Y+H I+H D+KP N+ +D K+ DFGLAK R+ ++
Sbjct: 128 ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 506 --MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT 563
+T GT Y+A E+ + G+ + K D+YS G++ EM + P T G
Sbjct: 185 DNLTSAIGTAMYVATEV-LDGTGHYNEKIDMYSLGIIFFEM------IYPFST--GMERV 235
Query: 564 EAYFPDWIYDKLIQPEKEDFVEEEDDCI---ARKMIIVGLWCIQINPKDRPS 612
I KL E F + DD +K+I I +P RP
Sbjct: 236 N------ILKKLRSVSIE-FPPDFDDNKMKVEKKII---RLLIDHDPNKRPG 277
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 68/317 (21%), Positives = 115/317 (36%), Gaps = 61/317 (19%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
+ LG GG+G V++ K D A+K L + + EV + ++ H I+
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 409 FCCDG---------STRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHA 456
+ S + +Y + +L D ++ + + L I L +A A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 457 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA----------HSRNRSVVTM 506
+E+LH ++H D+KP N+ D KV DFGL A + +
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 507 TGPRGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEA 565
TG GT Y++PE GN S K D++S G++L E+ L P T
Sbjct: 188 TGQVGTKLYMSPEQIH---GNSYSHKVDIFSLGLILFEL------LYPFSTQMERVR--- 235
Query: 566 YFPDWIYDKL----IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621
+ P E + + +P +RP ++
Sbjct: 236 -----TLTDVRNLKFPPLFTQKYPCEYVMVQ--------DMLSPSPMERPEAI---NIIE 279
Query: 622 SASAEAIEMPPKPLFPS 638
+A E ++ P K +
Sbjct: 280 NAVFEDLDFPGKTVLRQ 296
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-38
Identities = 55/283 (19%), Positives = 112/283 (39%), Gaps = 52/283 (18%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFC 410
E +G+GG+G V+K K DG+ +K ++ + + EV + ++ HVNI+H G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCW 73
Query: 411 CDGSTRA----------------LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVA 454
+ E+ G+L + + + L LE+ +
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LDKVLALELFEQIT 132
Query: 455 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 514
++Y+H ++++ D+KP N+ L K+ DFGL + + GT+
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK---GTLR 186
Query: 515 YIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573
Y++PE + D+Y+ G++L E++ ET+ +
Sbjct: 187 YMSPEQIS---SQDYGKEVDLYALGLILAELLHVCDT--AFETSK------------FFT 229
Query: 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRV 616
L D +++ + ++ + P+DRP+ + +
Sbjct: 230 DLRDGIISDIFDKK----EKTLL---QKLLSKKPEDRPNTSEI 265
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 73/287 (25%), Positives = 116/287 (40%), Gaps = 47/287 (16%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIHL 406
E++G G +G V+ G+ D LVAVK + F+ E + + H NI+ L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
+G C ++ E + G L E L +K LL++ A +EYL
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYLE---SK 232
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT--IGYIAPEIFMRN 524
+H D+ +N L+ K+SDFG+++ + V +G + + APE N
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG--VYAASGGLRQVPVKWTAPEAL--N 288
Query: 525 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584
G S +SDV+S+G+LL E + P Y L + +FV
Sbjct: 289 YGRYSSESDVWSFGILLWETF-----------------SLGASP---YPNLSNQQTREFV 328
Query: 585 EE------EDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
E+ + C + R M C P RPS + + + L S
Sbjct: 329 EKGGRLPCPELCPDAVFRLM----EQCWAYEPGQRPSFSTIYQELQS 371
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-38
Identities = 69/282 (24%), Positives = 121/282 (42%), Gaps = 41/282 (14%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
+ KLG G +G V+ G + VA+K L+ + + F+ E + ++ H ++ L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA- 246
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
++ EYM GSL D L + + L+ +L+++A +A + Y+ + +
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 529
H D++ N+L+ + KV+DFGLA+ N G + I + APE G +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAA--LYGRFT 359
Query: 530 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE--- 586
KSDV+S+G+LL E+ T+ P Y ++ E D VE
Sbjct: 360 IKSDVWSFGILLTELT-----------------TKGRVP---YPGMVNREVLDQVERGYR 399
Query: 587 ---EDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+C + M C + P++RP+ + L
Sbjct: 400 MPCPPECPESLHDLM----CQCWRKEPEERPTFEYLQAFLED 437
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-38
Identities = 63/283 (22%), Positives = 104/283 (36%), Gaps = 29/283 (10%)
Query: 342 DIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HH 400
+ K++ K+ LG G G + D R VAVK + EV + H
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEH 77
Query: 401 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 460
N+I D + + E +L + + ++ + + +L
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI--TLLQQTTSGLAHL 134
Query: 461 HNGCELRILHLDIKPQNVLL-----DPDFTPKVSDFGLAKAHSRNR-SVVTMTGPRGTIG 514
H L I+H D+KP N+L+ +SDFGL K + R S +G GT G
Sbjct: 135 H---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 515 YIAPEIFMRNL-GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573
+IAPE+ + NP+ D++S G + +I E H S +A
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF-----GKSLQRQANILLGACS 246
Query: 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRV 616
++ + I + I ++P+ RPS V
Sbjct: 247 LDCLHPEKHEDVIARELIEK--------MIAMDPQKRPSAKHV 281
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 26/287 (9%)
Query: 350 FKEKLGTGGYGNVYKGKFP-----DGRLVAVKVL-EKTSNFSDNFINEVATIGRIHHVNI 403
F ++LG G +G+V ++ G +VAVK L T +F E+ + + H NI
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 404 IHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
+ G C R LI EY+P GSL D L + KE + +LL+ + +EYL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICKGMEYLG 131
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPE- 519
R +H D+ +N+L++ + K+ DFGL K +++ + P + I + APE
Sbjct: 132 ---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 520 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579
+ S SDV+S+G++L E+ + + I LI+
Sbjct: 189 LTESKF---SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 580 KEDF-VEEEDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
K + + D C I M C N RPS + +
Sbjct: 246 KNNGRLPRPDGCPDEIYMIM----TECWNNNVNQRPSFRDLALRVDQ 288
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-37
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 352 EKLGTGGYGNVYKGKFPD---GRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNII 404
+KLG GG VY + D VA+K + F EV ++ H NI+
Sbjct: 17 DKLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
++ + L+ EY+ +L + + L + + I++ H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAH--- 128
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-GTIGYIAPEIFMR 523
++RI+H DIKPQN+L+D + T K+ DFG+AKA S + +T T GT+ Y +PE
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--ETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 524 NLGNPSGKSDVYSYGMLLLEMI 545
+D+YS G++L EM+
Sbjct: 187 --EATDECTDIYSIGIVLYEML 206
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-37
Identities = 78/283 (27%), Positives = 126/283 (44%), Gaps = 41/283 (14%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
K KLG G YG VY+G + VAVK L++ + + F+ E A + I H N++ LLG
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
C +I E+M G+L D L RE + LL +A ++ A+EYL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
+H ++ +N L+ + KV+DFGL++ + + G + I + APE
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESL--AYNKF 396
Query: 529 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE- 587
S KSDV+++G+LL E+ T P Y + + + +E++
Sbjct: 397 SIKSDVWAFGVLLWEIA-----------------TYGMSP---YPGIDLSQVYELLEKDY 436
Query: 588 -----DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+ C + M C Q NP DRPS + + +
Sbjct: 437 RMERPEGCPEKVYELM----RACWQWNPSDRPSFAEIHQAFET 475
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 350 FKEKLGTGGYGNVYKGKF--PDGRL---VAVKVL--EKTSNFSDNFINEVATIGRIHHVN 402
+ LG+G +G VYKG + ++ VA+K L + + ++E + + + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
+ LLG C ST LI + MP G L D + K+N+ + LL + +A + YL
Sbjct: 79 VCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQIAKGMNYLE- 134
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
+ R++H D+ +NVL+ K++DFGLAK G + I ++A E
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI- 191
Query: 523 RNLGNPSGKSDVYSYGMLLLEMI 545
+ +SDV+SYG+ + E++
Sbjct: 192 -LHRIYTHQSDVWSYGVTVWELM 213
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 26/287 (9%)
Query: 350 FKEKLGTGGYGNVYKGKFP-----DGRLVAVKVL-EKTSNFSDNFINEVATIGRIHHVNI 403
F ++LG G +G+V ++ G +VAVK L T +F E+ + + H NI
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 404 IHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
+ G C R LI EY+P GSL D L + KE + +LL+ + +EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICKGMEYLG 162
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPE- 519
R +H D+ +N+L++ + K+ DFGL K +++ + P + I + APE
Sbjct: 163 ---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 520 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579
+ S SDV+S+G++L E+ + + I LI+
Sbjct: 220 LTESKF---SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
Query: 580 KEDF-VEEEDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
K + + D C I M C N RPS + +
Sbjct: 277 KNNGRLPRPDGCPDEIYMIM----TECWNNNVNQRPSFRDLALRVDQ 319
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 26/208 (12%)
Query: 352 EKLGTGGYGNVYKGKFPD---GRLVAVKVLEKTSNFSDN------FINEVATIGRIHHVN 402
E LG GG V+ + D R VAVKVL ++ + + F E ++H
Sbjct: 18 EILGFGGMSEVHLAR--DLRDHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 403 IIHLLGFCCDGSTRALIY----EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 458
I+ + + + EY+ +L D++ E + P R +E+ A+
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALN 130
Query: 459 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-GTIGYIA 517
+ H + I+H D+KP N+++ KV DFG+A+A + + + VT T GT Y++
Sbjct: 131 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 518 PEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
PE + +SDVYS G +L E++
Sbjct: 188 PEQARG--DSVDARSDVYSLGCVLYEVL 213
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-36
Identities = 69/282 (24%), Positives = 121/282 (42%), Gaps = 41/282 (14%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
+ KLG G +G V+ G + VA+K L+ + + F+ E + ++ H ++ L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA- 329
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
++ EYM GSL D L + + L+ +L+++A +A + Y+ + +
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 529
H D++ N+L+ + KV+DFGLA+ N G + I + APE G +
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAA--LYGRFT 442
Query: 530 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE--- 586
KSDV+S+G+LL E+ T+ P Y ++ E D VE
Sbjct: 443 IKSDVWSFGILLTELT-----------------TKGRVP---YPGMVNREVLDQVERGYR 482
Query: 587 ---EDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+C + M C + P++RP+ + L
Sbjct: 483 MPCPPECPESLHDLM----CQCWRKEPEERPTFEYLQAFLED 520
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 67/276 (24%), Positives = 117/276 (42%), Gaps = 30/276 (10%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFS----DNFINEVATIGRIHHVNIIHL 406
+K+G G + VY+ DG VA+K ++ + I E+ + +++H N+I
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKP-ARLLEIALGVAHAIEYLHNGCE 465
+ + ++ E G L ++ K+ L P + + + + A+E++H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---S 154
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV-TMTGPRGTIGYIAPEIFMRN 524
R++H DIKP NV + K+ D GL + S + ++ GT Y++PE
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIH-- 209
Query: 525 LGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583
N + KSD++S G LL EM L+ N I P D
Sbjct: 210 -ENGYNFKSDIWSLGCLLYEMAA----LQSPFYGDKMNLYSLCKK--IEQCDYPPLPSDH 262
Query: 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619
EE R+++ CI +P+ RP +T V ++
Sbjct: 263 YSEE----LRQLV---NMCINPDPEKRPDVTYVYDV 291
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 62/274 (22%), Positives = 104/274 (37%), Gaps = 38/274 (13%)
Query: 350 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDN---FINEVATIGRIHHVNIIH 405
F ++G G + VYKG VA L+ F E + + H NI+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 406 LLGFCCDGSTRA----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
L+ E M +G+L L R K +K L + +++LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH 146
Query: 462 NGCELRILHLDIKPQNVLLD-PDFTPKVSDFGLAKAHSRN--RSVVTMTGPRGTIGYIAP 518
I+H D+K N+ + P + K+ D GLA + ++V+ GT ++AP
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI------GTPEFMAP 199
Query: 519 EIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578
E++ DVY++GM +LEM + S IY ++
Sbjct: 200 EMYEEKYDE---SVDVYAFGMCMLEMATSEYPY------SECQNAAQ-----IYRRVTSG 245
Query: 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
K ++ +++I CI+ N +R S
Sbjct: 246 VKPASFDKVAIPEVKEII---EGCIRQNKDERYS 276
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-36
Identities = 47/204 (23%), Positives = 81/204 (39%), Gaps = 29/204 (14%)
Query: 352 EKLGTGGYGNVYKGK--FPDGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNI--IH 405
+ GG G +Y +GR V +K L + + + E + + H +I I
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 406 LLGFCCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
D + Y EY+ SL ++ L A + L + A+ YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH- 199
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-GTIGYIAPEIF 521
+ +++ D+KP+N++L + K+ D G + G GT G+ APEI
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR-------INSFGYLYGTPGFQAPEIV 249
Query: 522 MRNLGNPSGKSDVYSYGMLLLEMI 545
P+ +D+Y+ G L +
Sbjct: 250 R---TGPTVATDIYTVGRTLAALT 270
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 69/285 (24%), Positives = 121/285 (42%), Gaps = 47/285 (16%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
++LG+G +G V GK+ VAVK++++ S D F E T+ ++ H ++ G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
C ++ EY+ NG L + L + L+P++LLE+ V + +L + +
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLE---SHQFI 126
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT---IGYIAPEIFMRNLG 526
H D+ +N L+D D KVSDFG+ + + GT + + APE+F +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDD----QYVSSVGTKFPVKWSAPEVF--HYF 180
Query: 527 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586
S KSDV+++G+L+ E+ + P YD E V +
Sbjct: 181 KYSSKSDVWAFGILMWEVF-----------------SLGKMP---YDLYTNSEVVLKVSQ 220
Query: 587 E------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
I + M C P+ RP+ +++ +
Sbjct: 221 GHRLYRPHLASDTIYQIM----YSCWHELPEKRPTFQQLLSSIEP 261
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 72/319 (22%), Positives = 129/319 (40%), Gaps = 55/319 (17%)
Query: 350 FKEKLGTGGYGNVYKGKFP-----DGRLVAVKVL-EKTSNFSDNFINEVATIGRIHHVNI 403
+ +LG G +G+V ++ G LVAVK L + +F E+ + +H I
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 404 IHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
+ G ++ L+ EY+P+G L D L R + L RLL + + +EYL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLG 144
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPE- 519
R +H D+ +N+L++ + K++DFGLAK ++ + P + I + APE
Sbjct: 145 ---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 520 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579
+ S +SDV+S+G++L E+ T ++ P + +++ E
Sbjct: 202 LSDNIF---SRQSDVWSFGVVLYELF-----------TYCD---KSCSPSAEFLRMMGCE 244
Query: 580 KEDFVEEE--------------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
++ C + M C +P+DRPS + + L
Sbjct: 245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELM----KLCWAPSPQDRPSFSALGPQLDM 300
Query: 623 --ASAEAIEMPPKPLFPSP 639
+ + E P
Sbjct: 301 LWSGSRGCETHAFTAHPEG 319
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-36
Identities = 67/295 (22%), Positives = 127/295 (43%), Gaps = 45/295 (15%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
++KLG G +G V+ + VAVK ++ S + F+ E + + H ++ L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA- 250
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
+I E+M GSL D L + E +L++ + +A + ++ + +
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 306
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 529
H D++ N+L+ K++DFGLA+ + G + I + APE N G+ +
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI--NFGSFT 363
Query: 530 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE-- 587
KSDV+S+G+LL+E++ T P Y + PE +E
Sbjct: 364 IKSDVWSFGILLMEIV-----------------TYGRIP---YPGMSNPEVIRALERGYR 403
Query: 588 ----DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLS----SASAEAIEMP 631
++C + M + C + P++RP+ + +L + ++ E+P
Sbjct: 404 MPRPENCPEELYNIM----MRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP 454
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 68/288 (23%), Positives = 122/288 (42%), Gaps = 28/288 (9%)
Query: 350 FKEKLGTGGYGNVYKGKFP-----DGRLVAVKVL--EKTSNFSDNFINEVATIGRIHHVN 402
LG G +G V ++ G VAVK L E N + E+ + ++H N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 403 IIHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 460
I+ G C + LI E++P+GSL + L + K ++LK + L+ A+ + ++YL
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLK--QQLKYAVQICKGMDYL 142
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPE 519
+ +H D+ +NVL++ + K+ DFGL KA ++ T+ R + + + APE
Sbjct: 143 G---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199
Query: 520 -IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578
+ SDV+S+G+ L E++ + +L+
Sbjct: 200 CLMQSKF---YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH-GQMTVTRLVNT 255
Query: 579 EKEDFV-EEEDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
KE +C + + M C + P +R S ++E +
Sbjct: 256 LKEGKRLPCPPNCPDEVYQLM----RKCWEFQPSNRTSFQNLIEGFEA 299
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 352 EKLGTGGYGNVYKGKFPD---GRLVAVKVLEKTSNFSDN------FINEVATIGRIHHVN 402
+G GG G+VY+ + D R+VA+K++ + S + E T GR+ +
Sbjct: 40 RLVGRGGMGDVYEAE--DTVRERIVALKLM--SETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
++ + F + + L +L R+ L P R + I + A++ H
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAH- 151
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-GTIGYIAPEIF 521
H D+KP+N+L+ D + DFG+A A + + +T G GT+ Y+APE F
Sbjct: 152 --AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK--LTQLGNTVGTLYYMAPERF 207
Query: 522 MRNLGNPSGKSDVYSYGMLLLEMI 545
+ + ++D+Y+ +L E +
Sbjct: 208 SE--SHATYRADIYALTCVLYECL 229
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-36
Identities = 67/285 (23%), Positives = 129/285 (45%), Gaps = 47/285 (16%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
F +++G+G +G V+ G + + VA+K + + + ++FI E + ++ H ++ L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
C + + L+ E+M +G L D L ++ + + LL + L V + YL E ++
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYL---EEACVI 126
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT---IGYIAPEIFMRNLG 526
H D+ +N L+ + KVSDFG+ + + T GT + + +PE+F +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWASPEVF--SFS 180
Query: 527 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586
S KSDV+S+G+L+ E+ +E P Y+ E + +
Sbjct: 181 RYSSKSDVWSFGVLMWEVF-----------------SEGKIP---YENRSNSEVVEDIST 220
Query: 587 E------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+ + M C + P+DRP+ +R++ L+
Sbjct: 221 GFRLYKPRLASTHVYQIM----NHCWRERPEDRPAFSRLLRQLAE 261
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-36
Identities = 77/285 (27%), Positives = 125/285 (43%), Gaps = 47/285 (16%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
E+LG G +G V+ G + VAVK L++ S D F+ E + ++ H ++ L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA- 75
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
+I EYM NGSL D L + + L +LL++A +A + ++ E +
Sbjct: 76 VVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT---IGYIAPEIFMRNLG 526
H D++ N+L+ + K++DFGLA+ N T G I + APE N G
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKWTAPEAI--NYG 185
Query: 527 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586
+ KSDV+S+G+LL E++ T P Y + PE +E
Sbjct: 186 TFTIKSDVWSFGILLTEIV-----------------THGRIP---YPGMTNPEVIQNLER 225
Query: 587 E------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
D+C + + M C + P+DRP+ + +L
Sbjct: 226 GYRMVRPDNCPEELYQLM----RLCWKERPEDRPTFDYLRSVLED 266
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 74/313 (23%), Positives = 130/313 (41%), Gaps = 53/313 (16%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRL-----VAVKVLEKTSNFSDN--FINEVATIGRIHHVN 402
+ LG+G +G V+KG + V +KV+E S + + IG + H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
I+ LLG C GS+ L+ +Y+P GSL D + + + L + LL + +A + YL
Sbjct: 77 IVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQ--LLLNWGVQIAKGMYYLE- 132
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
E ++H ++ +NVLL +V+DFG+A + + + + I ++A E
Sbjct: 133 --EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI- 189
Query: 523 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582
+ G + +SDV+SYG+ + E++ T G+ P Y L E D
Sbjct: 190 -HFGKYTHQSDVWSYGVTVWELM-----------TFGAE------P---YAGLRLAEVPD 228
Query: 583 FVEE------EDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLS-----SASAEAI 628
+E+ C + M + C I+ RP+ + + I
Sbjct: 229 LLEKGERLAQPQICTIDVYMVM----VKCWMIDENIRPTFKELANEFTRMARDPPRYLVI 284
Query: 629 EMPPKPLFPSPPQ 641
+ P P+
Sbjct: 285 KRESGPGIAPGPE 297
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-35
Identities = 76/283 (26%), Positives = 120/283 (42%), Gaps = 47/283 (16%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
+ +G G +G+V G + G VAVK + K + F+ E + + ++ H N++ LLG
Sbjct: 197 LLQTIGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 410 CCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+ ++ EYM GSL D L R + L LL+ +L V A+EYL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 310
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
+H D+ +NVL+ D KVSDFGL K S + + + + APE
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEAL--REKKF 363
Query: 529 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE-- 586
S KSDV+S+G+LL E+ + P Y ++ + VE+
Sbjct: 364 STKSDVWSFGILLWEIY-----------------SFGRVP---YPRIPLKDVVPRVEKGY 403
Query: 587 ----EDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
D C + M C ++ RP+ ++ E L
Sbjct: 404 KMDAPDGCPPAVYDVM----KNCWHLDAATRPTFLQLREQLEH 442
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 62/268 (23%), Positives = 100/268 (37%), Gaps = 39/268 (14%)
Query: 352 EKLGTGGYGNVYKG-KFPDGRLVAVKVLEK---TSNFSDNFINEVATIGRI-HHVNIIHL 406
+LG G YG V+K DGRL AVK + EV + ++ H + L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
+G L E SL +L A++ A+ +LH
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWGASLP--EAQVWGYLRDTLLALAHLH---SQ 176
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
++HLD+KP N+ L P K+ DFGL + G Y+APE+ G
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPELLQ---G 230
Query: 527 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW--IYDKLIQPEKEDFV 584
+ +DV+S G+ +LE+ + P W + + PE +
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL--PH-----------GGEGWQQLRQGYLPPEFTAGL 277
Query: 585 EEEDDCIARKMIIVGLWCIQINPKDRPS 612
E R ++ + ++ +PK R +
Sbjct: 278 SSE----LRSVL---VMMLEPDPKLRAT 298
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 80/283 (28%), Positives = 128/283 (45%), Gaps = 41/283 (14%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRL-VAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
K KLG G YG VY+G + L VAVK L++ + + F+ E A + I H N++ LLG
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
C +I E+M G+L D L RE + LL +A ++ A+EYL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 132
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
+H D+ +N L+ + KV+DFGL++ + + + G + I + APE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESL--AYNKF 189
Query: 529 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE- 587
S KSDV+++G+LL E+ T P Y + + + +E++
Sbjct: 190 SIKSDVWAFGVLLWEIA-----------------TYGMSP---YPGIDLSQVYELLEKDY 229
Query: 588 -----DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+ C + M C Q NP DRPS + + +
Sbjct: 230 RMERPEGCPEKVYELM----RACWQWNPSDRPSFAEIHQAFET 268
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 67/285 (23%), Positives = 118/285 (41%), Gaps = 47/285 (16%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
F ++LGTG +G V GK+ VA+K++++ S D FI E + + H ++ L G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
C +I EYM NG L + L + + +LLE+ V A+EYL + L
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 142
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT---IGYIAPEIFMRNLG 526
H D+ +N L++ KVSDFGL++ + T G+ + + PE+
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EYTSSVGSKFPVRWSPPEVL--MYS 196
Query: 527 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586
S KSD++++G+L+ E+ + P Y++ E + + +
Sbjct: 197 KFSSKSDIWAFGVLMWEIY-----------------SLGKMP---YERFTNSETAEHIAQ 236
Query: 587 E------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+ M C +RP+ ++ +
Sbjct: 237 GLRLYRPHLASEKVYTIM----YSCWHEKADERPTFKILLSNILD 277
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 67/331 (20%), Positives = 127/331 (38%), Gaps = 41/331 (12%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRI--HHVNIIHL 406
+++G+GG V++ ++ A+K + D++ NE+A + ++ H II L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
+ ++ E N L L ++K+++ + + A+ +H +
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKS--YWKNMLEAVHTIH---QH 127
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
I+H D+KP N L+ D K+ DFG+A + + V GT+ Y+ PE
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 527 NPSG---------KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 577
+ KSDV+S G +L M K T N I D +
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK-----TPFQQIINQISKLHA--IIDPNHE 239
Query: 578 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA--SAEAIEMPPKPL 635
E D E++ + ++ C++ +PK R S+ E+L+ + +
Sbjct: 240 IEFPDIPEKD----LQDVL---KCCLKRDPKQRISIP---ELLAHPYVQIQTHPVNQMAK 289
Query: 636 FPSPPQLQTQNEIISFDSITSELPLQHDSQE 666
+ +++ +S S L E
Sbjct: 290 GTTEEMKYVLGQLVGLNSPNSILKAAKTLYE 320
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 60/279 (21%), Positives = 113/279 (40%), Gaps = 42/279 (15%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRI--HHVNIIHL 406
+++G+GG V++ ++ A+K + D++ NE+A + ++ H II L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
+ ++ E N L L ++K+++ + + A+ +H +
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKS--YWKNMLEAVHTIH---QH 146
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
I+H D+KP N L+ D K+ DFG+A + + V GT+ Y+ PE
Sbjct: 147 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 527 NPSG---------KSDVYSYGMLLLEMIEEK---KHLRPTETTSGSNTTEAYFPDWIYDK 574
+ KSDV+S G +L M K + + N I D
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--------INQISKLHA--IIDP 255
Query: 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSM 613
+ E D E++ + ++ C++ +PK R S+
Sbjct: 256 NHEIEFPDIPEKD----LQDVL---KCCLKRDPKQRISI 287
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-35
Identities = 69/315 (21%), Positives = 121/315 (38%), Gaps = 52/315 (16%)
Query: 331 RSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFIN 390
R A + N+ +K + ++ LG G G V GR VAVK + +F D +
Sbjct: 2 RIANIPNFE-QSLKNLVV-SEKILGYGSSGTVVFQGSFQGRPVAVKRMLI--DFCDIALM 57
Query: 391 EVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR----EKENLSLKPAR 445
E+ + H N+I + E N +L DL+ ++ K
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 116
Query: 446 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-------------PDFTPKVSDFG 492
+ + +A + +LH L+I+H D+KPQN+L+ + +SDFG
Sbjct: 117 PISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 493 LAKAHSRNRS--VVTMTGPRGTIGYIAPEIFMRNLGNPSGKS-----DVYSYGMLLLEMI 545
L K +S + P GT G+ APE+ + + + D++S G + ++
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 546 EEKKHLRPTETTSGSNTTEAYF----PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLW 601
+ KH + + SN F ++D+ + E D +
Sbjct: 234 SKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS---------------Q 278
Query: 602 CIQINPKDRPSMTRV 616
I +P RP+ +V
Sbjct: 279 MIDHDPLKRPTAMKV 293
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 73/311 (23%), Positives = 127/311 (40%), Gaps = 49/311 (15%)
Query: 350 FKEKLGTGGYGNVYKGKF--PDGRL---VAVKVL--EKTSNFSDNFINEVATIGRIHHVN 402
+ LG+G +G VYKG + ++ VA+K L + + ++E + + + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
+ LLG C ST LI + MP G L D + K+N+ + LL + +A + YL
Sbjct: 79 VCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQIAKGMNYLE- 134
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
+ R++H D+ +NVL+ K++DFGLAK G + I ++A E
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI- 191
Query: 523 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW----IYDKLIQP 578
+ +SDV+SYG+ + E++ T G + I L +
Sbjct: 192 -LHRIYTHQSDVWSYGVTVWELM-----------TFG----SKPYDGIPASEISSILEKG 235
Query: 579 EKEDFVEEEDDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLS-----SASAEAIEM 630
E+ + + C + M + C I+ RP ++ S I+
Sbjct: 236 ER---LPQPPICTIDVYMIM----VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 288
Query: 631 PPKPLFPSPPQ 641
+ PSP
Sbjct: 289 DERMHLPSPTD 299
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 64/297 (21%), Positives = 119/297 (40%), Gaps = 60/297 (20%)
Query: 350 FKEKLGTGGYGNVYKGKF--------PDGRLVAVKVL-EKTSNFSDNFINEVATIGRIHH 400
F E LG G + ++KG V +KVL + N+S++F + + ++ H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 401 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 460
+++ G C G L+ E++ GSL L + K +++ LE+A +A A+ +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL--WKLEVAKQLAAAMHFL 129
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTP--------KVSDFGLAKAHSRNRSVVTMTGPRGT 512
E ++H ++ +N+LL + K+SD G++ +V+ +
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS------ITVLPKDILQER 180
Query: 513 IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 572
I ++ PE N N + +D +S+G L E+ + P
Sbjct: 181 IPWVPPECIE-NPKNLNLATDKWSFGTTLWEIC-----------------SGGDKP---L 219
Query: 573 DKLIQPEKEDFVEE-------EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
L K F E+ + +A + C+ P RPS ++ L+S
Sbjct: 220 SALDSQRKLQFYEDRHQLPAPKAAELANLI----NNCMDYEPDHRPSFRAIIRDLNS 272
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 71/297 (23%), Positives = 115/297 (38%), Gaps = 48/297 (16%)
Query: 350 FKEKLGTGGYGNVYKGKF-----PDGRLVAVKVL--EKTSNFSDNFINEVATIGRIHHVN 402
LG G +G V + G +VAVK L + + E+ + ++H +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 403 IIHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 460
II G C D + L+ EY+P GSL D L R + A+LL A + + YL
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYL 150
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IGYIAPE 519
H +H D+ +NVLLD D K+ DFGLAKA + + + + APE
Sbjct: 151 H---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 520 -----IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 574
F SDV+S+G+ L E++ H +++ +
Sbjct: 208 CLKEYKF-------YYASDVWSFGVTLYELL---THCDSSQSPPTKFLELIGIA---QGQ 254
Query: 575 LIQPEKEDFVEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+ + +E D C + M C + RP+ ++ +L +
Sbjct: 255 MTVLRLTELLERGERLPRPDKCPAEVYHLM----KNCWETEASFRPTFENLIPILKT 307
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 62/305 (20%), Positives = 114/305 (37%), Gaps = 47/305 (15%)
Query: 350 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFS--DNFINEVATIGRIHHVNIIHL 406
+ LG G NV++G+ G L A+KV S D + E + +++H NI+ L
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 407 LGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
+ +TR LI E+ P GSL +L L + L + V + +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--- 129
Query: 465 ELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 520
E I+H +IKP N++ D K++DFG A+ + V++ GT Y+ P++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGTEEYLHPDM 186
Query: 521 FMRNLGNPSG------KSDVYSYGMLL-------------------LEMIEEKKHLRPTE 555
+ R + D++S G+ E++ + +P+
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 556 TTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR 615
SG E DW D + ++ + + ++ + + +
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI-------LEADQEKCWGFDQ 299
Query: 616 VVEML 620
Sbjct: 300 FFAET 304
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 74/353 (20%), Positives = 137/353 (38%), Gaps = 42/353 (11%)
Query: 330 YRSALLSNYSYNDIKKMTN-GFKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEK---TSNF 384
+ S + + M +K+G G +G K DGR +K + +S
Sbjct: 7 HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66
Query: 385 SDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPA 444
+ EVA + + H NI+ + + ++ +Y G L ++ +K L +
Sbjct: 67 REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-FQED 125
Query: 445 RLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504
++L+ + + A++++H + +ILH DIK QN+ L D T ++ DFG+A+ + +
Sbjct: 126 QILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182
Query: 505 -TMTGPRGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT 562
GT Y++PEI P + KSD+++ G +L E+ L+ +
Sbjct: 183 RACI---GTPYYLSPEICE---NKPYNNKSDIWALGCVLYELCT----LKHAFE--AGSM 230
Query: 563 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS---------M 613
I P + + R ++ + NP+DRPS +
Sbjct: 231 KNLVLK--IISGSFPPVSLHYSYD-----LRSLV---SQLFKRNPRDRPSVNSILEKGFI 280
Query: 614 TRVVEMLSSASAEAIEMPPKPLFPSPPQLQTQNEIISFDSITSELPLQHDSQE 666
+ +E S A E K Q S + S +P Q ++
Sbjct: 281 AKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKP 333
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 77/325 (23%), Positives = 136/325 (41%), Gaps = 51/325 (15%)
Query: 350 FKEKLGTGGYGNVYKG--KFPDGR--LVAVKVL--EKTSNFSDNFINEVATIGRIHHVNI 403
+ +G G +G V G K P + VA+K L T +F+ E + +G+ H NI
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 404 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 463
I L G ++ EYM NGSL L R+ + +L+ + G+A ++YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDA-QFTVIQLVGMLRGIASGMKYLS-- 164
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEIFM 522
++ +H D+ +N+L++ + KVSDFGL + + T G + I + +PE
Sbjct: 165 -DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI- 222
Query: 523 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582
+ SDV+SYG++L E++ + P Y ++ +
Sbjct: 223 -AYRKFTSASDVWSYGIVLWEVM-----------------SYGERP---YWEMSNQDVIK 261
Query: 583 FVEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLS----SASAEAIE 629
V+E DC + + M L C Q + +RP ++V +L + + I
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLM----LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 317
Query: 630 MPPKPLFPSPPQLQTQNEIISFDSI 654
+ Q+ +I +F +
Sbjct: 318 TSAAARPSNLLLDQSNVDITTFRTT 342
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
+ +G G +G+V G + G VAVK + K + F+ E + + ++ H N++ LLG
Sbjct: 25 LLQTIGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 410 CCDGSTRALI-YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+ I EYM GSL D L R + L LL+ +L V A+EYL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 138
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
+H D+ +NVL+ D KVSDFGL K S + + + + APE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEAL--REKKF 191
Query: 529 SGKSDVYSYGMLLLEMI 545
S KSDV+S+G+LL E+
Sbjct: 192 STKSDVWSFGILLWEIY 208
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 62/307 (20%), Positives = 112/307 (36%), Gaps = 47/307 (15%)
Query: 350 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFS--DNFINEVATIGRIHHVNIIHL 406
+ LG G NV++G+ G L A+KV S D + E + +++H NI+ L
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 407 LGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
+ +TR LI E+ P GSL +L L + L + V + +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--- 129
Query: 465 ELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 520
E I+H +IKP N++ D K++DFG A+ + V++ GT Y+ P++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYLHPDM 186
Query: 521 FMRNLGNPSG------KSDVYSYGMLLLEMI-------------------EEKKHLRPTE 555
+ R + D++S G+ + +P+
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 556 TTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR 615
SG E DW D + ++ + + ++ + + +
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI-------LEADQEKCWGFDQ 299
Query: 616 VVEMLSS 622
S
Sbjct: 300 FFAETSD 306
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 351 KEKLGTGGYGNVYKG--KFPDGRL-VAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIH 405
+LG G +G+V +G + ++ VA+KVL ++ + E + ++ + I+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
L+G C L+ E G L L ++E + + + E+ V+ ++YL E
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYL---EE 128
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT-GPRGTIGYIAPEIFMRN 524
+H D+ +NVLL K+SDFGL+KA + S T + + + APE N
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--N 186
Query: 525 LGNPSGKSDVYSYGMLLLEMI 545
S +SDV+SYG+ + E +
Sbjct: 187 FRKFSSRSDVWSYGVTMWEAL 207
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 59/304 (19%), Positives = 111/304 (36%), Gaps = 38/304 (12%)
Query: 350 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNIIHLL 407
F +KLG GG+ V + DG A+K + + E +H NI+ L+
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 408 GFCCDGSTRA----LIYEYMPNGSLGDLL-SREKENLSLKPARLLEIALGVAHAIEYLHN 462
+C L+ + G+L + + + + L ++L + LG+ +E +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH- 151
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-------AHSRNRSVVTMTGPRGTIGY 515
H D+KP N+LL + P + D G + ++ R TI Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 516 IAPEIFMRNLGNPSG-KSDVYSYGMLLLEMIEEKKHLRP---TETTSGSNTTEAYFPDWI 571
APE+F ++DV+S G +L M+ G + A +
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMM----FGEGPYDMVFQKGDSVALA-----V 260
Query: 572 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMP 631
++L P+ +++ + ++P RP + ++ L + A
Sbjct: 261 QNQLSIPQSPRHSSA-----LWQLLN---SMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312
Query: 632 PKPL 635
+
Sbjct: 313 TTQI 316
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 59/270 (21%), Positives = 97/270 (35%), Gaps = 37/270 (13%)
Query: 351 KEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
+ ++G G +G V++ K G AVK + + E+ + I+ L G
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPRIVPLYGA 118
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSR---EKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
+G + E + GSLG L+ + E+ +L + G+ EYLH
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG--QALEGL----EYLH---TR 169
Query: 467 RILHLDIKPQNVLLDPDFTP-KVSDFGLAKAHSRNRSVVTMTGP---RGTIGYIAPEIFM 522
RILH D+K NVLL D + + DFG A + ++ GT ++APE+ M
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 523 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582
K D++S ++L M+ P + I+
Sbjct: 230 GK--PCDAKVDIWSSCCMMLHMLNGC---HP---WTQYFRGPLCLKIASEPPPIREIPPS 281
Query: 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
I ++ P R S
Sbjct: 282 CAPLTAQAIQE--------GLRKEPVHRAS 303
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 64/334 (19%), Positives = 126/334 (37%), Gaps = 47/334 (14%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHH--VNIIHL 406
+++G+GG V++ ++ A+K + D++ NE+A + ++ II L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
+ ++ E N L L ++K+++ + + A+ +H +
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKS--YWKNMLEAVHTIH---QH 174
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
I+H D+KP N L+ D K+ DFG+A + + V G + Y+ PE
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 527 NPSG---------KSDVYSYGMLLLEMIEEK---KHLRPTETTSGSNTTEAYFPDWIYDK 574
+ KSDV+S G +L M K + + N I D
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI--------INQISKLHA--IIDP 283
Query: 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA--SAEAIEMPP 632
+ E D E++ + ++ C++ +PK R S+ E+L+ + +
Sbjct: 284 NHEIEFPDIPEKD----LQDVL---KCCLKRDPKQRISIP---ELLAHPYVQIQTHPVNQ 333
Query: 633 KPLFPSPPQLQTQNEIISFDSITSELPLQHDSQE 666
+ +++ +S S L E
Sbjct: 334 MAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYE 367
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 77/314 (24%), Positives = 130/314 (41%), Gaps = 54/314 (17%)
Query: 350 FKEKLGTGGYGNVYKG--KFPDGR---LVAVKVL--EKTSNFSDNFINEVATIGRIHHVN 402
++ +G G +G VYKG K G+ VA+K L T +F+ E +G+ H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
II L G +I EYM NG+L L + S+ +L+ + G+A ++YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL--QLVGMLRGIAAGMKYLA- 164
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEIF 521
+ +H D+ +N+L++ + KVSDFGL++ + T +G + I + APE
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 522 MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581
+ + SDV+S+G+++ E++ T P Y +L E
Sbjct: 223 --SYRKFTSASDVWSFGIVMWEVM-----------------TYGERP---YWELSNHEVM 260
Query: 582 DFVEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLS------SASAE 626
+ + DC I + M + C Q RP +V +L +
Sbjct: 261 KAINDGFRLPTPMDCPSAIYQLM----MQCWQQERARRPKFADIVSILDKLIRAPDSLKT 316
Query: 627 AIEMPPKPLFPSPP 640
+ P+ P
Sbjct: 317 LADFDPRVSIRLPS 330
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 79/299 (26%), Positives = 117/299 (39%), Gaps = 51/299 (17%)
Query: 350 FKEKLGTGGYGNVYKG--KFPDGRL--VAVKVL----EKTSNFSDNFINEVATIGRIHHV 401
EKLG G +G V +G P G+ VAVK L D+FI EV + + H
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
N+I L G ++ E P GSL D L + + + L L A+ VA + YL
Sbjct: 82 NLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLE 138
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT-GPRGTIGYIAPEI 520
R +H D+ +N+LL K+ DFGL +A +N M + + APE
Sbjct: 139 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580
S SD + +G+ L EM T G P + L +
Sbjct: 196 L--KTRTFSHASDTWMFGVTLWEMF-----------TYGQE------P---WIGLNGSQI 233
Query: 581 EDFVEEE-------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIE 629
+++E +DC I M + C P+DRP+ + + L A +
Sbjct: 234 LHKIDKEGERLPRPEDCPQDIYNVM----VQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 350 FKEKLGTGGYGNVYKG--KFPDGR--LVAVKVL--EKTSNFSDNFINEVATIGRIHHVNI 403
++ +G+G G V G + P R VA+K L T +F++E + +G+ H NI
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 404 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 463
I L G G ++ EYM NGSL L ++ +L+ + GV + YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM--QLVGMLRGVGAGMRYLS-- 168
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEIFM 522
+L +H D+ +NVL+D + KVSDFGL++ + T TG + I + APE
Sbjct: 169 -DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI- 226
Query: 523 RNLGNPSGKSDVYSYGMLLLEMI 545
S SDV+S+G+++ E++
Sbjct: 227 -AFRTFSSASDVWSFGVVMWEVL 248
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 64/279 (22%), Positives = 111/279 (39%), Gaps = 33/279 (11%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLL 407
+GTG YG K + DG+++ K L+ T ++EV + + H NI+
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 408 GFCCDGSTRAL--IYEYMPNGSLGDLLSREKENLSLKP-ARLLEIALGVAHAIEYLH--N 462
D + L + EY G L ++++ + +L + + A++ H +
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV-TMTGPRGTIGYIAPEIF 521
+LH D+KP NV LD K+ DFGLA+ + + S T GT Y++PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV---GTPYYMSPEQM 188
Query: 522 MRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580
+ KSD++S G LL E+ P S I + +
Sbjct: 189 N---RMSYNEKSDIWSLGCLLYELCALM---PPFTAFSQKELAGK-----IREGKFRRIP 237
Query: 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619
+ +E ++I + + RPS+ ++E
Sbjct: 238 YRYSDE-----LNEII---TRMLNLKDYHRPSVEEILEN 268
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 62/288 (21%), Positives = 114/288 (39%), Gaps = 48/288 (16%)
Query: 350 FKEKLGTGGYGNVYKG--KFPDGR--LVAVKVL--EKTSNFSDNFINEVATIGRIHHVNI 403
+G G +G+V++G P+ VA+K + + + F+ E T+ + H +I
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 404 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 463
+ L+G + +I E G L L K +L L L+ A ++ A+ YL
Sbjct: 79 VKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE-- 133
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
R +H DI +NVL+ + K+ DFGL++ + + + + I ++APE
Sbjct: 134 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESI-- 189
Query: 524 NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583
N + SDV+ +G+ + E++ P + + +
Sbjct: 190 NFRRFTSASDVWMFGVCMWEIL-----------------MHGVKP---FQGVKNNDVIGR 229
Query: 584 VEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+E +C + M C +P RP T + LS+
Sbjct: 230 IENGERLPMPPNCPPTLYSLM----TKCWAYDPSRRPRFTELKAQLST 273
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 53/298 (17%)
Query: 331 RSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPD-GRLVAVK-VLEKTSNFSDNF 388
L +Y Y++ + LG G YG VY G+ +A+K + E+ S +S
Sbjct: 12 SDLLEYDYEYDENGD-----RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL 66
Query: 389 INEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE 448
E+A + H NI+ LG + + E +P GSL LL + L +
Sbjct: 67 HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF 126
Query: 449 IALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAK----AHSRNRSV 503
+ ++YLH + +I+H DIK NVL++ K+SDFG +K + +
Sbjct: 127 YTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF 183
Query: 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP----TETTS- 558
GT+ Y+APEI + +D++S G ++EM K P E +
Sbjct: 184 T------GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK---PPFYELGEPQAA 234
Query: 559 ----GSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
G P+ + E + F+ + C + +P R
Sbjct: 235 MFKVGMFKVHPEIPES-----MSAEAKAFILK---------------CFEPDPDKRAC 272
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 57/249 (22%), Positives = 99/249 (39%), Gaps = 32/249 (12%)
Query: 322 NVKQFIKTYRSALLSNYSYNDIKKMTNGFK--EKLGTGGYGNVYKGKFPDGRLVAVKVLE 379
++K + Y + + N + K N ++ L G + + + D + A+K E
Sbjct: 5 SMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYE 63
Query: 380 KT------------------SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421
K+ + D+F NE+ I I + + G + +IYE
Sbjct: 64 KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYE 123
Query: 422 YMPNGSLGDLLSREKENLSLKPARLLE-----IALGVAHAIEYLHNGCELRILHLDIKPQ 476
YM N S+ + I V ++ Y+HN E I H D+KP
Sbjct: 124 YMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPS 181
Query: 477 NVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYS 536
N+L+D + K+SDFG ++ + ++ + RGT ++ PE F K D++S
Sbjct: 182 NILMDKNGRVKLSDFGESE-YMVDKKIKGS---RGTYEFMPPEFFSNESSYNGAKVDIWS 237
Query: 537 YGMLLLEMI 545
G+ L M
Sbjct: 238 LGICLYVMF 246
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 350 FKEKLGTGGYGNVYKG--KFPDGR--LVAVKVLEKTSNFSD--NFINEVATIGRIHHVNI 403
F E +G G +G VY G DG+ AVK L + ++ + F+ E + H N+
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 404 IHLLGFCCDGSTRAL-IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
+ LLG C L + YM +G L + + E N ++K L+ L VA ++YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYLA- 145
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR--SVVTMTGPRGTIGYIAPE- 519
+ +H D+ +N +LD FT KV+DFGLA+ SV TG + + ++A E
Sbjct: 146 --SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 520 ----IFMRNLGNPSGKSDVYSYGMLLLEMI 545
F + KSDV+S+G+LL E++
Sbjct: 204 LQTQKF-------TTKSDVWSFGVLLWELM 226
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 59/286 (20%), Positives = 106/286 (37%), Gaps = 54/286 (18%)
Query: 352 EKLGTGGYGNVYKG-KFPDGRLVAVKVLEK---TSNFSDNFINEVATIGRI-HHVNIIHL 406
EK+G+G +G+V+K K DG + A+K +K S N + EV + H +++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLS-REKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
+ + EY GSL D +S + K A L ++ L V + Y+H
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133
Query: 466 LRILHLDIKPQNVLLDPD-------------------FTPKVSDFGLAKAHSRNRSVVTM 506
+ ++H+DIKP N+ + K+ D G S +
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-- 191
Query: 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAY 566
G ++A E+ N + K+D+++ + ++ + L P +
Sbjct: 192 ----GDSRFLANEVLQENYTH-LPKADIFALALTVVCAA-GAEPL-PRNGDQWHEIRQGR 244
Query: 567 FPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
P I L E + ++ I +P+ RPS
Sbjct: 245 LPR-IPQVL-SQEFTELLK---------------VMIHPDPERRPS 273
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 71/276 (25%), Positives = 118/276 (42%), Gaps = 46/276 (16%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLG 408
LG G +GNVY + ++A+KVL K + EV + H NI+ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+ D + LI EY P G++ L + + + +A+A+ Y H R+
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTAT--YITELANALSYCH---SKRV 130
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
+H DIKP+N+LL K++DFG + H+ + + GT+ Y+ PE+ + +
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLC---GTLDYLPPEMIEGRMHDE 186
Query: 529 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT------TEAYFPDWIYDKLIQPEKED 582
K D++S G+L E + K P E + T E FPD+ + D
Sbjct: 187 --KVDLWSLGVLCYEFLVGKP---PFEANTYQETYKRISRVEFTFPDF-----VTEGARD 236
Query: 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ ++ ++ NP RP + V+E
Sbjct: 237 LI--------SRL-------LKHNPSQRPMLREVLE 257
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 353 KLGTGGYGNVYKGKFPDGRL---VAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHL 406
+LG+G +G V KG + ++ VAVK+L+ + D + E + ++ + I+ +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
+G C + + L+ E G L L ++N +K ++E+ V+ ++YL E
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLE---ES 136
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG----PRGTIGYIAPEIFM 522
+H D+ +NVLL K+SDFGL+KA + + P + + APE
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP---VKWYAPECI- 192
Query: 523 RNLGNPSGKSDVYSYGMLLLEMI 545
N S KSDV+S+G+L+ E
Sbjct: 193 -NYYKFSSKSDVWSFGVLMWEAF 214
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 68/310 (21%), Positives = 121/310 (39%), Gaps = 64/310 (20%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGR----LVAVKVLEKTSNFSD--NFINEVATIGRIHHVNI 403
+G G +G VY G++ D A+K L + + F+ E + ++H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 404 IHLLGFCCDGSTRALI-YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
+ L+G + YM +G L + + N ++K L+ L VA +EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVK--DLISFGLQVARGMEYLA- 141
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT--IGYIAPE- 519
E + +H D+ +N +LD FT KV+DFGLA+ + + A E
Sbjct: 142 --EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 520 ----IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575
F + KSDV+S+G+LL E++ T P Y +
Sbjct: 200 LQTYRF-------TTKSDVWSFGVLLWELL-----------------TRGAPP---YRHI 232
Query: 576 IQPEKEDFVEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEML-----S 621
+ F+ + + C + + M C + +P RP+ +V + +
Sbjct: 233 DPFDLTHFLAQGRRLPQPEYCPDSLYQVM----QQCWEADPAVRPTFRVLVGEVEQIVSA 288
Query: 622 SASAEAIEMP 631
+++P
Sbjct: 289 LLGDHYVQLP 298
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 77/308 (25%), Positives = 126/308 (40%), Gaps = 54/308 (17%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIH 405
LG G +G V K K + AVKV+ K + + + EV + ++ H NI+
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNG 463
L D S+ ++ E G G+L +++ S A I V I Y+H
Sbjct: 86 LFEILEDSSSFYIVGELY-TG--GELFDEIIKRKRFSEHDAA--RIIKQVFSGITYMH-- 138
Query: 464 CELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 520
+ I+H D+KP+N+LL + D K+ DFGL+ +N M GT YIAPE+
Sbjct: 139 -KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEV 194
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW------IYDK 574
K DV+S G++L ++ SG P + I +
Sbjct: 195 LRGTYDE---KCDVWSAGVILYILL------------SG------TPPFYGKNEYDILKR 233
Query: 575 LIQPEKEDFVEEEDDCIAR--KMIIVGLWCIQINPKDRPSMTRVVEM--LSSASAEAIEM 630
++ K F + I+ K +I + + +P R + T+ +E + S+E +
Sbjct: 234 -VETGKYAFDLPQWRTISDDAKDLIRKM--LTFHPSLRITATQCLEHPWIQKYSSETPTI 290
Query: 631 PPKPLFPS 638
P S
Sbjct: 291 SDLPSLES 298
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 350 FKEKLGTGGYGNVYKG--KFPDGR--LVAVKVLEKTSNFSD--NFINEVATIGRIHHVNI 403
F E +G G +G VY G DG+ AVK L + ++ + F+ E + H N+
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 404 IHLLGFCCDGST-RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
+ LLG C ++ YM +G L + + E N ++K L+ L VA +++L
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFLA- 209
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK--AHSRNRSVVTMTGPRGTIGYIAPE- 519
+ +H D+ +N +LD FT KV+DFGLA+ SV TG + + ++A E
Sbjct: 210 --SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 520 ----IFMRNLGNPSGKSDVYSYGMLLLEMI 545
F + KSDV+S+G+LL E++
Sbjct: 268 LQTQKF-------TTKSDVWSFGVLLWELM 290
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 74/314 (23%), Positives = 118/314 (37%), Gaps = 56/314 (17%)
Query: 318 GDGLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVK 376
G G + + +S + LG G +G V K G+ AVK
Sbjct: 1 GPGSMMDHL--HATPGMFVQHSTAIFSDRYK-GQRVLGKGSFGEVILCKDKITGQECAVK 57
Query: 377 VLEK----TSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL 432
V+ K ++ + EV + ++ H NI+ L F D L+ E G G+L
Sbjct: 58 VISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY-TG--GELF 114
Query: 433 SR--EKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPK 487
++ S A I V I Y+H + +I+H D+KP+N+LL D +
Sbjct: 115 DEIISRKRFSEVDAA--RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIR 169
Query: 488 VSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEE 547
+ DFGL+ ++ M GT YIAPE+ K DV+S G++L ++
Sbjct: 170 IIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHGTYDE---KCDVWSTGVILYILL-- 221
Query: 548 KKHLRPTETTSGSNTTEAYFPDW------IYDKLIQPEKEDFVEEEDDCIAR--KMIIVG 599
SG P I K ++ K F + ++ K +I
Sbjct: 222 ----------SG------CPPFNGANEYDILKK-VEKGKYTFELPQWKKVSESAKDLIRK 264
Query: 600 LWCIQINPKDRPSM 613
+ + P R S
Sbjct: 265 M--LTYVPSMRISA 276
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 67/291 (23%), Positives = 113/291 (38%), Gaps = 54/291 (18%)
Query: 350 FKEKLGTGGYGNVYKGKF--PDGR--LVAVKVLEKTSNFS--DNFINEVATIGRIHHVNI 403
LG G +G VY+G + G VAVK +K + F++E + + H +I
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 404 IHLLGFCCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 460
+ L+G + E P G LG L R K +L + L+ +L + A+ YL
Sbjct: 76 VKLIGII----EEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQICKAMAYL 129
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 520
+ +H DI +N+L+ K+ DFGL++ + R I +++PE
Sbjct: 130 E---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPES 185
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580
N + SDV+ + + + E++ + P + L +
Sbjct: 186 I--NFRRFTTASDVWMFAVCMWEIL-----------------SFGKQP---FFWLENKDV 223
Query: 581 EDFVEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+E+ D C + M C +P DRP T +V LS
Sbjct: 224 IGVLEKGDRLPKPDLCPPVLYTLM----TRCWDYDPSDRPRFTELVCSLSD 270
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 82/323 (25%), Positives = 126/323 (39%), Gaps = 64/323 (19%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGR------LVAVKVLEKTSNFSD--NFINEVATIGRIHHV 401
LG G +G VY+G+ VAVK L + + D +F+ E I + +H
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLL----SREKENLSLKPARLLEIALGVAHAI 457
NI+ +G R ++ E M G L L R + SL LL +A +A
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 458 EYLHNGCELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSRN--RSVVTMTGPRGT 512
+YL E +H DI +N LL P K+ DFG+A R+ R+ G
Sbjct: 154 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----RDIYRASYYRKGGCAM 206
Query: 513 --IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW 570
+ ++ PE FM G + K+D +S+G+LL E+ + Y P
Sbjct: 207 LPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIF-----------------SLGYMP-- 245
Query: 571 IYDKLIQPEKEDFVEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621
Y E +FV +C + R M C Q P+DRP+ ++E +
Sbjct: 246 -YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIM----TQCWQHQPEDRPNFAIILERIE 300
Query: 622 --SASAEAIEMP-PKPLFPSPPQ 641
+ + I P P +
Sbjct: 301 YCTQDPDVINTALPIEYGPLVEE 323
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 71/324 (21%), Positives = 115/324 (35%), Gaps = 53/324 (16%)
Query: 351 KEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFI-NEVATIGRI-HHVNIIHLL 407
+ L GG+ VY+ + GR A+K L + I EV + ++ H NI+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 408 GFCC-------DGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 460
G L+ + G L + L + + L +L+I A++++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR---------- 510
H + I+H D+K +N+LL T K+ DFG A S R
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 511 GTIGYIAPEIFMRNLGNPSG-KSDVYSYGMLLLEMI------EEKKHLRPTETTSGSNTT 563
T Y PEI P G K D+++ G +L + E+ LR +G +
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---IVNGKYS- 267
Query: 564 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623
P + F +I +Q+NP++R S+ VV L
Sbjct: 268 ---IPPH------DTQYTVF---------HSLIR---AMLQVNPEERLSIAEVVHQLQEI 306
Query: 624 SAEAIEMPPKPLFPSPPQLQTQNE 647
+A P P+ Q
Sbjct: 307 AAARNVNPKSPITELLEQNGGYGS 330
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 4e-31
Identities = 62/288 (21%), Positives = 114/288 (39%), Gaps = 48/288 (16%)
Query: 350 FKEKLGTGGYGNVYKG--KFPDGR--LVAVKVL--EKTSNFSDNFINEVATIGRIHHVNI 403
+G G +G+V++G P+ VA+K + + + F+ E T+ + H +I
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 404 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 463
+ L+G + +I E G L L K +L L L+ A ++ A+ YL
Sbjct: 454 VKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLA--SLILYAYQLSTALAYLE-- 508
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
R +H DI +NVL+ + K+ DFGL++ + + + + I ++APE
Sbjct: 509 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESI-- 564
Query: 524 NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583
N + SDV+ +G+ + E++ P + + +
Sbjct: 565 NFRRFTSASDVWMFGVCMWEIL-----------------MHGVKP---FQGVKNNDVIGR 604
Query: 584 VEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+E +C + M C +P RP T + LS+
Sbjct: 605 IENGERLPMPPNCPPTLYSLM----TKCWAYDPSRRPRFTELKAQLST 648
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-31
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 351 KEKLGTGGYGNVYKG--KFPDGRL-VAVKVL--EKTSNFSDNFINEVATIGRIHHVNIIH 405
+LG G +G+V +G + ++ VA+KVL ++ + E + ++ + I+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
L+G C L+ E G L L ++E + + + E+ V+ ++YL E
Sbjct: 401 LIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYL---EE 454
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT-GPRGTIGYIAPEIFMRN 524
+H ++ +NVLL K+SDFGL+KA + S T + + + APE N
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--N 512
Query: 525 LGNPSGKSDVYSYGMLLLEMI 545
S +SDV+SYG+ + E +
Sbjct: 513 FRKFSSRSDVWSYGVTMWEAL 533
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 68/307 (22%), Positives = 117/307 (38%), Gaps = 56/307 (18%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLG 408
LG GG+ ++ + A K++ K+ + + E++ + H +++ G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
F D ++ E SL +L R K L+ AR + +YLH R+
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEPEAR--YYLRQIVLGCQYLHR---NRV 136
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLA-KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
+H D+K N+ L+ D K+ DFGLA K + GT YIAPE+ +
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKG-- 191
Query: 528 PSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT------TEAYFPDWIYDKLIQPEKE 581
S + DV+S G ++ ++ K P ET+ T E P I
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKP---PFETSCLKETYLRIKKNEYSIPKHINPV------- 241
Query: 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE--------MLSSASAEAIEMPPK 633
A +I +Q +P RP++ ++ + + + +PP+
Sbjct: 242 ----------AASLIQ---KMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPR 288
Query: 634 PLFPSPP 640
F P
Sbjct: 289 --FSIAP 293
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 70/314 (22%), Positives = 118/314 (37%), Gaps = 87/314 (27%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGR------LVAVKVL-EKTSNFSDNFINEVATIGRIHHVN 402
K +LG G +G V+ + + LVAVK L E + + +F E + + H +
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLL------------SREKENLSLKPARLLEIA 450
I+ G C +G +++EYM +G L L + L +LL +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 451 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN--RSVVTMTG 508
VA + YL L +H D+ +N L+ K+ DFG+ SR+ + G
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGM----SRDIYSTDYYRVG 217
Query: 509 PRGT--IGYIAPEIFMRNLGNPSGKSDVYSYGMLL-------------------LEMIEE 547
R I ++ PE + + +SDV+S+G++L ++ I +
Sbjct: 218 GRTMLPIRWMPPESIL--YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275
Query: 548 KKHL-RPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQIN 606
+ L RP P +Y +++ C W Q
Sbjct: 276 GRELERPRAC-----------PPEVYA-IMR-----------GC----------W--QRE 300
Query: 607 PKDRPSMTRVVEML 620
P+ R S+ V L
Sbjct: 301 PQQRHSIKDVHARL 314
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 37/218 (16%), Positives = 72/218 (33%), Gaps = 29/218 (13%)
Query: 350 FKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTSNFSDNFI--NEVATIGRIHHV 401
LG G + VY+ D + +KV + +N + +I + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-ANPWEFYIGTQLMERLKPSMQH 127
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLS--LKPARLLEIALGVAHAIEY 459
+ + L+ E G+L + ++ K + ++ A+ + + IE
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFTP-----------KVSDFGLAKAHSRNRSVVTMTG 508
+H + I+H DIKP N +L F + D G + T
Sbjct: 188 VH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 509 PRGTIGYIAPEIFMRNLGNPSG-KSDVYSYGMLLLEMI 545
T G+ E+ P + D + + M+
Sbjct: 245 KCETSGFQCVEMLS---NKPWNYQIDYFGVAATVYCML 279
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 70/319 (21%), Positives = 116/319 (36%), Gaps = 96/319 (30%)
Query: 350 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVL-EKTSNFSDNFINEVATIGRIHHVN 402
K +LG G +G V+ D LVAVK L + T +F E + + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLL-------------SREKENLSLKPARLLEI 449
I+ G C DG +++EYM +G L L + L +++L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 450 ALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 509
A +A + YL +H D+ +N L+ + K+ DFG++ R V +
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMS------RDV--YSTD 187
Query: 510 ---RGTIGYI-----APEIFMRNLGNPSGKSDVYSYGMLL-------------------L 542
G + PE M + +SDV+S+G++L +
Sbjct: 188 YYRVGGHTMLPIRWMPPESIM--YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 245
Query: 543 EMIEEKKHL-RPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLW 601
E I + + L RP P +YD + M L
Sbjct: 246 ECITQGRVLERPRVC-----------PKEVYD--V------------------M----LG 270
Query: 602 CIQINPKDRPSMTRVVEML 620
C Q P+ R ++ + ++L
Sbjct: 271 CWQREPQQRLNIKEIYKIL 289
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 35/305 (11%), Positives = 68/305 (22%), Gaps = 54/305 (17%)
Query: 350 FKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEK----TSNFSDNFINEVATIGRIHHVNII 404
E L G V+ + + A+KV + + + R+ +
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125
Query: 405 HLLGFC-----------------------CDGSTRALIYEYMP--NGSLGDLLSR----E 435
D A MP + L L S
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVY 185
Query: 436 KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495
L + + L ++H P N+ + PD + D
Sbjct: 186 VFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 496 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTE 555
+ + Y E + + + + G+ + + P
Sbjct: 243 KVGTRGPASS-----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF---LPFG 294
Query: 556 TTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCI--ARKMIIVGLWCIQINPKDRPSM 613
T W L P + + K +I + + + R
Sbjct: 295 L-----VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF--LNFDRRRRLLP 347
Query: 614 TRVVE 618
+E
Sbjct: 348 LEAME 352
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 70/321 (21%), Positives = 112/321 (34%), Gaps = 95/321 (29%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGR------LVAVKVLEKTSNFSD--NFINEVATIGRIHHV 401
F E+LG +G VYKG VA+K L+ + F +E R+ H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLL-------------SREKENLSLKPARLLE 448
N++ LLG ++I+ Y +G L + L +L+P +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 449 IALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV----- 503
+ +A +EYL ++H D+ +NVL+ K+SD GL R V
Sbjct: 133 LVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLF------REVYAADY 183
Query: 504 -VTMTGPRGTIGYIAPE-IFMRNLGNPSGKSDVYSYGMLL-------------------L 542
+ I ++APE I S SD++SYG++L +
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKF---SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 240
Query: 543 EMIEEKKHL-RPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLW 601
EMI ++ L P + P W+Y +I+
Sbjct: 241 EMIRNRQVLPCPDDC-----------PAWVYALMIE------------------------ 265
Query: 602 CIQINPKDRPSMTRVVEMLSS 622
C P RP + L +
Sbjct: 266 CWNEFPSRRPRFKDIHSRLRA 286
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 46/277 (16%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLG 408
LG GG+ ++ + A K++ K+ + + E++ + H +++ G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
F D ++ E SL +L R K L+ AR + +YLH R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEPEAR--YYLRQIVLGCQYLHR---NRV 162
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLA-KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
+H D+K N+ L+ D K+ DFGLA K + GT YIAPE+ +
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGH- 218
Query: 528 PSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT------TEAYFPDWIYDKLIQPEKE 581
S + DV+S G ++ ++ K P ET+ T E P I
Sbjct: 219 -SFEVDVWSIGCIMYTLLVGKP---PFETSCLKETYLRIKKNEYSIPKHINPV------- 267
Query: 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
A +I +Q +P RP++ ++
Sbjct: 268 ----------AASLIQ---KMLQTDPTARPTINELLN 291
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 82/327 (25%), Positives = 124/327 (37%), Gaps = 72/327 (22%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGR------LVAVKVLEKTSNFSD--NFINEVATIGRIHHV 401
LG G +G VY+G+ VAVK L + + D +F+ E I + +H
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLL----SREKENLSLKPARLLEIALGVAHAI 457
NI+ +G R ++ E M G L L R + SL LL +A +A
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 458 EYLHNGCELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSRN---RSVVTMTGPRG 511
+YL E +H DI +N LL P K+ DFG+A+ R R +G
Sbjct: 195 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR--------KG 243
Query: 512 TIGYI-----APEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAY 566
+ PE FM G + K+D +S+G+LL E+ + Y
Sbjct: 244 GCAMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIF-----------------SLGY 284
Query: 567 FPDWIYDKLIQPEKEDFVEEE------DDC---IARKMIIVGLWCIQINPKDRPSMTRVV 617
P Y E +FV +C + R M C Q P+DRP+ ++
Sbjct: 285 MP---YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIM----TQCWQHQPEDRPNFAIIL 337
Query: 618 EMLS--SASAEAIEMP-PKPLFPSPPQ 641
E + + + I P P +
Sbjct: 338 ERIEYCTQDPDVINTALPIEYGPLVEE 364
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 5e-30
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 20/208 (9%)
Query: 350 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFS--DNFINEVATIGRIHHVNIIHL 406
KE+LGTGG+G V + G VA+K + + + + E+ + +++H N++
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 407 L------GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 460
L EY G L L++ + LK + + ++ A+ YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 461 HNGCELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 517
H E RI+H D+KP+N++L K+ D G AK + GT+ Y+A
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF---VGTLQYLA 191
Query: 518 PEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
PE+ + D +S+G L E I
Sbjct: 192 PELLEQKKYTV--TVDYWSFGTLAFECI 217
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 5e-30
Identities = 40/329 (12%), Positives = 86/329 (26%), Gaps = 65/329 (19%)
Query: 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINE------------------- 391
LG + G V V T N I +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 392 -------VATIGRIHHVNIIHLLGFCCDGSTRALIYEYM----PNGSLGD----LLSREK 436
+ + ++ D ++ + +L LLS
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 437 ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496
+ SL L++ L V + LH ++H ++P +++LD ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 497 HSRNRSVVTMTGPR-GTIGYIAPEIFMRNLGNP---SGKSDVYSYGMLLLEMIEEKKHLR 552
S V+ G A + +P + D ++ G+ + +
Sbjct: 261 D--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD---L 315
Query: 553 PTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
P + +E F ++ + + ++ +DR
Sbjct: 316 PNTDDAALGGSEWIFRSC----------KNIPQPVRALLEG--------FLRYPKEDRLL 357
Query: 613 MTRVVEMLSSASAEAIEMPPKPLFPSPPQ 641
+ +E PL+ + +
Sbjct: 358 PLQAMETPEYEQLRTELSAALPLYQTDGE 386
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 65/217 (29%), Positives = 109/217 (50%), Gaps = 31/217 (14%)
Query: 350 FKEKLGTGGYGNVYKGKFPDG---RLVAVKVLEKTSNFSD--NFINEVATIGRI-HHVNI 403
F++ +G G +G V K + A+K +++ ++ D +F E+ + ++ HH NI
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 404 IHLLGFCCDGSTRALIYEYMPNGSLGDLL--SREKENL-----------SLKPARLLEIA 450
I+LLG C L EY P+G+L D L SR E +L +LL A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 451 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV-VTMTGP 509
VA ++YL + + +H D+ +N+L+ ++ K++DFGL SR + V V T
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL----SRGQEVYVKKTMG 201
Query: 510 RGTIGYIAPE-IFMRNLGNPSGKSDVYSYGMLLLEMI 545
R + ++A E + + SDV+SYG+LL E++
Sbjct: 202 RLPVRWMAIESLNYSVY---TTNSDVWSYGVLLWEIV 235
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-30
Identities = 70/286 (24%), Positives = 115/286 (40%), Gaps = 62/286 (21%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIH 405
+KLG+G YG V + A+K++ K +++ + + EVA + + H NI+
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNG 463
L F D L+ E G G+L + + A I V + YLH
Sbjct: 101 LYDFFEDKRNYYLVMECY-KG--GELFDEIIHRMKFNEVDAA--VIIKQVLSGVTYLH-- 153
Query: 464 CELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 520
+ I+H D+KP+N+LL + D K+ DFGL+ + M GT YIAPE+
Sbjct: 154 -KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEV 209
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW------IYDK 574
+ K DV+S G++L ++ +G Y P I K
Sbjct: 210 LRKKYDE---KCDVWSIGVILFILL------------AG------YPPFGGQTDQEILRK 248
Query: 575 LIQPEKEDFVEEEDDCIA-------RKMIIVGLWCIQINPKDRPSM 613
++ K F E ++ ++M +Q + + R S
Sbjct: 249 -VEKGKYTFDSPEWKNVSEGAKDLIKQM-------LQFDSQRRISA 286
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 66/341 (19%), Positives = 126/341 (36%), Gaps = 96/341 (28%)
Query: 350 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHV 401
+LG G +G VY+G K VA+K + + ++ + F+NE + + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLL-------SREKENLSLKPARLLEIALGVA 454
+++ LLG G +I E M G L L + ++++++A +A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 455 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN--RSVVTMTGPRGT 512
+ YL+ + +H D+ +N ++ DFT K+ DFG+ R+ + G +G
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMT----RDIYETDYYRKGGKGL 201
Query: 513 --IGYIAPE-----IFMRNLGNPSGKSDVYSYGMLL-------------------LEMIE 546
+ +++PE +F + SDV+S+G++L L +
Sbjct: 202 LPVRWMSPESLKDGVF-------TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254
Query: 547 EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQIN 606
E L + PD +++ + C Q N
Sbjct: 255 EGGLLDKPDNC----------PDMLFELMRM------------------------CWQYN 280
Query: 607 PKDRPSMTRVVEML-----SSASAEAIEMPPKPLFPSPPQL 642
PK RPS ++ + + + P P +L
Sbjct: 281 PKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPEPEEL 321
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 68/276 (24%), Positives = 115/276 (41%), Gaps = 43/276 (15%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLG 408
LG G + VY+ + G VA+K+++K + NEV ++ H +I+ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+ D + L+ E NG + L + S AR + + YLH I
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--HFMHQIITGMLYLH---SHGI 133
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
LH D+ N+LL + K++DFGLA + T GT YI+PEI R+
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYT-LCGTPNYISPEIATRSAHGL 191
Query: 529 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT------TEAYFPDWIYDKLIQPEKED 582
+SDV+S G + ++ + P +T + NT + P + + E +D
Sbjct: 192 --ESDVWSLGCMFYTLLIGRP---PFDTDTVKNTLNKVVLADYEMPSF-----LSIEAKD 241
Query: 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ +++ NP DR S++ V++
Sbjct: 242 LI--------HQLLRR-------NPADRLSLSSVLD 262
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 17/197 (8%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLG 408
LG G +GNVY + + ++A+KVL K+ E+ + H NI+ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+ D L+ E+ P G L L + + + +A A+ Y H E ++
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSAT--FMEELADALHYCH---ERKV 135
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
+H DIKP+N+L+ K++DFG + H+ + TM GT+ Y+ PE+ +
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRTMC---GTLDYLPPEMIEGKTHDE 191
Query: 529 SGKSDVYSYGMLLLEMI 545
K D++ G+L E +
Sbjct: 192 --KVDLWCAGVLCYEFL 206
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 73/338 (21%), Positives = 122/338 (36%), Gaps = 77/338 (22%)
Query: 307 KKPFSEERQNIGDGLNVKQ--FIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYK 364
S G+ + +++ + +Y KLG+G YG V
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYF----------KVRKLGSGAYGEVLL 54
Query: 365 GKF-PDGRLVAVKVLEK--------------TSNFSDNFINEVATIGRIHHVNIIHLLGF 409
K A+KV++K F + NE++ + + H NII L
Sbjct: 55 CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
D L+ E+ G G+L + + A I + I YLH +
Sbjct: 115 FEDKKYFYLVTEFY-EG--GELFEQIINRHKFDECDAA--NIMKQILSGICYLH---KHN 166
Query: 468 ILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
I+H DIKP+N+LL + K+ DFGL+ S++ + GT YIAPE+ +
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKKK 223
Query: 525 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW------IYDKLIQP 578
K DV+S G+++ ++ G Y P I K ++
Sbjct: 224 YNE---KCDVWSCGVIMYILL------------CG------YPPFGGQNDQDIIKK-VEK 261
Query: 579 EKEDFVEEEDDCI---ARKMIIVGLWCIQINPKDRPSM 613
K F + I A+++I + + R +
Sbjct: 262 GKYYFDFNDWKNISDEAKELI---KLMLTYDYNKRCTA 296
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 350 FKEKLGTGGYGNVYKG--KFPDGR--LVAVKVLEKTSNFSD----NFINEVATIGRIHHV 401
+ LG G +G+V +G K DG VAVK + K N S F++E A + H
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 402 NIIHLLGFCCDGSTRA-----LIYEYMPNGSLGDLL--SREKEN-LSLKPARLLEIALGV 453
N+I LLG C + S++ +I +M G L L SR + + LL+ + +
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 454 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 513
A +EYL LH D+ +N +L D T V+DFGL+K + +
Sbjct: 157 ALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 514 GYIAPE-----IFMRNLGNPSGKSDVYSYGMLLLEMI 545
+IA E ++ + KSDV+++G+ + E+
Sbjct: 214 KWIAIESLADRVY-------TSKSDVWAFGVTMWEIA 243
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 350 FKEKLGTGGYGNVYKG--KFPDGR--LVAVKVLEKTSNFSDN----FINEVATIGRIHHV 401
LG G +G+V + K DG VAVK+L K + + F+ E A + H
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDHP 85
Query: 402 NIIHLLGFCCDGSTRA------LIYEYMPNGSLGDLL--SREKEN-LSLKPARLLEIALG 452
++ L+G + +I +M +G L L SR EN +L L+ +
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145
Query: 453 VAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT 512
+A +EYL +H D+ +N +L D T V+DFGL++ +
Sbjct: 146 IACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP 202
Query: 513 IGYIAPE-----IFMRNLGNPSGKSDVYSYGMLLLEMI 545
+ ++A E ++ + SDV+++G+ + E++
Sbjct: 203 VKWLALESLADNLY-------TVHSDVWAFGVTMWEIM 233
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 64/281 (22%), Positives = 109/281 (38%), Gaps = 40/281 (14%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
E +G+G V P VA+K LEK D + E+ + + HH NI+
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE--IAL---GVAHAIEYLHNG 463
L+ + + GS+ D++ K L E IA V +EYLH
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK- 139
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT-IG---YIAPE 519
+H D+K N+LL D + +++DFG++ A +T R T +G ++APE
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVS-AFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 520 IFMRNLGNPSGKSDVYSYGMLLLEMIEEK---KHLRPTE-----TTSGSNTTEAYFPDWI 571
+ + G K+D++S+G+ +E+ P + + + E D
Sbjct: 197 VMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKE 255
Query: 572 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
K + C+Q +P+ RP+
Sbjct: 256 MLKKYGKSFRKMIS---------------LCLQKDPEKRPT 281
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 38/297 (12%), Positives = 86/297 (28%), Gaps = 60/297 (20%)
Query: 352 EKLGTGGYGNVYKGKFPD---GRLVAVKVLE----KTSNFSDNFINEVATIGRIHHVNII 404
G ++ D R VA+ ++ + ++ + RI +
Sbjct: 37 IFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
+L + ++ E++ GSL ++ S P + +A A + H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAH--- 146
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
+ P V + D ++ +
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA----- 179
Query: 525 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584
+ + D+ G L ++ + P + D + I+P
Sbjct: 180 ----NPQDDIRGIGASLYALLVNR---WPLPEAGVRSGLAPAERD-TAGQPIEP------ 225
Query: 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEM-PPKPLFPSPP 640
+ D I ++ V +Q + R + T ++ ++ A+A A P+ +P
Sbjct: 226 ADIDRDIPFQISAVAARSVQGDGGIRSAST-LLNLMQQATAVADRTEVLGPIDEAPV 281
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 350 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSDN--FINEVATIGRI-HH 400
F + LG G +G V + K VAVK+L+ T++ + ++E+ + + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 401 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL-----------SREKENLSLKPARLLEI 449
NI++LLG C G +I EY G L + L + N + LL
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 450 ALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 509
+ VA + +L +H D+ +NVLL K+ DFGLA+ + + +
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 510 RGTIGYIAPE-----IFMRNLGNPSGKSDVYSYGMLLLEMI 545
R + ++APE ++ + +SDV+SYG+LL E+
Sbjct: 227 RLPVKWMAPESIFDCVY-------TVQSDVWSYGILLWEIF 260
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIH 405
LG G +G V K K + AVKV+ K + + + EV + ++ H NI+
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
L D S+ ++ E G L D + +++ S A I V I Y+H +
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAA--RIIKQVFSGITYMH---K 139
Query: 466 LRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
I+H D+KP+N+LL + D K+ DFGL+ +N M GT YIAPE+
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLR 196
Query: 523 RNLGNPSGKSDVYSYGMLL 541
K DV+S G++L
Sbjct: 197 GTYDE---KCDVWSAGVIL 212
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 31/221 (14%)
Query: 350 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRI-HH 400
F + LG G +G V + K VAVK+L+ +++ ++ ++E+ + + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 401 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL---------------SREKENLSLKPAR 445
+NI++LLG C G +I EY G L + L E + L+L
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 446 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505
LL + VA + +L +H D+ +N+LL K+ DFGLA+ + + V
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 506 MTGPRGTIGYIAPE-IFMRNLGNPSGKSDVYSYGMLLLEMI 545
R + ++APE IF + +SDV+SYG+ L E+
Sbjct: 204 KGNARLPVKWMAPESIFNCVY---TFESDVWSYGIFLWELF 241
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 69/331 (20%), Positives = 118/331 (35%), Gaps = 111/331 (33%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGR------LVAVKVLEKTSNFSD--NFINEVATIGRIHHV 401
+ +G G +G V++ + P +VAVK+L++ ++ +F E A + +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLL---------------------SREKENLS 440
NI+ LLG C G L++EYM G L + L
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 441 LKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500
L A L IA VA + YL E + +H D+ +N L+ + K++DFGL+
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLS------ 221
Query: 501 RSV------VTMTGPRGTIGYIAPE-----IFMRNLGNPSGKSDVYSYGMLL-------- 541
R++ I ++ PE + + +SDV++YG++L
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESIFYNRY-------TTESDVWAYGVVLWEIFSYGL 274
Query: 542 -----------LEMIEEKKHL-RPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589
+ + + L P P +Y+ L++
Sbjct: 275 QPYYGMAHEEVIYYVRDGNILACPENC-----------PLELYN-LMR-----------L 311
Query: 590 CIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
C W P DRPS + +L
Sbjct: 312 C----------W--SKLPADRPSFCSIHRIL 330
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 6e-28
Identities = 53/363 (14%), Positives = 99/363 (27%), Gaps = 76/363 (20%)
Query: 300 KRIPSFFKKPFSEERQNIGDGLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGY 359
RIP + SE Q+ D L T + + + + + G LG
Sbjct: 29 NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRG--TVLGQEDP 86
Query: 360 GNVYKGK-FPDGRLVAVKVLEKTSNFSDNFI----NEVATIGRI---------------- 398
+ G V V T N I EV + +
Sbjct: 87 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146
Query: 399 ---------HHVNIIHLLGFCCDGSTRALIYEYM-PNGSLGD----LLSREKENLSLKPA 444
+I + D + + Y +L LLS + SL
Sbjct: 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHH 206
Query: 445 RLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504
L++ L V + LH+ ++H ++P +++LD ++ F
Sbjct: 207 ARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV-- 261
Query: 505 TMTGPRGTIGYIAPEIFMRNLGNPSG---------KSDVYSYGMLLLEMIEEKKHLRPTE 555
+ G+ PE+ R D ++ G+++ + P
Sbjct: 262 ----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD---LPIT 314
Query: 556 TTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR 615
+ +E F I +E ++ +DR +
Sbjct: 315 KDAALGGSEWIFRSCKN---IPQPVRALLE---------------GFLRYPKEDRLLPLQ 356
Query: 616 VVE 618
+E
Sbjct: 357 AME 359
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 23/200 (11%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNIIHLL 407
F E LG+G + V+ K G+L A+K ++K+ F + NE+A + +I H NI+ L
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
+ L+ + + G G+L R E+ + K A + V A++YLH E
Sbjct: 73 DIYESTTHYYLVMQLVS-G--GELFDRILERGVYTEKDAS--LVIQQVLSAVKYLH---E 124
Query: 466 LRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
I+H D+KP+N+L + + ++DFGL+K M+ GT GY+APE+
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLA 180
Query: 523 RNLGNPSGKS-DVYSYGMLL 541
+ P K+ D +S G++
Sbjct: 181 Q---KPYSKAVDCWSIGVIT 197
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 44/230 (19%)
Query: 350 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHV 401
+ LG G +G V K VAVK+L++ ++ S+ + ++E + +++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLL---------------------SREKENLS 440
++I L G C LI EY GSL L + +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 441 LKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500
L L+ A ++ ++YL E++++H D+ +N+L+ K+SDFGL++
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 501 RSVVTMTGPRGTIGYIAPE-----IFMRNLGNPSGKSDVYSYGMLLLEMI 545
S V + R + ++A E I+ + +SDV+S+G+LL E++
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIY-------TTQSDVWSFGVLLWEIV 246
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 20/201 (9%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNIIHL 406
FK KLG+G +G+V+ + G +K + K + E+ + + H NII +
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 407 LGFCCDGSTRALIYEYMPNGSLGD---LLSREKENLSLKPARLLEIALGVAHAIEYLHNG 463
D ++ E G L + + LS E+ + +A+ Y H
Sbjct: 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA--ELMKQMMNALAYFH-- 141
Query: 464 CELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 520
++H D+KP+N+L P K+ DFGLA+ + T GT Y+APE+
Sbjct: 142 -SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEV 197
Query: 521 FMRNLGNPSGKSDVYSYGMLL 541
F R++ K D++S G+++
Sbjct: 198 FKRDVTF---KCDIWSAGVVM 215
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 39/225 (17%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGR--------LVAVKVLEKTSNFSD--NFINEVATIGRI- 398
+ LG G +G V + VAVK+L+ + D + ++E+ + I
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 399 HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL-------------SREKENLSLKPAR 445
H NII+LLG C +I EY G+L + L +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 446 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505
L+ +A +EYL + +H D+ +NVL+ + K++DFGLA+ +
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 506 MTGPRGTIGYIAPE-----IFMRNLGNPSGKSDVYSYGMLLLEMI 545
T R + ++APE ++ + +SDV+S+G+L+ E+
Sbjct: 216 TTNGRLPVKWMAPEALFDRVY-------THQSDVWSFGVLMWEIF 253
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 36/226 (15%)
Query: 350 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRI-HH 400
F + LG+G +G V K VAVK+L++ ++ S+ ++E+ + ++ H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 401 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL--------------------SREKENLS 440
NI++LLG C LI+EY G L + L E++
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 441 LKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500
L LL A VA +E+L +H D+ +NVL+ K+ DFGLA+ +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 501 RSVVTMTGPRGTIGYIAPE-IFMRNLGNPSGKSDVYSYGMLLLEMI 545
+ V R + ++APE +F + KSDV+SYG+LL E+
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIY---TIKSDVWSYGILLWEIF 268
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 64/289 (22%), Positives = 107/289 (37%), Gaps = 65/289 (22%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN--FINEVATIGR-IHHVNIIHLL 407
++G G YG+V K P G+++AVK + T + + + ++ + R I+
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE-----IALGVAHAIEYLHN 462
G + E M + S K S+ + E I L A+ +L
Sbjct: 88 GALFREGDCWICMELM-STSFDKFY---KYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAP 518
L+I+H DIKP N+LLD K+ DFG L + ++ R G Y+AP
Sbjct: 144 --NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA-------GCRPYMAP 194
Query: 519 EIFMRNLGNP--SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW--IYD- 573
E + +SDV+S G+ L E+ R +P W ++D
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELAT----GRFP------------YPKWNSVFDQ 238
Query: 574 ----------KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
+L E+ +F + + C+ + RP
Sbjct: 239 LTQVVKGDPPQLSNSEEREFSPSFINFVNL--------CLTKDESKRPK 279
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 7e-27
Identities = 49/214 (22%), Positives = 84/214 (39%), Gaps = 40/214 (18%)
Query: 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL 480
+ +L D ++R + L I + +A A+E+LH+ ++H D+KP N+
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFF 197
Query: 481 DPDFTPKVSDFGLAKA----------HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP-S 529
D KV DFGL A + + T TG GT Y++PE GN S
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH---GNNYS 254
Query: 530 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE-KEDFVEEED 588
K D++S G++L E+ L T I + + F ++
Sbjct: 255 HKVDIFSLGLILFEL------LYSFST--QMERVR------IITDVRNLKFPLLFTQKYP 300
Query: 589 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
M+ + +P +RP T +++ +
Sbjct: 301 Q--EHMMV---QDMLSPSPTERPEAT---DIIEN 326
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 48/211 (22%), Positives = 83/211 (39%), Gaps = 25/211 (11%)
Query: 352 EKLGTG--GYGNVYKGKF-PDGRLVAVKV--LEKTSNFSDNFI-NEVATIGRIHHVNIIH 405
+G G V ++ P G V V+ LE SN F+ E+ +H NI+
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE--IAL---GVAHAIEYL 460
+ ++ +M GS DL+ + + E IA GV A++Y+
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLIC------THFMDGMNELAIAYILQGVLKALDYI 144
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPR-GTIGY 515
H + +H +K ++L+ D +S + R R V + +
Sbjct: 145 H---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 516 IAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE 546
++PE+ +NL KSD+YS G+ E+
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELAN 232
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 39/225 (17%)
Query: 350 FKEKLGTGGYGNVYKG--------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRI- 398
+ LG G +G V K + VAVK+L+ + D + ++E+ + I
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 399 HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL-------------SREKENLSLKPAR 445
H NII+LLG C +I EY G+L + L +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 446 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505
L+ +A +EYL + +H D+ +NVL+ + K++DFGLA+ +
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 506 MTGPRGTIGYIAPE-----IFMRNLGNPSGKSDVYSYGMLLLEMI 545
T R + ++APE ++ + +SDV+S+G+L+ E+
Sbjct: 262 TTNGRLPVKWMAPEALFDRVY-------THQSDVWSFGVLMWEIF 299
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 51/197 (25%), Positives = 78/197 (39%), Gaps = 17/197 (8%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLL 407
+ +G G +G V A K + K D F E+ + + H NII L
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
D + L+ E G L + + K A I V A+ Y H +L
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAA--RIMKDVLSAVAYCH---KLN 126
Query: 468 ILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
+ H D+KP+N L PD K+ DFGLA + M GT Y++P++
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL 183
Query: 525 LGNPSGKSDVYSYGMLL 541
G + D +S G+++
Sbjct: 184 YGP---ECDEWSAGVMM 197
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 350 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRI-HH 400
+ LG G +G V + K R VAVK+L++ + S+ ++E+ + I HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 401 VNIIHLLGFCCD-GSTRALIYEYMPNGSLGDLL-------------SREKENLSLKPARL 446
+N+++LLG C G +I E+ G+L L + L L
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 447 LEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506
+ + VA +E+L + +H D+ +N+LL K+ DFGLA+ ++ V
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 507 TGPRGTIGYIAPE-----IFMRNLGNPSGKSDVYSYGMLLLEMI 545
R + ++APE ++ + +SDV+S+G+LL E+
Sbjct: 208 GDARLPLKWMAPETIFDRVY-------TIQSDVWSFGVLLWEIF 244
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 28/208 (13%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---------TSNFSDNFINEVATIGRIH 399
+ LG+G G V + VA++++ K ++ + N E+ + +++
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 400 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAI 457
H II + F D ++ E M G +L + + L + + A+
Sbjct: 199 HPCIIKIKNFF-DAEDYYIVLELMEGG---ELFDKVVGNKRLKEATCK--LYFYQMLLAV 252
Query: 458 EYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 514
+YLH E I+H D+KP+NVLL + D K++DFG +K + T+ GT
Sbjct: 253 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPT 306
Query: 515 YIAPEIFMRNLGNPSGKS-DVYSYGMLL 541
Y+APE+ + ++ D +S G++L
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 57/240 (23%), Positives = 86/240 (35%), Gaps = 51/240 (21%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK------TSNFSDNFINEVATIGRIHHVN 402
K +G G YG V + A+K++ K + EV + ++HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALG---------- 452
I L D L+ E G L D L+ ++ + K A +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 453 ---------------------------VAHAIEYLHNGCELRILHLDIKPQNVLL--DPD 483
+ A+ YLH I H DIKP+N L +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206
Query: 484 FTPKVSDFGLAKAHSRNRS--VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLL 541
F K+ DFGL+K + + MT GT ++APE+ + K D +S G+LL
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 64/294 (21%), Positives = 115/294 (39%), Gaps = 47/294 (15%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN--FINEVATIGRIHHVNIIHLLG 408
+LG G G V+K P G ++A K++ + I E+ + + I+ G
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
++ E+M GSL +L K+ + L ++++ V + YL + +I
Sbjct: 99 AFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKI 153
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAK--AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
+H D+KP N+L++ K+ DFG++ S S V GT Y++PE R G
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 204
Query: 527 NP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585
S +SD++S G+ L+EM + + P + + +P
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 586 EEDDCIARKMI--------IV---------GLW----------CIQINPKDRPS 612
+ +R + IV G++ C+ NP +R
Sbjct: 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 318
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS----------DNFINEVATIGRI 398
KE LG G V + P + AVK+++ T S + + EV + ++
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 399 -HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAI 457
H NII L + L+++ M G L D L+ EK LS K R +I + I
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETR--KIMRALLEVI 137
Query: 458 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 517
LH +L I+H D+KP+N+LLD D K++DFG + + GT Y+A
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLA 191
Query: 518 PEIFMRNLGNPS---GKS-DVYSYGMLL 541
PEI ++ + GK D++S G+++
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
+LG G +G VYK K G L A KV + D +I E+ + H I+ LLG
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHPYIVKLLG 83
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL---GVAHAIEYLHNGCE 465
++ E+ P G++ ++ L+ +I + + A+ +LH+
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-----QIQVVCRQMLEALNFLHSK-- 136
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPEIF 521
RI+H D+K NVL+ + +++DFG K + S + GT ++APE+
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVV 189
Query: 522 MRNLGNPSG---KSDVYSYGMLLLEMIE 546
M + K+D++S G+ L+EM +
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQ 217
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 33/207 (15%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
EK+G G G VY G+ VA++ L++ INE+ + + NI++ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLD 84
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE-----IALGVAHAIEYLHNG 463
G ++ EY+ GSL D++ + E + A+E+LH+
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVV---------TETCMDEGQIAAVCRECLQALEFLHS- 134
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPE 519
+++H DIK N+LL D + K++DFG + S+ ++V GT ++APE
Sbjct: 135 --NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV------GTPYWMAPE 186
Query: 520 IFMRNLGNPSGKSDVYSYGMLLLEMIE 546
+ R P K D++S G++ +EMIE
Sbjct: 187 VVTRKAYGP--KVDIWSLGIMAIEMIE 211
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 32/207 (15%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
EK+G G +G V+KG ++VA+K+ LE+ + ++ E+ + + + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE-----IALGVAHAIEYLHNG 463
+ +I EY+ GS DLL +P L E I + ++YLH+
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLL---------EPGPLDETQIATILREILKGLDYLHS- 137
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPE 519
+ +H DIK NVLL K++DFG L + + V GT ++APE
Sbjct: 138 --EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPE 189
Query: 520 IFMRNLGNPSGKSDVYSYGMLLLEMIE 546
+ ++ + K+D++S G+ +E+
Sbjct: 190 VIKQSAYDS--KADIWSLGITAIELAR 214
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 33/207 (15%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
K+G G G V + GR VAVK+ L K NEV + H N++ +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHFNVVEMYK 109
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE-----IALGVAHAIEYLHNG 463
G ++ E++ G+L D++ RL E + V A+ YLH
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIV---------SQVRLNEEQIATVCEAVLQALAYLHA- 159
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPE 519
++H DIK ++LL D K+SDFG ++K + +S+V GT ++APE
Sbjct: 160 --QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPE 211
Query: 520 IFMRNLGNPSGKSDVYSYGMLLLEMIE 546
+ R+L + D++S G++++EM++
Sbjct: 212 VISRSLYAT--EVDIWSLGIMVIEMVD 236
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 47/199 (23%), Positives = 87/199 (43%), Gaps = 18/199 (9%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIH 405
KE+LG G + V + G A K++ ++ E ++ H NI+
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
L + S L+++ + G L + + +E S A + +I Y H
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADAS--HCIQQILESIAYCH---S 123
Query: 466 LRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
I+H ++KP+N+LL K++DFGLA + + G GT GY++PE+
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLK 180
Query: 523 RNLGNPSGKSDVYSYGMLL 541
++ + D+++ G++L
Sbjct: 181 KDPYSK--PVDIWACGVIL 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 46/203 (22%), Positives = 80/203 (39%), Gaps = 18/203 (8%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS------DNFINEVATIGRIHHVN 402
E +G G + V + G+ AVK+++ S ++ E + + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGD-LLSREKENLSLKPARLLEIALGVAHAIEYLH 461
I+ LL +++E+M L ++ R A + A+ Y H
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 462 NGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 518
+ I+H D+KP VLL + K+ FG+A + V G GT ++AP
Sbjct: 148 ---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV--AGGRVGTPHFMAP 202
Query: 519 EIFMRNLGNPSGKSDVYSYGMLL 541
E+ R DV+ G++L
Sbjct: 203 EVVKREPYGK--PVDVWGCGVIL 223
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFC 410
EKLG G YG+VYK G++VA+K + S+ + I E++ + + +++ G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHVVKYYGSY 93
Query: 411 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL---GVAHAIEYLHNGCELR 467
+ ++ EY GS+ D++ + L+ EIA +EYLH +R
Sbjct: 94 FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED-----EIATILQSTLKGLEYLHF---MR 145
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
+H DIK N+LL+ + K++DFG L ++ +V+ GT ++APE+
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI------GTPFWMAPEVIQE 199
Query: 524 NLGNPSGKSDVYSYGMLLLEMIE 546
N +D++S G+ +EM E
Sbjct: 200 IGYNC--VADIWSLGITAIEMAE 220
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN--FINEVATIGR-IHHVNIIHLL 407
+LG G YG V K + P G+++AVK + T N + + ++ R + +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLE-----IALGVAHAIEYLHN 462
G + E M + SL + + K + E IA+ + A+E+LH+
Sbjct: 73 GALFREGDVWICMELM-DTSLDKFYKQVID----KGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAP 518
+L ++H D+KP NVL++ K+ DFG L +++ G Y+AP
Sbjct: 128 --KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-------GCKPYMAP 178
Query: 519 EIFMRNLGNP--SGKSDVYSYGMLLLEM 544
E L S KSD++S G+ ++E+
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-26
Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 31/235 (13%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEK----TSNFSDNFINEVATIGRIHHVNIIHLLG 408
+G G +G V + D ++ A+K + K N N E+ + + H +++L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGCEL 466
D ++ + + G L L + + + +L E+ + A++YL
Sbjct: 83 SFQDEEDMFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVM----ALDYLQ---NQ 134
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
RI+H D+KP N+LLD ++DF +A R + TM G T Y+APE+F G
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAG---TKPYMAPEMFSSRKG 191
Query: 527 NPSGKS-DVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAY---------FPDWI 571
+ D +S G+ E++ + RP S +++ E +P
Sbjct: 192 AGYSFAVDWWSLGVTAYELL---RGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW 243
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 76/309 (24%), Positives = 118/309 (38%), Gaps = 72/309 (23%)
Query: 350 FKEKLGTGGYGNVYKGKFPD--------GRLVAVKVLEKTSNFSD--NFINEVATIGRI- 398
+ LG G +G V + VAVK+L+ + D + I+E+ + I
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 399 HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL-------------SREKENLSLKPAR 445
H NII+LLG C +I EY G+L + L L
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 446 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505
L+ A VA +EYL + +H D+ +NVL+ D K++DFGLA+
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 506 MTGPRGTIGYIAPE-----IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS 560
T R + ++APE I+ + +SDV+S+G+LL E+
Sbjct: 250 TTNGRLPVKWMAPEALFDRIY-------THQSDVWSFGVLLWEIF--------------- 287
Query: 561 NTTEAYFPDWIYDKLIQPEKEDFVEEE------DDC---IARKMIIVGLWCIQINPKDRP 611
T P Y + E ++E +C + M C P RP
Sbjct: 288 --TLGGSP---YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMM----RDCWHAVPSQRP 338
Query: 612 SMTRVVEML 620
+ ++VE L
Sbjct: 339 TFKQLVEDL 347
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNIIHLL 407
E+LG+G +G V++ GR+ K + NE++ + ++HH +I+L
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
D LI E++ G L D ++ E +S ++++H E
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI--NYMRQACEGLKHMH---EHS 169
Query: 468 ILHLDIKPQNVLL--DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
I+HLDIKP+N++ + K+ DFGLA + + V T T + APEI R
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREP 226
Query: 526 GNPSGKSDVYSYG----MLL 541
+D+++ G +LL
Sbjct: 227 VGF--YTDMWAIGVLGYVLL 244
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 40/200 (20%), Positives = 78/200 (39%), Gaps = 19/200 (9%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
E LG G +G V++ + K ++ E++ + H NI+HL
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+I+E++ + + ++ L+ + V A+++LH I
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNEREIV--SYVHQVCEALQFLH---SHNI 123
Query: 469 LHLDIKPQNVLL--DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
H DI+P+N++ T K+ +FG A+ + + Y APE+
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQH--- 177
Query: 527 NPSGKS-DVYSYG----MLL 541
+ + D++S G +LL
Sbjct: 178 DVVSTATDMWSLGTLVYVLL 197
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 349 GFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK-TSNFSDNFINEVATIGRIHHVNIIHL 406
E LG G +G V+K + G +A K+++ + NE++ + ++ H N+I L
Sbjct: 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
+ L+ EY+ G L D + E NL+ + I ++H ++
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI--LFMKQICEGIRHMH---QM 206
Query: 467 RILHLDIKPQNVLL-DPDFTP-KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
ILHLD+KP+N+L + D K+ DFGLA+ + + GT ++APE+ +
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLAPEVVNYD 263
Query: 525 LGNPSGKSDVYSYG----MLL 541
+ +D++S G MLL
Sbjct: 264 FVSF--PTDMWSVGVIAYMLL 282
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-25
Identities = 44/201 (21%), Positives = 83/201 (41%), Gaps = 21/201 (10%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS---DNFINEVATIGRIHHVNIIH 405
E+LG G + V + G+ A ++ + E + H NI+
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNG 463
L + LI++ + G G+L +E S A + A+ + H
Sbjct: 75 LHDSISEEGHHYLIFDLVT-G--GELFEDIVAREYYSEADAS--HCIQQILEAVLHCH-- 127
Query: 464 CELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 520
++ ++H ++KP+N+LL K++DFGLA + G GT GY++PE+
Sbjct: 128 -QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSPEV 184
Query: 521 FMRNLGNPSGKSDVYSYGMLL 541
++ D+++ G++L
Sbjct: 185 LRKDPYGK--PVDLWACGVIL 203
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 63/196 (32%), Positives = 91/196 (46%), Gaps = 22/196 (11%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
+ +LG G VY+ K + A+KVL+KT + E+ + R+ H NII L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-VRTEIGVLLRLSHPNIIKLKE 115
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
+ +L+ E + G G+L R EK S + A + + A+ YLH E
Sbjct: 116 IFETPTEISLVLELVT-G--GELFDRIVEKGYYSERDAA--DAVKQILEAVAYLH---EN 167
Query: 467 RILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
I+H D+KP+N+L PD K++DFGL+K V M GT GY APEI
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRG 224
Query: 524 NLGNPSGKS-DVYSYG 538
G D++S G
Sbjct: 225 ---CAYGPEVDMWSVG 237
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 63/298 (21%), Positives = 121/298 (40%), Gaps = 50/298 (16%)
Query: 351 KEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-NFSDNFINEVATIGRI-HHVNIIHLL 407
++ LG G + V + AVK++EK + EV + + H N++ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
F + L++E M G G +LS ++ + + A + VA A+++LHN
Sbjct: 78 EFFEEEDRFYLVFEKM-RG--GSILSHIHKRRHFNELEAS--VVVQDVASALDFLHN--- 129
Query: 466 LRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNR-----SVVTMTGPRGTIGYIA 517
I H D+KP+N+L + K+ DF L N S + P G+ Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 518 PEIFMRNLGNPSG---KSDVYSYGMLLLEMI-------EEKKHLRPTETTSGSNTTEAYF 567
PE+ S + D++S G++L ++ + +
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ--- 246
Query: 568 PDWIYDKLIQPEKEDFVEEEDDCIA-------RKMIIVGLWCIQINPKDRPSMTRVVE 618
+ +++ IQ K +F +++ I+ K+++ + K R S +V++
Sbjct: 247 -NMLFES-IQEGKYEFPDKDWAHISCAAKDLISKLLVR-------DAKQRLSAAQVLQ 295
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-------DNFINEVATIGRIHHV 401
E+LG+G + V K + G A K ++K + + + EV+ + ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
N+I L + + LI E + G L D L +KE+LS + A + + YLH
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEAT--SFIKQILDGVNYLH 132
Query: 462 NGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 517
+I H D+KP+N++L P K+ DFGLA + GT ++A
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFVA 186
Query: 518 PEIFMRNLGNPSGKS-DVYSYG----MLL 541
PEI P G D++S G +LL
Sbjct: 187 PEIVNY---EPLGLEADMWSIGVITYILL 212
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-------DNFINEVATIGRIHHV 401
E+LG+G + V K + G A K ++K + + + EV+ + ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
NII L + + LI E + G L D L +KE+LS + A + + YLH
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEAT--SFIKQILDGVNYLH 132
Query: 462 NGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 517
+I H D+KP+N++L P K+ DFGLA + GT ++A
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFVA 186
Query: 518 PEIFMRNLGNPSGKS-DVYSYG----MLL 541
PEI P G D++S G +LL
Sbjct: 187 PEIVNY---EPLGLEADMWSIGVITYILL 212
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-------DNFINEVATIGRIHHV 401
E+LG+G + V K + G+ A K ++K S + EV + I H
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
NII L + + LI E + G L D L+ EKE+L+ A + + + YLH
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELFDFLA-EKESLTEDEAT--QFLKQILDGVHYLH 125
Query: 462 NGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 517
RI H D+KP+N++L P+ K+ DFG+A + GT ++A
Sbjct: 126 ---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVA 179
Query: 518 PEIFMRNLGNPSGKS-DVYSYG----MLL 541
PEI P G D++S G +LL
Sbjct: 180 PEIVNY---EPLGLEADMWSIGVITYILL 205
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 23/199 (11%)
Query: 351 KEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLG 408
+ LG G + K + AVK++ K N E+ + H NI+ L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM--EANTQKEITALKLCEGHPNIVKLHE 73
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
D L+ E + NG G+L R +K++ S A I + A+ ++H ++
Sbjct: 74 VFHDQLHTFLVMELL-NG--GELFERIKKKKHFSETEAS--YIMRKLVSAVSHMH---DV 125
Query: 467 RILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
++H D+KP+N+L + + K+ DFG A+ + + P T+ Y APE+ +
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTPCFTLHYAAPELLNQ 183
Query: 524 NLGNPSGKS-DVYSYGMLL 541
N +S D++S G++L
Sbjct: 184 ---NGYDESCDLWSLGVIL 199
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 68/296 (22%), Positives = 120/296 (40%), Gaps = 65/296 (21%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGF 409
E +G G YG VYKG+ G+L A+KV++ T + + E+ + + HH NI G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 410 CCDGSTRA------LIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL---GVAHAIEYL 460
+ L+ E+ GS+ DL+ +N + IA + + +L
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLI----KNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYI 516
H + +++H DIK QNVLL + K+ DFG L + R + + GT ++
Sbjct: 146 H---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWM 196
Query: 517 APEIFMRNLGNPSG---KSDVYSYGMLLLEMIEEK---KHLRPTE-----TTSGSNTTEA 565
APE+ + + KSD++S G+ +EM E + P + + ++
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 256
Query: 566 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621
W + + F+E C+ N RP+ +++
Sbjct: 257 --KKW------SKKFQSFIES---------------CLVKNHSQRPATE---QLMK 286
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 28/208 (13%)
Query: 350 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEK---------TSNFSDNFINEVATIGRIH 399
+ LG+G G V + VA+K++ K ++ + N E+ + +++
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 400 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAI 457
H II + F D ++ E M G +L + + L + + A+
Sbjct: 74 HPCIIKIKNFF-DAEDYYIVLELMEGG---ELFDKVVGNKRLKEATCK--LYFYQMLLAV 127
Query: 458 EYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 514
+YLH E I+H D+KP+NVLL + D K++DFG +K M GT
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPT 181
Query: 515 YIAPEIFMRNLGNPSGKS-DVYSYGMLL 541
Y+APE+ + ++ D +S G++L
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-25
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDN----FINEVATIGRIHHVNIIHLLG 408
+G G +G V K + ++ A+K+L K F E + I L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL-- 139
Query: 409 FCC--DGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGC 464
D + L+ +Y G L LLS+ ++ L + AR L E+ + AI+ +H
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI----AIDSVHQ-- 193
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
L +H DIKP N+L+D + +++DFG + +V + GT YI+PEI
Sbjct: 194 -LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISPEILQAM 251
Query: 525 LGNPS--GKS-DVYSYGMLLLEMI 545
G G D +S G+ + EM+
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEML 275
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 47/199 (23%), Positives = 87/199 (43%), Gaps = 18/199 (9%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIH 405
KE+LG G + V + G A K++ ++ E ++ H NI+
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 406 LLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
L + S L+++ + G L + + +E S A + +I Y H
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIV-AREFYSEADAS--HCIQQILESIAYCH---S 146
Query: 466 LRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
I+H ++KP+N+LL K++DFGLA + + G GT GY++PE+
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLK 203
Query: 523 RNLGNPSGKSDVYSYGMLL 541
++ + D+++ G++L
Sbjct: 204 KDPYSK--PVDIWACGVIL 220
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-------DNFINEVATIGRIHHV 401
E+LG+G + V K + G A K ++K S ++ EV+ + I H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
N+I L + + LI E + G L D L+ EKE+L+ + A E + + + YLH
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLA-EKESLTEEEAT--EFLKQILNGVYYLH 131
Query: 462 NGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 517
L+I H D+KP+N++L P K+ DFGLA + GT ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVA 185
Query: 518 PEIFMRNLGNPSGKSDVYSYG----MLL 541
PEI ++D++S G +LL
Sbjct: 186 PEIVNYEPLGL--EADMWSIGVITYILL 211
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 23/213 (10%)
Query: 342 DIKKMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGR 397
+ ++LG G + V + G+ A K L+K + ++E+A +
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 398 I-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGD-LLSREKENLSLKPARLLEIALGVAH 455
+I+L + S LI EY G + L E +S + +
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI--RLIKQILE 142
Query: 456 AIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT 512
+ YLH + I+HLD+KPQN+LL P K+ DFG+++ + + GT
Sbjct: 143 GVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM---GT 196
Query: 513 IGYIAPEIFMRNLGNPSGKSDVYSYG----MLL 541
Y+APEI + +D+++ G MLL
Sbjct: 197 PEYLAPEILNYDPITT--ATDMWNIGIIAYMLL 227
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 28/209 (13%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS---------NFSDNFINEVATIGRIH 399
K+ +G G V + G AVK++E T+ + E + ++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 400 -HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHA 456
H +II L+ S L+++ M G +L EK LS K R I + A
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKG---ELFDYLTEKVALSEKETR--SIMRSLLEA 212
Query: 457 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 516
+ +LH I+H D+KP+N+LLD + ++SDFG + + GT GY+
Sbjct: 213 VSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYL 266
Query: 517 APEIFMRNLGNPSG----KSDVYSYGMLL 541
APEI ++ + D+++ G++L
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 52/200 (26%), Positives = 84/200 (42%), Gaps = 19/200 (9%)
Query: 354 LGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFI----NEVATIGRIHHVNIIHLLG 408
LG G + V + R A+K+LEK +N + E + R+ H + L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCEL 466
D Y NG L + + R EI A+EYLH
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVS----ALEYLH---GK 149
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
I+H D+KP+N+LL+ D +++DFG AK S GT Y++PE+
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL---TE 206
Query: 527 NPSGKS-DVYSYGMLLLEMI 545
+ KS D+++ G ++ +++
Sbjct: 207 KSACKSSDLWALGCIIYQLV 226
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 50/286 (17%)
Query: 351 KEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLG 408
K+ LG G G V + G+ A+K+L S EV + +I+ +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGPHIVCILD 89
Query: 409 FCCDGSTRA----LIYEYMPNGSLGD-LLSREKENLSLKPARLLEIALGVAHAIEYLHNG 463
+ +I E M G L + R + + + A EI + AI++LH
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA--EIMRDIGTAIQFLH-- 145
Query: 464 CELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 520
I H D+KP+N+L + D K++DFG AK ++N + P T Y+APE+
Sbjct: 146 -SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEV 200
Query: 521 FMRNLGNPSGKS-DVYSYGMLLLEMIEEKKHLRPTETTSG-----SNTTEAYFPDWIYDK 574
KS D++S G+++ ++ G SNT +A P + +
Sbjct: 201 LGP---EKYDKSCDMWSLGVIMYILL------------CGFPPFYSNTGQAISPG-MKRR 244
Query: 575 LIQPEKEDFVEEEDDCIAR--KMIIVGLWCIQINPKDRPSMTRVVE 618
I+ + F E ++ K +I L ++ +P +R ++T+ +
Sbjct: 245 -IRLGQYGFPNPEWSEVSEDAKQLIRLL--LKTDPTERLTITQFMN 287
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 53/283 (18%), Positives = 104/283 (36%), Gaps = 58/283 (20%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKV--LEKTSNFSDNFINEVATIGR-IHHVNIIHLL 407
++G+G G V+K +F G ++AVK + + ++ + + I+
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
G + + E M L R + + + L ++ + + A+ YL +
Sbjct: 91 GTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPER--ILGKMTVAIVKALYYLKE--KHG 145
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFG----LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
++H D+KP N+LLD K+ DFG L +++RS G Y+APE
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA-------GCAAYMAPERIDP 198
Query: 524 NLGNPSG---KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW--IYDKLIQ- 577
++DV+S G+ L+E+ T + + + ++ L +
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELA----------------TGQFPYKNCKTDFEVLTKV 242
Query: 578 --------PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
P F + + C+ + + RP
Sbjct: 243 LQEEPPLLPGHMGFSGDFQSFVKD--------CLTKDHRKRPK 277
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 25/201 (12%)
Query: 350 FKEKLGTGGYGNVYKG-KFPDGRLVAVKVLEKTSNFSDNFINEVATIGR-IHHVNIIHLL 407
KE +G G Y + AVK+++K+ + E+ + R H NII L
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---RDPTEEIEILLRYGQHPNIITLK 82
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
DG ++ E M G +LL + ++ S + A + + +EYLH
Sbjct: 83 DVYDDGKYVYVVTELMKGG---ELLDKILRQKFFSEREAS--AVLFTITKTVEYLH---A 134
Query: 466 LRILHLDIKPQNVLL---DPDFTP-KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 521
++H D+KP N+L + ++ DFG AK + + P T ++APE+
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAPEVL 192
Query: 522 MRNLGNPSGKS-DVYSYGMLL 541
R + D++S G+LL
Sbjct: 193 ER---QGYDAACDIWSLGVLL 210
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 73/318 (22%), Positives = 115/318 (36%), Gaps = 73/318 (22%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGR-----------IH 399
LG GG+G V+ G D VA+KV+ + + +++ T
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 400 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAI 457
H +I LL + L+ E DL EK L P+R V AI
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKGPLGEGPSR--CFFGQVVAAI 152
Query: 458 EYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 516
++ H+ ++H DIK +N+L+D K+ DFG A + GT Y
Sbjct: 153 QHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFD---GTRVYS 205
Query: 517 APEIFMRNL--GNPSGKSDVYSYGMLLLEMI-------EEKKHLRPTETTSGSNTTEAYF 567
PE R+ P + V+S G+LL +M+ +++ L E +F
Sbjct: 206 PPEWISRHQYHALP---ATVWSLGILLYDMVCGDIPFERDQEILE----------AELHF 252
Query: 568 PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE---MLSSAS 624
P + DC +I C+ P RPS+ ++ M
Sbjct: 253 PAHV---------------SPDC--CALI---RRCLAPKPSSRPSLEEILLDPWM--QTP 290
Query: 625 AEAIEMPPKPLFPSPPQL 642
AE + + P P+P
Sbjct: 291 AEDVPLNPSKGGPAPLAW 308
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 60/243 (24%), Positives = 96/243 (39%), Gaps = 35/243 (14%)
Query: 322 NVKQFIKTYRSALLSNYSYNDIKKMTNG-----FKEKLGTGGYGNVYKGKFPD-GRLVAV 375
V F++ +K++ + +G G + V K G++ A+
Sbjct: 38 YVADFLQWAEP------IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAM 91
Query: 376 KVLEKTSNFSDN----FINEVATIGRIHHVNIIHLLGFCC--DGSTRALIYEYMPNGSLG 429
K++ K F E + I L D + L+ EY G L
Sbjct: 92 KIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL--HFAFQDENYLYLVMEYYVGGDLL 149
Query: 430 DLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPK 487
LLS+ E + + AR L EI + AI+ +H L +H DIKP N+LLD +
Sbjct: 150 TLLSKFGERIPAEMARFYLAEIVM----AIDSVH---RLGYVHRDIKPDNILLDRCGHIR 202
Query: 488 VSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS----GKS-DVYSYGMLLL 542
++DFG + +V ++ GT Y++PEI G P G D ++ G+
Sbjct: 203 LADFGSCLKLRADGTVRSLV-AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAY 261
Query: 543 EMI 545
EM
Sbjct: 262 EMF 264
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN---------EVATIGRIHHV 401
LG+G +G V+ + V VK ++K D +I E+A + R+ H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR--EKENLSLKPARLLEIALGVAHAIEY 459
NII +L + L+ E +G DL + L A I + A+ Y
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSG--LDLFAFIDRHPRLDEPLAS--YIFRQLVSAVGY 145
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 519
L I+H DIK +N+++ DFT K+ DFG A R + T GTI Y APE
Sbjct: 146 LRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPE 199
Query: 520 IFMRNLGNP-SG-KSDVYSYGMLL 541
+ M GNP G + +++S G+ L
Sbjct: 200 VLM---GNPYRGPELEMWSLGVTL 220
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 51/196 (26%), Positives = 86/196 (43%), Gaps = 14/196 (7%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNIIHLL 407
E+LGTG +G V++ G A K + + E+ T+ + H +++L
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
D + +IYE+M G L + ++ E +S A E V + ++H E
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV--EYMRQVCKGLCHMH---ENN 275
Query: 468 ILHLDIKPQNVLL--DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
+HLD+KP+N++ K+ DFGL +SV T GT + APE+
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA--EG 330
Query: 526 GNPSGKSDVYSYGMLL 541
+D++S G+L
Sbjct: 331 KPVGYYTDMWSVGVLS 346
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVL----EKTSNFSDNFINEVATIGRIHHVNIIHL 406
++G G +G VY + + +VA+K + ++++ + I EV + ++ H N I
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL---GVAHAIEYLHNG 463
G T L+ EY GS DLL K+ L EIA G + YLH+
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEV-----EIAAVTHGALQGLAYLHS- 172
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
++H D+K N+LL K+ DFG A + S V GT ++APE+ +
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILA 224
Query: 524 NLGNP-SGKSDVYSYGMLLLEMIE 546
GK DV+S G+ +E+ E
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAE 248
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 60/238 (25%), Positives = 103/238 (43%), Gaps = 30/238 (12%)
Query: 322 NVKQFIKTYRSALLSNYSYNDIKKMTNG-----FKEKLGTGGYGNVYKGKFPD-GRLVAV 375
N+ F+ Y+ + N I+ + + +G G +G V + ++ A+
Sbjct: 46 NIDNFLSRYKD------TINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 99
Query: 376 KVLEKTSNFSDN----FINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDL 431
K+L K + F E + + ++ L D ++ EYMP G L +L
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL 159
Query: 432 LSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 489
+S + K AR E+ L A++ +H + +H D+KP N+LLD K++
Sbjct: 160 MSNYD--VPEKWARFYTAEVVL----ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLA 210
Query: 490 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS-GKS-DVYSYGMLLLEMI 545
DFG ++ V T GT YI+PE+ G+ G+ D +S G+ L EM+
Sbjct: 211 DFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 66/278 (23%), Positives = 109/278 (39%), Gaps = 44/278 (15%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLEKT--SNFSDNFINEVATIGRIHHVNIIHLLGFC 410
LG G YG V VAVK+++ + +N E+ ++H N++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 411 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGCELRI 468
+G+ + L EY G L D + + A+ ++ GV YLH + I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGV----VYLHG---IGI 126
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
H DIKP+N+LLD K+SDFGLA N + GT+ Y+APE+ R +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 529 SGKSDVYSYGMLLLEMI------EEKKHLRPT--ETTSGSNTTEAYFPDWIYDKLIQPEK 580
DV+S G++L M+ ++ + + Y W I
Sbjct: 187 E-PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPWKK---IDSAP 238
Query: 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ K+++ NP R ++ + +
Sbjct: 239 LALL--------HKILVE-------NPSARITIPDIKK 261
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 23/201 (11%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLEKT-----SNFSDNFINEVATIGRIHHVNIIHLL 407
LG G YG V + AVK+L+K N N E+ + R+ H N+I L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 408 GFCCDGSTRALIY---EYMPNGS--LGDLLSREKENLSLKPARLL--EIALGVAHAIEYL 460
+ +Y EY G + D + ++ + A ++ G+ EYL
Sbjct: 73 DVL-YNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLIDGL----EYL 125
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 520
H+ I+H DIKP N+LL T K+S G+A+A + T +G+ + PEI
Sbjct: 126 HS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 521 FMRNLGNPSGKSDVYSYGMLL 541
K D++S G+ L
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTL 203
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 73/313 (23%), Positives = 120/313 (38%), Gaps = 68/313 (21%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN-------EVATIGRIHHV-- 401
LG+GG+G+VY G D VA+K +EK + EV + ++
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 402 NIIHLLGFCCDGSTRALIYEY-MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 460
+I LL + + LI E P L D ++ E+ L + AR V A+ +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-ERGALQEELAR--SFFWQVLEAVRHC 165
Query: 461 HNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 519
HN +LH DIK +N+L+D + K+ DFG A ++ GT Y PE
Sbjct: 166 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPE 218
Query: 520 IFMRNL--GNPSGKSDVYSYGMLLLEMI-------EEKKHLRPTETTSGSNTTEAYFPDW 570
+ G + V+S G+LL +M+ +++ +R + +F
Sbjct: 219 WIRYHRYHGRS---AAVWSLGILLYDMVCGDIPFEHDEEIIR----------GQVFFRQR 265
Query: 571 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE----MLSSASAE 626
+ +C + +I WC+ + P DRP+ + E
Sbjct: 266 V---------------SSEC--QHLI---RWCLALRPSDRPTFEEIQNHPWMQDVLLPQE 305
Query: 627 AIEMPPKPLFPSP 639
E+ L P P
Sbjct: 306 TAEIHLHSLSPGP 318
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 27/235 (11%)
Query: 322 NVKQFIKTYRSALLSNYSYNDIKKMTNG---FKEKLGTGGYGNVYKGKF-PDGRLVAVKV 377
+VK+F+ + L + + LGTG +G V K G A+K+
Sbjct: 14 SVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 378 LEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLS 433
L+K ++ +NE + ++ ++ L D S ++ EY+ G + L
Sbjct: 74 LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 434 REKENLSLKPARL--LEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDF 491
R S AR +I L EYLH L +++ D+KP+N+L+D +V+DF
Sbjct: 134 RIGR-FSEPHARFYAAQIVL----TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 492 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKS-DVYSYGMLLLEMI 545
G AK T T GT +APEI L K+ D ++ G+L+ EM
Sbjct: 186 GFAKRVKGR----TWT-LCGTPEALAPEII---LSKGYNKAVDWWALGVLIYEMA 232
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 38/210 (18%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHLL 407
EK+G G YG VYK K GR+VA+K + + + I E++ + +HH NI+ L+
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRI-RLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR-----LLEIALGVAHAIEYLHN 462
L++E+M L +L K L + LL + + H
Sbjct: 86 DVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLR-------GVAHCH- 136
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRS----VVTMTGPRGTIGYIA 517
+ RILH D+KPQN+L++ D K++DFGLA+A RS VVT+ Y A
Sbjct: 137 --QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL-------WYRA 187
Query: 518 PEIFMRNLGNP--SGKSDVYSYGMLLLEMI 545
P++ +G+ S D++S G + EMI
Sbjct: 188 PDVL---MGSKKYSTSVDIWSIGCIFAEMI 214
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 26/203 (12%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLL 407
+ LG G G V + A+K+L+ EV R +I+ ++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIV 121
Query: 408 GFCCDGSTRA----LIYEYMPNGSLGD-LLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
+ ++ E + G L + R + + + A EI + AI+YLH
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS--EIMKSIGEAIQYLH- 178
Query: 463 GCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 519
+ I H D+KP+N+L P+ K++DFG AK + + ++T P T Y+APE
Sbjct: 179 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPE 233
Query: 520 IFMRNLGNPSGKS-DVYSYGMLL 541
+ KS D++S G+++
Sbjct: 234 VLGP---EKYDKSCDMWSLGVIM 253
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 66/278 (23%), Positives = 109/278 (39%), Gaps = 44/278 (15%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLEKT--SNFSDNFINEVATIGRIHHVNIIHLLGFC 410
LG G YG V VAVK+++ + +N E+ ++H N++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 411 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGCELRI 468
+G+ + L EY G L D + + A+ ++ GV YLH + I
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGV----VYLHG---IGI 126
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
H DIKP+N+LLD K+SDFGLA N + GT+ Y+APE+ R +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 529 SGKSDVYSYGMLLLEMI------EEKKHLRPT--ETTSGSNTTEAYFPDWIYDKLIQPEK 580
DV+S G++L M+ ++ + + Y W I
Sbjct: 187 E-PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPWKK---IDSAP 238
Query: 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ K+++ NP R ++ + +
Sbjct: 239 LALL--------HKILVE-------NPSARITIPDIKK 261
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 20/195 (10%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN---EVATIGRIHHVNIIHLLGF 409
+G G + V + GR VA+K+++KT + EV + ++H NI+ L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 410 CCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
T +Y EY G + D L + K AR + A++Y H
Sbjct: 83 I---ETEKTLYLIMEYASGGEVFDYLV-AHGRMKEKEAR--SKFRQIVSAVQYCHQ---K 133
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
RI+H D+K +N+LLD D K++DFG + + + G Y APE+F
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPELFQGKKY 190
Query: 527 NPSGKSDVYSYGMLL 541
+ + DV+S G++L
Sbjct: 191 DGP-EVDVWSLGVIL 204
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 1e-21
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 28/205 (13%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHLL 407
EK+G G YG VYK + G A+K + + + I E++ + + H NI+ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKI-RLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
L++E++ L LL + L A+ + L + I Y H + R
Sbjct: 67 DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQL--LNGIAYCH---DRR 120
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRS----VVTMTGPRGTIGYIAPEIFM 522
+LH D+KPQN+L++ + K++DFGLA+A R +VT+ Y AP++
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL-------WYRAPDVL- 172
Query: 523 RNLGNP--SGKSDVYSYGMLLLEMI 545
+G+ S D++S G + EM+
Sbjct: 173 --MGSKKYSTTIDIWSVGCIFAEMV 195
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-21
Identities = 68/259 (26%), Positives = 109/259 (42%), Gaps = 38/259 (14%)
Query: 307 KKPFSEERQNIGDGLNVKQFIKTYRSALLS---NYSYNDIKKMT-NGFKEK--LGTGGYG 360
K F E + + L+V F S + + + + + +T N F++ LG GG+G
Sbjct: 139 KDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFG 198
Query: 361 NVYKGKFPD-GRLVAVKVLEKTSNFSDNFI----NEVATIGRIHHVNIIHLLGFCCDGST 415
V + G++ A K LEK NE + +++ ++ L +
Sbjct: 199 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL--AYAYETK 256
Query: 416 RAL--IYEYMPNGSLGDL---LSRE-KENLSLKPARL--LEIALGVAHAIEYLHNGCELR 467
AL + M NG GDL + + A EI +E LH R
Sbjct: 257 DALCLVLTLM-NG--GDLKFHIYHMGQAGFPEARAVFYAAEICC----GLEDLH---RER 306
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
I++ D+KP+N+LLD ++SD GLA +++ GT+GY+APE+
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAPEVV---KNE 360
Query: 528 PSGKS-DVYSYGMLLLEMI 545
S D ++ G LL EMI
Sbjct: 361 RYTFSPDWWALGCLLYEMI 379
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 2e-21
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 39/219 (17%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHL 406
EK+G G YG V+K K +VA+K + + + + + E+ + + H NI+ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR-----LLEIALGVAHAIEYLH 461
L++E+ L +L + + LL+ + + H
Sbjct: 67 HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLK-------GLGFCH 118
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRS----VVTMTGPRGTIGYI 516
+LH D+KPQN+L++ + K+++FGLA+A R VVT+ Y
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL-------WYR 168
Query: 517 APEIFMRNLGNP--SGKSDVYSYGMLLLEMIEEKKHLRP 553
P++ G S D++S G + E+ + L P
Sbjct: 169 PPDVL---FGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 3e-21
Identities = 66/200 (33%), Positives = 99/200 (49%), Gaps = 24/200 (12%)
Query: 354 LGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFI----NEVATIGRIHHVNIIHLLG 408
LGTG +G V+ + +GR A+KVL+K + +E + + H II + G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCEL 466
D +I +Y+ G L LL + + A+ E+ L A+EYLH
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCL----ALEYLH---SK 125
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
I++ D+KP+N+LLD + K++DFG AK VT T GT YIAPE+
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYT-LCGTPDYIAPEVV---ST 177
Query: 527 NPSGKS-DVYSYGMLLLEMI 545
P KS D +S+G+L+ EM+
Sbjct: 178 KPYNKSIDWWSFGILIYEML 197
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 52/228 (22%)
Query: 351 KEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKT---------------------------S 382
K+++G G YG V D A+KVL K
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 383 NFSDNFINEVATIGRIHHVNIIHL---LGFCCDGSTRALIY---EYMPNGSLGDLLSREK 436
+ E+A + ++ H N++ L L D +Y E + G + ++ + +
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVL----DDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 437 ENLSLKPARLL--EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 494
LS AR ++ G+ EYLH +I+H DIKP N+L+ D K++DFG++
Sbjct: 134 --LSEDQARFYFQDLIKGI----EYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 495 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSG-KSDVYSYGMLL 541
+ ++++ T GT ++APE SG DV++ G+ L
Sbjct: 185 NEFKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 3e-21
Identities = 60/260 (23%), Positives = 101/260 (38%), Gaps = 38/260 (14%)
Query: 307 KKPFSEERQNIGDGLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKEK-------LGTGGY 359
F + I L F K S + + ++ +G GG+
Sbjct: 143 PDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGF 202
Query: 360 GNVYKGKFPD-GRLVAVKVLEKTSNFSDNFI----NE---VATIGRIHHVNIIHLLGFCC 411
G VY + D G++ A+K L+K NE ++ + I+ +
Sbjct: 203 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM--SYA 260
Query: 412 DGSTRAL--IYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNGCELR 467
+ L I + M G L LS+ S R EI L +E++H
Sbjct: 261 FHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIIL----GLEHMH---NRF 312
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-GTIGYIAPEIFMRNLG 526
+++ D+KP N+LLD ++SD GLA S+ + GT GY+APE+ + +
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHASVGTHGYMAPEVLQKGVA 367
Query: 527 NPSGKS-DVYSYGMLLLEMI 545
S D +S G +L +++
Sbjct: 368 Y--DSSADWFSLGCMLFKLL 385
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 6e-21
Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 23/200 (11%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD 412
+G+G +G + LVAVK +E+ + +N E+ + H NI+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 413 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNGCELRILH 470
+ A+I EY G L + + S AR ++ GV Y H+ ++I H
Sbjct: 88 PTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGV----SYCHS---MQICH 139
Query: 471 LDIKPQNVLLDPDFTP--KVSDFGLAKA---HSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
D+K +N LLD P K+ DFG +K+ HS+ +S V GT YIAPE+ +R
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLRQE 193
Query: 526 GNPSGKSDVYSYGMLLLEMI 545
+ +DV+S G+ L M+
Sbjct: 194 YDGK-IADVWSCGVTLYVML 212
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 30/208 (14%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNF----INEVATIGRIHHVNII 404
+ LG G + VYK + ++VA+K L S D + E+ + + H NII
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
LL S +L++++M L ++ + +L L P+ + L +EYLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYLH--- 129
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRS----VVTMTGPRGTIGYIAPE 519
+ ILH D+KP N+LLD + K++DFGLAK+ S NR+ VV T Y APE
Sbjct: 130 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-------TRWYRAPE 182
Query: 520 IFMRNLGNP--SGKSDVYSYGMLLLEMI 545
+ G D+++ G +L E++
Sbjct: 183 LL---FGARMYGVGVDMWAVGCILAELL 207
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 26/204 (12%)
Query: 352 EKLGTGGYGNVYKGKFPD-GRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
+KLG G Y VYKGK LVA+K LE I EV+ + + H NI+ L
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+ L++EY+ L L +++ +L L + Y H ++
Sbjct: 68 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL--LRGLAYCH---RQKV 121
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRS----VVTMTGPRGTIGYIAPEIFMR 523
LH D+KPQN+L++ K++DFGLA+A ++ VVT+ Y P+I
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTL-------WYRPPDIL-- 172
Query: 524 NLGNP--SGKSDVYSYGMLLLEMI 545
LG+ S + D++ G + EM
Sbjct: 173 -LGSTDYSTQIDMWGVGCIFYEMA 195
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 2e-20
Identities = 64/261 (24%), Positives = 104/261 (39%), Gaps = 39/261 (14%)
Query: 307 KKPFSEERQNIGDGLNVKQFIKTYRSALLS---NYSYNDIKKMT-NGFKEK--LGTGGYG 360
F + + L F + S + + + + M + F + LG GG+G
Sbjct: 140 DGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFG 199
Query: 361 NVYKGKFPD-GRLVAVKVLEKTSNFSDNFI----NEVATIGRIHHVNIIHLLGFCCDGST 415
V+ + G+L A K L K E + ++H I+ L +
Sbjct: 200 EVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL--AYAFETK 257
Query: 416 RAL--IYEYMPNGSLGDL------LSREKENLSLKPARL--LEIALGVAHAIEYLHNGCE 465
L + M NG GD+ + + A +I +E+LH +
Sbjct: 258 TDLCLVMTIM-NG--GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS----GLEHLH---Q 307
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
I++ D+KP+NVLLD D ++SD GLA ++ G GT G++APE+ L
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELL---L 362
Query: 526 GNPSGKS-DVYSYGMLLLEMI 545
G S D ++ G+ L EMI
Sbjct: 363 GEEYDFSVDYFALGVTLYEMI 383
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 41/214 (19%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
EKLG G Y VYKG G VA+K L+ I E++ + + H NI+ L
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAH----------AIE 458
+ L++E+M N DL K+ + + L + +
Sbjct: 71 VIHTENKLTLVFEFMDN----DL----KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 459 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRS----VVTMTGPRGTI 513
+ H +ILH D+KPQN+L++ K+ DFGLA+A + VVT+
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL------- 172
Query: 514 GYIAPEIFMRNLGNP--SGKSDVYSYGMLLLEMI 545
Y AP++ +G+ S D++S G +L EMI
Sbjct: 173 WYRAPDVL---MGSRTYSTSIDIWSCGCILAEMI 203
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-20
Identities = 58/198 (29%), Positives = 89/198 (44%), Gaps = 25/198 (12%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN----EVATIGRIHHVNIIHLLG 408
LG G +G V G+ G VAVK+L + S + + E+ + H +II L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 409 FCCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNG 463
ST + EY+ G L D + + + AR L +I V +Y H
Sbjct: 79 VI---STPTDFFMVMEYVSGGELFDYIC-KHGRVEEMEARRLFQQILSAV----DYCHR- 129
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
++H D+KP+NVLLD K++DFGL+ S + T G+ Y APE+
Sbjct: 130 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISG 184
Query: 524 NLGNPSGKSDVYSYGMLL 541
L + D++S G++L
Sbjct: 185 RLYAGP-EVDIWSCGVIL 201
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 35/208 (16%)
Query: 354 LGTGGYGNVY---KGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIG------RIHHVNI 403
LG G +G V+ K D +L A+KVL+K + + V T ++H I
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEVNHPFI 88
Query: 404 IHLLGFCC--DGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEY 459
+ L LI +++ G L LS+E + + + L E+AL A+++
Sbjct: 89 VKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELAL----ALDH 141
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAP 518
LH L I++ D+KP+N+LLD + K++DFGL+K + + GT+ Y+AP
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---GTVEYMAP 195
Query: 519 EIFMRNLGNPSGKS-DVYSYGMLLLEMI 545
E+ +S D +S+G+L+ EM+
Sbjct: 196 EVV---NRRGHTQSADWWSFGVLMFEML 220
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 35/211 (16%)
Query: 354 LGTGGYGNVY---KGKFPD-GRLVAVKVLEKTSNFSDNFINEVA-TIG--RI-----HHV 401
LGTG YG V+ K D G+L A+KVL+K + T ++
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA--KTTEHTRTERQVLEHIRQSP 119
Query: 402 NIIHLLGFCC--DGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAI 457
++ L + LI +Y+ G L LS+ + + + + EI L A+
Sbjct: 120 FLVTL--HYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVL----AL 172
Query: 458 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 517
E+LH +L I++ DIK +N+LLD + ++DFGL+K + + GTI Y+A
Sbjct: 173 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMA 228
Query: 518 PEIFMRNLGNPSG--KS-DVYSYGMLLLEMI 545
P+I G SG K+ D +S G+L+ E++
Sbjct: 229 PDIV---RGGDSGHDKAVDWWSLGVLMYELL 256
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 3e-19
Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 48/224 (21%)
Query: 351 KEKLGTGGYGNVYKGKFPD---GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLL 407
K+G G YG+VYK K D + A+K +E T S + E+A + + H N+I L
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPNVISLQ 84
Query: 408 GFCCDGSTRA--LIYEYMPNGSLGDLLS---------REKENLSLKPARLLEIALGVAHA 456
+ R L+++Y + DL K+ + L + + +
Sbjct: 85 KVFLSHADRKVWLLFDYAEH----DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 457 IEYLHNGCELRILHLDIKPQNVLLDPDFTP----KVSDFGLAKA---------HSRNRSV 503
I YLH +LH D+KP N+L+ + K++D G A+ V
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV-V 196
Query: 504 VTMTGPRGTIGYIAPEIFMRNLGNPS-GKS-DVYSYGMLLLEMI 545
V T Y APE+ LG K+ D+++ G + E++
Sbjct: 197 V-------TFWYRAPELL---LGARHYTKAIDIWAIGCIFAELL 230
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 47/207 (22%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 352 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHL 406
K+G G YG V+K + D G++VA+K S + E+ + ++ H N+++L
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHPNLVNL 67
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSR-EKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
L L++EY + +L ++ + + I A+ + H +
Sbjct: 68 LEVFRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---K 120
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRS----VVTMTGPRGTIGYIAPEI 520
+H D+KP+N+L+ K+ DFG A+ + V T Y +PE+
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW-------YRSPEL 173
Query: 521 FMRNLGNPS-GKS-DVYSYGMLLLEMI 545
+G+ G DV++ G + E++
Sbjct: 174 L---VGDTQYGPPVDVWAIGCVFAELL 197
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 43/186 (23%), Positives = 77/186 (41%), Gaps = 28/186 (15%)
Query: 320 GLNVKQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVL 378
G +VK ++ ++A++ +Y + LG G G V + A+K+L
Sbjct: 1 GPHVKSGLQIKKNAIIDDYKV---------TSQVLGLGINGKVLQIFNKRTQEKFALKML 51
Query: 379 EKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRA----LIYEYMPNGSLGD-LL 432
+ EV R +I+ ++ + ++ E + G L +
Sbjct: 52 QD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ 107
Query: 433 SREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVS 489
R + + + A EI + AI+YLH + I H D+KP+N+L P+ K++
Sbjct: 108 DRGDQAFTEREAS--EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLT 162
Query: 490 DFGLAK 495
DFG AK
Sbjct: 163 DFGFAK 168
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 59/211 (27%), Positives = 88/211 (41%), Gaps = 35/211 (16%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHL 406
KLG G YG VYK VA+K + + + + I EV+ + + H NII L
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
LI+EY N DL +N + + + + + + H+
Sbjct: 99 KSVIHHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR--- 151
Query: 467 RILHLDIKPQNVLLDPDFTP-----KVSDFGLAKAHSR-NRS----VVTMTGPRGTIGYI 516
R LH D+KPQN+LL K+ DFGLA+A R ++ T+ Y
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-------TLWYR 204
Query: 517 APEIFMRNLGNP--SGKSDVYSYGMLLLEMI 545
PEI LG+ S D++S + EM+
Sbjct: 205 PPEIL---LGSRHYSTSVDIWSIACIWAEML 232
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSNFSDNF----INEVATIGRIH---HV 401
++G G YG VYK + G VA+K + + EVA + R+ H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 402 NIIHLLGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHA 456
N++ L+ C T L++E++ L L + L + ++
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-PGLPAETIKDLMRQFLRG 132
Query: 457 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 516
+++LH I+H D+KP+N+L+ T K++DFGLA+ +S + +T T+ Y
Sbjct: 133 LDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLWYR 186
Query: 517 APEIFMRNLGNPSGKS-DVYSYGMLLLEMI 545
APE+ L + D++S G + EM
Sbjct: 187 APEVL---LQSTYATPVDMWSVGCIFAEMF 213
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 39/211 (18%)
Query: 352 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHL 406
+G G YG V K + D GR+VA+K S+ + E+ + ++ H N+++L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR-----LLEIALGVAHAIEYLH 461
L C L++E++ + ++ D L L + + ++ I + H
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN-------GIGFCH 141
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRS----VVTMTGPRGTIGYI 516
I+H DIKP+N+L+ K+ DFG A+ + V T Y
Sbjct: 142 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW-------YR 191
Query: 517 APEIFMRNLGNPS-GKS-DVYSYGMLLLEMI 545
APE+ +G+ GK+ DV++ G L+ EM
Sbjct: 192 APELL---VGDVKYGKAVDVWAIGCLVTEMF 219
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 41/212 (19%)
Query: 354 LGTGGYGNVY---KGKFPD-GRLVAVKVLEKTSNFSDNFINEVA-TIG------RIHHVN 402
LG GGYG V+ K + G++ A+KVL+K + + A T + H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA--KDTAHTKAERNILEEVKHPF 82
Query: 403 IIHLLGFCC--DGSTRALIYEYMPNGSLGDL---LSREKENLSLKPAR--LLEIALGVAH 455
I+ L G LI EY+ +G G+L L RE A L EI++
Sbjct: 83 IVDL--IYAFQTGGKLYLILEYL-SG--GELFMQLEREG-IFMEDTACFYLAEISM---- 132
Query: 456 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIG 514
A+ +LH + I++ D+KP+N++L+ K++DFGL K T GTI
Sbjct: 133 ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIE 186
Query: 515 YIAPEIFMRNLGNPSGKS-DVYSYGMLLLEMI 545
Y+APEI + + ++ D +S G L+ +M+
Sbjct: 187 YMAPEIL---MRSGHNRAVDWWSLGALMYDML 215
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 37/219 (16%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNF----INEVATIGRIHHVNIIHL 406
K+G G +G V+K + G+ VA+K + N + F + E+ + + H N+++L
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 407 LGFCCDGSTRA--------LIYEYMPNGSLGDLLSREKENLSLKPAR-----LLEIALGV 453
+ C ++ L++++ + L LLS +L + LL
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLN----- 135
Query: 454 AHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS--RNRSVVTMTGPRG 511
+ Y+H +ILH D+K NVL+ D K++DFGLA+A S +N T
Sbjct: 136 --GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190
Query: 512 TIGYIAPEIFMRNLGNP--SGKSDVYSYGMLLLEMIEEK 548
T+ Y PE+ LG D++ G ++ EM
Sbjct: 191 TLWYRPPELL---LGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-18
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 30/205 (14%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATI-------GRIHHVNIIH 405
LG G +G V K GR A+K+L+K + + EVA H +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD---EVAHTLTENRVLQNSRHPFLTA 212
Query: 406 LLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHN 462
L + R + EY G L LSRE+ S AR EI A++YLH+
Sbjct: 213 LK-YSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFYGAEIVS----ALDYLHS 266
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEIF 521
E +++ D+K +N++LD D K++DFGL K ++ T GT Y+APE+
Sbjct: 267 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---GTPEYLAPEVL 321
Query: 522 MRNLGNPSGKS-DVYSYGMLLLEMI 545
N G++ D + G+++ EM+
Sbjct: 322 ---EDNDYGRAVDWWGLGVVMYEMM 343
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 37/208 (17%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATI-------GRIHHVNIIH 405
LG G +G V + GR A+K+L K + + EVA H +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD---EVAHTVTESRVLQNTRHPFLTA 69
Query: 406 LLGFCCDGSTRA-LIYEYMPNGSLGDL---LSREKENLSLKPAR--LLEIALGVAHAIEY 459
L + R + EY NG G+L LSRE+ + + AR EI A+EY
Sbjct: 70 LK-YAFQTHDRLCFVMEYA-NG--GELFFHLSRERV-FTEERARFYGAEIVS----ALEY 120
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAP 518
LH +++ DIK +N++LD D K++DFGL K S ++ T GT Y+AP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAP 174
Query: 519 EIFMRNLGNPSGKS-DVYSYGMLLLEMI 545
E+ N G++ D + G+++ EM+
Sbjct: 175 EVL---EDNDYGRAVDWWGLGVVMYEMM 199
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 4e-18
Identities = 62/198 (31%), Positives = 93/198 (46%), Gaps = 25/198 (12%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN----EVATIGRIHHVNIIHLLG 408
LG G +G V GK G VAVK+L + S + + E+ + H +II L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 409 FCCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNG 463
ST + I+ EY+ G L D + + L K +R L +I GV +Y H
Sbjct: 84 VI---STPSDIFMVMEYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGV----DYCHR- 134
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
++H D+KP+NVLLD K++DFGL+ S + T G+ Y APE+
Sbjct: 135 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISG 189
Query: 524 NLGNPSGKSDVYSYGMLL 541
L + D++S G++L
Sbjct: 190 RLYAGP-EVDIWSSGVIL 206
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 48/217 (22%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFIN-EVATIGRIHHVNIIHLLG- 408
+ +G G +G VY+ K G LVA+K K F N E+ + ++ H NI+ L
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIK---KVLQDKR-FKNRELQIMRKLDHCNIVRLRYF 115
Query: 409 FCCDGSTRA-----LIYEYMPNGSLGDL------LSREKENLSLKPARLL--EIALGVAH 455
F G + L+ +Y+P + SR K+ L + +L ++ +A
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA- 170
Query: 456 AIEYLHNGCELRILHLDIKPQNVLLDPDFTP-KVSDFGLAKAHSRNRSVVTMTGPRGTIG 514
Y+H+ I H DIKPQN+LLDPD K+ DFG AK R V+
Sbjct: 171 ---YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------- 215
Query: 515 YI------APEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
YI APE+ + + + DV+S G +L E++
Sbjct: 216 YICSRYYRAPEL-IFGATDYTSSIDVWSAGCVLAELL 251
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 63/206 (30%), Positives = 93/206 (45%), Gaps = 32/206 (15%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 407
LG G +G V + + G L AVKVL+K D+ + T RI +H + L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 408 GFCCDGSTRA-LIYEYMPNGSLGDL---LSREKENLSLKPAR--LLEIALGVAHAIEYLH 461
C R + E++ NG GDL + + + AR EI A+ +LH
Sbjct: 91 -CCFQTPDRLFFVMEFV-NG--GDLMFHIQKSRR-FDEARARFYAAEIIS----ALMFLH 141
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEI 520
+ I++ D+K NVLLD + K++DFG+ K + T GT YIAPEI
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC---GTPDYIAPEI 195
Query: 521 FMRNLGNPSGKS-DVYSYGMLLLEMI 545
G + D ++ G+LL EM+
Sbjct: 196 L---QEMLYGPAVDWWAMGVLLYEML 218
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 44/218 (20%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVK-VLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
G G +G V GK G VA+K V++ F + + + + +HH NI+ L +
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSY 87
Query: 410 CCDGSTRA-------LIYEYMPNGSLGDL------LSREKENLSLKPARLL--EIALGVA 454
R ++ EY+P+ L R + ++ ++ +
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPD----TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIG 143
Query: 455 HAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 513
LH + + H DIKP NVL++ D T K+ DFG AK S +
Sbjct: 144 ----CLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNV------ 189
Query: 514 GYI------APEIFMRNLGNPSGKSDVYSYGMLLLEMI 545
YI APE+ + + + D++S G + EM+
Sbjct: 190 AYICSRYYRAPEL-IFGNQHYTTAVDIWSVGCIFAEMM 226
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 32/206 (15%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 407
+G G Y V + R+ A+KV++K D I+ V T + +H ++ L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 408 GFCCDGSTRA-LIYEYMPNGSLGDL---LSREKENLSLKPAR--LLEIALGVAHAIEYLH 461
C +R + EY+ NG GDL + R+++ L + AR EI+L A+ YLH
Sbjct: 77 -SCFQTESRLFFVIEYV-NG--GDLMFHMQRQRK-LPEEHARFYSAEISL----ALNYLH 127
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEI 520
E I++ D+K NVLLD + K++D+G+ K + T GT YIAPEI
Sbjct: 128 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEI 181
Query: 521 FMRNLGNPSGKS-DVYSYGMLLLEMI 545
G G S D ++ G+L+ EM+
Sbjct: 182 L---RGEDYGFSVDWWALGVLMFEMM 204
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 51/218 (23%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFIN-EVATIGRIHHVNIIHLLG-F 409
+ +G G +G V++ K + VA+K K F N E+ + + H N++ L F
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIK---KVLQDKR-FKNRELQIMRIVKHPNVVDLKAFF 101
Query: 410 CCDGSTRA-----LIYEYMPNGSLGDL------LSREKENLSLKPARLL--EIALGVAHA 456
+G + L+ EY+P + ++ K+ + + +L ++ +A
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE----TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA-- 155
Query: 457 IEYLHNGCELRILHLDIKPQNVLLDPDFTP-KVSDFGLAKAHSRNRSVVTMTGPRGTIGY 515
Y+H+ + I H DIKPQN+LLDP K+ DFG AK Y
Sbjct: 156 --YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE---PNV------SY 201
Query: 516 I------APEIFMRNLGNP--SGKSDVYSYGMLLLEMI 545
I APE+ G + D++S G ++ E++
Sbjct: 202 ICSRYYRAPELI---FGATNYTTNIDIWSTGCVMAELM 236
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 32/206 (15%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 407
+G G Y V + R+ A++V++K D I+ V T + +H ++ L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 408 GFCCDGSTRA-LIYEYMPNGSLGDL---LSREKENLSLKPAR--LLEIALGVAHAIEYLH 461
C +R + EY+ NG GDL + R+++ L + AR EI+L A+ YLH
Sbjct: 120 -SCFQTESRLFFVIEYV-NG--GDLMFHMQRQRK-LPEEHARFYSAEISL----ALNYLH 170
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEI 520
E I++ D+K NVLLD + K++D+G+ K + T GT YIAPEI
Sbjct: 171 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEI 224
Query: 521 FMRNLGNPSGKS-DVYSYGMLLLEMI 545
G G S D ++ G+L+ EM+
Sbjct: 225 L---RGEDYGFSVDWWALGVLMFEMM 247
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 407
LG G +G V + L AVK+L+K D+ + R+ + L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 408 GFCCDGSTRA-LIYEYMPNGSLGDL---LSREKENLSLKPAR--LLEIALGVAHAIEYLH 461
C R + EY+ NG GDL + + A EIA+ + +L
Sbjct: 88 -SCFQTMDRLYFVMEYV-NG--GDLMYHIQQVGR-FKEPHAVFYAAEIAI----GLFFLQ 138
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEI 520
I++ D+K NV+LD + K++DFG+ K + + T GT YIAPEI
Sbjct: 139 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---GTPDYIAPEI 192
Query: 521 FMRNLGNPSGKS-DVYSYGMLLLEMI 545
P GKS D +++G+LL EM+
Sbjct: 193 I---AYQPYGKSVDWWAFGVLLYEML 215
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 31/211 (14%)
Query: 352 EKLGTGGYGNVYKGK--FPDGRLVAVKVLEKTSNFSDNF----INEVAT---IGRIHHVN 402
++G G YG V+K + GR VA+K + + + I EVA + H N
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 403 IIHLLGFCCDGSTRA-----LIYEYMPNGSLGDL--LSREKENLSLKPARLLEIALGVAH 455
++ L C T L++E++ DL + + + ++ +
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 456 AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGY 515
+++LH R++H D+KPQN+L+ K++DFGLA+ +S + +T T+ Y
Sbjct: 132 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWY 185
Query: 516 IAPEIFMRNLGNPSGKS-DVYSYGMLLLEMI 545
APE+ L + D++S G + EM
Sbjct: 186 RAPEVL---LQSSYATPVDLWSVGCIFAEMF 213
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 26/198 (13%)
Query: 354 LGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN----EVATIGRIHHVNIIHLLG 408
LG G +G V + + VA+K + + + E++ + + H +II L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 409 FCCDGSTRALIY---EYMPNGSLGDLLSREKENLSLKPARLL--EIALGVAHAIEYLHNG 463
+T I EY G L D + EK+ ++ R +I AIEY H
Sbjct: 77 VI---TTPTDIVMVIEYA-GGELFDYIV-EKKRMTEDEGRRFFQQII----CAIEYCHR- 126
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
+I+H D+KP+N+LLD + K++DFGL+ + + T G+ Y APE+
Sbjct: 127 --HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVING 181
Query: 524 NLGNPSGKSDVYSYGMLL 541
L + DV+S G++L
Sbjct: 182 KLYAGP-EVDVWSCGIVL 198
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 26/203 (12%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 407
LG G +G V+ +F + A+K L+K D+ + R+ H + H+
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM- 83
Query: 408 GFCC--DGSTRALIYEYMPNGSLGDLLSREKENLSLKPAR--LLEIALGVAHAIEYLHNG 463
FC + EY+ G L + + L A EI L +++LH
Sbjct: 84 -FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIIL----GLQFLH-- 135
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
I++ D+K N+LLD D K++DFG+ K + + T T GT YIAPEI
Sbjct: 136 -SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFC-GTPDYIAPEIL-- 190
Query: 524 NLGNPSGKS-DVYSYGMLLLEMI 545
LG S D +S+G+LL EM+
Sbjct: 191 -LGQKYNHSVDWWSFGVLLYEML 212
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 30/205 (14%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH--LLGFC 410
+G G +G V + AVKVL+K + + + + N+ H L+G
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 411 CDGSTRALIY---EYMPNGSLGDL---LSREKENLSLKPAR--LLEIALGVAHAIEYLHN 462
T +Y +Y+ NG G+L L RE+ AR EIA A+ YLH
Sbjct: 106 FSFQTADKLYFVLDYI-NG--GELFYHLQRERC-FLEPRARFYAAEIAS----ALGYLH- 156
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEIF 521
L I++ D+KP+N+LLD ++DFGL K + N + T GT Y+APE+
Sbjct: 157 --SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC---GTPEYLAPEVL 211
Query: 522 MRNLGNPSGKS-DVYSYGMLLLEMI 545
P ++ D + G +L EM+
Sbjct: 212 ---HKQPYDRTVDWWCLGAVLYEML 233
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 9e-17
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 32/206 (15%)
Query: 354 LGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIHLL 407
LG G +G V + L AVK+L+K D+ + R+ + L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 408 GFCCDGSTRA-LIYEYMPNGSLGDL---LSREKENLSLKPAR--LLEIALGVAHAIEYLH 461
C R + EY+ NG GDL + + A EIA+ + +L
Sbjct: 409 -SCFQTMDRLYFVMEYV-NG--GDLMYHIQQVGR-FKEPHAVFYAAEIAI----GLFFLQ 459
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH-SRNRSVVTMTGPRGTIGYIAPEI 520
I++ D+K NV+LD + K++DFG+ K + + T GT YIAPEI
Sbjct: 460 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---GTPDYIAPEI 513
Query: 521 FMRNLGNPSGKS-DVYSYGMLLLEMI 545
P GKS D +++G+LL EM+
Sbjct: 514 I---AYQPYGKSVDWWAFGVLLYEML 536
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 38/216 (17%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIH 405
KLG G Y V++ + V VK+L+ E+ +I NII
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREI----KILENLRGGPNIIT 95
Query: 406 LLGFCCDGSTR--ALIYEYMPNGSLGDLLSREKENLSLKPAR-----LLEIALGVAHAIE 458
L D +R AL++E++ N L + L+ R +L+ A++
Sbjct: 96 LADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILK-------ALD 144
Query: 459 YLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 517
Y H+ I+H D+KP NV++D + ++ D+GLA+ + + + +
Sbjct: 145 YCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKG 198
Query: 518 PEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 553
PE+ + + D++S G +L MI K+
Sbjct: 199 PEL-LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 46/219 (21%), Positives = 83/219 (37%), Gaps = 37/219 (16%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDN---FIN---------EVATIGRIH 399
+ +G YG V G +G VA+K + T + + E+ + H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 400 HVNIIHLLGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPAR-----LLEI 449
H NI+ L A L+ E M L ++ ++ +S + + +L
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL-- 144
Query: 450 ALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 509
+ LH ++H D+ P N+LL + + DF LA+ + + + T
Sbjct: 145 -----LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHY 193
Query: 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 548
Y APE+ + + D++S G ++ EM K
Sbjct: 194 VTHRWYRAPEL-VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 57/249 (22%), Positives = 90/249 (36%), Gaps = 80/249 (32%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFIN-EVATIGRIHHVNIIHLL-G 408
+ LGTG +G V + G+ A+K K + N E+ + + HVNII L+
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALK---KVLQDP-RYKNRELDIMKVLDHVNIIKLVDY 68
Query: 409 FCCDGSTRA-------------------------------------LIYEYMPNGSLGDL 431
F G +I EY+P+ L
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD----TL 124
Query: 432 ------LSREKENLSLKPARLL--EIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP- 482
R ++ + + ++ V ++H+ L I H DIKPQN+L++
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVG----FIHS---LGICHRDIKPQNLLVNSK 177
Query: 483 DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI------APEIFMRNLGNPSGKSDVYS 536
D T K+ DFG AK + YI APE+ M + D++S
Sbjct: 178 DNTLKLCDFGSAKKLIPSE---PSV------AYICSRFYRAPEL-MLGATEYTPSIDLWS 227
Query: 537 YGMLLLEMI 545
G + E+I
Sbjct: 228 IGCVFGELI 236
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 50/218 (22%), Positives = 97/218 (44%), Gaps = 37/218 (16%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV--------- 401
KLG G + V+ K + VA+K++ +++ +E+ + R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 402 --NIIHLLG-FCCDGSTRA---LIYEYMPNGSLGDLLSREKEN-LSLKPARLLEIALGVA 454
+I+ LL F G +++E + +L L+ + + + L + +I+ +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK--QISKQLL 141
Query: 455 HAIEYLHNGCELRILHLDIKPQNVLLDP------DFTPKVSDFGLAKAHSRNRSVVTMTG 508
++Y+H C I+H DIKP+NVL++ K++D G A + + + T
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 509 PRGTIGYIAPEIFMRNLGNPSGKS-DVYSYGMLLLEMI 545
Y +PE+ LG P G D++S L+ E+I
Sbjct: 200 E-----YRSPEVL---LGAPWGCGADIWSTACLIFELI 229
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 32/211 (15%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIHHVNII 404
+ +G+G G V R VA+K K S N + E+ + ++H NII
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKCVNHKNII 87
Query: 405 HLLG-FCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 458
LL F S ++ E M +L + L R+ + + I+
Sbjct: 88 GLLNVFTPQKSLEEFQDVYIVMELMDA----NLCQVIQMELD--HERMSYLLYQMLCGIK 141
Query: 459 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 518
+LH+ I+H D+KP N+++ D T K+ DFGLA+ + MT T Y AP
Sbjct: 142 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP 195
Query: 519 EIFMRNLGNPSGKS-DVYSYGMLLLEMIEEK 548
E+ LG ++ D++S G ++ EMI+
Sbjct: 196 EVI---LGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIHHVNII 404
+G+G YG+V G VA+K K S + I E+ + + H N+I
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIK---KLSRPFQSEIFAKRAYRELLLLKHMQHENVI 86
Query: 405 HLLG-FCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 458
LL F S R L+ +M DL S ++ + + ++
Sbjct: 87 GLLDVFTPASSLRNFYDFYLVMPFMQT----DLQKIMGLKFS--EEKIQYLVYQMLKGLK 140
Query: 459 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 518
Y+H+ ++H D+KP N+ ++ D K+ DFGLA+ MTG T Y AP
Sbjct: 141 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD-----AEMTGYVVTRWYRAP 192
Query: 519 EIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 548
E+ + + + + D++S G ++ EM+ K
Sbjct: 193 EV-ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 9e-13
Identities = 53/209 (25%), Positives = 84/209 (40%), Gaps = 24/209 (11%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNF-----INEVATIGRIHHVNIIH 405
+G G YG V + VA+K K S F + E+ + R H NII
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIG 89
Query: 406 LLGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 460
+ + ++ + M DL K L + + ++Y+
Sbjct: 90 INDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 144
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR-SVVTMTGPRGTIGYIAPE 519
H+ +LH D+KP N+LL+ K+ DFGLA+ + +T T Y APE
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 520 IFMRNLGNPSGKSDVYSYGMLLLEMIEEK 548
I M N + D++S G +L EM+ +
Sbjct: 202 I-MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIHHVNII 404
+ +G+G G V R VA+K K S N + E+ + ++H NII
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 405 HLLG-FCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 458
LL F + L+ E M +L + L + L + I+
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQMELDHERMSYLLYQMLCG--IK 178
Query: 459 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 518
+LH+ I+H D+KP N+++ D T K+ DFGLA+ + MT T Y AP
Sbjct: 179 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAP 232
Query: 519 EIFMRNLGNPSGKS-DVYSYGMLLLEMIEEK 548
E+ LG ++ D++S G ++ EM+ K
Sbjct: 233 EVI---LGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 42/191 (21%), Positives = 79/191 (41%), Gaps = 39/191 (20%)
Query: 440 SLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499
L L+ + VA +E+L + +H D+ +N+LL K+ DFGLA+ +
Sbjct: 189 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245
Query: 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG 559
+ V R + ++APE + + +SDV+S+G+LL E+ + G
Sbjct: 246 DPDYVRKGDARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIF-----------SLG 292
Query: 560 SN-----TTEAYFPDWIYD--KLIQPEKEDFVEEEDDC---IARKMIIVGLWCIQINPKD 609
++ + F + + ++ P+ + + M L C P
Sbjct: 293 ASPYPGVKIDEEFCRRLKEGTRMRAPD---------YTTPEMYQTM----LDCWHGEPSQ 339
Query: 610 RPSMTRVVEML 620
RP+ + +VE L
Sbjct: 340 RPTFSELVEHL 350
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 33/174 (18%), Positives = 64/174 (36%), Gaps = 20/174 (11%)
Query: 350 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSDN--FINEVATIGRI-HH 400
+ LG G +G V + K R VAVK+L++ + S++ ++E+ + I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 401 VNIIHLLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY 459
+N+++LLG C +I E+ G+L L ++ +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY----------KTKGARF 135
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTI 513
+ + +D+K + + + S F K+ S
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF 189
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 58/359 (16%), Positives = 124/359 (34%), Gaps = 116/359 (32%)
Query: 353 KLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN--------I 403
KLG G + V+ + VA+KV++ ++++ ++E+ + + + + +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 404 IHLLG-FCCDGST---RALIYEYMPNG-SLGDLLSREKENLSLKPARLLEIALGVAHAIE 458
+ LL F G +++E + G L + + L + +I V ++
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQG-LPLPCVKKIIQQVLQGLD 160
Query: 459 YLHNGCELRILHLDIKPQNVLLDPD----------------------------------- 483
YLH + RI+H DIKP+N+LL +
Sbjct: 161 YLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 484 --------------FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP- 528
K++D G A ++ T T Y + E+ +G+
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEVL---IGSGY 270
Query: 529 SGKSDVYSYGMLLLEMIE---------------EKKHLR---------PTETTSGSNTTE 564
+ +D++S + E+ ++ H+ P + ++
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330
Query: 565 AYF---PDWIYDKLIQP--------EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
+F D + ++P EK ++ +EE A L +++ P+ R +
Sbjct: 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEE----AAGFTDFLLPMLELIPEKRAT 385
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 41/152 (26%), Positives = 65/152 (42%), Gaps = 16/152 (10%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH-VNIIHLLGF 409
+K+G G +G + GK VA+K LE + + E ++ I + F
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 410 CCDGSTRALIYEYMPNG-SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
G A++ E + G SL DL SLK L IA+ + +EY+H+ +
Sbjct: 74 GPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTV--LMIAIQLISRMEYVHS---KNL 126
Query: 469 LHLDIKPQNVLLDPDFTPKVS-----DFGLAK 495
++ D+KP+N L+ DF LAK
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIHHVNII 404
+ +G+G YG V G VA+K K + + E+ + + H N+I
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHMRHENVI 87
Query: 405 HLLG-FCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 458
LL F D + L+ +M LG L+ EK L R+ + + +
Sbjct: 88 GLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK----LGEDRIQFLVYQMLKGLR 142
Query: 459 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 518
Y+H I+H D+KP N+ ++ D K+ DFGLA+ MTG T Y AP
Sbjct: 143 YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAP 194
Query: 519 EIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 548
E+ + N + D++S G ++ EMI K
Sbjct: 195 EV-ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIHHVNII 404
+G+G YG+V G VAVK K S + I+ E+ + + H N+I
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHMKHENVI 91
Query: 405 HLLG-FCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 458
LL F S L+ M L +++ +K L + + + ++
Sbjct: 92 GLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK----LTDDHVQFLIYQILRGLK 146
Query: 459 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 518
Y+H+ I+H D+KP N+ ++ D K+ DFGLA+ + MTG T Y AP
Sbjct: 147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAP 198
Query: 519 EIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 548
EI M N + + D++S G ++ E++ +
Sbjct: 199 EI-MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 36/152 (23%), Positives = 66/152 (43%), Gaps = 16/152 (10%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH-VNIIHLLGF 409
++G G +G +++G + + VA+K E + + +E T + I ++ F
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 410 CCDGSTRALIYEYMPNG-SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+G L+ + + G SL DLL S+K A + ++ +H E +
Sbjct: 75 GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTV--AMAAKQMLARVQSIH---EKSL 127
Query: 469 LHLDIKPQNVLLDPDFTPK-----VSDFGLAK 495
++ DIKP N L+ + V DFG+ K
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 67/300 (22%), Positives = 109/300 (36%), Gaps = 52/300 (17%)
Query: 350 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNF-----INEVATIGRIHHVNI 403
K LG G YG V P G +VA+K K F + E+ + H NI
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 404 IHLLGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 458
I + S +I E M L ++S + L + A++
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQM----LSDDHIQYFIYQTLRAVK 126
Query: 459 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT--------MTGPR 510
LH ++H D+KP N+L++ + KV DFGLA+ + + + M
Sbjct: 127 VLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 511 GTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW 570
T Y APE+ M S DV+S G +L E+ ++ + P G +
Sbjct: 184 ATRWYRAPEV-MLTSAKYSRAMDVWSCGCILAELF-LRRPIFP-----GRDYRHQL--LL 234
Query: 571 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRV--VEMLSSASAEAI 628
I+ + P ++ + + AR+ I K P +M + + I
Sbjct: 235 IFGIIGTPHSDNDLRCIESPRAREYI-----------KSLPMYPAAPLEKMFPRVNPKGI 283
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 51/256 (19%), Positives = 92/256 (35%), Gaps = 72/256 (28%)
Query: 351 KEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIHHVNI 403
+ +GTG YG+V + + R+VA+K K ++ I+ E+A + R++H ++
Sbjct: 58 RHLIGTGSYGHVCEAYDKLEKRVVAIK---KILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 404 IHLLGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLE--IALGVAH- 455
+ +L ++ E + D +L + L H
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADS----DF------------KKLFRTPVYLTELHI 158
Query: 456 ---------AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506
++Y+H+ ILH D+KP N L++ D + KV DFGLA+ + +
Sbjct: 159 KTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 507 TGPRGTIG-------------------------YIAPEIFMRNLGNPSGKSDVYSYGMLL 541
Y APE+ + N + DV+S G +
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL-ILLQENYTEAIDVWSIGCIF 274
Query: 542 LEMIEEKKHLRPTETT 557
E++ K
Sbjct: 275 AELLNMIKENVAYHAD 290
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 49/216 (22%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV------NII 404
+ +G G +G V K + VA+K++ F E+ + + N+I
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 405 HLL------GFCCDGSTRALIYEYMPNGSLGDLLSREKEN-LSLKPARLLEIALGVAHAI 457
H+L C + +E + + +L +L+ + K SL R + A + +
Sbjct: 163 HMLENFTFRNHIC------MTFELL-SMNLYELIKKNKFQGFSLPLVR--KFAHSILQCL 213
Query: 458 EYLHNGCELRILHLDIKPQNVLL-DPDFTP-KVSDFGLAKAHSRNRSVVTMTGPRGTIGY 515
+ LH + RI+H D+KP+N+LL + KV DFG + + Y
Sbjct: 214 DALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT-----------Y 259
Query: 516 I------APEIFMRNLGNP-SGKSDVYSYGMLLLEM 544
I APE+ LG D++S G +L E+
Sbjct: 260 IQSRFYRAPEVI---LGARYGMPIDMWSLGCILAEL 292
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 59/330 (17%), Positives = 103/330 (31%), Gaps = 73/330 (22%)
Query: 351 KEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIHHVNI 403
K +G G YG VY + VA+K K + ++ I+ E+ + R+ I
Sbjct: 31 KHLIGRGSYGYVYLAYDKNTEKNVAIK---KVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 404 IHLLGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 458
I L ++ E + DL K + L + I +
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIADS----DLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 459 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG---- 514
++H I+H D+KP N LL+ D + KV DFGLA+ + + +
Sbjct: 144 FIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 515 ----------------YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI----------EEK 548
Y APE+ + N + D++S G + E++ +
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPEL-ILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259
Query: 549 KHLRPTETTSGSNTTEAYFPDWIYDKLIQ----------PEKEDFVEEEDDCIARKMIIV 598
L P + + Q P ++D K I
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPE-VIKYI-- 316
Query: 599 GLWCIQINPKDRPSMTRVVEMLSSASAEAI 628
+ ++ + S S + I
Sbjct: 317 ----KLFPHRKPINLK---QKYPSISDDGI 339
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 34/169 (20%), Positives = 63/169 (37%), Gaps = 32/169 (18%)
Query: 352 EKLGTGGYGNVYKGK---------FPDGRLVAVKV------LEKTSNFSDNF-----INE 391
G +Y+ P + ++K+ L NF +N+
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 392 VATIGRIHHVNIIHLLGF-CCDGSTRALIYEYMPNG-SLGDLLSR-EKENLSLKPARLLE 448
+ + I +GF R L+ + G SL L K LS + L+
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSV--LQ 163
Query: 449 IALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKV--SDFGLAK 495
+A + A+E+LH E +H ++ +N+ +DP+ +V + +G A
Sbjct: 164 VACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 42/150 (28%), Positives = 64/150 (42%), Gaps = 14/150 (9%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH-VNIIHLLGF 409
K+G+G +G++Y G G VA+K+ E E + V I +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 410 CCDGSTRALIYEYMPNG-SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+G ++ E + G SL DL + SLK L +A + IEY+H+
Sbjct: 74 GAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTV--LLLADQMISRIEYIHS---KNF 126
Query: 469 LHLDIKPQNVLLDPDFTPK---VSDFGLAK 495
+H D+KP N L+ + DFGLAK
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 47/216 (21%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI--------HHVN 402
+G G +G V K + VA+K+++ F + EV + + ++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYY-- 117
Query: 403 IIHLLGF-------CCDGSTRALIYEYMPNGSLGDLLSREKEN----LSLKPARLLEIAL 451
I+HL C L++E + + +L DLL + +SL R + A
Sbjct: 118 IVHLKRHFMFRNHLC-------LVFEML-SYNLYDLL---RNTNFRGVSLNLTR--KFAQ 164
Query: 452 GVAHAIEYLHNGCELRILHLDIKPQNVLL-DPDFTP-KVSDFGLAKAHSRNRSVVTMTGP 509
+ A+ +L EL I+H D+KP+N+LL +P + K+ DFG + + +
Sbjct: 165 QMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS-- 221
Query: 510 RGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEM 544
R Y +PE+ LG P D++S G +L+EM
Sbjct: 222 R---FYRSPEVL---LGMPYDLAIDMWSLGCILVEM 251
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 1e-09
Identities = 45/293 (15%), Positives = 79/293 (26%), Gaps = 79/293 (26%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVL---------EKTSNFSDNFINEVA--------- 393
EK+G G +G V++ D VA+K++ + + E+
Sbjct: 26 EKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLS 84
Query: 394 TIGRIHHVNIIHLLGFCC------------------------------DGSTRALIYEYM 423
I L C ++ E+
Sbjct: 85 GEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFE 144
Query: 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD 483
G DL + SL A+ I + ++ LR H D+ NVLL
Sbjct: 145 FGGI--DLEQMRTKLSSLATAK--SILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKT 198
Query: 484 FTPKVSDFGLAKA-----HSRNRSVVTMTGPRGTIG--------YIAPEIFMRNLGNPSG 530
K+ K+ S++ T R + ++F G+
Sbjct: 199 SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT---GDGDY 255
Query: 531 KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT-EAYFPDWIYDKLIQPEKED 582
+ D+Y + H SN Y D + ++ K +
Sbjct: 256 QFDIYRLMKKENNNRWGEYHPY-------SNVLWLHYLTDKMLKQMTFKTKCN 301
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 34/167 (20%), Positives = 63/167 (37%), Gaps = 31/167 (18%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKV--LEKTSN-------------FSDNFINEVATI 395
+K+G+GG+G +Y A V +E N + I +
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 396 GRIHHVNIIHLLGF----CCDGSTRALIYEYMPNG-SLGDLLSREKENLSLKPARLLEIA 450
++ ++ I G S R ++ E + G L + + L++
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS-GQNGTFKKSTV--LQLG 157
Query: 451 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKV--SDFGLAK 495
+ + +EY+H E +H DIK N+LL +V +D+GL+
Sbjct: 158 IRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 35/169 (20%), Positives = 61/169 (36%), Gaps = 32/169 (18%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKV-----LEKTSN-------------FSDNFINEVA 393
+G GG+G +Y V +E + N I +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 394 TIGRIHHVNIIHLLGF----CCDGSTRALIYEYMPNG-SLGDLLSREKENLSLKPARLLE 448
++ ++ + G S R +I + G L + + S K L+
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTV--LQ 156
Query: 449 IALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKV--SDFGLAK 495
++L + +EY+H E +H DIK N+LL+ +V D+GLA
Sbjct: 157 LSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 48/219 (21%), Positives = 90/219 (41%), Gaps = 35/219 (15%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNF-----INEVATIGRIHHVNIIH 405
+ LG GG G V+ + VA+K K +D + E+ I R+ H NI+
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIK---KIV-LTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 406 LLGFCCDGSTRA--------------LIYEYMPNGSLGDLLSREKENLSLKPARLLEIAL 451
+ ++ ++ EYM DL + ++ L
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQG-PLLEEHARLFMY 127
Query: 452 GVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSDFGLAKAHSRNRS-VVTMTGP 509
+ ++Y+H+ +LH D+KP N+ ++ D K+ DFGLA+ + S ++
Sbjct: 128 QLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 548
T Y +P + + + N + D+++ G + EM+ K
Sbjct: 185 LVTKWYRSPRL-LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 42/150 (28%), Positives = 65/150 (43%), Gaps = 14/150 (9%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGF 409
K+G+G +G +Y G VA+K+ E + E + I ++ F
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 410 CCDGSTRALIYEYMPNG-SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+G L+ + + G SL DL + LSLK L +A + + +E++H
Sbjct: 72 GVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTV--LMLADQMINRVEFVH---SKSF 124
Query: 469 LHLDIKPQNVLLDPDFTPK---VSDFGLAK 495
LH DIKP N L+ + DFGLAK
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 63/238 (26%), Positives = 100/238 (42%), Gaps = 61/238 (25%)
Query: 350 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFIN------EVATIGRIH-HV 401
+KLG G YG V+K G +VAVK K + N + E+ + + H
Sbjct: 13 LVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 402 NIIHLLGFCCDGSTRA--LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAH---- 455
NI++LL + R L+++YM DL + ++ L + H
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYMET----DL------HAVIRANILEPV-----HKQYV 114
Query: 456 ------AIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT---- 505
I+YLH+G +LH D+KP N+LL+ + KV+DFGL+++ R V
Sbjct: 115 VYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 506 ---------------MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 548
+T T Y APEI + + D++S G +L E++ K
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEI-LLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 1e-06
Identities = 84/622 (13%), Positives = 171/622 (27%), Gaps = 193/622 (31%)
Query: 92 YQVRNFFSSQDDRLITVVDTQLIKD-----LSSGSCESLYNLSVAINS--YSIGSLTLPS 144
YQ ++ S +D + D + ++D LS + + A++ +L
Sbjct: 16 YQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ 75
Query: 145 GNLNLTFFKCPRRLSLSQNFTDKGVSNVSCND---GHVLYL-WRNRTQSGRPSFDP--VS 198
+ F + L ++ F + +Y+ R+R + F VS
Sbjct: 76 EEMVQKFVE--EVLRINYKFLMSPIKTE-QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS 132
Query: 199 APSGCDSV------VVPVSSVTSLY---------LGADV--FDTLRQGFPLE--WPKLDD 239
+ + P +V + + DV ++ + W L +
Sbjct: 133 RLQPYLKLRQALLELRPAKNVL-IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKN 191
Query: 240 C-------EKCQNRSGRCGYNGSLKKITCFCKGGRCDSVKRRKSRL--------PLII-- 282
C E Q + N + + R S++ RL L++
Sbjct: 192 CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL 251
Query: 283 -----------AGSCCMVL------VAVALLVFRKRIPS--FFKKPFSEE---------- 313
SC ++L V L S + +
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL 311
Query: 314 RQNIGD----------------GLNVKQFIKTYRSALLSNYSYNDIKKMTNGFK---EKL 354
D +++ + T+ N+ + + K+T + L
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIRDGLATW-----DNWKHVNCDKLTTIIESSLNVL 366
Query: 355 GTGGYGNVYK--GKFPDGRLVAVKVL-----EKTSNFSDNFINEVATIGRIHHVNIIHLL 407
Y ++ FP + +L + + +N+
Sbjct: 367 EPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK---------------- 410
Query: 408 GFCCDGSTRALIYEYMPNG--SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
+L+ + S+ + K L + A LH
Sbjct: 411 --LHK---YSLVEKQPKESTISIPSIYLELKVKLENEYA---------------LHR--- 447
Query: 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI--FMR 523
I+ P+ D D P D Y I ++
Sbjct: 448 -SIVDHYNIPKTFDSD-DLIPPYLD-----------------------QYFYSHIGHHLK 482
Query: 524 NLGNPSGKSDVYSYGMLLLEMIEEK-KHLRPTETTSGS--NTTE--AYFPDWIYDKLIQP 578
N+ + + ++ L +E+K +H SGS NT + ++ +I D +
Sbjct: 483 NIEH-PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKY 541
Query: 579 EK-----EDFVEE-EDDCIARK 594
E+ DF+ + E++ I K
Sbjct: 542 ERLVNAILDFLPKIEENLICSK 563
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 6e-05
Identities = 74/441 (16%), Positives = 124/441 (28%), Gaps = 139/441 (31%)
Query: 71 PNYQITCDSSSVPKLLLSGRLYQVRNFFSSQ---------DDRLITVVDTQLIKDLSSGS 121
PN+ D SS KL + ++R S+ + V + + + S
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN----VQNAKAWNAFN-LS 265
Query: 122 CESLY---NLSVAINSYSIGSLTLPSGNLNLTFFKCPRRLSLSQNFTDKGVSNVS---CN 175
C+ L V + S + T S + + SL + D ++
Sbjct: 266 CKILLTTRFKQVT-DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVL- 323
Query: 176 DGHVLYL-------------WRNRTQSGRPSFDPVSAPSGCDSVVVPVSSVTSLYLGADV 222
+ L W N + SS+ L
Sbjct: 324 TTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE-----------SSLNVLE----- 367
Query: 223 FDTLRQG------FP---------LE--WPKLD--DCE----KCQNRSGRCGYNGSLKKI 259
R+ FP L W + D K S ++K
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS-------LVEK- 419
Query: 260 TCFCKGGRCDSVKRRKSRLPLIIAGSCCMVLVAVALLVFRKRIPSFFKKPFSEERQNIGD 319
K +P I + AL + I + NI
Sbjct: 420 ----------QPKESTISIPSIYLELKVKLENEYAL---HRSIV---------DHYNIPK 457
Query: 320 GLNVKQFIKTYRSALLSNYSYNDI----KKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAV 375
+ I Y L Y Y+ I K + + + L ++ F D R +
Sbjct: 458 TFDSDDLIPPY----LDQYFYSHIGHHLKNIEHPERMTL--------FRMVFLDFRFLEQ 505
Query: 376 KVLEKTSNFSDNFINEVATIGRIHHVNIIHLL----GFCCDGSTRALIYEYMPNGSLGDL 431
K+ ++ + N +I +N + L + CD + YE + N ++ D
Sbjct: 506 KIRHDSTAW-----NASGSI-----LNTLQQLKFYKPYICDNDPK---YERLVN-AILDF 551
Query: 432 LSREKENLSLKP-ARLLEIAL 451
L + +ENL LL IAL
Sbjct: 552 LPKIEENLICSKYTDLLRIAL 572
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 4e-04
Identities = 59/369 (15%), Positives = 102/369 (27%), Gaps = 107/369 (28%)
Query: 324 KQFIKTYRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAV--KVLEKT 381
K + + A + N+ D++ M K L ++ K + + +L K
Sbjct: 19 KDILSVFEDAFVDNFDCKDVQDMP---KSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ 75
Query: 382 SNFSDNFINEVATI------GRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDL---- 431
F+ EV I I S +Y + D
Sbjct: 76 EEMVQKFVEEVLRINYKFLMSPIKTEQR--------QPSMMTRMYIEQRDRLYNDNQVFA 127
Query: 432 ---LSREKENLSLKPARLLEI--ALGVA-H----------AIE----------------Y 459
+SR + L L+ A LLE+ A V A++ +
Sbjct: 128 KYNVSRLQPYLKLRQA-LLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW 186
Query: 460 LHNGCELRILHLDIKPQNVL---LDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 516
L+ ++ L +DP++T + HS N + I I
Sbjct: 187 LNLKNCNSP-ETVLEMLQKLLYQIDPNWTSRSD-------HSSN--------IKLRIHSI 230
Query: 517 APEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTE-------TTSGSNTTEAYFPD 569
E+ R L KS Y +L+L ++ K TT T+
Sbjct: 231 QAEL--RRLL----KSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAA 284
Query: 570 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM-------LSS 622
+ +E + K + P+D P E+ LS
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLK-------YLDCRPQDLPR-----EVLTTNPRRLSI 332
Query: 623 ASAEAIEMP 631
+ +
Sbjct: 333 IAESIRDGL 341
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 53/232 (22%), Positives = 91/232 (39%), Gaps = 63/232 (27%)
Query: 352 EKLGTGGYGNVYKGK--FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI------HHVNI 403
+ LG G +G V + GR VAVK+++ + + +E+ + +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 404 IHLLGF-------CCDGSTRALIYEYMPNGSLGDLLSREKEN----LSLKPARLLEIALG 452
+ +L + C +++E + S D + KEN L R ++A
Sbjct: 80 VQMLEWFEHHGHIC-------IVFELL-GLSTYDFI---KENGFLPFRLDHIR--KMAYQ 126
Query: 453 VAHAIEYLHNGCELRILHLDIKPQNVLL-DPDFTP------------------KVSDFGL 493
+ ++ +LH ++ H D+KP+N+L D+T KV DFG
Sbjct: 127 ICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183
Query: 494 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEM 544
A + S + T Y APE+ L S DV+S G +L+E
Sbjct: 184 ATYDDEHHSTLVSTRH-----YRAPEVI---LALGWSQPCDVWSIGCILIEY 227
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 47/234 (20%), Positives = 85/234 (36%), Gaps = 67/234 (28%)
Query: 352 EKLGTGGYGNVYKG--KFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI--------HHV 401
LG G +G V + VA+K++ + + E+ + +I
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFL- 83
Query: 402 NIIHLLGF-------CCDGSTRALIYEYMPNGSLGDLLSREKEN----LSLKPARLLEIA 450
+ + + C + +E + + + L KEN L R +A
Sbjct: 84 -CVLMSDWFNFHGHMC-------IAFELL-GKNTFEFL---KENNFQPYPLPHVR--HMA 129
Query: 451 LGVAHAIEYLHNGCELRILHLDIKPQNVLL-DPDFTP------------------KVSDF 491
+ HA+ +LH E ++ H D+KP+N+L + +F +V+DF
Sbjct: 130 YQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 492 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEM 544
G A + + + T Y PE+ L + DV+S G +L E
Sbjct: 187 GSATFDHEHHTTIVATRH-----YRPPEVI---LELGWAQPCDVWSIGCILFEY 232
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 59/290 (20%), Positives = 107/290 (36%), Gaps = 82/290 (28%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-----HHVNIIH 405
K+G G +G V + + + AVKV+ ++ + E + +I ++ NI+
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 406 LLGF-------CCDGSTRALIYEYMPNGSLGDLLSREKEN----LSLKPARLLEIALGVA 454
G C LI+E + SL +++ N ++ + + +
Sbjct: 101 YHGKFMYYDHMC-------LIFEPL-GPSLYEII---TRNNYNGFHIEDIK--LYCIEIL 147
Query: 455 HAIEYLHNGCELRILHLDIKPQNVLL-DPDFTP------------------------KVS 489
A+ YL ++ + H D+KP+N+LL DP F K+
Sbjct: 148 KALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 490 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMI--- 545
DFG A S + T R Y APE+ L SD++S+G +L E+
Sbjct: 205 DFGCATFKSDYHGSIINT--R---QYRAPEVI---LNLGWDVSSDMWSFGCVLAELYTGS 256
Query: 546 ------EEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589
E +HL E+ P + + + +V +++
Sbjct: 257 LLFRTHEHMEHLAMMESIIQP------IPKNMLYEATKTNGSKYVNKDEL 300
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 667 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.39 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.3 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.23 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.88 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.65 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.48 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.33 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.32 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.26 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.23 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.19 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.07 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.06 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.0 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.7 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.45 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.03 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.25 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.47 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.23 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=455.69 Aligned_cols=257 Identities=24% Similarity=0.398 Sum_probs=210.3
Q ss_pred HHHHhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeE
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 417 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 417 (667)
.+.+|.++||+|+||+||+|++. +++.||||+++... ...++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34457899999999999999873 46789999997543 34578999999999999999999999999999999
Q ss_pred EEEEEcCCCCccccccccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC
Q 005953 418 LIYEYMPNGSLGDLLSREK-------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF 484 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~ 484 (667)
|||||+++|+|.++|.... ....++|..+++|+.|||+||+|||+. +||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 9999999999999996432 124689999999999999999999998 999999999999999999
Q ss_pred ceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCc
Q 005953 485 TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTT 563 (667)
Q Consensus 485 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~ 563 (667)
.+||+|||+|+...............||++|||||++.. +.++.++|||||||++|||+| |+.||.....
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------- 253 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------- 253 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-------
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-------
Confidence 999999999987654443333345679999999999976 478999999999999999998 8899864321
Q ss_pred cccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 564 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
..+...+..+..... +..++..+.+++.+||+.||++||||+||+++|+..
T Consensus 254 -----~~~~~~i~~~~~~~~----p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 254 -----QDVVEMIRNRQVLPC----PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -----HHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -----HHHHHHHHcCCCCCC----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 122333333222111 223456788999999999999999999999999843
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=445.38 Aligned_cols=258 Identities=27% Similarity=0.434 Sum_probs=200.7
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.+.++||+|+||+||+|++.+ .||||+++... ...++|.+|+.+|++++|||||+++|++.+ +..+|||||+++
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g 115 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG 115 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred EEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence 356899999999999999843 59999987543 334679999999999999999999998865 568999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.++|+... ..+++.++++|+.|||+||+|||+. +||||||||+||||++++.+||+|||+|+..........
T Consensus 116 GsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 116 SSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp CBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred CCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 99999997543 3599999999999999999999998 999999999999999999999999999987755443333
Q ss_pred ecCCCCCccccchhhhhhh-cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....||+.|||||++... .+.++.|+|||||||++|||+||+.||..... ...+...+.........
T Consensus 191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-----------~~~~~~~~~~~~~~p~~ 259 (307)
T 3omv_A 191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-----------RDQIIFMVGRGYASPDL 259 (307)
T ss_dssp ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----------HHHHHHHHHTTCCCCCS
T ss_pred ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-----------HHHHHHHHhcCCCCCCc
Confidence 4556799999999999753 24689999999999999999999999964321 11122222221111111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
......++..+.+++.+||+.||++||||.||+++|+.+..
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11122345678899999999999999999999999985543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=448.98 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=199.5
Q ss_pred hhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.++||+|+||+||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+.+..+|||||
T Consensus 45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 5678999999999999864 47899999997654 3457899999999999999999999999999999999999
Q ss_pred cCCCCccccccccc------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEe
Q 005953 423 MPNGSLGDLLSREK------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSD 490 (667)
Q Consensus 423 ~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~D 490 (667)
+++|+|.++|+... ....++|.++++|+.||++||+|||+. +||||||||+||||++++.+||+|
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcc
Confidence 99999999997532 124699999999999999999999998 999999999999999999999999
Q ss_pred CCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchH
Q 005953 491 FGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPD 569 (667)
Q Consensus 491 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 569 (667)
||+|+...........+...||+.|||||++.+. .++.++|||||||++|||+| |+.||..... .
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------------~ 267 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------------T 267 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH------------H
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCCCCH------------H
Confidence 9999977554433333456799999999999764 78999999999999999999 8999864321 1
Q ss_pred HHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 570 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
.+...+..+.... .+..++..+.+++.+||+.||++||||+||+++|+.+
T Consensus 268 ~~~~~i~~g~~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 268 EAIDCITQGRELE----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHHHHHHHTCCCC----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCC----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1222222221111 1122356788999999999999999999999999854
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=444.91 Aligned_cols=254 Identities=24% Similarity=0.427 Sum_probs=207.6
Q ss_pred hhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.++||+|+||+||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..+|||||
T Consensus 17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEc
Confidence 5688999999999999874 47789999997654 3457899999999999999999999999999999999999
Q ss_pred cCCCCccccccccc----------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCC
Q 005953 423 MPNGSLGDLLSREK----------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG 492 (667)
Q Consensus 423 ~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFG 492 (667)
+++|+|.++|+... ....++|.++++|+.||++||+|||++ +|+||||||+||||++++.+||+|||
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFG 173 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG 173 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCS
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcc
Confidence 99999999997532 235799999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHH
Q 005953 493 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWI 571 (667)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 571 (667)
+|+...............||++|||||++.+. .++.|+|||||||++|||+| |+.||..... ..+
T Consensus 174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------------~~~ 239 (299)
T 4asz_A 174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------------NEV 239 (299)
T ss_dssp CHHHHTGGGCEEETTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------------HHH
T ss_pred cceecCCCCceeecCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------------HHH
Confidence 99876554433333345689999999999864 78999999999999999999 8999864321 122
Q ss_pred HHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 572 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
...+..+.... .+..++..+.+++.+||+.||++||||+||++.|+++.
T Consensus 240 ~~~i~~~~~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 240 IECITQGRVLQ----RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHHHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCCCC----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 22222222111 11224567889999999999999999999999998653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=427.57 Aligned_cols=271 Identities=23% Similarity=0.294 Sum_probs=202.7
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCC----eeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGS----TRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----~~~lV~e~~~~ 425 (667)
+.++||+|+||+||+|++ +|+.||||++.........+.+|+..+.+++|||||+++|++.+.+ ..+|||||+++
T Consensus 7 L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~ 85 (303)
T 3hmm_A 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence 457899999999999998 6899999999765543344556777778899999999999998654 57999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG-----CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~-----~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
|+|.++|++. .+++..+.+|+.|+++||+|||++ ..++|+||||||+||||++++++||+|||+|+.....
T Consensus 86 gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 161 (303)
T 3hmm_A 86 GSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence 9999999753 489999999999999999999975 2458999999999999999999999999999877554
Q ss_pred Ccee--eecCCCCCccccchhhhhhhc----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC---CCccccchHHH
Q 005953 501 RSVV--TMTGPRGTIGYIAPEIFMRNL----GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS---NTTEAYFPDWI 571 (667)
Q Consensus 501 ~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~ 571 (667)
.... ......||+.|||||++.+.. +.++.|+|||||||++|||+||+.|+......... ..........+
T Consensus 162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 241 (303)
T 3hmm_A 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence 4322 123456999999999996531 13567999999999999999999887543221000 00011111222
Q ss_pred HHhhcCcccc-cccc-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 572 YDKLIQPEKE-DFVE-EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 572 ~~~~~~~~~~-~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
...+...... .... .......+.+.+++.+||+.||++||||.||++.|+++..
T Consensus 242 ~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 2222222211 1111 1122356778999999999999999999999999986543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=438.30 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=207.8
Q ss_pred HHHhhhhcccCCCeEEEEEEeCC------CcEEEEEEcccCC--cchHHHHHHHHHHhhccc-ceEEeecceEecC-Cee
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTS--NFSDNFINEVATIGRIHH-VNIIHLLGFCCDG-STR 416 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~-~~~ 416 (667)
.+.+.++||+|+||+||+|++.. ++.||||++.... ...++|.+|+++|.+++| ||||+++|+|.+. +..
T Consensus 65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~ 144 (353)
T 4ase_A 65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 144 (353)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEE
Confidence 34566899999999999998632 3689999997654 234679999999999965 9999999999764 568
Q ss_pred EEEEEEcCCCCcccccccccc-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC
Q 005953 417 ALIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD 483 (667)
Q Consensus 417 ~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~ 483 (667)
+||||||++|+|.++|+.... ...+++..++.|+.|||+||+|||++ +||||||||+||||+++
T Consensus 145 ~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 145 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 221 (353)
T ss_dssp EEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCC
Confidence 999999999999999975321 24589999999999999999999998 99999999999999999
Q ss_pred CceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCC
Q 005953 484 FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNT 562 (667)
Q Consensus 484 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 562 (667)
+.+||+|||+|+....+..........||+.|||||++.+. .++.++|||||||++|||+| |+.||.....
T Consensus 222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~------ 293 (353)
T 4ase_A 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------ 293 (353)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC------
T ss_pred CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCCCCCCCCCCH------
Confidence 99999999999987665554445566789999999999874 78999999999999999998 8999864321
Q ss_pred ccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 563 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
...+...+..+.... .+...+..+.+++.+||+.||++|||+.||+++|+.+
T Consensus 294 -----~~~~~~~i~~g~~~~----~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 294 -----DEEFCRRLKEGTRMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp -----SHHHHHHHHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHHHHHHcCCCCC----CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 112222222221111 1112345788899999999999999999999999854
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=432.15 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=198.2
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
|.+.++||+|+||+||+|++. +|+.||||++.... ...+.+.+|+++|++++|||||++++++.+++..||||||+
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 345689999999999999985 69999999997643 23467999999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.++|.... ...+++..++.|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+.......
T Consensus 106 ~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 180 (350)
T 4b9d_A 106 EGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE- 180 (350)
T ss_dssp TTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH-
T ss_pred CCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCcc-
Confidence 9999999997543 34678999999999999999999998 999999999999999999999999999987643221
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
..+...||+.|||||++.+. .++.++|||||||++|||++|+.||..... ..+...+.......
T Consensus 181 -~~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~------------~~~~~~i~~~~~~~- 244 (350)
T 4b9d_A 181 -LARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSM------------KNLVLKIISGSFPP- 244 (350)
T ss_dssp -HHHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------------HHHHHHHHHTCCCC-
T ss_pred -cccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------------HHHHHHHHcCCCCC-
Confidence 12335699999999999764 688999999999999999999999965321 11222222221111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
....++..+.+++.+||+.||++|||++|++++
T Consensus 245 ---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 ---VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112245678889999999999999999999874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=426.12 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=203.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.++||+|+||+||+|++. +|+.||||++.... ...+.+.+|+++|++++|||||++++++.+++..||||||+++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 344578999999999999985 69999999996543 3456788999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++.+. .+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+......
T Consensus 156 g~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-- 226 (346)
T 4fih_A 156 GALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-- 226 (346)
T ss_dssp EEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--
T ss_pred CcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--
Confidence 9999998643 489999999999999999999998 9999999999999999999999999999877554332
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|||||++.+. .++.++|||||||++|||++|+.||..... ..+...+....... .
T Consensus 227 ~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~------------~~~~~~i~~~~~~~--~ 290 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------------LKAMKMIRDNLPPR--L 290 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------------HHHHHHHHHSSCCC--C
T ss_pred ccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------------HHHHHHHHcCCCCC--C
Confidence 2456799999999999764 679999999999999999999999964321 11112221111111 1
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.....++..+.+++.+||+.||++|||++|++++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1122345678889999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=413.99 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=196.5
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEec----CCeeEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD----GSTRALIYE 421 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~~~lV~e 421 (667)
|.++||+|+||+||+|.+. +++.||+|++.... ...+.|.+|+++|++++|||||++++++.+ ....+||||
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE 109 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence 4578999999999999985 58999999986543 334679999999999999999999999865 345899999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC-CCceEEEeCCCccccCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~-~~~~ki~DFGla~~~~~~ 500 (667)
|+++|+|.++|.+. ..+++..+..|+.||+.||+|||++ .++|+||||||+||||+. ++.+||+|||+|+.....
T Consensus 110 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 110 LMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred CCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 99999999999754 3589999999999999999999987 123999999999999974 799999999999865433
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
.. ....||+.|||||++.+ .++.++|||||||++|||+||+.||..... ...+...+..+..
T Consensus 186 ~~----~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----------~~~~~~~i~~~~~ 247 (290)
T 3fpq_A 186 FA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQN-----------AAQIYRRVTSGVK 247 (290)
T ss_dssp SB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----------HHHHHHHHTTTCC
T ss_pred cc----CCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----------HHHHHHHHHcCCC
Confidence 22 23569999999998853 588999999999999999999999964321 1222333333222
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.. ..+...+..+.+++.+||+.||++|||++|++++
T Consensus 248 ~~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 248 PA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CC---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 1111223467889999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=419.68 Aligned_cols=251 Identities=25% Similarity=0.275 Sum_probs=201.0
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
+.++||+|+||+||+|++. +|+.||||+++.... ..+|+.++++++|||||++++++.+++..||||||+++|+|
T Consensus 62 ~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred eCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 4578999999999999985 699999999976543 24799999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC-ceEEEeCCCccccCCCCce---e
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNRSV---V 504 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~-~~ki~DFGla~~~~~~~~~---~ 504 (667)
.++|.+.. .+++..+..|+.||+.||+|||++ +||||||||+||||+.++ .+||+|||+|+....+... .
T Consensus 138 ~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 138 GQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp HHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 99997543 589999999999999999999998 999999999999999987 6999999999987544322 1
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
......||+.|||||++.+. .++.++|||||||++|||++|+.||...... .....+... . . ..
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i~~~---~-~--~~ 275 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--------PLCLKIASE---P-P--PI 275 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--------CCHHHHHHS---C-C--GG
T ss_pred cCCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHHHHcC---C-C--Cc
Confidence 22335699999999999864 7889999999999999999999999654321 111111111 1 0 00
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
.+....++..+.+++.+||+.||++|||+.|++++|..+..+
T Consensus 276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 111223456788899999999999999999999999865543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=418.18 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=205.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.+.++||+|+||+||+|+.. +|+.||||++.+. ....+.+.+|+++|++++|||||++++++.+.+..|+||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 456789999999999999885 6999999999743 34457899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.++|.+.. .+++..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+.+.....
T Consensus 114 ~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 114 AKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999997543 589999999999999999999998 999999999999999999999999999998765544
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
........||+.|||||++.+. .++.++||||+||++|||++|+.||..... ..+...+......
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~------------~~~~~~i~~~~~~- 252 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE------------GLIFAKIIKLEYD- 252 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHTCCC-
T ss_pred cccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHcCCCC-
Confidence 3334556799999999999874 678999999999999999999999965321 1122222222111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 618 (667)
. +..++..+.+++.+||+.||++|||++|++.
T Consensus 253 ~----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 253 F----PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp C----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred C----CcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 1 1123556788999999999999999998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=427.21 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=203.4
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.++||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+++..|||||||++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 345678999999999999985 69999999997543 3456789999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... .+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+......
T Consensus 233 G~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-- 303 (423)
T 4fie_A 233 GALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-- 303 (423)
T ss_dssp EEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC--
T ss_pred CcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc--
Confidence 9999998643 489999999999999999999998 9999999999999999999999999999877544322
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|||||++.+. .++.++|||||||++|||++|+.||..... ..+...+....... .
T Consensus 304 ~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~------------~~~~~~i~~~~~~~--~ 367 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------------LKAMKMIRDNLPPR--L 367 (423)
T ss_dssp BCCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------------HHHHHHHHHSCCCC--C
T ss_pred ccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------------HHHHHHHHcCCCCC--C
Confidence 2456799999999999764 679999999999999999999999964321 11112221111100 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.....++..+.+|+.+||+.||++|||+.|++++
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112245678889999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=403.49 Aligned_cols=244 Identities=21% Similarity=0.355 Sum_probs=188.7
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
|.+.+.||+|+||+||+|+.. +|+.||||++.+.. ...+.+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 94 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY 94 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 345689999999999999875 69999999987542 3346799999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+ +|+|.+++.+. ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 95 ~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 95 A-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp C-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred C-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 9 78999988654 3599999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
.....||+.|||||++.+. ...+.++||||+||++|||++|+.||..... ..+...+......
T Consensus 168 ---~~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~~~------------~~~~~~i~~~~~~- 230 (275)
T 3hyh_A 168 ---LKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDESI------------PVLFKNISNGVYT- 230 (275)
T ss_dssp ----------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHTCCC-
T ss_pred ---cCCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHcCCCC-
Confidence 2345699999999999765 3446899999999999999999999964321 1122222221111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.+..++..+.+++.+||+.||++|||++|++++
T Consensus 231 ----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 231 ----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111235567889999999999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=408.42 Aligned_cols=245 Identities=23% Similarity=0.313 Sum_probs=192.7
Q ss_pred HHhhhhcccCCCeEEEEEEeC----CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
|++.++||+|+||+||+|+.. .++.||||+++... .....+.+|+++|++++|||||++++++.+.+..|+||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 346789999999999999862 47899999997542 23357889999999999999999999999999999999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||+++|+|.++|.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 106 Ey~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp CCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999997643 589999999999999999999998 9999999999999999999999999999865433
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
.. ......||+.|||||++.+. .++.++|||||||++|||++|+.||..... ..+...+.....
T Consensus 180 ~~--~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~------------~~~~~~i~~~~~ 243 (304)
T 3ubd_A 180 EK--KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDR------------KETMTMILKAKL 243 (304)
T ss_dssp -C--CCCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCC
T ss_pred Cc--cccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCH------------HHHHHHHHcCCC
Confidence 22 12446799999999999764 788999999999999999999999965322 112222222111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEM 619 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~~ 619 (667)
. .+..++..+.+++.+||+.||++||| ++|++++
T Consensus 244 ~-----~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 G-----MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp C-----CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred C-----CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 1 11123557888999999999999998 4677754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=405.42 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=186.0
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCC-----------
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS----------- 414 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----------- 414 (667)
.+.+.||+|+||+||+|++. +|+.||||+++... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 8 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~ 87 (299)
T 4g31_A 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87 (299)
T ss_dssp EEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------C
T ss_pred EEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCC
Confidence 45688999999999999985 69999999987543 23467899999999999999999999987544
Q ss_pred -eeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCC
Q 005953 415 -TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 493 (667)
Q Consensus 415 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGl 493 (667)
..|+||||+++|+|.+++.........++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+
T Consensus 88 ~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 88 VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp EEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred cEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCcc
Confidence 3689999999999999997654444567778899999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCce----------eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCc
Q 005953 494 AKAHSRNRSV----------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT 563 (667)
Q Consensus 494 a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~ 563 (667)
|+........ ...++..||+.|||||++.+. .++.++|||||||++|||++ ||.....
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~~~------- 232 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQME------- 232 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSHHH-------
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCccH-------
Confidence 9876543221 112345799999999999764 78999999999999999996 5532110
Q ss_pred cccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 564 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.......+.... ...........+.+++.+||+.||++|||+.|++++
T Consensus 233 ----~~~~~~~~~~~~----~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 233 ----RVRTLTDVRNLK----FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp ----HHHHHHHHHTTC----CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----HHHHHHHHhcCC----CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001111111111 112223334556789999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=397.12 Aligned_cols=256 Identities=20% Similarity=0.288 Sum_probs=197.3
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHHhhcccceEEeecceEec------CCeeE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCD------GSTRA 417 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------~~~~~ 417 (667)
|.+.++||+|+||+||+|++. +|+.||||+++.... ..+.+.+|+++|++++|||||++++++.. .+..|
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 445689999999999999985 699999999976532 34578899999999999999999998753 36789
Q ss_pred EEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcccc
Q 005953 418 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~ 497 (667)
|||||++ |+|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 136 ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 136 VVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 9999995 7899988653 3699999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCc--eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh
Q 005953 498 SRNRS--VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575 (667)
Q Consensus 498 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (667)
..... ........||+.|||||++.+. ..++.++||||+||++|||++|+.||...... .....+....
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~--------~~l~~I~~~~ 279 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV--------HQLQLIMMVL 279 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--------HHHHHHHHHH
T ss_pred ccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHH--------HHHHHHHHhc
Confidence 43321 1223456799999999998764 46789999999999999999999999654320 0000111111
Q ss_pred cCcc----------------------cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 576 IQPE----------------------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 576 ~~~~----------------------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
..+. ...............+.+|+.+||+.||++|||+.|++++
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0000000111234567889999999999999999999976
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=384.22 Aligned_cols=196 Identities=23% Similarity=0.345 Sum_probs=166.2
Q ss_pred HHhhhhcccCCCeEEEEEEeC----CCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
|.+.++||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|+++ +|||||++++++.+.+..++||||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~ 101 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY 101 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence 445689999999999999753 46899999987654 346788999999998 699999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC-CceEEEeCCCccccCCCC
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~-~~~ki~DFGla~~~~~~~ 501 (667)
+++|+|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+......
T Consensus 102 ~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 102 LEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp CCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred CCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999983 388999999999999999999998 99999999999999877 799999999998653321
Q ss_pred c--------------------------eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 005953 502 S--------------------------VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPT 554 (667)
Q Consensus 502 ~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~ 554 (667)
. ....+...||+.|+|||++.+. ..++.++||||+||++|||++|+.||...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 1 0112345699999999999764 35788999999999999999999999644
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=368.59 Aligned_cols=265 Identities=32% Similarity=0.549 Sum_probs=212.9
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
+.+.||+|+||+||+|++.+++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 43 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 122 (321)
T 2qkw_B 43 HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122 (321)
T ss_dssp CCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred ccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence 346899999999999998889999999987654 4457899999999999999999999999999999999999999999
Q ss_pred cccccccc-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 429 GDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 429 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++............
T Consensus 123 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 199 (321)
T 2qkw_B 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199 (321)
T ss_dssp GGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBC
T ss_pred HHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 99997543 234689999999999999999999998 99999999999999999999999999998654332222223
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc-----cc
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK-----ED 582 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 582 (667)
...||+.|+|||++.+. .++.++||||||+++|||++|+.||....... ......|.......... ..
T Consensus 200 ~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 272 (321)
T 2qkw_B 200 VVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-----MVNLAEWAVESHNNGQLEQIVDPN 272 (321)
T ss_dssp CCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS-----CCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred ccCCCccccCHHHhcCC--CCCcccchHhHHHHHHHHHhCCCcccccCcHH-----HHHHHHHhhhccccccHHHhcChh
Confidence 44589999999998764 68899999999999999999999997543311 11112222221111111 11
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
............+.+++.+||+.||++|||+.|++++|+.+.
T Consensus 273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 222334566788999999999999999999999999999654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=398.42 Aligned_cols=249 Identities=21% Similarity=0.297 Sum_probs=204.4
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
|.+.++||+|+||+||+|+.. +|+.||+|++.... ...+.+.+|+.+|++++|||||++++++.+....+|||||+++
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 446789999999999999885 69999999987654 3346788999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC--CceEEEeCCCccccCCCCce
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD--FTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~--~~~ki~DFGla~~~~~~~~~ 503 (667)
|+|.++|.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+......
T Consensus 239 g~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 239 GELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp CBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 99999986432 3589999999999999999999998 99999999999999854 89999999999988665443
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
. ...||+.|||||++.+. .++.++|||||||++|||++|+.||..... ......+..... ..
T Consensus 314 ~---~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~------------~~~~~~i~~~~~-~~ 375 (573)
T 3uto_A 314 K---VTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGEND------------DETLRNVKSCDW-NM 375 (573)
T ss_dssp E---EECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------------HHHHHHHHTTCC-CC
T ss_pred e---eeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------------HHHHHHHHhCCC-CC
Confidence 2 34689999999999864 678999999999999999999999965432 112222222211 11
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.......++..+.+|+.+||+.||++|||+.|++++
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111222345677889999999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=395.94 Aligned_cols=247 Identities=23% Similarity=0.313 Sum_probs=197.0
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHH---HHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFIN---EVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~---Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
.+.++||+|+||+||+|+.. +|+.||||++.+.. .....+.+ ++.+++.++|||||++++++.+.+..||||
T Consensus 192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm 271 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271 (689)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence 45688999999999999885 69999999986432 22233333 466777889999999999999999999999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||++||+|.++|.+.. .+++..+..++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+.....
T Consensus 272 Ey~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 272 DLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp CCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 9999999999997643 589999999999999999999998 9999999999999999999999999999877544
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
.. ....||+.|||||++.+. ..++.++|+|||||++|||++|+.||...... . ...+...+.....
T Consensus 346 ~~----~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~----~-----~~~i~~~i~~~~~ 411 (689)
T 3v5w_A 346 KP----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----D-----KHEIDRMTLTMAV 411 (689)
T ss_dssp CC----CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC----C-----HHHHHHHHHHCCC
T ss_pred CC----CCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----H-----HHHHHHhhcCCCC
Confidence 32 345799999999999653 36789999999999999999999999643221 0 1111222111111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEML 620 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~~L 620 (667)
..+..++..+.+++.+||+.||++|++ ++||++|=
T Consensus 412 -----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 412 -----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 111223557888999999999999998 78888654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=369.64 Aligned_cols=282 Identities=38% Similarity=0.653 Sum_probs=223.7
Q ss_pred CCCCCHHHHHHHHHHh--hhhcccCCCeEEEEEEeCCCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceE
Q 005953 335 LSNYSYNDIKKMTNGF--KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFC 410 (667)
Q Consensus 335 ~~~~~~~~l~~~~~~~--~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~ 410 (667)
...|++.++...+.+| .+.||+|+||+||+|+..+++.||||++.... .....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 4457777777666555 47899999999999998889999999997643 2234789999999999999999999999
Q ss_pred ecCCeeEEEEEEcCCCCccccccccc-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEE
Q 005953 411 CDGSTRALIYEYMPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 489 (667)
Q Consensus 411 ~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~ 489 (667)
.+....++||||+++|+|.+++.... ....+++..+..|+.|++.||+|||+.+.++|+||||||+|||+++++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997643 34469999999999999999999999766799999999999999999999999
Q ss_pred eCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchH
Q 005953 490 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPD 569 (667)
Q Consensus 490 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 569 (667)
|||+++......... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...... .........
T Consensus 177 Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~ 250 (326)
T 3uim_A 177 DFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLA---NDDDVMLLD 250 (326)
T ss_dssp CCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHHHHCCCSBCHHHHT---TTSCSBHHH
T ss_pred cCccccccCcccccc-cccccCCcCccCHHHhccC--CCCccccchhHHHHHHHHHhCCCcccccccc---cccchhHHH
Confidence 999998765443332 3445699999999999764 6788999999999999999999999632211 111222333
Q ss_pred HHHHhhcCcccc-----cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 570 WIYDKLIQPEKE-----DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 570 ~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
|+.......... ...........+.+.+++.+||+.||++|||+.||+++|++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 333222221111 11223345567889999999999999999999999999984
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=359.04 Aligned_cols=275 Identities=35% Similarity=0.586 Sum_probs=223.1
Q ss_pred CCCCCHHHHHHHHHHhh--------hhcccCCCeEEEEEEeCCCcEEEEEEcccC-----CcchHHHHHHHHHHhhcccc
Q 005953 335 LSNYSYNDIKKMTNGFK--------EKLGTGGYGNVYKGKFPDGRLVAVKVLEKT-----SNFSDNFINEVATIGRIHHV 401 (667)
Q Consensus 335 ~~~~~~~~l~~~~~~~~--------~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~-----~~~~~~~~~Ei~~l~~l~h~ 401 (667)
...|++.++.+++.+|. ++||+|+||+||+|+. +++.||||++... ....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 45789999999998886 4599999999999998 6889999998643 23356799999999999999
Q ss_pred eEEeecceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC
Q 005953 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD 481 (667)
Q Consensus 402 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~ 481 (667)
||+++++++.+.+..++||||+++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 99999999999999999999999999999997655456799999999999999999999998 999999999999999
Q ss_pred CCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC
Q 005953 482 PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN 561 (667)
Q Consensus 482 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~ 561 (667)
+++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||.......
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--- 241 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--- 241 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS---
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchH---
Confidence 999999999999987655443333344568999999998864 46889999999999999999999997543211
Q ss_pred CccccchHHHHHhhcCccc------ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 562 TTEAYFPDWIYDKLIQPEK------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
....+ ...+..... ..............+.+++.+||+.||++|||+.+|+++|+++.
T Consensus 242 ----~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 242 ----LLLDI-KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp ----BTTHH-HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred ----HHHHH-HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11111 111111000 01112233456778999999999999999999999999999653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=368.99 Aligned_cols=257 Identities=28% Similarity=0.480 Sum_probs=197.4
Q ss_pred HHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.++||+|+||+||+|++ +++.||||++.... ...+++.+|++++++++||||+++++++.+....++||||++
T Consensus 39 y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 3p86_A 39 LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS 117 (309)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred ceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCC
Confidence 34568899999999999988 68899999987654 233578999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR--ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~--ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+|+|.+++........+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++.......
T Consensus 118 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 194 (309)
T 3p86_A 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL 194 (309)
T ss_dssp TCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred CCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc
Confidence 999999997654333589999999999999999999997 7 99999999999999999999999999986543321
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ...............
T Consensus 195 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~-----------~~~~~~~~~~~~~~~ 259 (309)
T 3p86_A 195 --SSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLNP-----------AQVVAAVGFKCKRLE 259 (309)
T ss_dssp ---------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-----------HHHHHHHHHSCCCCC
T ss_pred --ccccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhcCCCCC
Confidence 12345689999999999764 678999999999999999999999864322 011111100111111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccccc
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEA 627 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 627 (667)
....+...+.+++.+||+.||++|||+.|+++.|+......
T Consensus 260 ----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 260 ----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 11123456888999999999999999999999999765543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=365.37 Aligned_cols=271 Identities=24% Similarity=0.305 Sum_probs=207.2
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCC----eeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGS----TRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----~~~lV~e~~~ 424 (667)
.+.++||+|+||+||+|++. ++.||||++.........+.+|+.++++++||||+++++++.+.. ..++||||++
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~ 105 (322)
T 3soc_A 27 QLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHE 105 (322)
T ss_dssp EEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred hhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCC
Confidence 35688999999999999984 899999999876655667778999999999999999999998744 4699999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCC-------CCCeeecCCCCCcEEECCCCceEEEeCCCcccc
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC-------ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~-------~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~ 497 (667)
+|+|.+++... .+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~ 181 (322)
T 3soc_A 106 KGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181 (322)
T ss_dssp TCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEE
T ss_pred CCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccc
Confidence 99999999653 4899999999999999999999741 238999999999999999999999999999877
Q ss_pred CCCCceeeecCCCCCccccchhhhhhhc---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCc----cccchHH
Q 005953 498 SRNRSVVTMTGPRGTIGYIAPEIFMRNL---GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT----EAYFPDW 570 (667)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~----~~~~~~~ 570 (667)
.............||+.|+|||++.+.. ..++.++||||||+++|||++|+.||............ .......
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (322)
T 3soc_A 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261 (322)
T ss_dssp CTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHH
T ss_pred ccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhh
Confidence 6554433344567999999999987521 13456889999999999999999999754331111100 0001111
Q ss_pred HHHhhcCcccccccch--hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 571 IYDKLIQPEKEDFVEE--EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 571 ~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
+............... ........+.+++.+||+.||++|||+.||++.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 262 MQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1222222111111111 12234567899999999999999999999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=371.66 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=205.3
Q ss_pred HhhhhcccCCCeEEEEEEeC--------CCcEEEEEEcccCCc--chHHHHHHHHHHhhc-ccceEEeecceEecCCeeE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP--------DGRLVAVKVLEKTSN--FSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRA 417 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 417 (667)
.+.+.||+|+||+||+|++. ++..||||+++.... ..+.+.+|+.+++++ +||||+++++++.+.+..+
T Consensus 84 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 163 (370)
T 2psq_A 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 163 (370)
T ss_dssp EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCE
T ss_pred EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEE
Confidence 45678999999999999862 356799999976542 346799999999999 8999999999999999999
Q ss_pred EEEEEcCCCCcccccccccc-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC
Q 005953 418 LIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF 484 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~ 484 (667)
+||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENN 240 (370)
T ss_dssp EEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTC
T ss_pred EEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCC
Confidence 99999999999999975431 23589999999999999999999998 999999999999999999
Q ss_pred ceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCc
Q 005953 485 TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTT 563 (667)
Q Consensus 485 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~ 563 (667)
.+||+|||+++...............+|+.|+|||++.+. .++.++||||||+++|||++ |+.||.....
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~~~~------- 311 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------- 311 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-------
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence 9999999999876544332223445678899999999763 78899999999999999999 9998864321
Q ss_pred cccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 564 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
..+...+........ ...+...+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 312 -----~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 312 -----EELFKLLKEGHRMDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp -----GGHHHHHHTTCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHHHHhcCCCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111122222211111 1123457888999999999999999999999999654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=354.26 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=210.0
Q ss_pred HHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
+.+.+.||+|+||+||+|++.++..||+|++.......+++.+|++++++++||||+++++++.+....++||||+++++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (268)
T 3sxs_A 10 ITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC 89 (268)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence 34568899999999999999888899999998877677889999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 90 L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~ 163 (268)
T 3sxs_A 90 LLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSV 163 (268)
T ss_dssp HHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-ECC
T ss_pred HHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh-ccc
Confidence 999997542 3589999999999999999999998 9999999999999999999999999999876554432 234
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
...+|+.|+|||.+.+. .++.++||||||+++|||++ |+.||..... ......+........
T Consensus 164 ~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------~~~~~~~~~~~~~~~--- 226 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTN------------SEVVLKVSQGHRLYR--- 226 (268)
T ss_dssp SCCCCGGGCCHHHHHHS--EEETTHHHHHHHHHHHHHHTTTCCTTTTSCH------------HHHHHHHHTTCCCCC---
T ss_pred CCCcCcccCCHHHHhcc--CCchhhhhHHHHHHHHHHHcCCCCCccccCh------------HHHHHHHHcCCCCCC---
Confidence 55678899999999764 67889999999999999999 9999864322 111112221111111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
.......+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 227 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 227 -PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp -CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred -CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 11124468889999999999999999999999996643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=354.49 Aligned_cols=253 Identities=24% Similarity=0.460 Sum_probs=208.6
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
.+.+.||+|+||+||+|++.+++.||+|++.......+++.+|++++++++||||+++++++.+....++||||+++|+|
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 92 (269)
T 4hcu_A 13 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 92 (269)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred eeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcH
Confidence 45688999999999999998889999999988776778899999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........ ....
T Consensus 93 ~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~ 166 (269)
T 4hcu_A 93 SDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTG 166 (269)
T ss_dssp HHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTS
T ss_pred HHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccc-cccC
Confidence 99996543 3589999999999999999999998 9999999999999999999999999999866443221 2234
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 587 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (667)
..+|+.|+|||.+... .++.++||||||+++|||++ |+.||..... ..+...+........
T Consensus 167 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~------------~~~~~~~~~~~~~~~---- 228 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------------SEVVEDISTGFRLYK---- 228 (269)
T ss_dssp TTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------HHHHHHHHTTCCCCC----
T ss_pred cccccccCCHHHhcCC--CCCchhhhHHHHHHHHHHhcCCCCCCCCCCH------------HHHHHHHhcCccCCC----
Confidence 5578899999999764 78899999999999999999 8988864321 112222222211111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 588 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
.......+.+++.+||+.||++|||+.|++++|+++..
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 11124568889999999999999999999999996543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=355.44 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=201.1
Q ss_pred HhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 349 GFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
.+.++||+|+||+||+|.. .+++.||||++.... ...+.+.+|+.++++++||||+++++++.+++..++||||+++|
T Consensus 23 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (297)
T 3fxz_A 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (297)
T ss_dssp CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCC
Confidence 3457899999999999987 468999999986543 44567899999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 103 ~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~ 173 (297)
T 3fxz_A 103 SLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--R 173 (297)
T ss_dssp BHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--B
T ss_pred CHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc--c
Confidence 999999653 488999999999999999999998 9999999999999999999999999999876544332 2
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ............. . ..
T Consensus 174 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------~~~~~~~~~~~~~-~--~~ 237 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----------LRALYLIATNGTP-E--LQ 237 (297)
T ss_dssp CCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHHCSC-C--CS
T ss_pred CCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHHhCCCC-C--CC
Confidence 345689999999999764 678999999999999999999999864321 0001110000000 0 01
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
....+...+.+++.+||+.||++|||+.|++++-
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 1122355688899999999999999999999754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=362.80 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=203.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC----CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
+.+.++||+|+||+||+|++. .+..||||+++... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 51 y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 130 (325)
T 3kul_A 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE 130 (325)
T ss_dssp EEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEE
T ss_pred eEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEee
Confidence 445578999999999999984 34569999997643 334679999999999999999999999999999999999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 131 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 131 YMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp CCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred CCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 999999999996542 3589999999999999999999998 99999999999999999999999999998775443
Q ss_pred ce-eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 502 SV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 502 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
.. .......+|+.|+|||++.+. .++.++||||||+++|||++ |+.||..... ..+...+....
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~------------~~~~~~~~~~~ 271 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTN------------RDVISSVEEGY 271 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTSCH------------HHHHHHHHTTC
T ss_pred cceeeccCCCCcccccCHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCcccCCH------------HHHHHHHHcCC
Confidence 22 223344578899999999764 67889999999999999999 9999854321 11222222221
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
... ....+...+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 272 ~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 272 RLP----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCC----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 111 1112345788899999999999999999999999976544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=356.55 Aligned_cols=261 Identities=21% Similarity=0.332 Sum_probs=210.0
Q ss_pred CCCCHHHHHHHHHH------------hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccc
Q 005953 336 SNYSYNDIKKMTNG------------FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHV 401 (667)
Q Consensus 336 ~~~~~~~l~~~~~~------------~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~ 401 (667)
..+++++++.++.. ..++||+|+||+||+|+.. +|+.||||++.... ...+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 35778888877754 2357999999999999986 69999999987544 4456789999999999999
Q ss_pred eEEeecceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC
Q 005953 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD 481 (667)
Q Consensus 402 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~ 481 (667)
||+++++++...+..++||||+++|+|.+++.+. .+++..+..++.|++.||+|||+. +|+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC
Confidence 9999999999999999999999999999998643 489999999999999999999998 999999999999999
Q ss_pred CCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC
Q 005953 482 PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN 561 (667)
Q Consensus 482 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~ 561 (667)
.++.+||+|||+++........ .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~----- 246 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSP----- 246 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----
T ss_pred CCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence 9999999999999876543322 234568999999999975 3678999999999999999999999864321
Q ss_pred CccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 562 TTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
......+........ .....+...+.+++.+||+.||++|||+.|++++--
T Consensus 247 -------~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 247 -------VQAMKRLRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp -------HHHHHHHHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred -------HHHHHHHhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 111111111111100 111223456888999999999999999999998643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=353.54 Aligned_cols=256 Identities=21% Similarity=0.373 Sum_probs=203.6
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
+.++||+|+||+||+|++. +++.||+|++.... ...+.+.+|++++++++||||+++++++.++...++||||+++|+
T Consensus 14 ~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 93 (310)
T 3s95_A 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGT 93 (310)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred ccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCc
Confidence 4578999999999999985 58999999886543 445789999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee---
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV--- 504 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~--- 504 (667)
|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 94 L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 94 LRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp HHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred HHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 99999763 23589999999999999999999998 99999999999999999999999999998764432211
Q ss_pred ---------eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh
Q 005953 505 ---------TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575 (667)
Q Consensus 505 ---------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (667)
......||+.|+|||++.+ ..++.++||||||+++|||++|..|+........ .......... ...
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~--~~~~~~~~~~-~~~ 243 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM--DFGLNVRGFL-DRY 243 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT--TSSBCHHHHH-HHT
T ss_pred ccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH--HHhhhhhccc-ccc
Confidence 0114568999999999976 4788999999999999999999998865432110 0000111111 110
Q ss_pred cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
. ...++..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 244 ~-----------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 244 C-----------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp C-----------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C-----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 011234577899999999999999999999999976544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.21 Aligned_cols=245 Identities=23% Similarity=0.373 Sum_probs=201.1
Q ss_pred HhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.+.||+|+||.||+|++ .+|+.||||++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 18 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 97 (328)
T 3fe3_A 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS 97 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCC
Confidence 3558899999999999998 479999999987543 234678899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 98 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-- 169 (328)
T 3fe3_A 98 GGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-- 169 (328)
T ss_dssp TCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG--
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc--
Confidence 999999996543 589999999999999999999998 999999999999999999999999999987654432
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....||+.|+|||++.+. ...+.++|||||||++|||++|+.||..... ..+...+.......
T Consensus 170 -~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~------------~~~~~~i~~~~~~~-- 233 (328)
T 3fe3_A 170 -LDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------------KELRERVLRGKYRI-- 233 (328)
T ss_dssp -GGTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCCCC--
T ss_pred -cccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCCCC--
Confidence 2456799999999999764 2335799999999999999999999965321 11122222111110
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
+...+..+.+++.+||+.||++|||++|++++-
T Consensus 234 ---p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 234 ---PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp ---CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred ---CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 111245677899999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=378.44 Aligned_cols=254 Identities=22% Similarity=0.412 Sum_probs=207.0
Q ss_pred HHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
+.+.++||+|+||+||+|++.++..||||+++......+.|.+|+.+|++++||||+++++++. .+..++||||+++|+
T Consensus 190 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~ 268 (454)
T 1qcf_A 190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGS 268 (454)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred eEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence 3456889999999999999988899999999877767789999999999999999999999986 667899999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 269 L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~-~~~ 343 (454)
T 1qcf_A 269 LLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-ARE 343 (454)
T ss_dssp HHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH-TTC
T ss_pred HHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee-ccC
Confidence 999997543 23578899999999999999999998 9999999999999999999999999999876432211 123
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
...+|+.|+|||++.. +.++.++||||||+++|||++ |+.||..... ..+...+...... .
T Consensus 344 ~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~------------~~~~~~i~~~~~~----~ 405 (454)
T 1qcf_A 344 GAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------------PEVIRALERGYRM----P 405 (454)
T ss_dssp SSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------------HHHHHHHHHTCCC----C
T ss_pred CCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCC----C
Confidence 3456889999999976 478999999999999999999 9999864321 1111222111110 1
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
....++..+.+++.+||+.||++|||+++|++.|++...
T Consensus 406 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 112235578899999999999999999999999996543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=352.04 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=206.2
Q ss_pred HHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
+.+.++||+|+||+||+|++.+++.||||++.......+++.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 105 (283)
T 3gen_A 26 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 105 (283)
T ss_dssp EEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred HHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence 34568899999999999999888899999998877677889999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ...
T Consensus 106 L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 179 (283)
T 3gen_A 106 LLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSV 179 (283)
T ss_dssp HHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-STT
T ss_pred HHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccc-ccc
Confidence 999997633 3589999999999999999999998 9999999999999999999999999999876443221 223
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
...+|+.|+|||.+... .++.++||||||+++|||++ |+.||..... ......+........
T Consensus 180 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~------------~~~~~~~~~~~~~~~--- 242 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------------SETAEHIAQGLRLYR--- 242 (283)
T ss_dssp STTSCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH------------HHHHHHHHTTCCCCC---
T ss_pred CCccCcccCCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccCh------------hHHHHHHhcccCCCC---
Confidence 44578899999999764 67899999999999999998 9999864322 111222222211111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
.......+.+++.+||+.||++|||+.|++++|+++..
T Consensus 243 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 243 -PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp -CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 11123568889999999999999999999999986543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=380.24 Aligned_cols=254 Identities=30% Similarity=0.469 Sum_probs=209.8
Q ss_pred HHhhhhcccCCCeEEEEEEeCC-CcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.+.++||+|+||.||+|++.. +..||||+++......++|.+|+.+|++++||||+++++++.+....++||||+++|
T Consensus 222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g 301 (495)
T 1opk_A 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 301 (495)
T ss_dssp EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence 4466899999999999999864 889999999877767789999999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 302 ~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~ 376 (495)
T 1opk_A 302 NLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAH 376 (495)
T ss_dssp BHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-ECC
T ss_pred CHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce-eec
Confidence 9999997543 34589999999999999999999998 999999999999999999999999999987754432 223
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
....+++.|+|||++... .++.++||||||+++|||++ |+.||..... ..+...+......
T Consensus 377 ~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~------------~~~~~~~~~~~~~---- 438 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------------SQVYELLEKDYRM---- 438 (495)
T ss_dssp TTCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCG------------GGHHHHHHTTCCC----
T ss_pred CCCcCCcceeCHhHHhcC--CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCC----
Confidence 445578899999999763 67899999999999999999 8888864321 0112222221111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
.....++..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111223457888999999999999999999999999653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=350.07 Aligned_cols=265 Identities=21% Similarity=0.310 Sum_probs=208.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCC--eeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS--TRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--~~~lV~e~~ 423 (667)
.+.++||+|+||+||+|++. +++.||||++.... ...+.+.+|++++++++||||+++++++.+.. ..++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 91 (319)
T 4euu_A 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91 (319)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred EEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCC
Confidence 35688999999999999986 48999999987543 34577889999999999999999999988765 779999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE----CCCCceEEEeCCCccccCC
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll----~~~~~~ki~DFGla~~~~~ 499 (667)
++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 92 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp TTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred CCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 9999999998765555699999999999999999999998 99999999999999 8888999999999987755
Q ss_pred CCceeeecCCCCCccccchhhhhhh------cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHH
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRN------LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 573 (667)
.... ....||+.|+|||++... ...++.++||||||+++|||++|+.||....... ....... .+..
T Consensus 169 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~-~~~~ 241 (319)
T 4euu_A 169 DEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR---RNKEVMY-KIIT 241 (319)
T ss_dssp TCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG---GCHHHHH-HHHH
T ss_pred CCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc---hhHHHHH-HHhc
Confidence 4432 345689999999998642 2477889999999999999999999996533210 0000000 0111
Q ss_pred hhcCcc----------------cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 574 KLIQPE----------------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 574 ~~~~~~----------------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
...... ...........+...+.+++.+||+.||++|||++|++++.++.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 000000 00011123356677889999999999999999999999999854
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=371.04 Aligned_cols=253 Identities=24% Similarity=0.405 Sum_probs=202.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.+.++||+|+||+||+|++. +++.||||+++... ...++|.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 196 (377)
T 3cbl_A 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 196 (377)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence 35688999999999999986 68999999987543 2335688999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..........
T Consensus 197 g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~ 271 (377)
T 3cbl_A 197 GDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS 271 (377)
T ss_dssp CBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence 99999997542 3488999999999999999999998 999999999999999999999999999986543321111
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....+++.|+|||.+.. +.++.++||||||+++|||++ |+.||..... ..+...+........
T Consensus 272 ~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~------------~~~~~~~~~~~~~~~- 336 (377)
T 3cbl_A 272 GGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSN------------QQTREFVEKGGRLPC- 336 (377)
T ss_dssp SSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH------------HHHHHHHHTTCCCCC-
T ss_pred CCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCCCC-
Confidence 111235778999999976 367889999999999999998 8888864321 111222222111111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 337 ---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 337 ---PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1123456888999999999999999999999998653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.38 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=200.7
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.+.++||+|+||+||+|++. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 10 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 89 (323)
T 3tki_A 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 89 (323)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCC
Confidence 34578999999999999886 68999999986543 2346688999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 90 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 90 GELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp EEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 9999999654 3489999999999999999999998 999999999999999999999999999987654433333
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|+|||++.+. ...+.++||||||+++|||++|+.||...... ...+..+. .... ..
T Consensus 164 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~-----~~~~---~~ 228 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYSDWK-----EKKT---YL 228 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT------SHHHHHHH-----TTCT---TS
T ss_pred cCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHh-----cccc---cC
Confidence 3456799999999999764 23477899999999999999999999654321 01111111 1110 00
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.....+...+.+++.+||+.||++|||+.|++++--
T Consensus 229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 111223456778999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=369.81 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=203.5
Q ss_pred HHhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 419 (667)
+.+.++||+|+||+||+|++. +++.||||++.... ....++.+|+.++++++||||+++++++.+....++|
T Consensus 73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 152 (367)
T 3l9p_A 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 152 (367)
T ss_dssp EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEE
Confidence 345688999999999999853 46789999997543 3345789999999999999999999999999999999
Q ss_pred EEEcCCCCccccccccc----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC---ceEEEeCC
Q 005953 420 YEYMPNGSLGDLLSREK----ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF---TPKVSDFG 492 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~---~~ki~DFG 492 (667)
|||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 99999999999997532 224689999999999999999999998 999999999999999554 59999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHH
Q 005953 493 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWI 571 (667)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 571 (667)
+++...............||+.|+|||++.+. .++.++|||||||++|||++ |+.||..... ..+
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~~------------~~~ 295 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------------QEV 295 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------------HHH
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------------HHH
Confidence 99755322211112234578999999999764 78899999999999999998 9888864321 112
Q ss_pred HHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 572 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
...+........ ...+...+.+++.+||+.||++|||+.||+++|+.....
T Consensus 296 ~~~i~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 296 LEFVTSGGRMDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHcCCCCCC----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 222222211111 112345688899999999999999999999999865543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=349.10 Aligned_cols=256 Identities=24% Similarity=0.344 Sum_probs=200.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.++||+|+||+||+|++. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 93 (294)
T 4eqm_A 14 KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI 93 (294)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCC
Confidence 45688999999999999875 68999999985432 23467899999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 94 ~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 94 EGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp CSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 9999999997543 589999999999999999999998 9999999999999999999999999999876543222
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
......||+.|+|||.+.+. .++.++||||||+++|||++|+.||..... .......+.. .....
T Consensus 168 -~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----------~~~~~~~~~~-~~~~~ 232 (294)
T 4eqm_A 168 -QTNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETA-----------VSIAIKHIQD-SVPNV 232 (294)
T ss_dssp --------CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-----------HHHHHHHHSS-CCCCH
T ss_pred -ccCccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHhhc-cCCCc
Confidence 12335689999999999764 678899999999999999999999965322 1111111111 11111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhccc
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRP-SMTRVVEMLSSASA 625 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~evl~~L~~~~~ 625 (667)
.......++..+.+++.+||+.||++|| +++++.+.|+....
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 1111122456788899999999999998 99999999986544
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=349.96 Aligned_cols=258 Identities=24% Similarity=0.394 Sum_probs=196.5
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhh--cccceEEeecceEec----CCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGR--IHHVNIIHLLGFCCD----GSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~g~~~~----~~~~~lV~e~ 422 (667)
.+.++||+|+||+||+|++ +++.||||++.... .+.+.+|.+++.. ++||||+++++++.+ ....++||||
T Consensus 11 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~ 87 (301)
T 3q4u_A 11 TLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHY 87 (301)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred EEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhh
Confidence 3568899999999999998 78999999987543 3556666666666 799999999998754 3458899999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeeecCCCCCcEEECCCCceEEEeCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH--------NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 494 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH--------~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla 494 (667)
+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 88 HEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp CTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 9999999999543 5899999999999999999999 66 9999999999999999999999999999
Q ss_pred cccCCCCceee--ecCCCCCccccchhhhhhhcC----CCCCcccHHHHHHHHHHHHhC----------CCCCCCCCcCC
Q 005953 495 KAHSRNRSVVT--MTGPRGTIGYIAPEIFMRNLG----NPSGKSDVYSYGMLLLEMIEE----------KKHLRPTETTS 558 (667)
Q Consensus 495 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~----~~s~k~DvwSlGvvl~elltg----------~~p~~~~~~~~ 558 (667)
+.......... .....||+.|+|||++.+... .++.++||||||+++|||++| +.||......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~- 239 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN- 239 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS-
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC-
Confidence 87655443322 223468999999999975421 234689999999999999999 5665432211
Q ss_pred CCCCccccchHHHHHhhcC-ccccccc-chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 559 GSNTTEAYFPDWIYDKLIQ-PEKEDFV-EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
...+.. ....... ....... ..........+.+++.+||+.||++|||+.||++.|+++
T Consensus 240 -----~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 -----DPSFED-MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp -----SCCHHH-HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred -----Ccchhh-hhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 111111 1111111 1111111 112334577899999999999999999999999999854
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=366.20 Aligned_cols=254 Identities=24% Similarity=0.427 Sum_probs=192.6
Q ss_pred HhhhhcccCCCeEEEEEEeC----CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.+.+.||+|+||+||+|++. ++..||||+++... ...++|.+|+.++++++||||+++++++.+....++||||
T Consensus 48 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 127 (373)
T 2qol_A 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY 127 (373)
T ss_dssp CCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeC
Confidence 45578999999999999874 47789999997643 3346799999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 128 ~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 128 MENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp CTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 9999999999754 34589999999999999999999998 999999999999999999999999999987654332
Q ss_pred e-eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 503 V-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 503 ~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
. .......+++.|+|||++... .++.++||||||+++|||++ |+.||..... ..+...+.....
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~------------~~~~~~i~~~~~ 268 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSN------------QDVIKAVDEGYR 268 (373)
T ss_dssp -----------CTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH------------HHHHHHHHTTEE
T ss_pred cceeccCCCcCCCccChhhhccC--CcCchhcHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCC
Confidence 2 112233467899999999764 78899999999999999998 9999854321 111222222211
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
... ...+...+.+++.+||+.||++||++.||++.|+.+..
T Consensus 269 ~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 269 LPP----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp CCC----CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC----CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 111 11234578889999999999999999999999986644
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=373.67 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=201.6
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
.+.++||+|+||+||+|++.++..||||+++......++|.+|+.+|++++||||+++++++.+ +..++||||+++|+|
T Consensus 187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL 265 (452)
T 1fmk_A 187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 265 (452)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBH
T ss_pred eeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCH
Confidence 4567899999999999999888889999998766667889999999999999999999999876 678999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++........ ....
T Consensus 266 ~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~ 340 (452)
T 1fmk_A 266 LDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQG 340 (452)
T ss_dssp HHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred HHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee-cccC
Confidence 99997532 34589999999999999999999998 9999999999999999999999999999876543221 2234
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 587 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (667)
..+++.|+|||.+.. +.++.++||||||+++|||++ |+.||..... ..+...+....... .
T Consensus 341 ~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------------~~~~~~i~~~~~~~----~ 402 (452)
T 1fmk_A 341 AKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------------REVLDQVERGYRMP----C 402 (452)
T ss_dssp --CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------HHHHHHHHTTCCCC----C
T ss_pred CcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCCC----C
Confidence 457889999999976 478999999999999999999 8988854321 11222222221111 1
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 588 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
...++..+.+++.+||+.||++|||+++|++.|++...
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 12235578889999999999999999999999996543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=357.81 Aligned_cols=267 Identities=25% Similarity=0.431 Sum_probs=200.5
Q ss_pred HHhhhhcccCCCeEEEEEEe-----CCCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecC--CeeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF-----PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV 419 (667)
+.+.++||+|+||+||+|++ .+++.||||++.... ...+.+.+|++++++++||||+++++++... ...++|
T Consensus 12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 91 (295)
T 3ugc_A 12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 91 (295)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEE
T ss_pred hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEE
Confidence 34568999999999999984 258899999997654 3346789999999999999999999998653 568999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 92 MEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 99999999999997643 2489999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcee-eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC----CCCCccccchHHHHHh
Q 005953 500 NRSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS----GSNTTEAYFPDWIYDK 574 (667)
Q Consensus 500 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~ 574 (667)
..... ......++..|+|||.+.+. .++.++||||||+++|||++|..|+....... ............+...
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCC--CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 43221 12334578889999999764 78899999999999999999998875432100 0000000011111122
Q ss_pred hcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
+...... .....++..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 245 ~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 245 LKNNGRL----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHTTCCC----CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhccCcC----CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 2111111 1112235678899999999999999999999999997644
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=365.77 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=203.4
Q ss_pred HHhhhhcccCCCeEEEEEEe------CCCcEEEEEEcccCCc--chHHHHHHHHHHhhc-ccceEEeecceEecCC-eeE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTSN--FSDNFINEVATIGRI-HHVNIIHLLGFCCDGS-TRA 417 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~-~~~ 417 (667)
+.+.++||+|+||.||+|++ .+++.||||+++.... ..+.+.+|++++.++ +||||+++++++.+.+ ..+
T Consensus 24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~ 103 (359)
T 3vhe_A 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 103 (359)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence 34568899999999999974 2468999999976542 345799999999999 7999999999998755 489
Q ss_pred EEEEEcCCCCcccccccccc------------------------------------------------------------
Q 005953 418 LIYEYMPNGSLGDLLSREKE------------------------------------------------------------ 437 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 437 (667)
+||||+++|+|.+++.....
T Consensus 104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3vhe_A 104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183 (359)
T ss_dssp EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence 99999999999999975431
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCCCCCcc
Q 005953 438 ---NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 514 (667)
Q Consensus 438 ---~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~ 514 (667)
...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...............||+.
T Consensus 184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~ 260 (359)
T 3vhe_A 184 DLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260 (359)
T ss_dssp CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred chhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence 12288999999999999999999998 999999999999999999999999999987755444444455668999
Q ss_pred ccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHH
Q 005953 515 YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIAR 593 (667)
Q Consensus 515 y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (667)
|+|||++.+ ..++.++||||||+++|||++ |+.||..... ...+...+........ ...+..
T Consensus 261 y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----------~~~~~~~~~~~~~~~~----~~~~~~ 323 (359)
T 3vhe_A 261 WMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-----------DEEFCRRLKEGTRMRA----PDYTTP 323 (359)
T ss_dssp GCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-----------SHHHHHHHHHTCCCCC----CTTCCH
T ss_pred eEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccch-----------hHHHHHHHHcCCCCCC----CCCCCH
Confidence 999999976 478899999999999999998 9999864322 1111111111111111 111345
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 594 KMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 594 ~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
.+.+++.+||+.||++|||+.|++++|+++.
T Consensus 324 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 6888999999999999999999999998654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=348.80 Aligned_cols=254 Identities=27% Similarity=0.379 Sum_probs=197.8
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.+.++||+|+||+||+|++.+++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 24 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~- 102 (311)
T 3niz_A 24 QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME- 102 (311)
T ss_dssp EEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-
T ss_pred HhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-
Confidence 3458899999999999999889999999987543 234678999999999999999999999999999999999997
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 103 ~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-- 175 (311)
T 3niz_A 103 KDLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS-- 175 (311)
T ss_dssp EEHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred CCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCccc--
Confidence 57888776532 3589999999999999999999998 9999999999999999999999999999876533322
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc-----
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK----- 580 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 580 (667)
.....||+.|+|||++.+. ..++.++||||||+++|||++|+.||....... ....+...+..+..
T Consensus 176 ~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD--------QLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp --CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT--------HHHHHHHHHCCCCTTTSGG
T ss_pred ccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHHHHCCCChHHhhh
Confidence 2345689999999998754 467899999999999999999999996543210 00111111111000
Q ss_pred ----------------ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 581 ----------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 581 ----------------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
..........+...+.+++.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000001111234578899999999999999999999975
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=363.84 Aligned_cols=259 Identities=27% Similarity=0.401 Sum_probs=208.6
Q ss_pred HHHHhhhhcccCCCeEEEEEEeC--------CCcEEEEEEcccCCc--chHHHHHHHHHHhhc-ccceEEeecceEecCC
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFP--------DGRLVAVKVLEKTSN--FSDNFINEVATIGRI-HHVNIIHLLGFCCDGS 414 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~ 414 (667)
..+.+.++||+|+||+||+|++. ++..||||++..... ..+.+.+|+++++++ +||||+++++++.+.+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 34456688999999999999862 235799999976543 346789999999999 8999999999999999
Q ss_pred eeEEEEEEcCCCCcccccccccc-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC
Q 005953 415 TRALIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD 481 (667)
Q Consensus 415 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~ 481 (667)
..++||||+++|+|.+++..... ...+++..++.|+.|++.||+|||+. +|+||||||+|||++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEc
Confidence 99999999999999999975431 23589999999999999999999998 999999999999999
Q ss_pred CCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCC
Q 005953 482 PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGS 560 (667)
Q Consensus 482 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~ 560 (667)
+++.+||+|||+++...............+|+.|+|||++.+ ..++.++||||||+++|||++ |+.||.....
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---- 299 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 299 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 999999999999987755443333345567899999999976 478899999999999999999 9988854321
Q ss_pred CCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 561 NTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
..+...+......... ..+...+.+++.+||+.||++|||+.||+++|+++..
T Consensus 300 --------~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 300 --------EELFKLLKEGHRMDKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp --------HHHHHHHHTTCCCCCC----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HHHHHHHHcCCCCCCC----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1122222222111111 1234568889999999999999999999999996654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=371.43 Aligned_cols=249 Identities=28% Similarity=0.453 Sum_probs=201.8
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCC-eeEEEEEEcCCCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGS-TRALIYEYMPNGS 427 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-~~~lV~e~~~~gs 427 (667)
.+.++||+|+||.||+|++ .++.||||+++... ..+.|.+|+.+|++++||||+++++++.+.. ..++||||+++|+
T Consensus 196 ~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~ 273 (450)
T 1k9a_A 196 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273 (450)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred EEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence 3568899999999999998 47899999998654 4678999999999999999999999987665 7899999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 274 L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~ 344 (450)
T 1k9a_A 274 LVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D 344 (450)
T ss_dssp HHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred HHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----c
Confidence 999997643 33478999999999999999999998 99999999999999999999999999998653321 1
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
...+++.|+|||.+.. ..++.++||||||+++|||++ |+.||...... .+...+..+... .
T Consensus 345 ~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------------~~~~~i~~~~~~----~ 406 (450)
T 1k9a_A 345 TGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------------DVVPRVEKGYKM----D 406 (450)
T ss_dssp --CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT------------THHHHHHTTCCC----C
T ss_pred CCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------------HHHHHHHcCCCC----C
Confidence 2356889999999975 478999999999999999998 99998643221 011222222111 1
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
.+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 1122356788999999999999999999999999976543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=352.65 Aligned_cols=250 Identities=19% Similarity=0.264 Sum_probs=204.6
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
.+.+.||+|+||+||+++.. +++.||+|++.........+.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus 8 ~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~ 87 (321)
T 1tki_A 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCC
Confidence 35688999999999999985 58899999998766666778999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC--CCceEEEeCCCccccCCCCceee
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP--DFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~--~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++........
T Consensus 88 L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~-- 160 (321)
T 1tki_A 88 IFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-- 160 (321)
T ss_dssp HHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE--
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc--
Confidence 99999653 23589999999999999999999998 9999999999999987 789999999999887654432
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ..+...+..... ....
T Consensus 161 -~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------~~~~~~i~~~~~-~~~~ 224 (321)
T 1tki_A 161 -RLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETN------------QQIIENIMNAEY-TFDE 224 (321)
T ss_dssp -EEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHHTCC-CCCH
T ss_pred -ccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCH------------HHHHHHHHcCCC-CCCh
Confidence 234589999999999753 568899999999999999999999964321 111122211111 1111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.....++..+.+++.+||+.||++|||+.|++++--
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence 112234567889999999999999999999998654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=359.19 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=205.2
Q ss_pred HhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
.+.+.||+|+||.||+|++. +++.||||+++... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 50 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 129 (343)
T 1luf_A 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF 129 (343)
T ss_dssp EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEE
Confidence 35678999999999999874 34889999997653 23467999999999999999999999999999999999
Q ss_pred EEcCCCCcccccccccc---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEE
Q 005953 421 EYMPNGSLGDLLSREKE---------------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVL 479 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIl 479 (667)
||+++|+|.+++..... ...+++..++.++.|+++||+|||++ +|+||||||+|||
T Consensus 130 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl 206 (343)
T 1luf_A 130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL 206 (343)
T ss_dssp ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred ecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEE
Confidence 99999999999975321 24689999999999999999999998 9999999999999
Q ss_pred ECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCC
Q 005953 480 LDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTS 558 (667)
Q Consensus 480 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~ 558 (667)
++.++.+||+|||+++...............+|+.|+|||.+... .++.++||||||+++|||++ |+.||.....
T Consensus 207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~-- 282 (343)
T 1luf_A 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-- 282 (343)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--
T ss_pred ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC--CcCcccccHHHHHHHHHHHhcCCCcCCCCCh--
Confidence 999999999999999866433322222345689999999999764 68899999999999999999 9988864321
Q ss_pred CCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 559 GSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
..+...+........ ...+...+.+++.+||+.||++|||+.+++++|+++..
T Consensus 283 ----------~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 283 ----------EEVIYYVRDGNILAC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp ----------HHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ----------HHHHHHHhCCCcCCC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 112222222221111 11234578889999999999999999999999997644
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.47 Aligned_cols=255 Identities=24% Similarity=0.419 Sum_probs=206.5
Q ss_pred HhhhhcccCCCeEEEEEEe------CCCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
.+.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 105 (314)
T 2ivs_A 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV 105 (314)
T ss_dssp EEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEE
Confidence 3568899999999999986 245899999997643 33467899999999999999999999999999999999
Q ss_pred EEcCCCCcccccccccc---------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEE
Q 005953 421 EYMPNGSLGDLLSREKE---------------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVL 479 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIl 479 (667)
||+++|+|.+++..... ...+++..++.++.|+++||+|||++ +|+||||||+|||
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIl 182 (314)
T 2ivs_A 106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNIL 182 (314)
T ss_dssp ECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred eecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEE
Confidence 99999999999975432 23488999999999999999999998 9999999999999
Q ss_pred ECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCC
Q 005953 480 LDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTS 558 (667)
Q Consensus 480 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~ 558 (667)
+++++.+||+|||+++...............+|+.|+|||.+.+. .++.++||||||+++|||++ |+.||.....
T Consensus 183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~-- 258 (314)
T 2ivs_A 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-- 258 (314)
T ss_dssp EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC--CcCchhhHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 999999999999999877655444333455678999999999763 67889999999999999999 9999864322
Q ss_pred CCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 559 GSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
..+...+........ ...+...+.+++.+||+.||++|||+.|++++|+++.
T Consensus 259 ----------~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 259 ----------ERLFNLLKTGHRMER----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp ----------GGHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------HHHHHHhhcCCcCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111122222111111 1123457888999999999999999999999998653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=349.99 Aligned_cols=245 Identities=24% Similarity=0.352 Sum_probs=200.4
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||+||+++.. +|+.||+|+++.. ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~ 87 (337)
T 1o6l_A 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 34588999999999999885 6899999999753 334567899999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 88 ~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 88 NGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp TTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 9999999987543 589999999999999999999998 9999999999999999999999999999864332221
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
.....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ..+...+...... .
T Consensus 162 --~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~------------~~~~~~i~~~~~~-~ 224 (337)
T 1o6l_A 162 --MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------ERLFELILMEEIR-F 224 (337)
T ss_dssp --BCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCCC-C
T ss_pred --ccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCCH------------HHHHHHHHcCCCC-C
Confidence 2345689999999998764 678999999999999999999999864321 1112222111110 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 620 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~L 620 (667)
+..+...+.+++.+||+.||++|| +++|++++-
T Consensus 225 ----p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 225 ----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ----CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 112345678899999999999999 899998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=354.07 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=202.1
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc-------chHHHHHHHHHHhhcccceEEeecceEecCCeeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN-------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 419 (667)
+.+.+.||+|+||+||+++.. +|+.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence 345688999999999999985 689999999875432 246789999999999999999999999999999999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC----ceEEEeCCCcc
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF----TPKVSDFGLAK 495 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~----~~ki~DFGla~ 495 (667)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++ .+||+|||+++
T Consensus 94 ~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 94 LELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 9999999999999653 3589999999999999999999998 999999999999998877 79999999998
Q ss_pred ccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh
Q 005953 496 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575 (667)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (667)
....... .....||+.|+|||++... .++.++|||||||++|||++|+.||..... ......+
T Consensus 168 ~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------------~~~~~~i 230 (361)
T 2yab_A 168 EIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTK------------QETLANI 230 (361)
T ss_dssp ECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------------HHHHHHH
T ss_pred EcCCCCc---cccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHH
Confidence 7655432 2345699999999998753 678999999999999999999999964321 1112222
Q ss_pred cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
..... .........+...+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 231 TAVSY-DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HTTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhcCC-CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22111 11111122345678889999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=351.29 Aligned_cols=248 Identities=24% Similarity=0.328 Sum_probs=195.9
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCC-----------
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS----------- 414 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----------- 414 (667)
.+.+.||+|+||+||+|++. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~ 88 (332)
T 3qd2_B 9 EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEI 88 (332)
T ss_dssp EEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-
T ss_pred ceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhh
Confidence 45578999999999999986 79999999987543 34578999999999999999999999986543
Q ss_pred ----------------------------------------------eeEEEEEEcCCCCccccccccccCCCCCHHHHHH
Q 005953 415 ----------------------------------------------TRALIYEYMPNGSLGDLLSREKENLSLKPARLLE 448 (667)
Q Consensus 415 ----------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~ 448 (667)
..++||||+++|+|.+++.+........+..++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 168 (332)
T 3qd2_B 89 WLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH 168 (332)
T ss_dssp -------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHH
T ss_pred hhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHH
Confidence 2789999999999999998765555677888999
Q ss_pred HHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce----------eeecCCCCCccccch
Q 005953 449 IALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV----------VTMTGPRGTIGYIAP 518 (667)
Q Consensus 449 i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~----------~~~~~~~gt~~y~aP 518 (667)
++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .......||+.|+||
T Consensus 169 i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 169 IFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 999999999999998 9999999999999999999999999999877654321 112345699999999
Q ss_pred hhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHH
Q 005953 519 EIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIV 598 (667)
Q Consensus 519 E~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 598 (667)
|++.+. .++.++||||||+++|||++|..|+... .......... ............+.++
T Consensus 246 E~~~~~--~~~~~~Di~slG~il~el~~~~~~~~~~--------------~~~~~~~~~~----~~~~~~~~~~~~~~~l 305 (332)
T 3qd2_B 246 EQIHGN--NYSHKVDIFSLGLILFELLYSFSTQMER--------------VRIITDVRNL----KFPLLFTQKYPQEHMM 305 (332)
T ss_dssp HHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHHHH--------------HHHHHHHHTT----CCCHHHHHHCHHHHHH
T ss_pred HHhcCC--CCcchhhHHHHHHHHHHHHHcCCChhHH--------------HHHHHHhhcc----CCCcccccCChhHHHH
Confidence 999764 7789999999999999999976543110 0111111111 1122233445667889
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 005953 599 GLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 599 ~~~cl~~~P~~RPt~~evl~~ 619 (667)
+.+||+.||++|||+.|++++
T Consensus 306 i~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHccCCCCcCCCHHHHhhc
Confidence 999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=359.06 Aligned_cols=259 Identities=28% Similarity=0.412 Sum_probs=204.8
Q ss_pred HHhhhhcccCCCeEEEEEEe------CCCcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 418 (667)
+.+.+.||+|+||+||+|++ .+++.||||++.... ...+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 126 (344)
T 1rjb_A 47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 126 (344)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEE
Confidence 44568899999999999986 245689999997542 3457899999999999 89999999999999999999
Q ss_pred EEEEcCCCCccccccccccC--------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcE
Q 005953 419 IYEYMPNGSLGDLLSREKEN--------------------LSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNV 478 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NI 478 (667)
||||+++|+|.+++...... ..+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NI 203 (344)
T 1rjb_A 127 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNV 203 (344)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGE
T ss_pred EEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhE
Confidence 99999999999999754321 2478999999999999999999998 999999999999
Q ss_pred EECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcC
Q 005953 479 LLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETT 557 (667)
Q Consensus 479 ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~ 557 (667)
|++.++.+||+|||+++...............||+.|+|||.+.+ +.++.++||||||+++|||++ |+.||.....
T Consensus 204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~- 280 (344)
T 1rjb_A 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV- 280 (344)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCCCcccCCc-
Confidence 999999999999999987655444333344567889999999876 478899999999999999998 9999865422
Q ss_pred CCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 558 SGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
.......+........ .......+.+++.+||+.||++|||+.|++++|+....+
T Consensus 281 ----------~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 281 ----------DANFYKLIQNGFKMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp ----------SHHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ----------HHHHHHHHhcCCCCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 0111111111111111 112245788899999999999999999999999966543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.02 Aligned_cols=253 Identities=25% Similarity=0.425 Sum_probs=196.4
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCc----EEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGR----LVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
.+.++||+|+||+||+|++. +++ .||+|.+.... ...+++.+|+.++++++||||+++++++.++. .++|+|
T Consensus 18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e 96 (327)
T 3poz_A 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQ 96 (327)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEE
T ss_pred ccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEE
Confidence 45588999999999999874 344 36888876432 44578999999999999999999999998754 789999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 97 LMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp CCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred ecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 999999999997643 3589999999999999999999998 99999999999999999999999999998776554
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
.........+|+.|+|||++.+ ..++.++||||||+++|||++ |+.||...... . +...+.....
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~----~~~~~~~~~~ 237 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------E----ISSILEKGER 237 (327)
T ss_dssp C-------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------G----HHHHHHTTCC
T ss_pred ccccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--------H----HHHHHHcCCC
Confidence 4434445567899999999976 478899999999999999999 99998643221 1 1111211111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
... .......+.+++.+||+.||++||++.|++++|+.+..
T Consensus 238 ~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 238 LPQ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCC----CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCC----CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111 11124468889999999999999999999999986544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=353.77 Aligned_cols=259 Identities=26% Similarity=0.454 Sum_probs=208.0
Q ss_pred HHhhhhcccCCCeEEEEEEe------CCCcEEEEEEcccCCc--chHHHHHHHHHHhhc-ccceEEeecceEecCCeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTSN--FSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 418 (667)
+.+.+.||+|+||+||+|++ .+++.||||++..... ..+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 104 (313)
T 1t46_A 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (313)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEE
Confidence 34568899999999999985 3468999999976542 346789999999999 89999999999999999999
Q ss_pred EEEEcCCCCcccccccccc---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC
Q 005953 419 IYEYMPNGSLGDLLSREKE---------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD 483 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~ 483 (667)
||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181 (313)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETT
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCC
Confidence 9999999999999975432 22589999999999999999999998 99999999999999999
Q ss_pred CceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCC
Q 005953 484 FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNT 562 (667)
Q Consensus 484 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 562 (667)
+.+||+|||+++...............+|+.|+|||.+.+ ..++.++||||||+++|||++ |+.||.....
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------ 253 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV------ 253 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS------
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCcccc------
Confidence 9999999999987765544433344557889999999876 378899999999999999999 9998864322
Q ss_pred ccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 563 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
.......+...... .........+.+++.+||+.||++|||+.|++++|++...+
T Consensus 254 -~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 254 -DSKFYKMIKEGFRM--------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp -SHHHHHHHHHTCCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -hhHHHHHhccCCCC--------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11111111111110 00112345788899999999999999999999999965443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=349.89 Aligned_cols=251 Identities=28% Similarity=0.462 Sum_probs=194.1
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
+.+.||+|+||+||+|++ .++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||+++|+|.
T Consensus 12 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~ 87 (307)
T 2eva_A 12 VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLY 87 (307)
T ss_dssp EEEEEECCSSSEEEEEEE-TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHH
T ss_pred eeeEeecCCCceEEEEEE-CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHH
Confidence 457899999999999998 5788999998754 345789999999999999999999998864 479999999999999
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCc-eEEEeCCCccccCCCCceeeecC
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT-PKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~-~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
+++........+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++....... ..
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-----~~ 162 (307)
T 2eva_A 88 NVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-----TN 162 (307)
T ss_dssp HHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------------
T ss_pred HHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----cc
Confidence 99976544445889999999999999999999842238999999999999988876 7999999997654321 23
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (667)
..||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... . .. +............ .
T Consensus 163 ~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~-~~-~~~~~~~~~~~~~----~ 226 (307)
T 2eva_A 163 NKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--------A-FR-IMWAVHNGTRPPL----I 226 (307)
T ss_dssp --CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS--------H-HH-HHHHHHTTCCCCC----B
T ss_pred CCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc--------H-HH-HHHHHhcCCCCCc----c
Confidence 458999999999875 37889999999999999999999998643210 0 01 1111111111111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 589 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 589 ~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
..+...+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1234567889999999999999999999999986544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=351.74 Aligned_cols=257 Identities=19% Similarity=0.263 Sum_probs=202.5
Q ss_pred hhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
+.+.||+|+||+||+|+. .+++.||||++..... .+.+.+|+.+++++ +||||+++++++.+....++||||+ +++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (330)
T 2izr_A 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPS 90 (330)
T ss_dssp EEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCC
Confidence 457899999999999997 4789999999875432 35688999999999 8999999999999999999999999 999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCc-----eEEEeCCCccccCCCCc
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT-----PKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~-----~ki~DFGla~~~~~~~~ 502 (667)
|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.......
T Consensus 91 L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~ 165 (330)
T 2izr_A 91 LEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165 (330)
T ss_dssp HHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred HHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence 99999754 24689999999999999999999998 9999999999999999887 99999999987644332
Q ss_pred ee-----eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcC
Q 005953 503 VV-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 577 (667)
Q Consensus 503 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (667)
.. ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...... . .......+..
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~~~----~-----~~~~~~~i~~ 234 (330)
T 2izr_A 166 KKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLKAD----T-----LKERYQKIGD 234 (330)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS----S-----HHHHHHHHHH
T ss_pred CccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCccccccc----c-----HHHHHHHHHh
Confidence 11 12345699999999999763 6789999999999999999999999754321 1 1111111111
Q ss_pred cccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 578 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 578 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
..............+ .+.+++.+||+.||++||++++|++.|++...
T Consensus 235 ~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 235 TKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred hhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 100000000011123 78899999999999999999999999986543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=344.69 Aligned_cols=253 Identities=24% Similarity=0.451 Sum_probs=207.7
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
.+.+.||+|+||.||+|++.+++.||+|++.......+++.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (267)
T 3t9t_A 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL 90 (267)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred eeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcH
Confidence 35678999999999999998889999999988776678899999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....... .....
T Consensus 91 ~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 164 (267)
T 3t9t_A 91 SDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTG 164 (267)
T ss_dssp HHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTS
T ss_pred HHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc-ccccc
Confidence 99996542 3588999999999999999999998 999999999999999999999999999987643221 11234
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 587 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (667)
..+++.|+|||++... .++.++||||||+++|||++ |+.||..... ......+........
T Consensus 165 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------~~~~~~i~~~~~~~~---- 226 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------------SEVVEDISTGFRLYK---- 226 (267)
T ss_dssp TTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------HHHHHHHHTTCCCCC----
T ss_pred ccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCCH------------HHHHHHHhcCCcCCC----
Confidence 4578899999999764 67899999999999999999 8888864321 111222222211111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 588 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
.......+.+++.+||+.||++|||+.|++++|+++..
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11124568889999999999999999999999996543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=355.88 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=197.8
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcE----EEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRL----VAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~----vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.++||+|+||+||+|++. +++. ||+|++.... ...+.+.+|+.++++++||||+++++++. +...++|+||
T Consensus 17 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~ 95 (325)
T 3kex_A 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQY 95 (325)
T ss_dssp EEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEEC
T ss_pred eeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEe
Confidence 4578999999999999874 3443 7888875432 33456789999999999999999999886 4678999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 96 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 96 LPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp CTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred CCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 99999999997542 2578889999999999999999998 999999999999999999999999999998765544
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
........||..|+|||++... .++.++||||||+++|||++ |+.||...... .+...+......
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------------~~~~~~~~~~~~ 236 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA------------EVPDLLEKGERL 236 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT------------HHHHHHHTTCBC
T ss_pred cccccCCCCcccccChHHhccC--CCChhhHhHHhHHHHHHHHhCCCCCccccCHH------------HHHHHHHcCCCC
Confidence 4334455688899999999764 78899999999999999999 99998653220 111112111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
... ......+.+++.+||+.||++|||+.|++++|+++..+
T Consensus 237 ~~~----~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 237 AQP----QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CCC----TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CCC----CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 110 11233567789999999999999999999999876543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=347.90 Aligned_cols=247 Identities=22% Similarity=0.325 Sum_probs=192.7
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc---------------------------chHHHHHHHHHHhhccc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---------------------------FSDNFINEVATIGRIHH 400 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------------------------~~~~~~~Ei~~l~~l~h 400 (667)
.+.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|++++++++|
T Consensus 16 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 95 (298)
T 2zv2_A 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDH 95 (298)
T ss_dssp EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCC
T ss_pred EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCC
Confidence 35688999999999999875 689999999865421 13568899999999999
Q ss_pred ceEEeecceEec--CCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcE
Q 005953 401 VNIIHLLGFCCD--GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNV 478 (667)
Q Consensus 401 ~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NI 478 (667)
|||+++++++.+ ....++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||
T Consensus 96 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 96 PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL 168 (298)
T ss_dssp TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence 999999999986 5688999999999999987643 3589999999999999999999998 999999999999
Q ss_pred EECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCC-CCCcccHHHHHHHHHHHHhCCCCCCCCCcC
Q 005953 479 LLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN-PSGKSDVYSYGMLLLEMIEEKKHLRPTETT 557 (667)
Q Consensus 479 ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~s~k~DvwSlGvvl~elltg~~p~~~~~~~ 557 (667)
|++.++.+||+|||+++........ .....||+.|+|||.+.+.... .+.++||||||+++|||++|+.||.....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~- 245 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI- 245 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred EECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH-
Confidence 9999999999999999876544322 2445799999999998754211 36789999999999999999999864321
Q ss_pred CCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 558 SGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
......+....... .....+...+.+++.+||+.||++|||+.|++++
T Consensus 246 -----------~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 -----------MCLHSKIKSQALEF---PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp -----------HHHHHHHHHCCCCC---CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred -----------HHHHHHHhcccCCC---CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 11111111111100 0011234568889999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=345.56 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=207.1
Q ss_pred HHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
+.+.+.||+|+||+||+|++.+++.||||++.......+.+.+|++++++++||||+++++++. .+..++||||+++++
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 93 (279)
T 1qpc_A 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGS 93 (279)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred hhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCC
Confidence 3456889999999999999988889999999877666788999999999999999999999886 456899999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++........ ...
T Consensus 94 L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 168 (279)
T 1qpc_A 94 LVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-ARE 168 (279)
T ss_dssp HHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCT
T ss_pred HHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc-ccc
Confidence 999997542 23589999999999999999999998 9999999999999999999999999999876544322 223
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
...++..|+|||.+.. +.++.++||||||+++|||++ |+.||..... ..+...+.......
T Consensus 169 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------------~~~~~~~~~~~~~~---- 230 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------------PEVIQNLERGYRMV---- 230 (279)
T ss_dssp TCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------HHHHHHHHTTCCCC----
T ss_pred CCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCH------------HHHHHHHhcccCCC----
Confidence 4557889999999975 367889999999999999999 8888854321 11122222211111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
....+...+.+++.+||+.||++|||+.++++.|++....
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 1112345788899999999999999999999999976544
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=353.39 Aligned_cols=257 Identities=23% Similarity=0.372 Sum_probs=191.7
Q ss_pred HHhhhhcccCCCeEEEEEEeCC-C---cEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecCCee----
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPD-G---RLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTR---- 416 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~---- 416 (667)
+.+.+.||+|+||+||+|++.. + ..||||++... ....+.+.+|++++++++||||+++++++.+....
T Consensus 25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (323)
T 3qup_A 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP 104 (323)
T ss_dssp CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence 4456899999999999998754 3 27999999764 23457899999999999999999999999877655
Q ss_pred --EEEEEEcCCCCccccccccc---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeC
Q 005953 417 --ALIYEYMPNGSLGDLLSREK---ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDF 491 (667)
Q Consensus 417 --~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DF 491 (667)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeec
Confidence 99999999999999996532 223589999999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHH
Q 005953 492 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDW 570 (667)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 570 (667)
|+++...............+++.|+|||.+.+. .++.++||||||+++|||++ |+.||...... .
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------------~ 247 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA------------E 247 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------------G
T ss_pred cccccccccccccccccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccccChH------------H
Confidence 999876554433333445578899999999764 68899999999999999999 88888643221 1
Q ss_pred HHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 571 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
+...+........ ...+...+.+++.+||+.||++|||+.++++.|+++..
T Consensus 248 ~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 248 IYNYLIGGNRLKQ----PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HHHHHHTTCCCCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCC----CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1122222111111 11234568899999999999999999999999996654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=346.58 Aligned_cols=258 Identities=27% Similarity=0.462 Sum_probs=190.5
Q ss_pred HHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCc---chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.++||+|+||+||+|++. ..||||+++.... ..+.+.+|+.++++++||||++++++. .....++||||++
T Consensus 26 y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~ 102 (289)
T 3og7_A 26 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCE 102 (289)
T ss_dssp CEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCC
T ss_pred eeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecC
Confidence 446689999999999999874 3599999875542 346789999999999999999999965 4567899999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 103 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 103 GSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp EEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred CCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 999999996542 4589999999999999999999998 99999999999999999999999999998665433333
Q ss_pred eecCCCCCccccchhhhhhh-cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
......||+.|+|||.+... ...++.++||||||+++|||++|+.||..... .......+.........
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~--- 247 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQIIEMVGRGSLSPDL--- 247 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-------HHHHHHHHHHTSCCCCT---
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-------HHHHHHHhcccccCcch---
Confidence 33445689999999998622 24678899999999999999999999864322 01111111111111111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
......++..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 248 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 248 -SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1111223567889999999999999999999999999664
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=343.27 Aligned_cols=248 Identities=28% Similarity=0.473 Sum_probs=188.9
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC-----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.++||+|+||+||+|++ .++.||||++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (271)
T 3dtc_A 10 TLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA 88 (271)
T ss_dssp EEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECC
T ss_pred eeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcC
Confidence 3557899999999999998 58899999987542 23467899999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC--------CCceEEEeCCCcc
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP--------DFTPKVSDFGLAK 495 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~--------~~~~ki~DFGla~ 495 (667)
++++|.+++.. ..+++..++.++.|++.||+|||+....+|+||||||+|||++. ++.+||+|||+++
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 89 RGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp TTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred CCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 99999999853 35899999999999999999999982122999999999999986 7789999999998
Q ss_pred ccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh
Q 005953 496 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575 (667)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (667)
....... ....||+.|+|||.+.+. .++.++||||||+++|||++|+.||..... ........
T Consensus 165 ~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------~~~~~~~~ 227 (271)
T 3dtc_A 165 EWHRTTK----MSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDG-----------LAVAYGVA 227 (271)
T ss_dssp ---------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-----------HHHHHHHH
T ss_pred ccccccc----cCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHhhh
Confidence 6654322 234589999999999764 678999999999999999999999864321 01111111
Q ss_pred cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
....... ....+...+.+++.+||+.||++|||+.|++++|++
T Consensus 228 ~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 228 MNKLALP----IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp TSCCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred cCCCCCC----CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111111 111234568889999999999999999999999984
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.90 Aligned_cols=250 Identities=23% Similarity=0.285 Sum_probs=201.9
Q ss_pred HHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc-------chHHHHHHHHHHhhcccceEEeecceEecCCeeEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN-------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 418 (667)
.+.+.+.||+|+||+||+++.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3456789999999999999985 589999999865421 35679999999999999999999999999999999
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC----ceEEEeCCCc
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF----TPKVSDFGLA 494 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~----~~ki~DFGla 494 (667)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 92 ILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 99999999999999653 3589999999999999999999998 999999999999999887 8999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHh
Q 005953 495 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 574 (667)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 574 (667)
+....... .....||+.|+|||++.. ..++.++||||||+++|||++|+.||..... ......
T Consensus 166 ~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------~~~~~~ 228 (326)
T 2y0a_A 166 HKIDFGNE---FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTK------------QETLAN 228 (326)
T ss_dssp EECCTTSC---CCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------------HHHHHH
T ss_pred eECCCCCc---cccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH------------HHHHHH
Confidence 87754332 234568999999999865 3678999999999999999999999864321 011111
Q ss_pred hcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
+..... .............+.+++.+||+.||++|||+.|++++-
T Consensus 229 ~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 229 VSAVNY-EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp HHHTCC-CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred HHhcCC-CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 111100 011111122345688899999999999999999999854
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=355.25 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=198.9
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.+.++||+|+||+||+++.. +++.||+|++++.. ...+.+.+|..++.++ +||||+++++++.+.+..++||||
T Consensus 55 ~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~ 134 (396)
T 4dc2_A 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 134 (396)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEc
Confidence 45688999999999999986 58899999997542 2335688999999887 899999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 135 ~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 208 (396)
T 4dc2_A 135 VNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208 (396)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence 99999999997543 589999999999999999999998 999999999999999999999999999986433222
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .........+...+......
T Consensus 209 --~~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~~~~~---~~~~~~~~~~~~~i~~~~~~- 280 (396)
T 4dc2_A 209 --TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD---NPDQNTEDYLFQVILEKQIR- 280 (396)
T ss_dssp --CBCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------CCHHHHHHHHHHCCCC-
T ss_pred --ccccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccccc---ccchhhHHHHHHHHhccccC-
Confidence 12445699999999999764 67899999999999999999999996532211 00111122223322222111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSM------TRVVEML 620 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~------~evl~~L 620 (667)
.+..+...+.+++.+||+.||++||++ .|++++-
T Consensus 281 ----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp 320 (396)
T 4dc2_A 281 ----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320 (396)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred ----CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence 111234567889999999999999985 6776653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=354.31 Aligned_cols=253 Identities=19% Similarity=0.304 Sum_probs=202.5
Q ss_pred HHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC------CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEE
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT------SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 418 (667)
..|.+.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34566789999999999999875 6899999998532 1245789999999999999999999999999999999
Q ss_pred EEEEcCCCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCc---eEEEeCCCc
Q 005953 419 IYEYMPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT---PKVSDFGLA 494 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~---~ki~DFGla 494 (667)
||||+++|+|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999888643 2344689999999999999999999998 9999999999999987654 999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHh
Q 005953 495 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 574 (667)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 574 (667)
+........ .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .+...
T Consensus 181 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------~~~~~ 243 (351)
T 3c0i_A 181 IQLGESGLV--AGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTKE-------------RLFEG 243 (351)
T ss_dssp EECCTTSCB--CCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------------HHHHH
T ss_pred eEecCCCee--ecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------------HHHHH
Confidence 876544321 2345699999999999764 678999999999999999999999964211 11122
Q ss_pred hcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
+...... ........+...+.+++.+||+.||++|||+.|++++
T Consensus 244 i~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 244 IIKGKYK-MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHTCCC-CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHcCCCC-CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2111110 1111112345678899999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=344.74 Aligned_cols=260 Identities=17% Similarity=0.235 Sum_probs=205.2
Q ss_pred HhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 349 GFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
.+.+.||+|+||+||+|+. .+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++.+....++||||+ ++
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 90 (298)
T 1csn_A 13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 90 (298)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CC
Confidence 3557899999999999997 478999999986543 235688999999999 7999999999999999999999999 99
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCc-----eEEEeCCCccccCCCC
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT-----PKVSDFGLAKAHSRNR 501 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~-----~ki~DFGla~~~~~~~ 501 (667)
+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++......
T Consensus 91 ~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 91 SLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp BHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 9999997542 3589999999999999999999988 9999999999999987776 9999999998765443
Q ss_pred cee-----eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhc
Q 005953 502 SVV-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 576 (667)
Q Consensus 502 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (667)
... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...... . .......+.
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~----~-----~~~~~~~~~ 234 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAA----T-----NKQKYERIG 234 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC----C-----HHHHHHHHH
T ss_pred ccccccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcchhhcc----c-----cHHHHHHHH
Confidence 211 12345699999999998763 6789999999999999999999999754321 1 111111111
Q ss_pred CcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 577 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
..............++..+.+++.+||+.||++||++++|++.|+++..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 235 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 11111111111123456788999999999999999999999999976554
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=343.48 Aligned_cols=254 Identities=25% Similarity=0.331 Sum_probs=195.6
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.+.++||+|+||+||+|+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 83 (288)
T 1ob3_A 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD- 83 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred hhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC-
Confidence 3568899999999999999889999999986543 234678899999999999999999999999999999999997
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 156 (288)
T 1ob3_A 84 QDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-- 156 (288)
T ss_dssp EEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccccc--
Confidence 48988886532 3588999999999999999999998 9999999999999999999999999999876433221
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc------
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE------ 579 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 579 (667)
.....||+.|+|||++.+. ..++.++||||||+++|||++|+.||...... .....+...+..+.
T Consensus 157 ~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--------DQLMRIFRILGTPNSKNWPN 227 (288)
T ss_dssp -----CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHHCCCChhhchh
Confidence 2344689999999998654 45789999999999999999999999653210 00000111000000
Q ss_pred ----------c----ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 580 ----------K----EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 580 ----------~----~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
. ..........+...+.+++.+||+.||++|||++|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 000001112235577899999999999999999999865
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=351.77 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=205.9
Q ss_pred HHHhhhhcccCCCeEEEEEEeC--------CCcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEecCCe
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP--------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGST 415 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~ 415 (667)
.+.+.+.||+|+||+||+|++. +++.||||++.... ...+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 115 (334)
T 2pvf_A 36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 115 (334)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCc
Confidence 3445688999999999999863 46789999997654 2346789999999999 89999999999999999
Q ss_pred eEEEEEEcCCCCcccccccccc-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC
Q 005953 416 RALIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP 482 (667)
Q Consensus 416 ~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~ 482 (667)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 116 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTE 192 (334)
T ss_dssp CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcC
Confidence 9999999999999999975431 23489999999999999999999998 9999999999999999
Q ss_pred CCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCC
Q 005953 483 DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSN 561 (667)
Q Consensus 483 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~ 561 (667)
++.+||+|||+++...............+|+.|+|||++.+. .++.++||||||+++|||++ |+.||.....
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~----- 265 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 265 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred CCCEEEccccccccccccccccccCCCCcccceeChHHhcCC--CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence 999999999999877655443333445678999999998763 67889999999999999999 9988854321
Q ss_pred CccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 562 TTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
..+...+........ ...+...+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 266 -------~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 266 -------EELFKLLKEGHRMDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp -------HHHHHHHHHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HHHHHHHhcCCCCCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111111111111111 11234568889999999999999999999999996644
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=348.36 Aligned_cols=255 Identities=29% Similarity=0.467 Sum_probs=209.8
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.+.++||+|+||+||+|.+. +++.||+|++.......+.+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 15 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 94 (288)
T 3kfa_A 15 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 94 (288)
T ss_dssp EEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred eeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCC
Confidence 445688999999999999986 4889999999887777788999999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........ ..
T Consensus 95 ~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~ 169 (288)
T 3kfa_A 95 NLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AH 169 (288)
T ss_dssp EHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE-EE
T ss_pred cHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccc-cc
Confidence 9999997543 34689999999999999999999998 9999999999999999999999999999877654432 23
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
....+|+.|+|||.+... .++.++||||||+++|||++ |+.||..... .. +...+.......
T Consensus 170 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--------~~----~~~~~~~~~~~~--- 232 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQ----VYELLEKDYRME--- 232 (288)
T ss_dssp TTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--------GG----HHHHHHTTCCCC---
T ss_pred cCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HH----HHHHHhccCCCC---
Confidence 445578899999999764 78899999999999999999 8888864322 01 111111111111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
....++..+.+++.+||+.||++|||+.|+++.|+....
T Consensus 233 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 233 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 111234578889999999999999999999999986543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.26 Aligned_cols=249 Identities=24% Similarity=0.294 Sum_probs=196.2
Q ss_pred HHHHHHHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHHhhc-ccceEEeecceEecCCe
Q 005953 341 NDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRI-HHVNIIHLLGFCCDGST 415 (667)
Q Consensus 341 ~~l~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~ 415 (667)
.++....+.+.++||+|+||+||+|++. +++.||||++..... ....+..|+..+.++ +||||+++++++.+++.
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 3444455666789999999999999986 699999999865432 234566677766666 89999999999999999
Q ss_pred eEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 416 RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 416 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
.++||||+ +++|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV 205 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred EEEEEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeee
Confidence 99999999 789999886543 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh
Q 005953 496 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575 (667)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (667)
....... .....||+.|+|||++.+ .++.++||||||+++|||++|+.++..... +..+
T Consensus 206 ~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~---------------~~~~ 264 (311)
T 3p1a_A 206 ELGTAGA---GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEG---------------WQQL 264 (311)
T ss_dssp ECC---------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------------HHHH
T ss_pred ecccCCC---CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------------HHHH
Confidence 7654332 234568999999998864 678999999999999999999776542211 1222
Q ss_pred cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
..... .......+...+.+++.+||+.||++|||+.|++++
T Consensus 265 ~~~~~---~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 265 RQGYL---PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp TTTCC---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hccCC---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 22111 111122345678899999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=360.16 Aligned_cols=250 Identities=20% Similarity=0.287 Sum_probs=200.7
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
+.+.++||+|+||+||++... +|+.+|+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 92 (444)
T 3soa_A 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLV 92 (444)
T ss_dssp EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeC
Confidence 455689999999999999874 68999999987654 23456889999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC---CCCceEEEeCCCccccCCC
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~---~~~~~ki~DFGla~~~~~~ 500 (667)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++ +++.+||+|||+++.....
T Consensus 93 ~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 93 TGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp BCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred CCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 999999988754 3589999999999999999999998 999999999999998 5688999999999876544
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+.....
T Consensus 167 ~~~--~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~------------~~~~~~i~~~~~ 230 (444)
T 3soa_A 167 QQA--WFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQ------------HRLYQQIKAGAY 230 (444)
T ss_dssp CCB--CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSH------------HHHHHHHHHTCC
T ss_pred Cce--eecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccH------------HHHHHHHHhCCC
Confidence 322 2456799999999999763 678999999999999999999999964321 111222221111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
. ........+...+.+++.+||+.||++|||+.|++++-
T Consensus 231 ~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 231 D-FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp C-CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred C-CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 1 11111123355788899999999999999999999763
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=377.45 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=206.3
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
.+.++||+|+||+||+|++.++..||||+++......++|.+|+++|++++||||+++++++.+ +..++||||+++|+|
T Consensus 270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL 348 (535)
T 2h8h_A 270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 348 (535)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEH
T ss_pred hhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcH
Confidence 4568899999999999999888889999998766667889999999999999999999999876 678999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.++|.... ...+++..++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... .....
T Consensus 349 ~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~ 423 (535)
T 2h8h_A 349 LDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQG 423 (535)
T ss_dssp HHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-HTTCS
T ss_pred HHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-ecccC
Confidence 99997532 23589999999999999999999998 999999999999999999999999999987653221 11233
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 587 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (667)
..++..|+|||++.. +.++.++||||||+++|||++ |+.||..... ..+...+....... .
T Consensus 424 ~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------------~~~~~~i~~~~~~~----~ 485 (535)
T 2h8h_A 424 AKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------------REVLDQVERGYRMP----C 485 (535)
T ss_dssp TTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------------HHHHHHHHTTCCCC----C
T ss_pred CcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCCC----C
Confidence 457889999999876 478999999999999999999 8888854321 11222222221111 1
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 588 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
...+...+.+++.+||+.||++|||+++|++.|+++.
T Consensus 486 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 486 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1123557888999999999999999999999999654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=345.61 Aligned_cols=273 Identities=25% Similarity=0.345 Sum_probs=197.4
Q ss_pred HHHHHHHHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhh--cccceEEeecceEecC----Ce
Q 005953 342 DIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGR--IHHVNIIHLLGFCCDG----ST 415 (667)
Q Consensus 342 ~l~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~g~~~~~----~~ 415 (667)
+.....+.+.++||+|+||+||+|++. ++.||||++..... ..+.+|.+++.. ++||||+++++++.+. ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 333445566789999999999999984 89999999865443 344555555554 4899999999999877 68
Q ss_pred eEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeeecCCCCCcEEECCCCceEEEe
Q 005953 416 RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC-----ELRILHLDIKPQNVLLDPDFTPKVSD 490 (667)
Q Consensus 416 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~-----~~~ivH~Dikp~NIll~~~~~~ki~D 490 (667)
.++||||+++|+|.+++... .+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 89999999999999999643 4899999999999999999999741 33899999999999999999999999
Q ss_pred CCCccccCCCCceee--ecCCCCCccccchhhhhhhcCCCCC------cccHHHHHHHHHHHHhCCCCCCCCCcCC----
Q 005953 491 FGLAKAHSRNRSVVT--MTGPRGTIGYIAPEIFMRNLGNPSG------KSDVYSYGMLLLEMIEEKKHLRPTETTS---- 558 (667)
Q Consensus 491 FGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~s~------k~DvwSlGvvl~elltg~~p~~~~~~~~---- 558 (667)
||+++.......... .....||+.|+|||++.+. ..+. ++||||||+++|||++|..|+.......
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 999987654332211 1245689999999999764 3333 4899999999999999955442211100
Q ss_pred CCCCccccchHHHHHhhcCccc-cccc-chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 559 GSNTTEAYFPDWIYDKLIQPEK-EDFV-EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
........+. ........... .... ......+...+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 264 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 264 DLVPSDPSYE-DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp TTSCSSCCHH-HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCCCCchh-hhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 0000011111 11111111111 1111 1112356778999999999999999999999999999654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=361.97 Aligned_cols=253 Identities=21% Similarity=0.224 Sum_probs=200.7
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.++||+|+||+||+|++. +++.||+|++.+.. ...+.+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 78 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~ 157 (437)
T 4aw2_A 78 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYV 157 (437)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCC
Confidence 4578999999999999986 47899999986532 223458899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|+|.+++.+. ...+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++........
T Consensus 158 gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~- 231 (437)
T 4aw2_A 158 GGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV- 231 (437)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-
T ss_pred CCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc-
Confidence 99999999763 23589999999999999999999998 9999999999999999999999999999876554432
Q ss_pred eecCCCCCccccchhhhhhh---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
......||+.|+|||++... .+.++.++|||||||++|||++|+.||..... ......+......
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~------------~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------------VETYGKIMNHKER 299 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHTHHHH
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh------------hHHHHhhhhcccc
Confidence 23446799999999999731 24678899999999999999999999965321 1112222211100
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKD--RPSMTRVVEML 620 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~~L 620 (667)
.........+...+.+++.+||+.+|++ ||+++|++++=
T Consensus 300 ~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 300 FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 0001111113456778999999888888 99999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=356.43 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=192.0
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.+.++||+|+||+||+++.. +++.||||++.......+.+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 101 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG 101 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCC
Confidence 345689999999999999986 6899999999877666678999999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCc--eEEEeCCCccccCCCCcee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT--PKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~--~ki~DFGla~~~~~~~~~~ 504 (667)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.......
T Consensus 102 ~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~-- 173 (361)
T 3uc3_A 102 ELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 173 (361)
T ss_dssp BHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC--
Confidence 9999986543 589999999999999999999998 9999999999999987765 99999999975432221
Q ss_pred eecCCCCCccccchhhhhhhcCCC-CCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~-s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
.....||+.|+|||++.+. .+ +.++||||||+++|||++|+.||...... ..+... ...+.......
T Consensus 174 -~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~~-~~~~~~~~~~~- 241 (361)
T 3uc3_A 174 -PKSTVGTPAYIAPEVLLRQ--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------RDYRKT-IQRILSVKYSI- 241 (361)
T ss_dssp --------CTTSCHHHHHCS--SCCHHHHHHHHHHHHHHHHHHSSCSCC----C-------CCHHHH-HHHHHTTCCCC-
T ss_pred -CCCCcCCCCcCChhhhcCC--CCCCCeeeeehhHHHHHHHHhCCCCCCCCccH-------HHHHHH-HHHHhcCCCCC-
Confidence 2334689999999999764 44 34489999999999999999999654321 111111 11221111110
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.....+...+.+++.+||+.||++|||+.|++++-
T Consensus 242 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 242 --PDDIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp --CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred --CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 00111245678899999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=351.46 Aligned_cols=257 Identities=22% Similarity=0.377 Sum_probs=205.0
Q ss_pred HHhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 419 (667)
+.+.+.||+|+||.||+|++. +++.||||++..... ....+.+|+.++++++||||+++++++.+....++|
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 106 (322)
T 1p4o_A 27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 106 (322)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEE
Confidence 345688999999999999764 367899999976543 345689999999999999999999999999999999
Q ss_pred EEEcCCCCcccccccccc-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCC
Q 005953 420 YEYMPNGSLGDLLSREKE-------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG 492 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFG 492 (667)
|||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCc
Confidence 999999999999975321 24578999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHH
Q 005953 493 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWI 571 (667)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 571 (667)
+++...............+|+.|+|||++.+. .++.++||||||+++|||++ |+.|+..... ..+
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~------------~~~ 249 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------------EQV 249 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------------HHH
T ss_pred cccccccccccccccCCCCCCCccChhhhccC--CCCchhhHHHHHHHHHHHHhcCCCccccCCH------------HHH
Confidence 99866543332222334568899999998763 68899999999999999999 7888754321 111
Q ss_pred HHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 572 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
...+........ ...+...+.+++.+||+.||++|||+.|++++|++...
T Consensus 250 ~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 LRFVMEGGLLDK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHcCCcCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 222222211111 11234568889999999999999999999999996543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=357.25 Aligned_cols=268 Identities=18% Similarity=0.239 Sum_probs=200.4
Q ss_pred HHhhhhcccC--CCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 348 NGFKEKLGTG--GYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 348 ~~~~~~LG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
+.+.++||+| +||+||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 106 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 106 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence 3456899999 99999999986 69999999997543 234568889999999999999999999999999999999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 107 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 107 FMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp CCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred ccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999999999997643 23589999999999999999999998 99999999999999999999999999986543221
Q ss_pred ce-----eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC-CccccchHHH----
Q 005953 502 SV-----VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN-TTEAYFPDWI---- 571 (667)
Q Consensus 502 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~---- 571 (667)
.. .......||+.|+|||++.+....++.++|||||||++|||++|+.||.......... ......+...
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 11 1112346899999999997644468899999999999999999999996543210000 0000000000
Q ss_pred -------------------HHhhcCcc-----cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 572 -------------------YDKLIQPE-----KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 572 -------------------~~~~~~~~-----~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
........ ...........+...+.+++.+||+.||++|||+.|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000000 0000011122345678899999999999999999999976
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=352.00 Aligned_cols=249 Identities=21% Similarity=0.345 Sum_probs=201.1
Q ss_pred HHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.+.+.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~ 109 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 3556789999999999999885 68999999997643 2345788999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC---CceEEEeCCCccccCC
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD---FTPKVSDFGLAKAHSR 499 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~---~~~ki~DFGla~~~~~ 499 (667)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 110 ~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 110 VTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred CCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 9999999988653 3589999999999999999999998 99999999999999765 4599999999987654
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+....
T Consensus 184 ~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------------~~~~~~i~~~~ 246 (362)
T 2bdw_A 184 SEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQ------------HRLYAQIKAGA 246 (362)
T ss_dssp CCS---CCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHTC
T ss_pred Ccc---cccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHhCC
Confidence 332 2345689999999999763 678999999999999999999999864321 11112221111
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.. ........+...+.+++.+||+.||++|||+.|++++
T Consensus 247 ~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 247 YD-YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CC-CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CC-CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 1111112345678889999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=339.66 Aligned_cols=249 Identities=22% Similarity=0.400 Sum_probs=198.9
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecC--CeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV~e~~ 423 (667)
.+.++||+|+||+||+|++ +++.||||++.... ...+.+.+|+.++++++||||+++++++.+. ...++||||+
T Consensus 13 ~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 91 (271)
T 3kmu_A 13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM 91 (271)
T ss_dssp EEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECC
T ss_pred HHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeeccc
Confidence 3568899999999999998 58899999997653 3346799999999999999999999999887 7889999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR--ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~--ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
++|+|.+++.... ...+++..++.++.|++.||+|||+. + |+||||||+|||+++++.++|.|||++.....
T Consensus 92 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-- 165 (271)
T 3kmu_A 92 PYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-- 165 (271)
T ss_dssp TTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred CCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence 9999999997643 33689999999999999999999987 7 99999999999999999999999988765332
Q ss_pred ceeeecCCCCCccccchhhhhhhc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNL-GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
....||+.|+|||.+.+.. ...+.++||||||+++|||++|+.||..... .............
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~~~~~~~~~~ 229 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-----------MEIGMKVALEGLR 229 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-----------HHHHHHHHHSCCC
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-----------HHHHHHHHhcCCC
Confidence 2345799999999987531 2234479999999999999999999864321 1111111111111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
... ...+...+.+++.+||+.||++|||++|+++.|+++.
T Consensus 230 ~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 230 PTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111 1123456888999999999999999999999998653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.89 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=196.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 421 (667)
+.+.++||+|+||+||+|+.. +++.||||+++.. ....+.+.+|..+++.+ +||||+++++++.+.+..++|||
T Consensus 25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E 104 (353)
T 3txo_A 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME 104 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence 345688999999999999885 5899999998753 23446688999999998 69999999999999999999999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 105 FVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 999999999997643 589999999999999999999998 99999999999999999999999999998643322
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 179 ~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~------------~~~~~~i~~~~~~ 242 (353)
T 3txo_A 179 V--TTATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEAENE------------DDLFEAILNDEVV 242 (353)
T ss_dssp ---------CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCCC
T ss_pred c--cccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCCCCH------------HHHHHHHHcCCCC
Confidence 2 22345699999999999775 678899999999999999999999965422 1122222221111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSM------TRVVEML 620 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~------~evl~~L 620 (667)
. +..+...+.+++.+||+.||++||++ .|++++-
T Consensus 243 -~----p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 243 -Y----PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp -C----CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred -C----CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 0 11134567889999999999999998 7887643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=344.01 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=190.1
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.++||+|+||+||+|+.. +++.||+|+++... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD 86 (317)
T ss_dssp ------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC
T ss_pred eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC
Confidence 345688999999999999875 58999999987543 344678999999999999999999999999999999999997
Q ss_pred CCCccccccccc---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 425 NGSLGDLLSREK---ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 425 ~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 87 -~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 87 -NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp -CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred -CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 69999886532 224589999999999999999999998 99999999999999999999999999998765332
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc---
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP--- 578 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 578 (667)
.. .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||...... .....+.+....+
T Consensus 163 ~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~ 231 (317)
T 2pmi_A 163 NT--FSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDE--------EQLKLIFDIMGTPNES 231 (317)
T ss_dssp CC--CCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCSCCTT
T ss_pred cc--CCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHHHhCCCChh
Confidence 21 2345689999999998753 36789999999999999999999999654320 0000011100000
Q ss_pred -------------cccc-----c----cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 579 -------------EKED-----F----VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 579 -------------~~~~-----~----~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.... . .......+...+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000 0 000001234578899999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=336.83 Aligned_cols=249 Identities=27% Similarity=0.446 Sum_probs=197.1
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcc--------hHHHHHHHHHHhhcccceEEeecceEecCCeeEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNF--------SDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--------~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 419 (667)
.+.+.||+|+||+||+|++. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.. ++|
T Consensus 22 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv 99 (287)
T 4f0f_A 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMV 99 (287)
T ss_dssp EEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEE
T ss_pred eehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEE
Confidence 45688999999999999984 6899999998653311 167899999999999999999999986654 799
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCcEEECCCCc-----eEEEeCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR--ILHLDIKPQNVLLDPDFT-----PKVSDFG 492 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~--ivH~Dikp~NIll~~~~~-----~ki~DFG 492 (667)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+. + |+||||||+|||++.++. +||+|||
T Consensus 100 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 100 MEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred EEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 99999999998886542 3689999999999999999999998 7 999999999999988776 9999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHH
Q 005953 493 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 572 (667)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 572 (667)
+++..... .....||+.|+|||++......++.++||||||+++|||++|+.||...... .......+.
T Consensus 175 ~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~ 243 (287)
T 4f0f_A 175 LSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------KIKFINMIR 243 (287)
T ss_dssp TCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC------HHHHHHHHH
T ss_pred cccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc------HHHHHHHHh
Confidence 99754432 2345689999999998544346788999999999999999999999643221 111111111
Q ss_pred HhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 573 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
. ...... ....+...+.+++.+||+.||++|||+.|+++.|++
T Consensus 244 ~---~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 E---EGLRPT----IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp H---SCCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred c---cCCCCC----CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1 111111 111234578899999999999999999999999984
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=355.12 Aligned_cols=252 Identities=22% Similarity=0.291 Sum_probs=201.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.++||+|+||+||+|+.. +++.||+|++.+. ....+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 72 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~ 151 (410)
T 3v8s_A 72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 151 (410)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 34578999999999999986 5899999998652 223456889999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 152 ~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 152 PGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp TTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 999999998643 488999999999999999999998 9999999999999999999999999999877654322
Q ss_pred eeecCCCCCccccchhhhhhhcC--CCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLG--NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~--~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
......||+.|+|||++....+ .++.++|||||||++|||++|+.||..... ......+......
T Consensus 225 -~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------------~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 225 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------------VGTYSKIMNHKNS 291 (410)
T ss_dssp -ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHTHHHH
T ss_pred -cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------------hhHHHHHHhcccc
Confidence 2345679999999999976421 267899999999999999999999964321 1112222221110
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHh
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKD--RPSMTRVVEMLS 621 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~~L~ 621 (667)
... .....++..+.+++.+||+.+|++ ||+++|++++--
T Consensus 292 ~~~-p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 292 LTF-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp CCC-CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred ccC-CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 000 001123456788999999999988 999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=339.94 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=196.0
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.++||+|+||+||+|++. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (292)
T 3o0g_A 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCC
Confidence 35688999999999999985 68999999987543 334678899999999999999999999999999999999997
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 85 ~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 157 (292)
T 3o0g_A 85 Q-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC- 157 (292)
T ss_dssp E-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC-
T ss_pred C-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc-
Confidence 5 555555432 23589999999999999999999998 9999999999999999999999999999876533222
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc----
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK---- 580 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 580 (667)
.....||+.|+|||++.+. ..++.++||||||+++|||++|+.|+...... . .....+......+..
T Consensus 158 -~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~------~-~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 158 -YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDV------D-DQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH------H-HHHHHHHHHHCCCCTTTCT
T ss_pred -ccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH------H-HHHHHHHHHhCCCChhhhh
Confidence 2345689999999999764 34789999999999999999998886432210 0 000111111111000
Q ss_pred ----------------ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 581 ----------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 581 ----------------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
..........+...+.+++.+||+.||++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000011112245577889999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=351.35 Aligned_cols=245 Identities=23% Similarity=0.335 Sum_probs=198.0
Q ss_pred HhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||+||+|.+ .+++.||||++... ....+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 12 ~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~ 91 (336)
T 3h4j_B 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA 91 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC
Confidence 3568899999999999997 46899999998643 233467899999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 92 -~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~ 164 (336)
T 3h4j_B 92 -GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL 164 (336)
T ss_dssp -CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT
T ss_pred -CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCccc
Confidence 789998886543 589999999999999999999998 9999999999999999999999999999876544322
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
....||+.|+|||++.+. ...+.++||||||+++|||++|+.||........ ...+.....
T Consensus 165 ---~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------------~~~i~~~~~--- 225 (336)
T 3h4j_B 165 ---KTSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL------------FKKVNSCVY--- 225 (336)
T ss_dssp ---CCCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC------------BCCCCSSCC---
T ss_pred ---ccccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH------------HHHHHcCCC---
Confidence 345689999999998754 2336799999999999999999999965432110 000000000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
..+..++..+.+++.+||+.||++|||++|++++--
T Consensus 226 --~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 226 --VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp --CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred --CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 011123456788999999999999999999997653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.90 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=200.1
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||.||+++.. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 18 ~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~ 97 (384)
T 4fr4_A 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLL 97 (384)
T ss_dssp EEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecC
Confidence 45688999999999999885 5899999998643 234567899999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 98 ~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 170 (384)
T 4fr4_A 98 LGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ- 170 (384)
T ss_dssp TTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCCc-
Confidence 999999999753 3589999999999999999999998 999999999999999999999999999987654432
Q ss_pred eeecCCCCCccccchhhhhhh-cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
.....||+.|+|||++... ...++.++|||||||++|||++|+.||...... . ...+...+.....
T Consensus 171 --~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~----~-----~~~~~~~~~~~~~-- 237 (384)
T 4fr4_A 171 --ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST----S-----SKEIVHTFETTVV-- 237 (384)
T ss_dssp --BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS----C-----HHHHHHHHHHCCC--
T ss_pred --eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc----c-----HHHHHHHHhhccc--
Confidence 2445699999999998642 235788999999999999999999999643221 0 1111111111110
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPS-MTRVVEM 619 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-~~evl~~ 619 (667)
..+..+...+.+++.+||+.||++||+ +++++++
T Consensus 238 ---~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 238 ---TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred ---CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 011123457888999999999999998 7777753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=342.28 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=190.8
Q ss_pred HHhhhhcccCCCeEEEEEEeCC----CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
+.+.+.||+|+||+||+|++.. +..||+|++.... ...+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 95 (281)
T 1mp8_A 17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 95 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEe
Confidence 4456889999999999998742 4579999987643 33467899999999999999999999984 567899999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 96 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 96 LCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp CCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 99999999999754 23589999999999999999999998 99999999999999999999999999998765433
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
.. ......+|+.|+|||++... .++.++||||||+++|||++ |+.||...... .....+.....
T Consensus 171 ~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~------------~~~~~i~~~~~ 235 (281)
T 1mp8_A 171 YY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------------DVIGRIENGER 235 (281)
T ss_dssp ---------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------------GHHHHHHTTCC
T ss_pred cc-ccccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCHH------------HHHHHHHcCCC
Confidence 22 12234468899999999753 77889999999999999996 88898643221 11112222111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
... ...++..+.+++.+||+.||++|||+.|++++|+++..
T Consensus 236 ~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 236 LPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111 11234578889999999999999999999999986543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=348.74 Aligned_cols=257 Identities=24% Similarity=0.298 Sum_probs=197.3
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC------CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT------SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
+.+.+.||+|+||+||+|+.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 28 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 107 (345)
T 3hko_A 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107 (345)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEE
Confidence 345688999999999999885 6889999998643 244578999999999999999999999999999999999
Q ss_pred EEcCCCCcccccccccc-------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHcC
Q 005953 421 EYMPNGSLGDLLSREKE-------------------------------------NLSLKPARLLEIALGVAHAIEYLHNG 463 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i~~gl~yLH~~ 463 (667)
||+++|+|.+++..... ...+++..+..++.|++.||+|||+.
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 187 (345)
T 3hko_A 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ 187 (345)
T ss_dssp ECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 99999999999853110 11235677889999999999999998
Q ss_pred CCCCeeecCCCCCcEEECCCC--ceEEEeCCCccccCCCCc--eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHH
Q 005953 464 CELRILHLDIKPQNVLLDPDF--TPKVSDFGLAKAHSRNRS--VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGM 539 (667)
Q Consensus 464 ~~~~ivH~Dikp~NIll~~~~--~~ki~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGv 539 (667)
+|+||||||+|||++.++ .+||+|||+++....... ........||+.|+|||++......++.++||||||+
T Consensus 188 ---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 188 ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp ---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred ---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999998776 899999999986543221 1123445689999999999754457889999999999
Q ss_pred HHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 540 LLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 540 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
++|||++|+.||..... .+. ...+..... .........+...+.+++.+||+.||++|||+.|++++
T Consensus 265 il~el~~g~~pf~~~~~-----------~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVND-----------ADT-ISQVLNKKL-CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHSSCSSCCSSH-----------HHH-HHHHHHCCC-CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHCCCCCCCCCh-----------HHH-HHHHHhccc-ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999864322 111 111111111 01111112235678889999999999999999999975
Q ss_pred H
Q 005953 620 L 620 (667)
Q Consensus 620 L 620 (667)
-
T Consensus 332 p 332 (345)
T 3hko_A 332 P 332 (345)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.38 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=192.6
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCc---chHHHHHHHHHHhhccc--ceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN---FSDNFINEVATIGRIHH--VNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||+||++...+++.||||++..... ..+.+.+|+.++.+++| +||+++++++.+....++||| +
T Consensus 12 ~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~ 90 (343)
T 3dbq_A 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-C 90 (343)
T ss_dssp EEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-C
T ss_pred EEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-C
Confidence 45688999999999999998899999999875432 33678999999999976 999999999999999999999 5
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
.+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++........
T Consensus 91 ~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 91 GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp CSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 688999999753 3589999999999999999999998 999999999999997 578999999999877654433
Q ss_pred eeecCCCCCccccchhhhhhh---------cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHh
Q 005953 504 VTMTGPRGTIGYIAPEIFMRN---------LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 574 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~---------~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 574 (667)
.......||+.|+|||++... .+.++.++||||||+++|||++|+.||..... .... ...
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----------~~~~-~~~ 232 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----------QISK-LHA 232 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS----------HHHH-HHH
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh----------HHHH-HHH
Confidence 333456799999999998641 14678899999999999999999999864321 0011 111
Q ss_pred hcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
+........... .....+.+++.+||+.||++|||+.|++++.-
T Consensus 233 ~~~~~~~~~~~~---~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 233 IIDPNHEIEFPD---IPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp HHCTTSCCCCCC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HhcCCcccCCcc---cCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 111111111111 11346778999999999999999999998754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=356.19 Aligned_cols=252 Identities=21% Similarity=0.226 Sum_probs=200.2
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.++||+|+||+||+++.. +++.||||++.+.. ...+.+.+|..++.+++||||+++++++.+.+..++||||++
T Consensus 65 ~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~ 144 (412)
T 2vd5_A 65 ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYV 144 (412)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence 4578999999999999985 69999999997532 233458899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|+|.+++.+.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 145 gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~- 218 (412)
T 2vd5_A 145 GGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV- 218 (412)
T ss_dssp SCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCcc-
Confidence 999999997542 3589999999999999999999998 9999999999999999999999999999877654432
Q ss_pred eecCCCCCccccchhhhhhh-----cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 505 TMTGPRGTIGYIAPEIFMRN-----LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~-----~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
......||+.|+|||++... .+.++.++|||||||++|||++|+.||..... ......+....
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------------~~~~~~i~~~~ 286 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------------AETYGKIVHYK 286 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHTHH
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH------------HHHHHHHHhcc
Confidence 22345799999999999742 23578899999999999999999999965322 11122222111
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHHH
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDR---PSMTRVVEML 620 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---Pt~~evl~~L 620 (667)
...........++..+.+++.+||+ +|++| |+++|++++=
T Consensus 287 ~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 287 EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 1000111112345678889999999 99998 6999998764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=346.44 Aligned_cols=251 Identities=21% Similarity=0.311 Sum_probs=183.9
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
++||+|+||+||+|++. +++.||||++... ....+.+|+.+++++. ||||+++++++.+....++||||+++|+|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 67999999999999985 6899999998653 3467889999999997 999999999999999999999999999999
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC---ceEEEeCCCccccCCCCceeee
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF---TPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~---~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+++... ..+++..+..|+.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++........ .
T Consensus 95 ~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~--~ 166 (325)
T 3kn6_A 95 ERIKKK---KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--L 166 (325)
T ss_dssp HHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--c
Confidence 999754 3589999999999999999999998 999999999999997665 8999999999876543322 2
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
....||+.|+|||++.+. .++.++||||||+++|||++|+.||....... .......+...+..+.. ....+
T Consensus 167 ~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~i~~~~~-~~~~~ 238 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-----TCTSAVEIMKKIKKGDF-SFEGE 238 (325)
T ss_dssp -----------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC------------CCCHHHHHHHHTTTCC-CCCSH
T ss_pred cccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCcccc-----ccccHHHHHHHHHcCCC-CCCcc
Confidence 345689999999998764 67899999999999999999999997543211 11112223333333322 11222
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
....+...+.+++.+||+.||++|||+.|++++-
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~ 272 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence 2234567788999999999999999999998664
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.16 Aligned_cols=242 Identities=28% Similarity=0.363 Sum_probs=199.2
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||+||+++.. +|+.||+|+++.. ....+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 9 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~ 88 (318)
T 1fot_A 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 88 (318)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCC
Confidence 35588999999999999985 6899999998753 234567889999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~-- 160 (318)
T 1fot_A 89 EGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 160 (318)
T ss_dssp CSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCcc--
Confidence 9999999997543 589999999999999999999998 99999999999999999999999999998764321
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ......+...... .
T Consensus 161 ---~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~------------~~~~~~i~~~~~~-~ 222 (318)
T 1fot_A 161 ---YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNT------------MKTYEKILNAELR-F 222 (318)
T ss_dssp ---CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHHCCCC-C
T ss_pred ---ccccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCCC-C
Confidence 235689999999998764 678899999999999999999999964321 1111222211111 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 620 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~L 620 (667)
+......+.+++.+||+.||++|| +++|++++=
T Consensus 223 ----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 223 ----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp ----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred ----CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 112345678899999999999999 899998653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=347.87 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=204.5
Q ss_pred HHhhhhcccCCCeEEEEEEe------CCCcEEEEEEcccCCc--chHHHHHHHHHHhhc-ccceEEeecceEecCC-eeE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTSN--FSDNFINEVATIGRI-HHVNIIHLLGFCCDGS-TRA 417 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~-~~~ 417 (667)
+.+.+.||+|+||+||+|++ .+++.||||++..... ..+.+.+|+.++.++ +||||+++++++.+.+ ..+
T Consensus 29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~ 108 (316)
T 2xir_A 29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 108 (316)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceE
Confidence 34568899999999999974 3468999999976543 345789999999999 7999999999987654 589
Q ss_pred EEEEEcCCCCcccccccccc-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC
Q 005953 418 LIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF 484 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~ 484 (667)
+||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN 185 (316)
T ss_dssp EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCC
Confidence 99999999999999976432 12378999999999999999999998 999999999999999999
Q ss_pred ceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCc
Q 005953 485 TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTT 563 (667)
Q Consensus 485 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~ 563 (667)
.+||+|||+++...............||+.|+|||++.+. .++.++||||||+++|||++ |+.||.....
T Consensus 186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------- 256 (316)
T 2xir_A 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------- 256 (316)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-------
T ss_pred CEEECCCccccccccCccceeccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCCCCCcccch-------
Confidence 9999999999877655444444455678999999999764 78899999999999999998 9999864321
Q ss_pred cccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 564 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
...+...+........ .......+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 257 ----~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 257 ----DEEFCRRLKEGTRMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp ----SHHHHHHHHHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----hHHHHHHhccCccCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0111111111111111 11134568889999999999999999999999986543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=352.11 Aligned_cols=264 Identities=15% Similarity=0.194 Sum_probs=197.0
Q ss_pred HHhhhhcccCCCeEEEEEEeCC------CcEEEEEEcccCCcc------------hHHHHHHHHHHhhcccceEEeecce
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTSNF------------SDNFINEVATIGRIHHVNIIHLLGF 409 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~------------~~~~~~Ei~~l~~l~h~niv~l~g~ 409 (667)
+.+.++||+|+||+||+|++.+ ++.||||++...... ...+..|+..+..++||||++++++
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 116 (364)
T 3op5_A 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116 (364)
T ss_dssp EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence 3456889999999999998854 478999998765421 1234456667778889999999999
Q ss_pred EecC----CeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC--CC
Q 005953 410 CCDG----STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD--PD 483 (667)
Q Consensus 410 ~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~--~~ 483 (667)
+.+. ...++||||+ +++|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+|||++ .+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCT
T ss_pred eeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCC
Confidence 8764 4589999999 99999999763 24699999999999999999999998 999999999999998 88
Q ss_pred CceEEEeCCCccccCCCCceee-----ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC
Q 005953 484 FTPKVSDFGLAKAHSRNRSVVT-----MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS 558 (667)
Q Consensus 484 ~~~ki~DFGla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~ 558 (667)
+.+||+|||+++.+........ .....||+.|+|||++.+. .++.++||||||+++|||++|+.||......
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~- 267 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDLEILGYCMIQWLTGHLPWEDNLKD- 267 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCccccccC-
Confidence 9999999999987643322111 1234599999999999764 6899999999999999999999999643210
Q ss_pred CCCCccccchHHHHHhhcCcccccccchh--hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccccc
Q 005953 559 GSNTTEAYFPDWIYDKLIQPEKEDFVEEE--DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEA 627 (667)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 627 (667)
.............. ........ ....+..+.+++.+||+.+|++||++.+|++.|+++....
T Consensus 268 ------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 268 ------PKYVRDSKIRYREN-IASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp ------HHHHHHHHHHHHHC-HHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ------HHHHHHHHHHhhhh-HHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 00111111110000 00000000 0112457889999999999999999999999998765543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=350.33 Aligned_cols=245 Identities=23% Similarity=0.299 Sum_probs=194.2
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
+.||+|+||.||+|+.. +|+.||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~ 174 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence 57999999999999875 68999999998654 34567999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE--CCCCceEEEeCCCccccCCCCceeeec
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL--DPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll--~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++........ .
T Consensus 175 ~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~---~ 246 (373)
T 2x4f_A 175 DRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---K 246 (373)
T ss_dssp HHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC---C
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc---c
Confidence 9886532 3588999999999999999999998 99999999999999 67789999999999877554322 3
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchh
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 587 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (667)
...||+.|+|||++.. ..++.++||||||+++|||++|+.||..... ......+..... ......
T Consensus 247 ~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~------------~~~~~~i~~~~~-~~~~~~ 311 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------------AETLNNILACRW-DLEDEE 311 (373)
T ss_dssp CCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHHTCC-CSCSGG
T ss_pred cccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhccC-CCChhh
Confidence 3468999999999865 3678899999999999999999999964322 011111111110 011111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 588 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
...+...+.+++.+||+.||++|||+.|++++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 22345678899999999999999999999974
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=351.73 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=194.6
Q ss_pred HHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHHhhcc--cceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIH--HVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.+.++||+|+||+||++...+++.||||++.... ...+.+.+|+.++++++ ||||+++++++......++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 44568899999999999999889999999987543 23467899999999996 5999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+.+++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++.......
T Consensus 137 ~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 137 CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 56899999997543 588999999999999999999998 999999999999996 57999999999987755443
Q ss_pred eeeecCCCCCccccchhhhhhh---------cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHH
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRN---------LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 573 (667)
........||+.|+|||++.+. ...++.++|||||||++|||++|+.||..... .... ..
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----------~~~~-~~ 278 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----------QISK-LH 278 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC----------HHHH-HH
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH----------HHHH-HH
Confidence 3333456799999999998641 13578899999999999999999999964321 0011 11
Q ss_pred hhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.+..+........ .....+.+++.+||+.||++|||+.|++++-.
T Consensus 279 ~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 279 AIIDPNHEIEFPD---IPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp HHHCTTSCCCCCC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHhCccccCCCCc---cchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 2222211111111 11346788999999999999999999997653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=351.69 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=204.4
Q ss_pred HHhhhhcccCCCeEEEEEEeCC------CcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 418 (667)
+.+.+.||+|+||+||+|++.. ...||+|++.... ...+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 127 (333)
T 2i1m_A 48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV 127 (333)
T ss_dssp EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence 3456889999999999998742 2489999997654 2346789999999999 89999999999999999999
Q ss_pred EEEEcCCCCcccccccccc-----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceE
Q 005953 419 IYEYMPNGSLGDLLSREKE-----------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPK 487 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 487 (667)
||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 204 (333)
T 2i1m_A 128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAK 204 (333)
T ss_dssp EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEE
T ss_pred EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEE
Confidence 9999999999999975321 34579999999999999999999998 999999999999999999999
Q ss_pred EEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCcccc
Q 005953 488 VSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAY 566 (667)
Q Consensus 488 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 566 (667)
|+|||+++...............+|+.|+|||.+.+. .++.++||||||+++|||++ |+.||..... ...
T Consensus 205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------~~~ 275 (333)
T 2i1m_A 205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNPYPGILV-------NSK 275 (333)
T ss_dssp BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS-------SHH
T ss_pred ECccccccccccccceeecCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCCCcccch-------hHH
Confidence 9999999876544433333445578899999998764 78899999999999999998 8888864321 111
Q ss_pred chHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 567 FPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
+...+...... .. .......+.+++.+||+.||++|||+.||+++|++..
T Consensus 276 ~~~~~~~~~~~-~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 276 FYKLVKDGYQM-AQ-------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHHHHTCCC-CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCCCC-CC-------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 11111111110 00 1112456788999999999999999999999998654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=353.67 Aligned_cols=265 Identities=21% Similarity=0.329 Sum_probs=208.9
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCC--eeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS--TRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--~~~lV~e~~ 423 (667)
.+.++||+|+||+||+|++. +++.||||++.... ...+.+.+|++++++++||||+++++++.+.. ..++||||+
T Consensus 12 ~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~ 91 (396)
T 4eut_A 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91 (396)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCC
T ss_pred EEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecC
Confidence 35688999999999999986 48999999987543 34577889999999999999999999998755 679999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE----CCCCceEEEeCCCccccCC
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll----~~~~~~ki~DFGla~~~~~ 499 (667)
++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 92 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~ 168 (396)
T 4eut_A 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (396)
T ss_dssp TTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred CCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence 9999999998765555699999999999999999999998 99999999999999 7888899999999987654
Q ss_pred CCceeeecCCCCCccccchhhhhhhc------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHH
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNL------GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 573 (667)
.... ....||+.|+|||++.+.. ..++.++||||||+++|||++|+.||....... . ....+..
T Consensus 169 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~---~----~~~~~~~ 238 (396)
T 4eut_A 169 DEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR---R----NKEVMYK 238 (396)
T ss_dssp GGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT---T----CHHHHHH
T ss_pred CCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc---c----hHHHHHH
Confidence 4322 3456899999999986521 245678999999999999999999996543211 0 0111111
Q ss_pred hhcCc-c------------------cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 574 KLIQP-E------------------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 574 ~~~~~-~------------------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
.+... . ...........+...+.+++.+||+.||++||++.|+++.|+++...
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11100 0 00011122356677889999999999999999999999999866543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=348.88 Aligned_cols=248 Identities=25% Similarity=0.329 Sum_probs=185.5
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
.+.++||+|+||+||+|++. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 56 ~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 134 (349)
T 2w4o_A 56 EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134 (349)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence 34578999999999999986 58899999997653 34668899999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC---CCceEEEeCCCccccCCCCcee
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~---~~~~ki~DFGla~~~~~~~~~~ 504 (667)
|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 135 L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 206 (349)
T 2w4o_A 135 LFDRIVEK---GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-- 206 (349)
T ss_dssp HHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc--
Confidence 99998654 3589999999999999999999998 9999999999999975 88999999999987654322
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .......+...... ..
T Consensus 207 -~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------~~~~~~~i~~~~~~-~~ 271 (349)
T 2w4o_A 207 -MKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERG-----------DQFMFRRILNCEYY-FI 271 (349)
T ss_dssp -------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-----------HHHHHHHHHTTCCC-CC
T ss_pred -cccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCcc-----------cHHHHHHHHhCCCc-cC
Confidence 2335689999999999763 678999999999999999999999864321 11122222222111 11
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
......+...+.+++.+||+.||++|||+.|++++-
T Consensus 272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 307 (349)
T 2w4o_A 272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP 307 (349)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 111123455788999999999999999999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=372.96 Aligned_cols=250 Identities=23% Similarity=0.361 Sum_probs=198.2
Q ss_pred hcccCCCeEEEEEEeC---CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 353 KLGTGGYGNVYKGKFP---DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
+||+|+||+||+|.+. ++..||||+++... ...++|.+|+++|++++|||||++++++.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999874 46689999997643 346789999999999999999999999976 56899999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee-e
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT-M 506 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~-~ 506 (667)
|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+||||++++.+||+|||+++.......... .
T Consensus 422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 99999654 34689999999999999999999998 999999999999999999999999999987654332211 1
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
....+++.|+|||++.. +.++.++|||||||++|||++ |+.||..... ..+...+..+....
T Consensus 497 ~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------------~~~~~~i~~~~~~~--- 559 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------------PEVMAFIEQGKRME--- 559 (613)
T ss_dssp -----CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS------------HHHHHHHHTTCCCC---
T ss_pred cCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH------------HHHHHHHHcCCCCC---
Confidence 23346789999999976 478999999999999999998 9999865322 11222222222111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
....+...+.+++.+||+.||++||++.+|++.|+.....
T Consensus 560 -~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 560 -CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp -CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 1122356788999999999999999999999999865443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=340.50 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=196.7
Q ss_pred HHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC------cchHHHHHHHHHHhhcc---cceEEeecceEecCC--
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS------NFSDNFINEVATIGRIH---HVNIIHLLGFCCDGS-- 414 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~-- 414 (667)
.+.+.++||+|+||+||+|++. +++.||||++.... .....+.+|+.++++++ ||||+++++++....
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~ 89 (308)
T 3g33_A 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD 89 (308)
T ss_dssp CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence 3456689999999999999974 68999999986422 22356778888887775 999999999998755
Q ss_pred ---eeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeC
Q 005953 415 ---TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDF 491 (667)
Q Consensus 415 ---~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DF 491 (667)
..++||||+. |+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 90 REIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp SEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSC
T ss_pred CceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeC
Confidence 4789999996 69999987643 23489999999999999999999998 9999999999999999999999999
Q ss_pred CCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHH
Q 005953 492 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI 571 (667)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 571 (667)
|+++....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...... .....+
T Consensus 165 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------~~~~~i 231 (308)
T 3g33_A 165 GLARIYSYQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--------DQLGKI 231 (308)
T ss_dssp SCTTTSTTCCC---SGGGGCCCSSCCHHHHHTS--CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH--------HHHHHH
T ss_pred ccccccCCCcc---cCCccccccccCchHHcCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHH
Confidence 99987654332 2345689999999999764 6889999999999999999999999654321 001111
Q ss_pred HHhhcCccc------------------ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 572 YDKLIQPEK------------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 572 ~~~~~~~~~------------------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
...+..+.. ..........+...+.+++.+||+.||++|||+.|++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~ 298 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence 111110000 0000011112346788899999999999999999998753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=345.67 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=199.1
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.+.+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|+.++.++ +||||+++++++.+....++||||
T Consensus 12 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~ 91 (345)
T 3a8x_A 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 91 (345)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeC
Confidence 35588999999999999985 58999999997542 2345678999999988 899999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 92 ~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 92 VNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 99999999997543 589999999999999999999998 999999999999999999999999999986433222
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ........+...+......
T Consensus 166 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~i~~~~~~- 237 (345)
T 3a8x_A 166 --TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN---PDQNTEDYLFQVILEKQIR- 237 (345)
T ss_dssp --CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------CHHHHHHHHHHCCCC-
T ss_pred --cccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCcccccc---cccccHHHHHHHHHcCCCC-
Confidence 12345699999999999764 678999999999999999999999965322110 0011112222222221111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSM------TRVVEML 620 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~------~evl~~L 620 (667)
. +..+...+.+++.+||+.||++||++ .|++++=
T Consensus 238 ~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp 277 (345)
T 3a8x_A 238 I----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277 (345)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred C----CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence 1 11234567889999999999999995 6777553
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=350.63 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=201.1
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.+.||+|+||+||+|... +++.||+|++.... .....+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~g 132 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCC
Confidence 445688999999999999885 68999999987654 2345788999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC--CCceEEEeCCCccccCCCCce
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP--DFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~--~~~~ki~DFGla~~~~~~~~~ 503 (667)
|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++........
T Consensus 133 g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 133 GELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp CBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred CcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 9999998654 23589999999999999999999998 9999999999999974 478999999999887654432
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
. ...||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+..... ..
T Consensus 208 ~---~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~------------~~~~~~i~~~~~-~~ 269 (387)
T 1kob_A 208 K---VTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------------LETLQNVKRCDW-EF 269 (387)
T ss_dssp E---EECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------------HHHHHHHHHCCC-CC
T ss_pred e---eeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCC-CC
Confidence 2 23589999999999763 678899999999999999999999964321 001111111100 00
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.......+...+.+++.+||+.||++|||+.|++++-
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 1111122355788999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=334.59 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=201.5
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++|+||++
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (276)
T 2yex_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (276)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecC
Confidence 345688999999999999985 68999999986443 345788999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++..........
T Consensus 89 ~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 89 GGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp TEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999999653 3589999999999999999999998 99999999999999999999999999998765433222
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
......|++.|+|||.+.+. ...+.++||||||+++|||++|+.||...... ...+..+. .....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-----~~~~~--- 227 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYSDWK-----EKKTY--- 227 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT------SHHHHHHH-----TTCTT---
T ss_pred cccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHhh-----hcccc---
Confidence 23445689999999998754 23467899999999999999999999654321 01111111 11100
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
......+...+.+++.+||+.||++|||+.|++++-
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263 (276)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence 011122345678899999999999999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.73 Aligned_cols=273 Identities=16% Similarity=0.168 Sum_probs=204.3
Q ss_pred HHhhhhcccCCCeEEEEEEeCC---------CcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEe-------------
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPD---------GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIH------------- 405 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~------------- 405 (667)
+.+.+.||+|+||+||+|++.. ++.||||++... +.+.+|++++++++||||++
T Consensus 44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 119 (352)
T 2jii_A 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI 119 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence 4456889999999999998863 789999998754 46789999999999999998
Q ss_pred --ecceEec-CCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC
Q 005953 406 --LLGFCCD-GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP 482 (667)
Q Consensus 406 --l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~ 482 (667)
+++++.. +...++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 120 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 120 PTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP 194 (352)
T ss_dssp CCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEET
T ss_pred cchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcC
Confidence 5666665 67889999999 999999997542 34699999999999999999999998 9999999999999999
Q ss_pred CC--ceEEEeCCCccccCCCCcee-----eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 005953 483 DF--TPKVSDFGLAKAHSRNRSVV-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTE 555 (667)
Q Consensus 483 ~~--~~ki~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~ 555 (667)
++ .+||+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 98 99999999998765332211 11234689999999998763 67899999999999999999999986432
Q ss_pred cCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccccccCCCCCCC
Q 005953 556 TTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKPL 635 (667)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~~p~ 635 (667)
.. ...........................+...+.+++.+||+.||++|||+++|++.|+++.......+..|.
T Consensus 273 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~ 346 (352)
T 2jii_A 273 PN------TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPI 346 (352)
T ss_dssp TC------HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCC
T ss_pred cC------HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccc
Confidence 10 001111111001110000000000012245788899999999999999999999999977655444444444
Q ss_pred CC
Q 005953 636 FP 637 (667)
Q Consensus 636 ~~ 637 (667)
.+
T Consensus 347 dw 348 (352)
T 2jii_A 347 GL 348 (352)
T ss_dssp CC
T ss_pred cC
Confidence 43
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=347.63 Aligned_cols=244 Identities=21% Similarity=0.333 Sum_probs=198.4
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.+.+.||+|+||+||+|+.. +++.||||+++.. ....+.+.+|..++.++ +||||+++++++.+.+..++||||
T Consensus 20 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~ 99 (345)
T 1xjd_A 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEY 99 (345)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence 35688999999999999985 5899999999754 23456788999999987 899999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 100 LNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence 99999999997543 589999999999999999999998 999999999999999999999999999986543222
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 174 ~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~------------~~~~~~i~~~~~~- 236 (345)
T 1xjd_A 174 K--TNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------------EELFHSIRMDNPF- 236 (345)
T ss_dssp C--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCCC-
T ss_pred c--ccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCH------------HHHHHHHHhCCCC-
Confidence 1 2345689999999999764 678999999999999999999999964321 1112222111110
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMT-RVVEM 619 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-evl~~ 619 (667)
. +..+...+.+++.+||+.||++||++. |++++
T Consensus 237 ~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 237 Y----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp C----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred C----CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 0 112345678899999999999999997 77644
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=348.26 Aligned_cols=266 Identities=26% Similarity=0.377 Sum_probs=204.1
Q ss_pred HhhhhcccCCCeEEEEEEeC-----CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecC--CeeEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-----DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRALI 419 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV 419 (667)
.+.++||+|+||+||++.+. +++.||||++.... ...+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 45688999999999998653 57899999998654 3346789999999999999999999999874 578999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 114 ~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp ECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 9999999999999654 389999999999999999999998 999999999999999999999999999988765
Q ss_pred CCcee-eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCC---CCCccccchHHHHHhh
Q 005953 500 NRSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG---SNTTEAYFPDWIYDKL 575 (667)
Q Consensus 500 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~ 575 (667)
..... ......+|..|+|||++.+. .++.++||||||+++|||++|+.|+........ ...........+...+
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 44322 22345588899999999764 677899999999999999999998854311000 0000000000111111
Q ss_pred cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccccc
Q 005953 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEA 627 (667)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 627 (667)
..... ......+...+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 265 ~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 265 ERGER----LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hcccC----CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 11111 1111223567889999999999999999999999999765543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=347.83 Aligned_cols=265 Identities=23% Similarity=0.375 Sum_probs=202.4
Q ss_pred HHhhhhcccCCCeEEEEEEe-----CCCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecC--CeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF-----PDGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDG--STRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~l 418 (667)
+.+.++||+|+||.||+|++ .+++.||||++.... ...+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 34568899999999999984 368899999987543 3457899999999999999999999999876 66899
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 103 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccccc
Confidence 999999999999996543 3589999999999999999999998 99999999999999999999999999998776
Q ss_pred CCCcee-eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC---CCCCccccchHHHHHh
Q 005953 499 RNRSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS---GSNTTEAYFPDWIYDK 574 (667)
Q Consensus 499 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 574 (667)
...... ......||..|+|||.+.+. .++.++||||||+++|||++|+.|+....... ............+...
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQS--KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCC--CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 554332 22345688899999999764 67789999999999999999998753221000 0000000011111111
Q ss_pred hcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
+...... .....++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 256 ~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 256 LKEGKRL----PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccCCC----CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1111111 11122346788999999999999999999999999854
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=347.18 Aligned_cols=254 Identities=25% Similarity=0.422 Sum_probs=193.9
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCc----EEEEEEcccC--CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGR----LVAVKVLEKT--SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
.+.++||+|+||+||+|++. +++ .||+|.+... ....+.+.+|+.++++++||||+++++++.+.. .++|+|
T Consensus 18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~ 96 (327)
T 3lzb_A 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQ 96 (327)
T ss_dssp EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEEC
T ss_pred eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEE
Confidence 35688999999999999874 344 3577777543 345678999999999999999999999998754 789999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 97 LMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp CCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred ecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 999999999997643 3589999999999999999999998 99999999999999999999999999998775544
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
.........+|+.|+|||.+.+. .++.++||||||+++|||++ |+.||...... . +...+.....
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~----~~~~~~~~~~ 237 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------E----ISSILEKGER 237 (327)
T ss_dssp --------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------G----HHHHHHTTCC
T ss_pred ccccccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------H----HHHHHHcCCC
Confidence 43333455678899999999864 78899999999999999999 99998654321 1 1111111111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
... .......+.+++.+||+.||++||++.|+++.|+++..+
T Consensus 238 ~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 238 LPQ----PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 111 111344678899999999999999999999999976543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.45 Aligned_cols=258 Identities=25% Similarity=0.404 Sum_probs=199.6
Q ss_pred HHhhhhcccCCCeEEEEEEe------CCCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 419 (667)
+.+.+.||+|+||+||+|++ .+++.||||++.... ....++.+|+.++++++||||+++++++.+....++|
T Consensus 32 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (327)
T 2yfx_A 32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 111 (327)
T ss_dssp CEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEE
Confidence 44568899999999999984 247789999997543 3346789999999999999999999999999999999
Q ss_pred EEEcCCCCccccccccc----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC---CCceEEEeCC
Q 005953 420 YEYMPNGSLGDLLSREK----ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFG 492 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~---~~~~ki~DFG 492 (667)
|||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||++. +..+||+|||
T Consensus 112 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECccc
Confidence 99999999999997543 124589999999999999999999998 9999999999999984 4569999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHH
Q 005953 493 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWI 571 (667)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 571 (667)
+++...............||+.|+|||.+.+. .++.++||||||+++|||++ |+.||..... ..+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~------------~~~ 254 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------------QEV 254 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------------HHH
T ss_pred cccccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCH------------HHH
Confidence 99865443322222334578999999999764 67899999999999999998 8888854321 111
Q ss_pred HHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 572 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
...+........ ...+...+.+++.+||+.||++||++.|++++|+....+
T Consensus 255 ~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 255 LEFVTSGGRMDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhcCCCCCC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 222222111111 112345688899999999999999999999999966543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=353.97 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=189.9
Q ss_pred HhhhhcccCCCeEEEEEEeC--C--CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEec-CCeeEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP--D--GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCD-GSTRALIYE 421 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~--~--~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~lV~e 421 (667)
.+.++||+|+||+||+|++. + +..||||.++... ...++|.+|+.++++++||||+++++++.+ .+..++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 34578999999999999863 2 2468999987543 345789999999999999999999998764 457899999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++.... ..+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 172 ~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 172 YMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp CCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999999996542 3578999999999999999999998 99999999999999999999999999998664332
Q ss_pred ce--eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 502 SV--VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 502 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
.. .......+|+.|+|||.+.+ ..++.++||||||+++|||++ |.+||...... .... .+...
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--------~~~~----~~~~~ 312 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--------DITV----YLLQG 312 (373)
T ss_dssp -----------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--------CHHH----HHHTT
T ss_pred cccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--------HHHH----HHHcC
Confidence 11 12234557889999999976 478899999999999999999 56666433210 1111 11111
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
..... ...+...+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 313 ~~~~~----p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 313 RRLLQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 112345688899999999999999999999999966543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=346.56 Aligned_cols=273 Identities=25% Similarity=0.306 Sum_probs=194.6
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEec-----CCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD-----GSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-----~~~~~lV~e~~ 423 (667)
.+.+.||+|+||+||+|+. +++.||||++............|+..+..++||||+++++.+.. ....++||||+
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 94 (336)
T 3g2f_A 16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYY 94 (336)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCC
T ss_pred heeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecC
Confidence 3458899999999999988 78999999987554322223344444556899999999985532 33578999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCeeecCCCCCcEEECCCCceEEEeCCCcccc
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC------ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~------~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~ 497 (667)
++|+|.+++.... .++..+..++.|+++||+|||+.. .++|+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~ 170 (336)
T 3g2f_A 95 PNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170 (336)
T ss_dssp TTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeec
Confidence 9999999996543 588899999999999999999752 238999999999999999999999999999876
Q ss_pred CCCCc------eeeecCCCCCccccchhhhhhhc-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCc---
Q 005953 498 SRNRS------VVTMTGPRGTIGYIAPEIFMRNL-----GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT--- 563 (667)
Q Consensus 498 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~-----~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~--- 563 (667)
..... ........||+.|+|||++.+.. ..++.++||||||+++|||++|+.|+............
T Consensus 171 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~ 250 (336)
T 3g2f_A 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT 250 (336)
T ss_dssp SSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHH
T ss_pred ccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhc
Confidence 53321 11223456999999999986521 13456899999999999999998877544321110000
Q ss_pred ---cccchHHHHHhhcCccc-ccc--cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 564 ---EAYFPDWIYDKLIQPEK-EDF--VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 564 ---~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
................. ... ...........+.+++.+||+.||++|||++|+++.|+++...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 251 EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 00001111111111111 111 1111223566899999999999999999999999999976543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=342.60 Aligned_cols=243 Identities=23% Similarity=0.300 Sum_probs=200.6
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||.||+++.. +|+.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 44 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 123 (350)
T 1rdq_E 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123 (350)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 35578999999999999985 68999999986532 34567899999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 124 ~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-- 195 (350)
T 1rdq_E 124 AGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp TTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCCc--
Confidence 9999999997543 589999999999999999999998 99999999999999999999999999998765432
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ..+...+...... .
T Consensus 196 ---~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~------------~~~~~~i~~~~~~-~ 257 (350)
T 1rdq_E 196 ---WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP------------IQIYEKIVSGKVR-F 257 (350)
T ss_dssp ---CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCCC-C
T ss_pred ---ccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCH------------HHHHHHHHcCCCC-C
Confidence 234589999999999764 678999999999999999999999964321 1122222221111 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHh
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEMLS 621 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~~L~ 621 (667)
+..+...+.+++.+||+.||++||+ ++|++++--
T Consensus 258 ----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 258 ----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp ----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred ----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 1123456888999999999999998 899887643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=343.95 Aligned_cols=255 Identities=24% Similarity=0.334 Sum_probs=192.0
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.+.++||+|+||+||+|+.. +++.||||++..... ....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 83 (324)
T 3mtl_A 5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD- 83 (324)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-
T ss_pred EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-
Confidence 35678999999999999986 689999999875432 22345689999999999999999999999999999999996
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 84 ~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~ 156 (324)
T 3mtl_A 84 KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--T 156 (324)
T ss_dssp EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--c
Confidence 6888888654 23589999999999999999999998 999999999999999999999999999986543322 2
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc-----
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK----- 580 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 580 (667)
.....||+.|+|||++.+. ..++.++||||||+++|||++|+.||...... .....+...+..+..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE--------EQLHFIFRILGTPTEETWPG 227 (324)
T ss_dssp ------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCCCCTTTSTT
T ss_pred cccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhCCCChHhchh
Confidence 2345689999999998754 46789999999999999999999999654320 001111111111000
Q ss_pred ----------------ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 581 ----------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 581 ----------------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
..........+...+.+++.+||+.||++|||++|++++=
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 0000111122345678999999999999999999999854
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=349.85 Aligned_cols=247 Identities=26% Similarity=0.392 Sum_probs=197.4
Q ss_pred HHhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCCc----chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+...+.||+|+||+||+|+. .+++.||||++..... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 34457899999999999987 4789999999875432 235788999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+. |+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 136 ~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 136 CL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp CS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred CC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 96 7888887543 23689999999999999999999998 9999999999999999999999999999876432
Q ss_pred eeeecCCCCCccccchhhhhh-hcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
....||+.|+|||++.. ..+.++.++||||||+++|||++|+.||..... ...+.. +......
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-----------~~~~~~-~~~~~~~ 271 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSALYH-IAQNESP 271 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHH-HHHSCCC
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHH-HHhcCCC
Confidence 23458999999999863 225678999999999999999999999864321 111111 1111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
... .......+.+++.+||+.||++|||+.+++++.-
T Consensus 272 ~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 272 ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 111 1122456788999999999999999999997654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=337.34 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=202.5
Q ss_pred hhcccCCCeEEEEEEeC---CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 352 EKLGTGGYGNVYKGKFP---DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.||+|+||+||+|.+. +++.||||+++... ...+.+.+|++++++++||||+++++++ +.+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 38999999999999863 57889999998653 3456799999999999999999999999 556789999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee-
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT- 505 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~- 505 (667)
+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 95 ~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 169 (287)
T 1u59_A 95 PLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 169 (287)
T ss_dssp EHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred CHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeec
Confidence 999999643 34589999999999999999999998 999999999999999999999999999987754443221
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....+|+.|+|||.+... .++.++||||||+++|||++ |+.||..... ..+...+........
T Consensus 170 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~------------~~~~~~i~~~~~~~~- 234 (287)
T 1u59_A 170 RSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------------PEVMAFIEQGKRMEC- 234 (287)
T ss_dssp CCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT------------HHHHHHHHTTCCCCC-
T ss_pred cccccccccccCHHHhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCH------------HHHHHHHhcCCcCCC-
Confidence 2334578999999999753 67889999999999999998 9999864321 111222222211111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
...++..+.+++.+||+.||++||++.|++++|+++..+
T Consensus 235 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 235 ---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp ---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 112355788899999999999999999999999966544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=345.90 Aligned_cols=271 Identities=24% Similarity=0.381 Sum_probs=204.9
Q ss_pred HHhhhhcccCCCeEEEEEEe-----CCCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEe--cCCeeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF-----PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCC--DGSTRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~--~~~~~~lV 419 (667)
+.+.++||+|+||.||++++ .+++.||||++.... ...+.+.+|++++++++||||+++++++. +....++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 104 (327)
T 3lxl_A 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV 104 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEE
Confidence 34568899999999999984 358899999997654 33467899999999999999999999887 45668999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||+++|+|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 105 MEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 99999999999997643 2489999999999999999999998 999999999999999999999999999987755
Q ss_pred CCcee-eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC---CCCCccccchHHHHHhh
Q 005953 500 NRSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS---GSNTTEAYFPDWIYDKL 575 (667)
Q Consensus 500 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~ 575 (667)
..... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.|+....... ............+...+
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccC--CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 44332 22334588899999998764 67889999999999999999999875432100 00000000111111222
Q ss_pred cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccccccC
Q 005953 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIE 629 (667)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 629 (667)
...... .....+...+.+++.+||+.||++|||+.|++++|+.+......
T Consensus 258 ~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 258 EEGQRL----PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp HTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred hcccCC----CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 111111 11122356788999999999999999999999999977655433
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.92 Aligned_cols=247 Identities=25% Similarity=0.340 Sum_probs=190.9
Q ss_pred HHhhhhcccCCCeEEEEEEe----CCCcEEEEEEcccCC-----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF----PDGRLVAVKVLEKTS-----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 418 (667)
+.+.+.||+|+||.||+++. .+++.||+|+++... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 98 (327)
T 3a62_A 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL 98 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence 34568899999999999987 468999999987642 234567899999999999999999999999999999
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 99 ILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp EEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred EEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 999999999999997543 588999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
.... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ......+...
T Consensus 173 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~~~~~i~~~ 236 (327)
T 3a62_A 173 HDGT--VTHTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGENR------------KKTIDKILKC 236 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------------HHHHHHHHHT
T ss_pred cCCc--cccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHhC
Confidence 3322 12345689999999999764 678999999999999999999999964321 1111121111
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHh
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEMLS 621 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~L~ 621 (667)
... . ...+...+.+++.+||+.||++|| ++.|++++--
T Consensus 237 ~~~-~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 237 KLN-L----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp CCC-C----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred CCC-C----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 110 0 112345678899999999999999 7889887643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.09 Aligned_cols=263 Identities=21% Similarity=0.293 Sum_probs=195.8
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 57999999999999875 68999999997654 4467899999999995 799999999999999999999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCc---eEEEeCCCccccCCCCce--
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT---PKVSDFGLAKAHSRNRSV-- 503 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~---~ki~DFGla~~~~~~~~~-- 503 (667)
.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++........
T Consensus 99 ~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (316)
T 2ac3_A 99 LSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172 (316)
T ss_dssp HHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred HHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence 99997643 589999999999999999999998 9999999999999988776 999999999765432211
Q ss_pred ---eeecCCCCCccccchhhhhhh---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccc---hHHHHHh
Q 005953 504 ---VTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYF---PDWIYDK 574 (667)
Q Consensus 504 ---~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~ 574 (667)
.......||+.|+|||++... ...++.++||||||+++|||++|+.||................ ...+...
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
T 2ac3_A 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252 (316)
T ss_dssp ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHH
T ss_pred ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHH
Confidence 112234589999999998641 1246789999999999999999999997653321100000000 1111222
Q ss_pred hcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
+..... .........+...+.+++.+||+.||++|||+.|++++--
T Consensus 253 i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 253 IQEGKY-EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp HHHCCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred HhccCc-ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 211111 1111111224567889999999999999999999998643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=348.97 Aligned_cols=260 Identities=18% Similarity=0.243 Sum_probs=193.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC----CCcEEEEEEcccCCc------------chHHHHHHHHHHhhcccceEEeecceEe
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTSN------------FSDNFINEVATIGRIHHVNIIHLLGFCC 411 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~------------~~~~~~~Ei~~l~~l~h~niv~l~g~~~ 411 (667)
+.+.+.||+|+||+||+|++. ++..||||+...... ....+.+|+..++.++||||+++++++.
T Consensus 39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~ 118 (345)
T 2v62_A 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL 118 (345)
T ss_dssp EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEE
T ss_pred EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccc
Confidence 446689999999999999985 578899999876532 1234678889999999999999999998
Q ss_pred c----CCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC--c
Q 005953 412 D----GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF--T 485 (667)
Q Consensus 412 ~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~--~ 485 (667)
+ ....++||||+ +++|.+++.... .+++..++.|+.|++.||+|||+. +|+||||||+|||++.++ .
T Consensus 119 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 119 TEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTS
T ss_pred cccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCc
Confidence 7 77899999999 999999997654 689999999999999999999998 999999999999998887 9
Q ss_pred eEEEeCCCccccCCCCcee-----eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC
Q 005953 486 PKVSDFGLAKAHSRNRSVV-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS 560 (667)
Q Consensus 486 ~ki~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~ 560 (667)
+||+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.....
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~~---- 265 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWEQNLK---- 265 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTGGGTT----
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCcccccc----
Confidence 9999999998764322111 11345689999999998763 688999999999999999999999853211
Q ss_pred CCccccchHHHHHhhcCcccccccc-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 561 NTTEAYFPDWIYDKLIQPEKEDFVE-EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
. .... ................. .....++..+.+++.+||+.||++||++++|++.|++.
T Consensus 266 ~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 266 D--PVAV-QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp C--HHHH-HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred c--cHHH-HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 0 0000 01111110000000000 00002345788999999999999999999999999954
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=343.93 Aligned_cols=257 Identities=25% Similarity=0.373 Sum_probs=191.5
Q ss_pred HHhhhhcccCCCeEEEEEEeC----CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCC-----e
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS-----T 415 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-----~ 415 (667)
+.+.+.||+|+||+||+|++. .++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.. .
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 115 (313)
T 3brb_A 36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK 115 (313)
T ss_dssp EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence 345678999999999999763 34589999987543 23467899999999999999999999998755 3
Q ss_pred eEEEEEEcCCCCcccccccc---ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCC
Q 005953 416 RALIYEYMPNGSLGDLLSRE---KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG 492 (667)
Q Consensus 416 ~~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFG 492 (667)
.++||||+++|+|.+++... .....+++..++.++.|+++||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecC
Confidence 59999999999999998532 2345699999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHH
Q 005953 493 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWI 571 (667)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 571 (667)
+++...............+++.|+|||.+.+ ..++.++||||||+++|||++ |+.||..... ...
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------------~~~ 258 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN------------HEM 258 (313)
T ss_dssp CC----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------------GGH
T ss_pred cceecccccccCcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCH------------HHH
Confidence 9987654433222234457889999999975 377899999999999999999 8888754322 011
Q ss_pred HHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 572 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
...+........ ...+...+.+++.+||+.||++|||+.+++++|+++..
T Consensus 259 ~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 259 YDYLLHGHRLKQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HHHHHTTCCCCC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 122222111111 11234578889999999999999999999999996543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=339.65 Aligned_cols=269 Identities=23% Similarity=0.347 Sum_probs=206.0
Q ss_pred HHHHHHHHHHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhh--cccceEEeecceEecCC---
Q 005953 340 YNDIKKMTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGR--IHHVNIIHLLGFCCDGS--- 414 (667)
Q Consensus 340 ~~~l~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~g~~~~~~--- 414 (667)
..+.....+.+.+.||+|+||+||+|++ +++.||||++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 3444445566778999999999999998 6899999998654 34677889988887 78999999999998776
Q ss_pred -eeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeeecCCCCCcEEECCCCc
Q 005953 415 -TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH--------NGCELRILHLDIKPQNVLLDPDFT 485 (667)
Q Consensus 415 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH--------~~~~~~ivH~Dikp~NIll~~~~~ 485 (667)
..++||||+++|+|.+++.+. .+++..++.++.|++.||+||| +. +|+||||||+|||++.++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSC
T ss_pred ceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCC
Confidence 789999999999999999653 4899999999999999999999 66 9999999999999999999
Q ss_pred eEEEeCCCccccCCCCcee--eecCCCCCccccchhhhhhhcC----CCCCcccHHHHHHHHHHHHhC----------CC
Q 005953 486 PKVSDFGLAKAHSRNRSVV--TMTGPRGTIGYIAPEIFMRNLG----NPSGKSDVYSYGMLLLEMIEE----------KK 549 (667)
Q Consensus 486 ~ki~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~----~~s~k~DvwSlGvvl~elltg----------~~ 549 (667)
+||+|||+++......... ......||+.|+|||++.+... .++.++||||||+++|||++| +.
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 9999999998765544322 1234568999999999865311 123689999999999999999 45
Q ss_pred CCCCCCcCCCCCCccccchHHHHHhhcCcccccccch--hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 550 HLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE--EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 550 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
||..... .... ...+...+........... ........+.+++.+||+.||++|||+.||+++|+++..
T Consensus 266 p~~~~~~------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 266 PYYDLVP------SDPS-VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp TTTTTSC------SSCC-HHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccccCc------Cccc-HHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 5543211 0111 1112222222211111111 123456789999999999999999999999999996643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=340.46 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=196.2
Q ss_pred HhhhhcccCCCeEEEEEEeCC----CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEe-cCCeeEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCC-DGSTRALIYE 421 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~-~~~~~~lV~e 421 (667)
.+.++||+|+||+||+|++.+ +..||+|.+.... ...+.+.+|+.++++++||||+++++++. ..+..++|||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 107 (298)
T 3f66_A 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 107 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence 456889999999999998642 2368999987643 23467899999999999999999999865 4567899999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 108 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 108 YMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp CCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred CCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 99999999999653 34588999999999999999999998 99999999999999999999999999998765433
Q ss_pred ce--eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCC-CCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 502 SV--VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK-HLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 502 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
.. .......+|+.|+|||.+.+. .++.++||||||+++|||++|.. |+..... ... ...+...
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--------~~~----~~~~~~~ 248 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--------FDI----TVYLLQG 248 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT--------TTH----HHHHHTT
T ss_pred hhccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCccCCH--------HHH----HHHHhcC
Confidence 21 222445678999999999764 78899999999999999999554 4433221 011 1111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
..... .......+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 249 ~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 249 RRLLQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111 11123468889999999999999999999999997654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=345.26 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=195.6
Q ss_pred hhhhcccCCCeEEEEEEeCC-----CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFPD-----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.+.||+|+||+||+|++.. +..||||++.... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 127 (333)
T 1mqb_A 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 127 (333)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeC
Confidence 34789999999999998642 2469999997643 2345789999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 128 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 128 MENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp CTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred CCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 9999999999753 23689999999999999999999998 999999999999999999999999999987654322
Q ss_pred e-eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 503 V-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 503 ~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
. .......+|+.|+|||.+.. ..++.++||||||+++|||++ |+.||..... ..+...+.....
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------------~~~~~~~~~~~~ 268 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSN------------HEVMKAINDGFR 268 (333)
T ss_dssp --------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------HHHHHHHHTTCC
T ss_pred cccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------------HHHHHHHHCCCc
Confidence 1 11223446889999999865 478889999999999999999 9999854321 112222222211
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
... ...+...+.+++.+||+.||++||++.|++++|+++..
T Consensus 269 ~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 269 LPT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp CCC----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111 11234568889999999999999999999999986543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.35 Aligned_cols=247 Identities=23% Similarity=0.356 Sum_probs=194.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.++||+|+||+||+++.. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 103 (285)
T 3is5_A 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCE 103 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCC
Confidence 456689999999999999885 68999999987543 345789999999999999999999999999999999999999
Q ss_pred CCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE---CCCCceEEEeCCCccccCCC
Q 005953 425 NGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 425 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll---~~~~~~ki~DFGla~~~~~~ 500 (667)
+|+|.+++... .....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 104 GGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred CCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999998643 2345699999999999999999999998 99999999999999 45688999999999876543
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh--cCc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL--IQP 578 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 578 (667)
.. .....||+.|+|||.+. +.++.++||||||+++|||++|+.||..... ..+.... ...
T Consensus 181 ~~---~~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~il~~ll~g~~pf~~~~~------------~~~~~~~~~~~~ 242 (285)
T 3is5_A 181 EH---STNAAGTALYMAPEVFK---RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------------EEVQQKATYKEP 242 (285)
T ss_dssp ---------CTTGGGCCHHHHT---TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCC
T ss_pred cc---CcCcccccCcCChHHhc---cCCCcccCeehHHHHHHHHHhCCCCCCCCCH------------HHHHhhhccCCc
Confidence 32 23456899999999985 3678899999999999999999999864321 1111111 111
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
..... ...+...+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 243 NYAVE----CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccccc----cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11000 01124567789999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=343.41 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=189.1
Q ss_pred HhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCe----eEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGST----RALI 419 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~----~~lV 419 (667)
.+.++||+|+||+||+|++ .+++.||||++.... .....+.+|+.++++++||||+++++++..... .++|
T Consensus 15 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv 94 (311)
T 3ork_A 15 ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV 94 (311)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEE
Confidence 4568899999999999997 468999999997643 223578899999999999999999999876543 4999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 95 MEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 99999999999997543 589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCce-eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 500 NRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 500 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
.... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ...........
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----------~~~~~~~~~~~ 235 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----------VSVAYQHVRED 235 (311)
T ss_dssp -------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHHHHCC
T ss_pred cccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHhcCC
Confidence 3322 122335689999999999764 778899999999999999999999964322 11111111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH-HHHh
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVV-EMLS 621 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl-~~L~ 621 (667)
... .......++..+.+++.+||+.||++||++.+++ +.|.
T Consensus 236 ~~~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 236 PIP--PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp CCC--HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCC--cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 110 0011112356788899999999999999665555 4554
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=338.74 Aligned_cols=250 Identities=22% Similarity=0.283 Sum_probs=202.3
Q ss_pred HHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc-------chHHHHHHHHHHhhcccceEEeecceEecCCeeEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN-------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 418 (667)
.+.+.+.||+|+||.||+|+.. +|+.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3456789999999999999985 689999999865431 35679999999999999999999999999999999
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC----ceEEEeCCCc
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF----TPKVSDFGLA 494 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~----~~ki~DFGla 494 (667)
||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 93 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 93 ILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 99999999999999653 3588999999999999999999998 999999999999999888 7999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHh
Q 005953 495 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 574 (667)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 574 (667)
+....... .....||+.|+|||++.. ..++.++||||||+++|||++|+.||..... ......
T Consensus 167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~~~~ 229 (321)
T 2a2a_A 167 HEIEDGVE---FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTK------------QETLAN 229 (321)
T ss_dssp EECCTTCC---CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------------HHHHHH
T ss_pred eecCcccc---ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCH------------HHHHHH
Confidence 87654432 234568999999999875 3678999999999999999999999864321 111111
Q ss_pred hcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
+..... .............+.+++.+||+.||++|||+.|++++-
T Consensus 230 i~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 230 ITSVSY-DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp HHTTCC-CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred HHhccc-ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 111111 111111122345788999999999999999999999753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=355.76 Aligned_cols=244 Identities=23% Similarity=0.400 Sum_probs=200.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||.||+|++. +|+.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 19 ~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~ 98 (476)
T 2y94_A 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV 98 (476)
T ss_dssp EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 35678999999999999986 69999999986532 33467899999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 99 ~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~- 171 (476)
T 2y94_A 99 SGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 171 (476)
T ss_dssp SSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC-
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccccc-
Confidence 999999999653 3589999999999999999999998 999999999999999999999999999987654432
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
.....||+.|+|||++.+. ...+.++||||||+++|||++|+.||..... ..+...+.......
T Consensus 172 --~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------------~~~~~~i~~~~~~~- 235 (476)
T 2y94_A 172 --LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHV------------PTLFKKICDGIFYT- 235 (476)
T ss_dssp --BCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------------HHHHHHHHTTCCCC-
T ss_pred --ccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCH------------HHHHHHHhcCCcCC-
Confidence 2345689999999999764 2346799999999999999999999964321 11222222222111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
+..+...+.+++.+||+.||++|||+.|++++
T Consensus 236 ----p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 236 ----PQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----CccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 11124467889999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=343.37 Aligned_cols=240 Identities=25% Similarity=0.346 Sum_probs=197.0
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc---------chHHHHHHHHHHhhcccceEEeecceEecCCeeE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 417 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 417 (667)
+.+.+.||+|+||+||+|++. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 26 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~ 105 (335)
T 3dls_A 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ 105 (335)
T ss_dssp EEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEE
Confidence 445678999999999999874 689999999876431 2346778999999999999999999999999999
Q ss_pred EEEEEcCCC-CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 418 LIYEYMPNG-SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 418 lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
+||||+.+| +|.+++.... .+++..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 106 lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 106 LVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999777 9999886543 589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhc
Q 005953 497 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 576 (667)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (667)
....... ....||+.|+|||++.+. ...+.++||||||+++|||++|+.||.......
T Consensus 180 ~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------------ 237 (335)
T 3dls_A 180 LERGKLF---YTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------------ 237 (335)
T ss_dssp CCTTCCB---CEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------------
T ss_pred CCCCCce---eccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------------
Confidence 7654432 224589999999999764 233789999999999999999999986432110
Q ss_pred CcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 577 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
...... ...+...+.+++.+||+.||++|||+.|++++-
T Consensus 238 ~~~~~~-----~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 238 EAAIHP-----PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp TTCCCC-----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred hhccCC-----CcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 000000 001244678899999999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.27 Aligned_cols=196 Identities=25% Similarity=0.357 Sum_probs=171.8
Q ss_pred HHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcc-----cceEEeecceEecCCeeEEEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-----HVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-----h~niv~l~g~~~~~~~~~lV~ 420 (667)
.+.+.++||+|+||+||+|++. +++.||||++.......+.+..|+.++++++ ||||+++++++...+..++||
T Consensus 36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~ 115 (360)
T 3llt_A 36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIF 115 (360)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEE
Confidence 3445689999999999999984 6899999999876656677888999999996 999999999999999999999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC------------------
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP------------------ 482 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~------------------ 482 (667)
||+ +++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 116 e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 116 EPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp CCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred cCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccccccc
Confidence 999 999999997643 33589999999999999999999998 9999999999999976
Q ss_pred -------CCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 005953 483 -------DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPT 554 (667)
Q Consensus 483 -------~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~ 554 (667)
++.+||+|||+++...... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCC--CCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 7899999999998654322 235689999999999764 6889999999999999999999999653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=331.18 Aligned_cols=247 Identities=21% Similarity=0.289 Sum_probs=200.5
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC-CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT-SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.++||+|+||+||+|+.. ++..||+|++... ....+.+.+|++++++++||||+++++++.+....++||||+++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (277)
T 3f3z_A 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90 (277)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCC
Confidence 445688999999999999986 4779999998754 34467899999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE---CCCCceEEEeCCCccccCCCCc
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll---~~~~~~ki~DFGla~~~~~~~~ 502 (667)
++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++........
T Consensus 91 ~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 91 GELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp CBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 99999886543 489999999999999999999998 99999999999999 7889999999999987654432
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
. ....||+.|+|||.+.+ .++.++||||||+++|||++|+.||..... ......+..... .
T Consensus 165 ~---~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------~~~~~~~~~~~~-~ 225 (277)
T 3f3z_A 165 M---RTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTD------------SEVMLKIREGTF-T 225 (277)
T ss_dssp B---CCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCC-C
T ss_pred h---hccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHhCCC-C
Confidence 2 34568999999999864 578899999999999999999999864321 111111111111 0
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
........+...+.+++.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111235678899999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.90 Aligned_cols=263 Identities=20% Similarity=0.323 Sum_probs=195.1
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.++||+|+||+||+|++. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (311)
T 4agu_A 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD 85 (311)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCC
Confidence 34578999999999999985 589999999865543 24568899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 86 ~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 158 (311)
T 4agu_A 86 HTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY- 158 (311)
T ss_dssp EEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc-
Confidence 99999887643 3589999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC----CccccchHHH----HHhhc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN----TTEAYFPDWI----YDKLI 576 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~----~~~~~~~~~~----~~~~~ 576 (667)
.....||+.|+|||++.+. ..++.++||||||+++|||++|+.||.......... ......+.+. .....
T Consensus 159 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 159 -YDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp --------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred -cCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 2345689999999999754 467899999999999999999999996543210000 0000000000 00000
Q ss_pred Cccc----cc--ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 577 QPEK----ED--FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 577 ~~~~----~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.... .. ........+...+.+++.+||+.||++|||++|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 0000 00 00001123455688999999999999999999999763
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.47 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=199.1
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.+.+.||+|+||+||+|+.. +++.||||+++.. ....+.+.+|..++..+ +||||+++++++.+.+..++||||
T Consensus 23 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~ 102 (353)
T 2i0e_A 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 102 (353)
T ss_dssp EEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeC
Confidence 45688999999999999986 4889999998753 23456788999999988 799999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 103 ~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 176 (353)
T 2i0e_A 103 VNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176 (353)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc
Confidence 99999999997543 489999999999999999999998 999999999999999999999999999986433222
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 177 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~------------~~~~~~i~~~~~~- 239 (353)
T 2i0e_A 177 --TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------------DELFQSIMEHNVA- 239 (353)
T ss_dssp --CBCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCCC-
T ss_pred --ccccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCCH------------HHHHHHHHhCCCC-
Confidence 12345699999999999764 678999999999999999999999964321 1122222221111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEML 620 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~~L 620 (667)
. +..+...+.+++.+||+.||++||+ ++|++++-
T Consensus 240 ~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 240 Y----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp C----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 0 1123557888999999999999995 57887653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.17 Aligned_cols=247 Identities=23% Similarity=0.426 Sum_probs=200.5
Q ss_pred HHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEec------------
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD------------ 412 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------------ 412 (667)
..+.+.+.||+|+||.||+|++. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 34455688999999999999986 79999999987654 356789999999999999999998854
Q ss_pred ----CCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEE
Q 005953 413 ----GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKV 488 (667)
Q Consensus 413 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki 488 (667)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+|+||||+|||+++++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEE
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEE
Confidence 345789999999999999997543 34689999999999999999999998 9999999999999999999999
Q ss_pred EeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccch
Q 005953 489 SDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFP 568 (667)
Q Consensus 489 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 568 (667)
+|||+++........ ....||+.|+|||.+.+. .++.++||||||+++|||++|..|+...
T Consensus 164 ~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~-------------- 224 (284)
T 2a19_B 164 GDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFET-------------- 224 (284)
T ss_dssp CCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHHHH--------------
T ss_pred Ccchhheeccccccc---cccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcchhH--------------
Confidence 999999877554322 334689999999998753 6789999999999999999998765311
Q ss_pred HHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 569 DWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
......+....... .+...+.+++.+||+.||++|||+.|++++|+....
T Consensus 225 ~~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 225 SKFFTDLRDGIISD-------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHHHHHHTTCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HHHHHHhhcccccc-------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 01112222211111 123457789999999999999999999999996544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=338.36 Aligned_cols=249 Identities=29% Similarity=0.458 Sum_probs=194.1
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecC-CeeEEEEEEcCCCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDG-STRALIYEYMPNGS 427 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-~~~~lV~e~~~~gs 427 (667)
.+.+.||+|+||+||+|++ +++.||||+++... ..+.+.+|+.++++++||||+++++++.+. +..++||||+++|+
T Consensus 24 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~ 101 (278)
T 1byg_A 24 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101 (278)
T ss_dssp EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred eEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCC
Confidence 4568899999999999998 58899999997654 457899999999999999999999987654 47899999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 102 L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~ 172 (278)
T 1byg_A 102 LVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D 172 (278)
T ss_dssp HHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred HHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc-----c
Confidence 999997542 22378899999999999999999998 99999999999999999999999999997654332 1
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
...+++.|+|||.+.+. .++.++||||||+++|||++ |+.||..... ..+...+.......
T Consensus 173 ~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------------~~~~~~~~~~~~~~---- 234 (278)
T 1byg_A 173 TGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------------KDVVPRVEKGYKMD---- 234 (278)
T ss_dssp ---CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG------------GGHHHHHTTTCCCC----
T ss_pred CCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHhcCCCCC----
Confidence 23468899999999763 77899999999999999998 9998864321 01112222221111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
....++..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 1122345788899999999999999999999999976543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=333.39 Aligned_cols=251 Identities=22% Similarity=0.253 Sum_probs=196.3
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC-----CcchHHHHHHHHHHhhcccceEEeecceEe--cCCeeEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT-----SNFSDNFINEVATIGRIHHVNIIHLLGFCC--DGSTRALIY 420 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~--~~~~~~lV~ 420 (667)
.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|+.++++++||||+++++++. +....++||
T Consensus 8 ~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (305)
T 2wtk_C 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVM 87 (305)
T ss_dssp CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEE
T ss_pred eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEe
Confidence 35688999999999999985 6889999998753 234577999999999999999999999984 456789999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||++++ |.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 88 e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 88 EYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp ECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred hhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 999876 777775433 34689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
..........||+.|+|||++.+.....+.++||||||+++|||++|+.||..... ......+.....
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~~~~~i~~~~~ 230 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------------YKLFENIGKGSY 230 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------------HHHHHHHHHCCC
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------------HHHHHHHhcCCC
Confidence 33333345668999999999875323347799999999999999999999864321 111122211111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
. . ...+...+.+++.+||+.||++|||+.|++++--
T Consensus 231 ~-~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 231 A-I----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp C-C----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred C-C----CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 0 0 1112456778999999999999999999997643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=350.67 Aligned_cols=255 Identities=26% Similarity=0.379 Sum_probs=185.8
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcc-cceEEeecceEecCC--eeEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGS--TRALIY 420 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~--~~~lV~ 420 (667)
+.+.++||+|+||+||+|.+. +++.||||++.... ...+.+.+|+.++.++. ||||+++++++...+ ..++||
T Consensus 11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 90 (388)
T 3oz6_A 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVF 90 (388)
T ss_dssp EEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEE
T ss_pred eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEe
Confidence 345688999999999999875 68999999986532 33467889999999997 999999999997544 689999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 91 e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 91 DYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp ECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred cccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 9996 6888888642 588999999999999999999998 9999999999999999999999999999865321
Q ss_pred C-------------------ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC
Q 005953 501 R-------------------SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN 561 (667)
Q Consensus 501 ~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~ 561 (667)
. .....+...||+.|+|||++.+. ..++.++|||||||++|||++|+.||......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---- 237 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTM---- 237 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH----
Confidence 1 11123445799999999999764 47889999999999999999999999654321
Q ss_pred CccccchHHHHHhhcCccc-----------------------------ccccchh---------hHHHHHHHHHHHHHhc
Q 005953 562 TTEAYFPDWIYDKLIQPEK-----------------------------EDFVEEE---------DDCIARKMIIVGLWCI 603 (667)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~---------~~~~~~~l~~l~~~cl 603 (667)
.....+...+..+.. ....... .......+.+++.+||
T Consensus 238 ----~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 238 ----NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp ----HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred ----HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 000000111100000 0000000 0012456889999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 005953 604 QINPKDRPSMTRVVEM 619 (667)
Q Consensus 604 ~~~P~~RPt~~evl~~ 619 (667)
+.||++|||++|++++
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 9999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=340.13 Aligned_cols=260 Identities=23% Similarity=0.354 Sum_probs=195.2
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 113 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence 345688999999999999874 68999999987532 2346789999999999999999999999999999999999
Q ss_pred cCCCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 423 MPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 423 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
+++|+|.+++... .....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 114 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 114 ADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp CCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred CCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 9999999999752 2345689999999999999999999998 99999999999999999999999999998765432
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
.. .....|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... . ...+...+......
T Consensus 191 ~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~-~~~~~~~~~~~~~~ 256 (310)
T 2wqm_A 191 TA--AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---------N-LYSLCKKIEQCDYP 256 (310)
T ss_dssp ----------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---C---------C-HHHHHHHHHTTCSC
T ss_pred cc--ccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccch---------h-HHHHHHHhhcccCC
Confidence 21 123458999999999876 3678899999999999999999999864321 0 11111222211111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccccc
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEA 627 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 627 (667)
... ...+...+.+++.+||+.||++|||+.+|++.|+++....
T Consensus 257 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 257 PLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp CCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 111 1123457888999999999999999999999999765543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.77 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=198.6
Q ss_pred hhhcccCCCeEEEEEEeC-C---CcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCee-EEEEEEc
Q 005953 351 KEKLGTGGYGNVYKGKFP-D---GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTR-ALIYEYM 423 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~---~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~-~lV~e~~ 423 (667)
.++||+|+||+||+|++. + +..||+|++..... ..+.+.+|+.++++++||||+++++++.+.+.. ++|+||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 478999999999999863 2 23799999876443 346789999999999999999999999876655 9999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
.+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 106 ~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 106 CHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred cCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 999999999753 34688999999999999999999998 9999999999999999999999999999865433211
Q ss_pred --eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 504 --VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 504 --~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
.......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+..... ... +...+......
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-------~~~----~~~~~~~~~~~ 247 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHID-------PFD----LTHFLAQGRRL 247 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------GGG----HHHHHHTTCCC
T ss_pred ccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCC-------HHH----HHHHhhcCCCC
Confidence 12234567899999999975 3778999999999999999997666432211 011 11111111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
.. .......+.+++.+||+.||++|||+.++++.|+++...
T Consensus 248 ~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 248 PQ----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC----CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11 111245688899999999999999999999999976544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=373.58 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=197.2
Q ss_pred hhcccCCCeEEEEEEeC---CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP---DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
++||+|+||+||+|.+. .++.||||+++... ...+++.+|+++|++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999997643 335789999999999999999999999964 568899999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce-e
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV-V 504 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~-~ 504 (667)
|+|.+++... ..+++..++.|+.||+.||+|||+. +|+||||||+||||++++.+||+|||+++........ .
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 9999999653 3589999999999999999999998 9999999999999999999999999999877544322 1
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
......+|+.|+|||++.. ..++.++|||||||++|||++ |+.||..... ..+...+........
T Consensus 528 ~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------------~~~~~~i~~~~~~~~ 593 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------------SEVTAMLEKGERMGC 593 (635)
T ss_dssp -------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------HHHHHHHHTTCCCCC
T ss_pred cccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCCCC
Confidence 2233457889999999976 478999999999999999998 9999864322 112222322221111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
...++..+.+++.+||+.||++||++.+|++.|++...
T Consensus 594 ----p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 594 ----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11235678899999999999999999999999986543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=357.01 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=190.5
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.++||+|+||.||+|+.. +++.||||++... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 151 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 230 (446)
T 4ejn_A 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 230 (446)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCC
T ss_pred EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeC
Confidence 45678999999999999875 6899999998743 233467889999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
++|+|.+++.... .+++..+..++.|++.||+|||+ . +|+||||||+||||+.++.+||+|||+++.......
T Consensus 231 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 231 NGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp SSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 9999999996543 58999999999999999999997 6 999999999999999999999999999986443322
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ..+...+......
T Consensus 305 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~------------~~~~~~i~~~~~~- 367 (446)
T 4ejn_A 305 --TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------EKLFELILMEEIR- 367 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCCC-
T ss_pred --ccccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCH------------HHHHHHHHhCCCC-
Confidence 23456799999999999764 789999999999999999999999964321 1111111111110
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 620 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~L 620 (667)
. +..+...+.+++.+||+.||++|| +++|++++-
T Consensus 368 ~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 368 F----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred C----CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 0 112345678899999999999999 999999754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.67 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=197.3
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
..||+|+||+||+|++. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 47999999999999974 68899999987654 34577999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC-CCceEEEeCCCccccCCCCceeeecC
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~-~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
+++........+++..+..++.|++.||+|||+. +|+|+||||+||+++. ++.+||+|||+++........ ...
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~--~~~ 182 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TET 182 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--ccc
Confidence 9997654455678999999999999999999998 9999999999999987 899999999999876543221 234
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (667)
..|++.|+|||++.+....++.++||||||+++|||++|+.||...... ........... ... ...
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------~~~~~~~~~~~-~~~----~~~ 248 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---------QAAMFKVGMFK-VHP----EIP 248 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---------HHHHHHHHHHC-CCC----CCC
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---------hHHHHhhcccc-ccc----ccc
Confidence 5689999999999764334788999999999999999999998532210 00000101100 000 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 589 DCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 589 ~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
..+...+.+++.+||+.||++|||+.|++++-
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~ 280 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLVDE 280 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSG
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 12345678899999999999999999998653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=339.54 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=196.1
Q ss_pred HHhhhhcccCCCeEEEEEEeCC-C-------cEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPD-G-------RLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~-~-------~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 418 (667)
+.+.+.||+|+||+||+|++.. + ..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL 89 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence 3456889999999999998743 3 479999986543 445789999999999999999999999999999999
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCc--------eEEEe
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT--------PKVSD 490 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~--------~ki~D 490 (667)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|
T Consensus 90 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 90 VQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999999997643 2488999999999999999999998 9999999999999998887 99999
Q ss_pred CCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHH
Q 005953 491 FGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW 570 (667)
Q Consensus 491 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 570 (667)
||+++...... ...||+.|+|||++.+. ..++.++||||||+++|||++|..|+..... ...
T Consensus 165 fg~~~~~~~~~------~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~ 226 (289)
T 4fvq_A 165 PGISITVLPKD------ILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALD-----------SQR 226 (289)
T ss_dssp CCSCTTTSCHH------HHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----------HHH
T ss_pred CcccccccCcc------ccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccc-----------hHH
Confidence 99997654322 12368899999999753 3678899999999999999996654432211 000
Q ss_pred HHHhhcC-cccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 571 IYDKLIQ-PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 571 ~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
....... ...... ....+.+++.+||+.||++|||+.|++++|+++..
T Consensus 227 ~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 227 KLQFYEDRHQLPAP-------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHHHTTCCCCCC-------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHHHhhccCCCCCC-------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0111111 111111 12357789999999999999999999999996543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=334.96 Aligned_cols=252 Identities=26% Similarity=0.383 Sum_probs=196.7
Q ss_pred HhhhhcccCCCeEEEEEEeCC----CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.+.+.||+|+||+||+|++.+ +..||+|++.... ...+.+.+|+.++++++||||+++++++.+ +..++||||
T Consensus 15 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 93 (281)
T 3cc6_A 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMEL 93 (281)
T ss_dssp EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEec
Confidence 345789999999999998632 3469999987653 345679999999999999999999999865 457899999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 94 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 94 YPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp CTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred CCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 99999999997542 3589999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
. ......+++.|+|||.+.. ..++.++||||||+++|||++ |+.||...... .....+.. ....
T Consensus 169 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--------~~~~~~~~----~~~~ 233 (281)
T 3cc6_A 169 Y-KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--------DVIGVLEK----GDRL 233 (281)
T ss_dssp -----CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--------GHHHHHHH----TCCC
T ss_pred c-ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChH--------HHHHHHhc----CCCC
Confidence 2 1234457889999999975 377899999999999999998 99998643220 11111111 1110
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
.. ...+...+.+++.+||+.||++|||+.|++++|+++..
T Consensus 234 ~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 234 PK----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 00 11134568889999999999999999999999986543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=355.66 Aligned_cols=193 Identities=25% Similarity=0.418 Sum_probs=151.0
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEec-----CCeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD-----GSTRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-----~~~~~l 418 (667)
+.+.++||+|+||+||+|++. +++.||||++.... ...+.+.+|+.+|++++||||+++++++.. ....++
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 134 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134 (458)
T ss_dssp EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence 445688999999999999875 68999999986542 234678999999999999999999999853 357899
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
||||+ +|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 135 v~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 135 VLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 99998 67898888643 3589999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCce-------------------------eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCC
Q 005953 499 RNRSV-------------------------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK 548 (667)
Q Consensus 499 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~ 548 (667)
..... ...+...||+.|+|||++... ..++.++|||||||++|||++|.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhc
Confidence 32210 123456789999999987543 46899999999999999999953
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=347.42 Aligned_cols=248 Identities=21% Similarity=0.281 Sum_probs=188.4
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEec----CCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCD----GSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~----~~~~~lV~e~~~~ 425 (667)
++||+|+||+||++.+. +++.||||++... ..+.+|+.++.++ +||||+++++++.. ....++||||+++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 57999999999999885 6899999998642 4677899887555 89999999998875 5678999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC---CCceEEEeCCCccccCCCCc
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~---~~~~ki~DFGla~~~~~~~~ 502 (667)
|+|.+++.... ...+++..+..|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 144 g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~ 219 (400)
T 1nxk_A 144 GELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219 (400)
T ss_dssp EEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred CcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCCc
Confidence 99999997643 34689999999999999999999998 9999999999999988 78999999999987653322
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ........+. .....
T Consensus 220 ---~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~i~----~~~~~- 285 (400)
T 1nxk_A 220 ---LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKTRIR----MGQYE- 285 (400)
T ss_dssp ----------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCS----SCCSHHHHHH----HTCCC-
T ss_pred ---cccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCcccc----ccHHHHHHHH----cCccc-
Confidence 234568999999999865 478899999999999999999999997543211 0001111111 11110
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
........+...+.+++.+||+.||++|||+.|++++--
T Consensus 286 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 286 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 001111224567889999999999999999999998753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=343.47 Aligned_cols=249 Identities=16% Similarity=0.134 Sum_probs=198.4
Q ss_pred HHhhhhcccCCCeEEEEEE------eCCCcEEEEEEcccCCcchHHHHHHHHHHhhcc---cceEEeecceEecCCeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGK------FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH---HVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~l 418 (667)
+.+.++||+|+||+||+|. ..+++.||||++... ...++.+|++++++++ |+||+++++++...+..++
T Consensus 67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l 144 (365)
T 3e7e_A 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence 3345789999999999994 346889999998754 3567788888888886 9999999999999999999
Q ss_pred EEEEcCCCCccccccccc--cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC-----------CCc
Q 005953 419 IYEYMPNGSLGDLLSREK--ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-----------DFT 485 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~-----------~~~ 485 (667)
||||+++|+|.+++.... ....+++..++.|+.|++.||+|||+. +|+||||||+||||+. ++.
T Consensus 145 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTT
T ss_pred EEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCC
Confidence 999999999999997532 245699999999999999999999998 9999999999999998 899
Q ss_pred eEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccc
Q 005953 486 PKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEA 565 (667)
Q Consensus 486 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~ 565 (667)
+||+|||+|+...............||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~----~--- 292 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGG----E--- 292 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCCEEEETT----E---
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCccccCCCC----c---
Confidence 999999999765433333344667799999999999764 6889999999999999999999998543221 0
Q ss_pred cchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhhcc
Q 005953 566 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDR-PSMTRVVEMLSSAS 624 (667)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R-Pt~~evl~~L~~~~ 624 (667)
. . ......... ..+.+.+++..|++.+|.+| |+++++.+.|++..
T Consensus 293 ~-------~-~~~~~~~~~------~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 293 C-------K-PEGLFRRLP------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp E-------E-ECSCCTTCS------SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred e-------e-echhccccC------cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 0 0 000000000 13356678888999999999 68888888887543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.19 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=189.0
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---------cchHHHHHHHHHHhhcccceEEeecceEecCCeeE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRA 417 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 417 (667)
+.+.++||+|+||+||+|... +++.||||++.... .....+.+|+.+|++++||||+++++++. .+..+
T Consensus 137 y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~ 215 (419)
T 3i6u_A 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYY 215 (419)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEE
T ss_pred EEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceE
Confidence 345688999999999999875 58999999986532 11235889999999999999999999975 45689
Q ss_pred EEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC---CceEEEeCCCc
Q 005953 418 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD---FTPKVSDFGLA 494 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~---~~~ki~DFGla 494 (667)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 216 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 216 IVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred EEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccc
Confidence 999999999999998654 3589999999999999999999998 99999999999999654 45999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhhhh-hcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHH
Q 005953 495 KAHSRNRSVVTMTGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573 (667)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 573 (667)
+....... .....||+.|+|||++.. ....++.++||||||+++|||++|+.||...... .... .
T Consensus 290 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-------~~~~----~ 355 (419)
T 3i6u_A 290 KILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-------VSLK----D 355 (419)
T ss_dssp TSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-------CCHH----H
T ss_pred eecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-------HHHH----H
Confidence 87654322 234568999999999853 2246788999999999999999999999643221 1111 1
Q ss_pred hhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.+..... .........+...+.+++.+||+.||++|||+.|++++-
T Consensus 356 ~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 356 QITSGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp HHHTTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHhcCCC-CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 1111111 111111223456788999999999999999999999754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=335.59 Aligned_cols=261 Identities=20% Similarity=0.298 Sum_probs=201.4
Q ss_pred HhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceE-ecCCeeEEEEEEcCCC
Q 005953 349 GFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFC-CDGSTRALIYEYMPNG 426 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~-~~~~~~~lV~e~~~~g 426 (667)
.+.+.||+|+||+||+|+. .+++.||||++..... .+++.+|+.++++++|++++..+..+ .+....++||||+ ++
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 3uzp_A 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence 3457899999999999997 4799999999875443 35689999999999988766655554 5677889999999 99
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE---CCCCceEEEeCCCccccCCCCce
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll---~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||+ ++++.+||+|||+++........
T Consensus 90 ~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 90 SLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp BHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 9999997432 3589999999999999999999998 99999999999999 48899999999999876544321
Q ss_pred e-----eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 504 V-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 504 ~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
. ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||...... .....+..........+
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAA----TKRQKYERISEKKMSTP 238 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS----SSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcCch----hhhhhhhhhcccccCCc
Confidence 1 11345689999999998764 6789999999999999999999999754321 11111111111111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccccc
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEA 627 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 627 (667)
.......++..+.+++.+||+.||++|||+.+|++.|+++....
T Consensus 239 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 239 -----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp -----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 01111223467889999999999999999999999999765543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=347.14 Aligned_cols=254 Identities=24% Similarity=0.293 Sum_probs=200.0
Q ss_pred HHhhhhcccCCCeEEEEEEe----CCCcEEEEEEcccCC-----cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF----PDGRLVAVKVLEKTS-----NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRA 417 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 417 (667)
+.+.++||+|+||+||+++. .+++.||||+++... ...+.+.+|+++++++ +||||+++++++.+....+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 34568899999999999987 368999999987532 2345677899999999 6999999999999999999
Q ss_pred EEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcccc
Q 005953 418 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~ 497 (667)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 136 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 9999999999999997543 589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcC
Q 005953 498 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 577 (667)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (667)
...... ......||+.|+|||++.+....++.++||||||+++|||++|+.||...... .....+...+..
T Consensus 210 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~~~ 280 (355)
T 1vzo_A 210 VADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--------NSQAEISRRILK 280 (355)
T ss_dssp CGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--------CCHHHHHHHHHH
T ss_pred ccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc--------chHHHHHHHHhc
Confidence 433221 12234689999999999764345788999999999999999999999643221 011111111111
Q ss_pred cccccccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHh
Q 005953 578 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEMLS 621 (667)
Q Consensus 578 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~L~ 621 (667)
... . ....+...+.+++.+||+.||++|| +++|++++.-
T Consensus 281 ~~~-~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 281 SEP-P----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp CCC-C----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred cCC-C----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 111 0 1112345678899999999999999 9999998875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=352.18 Aligned_cols=196 Identities=24% Similarity=0.377 Sum_probs=163.0
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecC-----CeeEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG-----STRALI 419 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~~~lV 419 (667)
.+.+.||+|+||+||+|++. +++.||||++.... ...+.+.+|+.+|++++||||+++++++... ...++|
T Consensus 29 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv 108 (432)
T 3n9x_A 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIV 108 (432)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEE
Confidence 45688999999999999885 58899999997542 2346789999999999999999999998766 578999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||+. |+|.+++... ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 109 ~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 109 LEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp EECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred EecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 99985 6999988653 3589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCce--------------------eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCC
Q 005953 500 NRSV--------------------VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLR 552 (667)
Q Consensus 500 ~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~ 552 (667)
.... ...+...||+.|+|||++... ..++.++|||||||++|||++|..|+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccc
Confidence 3211 123556799999999987544 468999999999999999999766654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=331.99 Aligned_cols=248 Identities=21% Similarity=0.344 Sum_probs=198.7
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.++||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 88 (284)
T 3kk8_A 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 88 (284)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCC
Confidence 34578999999999999885 58999999986543 234678899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCc---eEEEeCCCccccCCCC
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT---PKVSDFGLAKAHSRNR 501 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~---~ki~DFGla~~~~~~~ 501 (667)
+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++.......
T Consensus 89 ~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 89 GGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp SCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 99999888654 3589999999999999999999998 9999999999999986655 9999999998765443
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
. .....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ......+......
T Consensus 163 ~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------------~~~~~~~~~~~~~ 225 (284)
T 3kk8_A 163 A---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQ------------HRLYAQIKAGAYD 225 (284)
T ss_dssp B---CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHTCCC
T ss_pred c---ccCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCch------------hHHHHHHHhcccc
Confidence 2 2345689999999999763 678999999999999999999999864321 1111111111110
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
........+...+.+++.+||+.||++|||+.|++++-
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 226 -YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred -CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 01111122345688899999999999999999999753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=334.43 Aligned_cols=252 Identities=26% Similarity=0.432 Sum_probs=199.5
Q ss_pred hhh-hcccCCCeEEEEEEeC---CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 350 FKE-KLGTGGYGNVYKGKFP---DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 350 ~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.+ .||+|+||+||+|.+. +++.||||++.... ...+++.+|+.++++++||||+++++++ +.+..++||||
T Consensus 20 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~ 98 (291)
T 1xbb_A 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEM 98 (291)
T ss_dssp EEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred hccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEe
Confidence 345 8999999999999652 46889999997643 2356799999999999999999999999 56778999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 99 AELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp CTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 9999999999753 3589999999999999999999998 999999999999999999999999999987755443
Q ss_pred eee-ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 503 VVT-MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 503 ~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
... .....+++.|+|||.+... .++.++||||||+++|||++ |+.||..... ..+...+.....
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------~~~~~~~~~~~~ 238 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------------SEVTAMLEKGER 238 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------HHHHHHHHTTCC
T ss_pred cccccccCCCCceeeChHHhccC--CCChhhhHHHHHHHHHHHHhcCCCCCCCCCH------------HHHHHHHHcCCC
Confidence 321 2234467899999999763 67889999999999999999 9999864321 112222222211
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
... ...+...+.+++.+||+.||++||++.++++.|++....
T Consensus 239 ~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 239 MGC----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp CCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111 112355788899999999999999999999999876543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.46 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=198.1
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.+.||+|+||+||+++.. +++.||||++..... ...+|++++.++ +||||+++++++.++...++||||+++
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g 100 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence 445688999999999999985 589999999976543 245788889888 799999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC----CceEEEeCCCccccCCCC
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD----FTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~----~~~ki~DFGla~~~~~~~ 501 (667)
|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||+.++ +.+||+|||+++......
T Consensus 101 g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 101 GELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 9999998654 3589999999999999999999998 99999999999998443 359999999998765443
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .....+...+..+...
T Consensus 175 ~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~---------~~~~~~~~~i~~~~~~ 241 (342)
T 2qr7_A 175 GL--LMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPD---------DTPEEILARIGSGKFS 241 (342)
T ss_dssp CC--BCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCSSTT---------SCHHHHHHHHHHCCCC
T ss_pred Cc--eeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCCCCc---------CCHHHHHHHHccCCcc
Confidence 22 2345689999999999764 567899999999999999999999964321 1112222222222111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
........++..+.+++.+||+.||++|||+.|++++--
T Consensus 242 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 242 -LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp -CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred -cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 111111234567888999999999999999999997643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=329.75 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=198.5
Q ss_pred HHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-------cchHHHHHHHHHHhhcccceEEeecceEecCCeeEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 418 (667)
.+.+.+.||+|+||+||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 3556789999999999999986 68999999986542 135789999999999999999999999999999999
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC----ceEEEeCCCc
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF----TPKVSDFGLA 494 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~----~~ki~DFGla 494 (667)
||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 86 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 86 ILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 99999999999999653 3589999999999999999999998 999999999999998877 8999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHh
Q 005953 495 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 574 (667)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 574 (667)
+....... .....|++.|+|||++.. ..++.++||||||+++|||++|+.||..... ......
T Consensus 160 ~~~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~~~~~ 222 (283)
T 3bhy_A 160 HKIEAGNE---FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETK------------QETLTN 222 (283)
T ss_dssp EECC-----------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHH
T ss_pred eeccCCCc---ccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcch------------HHHHHH
Confidence 87654332 233458999999999865 3678999999999999999999999864321 111111
Q ss_pred hcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
+..... .............+.+++.+||+.||++|||+.|++++
T Consensus 223 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 223 ISAVNY-DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHTTCC-CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred hHhccc-CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 111111 11111112234578889999999999999999999974
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=335.62 Aligned_cols=262 Identities=20% Similarity=0.295 Sum_probs=200.7
Q ss_pred HHhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceE-ecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFC-CDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~-~~~~~~~lV~e~~~~ 425 (667)
+.+.+.||+|+||+||+|+. .+++.||||++..... .+.+.+|+.++++++|++++..++.+ .+....++||||+ +
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 4hgt_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred eEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-C
Confidence 44568899999999999997 4789999998765432 34588999999999988777666655 6677889999999 9
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE---CCCCceEEEeCCCccccCCCCc
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll---~~~~~~ki~DFGla~~~~~~~~ 502 (667)
++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 89 ~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 89 PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 99999997432 3589999999999999999999998 99999999999999 7889999999999987654432
Q ss_pred ee-----eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcC
Q 005953 503 VV-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 577 (667)
Q Consensus 503 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (667)
.. ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||...... ................
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAA----TKRQKYERISEKKMST 237 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS----SSSSHHHHHHHHHHHS
T ss_pred CccCCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcccchh----hhhhhhhhhhcccccc
Confidence 11 12345689999999999764 6789999999999999999999999754321 1111111111111111
Q ss_pred cccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccccc
Q 005953 578 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEA 627 (667)
Q Consensus 578 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 627 (667)
+ .......++..+.+++.+||+.||++|||++++++.|+++....
T Consensus 238 ~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 238 P-----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp C-----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred h-----hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 1 00111123457889999999999999999999999999765543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.12 Aligned_cols=244 Identities=24% Similarity=0.370 Sum_probs=179.3
Q ss_pred hhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.||+|+||+||+|+. .+++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 15 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (278)
T 3cok_A 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCH 94 (278)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCC
Confidence 457899999999999987 478999999986432 334678999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 95 ~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 168 (278)
T 3cok_A 95 NGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK- 168 (278)
T ss_dssp TEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred CCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc-
Confidence 99999998754 24689999999999999999999998 9999999999999999999999999999876533221
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....||+.|+|||.+.+. .++.++||||||+++|||++|+.||........ ..........
T Consensus 169 -~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------------~~~~~~~~~~--- 230 (278)
T 3cok_A 169 -HYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------------LNKVVLADYE--- 230 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------------CCSSCCC---
T ss_pred -ceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------------HHHHhhcccC---
Confidence 1234589999999998764 678899999999999999999999865432100 0011110000
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
....+...+.+++.+||+.||++|||+++++++
T Consensus 231 --~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 231 --MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --CccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 011234567889999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=346.46 Aligned_cols=267 Identities=25% Similarity=0.429 Sum_probs=203.7
Q ss_pred HHhhhhcccCCCeEEEEEEe-----CCCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCC--eeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF-----PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS--TRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--~~~lV 419 (667)
+.+.++||+|+||.||++++ .+++.||||++.... ...+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence 34568899999999999984 368899999987654 34567999999999999999999999987654 78999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 123 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp ECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 99999999999997543 3589999999999999999999998 999999999999999999999999999987765
Q ss_pred CCceee-ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC----CCCCccccchHHHHHh
Q 005953 500 NRSVVT-MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS----GSNTTEAYFPDWIYDK 574 (667)
Q Consensus 500 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~ 574 (667)
...... .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... +...........+.+.
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 443222 2234578889999999764 67889999999999999999998875321000 0000000001111111
Q ss_pred hcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
+....... ....++..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 276 ~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 276 LKNNGRLP----RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHTTCCCC----CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCCCCC----CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111111 112234678889999999999999999999999996543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.31 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=199.7
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcE--EEEEEcccC--CcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRL--VAVKVLEKT--SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~--vavK~l~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.+.+.||+|+||.||+|++. ++.. ||+|++... ....+.+.+|+++++++ +||||+++++++.+.+..++||||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 107 (327)
T 1fvr_A 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 107 (327)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEec
Confidence 45688999999999999874 4554 499988753 23456789999999999 899999999999999999999999
Q ss_pred cCCCCccccccccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEE
Q 005953 423 MPNGSLGDLLSREK-------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVS 489 (667)
Q Consensus 423 ~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~ 489 (667)
+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred CCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEc
Confidence 99999999997542 234689999999999999999999998 99999999999999999999999
Q ss_pred eCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccch
Q 005953 490 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFP 568 (667)
Q Consensus 490 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 568 (667)
|||+++...... ......+++.|+|||.+... .++.++||||||+++|||++ |+.||.....
T Consensus 185 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~------------ 247 (327)
T 1fvr_A 185 DFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------------ 247 (327)
T ss_dssp CTTCEESSCEEC---CC----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------
T ss_pred ccCcCccccccc---cccCCCCCccccChhhhccc--cCCchhcchHHHHHHHHHHcCCCCCCCCCcH------------
Confidence 999997433211 11233468899999998753 67889999999999999998 9999864321
Q ss_pred HHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 569 DWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
..+...+........ ...+...+.+++.+||+.||++|||+.|++++|++...+
T Consensus 248 ~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 248 AELYEKLPQGYRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HHHHHHGGGTCCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHhhcCCCCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 112222222111111 112345688899999999999999999999999966554
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=337.46 Aligned_cols=258 Identities=22% Similarity=0.299 Sum_probs=199.7
Q ss_pred HHHHHHHHhh-hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhc-ccceEEeecceEecCCe
Q 005953 342 DIKKMTNGFK-EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGST 415 (667)
Q Consensus 342 ~l~~~~~~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~ 415 (667)
+.-...+.+. ++||+|+||+||+|+.. +++.||+|++.... .....+.+|+.++.++ +||||+++++++.+...
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3333334444 78999999999999886 58999999987532 3357899999999999 47999999999999999
Q ss_pred eEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC---CCceEEEeCC
Q 005953 416 RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFG 492 (667)
Q Consensus 416 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~---~~~~ki~DFG 492 (667)
.++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 999999999999999986532 34689999999999999999999998 9999999999999988 7899999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHH
Q 005953 493 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 572 (667)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 572 (667)
+++....... .....||+.|+|||++.. ..++.++||||||+++|||++|+.||..... ....
T Consensus 180 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------~~~~ 242 (327)
T 3lm5_A 180 MSRKIGHACE---LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDN------------QETY 242 (327)
T ss_dssp GCEEC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHH
T ss_pred cccccCCccc---cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------------hHHH
Confidence 9987654332 233568999999999975 3778999999999999999999999864322 0111
Q ss_pred HhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 573 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
..+..... .........+...+.+++.+||+.||++|||++|++++--
T Consensus 243 ~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 243 LNISQVNV-DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp HHHHHTCC-CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred HHHHhccc-ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 11111000 0111111223556888999999999999999999997643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=341.49 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=198.7
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc---------chHHHHHHHHHHhhc-ccceEEeecceEecCCeeEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---------FSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 418 (667)
+.+.||+|+||.||+|++. +|+.||||++..... ..+.+.+|+.+++++ +||||+++++++......++
T Consensus 98 ~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 177 (365)
T 2y7j_A 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177 (365)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEE
T ss_pred cceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEE
Confidence 3478999999999999985 699999999865431 134678999999999 79999999999999999999
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++....
T Consensus 178 v~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 178 VFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 99999999999999753 3589999999999999999999998 99999999999999999999999999998776
Q ss_pred CCCceeeecCCCCCccccchhhhhhh----cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHh
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRN----LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 574 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 574 (667)
..... ....||+.|+|||++.+. ...++.++||||||+++|||++|+.||..... ......
T Consensus 252 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------------~~~~~~ 316 (365)
T 2y7j_A 252 PGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------------ILMLRM 316 (365)
T ss_dssp TTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHH
T ss_pred CCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH------------HHHHHH
Confidence 54322 345689999999998643 12468899999999999999999999864321 011111
Q ss_pred hcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 575 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
+...... ............+.+++.+||+.||++|||+.|++++
T Consensus 317 i~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 317 IMEGQYQ-FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHTCCC-CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhCCCC-CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111110 0011111234568889999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=331.01 Aligned_cols=243 Identities=24% Similarity=0.365 Sum_probs=194.7
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEec----CCeeEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD----GSTRALIYE 421 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~~~lV~e 421 (667)
+.++||+|+||+||+|.+. ++..||+|++.... ...+.+.+|+.++++++||||+++++++.. ....++|||
T Consensus 30 ~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 109 (290)
T 1t4h_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEE
Confidence 4568999999999999885 58899999987543 334678999999999999999999998865 456899999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCcEEEC-CCCceEEEeCCCccccC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR--ILHLDIKPQNVLLD-PDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~--ivH~Dikp~NIll~-~~~~~ki~DFGla~~~~ 498 (667)
|+++|+|.+++... ..+++..++.++.|++.||+|||+. + |+||||||+|||++ +++.+||+|||++....
T Consensus 110 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 110 LMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred ecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999999999753 3588999999999999999999987 7 99999999999997 78999999999997655
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
.... ....||+.|+|||++.+ .++.++||||||+++|||++|+.||..... .......+...
T Consensus 184 ~~~~----~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------~~~~~~~~~~~ 245 (290)
T 1t4h_A 184 ASFA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQN-----------AAQIYRRVTSG 245 (290)
T ss_dssp TTSB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----------HHHHHHHHTTT
T ss_pred cccc----ccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----------HHHHHHHHhcc
Confidence 4332 23458999999998863 578999999999999999999999864321 11122222222
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.... .........+.+++.+||+.||++|||+.|++++
T Consensus 246 ~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 246 VKPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CCCG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCcc---ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111 1111123468889999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=332.12 Aligned_cols=244 Identities=23% Similarity=0.346 Sum_probs=196.3
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.+.+.||+|+||+||+|+.. +++.||||++... .....++.+|+..+.++ +||||+++++++.+.+..++||||
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 92 (289)
T 1x8b_A 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY 92 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEe
Confidence 345688999999999999986 6999999998754 23456788999999999 899999999999999999999999
Q ss_pred cCCCCccccccccc-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC-------------------
Q 005953 423 MPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP------------------- 482 (667)
Q Consensus 423 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~------------------- 482 (667)
+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 93 CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp CTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------
T ss_pred cCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 99999999997542 224689999999999999999999998 9999999999999984
Q ss_pred CCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC
Q 005953 483 DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT 562 (667)
Q Consensus 483 ~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~ 562 (667)
...+||+|||++....... ...||+.|+|||.+.+. ..++.++||||||+++|||++|++++.....
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------ 236 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQ------ 236 (289)
T ss_dssp CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH------
T ss_pred ceEEEEcccccccccCCcc------ccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhH------
Confidence 4479999999998765432 23489999999999754 3556799999999999999999876532210
Q ss_pred ccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 563 TEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
...+......... ..+...+.+++.+||+.||++|||+.|++++-
T Consensus 237 ---------~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 237 ---------WHEIRQGRLPRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp ---------HHHHHTTCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred ---------HHHHHcCCCCCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 1122222111111 12345688899999999999999999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.54 Aligned_cols=255 Identities=23% Similarity=0.345 Sum_probs=195.0
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc----chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||+||+|+.. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++|+||+
T Consensus 37 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 2h34_A 37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI 116 (309)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEec
Confidence 35688999999999999985 689999999875432 2367889999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 117 ~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 117 NGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp CCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 999999999754 3589999999999999999999998 9999999999999999999999999999766543221
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
......|++.|+|||.+.+. .++.++||||||+++|||++|+.||..... ......+......
T Consensus 191 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~~~~~~~~~~~-- 253 (309)
T 2h34_A 191 -QLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQL------------SVMGAHINQAIPR-- 253 (309)
T ss_dssp -------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHH------------HHHHHHHHSCCCC--
T ss_pred -cccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCchH------------HHHHHHhccCCCC--
Confidence 22345689999999998753 678899999999999999999999864321 1111111111100
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhcccc
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRP-SMTRVVEMLSSASAE 626 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~evl~~L~~~~~~ 626 (667)
.......++..+.+++.+||+.||++|| +++++++.|+++...
T Consensus 254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 0111122345688899999999999999 999999999966544
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=358.27 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=202.3
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.||+|+||.||+|+.. +|+.||+|++... ......+.+|+.+|++++||||+++++++.+.+..++||||++
T Consensus 188 ~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~ 267 (576)
T 2acx_A 188 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 267 (576)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCC
Confidence 4478999999999999885 6999999998653 2345678899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++........
T Consensus 268 gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~- 342 (576)
T 2acx_A 268 GGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI- 342 (576)
T ss_dssp SCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCE-
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCccc-
Confidence 999999987543 34589999999999999999999998 9999999999999999999999999999877554322
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+...+..... ..
T Consensus 343 --~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~~~~~--------~~~~~i~~~i~~~~~-~~- 408 (576)
T 2acx_A 343 --KGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKK--------IKREEVERLVKEVPE-EY- 408 (576)
T ss_dssp --ECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSCSSSC--------CCHHHHHHHHHHCCC-CC-
T ss_pred --cccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCcccccc--------hhHHHHHHHhhcccc-cC-
Confidence 345799999999999763 6789999999999999999999999754321 011112222211111 11
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEML 620 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~L 620 (667)
...+...+.+++.+||+.||++|| +++|++++-
T Consensus 409 ---p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 409 ---SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred ---CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 112345788899999999999999 789998763
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.35 Aligned_cols=243 Identities=28% Similarity=0.423 Sum_probs=195.2
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.||+|+||+||+|++. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (279)
T 3fdn_A 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 92 (279)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCC
Confidence 4578999999999999885 57899999986432 234678899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 93 ~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~--- 163 (279)
T 3fdn_A 93 LGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--- 163 (279)
T ss_dssp TEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc---
Confidence 999999986543 589999999999999999999988 99999999999999999999999999986544332
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....|++.|+|||.+.+. .++.++||||||+++|||++|+.||..... ......+......
T Consensus 164 -~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~--- 225 (279)
T 3fdn_A 164 -RTDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTY------------QETYKRISRVEFT--- 225 (279)
T ss_dssp -----CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHHTCCC---
T ss_pred -ccccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCcH------------HHHHHHHHhCCCC---
Confidence 1334689999999998763 678899999999999999999999864321 1111111111110
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
........+.+++.+||+.||++|||+.|++++--
T Consensus 226 --~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 226 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp --CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred --CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence 01113456778999999999999999999998764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=351.79 Aligned_cols=258 Identities=23% Similarity=0.278 Sum_probs=189.0
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecC------CeeEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRAL 418 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~~l 418 (667)
.+.++||+|+||+||+|... +++.||||++.... ...+.+.+|+.++++++||||+++++++... ...++
T Consensus 65 ~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 144 (464)
T 3ttj_A 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 144 (464)
T ss_dssp EEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred EEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEE
Confidence 34678999999999999875 68999999997542 3356788999999999999999999999654 35799
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
||||+++ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 145 v~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 145 VMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp EEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred EEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 9999965 45555532 388999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC---------CCCCc--cccc
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS---------GSNTT--EAYF 567 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~---------~~~~~--~~~~ 567 (667)
.... .+...||+.|+|||++.+. .++.++|||||||++|||++|+.||....... +.... ....
T Consensus 216 ~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 216 TSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp -CCC---C----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred CCcc---cCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 4322 2445689999999999764 78899999999999999999999996543100 00000 0000
Q ss_pred hHHHHHhhcC-cc-------------cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 568 PDWIYDKLIQ-PE-------------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 568 ~~~~~~~~~~-~~-------------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.......+.. +. ......+........+.+++.+||+.||++|||++|++++=
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 0000000000 00 00001112223366789999999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.54 Aligned_cols=255 Identities=24% Similarity=0.296 Sum_probs=183.3
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcc-cceEEeecceEe--------cCCee
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIH-HVNIIHLLGFCC--------DGSTR 416 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~--------~~~~~ 416 (667)
+.+.++||+|+||+||+|++. +++.||||++.... ...+.+.+|+.++.++. ||||+++++++. .....
T Consensus 30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 109 (337)
T 3ll6_A 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109 (337)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence 445689999999999999975 68999999886544 34567899999999996 999999999984 33457
Q ss_pred EEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eeecCCCCCcEEECCCCceEEEeCCCc
Q 005953 417 ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR--ILHLDIKPQNVLLDPDFTPKVSDFGLA 494 (667)
Q Consensus 417 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~--ivH~Dikp~NIll~~~~~~ki~DFGla 494 (667)
++|+||+. |+|.+++........+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 110 LLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred EEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 89999995 89999987644455699999999999999999999987 7 999999999999999999999999999
Q ss_pred cccCCCCcee----------eecCCCCCccccchhhhhh-hcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCc
Q 005953 495 KAHSRNRSVV----------TMTGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT 563 (667)
Q Consensus 495 ~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~ 563 (667)
+......... ......||+.|+|||++.. ....++.++||||||+++|||++|+.||.......
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----- 260 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----- 260 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-----
Confidence 8765432211 1113458999999999832 12467889999999999999999999986432210
Q ss_pred cccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 564 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
.......... .. .....+.+++.+||+.||++|||+.|++++|+++..
T Consensus 261 ------~~~~~~~~~~-~~-------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 ------IVNGKYSIPP-HD-------TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -----------CCCCT-TC-------CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------hhcCcccCCc-cc-------ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0000110000 00 112246778999999999999999999999996644
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=364.47 Aligned_cols=245 Identities=21% Similarity=0.300 Sum_probs=201.1
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 421 (667)
+.+.++||+|+||+||+|+.. +++.||||+++.. ....+.+..|..++..+ +||||+++++++.+.+..++|||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E 422 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence 345678999999999999985 5889999998753 23456788999999988 79999999999999999999999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 423 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 423 YVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred CcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 999999999997643 589999999999999999999998 99999999999999999999999999998643332
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 497 ~~--~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~------------~~~~~~i~~~~~~ 560 (674)
T 3pfq_A 497 VT--TKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------------DELFQSIMEHNVA 560 (674)
T ss_dssp CC--BCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHSSCCC
T ss_pred cc--cccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCCH------------HHHHHHHHhCCCC
Confidence 21 2446799999999999754 779999999999999999999999965322 2223333332211
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSM-----TRVVEM 619 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~-----~evl~~ 619 (667)
.+..+...+.+++.+||+.||++||++ +||+++
T Consensus 561 -----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 561 -----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp -----CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred -----CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 111235578889999999999999997 777764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=343.87 Aligned_cols=241 Identities=24% Similarity=0.340 Sum_probs=186.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHH-HhhcccceEEeecceEecCCeeEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVAT-IGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~-l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
+.+.+.||+|+||+||+|+.. +++.||||++.+.. .....+.+|..+ ++.++||||+++++++.+.+..++|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 345689999999999999986 58899999997543 233456777776 567899999999999999999999999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 120 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 120 YINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 999999999997543 588999999999999999999998 99999999999999999999999999998643322
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 194 ~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~------------~~~~~~i~~~~~~ 257 (373)
T 2r5t_A 194 S--TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------------AEMYDNILNKPLQ 257 (373)
T ss_dssp C--CCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------------HHHHHHHHHSCCC
T ss_pred C--ccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCH------------HHHHHHHHhcccC
Confidence 1 12345689999999999764 678999999999999999999999964321 1122222211111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR 615 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e 615 (667)
. ...+...+.+++.+||+.||++||++.+
T Consensus 258 -~----~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 258 -L----KPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp -C----CSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred -C----CCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 0 1113456788999999999999999853
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=339.63 Aligned_cols=255 Identities=24% Similarity=0.317 Sum_probs=189.2
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
+.+.++||+|+||+||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 115 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA 115 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecC
Confidence 345688999999999999875 68999999997543 22456789999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE-----CCCCceEEEeCCCccccC
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL-----DPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll-----~~~~~~ki~DFGla~~~~ 498 (667)
+ |+|.+++.... .+++..+..|+.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++...
T Consensus 116 ~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 116 E-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp S-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred C-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 7 59999886543 589999999999999999999998 99999999999999 455669999999998765
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
..... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||...... .....+......+
T Consensus 189 ~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 189 IPIRQ--FTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--------DQLFKIFEVLGLP 257 (329)
T ss_dssp -------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHHHCCC
T ss_pred Ccccc--cCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--------HHHHHHHHHhCCC
Confidence 33222 2345679999999999764 35789999999999999999999998643220 0000001110000
Q ss_pred cc----------------cc-----ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 579 EK----------------ED-----FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 579 ~~----------------~~-----~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.. .. ........+...+.+++.+||+.||++|||+.|++++=
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 00 00 00001111345788999999999999999999998753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=335.07 Aligned_cols=258 Identities=21% Similarity=0.277 Sum_probs=196.6
Q ss_pred HHhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHHhhcc-cceEEeecceEec--CCeeEEEEEEc
Q 005953 348 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGFCCD--GSTRALIYEYM 423 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~--~~~~~lV~e~~ 423 (667)
+.+.++||+|+||+||+|+. .+++.||||++.... .+.+.+|+.++++++ ||||+++++++.+ ....++||||+
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred eEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 34568899999999999987 468999999987533 577899999999997 9999999999987 66789999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC-ceEEEeCCCccccCCCCc
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~-~~ki~DFGla~~~~~~~~ 502 (667)
++++|.+++.. +++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 116 ~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 116 NNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp CCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred CchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence 99999998842 78899999999999999999998 999999999999999776 899999999987654432
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC------CccccchHHHHH---
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN------TTEAYFPDWIYD--- 573 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~------~~~~~~~~~~~~--- 573 (667)
.....|+..|+|||++.+. ..++.++||||||+++|||++|+.||.......... ........++..
T Consensus 187 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 187 ---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp ---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred ---cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 2345689999999998753 467899999999999999999999985432100000 000000000000
Q ss_pred --------hhcCcc----cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 574 --------KLIQPE----KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 574 --------~~~~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
...... ...........+...+.+++.+||+.||++|||++|++++-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp 321 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence 000000 00001111122456788999999999999999999999753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=340.59 Aligned_cols=257 Identities=23% Similarity=0.311 Sum_probs=185.6
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCe-------eEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGST-------RALIY 420 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~-------~~lV~ 420 (667)
.+.++||+|+||+||+|++. +++.||||++.........+.+|++.+..++||||+++++++..... .++||
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~ 105 (360)
T 3e3p_A 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVM 105 (360)
T ss_dssp EEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEe
Confidence 34578999999999999985 68999999987766666678889999999999999999999875433 78999
Q ss_pred EEcCCCCcccccc-ccccCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCeeecCCCCCcEEECC-CCceEEEeCCCccc
Q 005953 421 EYMPNGSLGDLLS-REKENLSLKPARLLEIALGVAHAIEYLH--NGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKA 496 (667)
Q Consensus 421 e~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~~i~~gl~yLH--~~~~~~ivH~Dikp~NIll~~-~~~~ki~DFGla~~ 496 (667)
||+++ +|.+.+. .......+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 106 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~ 181 (360)
T 3e3p_A 106 EYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181 (360)
T ss_dssp ECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred ecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence 99976 4444443 2233456899999999999999999999 66 9999999999999996 89999999999987
Q ss_pred cCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHH------
Q 005953 497 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW------ 570 (667)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 570 (667)
....... ....||+.|+|||++.+. ..++.++||||||+++|||++|+.||...... ..+...
T Consensus 182 ~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-------~~~~~~~~~~~~ 250 (360)
T 3e3p_A 182 LSPSEPN---VAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-------GQLHEIVRVLGC 250 (360)
T ss_dssp CCTTSCC---CSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHHHCC
T ss_pred cCCCCCc---ccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-------HHHHHHHHHcCC
Confidence 7644322 345689999999998654 35789999999999999999999999654321 000000
Q ss_pred ----HHHhhcCcccc------------cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 571 ----IYDKLIQPEKE------------DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 571 ----~~~~~~~~~~~------------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.+..+...... .............+.+++.+||+.||++|||+.|++++-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 01111000000 000000111356788999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=349.32 Aligned_cols=254 Identities=21% Similarity=0.251 Sum_probs=191.3
Q ss_pred HHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCC------eeEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGS------TRALIYE 421 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------~~~lV~e 421 (667)
|.+.++||+|+||+||+|++.++..||+|++...... ..+|++++++++||||+++++++.... ..++|||
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 3456889999999999999977777999887654322 237999999999999999999986543 3789999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC-CCCceEEEeCCCccccCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~-~~~~~ki~DFGla~~~~~~ 500 (667)
|++++.+..+.........+++..+..++.|+++||+|||+. +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 997655444443333345799999999999999999999998 999999999999998 7999999999999876544
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcC---
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ--- 577 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 577 (667)
... ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||...... ..+ ..+...+..
T Consensus 196 ~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-------~~l-~~i~~~~g~p~~ 263 (394)
T 4e7w_A 196 EPN---VSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-------DQL-VEIIKVLGTPSR 263 (394)
T ss_dssp CCC---CSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHH-HHHHHHHCCCCH
T ss_pred CCC---cccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHH-HHHHHHhCCCCH
Confidence 322 345689999999998654 46889999999999999999999999654320 000 001111000
Q ss_pred ------------ccccccc-----chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 578 ------------PEKEDFV-----EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 578 ------------~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
....... ..........+.+++.+||+.||++|||+.|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000 00011234578899999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=335.80 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=197.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEe--cCCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCC--DGSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~--~~~~~~lV~e~ 422 (667)
.+.+.||+|+||+||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++. .....++||||
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 88 (279)
T 2w5a_A 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88 (279)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeC
Confidence 34578999999999999885 68999999997543 23467899999999999999999999875 35688999999
Q ss_pred cCCCCccccccccc-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-----eeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 423 MPNGSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELR-----ILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 423 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~-----ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
+++|+|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp CTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred CCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 99999999997532 234589999999999999999999987 6 99999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhc
Q 005953 497 HSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLI 576 (667)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 576 (667)
....... .....|++.|+|||.+.+. .++.++||||||+++|||++|+.||..... ..+...+.
T Consensus 166 ~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~~~~~i~ 229 (279)
T 2w5a_A 166 LNHDTSF--AKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ------------KELAGKIR 229 (279)
T ss_dssp C---CHH--HHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHH
T ss_pred ecccccc--ccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCH------------HHHHHHHh
Confidence 6543321 1223579999999998753 678899999999999999999999864321 11112221
Q ss_pred CcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 577 QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
....... ...+...+.+++.+||+.||++|||+.||++++.
T Consensus 230 ~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 230 EGKFRRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HTCCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred hcccccC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 1111111 1123457888999999999999999999999887
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=338.40 Aligned_cols=257 Identities=26% Similarity=0.366 Sum_probs=196.8
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC------cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
+.+.+.||+|+||.||+|++. +|+.||||++.... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 91 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 91 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEE
T ss_pred cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEE
Confidence 445688999999999999985 58999999987532 12357889999999999999999999999999999999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||+++ +|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 92 DFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp ECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 99975 8888886532 3578889999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
... .....||+.|+|||++.+. ..++.++||||||+++|||++|+.||...... .....+......+..
T Consensus 166 ~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--------~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 166 NRA--YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--------DQLTRIFETLGTPTE 234 (346)
T ss_dssp CCC--CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHHHCCCCT
T ss_pred ccc--CCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHHHcCCCCh
Confidence 322 2345689999999998653 35788999999999999999999988643210 000111111111000
Q ss_pred c---------------cc----cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 581 E---------------DF----VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 581 ~---------------~~----~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
. .. .......+...+.+++.+||+.||++|||+.|++++--
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 0 00 00011223467889999999999999999999998765
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=333.28 Aligned_cols=246 Identities=22% Similarity=0.339 Sum_probs=200.4
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
...++||+|+||+||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 104 (303)
T 3a7i_A 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 104 (303)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred HHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCC
Confidence 34578999999999999875 68999999987543 4457899999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++|.+++.. ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.........
T Consensus 105 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 175 (303)
T 3a7i_A 105 GSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-- 175 (303)
T ss_dssp EEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC--
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccccc--
Confidence 999999864 3589999999999999999999998 9999999999999999999999999999876543321
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|+|||++.+. .++.++||||||+++|||++|+.|+..... ......+........
T Consensus 176 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~~~-- 239 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHP------------MKVLFLIPKNNPPTL-- 239 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------------HHHHHHHHHSCCCCC--
T ss_pred cCccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcCH------------HHHHHHhhcCCCCCC--
Confidence 2345689999999999753 678899999999999999999999864321 011111111111111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
...+...+.+++.+||+.||++|||+.|++++.-
T Consensus 240 --~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 240 --EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp --CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred --ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 1122456888999999999999999999998653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=334.36 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=192.8
Q ss_pred HHhhhhcccCCCeEEEEEEeC--CCc--EEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP--DGR--LVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~--~~~--~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 419 (667)
+.+.+.||+|+||+||+|++. +++ .||||+++.. ....+.+.+|++++++++||||+++++++.+.. .++|
T Consensus 20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 98 (291)
T 1u46_A 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV 98 (291)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence 345688999999999999863 333 6899998753 234568899999999999999999999998754 8899
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
+||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++....
T Consensus 99 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 99 TELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp EECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred EecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 99999999999997542 3488999999999999999999998 999999999999999999999999999987755
Q ss_pred CCceee-ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcC
Q 005953 500 NRSVVT-MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 577 (667)
Q Consensus 500 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (667)
...... .....+|..|+|||.+... .++.++||||||+++|||++ |+.||..... ..+...+..
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------~~~~~~~~~ 239 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------------SQILHKIDK 239 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------HHHHHHHHT
T ss_pred cccchhhhccCCCCceeeCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcccCCH------------HHHHHHHHc
Confidence 443222 2334578899999999764 67889999999999999999 9999864321 111122211
Q ss_pred cccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 578 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 578 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
..... .....++..+.+++.+||+.||++|||+.++++.|+++..+
T Consensus 240 ~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 240 EGERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp SCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCCC---CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 11110 11112356788999999999999999999999999976543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.16 Aligned_cols=267 Identities=21% Similarity=0.321 Sum_probs=195.9
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEec--------CCe
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD--------GST 415 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--------~~~ 415 (667)
+.+.++||+|+||+||+|+.. +|+.||||++.... .....+.+|+.++++++||||+++++++.+ .+.
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (351)
T 3mi9_A 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 98 (351)
T ss_dssp EEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CE
T ss_pred eeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCce
Confidence 345688999999999999984 68999999986543 334678899999999999999999999887 346
Q ss_pred eEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 416 RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 416 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
.++||||++ |+|.+.+.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 99 ~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 99 IYLVFDFCE-HDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp EEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeccC-CCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 899999996 47777765432 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCc--eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCC--------CCCccc
Q 005953 496 AHSRNRS--VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG--------SNTTEA 565 (667)
Q Consensus 496 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~--------~~~~~~ 565 (667)
....... ........||+.|+|||++.+. ..++.++||||||+++|||++|+.||........ ......
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 7643221 1223455689999999998754 4578999999999999999999999875432100 000000
Q ss_pred cchHHHHHhhcCc-cc-ccccchhhHH-----HHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 566 YFPDWIYDKLIQP-EK-EDFVEEEDDC-----IARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 566 ~~~~~~~~~~~~~-~~-~~~~~~~~~~-----~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.++.+........ .. .......... ....+.+++.+||+.||++|||++|++++--
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence 0000000000000 00 0000000011 1345789999999999999999999997643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.28 Aligned_cols=248 Identities=27% Similarity=0.365 Sum_probs=197.4
Q ss_pred HHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.|.+.++||+|+||+||+|+.. +++.||+|++.... .....+.+|+.++++++||||+++++++.+....++||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 117 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 3556789999999999999986 68999999987542 3357789999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC---CceEEEeCCCccccCC
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD---FTPKVSDFGLAKAHSR 499 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~---~~~ki~DFGla~~~~~ 499 (667)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 118 ~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 118 YKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999988654 3589999999999999999999998 99999999999999764 5599999999987764
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
... .....||+.|+|||++. +.++.++|||||||++|||++|+.||..... ..+...+....
T Consensus 192 ~~~---~~~~~gt~~y~aPE~l~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------~~~~~~i~~~~ 253 (494)
T 3lij_A 192 QKK---MKERLGTAYYIAPEVLR---KKYDEKCDVWSIGVILFILLAGYPPFGGQTD------------QEILRKVEKGK 253 (494)
T ss_dssp TBC---BCCCCSCTTTCCHHHHT---TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHTC
T ss_pred Ccc---ccccCCCcCeeCHHHHc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCC
Confidence 432 23456899999999985 3678899999999999999999999965322 11122222111
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.. ........++..+.+++.+||+.||++|||+.|++++
T Consensus 254 ~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 254 YT-FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CC-CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CC-CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 11 1111122345678899999999999999999999965
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.79 Aligned_cols=245 Identities=22% Similarity=0.316 Sum_probs=199.3
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.||+|+||+||+++.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 98 (294)
T 2rku_A 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 98 (294)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCC
Confidence 4578999999999999986 58899999986542 234678899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 99 ~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 171 (294)
T 2rku_A 99 RRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER- 171 (294)
T ss_dssp TCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCccc-
Confidence 99999988653 3589999999999999999999998 9999999999999999999999999999876533322
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....||+.|+|||.+.+. .++.++||||||+++|||++|+.||..... ......+...... .
T Consensus 172 -~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~-~- 234 (294)
T 2rku_A 172 -KKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCL------------KETYLRIKKNEYS-I- 234 (294)
T ss_dssp -BCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHTTCCC-C-
T ss_pred -cccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHhhccCC-C-
Confidence 2335689999999998753 678899999999999999999999864321 0111111111111 0
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
...+...+.+++.+||+.||++|||+.|++++--
T Consensus 235 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 235 ---PKHINPVAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred ---ccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 1122446788999999999999999999998643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.19 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=194.0
Q ss_pred HHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---------cchHHHHHHHHHHhhcccceEEeecceEecCCee
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTR 416 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 416 (667)
.+.+.+.||+|+||.||+|+.. +++.||||++.... .....+.+|++++++++||||+++++++.... .
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~ 89 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y 89 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence 4556789999999999999885 58899999986532 12245889999999999999999999987654 8
Q ss_pred EEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCc---eEEEeCCC
Q 005953 417 ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT---PKVSDFGL 493 (667)
Q Consensus 417 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~---~ki~DFGl 493 (667)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp EEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred EEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 9999999999999988653 3589999999999999999999998 9999999999999987654 99999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhhhh-hcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHH
Q 005953 494 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMR-NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 572 (667)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 572 (667)
++........ ....||+.|+|||++.. ....++.++||||||+++|||++|+.||...... ......+.
T Consensus 164 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~ 233 (322)
T 2ycf_A 164 SKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-------VSLKDQIT 233 (322)
T ss_dssp CEECCCCHHH---HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-------SCHHHHHH
T ss_pred ceeccccccc---ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-------HHHHHHHH
Confidence 9876543211 22348999999999853 2246788999999999999999999999643221 11111111
Q ss_pred HhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 573 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
... . .........+...+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~----~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 SGK----Y-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HTC----C-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hCc----c-ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 110 0 11111112345678899999999999999999999853
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=354.17 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=200.3
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.+.||+|+||+||+++.. +|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 357999999999999985 69999999996532 3456789999999999999999999999999999999999999
Q ss_pred CCccccccccc-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 426 GSLGDLLSREK-ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 426 gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
|+|.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 270 g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~- 345 (543)
T 3c4z_A 270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345 (543)
T ss_dssp CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC-
T ss_pred CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc-
Confidence 99999987532 234699999999999999999999998 9999999999999999999999999999876544322
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+...+......
T Consensus 346 -~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~--------~~~~~~~~~i~~~~~~--- 411 (543)
T 3c4z_A 346 -TKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEK--------VENKELKQRVLEQAVT--- 411 (543)
T ss_dssp -BCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC--------CCHHHHHHHHHHCCCC---
T ss_pred -cccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccc--------hhHHHHHHHHhhcccC---
Confidence 2345799999999999763 6789999999999999999999999754221 0111222222211111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSM-----TRVVEM 619 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~-----~evl~~ 619 (667)
.+..+...+.+++.+||+.||++||++ ++++++
T Consensus 412 --~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 412 --YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred --CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 111235577889999999999999965 677654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=339.78 Aligned_cols=258 Identities=22% Similarity=0.311 Sum_probs=190.4
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCC------eeEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS------TRAL 418 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------~~~l 418 (667)
.+.+.||+|+||.||+|++. +|+.||||++.... ...+.+.+|+.++++++||||+++++++.... ..++
T Consensus 28 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~l 107 (367)
T 1cm8_A 28 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 107 (367)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEE
Confidence 34578999999999999984 69999999986532 23467889999999999999999999997653 4599
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
||||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 108 v~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 108 VMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp EEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 99999 88999998652 488999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC---ccccchHHHHHhh
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT---TEAYFPDWIYDKL 575 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~ 575 (667)
.. .+...||+.|+|||++.+. ..++.++|||||||++|||++|+.||........... .....+......+
T Consensus 180 ~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 180 SE-----MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp SS-----CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cc-----cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 32 2345689999999998763 4688999999999999999999999965432100000 0000000000000
Q ss_pred c-----------CcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 576 I-----------QPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 576 ~-----------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
. ..................+.+++.+||+.||++|||+.|++++-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 0 00000001111122345788999999999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=353.99 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=198.7
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--------------cchHHHHHHHHHHhhcccceEEeecceEec
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--------------NFSDNFINEVATIGRIHHVNIIHLLGFCCD 412 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~ 412 (667)
|.+.++||+|+||+||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 117 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 345689999999999999985 58899999987542 234678999999999999999999999999
Q ss_pred CCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC---ceEEE
Q 005953 413 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF---TPKVS 489 (667)
Q Consensus 413 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~---~~ki~ 489 (667)
....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 118 ~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 118 KKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEE
Confidence 99999999999999999988654 3589999999999999999999998 999999999999998776 69999
Q ss_pred eCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchH
Q 005953 490 DFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPD 569 (667)
Q Consensus 490 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 569 (667)
|||+++....... .....||+.|+|||++.+ .++.++||||||+++|||++|+.||..... .
T Consensus 192 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------~ 253 (504)
T 3q5i_A 192 DFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQND------------Q 253 (504)
T ss_dssp CCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------H
T ss_pred ECCCCEEcCCCCc---cccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCH------------H
Confidence 9999987765432 234568999999999863 678999999999999999999999965322 1
Q ss_pred HHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 570 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.+...+...... ........++..+.+++.+||+.||++|||+.|++++-
T Consensus 254 ~~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 254 DIIKKVEKGKYY-FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp HHHHHHHHCCCC-CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHHcCCCC-CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 122222211110 11111123456788999999999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=350.39 Aligned_cols=239 Identities=16% Similarity=0.144 Sum_probs=182.8
Q ss_pred hhhhcccCCCeEEEEEEe-CCCcEEEEEEcccC----CcchHHHHHHH---HHHhhcccceEEeec-------ceEecCC
Q 005953 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKT----SNFSDNFINEV---ATIGRIHHVNIIHLL-------GFCCDGS 414 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~Ei---~~l~~l~h~niv~l~-------g~~~~~~ 414 (667)
+.+.||+|+||+||+|++ .+|+.||||++... ....+.+.+|+ +.+++++|||||+++ +++.+.+
T Consensus 77 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 156 (377)
T 3byv_A 77 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156 (377)
T ss_dssp EEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTT
T ss_pred EcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccC
Confidence 457899999999999997 46999999998643 23457789999 555666899999998 5554443
Q ss_pred -----------------eeEEEEEEcCCCCcccccccccc----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCC
Q 005953 415 -----------------TRALIYEYMPNGSLGDLLSREKE----NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDI 473 (667)
Q Consensus 415 -----------------~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Di 473 (667)
..++||||+ +|+|.+++..... ...+++..++.|+.|++.||+|||+. +|+||||
T Consensus 157 ~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDi 232 (377)
T 3byv_A 157 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 232 (377)
T ss_dssp SCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 378999999 6899999975421 11234588889999999999999998 9999999
Q ss_pred CCCcEEECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhh---------cCCCCCcccHHHHHHHHHHH
Q 005953 474 KPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN---------LGNPSGKSDVYSYGMLLLEM 544 (667)
Q Consensus 474 kp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~k~DvwSlGvvl~el 544 (667)
||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. ...++.++|||||||++|||
T Consensus 233 kp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 233 RPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 99999999999999999999986432 1234557 999999999764 01578899999999999999
Q ss_pred HhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 545 IEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 545 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
++|+.||....... . . ..+.... ..+...+.+++.+||+.||++|||+.|++++
T Consensus 307 ltg~~Pf~~~~~~~---~-----~----~~~~~~~---------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 307 WCADLPITKDAALG---G-----S----EWIFRSC---------KNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHSSCCC------C---C-----S----GGGGSSC---------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHCCCCCccccccc---c-----h----hhhhhhc---------cCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999986543210 0 0 0000000 1124567889999999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.26 Aligned_cols=245 Identities=22% Similarity=0.323 Sum_probs=198.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||.||++++. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 44 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 123 (335)
T 2owb_A 44 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 123 (335)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecC
Confidence 34578999999999999986 58899999986542 23467889999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 124 ~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 124 RRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp TTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 999999988653 3589999999999999999999998 9999999999999999999999999999876533222
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
.....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... .. ....+...... .
T Consensus 198 --~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~-~~~~~~~~~~~-~ 260 (335)
T 2owb_A 198 --KKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----------KE-TYLRIKKNEYS-I 260 (335)
T ss_dssp --BCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------HH-HHHHHHHTCCC-C
T ss_pred --ccccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----------HH-HHHHHhcCCCC-C
Confidence 2345689999999999764 678899999999999999999999864321 01 11111111110 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
...+...+.+++.+||+.||++|||+.|++++-
T Consensus 261 ----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 261 ----PKHINPVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred ----CccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 112234677899999999999999999999753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=337.49 Aligned_cols=250 Identities=27% Similarity=0.389 Sum_probs=193.0
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEec------CCeeEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCD------GSTRALIY 420 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~------~~~~~lV~ 420 (667)
.+.+.||+|+||.||+|++. +++.||||++.......+.+.+|+.+++++ +||||+++++++.. ....++||
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 106 (326)
T 2x7f_A 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 106 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence 34588999999999999984 689999999987666678899999999999 79999999999986 46789999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 107 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 107 EFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp ECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred EcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 9999999999997543 34689999999999999999999998 9999999999999999999999999999866433
Q ss_pred CceeeecCCCCCccccchhhhhhh---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcC
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 577 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (667)
... .....||+.|+|||++... ...++.++||||||+++|||++|+.||..... ..........
T Consensus 183 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~ 249 (326)
T 2x7f_A 183 VGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----------MRALFLIPRN 249 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHS
T ss_pred ccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----------HHHHHHhhcC
Confidence 211 2334689999999998631 24678899999999999999999999854321 0011111111
Q ss_pred cccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 578 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 578 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.. .... ...+...+.+++.+||+.||++||++.|++++
T Consensus 250 ~~-~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 250 PA-PRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CC-CCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cc-ccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 10 0000 11224578889999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.84 Aligned_cols=195 Identities=23% Similarity=0.338 Sum_probs=169.2
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhc------ccceEEeecceEecCCeeEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRI------HHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l------~h~niv~l~g~~~~~~~~~lV~ 420 (667)
+.+.++||+|+||+||+|... +++.||||++.......+.+.+|+.+++.+ +|+||+++++++......++||
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 178 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF 178 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEE
Confidence 445689999999999999875 589999999987665567788899988888 4679999999999999999999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCc--eEEEeCCCccccC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT--PKVSDFGLAKAHS 498 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~--~ki~DFGla~~~~ 498 (667)
||+. ++|.+++.... ...+++..+..|+.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++...
T Consensus 179 e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 179 ELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp CCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred eccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 9995 78999887643 33589999999999999999999998 9999999999999999987 9999999997654
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPT 554 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~ 554 (667)
... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 254 ~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 254 QRV-----YTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CCC-----CSSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Ccc-----cccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 322 235689999999999864 6799999999999999999999998654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.06 Aligned_cols=256 Identities=20% Similarity=0.307 Sum_probs=181.7
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.+.+.||+|+||.||+|... +++.||||++.... ...+++.+|+.++++++||||+++++++...+..++||||+++
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 97 (303)
T 2vwi_A 18 ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97 (303)
T ss_dssp EEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTT
T ss_pred hhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccC
Confidence 35688999999999999874 68999999986542 3456788999999999999999999999999999999999999
Q ss_pred CCcccccccc-----ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 426 GSLGDLLSRE-----KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 426 gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
|+|.+++... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 174 (303)
T 2vwi_A 98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174 (303)
T ss_dssp CBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred CchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence 9999998642 1234589999999999999999999998 9999999999999999999999999999766433
Q ss_pred Cce---eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcC
Q 005953 501 RSV---VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 577 (667)
Q Consensus 501 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (667)
... .......||+.|+|||++... ..++.++||||||+++|||++|+.||...... .........
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----------~~~~~~~~~ 242 (303)
T 2vwi_A 175 GDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPM-----------KVLMLTLQN 242 (303)
T ss_dssp -------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----------GHHHHHHTS
T ss_pred CCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchh-----------hHHHHHhcc
Confidence 211 111234689999999998753 35788999999999999999999998654321 000111110
Q ss_pred ccc--cc--ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 578 PEK--ED--FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 578 ~~~--~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
... .. ........+...+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000 00 0000111234568889999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=338.10 Aligned_cols=262 Identities=22% Similarity=0.354 Sum_probs=194.1
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 107 (331)
T 4aaa_A 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD 107 (331)
T ss_dssp EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCC
Confidence 34578999999999999986 589999999865432 23567899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 108 ~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 180 (331)
T 4aaa_A 108 HTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV- 180 (331)
T ss_dssp EEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc-
Confidence 99998876543 3589999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC----ccccchHH----HHHhhc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT----TEAYFPDW----IYDKLI 576 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~----~~~~~~~~----~~~~~~ 576 (667)
.....||+.|+|||++.+. ..++.++||||||+++|||++|+.||........... .....+.. ......
T Consensus 181 -~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 181 -YDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp ----CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred -cCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 2345689999999998754 3678899999999999999999999865432100000 00000000 000000
Q ss_pred Cccc------ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 577 QPEK------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 577 ~~~~------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.... ..........+...+.+++.+||+.||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 000011112345678999999999999999999999865
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=352.06 Aligned_cols=249 Identities=27% Similarity=0.353 Sum_probs=200.8
Q ss_pred HHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
.|.+.++||+|+||+||+|+.. +++.||||++... ......+.+|++++++++||||+++++++.+....++||||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 102 (486)
T 3mwu_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102 (486)
T ss_dssp HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEc
Confidence 3556789999999999999985 6899999998642 33457899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC---CCCceEEEeCCCccccCC
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~---~~~~~ki~DFGla~~~~~ 499 (667)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++....
T Consensus 103 ~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 103 YTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999886543 589999999999999999999998 999999999999995 456899999999987654
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ..+...+....
T Consensus 177 ~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------~~~~~~i~~~~ 238 (486)
T 3mwu_A 177 NTK---MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNE------------YDILKRVETGK 238 (486)
T ss_dssp C-------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHTC
T ss_pred CCc---cCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCC
Confidence 432 234568999999999864 578899999999999999999999964321 11112221111
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.. ........++..+.+++.+||+.||++|||+.|++++-
T Consensus 239 ~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 239 YA-FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp CC-SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred CC-CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence 11 11111223456788999999999999999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=324.96 Aligned_cols=243 Identities=23% Similarity=0.375 Sum_probs=198.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||.||+|+.. +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 17 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 96 (284)
T 2vgo_A 17 DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFA 96 (284)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeC
Confidence 35578999999999999986 5789999998643 233567899999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 97 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 169 (284)
T 2vgo_A 97 PRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR- 169 (284)
T ss_dssp TTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB-
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccccc-
Confidence 9999999997543 589999999999999999999998 999999999999999999999999999976543221
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
....|++.|+|||++.+. .++.++||||||+++|||++|+.||..... ......+...... .
T Consensus 170 ---~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~~~~~~~~~~~-~ 231 (284)
T 2vgo_A 170 ---RTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSH------------TETHRRIVNVDLK-F 231 (284)
T ss_dssp ---CCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHTTCCC-C
T ss_pred ---ccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCCH------------hHHHHHHhccccC-C
Confidence 234689999999998763 678899999999999999999999864321 1111122111111 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
...+...+.+++.+||+.||++|||+.|++++-
T Consensus 232 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 232 ----PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred ----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 112345678899999999999999999999754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.19 Aligned_cols=259 Identities=21% Similarity=0.287 Sum_probs=197.6
Q ss_pred HHhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEe----cCCeeEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCC----DGSTRALIYE 421 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~----~~~~~~lV~e 421 (667)
+.+.+.||+|+||.||+++. .+++.||||++.... ...+.+.+|++++++++||||+++++++. .....++|+|
T Consensus 31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 110 (317)
T 2buj_A 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110 (317)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEE
Confidence 34568899999999999998 478999999886543 34567899999999999999999999987 3447889999
Q ss_pred EcCCCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 422 YMPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 422 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
|+++|+|.+++... .....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp CCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred eCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 99999999999753 2245689999999999999999999998 9999999999999999999999999998764321
Q ss_pred Cce-------eeecCCCCCccccchhhhhhhc-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHH
Q 005953 501 RSV-------VTMTGPRGTIGYIAPEIFMRNL-GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 572 (667)
Q Consensus 501 ~~~-------~~~~~~~gt~~y~aPE~~~~~~-~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 572 (667)
... .......||+.|+|||++.... ..++.++||||||+++|||++|+.||...... .......+.
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~ 261 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK------GDSVALAVQ 261 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT------TSCHHHHHH
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc------cchhhHHhh
Confidence 100 0011234799999999986431 13588999999999999999999998532110 000111111
Q ss_pred HhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 573 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
. ..... ....+...+.+++.+||+.||++|||+.|++++|+.+
T Consensus 262 ~----~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 262 N----QLSIP----QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp C----C--CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred c----cCCCC----ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 1 00000 0112345788899999999999999999999999954
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=349.19 Aligned_cols=258 Identities=20% Similarity=0.296 Sum_probs=200.9
Q ss_pred HhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHHhhccc-ceEEeecceEecCCeeEEEEEEcCCC
Q 005953 349 GFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH-VNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
.+.++||+|+||.||+|++ .+++.||||++..... ..++.+|+++++.++| +++..+..++.+....++||||+ ++
T Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~ 87 (483)
T 3sv0_A 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (483)
T ss_dssp ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CC
Confidence 3568899999999999997 4689999998765433 3458899999999976 56666777777888999999999 99
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE---CCCCceEEEeCCCccccCCCCce
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll---~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
+|.+++.... ..+++..++.|+.||+.||+|||+. +|+||||||+|||| +.++.+||+|||+++........
T Consensus 88 sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 88 SLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp BHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 9999997532 3589999999999999999999998 99999999999999 68899999999999876544322
Q ss_pred e-----eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 504 V-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 504 ~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
. ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...... .....+.......+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~----~~~~~~~~i~~~~~--- 233 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYEKISEKKV--- 233 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS----SHHHHHHHHHHHHH---
T ss_pred cccccccccccCCCccccCHHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccch----hHHHHHHHHhhccc---
Confidence 1 11245699999999999764 6789999999999999999999999754321 11111111111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
..........+...+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 234 --~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 234 --ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp --HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred --cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 11111111233567889999999999999999999999998653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=336.94 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=198.6
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCc----c--------------hHHHHHHHHHHhhcccceEEeecceE
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN----F--------------SDNFINEVATIGRIHHVNIIHLLGFC 410 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----~--------------~~~~~~Ei~~l~~l~h~niv~l~g~~ 410 (667)
.+.+.||+|+||.||+|+. +++.||||++..... . .+.+.+|+.++++++||||+++++++
T Consensus 34 ~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 112 (348)
T 2pml_X 34 RIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112 (348)
T ss_dssp EEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEE
T ss_pred EEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 3567899999999999999 999999999864321 1 17899999999999999999999999
Q ss_pred ecCCeeEEEEEEcCCCCcccc------ccccccCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCcEEECCC
Q 005953 411 CDGSTRALIYEYMPNGSLGDL------LSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDPD 483 (667)
Q Consensus 411 ~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivH~Dikp~NIll~~~ 483 (667)
.+.+..++||||+++|+|.++ +... ....+++..++.++.|++.||+|||+ . +|+||||||+|||++.+
T Consensus 113 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKN 188 (348)
T ss_dssp ESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECTT
T ss_pred eeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcCC
Confidence 999999999999999999999 5432 14579999999999999999999998 7 99999999999999999
Q ss_pred CceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCC-cccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC
Q 005953 484 FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSG-KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT 562 (667)
Q Consensus 484 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~-k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~ 562 (667)
+.+||+|||+++..... ......|++.|+|||.+.+. ..++. ++||||||+++|||++|+.||......
T Consensus 189 ~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----- 258 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL----- 258 (348)
T ss_dssp SCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-----
T ss_pred CcEEEeccccccccccc----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-----
Confidence 99999999999876543 23456689999999998753 24444 899999999999999999999654320
Q ss_pred ccccchHHHHHhhcCcccccc--------------cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 563 TEAYFPDWIYDKLIQPEKEDF--------------VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
......+........ .......+...+.+++.+||+.||++|||+.|++++
T Consensus 259 ------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 ------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp ------HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ------HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111111111000 000012345678899999999999999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=354.55 Aligned_cols=249 Identities=25% Similarity=0.322 Sum_probs=202.9
Q ss_pred HHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
.|.+.++||+|+||+||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 4556789999999999999986 6899999998653 2345789999999999999999999999999999999999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE---CCCCceEEEeCCCccccC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll---~~~~~~ki~DFGla~~~~ 498 (667)
|+.+|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 107 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 107 VYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp CCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred cCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 99999999988654 3589999999999999999999998 99999999999999 567899999999998765
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
..... ....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ..+...+...
T Consensus 181 ~~~~~---~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------~~~~~~i~~~ 242 (484)
T 3nyv_A 181 ASKKM---KDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANE------------YDILKKVEKG 242 (484)
T ss_dssp CCCSH---HHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHC
T ss_pred ccccc---ccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHcC
Confidence 44322 33458999999999864 678899999999999999999999965322 1112222211
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
... ........++..+.+++.+||+.||++|||+.|++++-
T Consensus 243 ~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 243 KYT-FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp CCC-CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred CCC-CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 111 11111223456788999999999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.01 Aligned_cols=265 Identities=21% Similarity=0.308 Sum_probs=182.7
Q ss_pred hhhcccCCCeEEEEEEeC---CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEec--CCeeEEEEEEcCC
Q 005953 351 KEKLGTGGYGNVYKGKFP---DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRALIYEYMPN 425 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~ 425 (667)
.++||+|+||+||+|++. +++.||||++.... ....+.+|+.+|++++||||+++++++.. ....++||||+.
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~- 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence 357999999999999975 57899999997653 34578899999999999999999999954 678999999995
Q ss_pred CCccccccccc------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE----CCCCceEEEeCCCcc
Q 005953 426 GSLGDLLSREK------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL----DPDFTPKVSDFGLAK 495 (667)
Q Consensus 426 gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll----~~~~~~ki~DFGla~ 495 (667)
|+|.+++.... ....+++..++.|+.|++.||+|||+. +|+||||||+|||| +.++.+||+|||+++
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 68888775321 123589999999999999999999998 99999999999999 778999999999998
Q ss_pred ccCCCCce-eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC-CCccccchHHHHH
Q 005953 496 AHSRNRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS-NTTEAYFPDWIYD 573 (667)
Q Consensus 496 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~ 573 (667)
........ .......||+.|+|||++.+. ..++.++|||||||++|||++|+.||......... ..........+..
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp ----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred ecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 76543221 222345689999999999764 35789999999999999999999999654321100 0000000011111
Q ss_pred hhcCccccc---------------------cc-chhhH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 574 KLIQPEKED---------------------FV-EEEDD-------CIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 574 ~~~~~~~~~---------------------~~-~~~~~-------~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
.+..+.... .. ..... .....+.+|+.+||+.||++|||++|++++=-
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 111110000 00 00000 01346788999999999999999999998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.66 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=196.7
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.+.+.||+|+||.||+|++. +|+.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 31 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (314)
T 3com_A 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG 109 (314)
T ss_dssp EEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred hhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCC
Confidence 345678999999999999886 58999999987654 3567899999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......... .
T Consensus 110 ~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~ 182 (314)
T 3com_A 110 SVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK--R 182 (314)
T ss_dssp EHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC--B
T ss_pred CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc--c
Confidence 999998643 34689999999999999999999998 9999999999999999999999999999876543221 2
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
....|++.|+|||.+.+. .++.++||||||+++|||++|+.||..... ...... +........ .
T Consensus 183 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~-~~~~~~~~~--~ 246 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHP-----------MRAIFM-IPTNPPPTF--R 246 (314)
T ss_dssp CCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHH-HHHSCCCCC--S
T ss_pred CccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHH-HhcCCCccc--C
Confidence 345689999999998753 678899999999999999999999864321 000110 000000000 1
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
....+...+.+++.+||+.||++|||+.+++++-
T Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 247 KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 1112345788899999999999999999998743
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.61 Aligned_cols=258 Identities=22% Similarity=0.371 Sum_probs=194.4
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.+.+.||+|+||+||+|++.+ .||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 36 ~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~ 113 (319)
T 2y4i_B 36 EIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG 113 (319)
T ss_dssp ECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCS
T ss_pred EEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccC
Confidence 356889999999999999843 48999987542 3345678999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc---
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS--- 502 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~--- 502 (667)
++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++.......
T Consensus 114 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 114 RTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp EEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence 9999999754 23588999999999999999999998 999999999999998 67999999999876532211
Q ss_pred eeeecCCCCCccccchhhhhhh-------cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRN-------LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~-------~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (667)
........|++.|+|||.+... ...++.++||||||+++|||++|+.||..... ..+...+
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------------~~~~~~~ 255 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------------EAIIWQM 255 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------------HHHHHHH
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHh
Confidence 1112334589999999998642 13568899999999999999999999864321 1111122
Q ss_pred cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccccccC
Q 005953 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIE 629 (667)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 629 (667)
.......... ..+...+.+++.+||+.||++|||+.++++.|+++......
T Consensus 256 ~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 256 GTGMKPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HTTCCCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred ccCCCCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 2211111110 01234677899999999999999999999999976554433
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=327.28 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=199.0
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----------cchHHHHHHHHHHhhcc-cceEEeecceEecCCeeE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----------NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRA 417 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----------~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~ 417 (667)
+.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+++++++. ||||+++++++.+....+
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 100 (298)
T 1phk_A 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF 100 (298)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred eeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEE
Confidence 4578999999999999985 68999999986543 12356889999999995 999999999999999999
Q ss_pred EEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcccc
Q 005953 418 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~ 497 (667)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++...
T Consensus 101 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 101 LVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 999999999999999753 3589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCceeeecCCCCCccccchhhhhhh----cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHH
Q 005953 498 SRNRSVVTMTGPRGTIGYIAPEIFMRN----LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573 (667)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 573 (667)
...... ....|++.|+|||++... ...++.++||||||+++|||++|+.||..... .....
T Consensus 175 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------~~~~~ 239 (298)
T 1phk_A 175 DPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------------MLMLR 239 (298)
T ss_dssp CTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHH
T ss_pred CCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------------HHHHH
Confidence 544322 345689999999998632 24578899999999999999999999864321 11111
Q ss_pred hhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.+...... ........+...+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 240 MIMSGNYQ-FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHTCCC-CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhcCCcc-cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 11111110 0111112345678899999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=349.36 Aligned_cols=252 Identities=10% Similarity=0.019 Sum_probs=176.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc----chHHHHHHHHHHhhc--ccceEEeec-------ceEecC-
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----FSDNFINEVATIGRI--HHVNIIHLL-------GFCCDG- 413 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l--~h~niv~l~-------g~~~~~- 413 (667)
.+.++||+|+||+||+|++. +++.||||++..... ..+.+.+|+.+++.+ +||||++++ +++...
T Consensus 65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~ 144 (371)
T 3q60_A 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETT
T ss_pred eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCC
Confidence 34578999999999999975 689999999987542 335677785555555 699988755 333322
Q ss_pred ----------------CeeEEEEEEcCCCCccccccccccCCCCCHHHH------HHHHHHHHHHHHHHHcCCCCCeeec
Q 005953 414 ----------------STRALIYEYMPNGSLGDLLSREKENLSLKPARL------LEIALGVAHAIEYLHNGCELRILHL 471 (667)
Q Consensus 414 ----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~gl~yLH~~~~~~ivH~ 471 (667)
...++||||++ |+|.+++..... .+.+..+ +.++.|++.||+|||++ +|+||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHr 218 (371)
T 3q60_A 145 QPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHG 218 (371)
T ss_dssp SCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred CCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccC
Confidence 34799999998 999999976432 2344455 67889999999999998 99999
Q ss_pred CCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCC
Q 005953 472 DIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHL 551 (667)
Q Consensus 472 Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~ 551 (667)
||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+....++.++|||||||++|||++|+.||
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998664321 134467999999999753236789999999999999999999999
Q ss_pred CCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 552 RPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
............... ................+...+.+++.+||+.||++|||+.|++++
T Consensus 294 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 294 GLVTPGIKGSWKRPS--------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TBCCTTCTTCCCBCC--------TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCcCcccccchhhhh--------hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 755321110000000 000000001111111235678889999999999999999999853
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=344.88 Aligned_cols=277 Identities=19% Similarity=0.265 Sum_probs=204.4
Q ss_pred hhcccCCCCCHHHHHHHHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcc--------c
Q 005953 330 YRSALLSNYSYNDIKKMTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH--------H 400 (667)
Q Consensus 330 ~~~~~~~~~~~~~l~~~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~--------h 400 (667)
+.......+...++....+.+.++||+|+||+||+|+.. +++.||||++.......+.+.+|+.++++++ |
T Consensus 21 ~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~ 100 (397)
T 1wak_A 21 YCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100 (397)
T ss_dssp -CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGG
T ss_pred CCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCc
Confidence 333333444444444445667789999999999999874 6889999999876656678999999999996 7
Q ss_pred ceEEeecceEe----cCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCC
Q 005953 401 VNIIHLLGFCC----DGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQ 476 (667)
Q Consensus 401 ~niv~l~g~~~----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~ 476 (667)
+||+++++++. +....++||||+ +++|.+++.... ...+++..++.|+.||+.||+|||+++ +|+||||||+
T Consensus 101 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~ 176 (397)
T 1wak_A 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPE 176 (397)
T ss_dssp GGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGG
T ss_pred ceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHH
Confidence 88999999987 566889999999 666666665432 245899999999999999999999842 8999999999
Q ss_pred cEEECCCC-------------------------------------------------ceEEEeCCCccccCCCCceeeec
Q 005953 477 NVLLDPDF-------------------------------------------------TPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 477 NIll~~~~-------------------------------------------------~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|||++.++ .+||+|||+++..... ..
T Consensus 177 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~ 251 (397)
T 1wak_A 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FT 251 (397)
T ss_dssp GEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SC
T ss_pred HeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----Cc
Confidence 99999775 7999999999876433 23
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc--------
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE-------- 579 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 579 (667)
...||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ........+...+....
T Consensus 252 ~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~ 327 (397)
T 1wak_A 252 EDIQTRQYRSLEVLIGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEEYT--RDEDHIALIIELLGKVPRKLIVAGK 327 (397)
T ss_dssp SCCSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSC--HHHHHHHHHHHHHCSCCHHHHHHCT
T ss_pred cCCCCCcccCChhhcCC--CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccC--chHHHHHHHHHhcCCCChHHhhccc
Confidence 45689999999999764 6889999999999999999999999754321100 00000000111000000
Q ss_pred -----------cc---c-----------ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 580 -----------KE---D-----------FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 580 -----------~~---~-----------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.. . ............+.+++.+||+.||++|||+.|++++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp TGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00 0 0001134556789999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=327.77 Aligned_cols=245 Identities=22% Similarity=0.404 Sum_probs=191.4
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||.||+|++. +++.||||++... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 14 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (276)
T 2h6d_A 14 VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93 (276)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEecc
Confidence 35578999999999999986 6899999998643 234567899999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 94 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 166 (276)
T 2h6d_A 94 SGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 166 (276)
T ss_dssp CSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred CCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc-
Confidence 9999999997543 488999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
.....|++.|+|||.+.+. ...+.++||||||+++|||++|+.||..... ......+...... .
T Consensus 167 --~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~-~ 230 (276)
T 2h6d_A 167 --LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHV------------PTLFKKIRGGVFY-I 230 (276)
T ss_dssp ------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCCC-C
T ss_pred --eecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcH------------HHHHHHhhcCccc-C
Confidence 1234589999999998754 2346799999999999999999999864321 1111111111100 0
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
...+...+.+++.+||+.||++|||+.|++++-
T Consensus 231 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~ 263 (276)
T 2h6d_A 231 ----PEYLNRSVATLLMHMLQVDPLKRATIKDIREHE 263 (276)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred ----chhcCHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence 111245678899999999999999999999863
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=337.39 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=196.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecC-----CeeEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDG-----STRALIY 420 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~~~lV~ 420 (667)
.+.++||+|+||.||+|+.. +++.||||++.... ...+.+.+|++++++++||||+++++++... ...++|+
T Consensus 30 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~ 109 (364)
T 3qyz_A 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQ 109 (364)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred EEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEE
Confidence 45688999999999999875 68899999997543 2346789999999999999999999998754 3689999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||+. |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 110 e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 110 DLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp ECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred cccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 9996 6898888543 489999999999999999999998 9999999999999999999999999999876543
Q ss_pred Ccee-eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 501 RSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 501 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
.... ......||+.|+|||++.+. ..++.++||||||+++|||++|+.||....... ....+...+..+.
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--------QLNHILGILGSPS 252 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG--------HHHHHHHHHCSCC
T ss_pred CCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH--------HHHHHHHHhCCCC
Confidence 2221 12345689999999998654 457899999999999999999999996543210 0001111000000
Q ss_pred c----------------------ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 580 K----------------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 580 ~----------------------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
. ..........+...+.+++.+||+.||++|||+.|++++-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0 0000011112345788999999999999999999999764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.56 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=197.9
Q ss_pred HHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.+.+.||+|+||+||+++.. +|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence 3455689999999999999985 68999999997653 234578899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE---CCCCceEEEeCCCccccCCCC
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL---DPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll---~~~~~~ki~DFGla~~~~~~~ 501 (667)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+++......
T Consensus 90 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 90 GGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp SCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred CccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 999999986543 589999999999999999999998 99999999999999 788999999999997654322
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
. ....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+......
T Consensus 164 ~----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~~~~i~~~~~~ 225 (304)
T 2jam_A 164 M----STACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETE------------SKLFEKIKEGYYE 225 (304)
T ss_dssp T----HHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH------------HHHHHHHHHCCCC
T ss_pred c----ccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHcCCCC
Confidence 1 22347999999999875 3678899999999999999999999864321 1111111111110
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
........+...+.+++.+||+.||++|||+.|++++-
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 226 -FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred -CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 01111122355788899999999999999999999754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=342.56 Aligned_cols=259 Identities=20% Similarity=0.314 Sum_probs=197.7
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.++||+|+||+||+|++. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 114 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 114 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred ceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCC
Confidence 445688999999999999986 68999999987653 334678999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|+|.+++.... .+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+++......
T Consensus 115 ~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 186 (360)
T 3eqc_A 115 GGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 186 (360)
T ss_dssp TCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccccc---
Confidence 999999997543 588999999999999999999972 179999999999999999999999999997553221
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCC----------CCC--------cccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG----------SNT--------TEAY 566 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~----------~~~--------~~~~ 566 (667)
.....||+.|+|||++.+. .++.++||||||+++|||++|+.||........ ... ....
T Consensus 187 -~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 187 -ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp -----CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred -ccCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 1234689999999999763 778999999999999999999999965321000 000 0000
Q ss_pred c------------hHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 567 F------------PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 567 ~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
+ .....+.+....... .....+...+.+++.+||+.||++|||+.|++++-
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPK---LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCC---CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCC---CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 0 000000000000000 00112345688999999999999999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=335.10 Aligned_cols=258 Identities=23% Similarity=0.274 Sum_probs=186.9
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCC------eeEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS------TRAL 418 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------~~~l 418 (667)
.+.+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.... ..++
T Consensus 28 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~l 107 (371)
T 2xrw_A 28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 107 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred eEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEE
Confidence 34578999999999999875 68999999987543 23467889999999999999999999997654 7899
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
||||++ |+|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 108 v~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 108 VMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp EEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred EEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 999996 578777742 488999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC----CCccccchHH----
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS----NTTEAYFPDW---- 570 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~----~~~~~~~~~~---- 570 (667)
... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......... .......+.+
T Consensus 179 ~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 179 TSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp --------------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccc---ccCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 332 12345689999999999763 6789999999999999999999999654320000 0000000000
Q ss_pred ---HHHhhc-Ccc-------------cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 571 ---IYDKLI-QPE-------------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 571 ---~~~~~~-~~~-------------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
+..... .+. ......+........+.+++.+||+.||++|||++|++++-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 000000 000 00011112233467889999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.61 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=189.5
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecC------CeeEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRALIYE 421 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~~lV~e 421 (667)
.+.++||+|+||.||+|++. +++.||||++..... .+.+|+++|++++||||+++++++... ...++|||
T Consensus 57 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred EeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehh
Confidence 34578999999999999985 589999999875432 234799999999999999999988542 23678999
Q ss_pred EcCCCCccccccc-cccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC-CceEEEeCCCccccCC
Q 005953 422 YMPNGSLGDLLSR-EKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSR 499 (667)
Q Consensus 422 ~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~-~~~ki~DFGla~~~~~ 499 (667)
|+++ +|.+++.. ......+++..+..++.||++||+|||+. +|+||||||+||||+.+ +.+||+|||+++....
T Consensus 134 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred cccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 9975 66665543 22345799999999999999999999998 99999999999999965 6789999999987654
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc-
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP- 578 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 578 (667)
.... ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||...... ..+. .+...+..+
T Consensus 210 ~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-------~~l~-~i~~~lg~p~ 277 (420)
T 1j1b_A 210 GEPN---VSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-------DQLV-EIIKVLGTPT 277 (420)
T ss_dssp TCCC---CSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHH-HHHHHHCSCC
T ss_pred CCCc---eeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHH-HHHHHhCCCC
Confidence 4322 345689999999998753 36789999999999999999999999654320 0000 011110000
Q ss_pred ---------cc-----ccccch-----hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 579 ---------EK-----EDFVEE-----EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 579 ---------~~-----~~~~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.. ...... ........+.+|+.+||+.||++|||+.|++++-
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 00 000000 0112345788999999999999999999999764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=329.28 Aligned_cols=260 Identities=19% Similarity=0.316 Sum_probs=199.3
Q ss_pred HHhhhhcccCCCeEEEEEEe--CCCcEEEEEEcccCCcchHHHHHHHHHHhhcccce------EEeecceEecCCeeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF--PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN------IIHLLGFCCDGSTRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~g~~~~~~~~~lV 419 (667)
+.+.++||+|+||+||+|.. .+++.||||+++......+.+.+|+.++++++|++ ++++++++.+.+..++|
T Consensus 16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv 95 (339)
T 1z57_A 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIV 95 (339)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEE
Confidence 34568899999999999987 36889999999876656678899999999998765 99999999999999999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC-----------------
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP----------------- 482 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~----------------- 482 (667)
|||+ +++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 96 ~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 96 FELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 9999 899999987543 34688999999999999999999998 9999999999999987
Q ss_pred --CCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC
Q 005953 483 --DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS 560 (667)
Q Consensus 483 --~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~ 560 (667)
++.+||+|||+++...... ....||+.|+|||++.+. .++.++||||||+++|||++|+.||.........
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp ESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred ccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 6789999999998654322 234689999999999763 6789999999999999999999999653221000
Q ss_pred CC---ccccchHHHHHhhcCccc------------------------ccccchhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 005953 561 NT---TEAYFPDWIYDKLIQPEK------------------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSM 613 (667)
Q Consensus 561 ~~---~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 613 (667)
.. .....+............ ..............+.+++.+||+.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 00 000000100000000000 000001112346678999999999999999999
Q ss_pred HHHHHH
Q 005953 614 TRVVEM 619 (667)
Q Consensus 614 ~evl~~ 619 (667)
.|++++
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999865
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=335.59 Aligned_cols=250 Identities=21% Similarity=0.285 Sum_probs=178.2
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecC------CeeEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRAL 418 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~~l 418 (667)
.+.+.||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+.++++++||||+++++++... ...++
T Consensus 32 ~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~l 111 (367)
T 2fst_X 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111 (367)
T ss_dssp EEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEE
Confidence 34578999999999999874 68999999987542 2346788999999999999999999998754 56799
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
|+|++ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 112 v~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 112 VTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp EEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred Eeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 99999 7899998864 2589999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
.. .+...||+.|+|||++.+. ..++.++|||||||++|||++|+.||...... .....+...+..+
T Consensus 184 ~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~l~~i~~~~g~p 249 (367)
T 2fst_X 184 DE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--------DQLKLILRLVGTP 249 (367)
T ss_dssp ------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCSC
T ss_pred cc-----CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhCCC
Confidence 32 2345689999999998763 46789999999999999999999999654320 0000111111000
Q ss_pred c----------------------cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 579 E----------------------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 579 ~----------------------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
. ...............+.+++.+||+.||++|||+.|++++-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 0 00000000112245688999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=330.90 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=193.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
.+.+.||+|+||+||+|++. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 22 ~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (302)
T 2j7t_A 22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG 101 (302)
T ss_dssp EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTE
T ss_pred eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCC
Confidence 35678999999999999986 58999999987543 45678999999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++........ ..
T Consensus 102 ~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 174 (302)
T 2j7t_A 102 AVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ--KR 174 (302)
T ss_dssp EHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH--C-
T ss_pred cHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc--cc
Confidence 9999886532 3589999999999999999999998 999999999999999999999999998754321111 11
Q ss_pred cCCCCCccccchhhhhh---hcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 507 TGPRGTIGYIAPEIFMR---NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~---~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
....||+.|+|||++.. ....++.++||||||+++|||++|+.|+..... ... ...+........
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~-~~~~~~~~~~~~ 242 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------MRV-LLKIAKSDPPTL 242 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHH-HHHHHHSCCCCC
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-----------HHH-HHHHhccCCccc
Confidence 23458999999999852 124678899999999999999999999864321 011 111111111000
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.....+...+.+++.+||+.||++|||+.|++++
T Consensus 243 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 --LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred --CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1112234568889999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.62 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=191.6
Q ss_pred HHhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecC-------------
Q 005953 348 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDG------------- 413 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------------- 413 (667)
+.+.++||+|+||+||+|++ .+|+.||||++...... ..+|++++++++||||+++++++...
T Consensus 9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence 34568999999999999987 46899999998755432 23799999999999999999998543
Q ss_pred -------------------------CeeEEEEEEcCCCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 005953 414 -------------------------STRALIYEYMPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELR 467 (667)
Q Consensus 414 -------------------------~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ 467 (667)
...++||||++ |+|.+.+... .....+++..+..++.|+++||+|||+. +
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---g 161 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---G 161 (383)
T ss_dssp ------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---T
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---c
Confidence 34789999997 6888877642 2345799999999999999999999988 9
Q ss_pred eeecCCCCCcEEEC-CCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh
Q 005953 468 ILHLDIKPQNVLLD-PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE 546 (667)
Q Consensus 468 ivH~Dikp~NIll~-~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt 546 (667)
|+||||||+|||++ +++.+||+|||+++........ ....||+.|+|||++.+. ..++.++||||||+++|||++
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHH
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHHHHh
Confidence 99999999999997 6899999999999876544322 334679999999998754 357899999999999999999
Q ss_pred CCCCCCCCCcCCCCCCccccchHHHHHhhcCcc---------------cc-----cccchhhHHHHHHHHHHHHHhcccC
Q 005953 547 EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE---------------KE-----DFVEEEDDCIARKMIIVGLWCIQIN 606 (667)
Q Consensus 547 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~-----~~~~~~~~~~~~~l~~l~~~cl~~~ 606 (667)
|+.||...... ..+ ..+...+..+. .. ..........+..+.+++.+||+.|
T Consensus 238 g~~pf~~~~~~-------~~~-~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 238 GKPLFSGETSI-------DQL-VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp SSCSSCCSSHH-------HHH-HHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred CCCCCCCCChH-------HHH-HHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 99999654221 000 00111100000 00 0000011123456889999999999
Q ss_pred CCCCCCHHHHHHH
Q 005953 607 PKDRPSMTRVVEM 619 (667)
Q Consensus 607 P~~RPt~~evl~~ 619 (667)
|++|||+.|++++
T Consensus 310 P~~R~t~~e~l~h 322 (383)
T 3eb0_A 310 PDLRINPYEAMAH 322 (383)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999964
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=327.09 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=190.3
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEec-------------C
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCD-------------G 413 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-------------~ 413 (667)
+.+.+.||+|+||+||+|+.. +++.||||++.......+.+.+|+.++++++||||+++++++.+ .
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKK 87 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CE
T ss_pred chhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccC
Confidence 345678999999999999975 68999999997665556789999999999999999999998865 3
Q ss_pred CeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCC
Q 005953 414 STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 493 (667)
Q Consensus 414 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGl 493 (667)
...++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 88 STLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp EEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred CceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 56889999999999999997532 3578889999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCc------------eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC
Q 005953 494 AKAHSRNRS------------VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN 561 (667)
Q Consensus 494 a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~ 561 (667)
++....... ........||+.|+|||++.+. +.++.++||||||+++|||++ |+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~----- 233 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGME----- 233 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchh-----
Confidence 987643211 1112345689999999998753 467899999999999999997 3321100
Q ss_pred CccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 562 TTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.......+..... .............+.+++.+||+.||++|||+.|++++-
T Consensus 234 ------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 234 ------RVNILKKLRSVSI-EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp ------HHHHHHHHHSTTC-CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred ------HHHHHHhcccccc-ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 0111122211111 111111122345678899999999999999999999753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=328.43 Aligned_cols=251 Identities=23% Similarity=0.316 Sum_probs=182.0
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcc--h-HHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNF--S-DNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~-~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
.+.++||+|+||+||+|+.. +++.||||++...... . +.+.++...++.++||||+++++++.+.+..++||||++
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 89 (290)
T 3fme_A 10 EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD 89 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS
T ss_pred hhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc
Confidence 45688999999999999984 6899999999765322 2 234445556888899999999999999999999999996
Q ss_pred CCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 425 NGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 425 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
|+|.+++... .....+++..+..++.|++.||+|||++ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 90 -~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 166 (290)
T 3fme_A 90 -TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166 (290)
T ss_dssp -EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred -cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence 6888887642 2345799999999999999999999973 28999999999999999999999999999876543322
Q ss_pred eeecCCCCCccccchhhhhh--hcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMR--NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~--~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
....||+.|+|||++.. ....++.++||||||+++|||++|+.||..... . ...+..........
T Consensus 167 ---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~-~~~~~~~~~~~~~~ 233 (290)
T 3fme_A 167 ---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT---------P-FQQLKQVVEEPSPQ 233 (290)
T ss_dssp ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC---------H-HHHHHHHHHSCCCC
T ss_pred ---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc---------h-HHHHHHHhccCCCC
Confidence 23458999999999731 124678899999999999999999999864321 0 01111111111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
. ....+...+.+++.+||+.||++|||+.|++++
T Consensus 234 -~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 234 -L---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp -C---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -c---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1 111234568889999999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=334.73 Aligned_cols=253 Identities=20% Similarity=0.287 Sum_probs=187.6
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCc------------chHHHHHHHHHHhhcccceEEeecceEec-----
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN------------FSDNFINEVATIGRIHHVNIIHLLGFCCD----- 412 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----- 412 (667)
+.+.||+|+||.||+|...+++.||||++..... ..+.+.+|+.++++++||||+++++++..
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (362)
T 3pg1_A 26 VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA 105 (362)
T ss_dssp EEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTT
T ss_pred EeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCC
Confidence 4578999999999999998899999999864321 12678999999999999999999999854
Q ss_pred CCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCC
Q 005953 413 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFG 492 (667)
Q Consensus 413 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFG 492 (667)
....++||||++ |+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 106 MHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp CCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred cceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEecC
Confidence 346899999997 6888887643 34689999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHH
Q 005953 493 LAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 572 (667)
Q Consensus 493 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 572 (667)
+++....... .....||+.|+|||++.+. ..++.++||||||+++|||++|+.||...... . ....+.
T Consensus 180 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~-~~~~i~ 247 (362)
T 3pg1_A 180 LAREDTADAN---KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-------N-QLNKIV 247 (362)
T ss_dssp C------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------H-HHHHHH
T ss_pred cccccccccc---cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHH
Confidence 9976543332 2334689999999998753 46789999999999999999999999654210 0 000000
Q ss_pred Hhh-------------------cCcccc----cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 573 DKL-------------------IQPEKE----DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 573 ~~~-------------------~~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
... ...... .............+.+++.+||+.||++|||+.|++++-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 318 (362)
T 3pg1_A 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP 318 (362)
T ss_dssp HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence 000 000000 000111112245688999999999999999999999764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=329.98 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=191.5
Q ss_pred HHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHHhhcc--cceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIH--HVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.+.+.||+|+||.||+++..+++.||||++.... ...+.+.+|+.++++++ |+||+++++++.+....++|||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 108 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence 34567899999999999999889999999986543 23467899999999997 5999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+.+++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+|||+++ +.+||+|||+++.......
T Consensus 109 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 109 CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 5689999999754 3588999999999999999999998 9999999999999964 8999999999987654433
Q ss_pred eeeecCCCCCccccchhhhhhh---------cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHH
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRN---------LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 573 (667)
........||+.|+|||.+... ...++.++||||||+++|||++|+.||..... .... ..
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------~~~~-~~ 250 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----------QISK-LH 250 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS----------HHHH-HH
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH----------HHHH-HH
Confidence 2222345689999999998641 13578899999999999999999999864321 0011 11
Q ss_pred hhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 574 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
............. .....+.+++.+||+.||++||++.|++++--
T Consensus 251 ~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 251 AIIDPNHEIEFPD---IPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HHHCTTSCCCCCC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHhcccccCCcc---cchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 1111111111111 11346788999999999999999999997653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=331.66 Aligned_cols=260 Identities=24% Similarity=0.337 Sum_probs=194.0
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecC-----CeeEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDG-----STRALIYE 421 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~~~lV~e 421 (667)
+.+.||+|+||+||+|++. +|+.||||++.... .....+.+|+.++++++||||+++++++... ...++|||
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 94 (353)
T 2b9h_A 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQE 94 (353)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEEC
T ss_pred EeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEe
Confidence 4578999999999999985 68999999997543 2345788999999999999999999987654 67899999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+. |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 95 LMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp CCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 996 6898888652 589999999999999999999998 99999999999999999999999999998765322
Q ss_pred cee--------eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC---------C----C
Q 005953 502 SVV--------TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS---------G----S 560 (667)
Q Consensus 502 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~---------~----~ 560 (667)
... ......||+.|+|||++... ..++.++||||||+++|||++|+.||....... + .
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred ccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 111 12234689999999998653 467889999999999999999999996543100 0 0
Q ss_pred CCcc----ccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 561 NTTE----AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 561 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.... .....++ ..+.... ..........+...+.+++.+||+.||++|||+.|++++-
T Consensus 246 ~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 246 NDLRCIESPRAREYI-KSLPMYP-AAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp TTTTTCCCHHHHHHH-HTSCCCC-CCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ccccccccchhhHHh-hcccCCC-CcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 0000 0000000 0000000 0000011123456788999999999999999999999854
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=360.36 Aligned_cols=253 Identities=23% Similarity=0.374 Sum_probs=198.0
Q ss_pred HHHhhhhcccCCCeEEEEEEeCC----CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
.+.+.+.||+|+||+||+|++.. +..||||++.... ...+.+.+|+.++++++||||+++++++. .+..++||
T Consensus 391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~ 469 (656)
T 2j0j_A 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 469 (656)
T ss_dssp GEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred cEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEE
Confidence 34456789999999999998742 4679999987543 23467999999999999999999999985 45689999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 470 E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 470 ELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp ECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 999999999999753 23589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
... ......+|+.|+|||++... .++.++||||||+++|||++ |+.||..... ..+...+....
T Consensus 545 ~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~------------~~~~~~i~~~~ 609 (656)
T 2j0j_A 545 TYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKN------------NDVIGRIENGE 609 (656)
T ss_dssp ----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------HHHHHHHHHTC
T ss_pred cce-eccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCH------------HHHHHHHHcCC
Confidence 322 22334578899999999764 78899999999999999997 8888864321 11111111111
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
.... ...++..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 610 ~~~~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 610 RLPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111 1123457888999999999999999999999998654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=327.55 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=194.4
Q ss_pred HhhhhcccCCCeEEEEEEe--CCCcEEEEEEcccCC---cchHHHHHHHHHHhhc---ccceEEeecceEe-----cCCe
Q 005953 349 GFKEKLGTGGYGNVYKGKF--PDGRLVAVKVLEKTS---NFSDNFINEVATIGRI---HHVNIIHLLGFCC-----DGST 415 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~-----~~~~ 415 (667)
.+.+.||+|+||+||+|++ .+++.||+|++.... .....+.+|+.+++++ +||||+++++++. ....
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 93 (326)
T 1blx_A 14 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 93 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred eeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCce
Confidence 3568899999999999998 368899999986432 2234677888877777 7999999999987 5567
Q ss_pred eEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 416 RALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 416 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
.++||||++ |+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 94 LTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 899999997 79999987543 23589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh
Q 005953 496 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575 (667)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (667)
....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...... .....+...+
T Consensus 169 ~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~ 235 (326)
T 1blx_A 169 IYSFQMA---LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--------DQLGKILDVI 235 (326)
T ss_dssp CCCGGGG---GCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHH
T ss_pred cccCCCC---ccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHHHc
Confidence 7643321 2345689999999999764 6789999999999999999999999654320 0001111111
Q ss_pred cCcc------------------cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 576 IQPE------------------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 576 ~~~~------------------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
..+. ...........+...+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 0000111112345678889999999999999999999965
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.25 Aligned_cols=255 Identities=21% Similarity=0.308 Sum_probs=190.6
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCee------EEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTR------ALI 419 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~------~lV 419 (667)
+.+.||+|+||+||+|.+. +|+.||||++.... ...+.+.+|+.++++++||||+++++++...... ++|
T Consensus 46 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 125 (371)
T 4exu_A 46 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125 (371)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred EEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEE
Confidence 4578999999999999875 68999999997643 2346788999999999999999999999877655 999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||+. ++|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 126 ~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 126 MPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp EECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred Ecccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99996 68887773 2489999999999999999999998 999999999999999999999999999986543
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCC---------CCCc------c
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG---------SNTT------E 564 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~---------~~~~------~ 564 (667)
. .....||+.|+|||++.+. ..++.++||||||+++|||++|+.||........ .... .
T Consensus 197 ~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 197 E-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred C-----cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 2 2345689999999998753 4678999999999999999999999965431000 0000 0
Q ss_pred ccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 565 AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
..........+.... ..........+...+.+++.+||+.||++|||+.|++++-
T Consensus 271 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 271 DKAAKSYIQSLPQTP-RKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp CHHHHHHHHHSCCCC-CCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred hhhhhhhhhccCCCc-chhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 000000000000000 0000111112356788999999999999999999999764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=320.88 Aligned_cols=249 Identities=26% Similarity=0.346 Sum_probs=199.1
Q ss_pred HHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
..+.+.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 34556789999999999999986 6899999998643 2345789999999999999999999999999999999999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC---CceEEEeCCCccccC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD---FTPKVSDFGLAKAHS 498 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~---~~~ki~DFGla~~~~ 498 (667)
|+++++|.+++.... .+++..++.++.|++.||+|||+. +|+|+||||+||+++.+ +.+||+|||+++...
T Consensus 102 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 102 LYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999999886543 589999999999999999999998 99999999999999764 479999999998765
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
..... ....||+.|+|||.+.+ .++.++||||||+++|||++|+.||..... ..+...+...
T Consensus 176 ~~~~~---~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------~~~~~~~~~~ 237 (287)
T 2wei_A 176 QNTKM---KDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNE------------YDILKRVETG 237 (287)
T ss_dssp CCSSC---SCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHC
T ss_pred CCCcc---ccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHcC
Confidence 43322 22347899999999864 578899999999999999999999864321 1111111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
... ........++..+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 238 KYA-FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CCC-CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCC-CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 110 0111112335578899999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=331.38 Aligned_cols=197 Identities=24% Similarity=0.313 Sum_probs=167.3
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcc-cc-----eEEeecceEecCCeeEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HV-----NIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~-----niv~l~g~~~~~~~~~lV~ 420 (667)
+.+.++||+|+||+||+|+.. +++.||||+++......+++.+|+.+++.++ |+ +|+++++++...+..++||
T Consensus 56 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 135 (382)
T 2vx3_A 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVF 135 (382)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEE
Confidence 345678999999999999875 6889999999876555677888999988885 44 4999999999999999999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC--CCCceEEEeCCCccccC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD--PDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~--~~~~~ki~DFGla~~~~ 498 (667)
||++ |+|.+++.... ...+++..+..++.|++.||+|||++ +.+|+||||||+|||++ .++.+||+|||+++...
T Consensus 136 e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~ 212 (382)
T 2vx3_A 136 EMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212 (382)
T ss_dssp ECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred ecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence 9995 69999987643 23589999999999999999999953 34899999999999994 57889999999998764
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPT 554 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~ 554 (667)
... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 213 ~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 213 QRI-----YQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccc-----ccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 322 345689999999999764 6889999999999999999999999754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=326.69 Aligned_cols=261 Identities=21% Similarity=0.322 Sum_probs=188.0
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEe--------------c
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCC--------------D 412 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~--------------~ 412 (667)
.+.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|++++++++||||+++++++. +
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 93 (320)
T 2i6l_A 14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTE 93 (320)
T ss_dssp EEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCS
T ss_pred eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccc
Confidence 34578999999999999986 48999999987554 34567899999999999999999998873 4
Q ss_pred CCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC-CCCceEEEeC
Q 005953 413 GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSDF 491 (667)
Q Consensus 413 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~-~~~~~ki~DF 491 (667)
....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++ +++.+||+||
T Consensus 94 ~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 94 LNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccC
Confidence 467899999997 699998854 3588999999999999999999998 999999999999997 5679999999
Q ss_pred CCccccCCCCce-eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC--------CC
Q 005953 492 GLAKAHSRNRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--------NT 562 (667)
Q Consensus 492 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~--------~~ 562 (667)
|+++........ .......+|..|+|||.+... ..++.++||||||+++|||++|+.||......... ..
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999876432211 112234578999999998653 46788999999999999999999999754320000 00
Q ss_pred cc-------ccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 563 TE-------AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 563 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.. ...+..+......+. .........+...+.+++.+||+.||++|||+.|++++-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPH--KPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCC--CCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred chhhhhhhhhcCcccccccccCCC--CChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence 00 000000000000000 000011122456788999999999999999999999753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=337.96 Aligned_cols=251 Identities=23% Similarity=0.309 Sum_probs=185.0
Q ss_pred hhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 351 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+....++||||+. |+|.
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 3679999999998766668999999998653 245678999999987 89999999999999999999999995 7999
Q ss_pred ccccccccCC----CCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC-------------CceEEEeCC
Q 005953 430 DLLSREKENL----SLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-------------FTPKVSDFG 492 (667)
Q Consensus 430 ~~l~~~~~~~----~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~-------------~~~ki~DFG 492 (667)
+++....... ..++..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 9997543211 113334678999999999999998 99999999999999654 589999999
Q ss_pred CccccCCCCcee--eecCCCCCccccchhhhhhh-----cCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCcc
Q 005953 493 LAKAHSRNRSVV--TMTGPRGTIGYIAPEIFMRN-----LGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTE 564 (667)
Q Consensus 493 la~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 564 (667)
+++......... ......||+.|+|||++.+. ...++.++|||||||++|||++ |+.||......
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------- 246 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR------- 246 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-------
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-------
Confidence 998776543221 12345699999999999651 1467899999999999999999 89998543210
Q ss_pred ccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 565 AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
...+....... ..........+...+.+++.+||+.||++|||+.|++++
T Consensus 247 ---~~~i~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 ---ESNIIRGIFSL--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp ---HHHHHHTCCCC--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---HHHHhcCCCCc--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 01111111111 111111233456788999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=329.66 Aligned_cols=242 Identities=25% Similarity=0.331 Sum_probs=190.3
Q ss_pred HHHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc-------chHHHHHHHHHHhhc----ccceEEeecceEecC
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN-------FSDNFINEVATIGRI----HHVNIIHLLGFCCDG 413 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l----~h~niv~l~g~~~~~ 413 (667)
..+.+.+.||+|+||.||+|+.. +++.||||++..... ....+.+|+.++.++ +||||+++++++.+.
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 34556789999999999999874 689999999975432 223466799999999 899999999999999
Q ss_pred CeeEEEEEE-cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC-CCCceEEEeC
Q 005953 414 STRALIYEY-MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSDF 491 (667)
Q Consensus 414 ~~~~lV~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~-~~~~~ki~DF 491 (667)
+..++|+|+ +.+++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++ +++.+||+||
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEc
Confidence 999999999 78999999997643 589999999999999999999998 999999999999999 8899999999
Q ss_pred CCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHH
Q 005953 492 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWI 571 (667)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 571 (667)
|+++...... .....|+..|+|||++.+. ...+.++||||||+++|||++|+.||..... +
T Consensus 185 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------------~ 245 (312)
T 2iwi_A 185 GSGALLHDEP----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE--------------I 245 (312)
T ss_dssp SSCEECCSSC----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------H
T ss_pred chhhhcccCc----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH--------------H
Confidence 9998765432 2345689999999998764 2335589999999999999999999853211 1
Q ss_pred HHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 572 YDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 572 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
...... . ...+...+.+++.+||+.||++|||+.|++++--
T Consensus 246 ~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 246 LEAELH-----F----PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp HHTCCC-----C----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred hhhccC-----C----cccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 111000 0 1112446788999999999999999999998654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=325.33 Aligned_cols=261 Identities=17% Similarity=0.257 Sum_probs=196.4
Q ss_pred HHhhhhcccCCCeEEEEEEeC-C-CcEEEEEEcccCCcchHHHHHHHHHHhhcccce------EEeecceEecCCeeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-D-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN------IIHLLGFCCDGSTRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~g~~~~~~~~~lV 419 (667)
+.+.+.||+|+||+||+|... + ++.||||+++......+.+.+|+.++++++|++ ++.+++++......++|
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv 100 (355)
T 2eu9_A 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIA 100 (355)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred EEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEE
Confidence 345688999999999999874 3 478999999876556678889999999998876 89999999999999999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEE-------------------
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLL------------------- 480 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll------------------- 480 (667)
|||+ +++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 101 ~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 101 FELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred Eecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccccc
Confidence 9999 677777775432 24589999999999999999999998 99999999999999
Q ss_pred CCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC
Q 005953 481 DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS 560 (667)
Q Consensus 481 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~ 560 (667)
+.++.+||+|||+++...... ....||+.|+|||++.+. .++.++||||||+++|||++|+.||.........
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp ESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 567899999999998654332 335689999999999753 7889999999999999999999999754321000
Q ss_pred C---CccccchHHHHHhhcCccc------------------------ccccchhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 005953 561 N---TTEAYFPDWIYDKLIQPEK------------------------EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSM 613 (667)
Q Consensus 561 ~---~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 613 (667)
. ......+............ ..............+.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 0 0000001100000000000 000000112235578899999999999999999
Q ss_pred HHHHHHH
Q 005953 614 TRVVEML 620 (667)
Q Consensus 614 ~evl~~L 620 (667)
.|++++-
T Consensus 329 ~e~l~hp 335 (355)
T 2eu9_A 329 AEALLHP 335 (355)
T ss_dssp HHHTTSG
T ss_pred HHHhcCh
Confidence 9998653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=327.04 Aligned_cols=255 Identities=21% Similarity=0.306 Sum_probs=190.3
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCe------eEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGST------RALI 419 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~------~~lV 419 (667)
+.+.||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.++++++||||+++++++..... .++|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 107 (353)
T 3coi_A 28 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107 (353)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred EeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEE
Confidence 4578999999999999885 68999999987543 224678899999999999999999999987654 4999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||+. |+|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 108 ~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 108 MPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp EECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred ecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 99996 688887742 489999999999999999999998 999999999999999999999999999986543
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC----ccccchHH-----
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT----TEAYFPDW----- 570 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~----~~~~~~~~----- 570 (667)
. .....||+.|+|||++.+. ..++.++||||||+++|||++|+.||........... .......+
T Consensus 179 ~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 179 E-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp ----------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred C-----ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 2 2345689999999998753 4678899999999999999999999965421000000 00000000
Q ss_pred ------HHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 571 ------IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 571 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
....+.. ............+...+.+++.+||+.||++|||+.|++++-
T Consensus 253 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 253 DKAAKSYIQSLPQ-TPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp CHHHHHHHHTSCB-CSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred hHHHHHHHHhCcC-CCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 0000000 000001111123456788999999999999999999999763
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=328.21 Aligned_cols=261 Identities=20% Similarity=0.277 Sum_probs=196.4
Q ss_pred HHHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcc-----------cceEEeecceEecCC
Q 005953 347 TNGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-----------HVNIIHLLGFCCDGS 414 (667)
Q Consensus 347 ~~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~g~~~~~~ 414 (667)
.+.+.+.||+|+||+||+|+.. +++.||||++.......+.+.+|+.++++++ |+||+++++++....
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~ 99 (373)
T 1q8y_A 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 99 (373)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccC
Confidence 3456689999999999999974 6899999999876555678889999999886 899999999988654
Q ss_pred ----eeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC------CCC
Q 005953 415 ----TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD------PDF 484 (667)
Q Consensus 415 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~------~~~ 484 (667)
..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||++ .+|+||||||+|||++ ..+
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 100 PNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp TTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcCcc
Confidence 788999999 899999997643 33589999999999999999999983 2899999999999994 445
Q ss_pred ceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCcc
Q 005953 485 TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTE 564 (667)
Q Consensus 485 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~ 564 (667)
.+||+|||+++..... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||........... .
T Consensus 176 ~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~-~ 247 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD-D 247 (373)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CH-H
T ss_pred eEEEcccccccccCCC-----CCCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh-H
Confidence 8999999999876432 2334689999999999764 678999999999999999999999975432110000 0
Q ss_pred ccchHHHHHhhcCc-----------------------ccc----------cccchhhHHHHHHHHHHHHHhcccCCCCCC
Q 005953 565 AYFPDWIYDKLIQP-----------------------EKE----------DFVEEEDDCIARKMIIVGLWCIQINPKDRP 611 (667)
Q Consensus 565 ~~~~~~~~~~~~~~-----------------------~~~----------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 611 (667)
... ..+...+... ... .............+.+++.+||+.||++||
T Consensus 248 ~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 248 DHI-AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHH-HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHH-HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 000 0000000000 000 000012245677899999999999999999
Q ss_pred CHHHHHHHH
Q 005953 612 SMTRVVEML 620 (667)
Q Consensus 612 t~~evl~~L 620 (667)
|+.|++++-
T Consensus 327 t~~ell~hp 335 (373)
T 1q8y_A 327 DAGGLVNHP 335 (373)
T ss_dssp CHHHHHTCG
T ss_pred CHHHHhhCh
Confidence 999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=328.22 Aligned_cols=239 Identities=26% Similarity=0.341 Sum_probs=193.7
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc-------chHHHHHHHHHHhhcc--cceEEeecceEecCCeeE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN-------FSDNFINEVATIGRIH--HVNIIHLLGFCCDGSTRA 417 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~~~~~~ 417 (667)
+.+.+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+.++++++ |+||+++++++.+.+..+
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~ 124 (320)
T 3a99_A 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 124 (320)
T ss_dssp EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEE
Confidence 345688999999999999874 689999999865421 2245778999999996 599999999999999999
Q ss_pred EEEEEcCC-CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC-CCCceEEEeCCCcc
Q 005953 418 LIYEYMPN-GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSDFGLAK 495 (667)
Q Consensus 418 lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~-~~~~~ki~DFGla~ 495 (667)
+|+|++.+ ++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++ +++.+||+|||+++
T Consensus 125 lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 125 LILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp EEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999976 8999998753 3589999999999999999999998 999999999999999 78999999999998
Q ss_pred ccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh
Q 005953 496 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575 (667)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (667)
...... .....||+.|+|||++... ...+.++||||||+++|||++|+.||..... ......
T Consensus 199 ~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------------~~~~~~ 260 (320)
T 3a99_A 199 LLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQV 260 (320)
T ss_dssp ECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHCCC
T ss_pred cccccc----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh-------------hhcccc
Confidence 765432 2335689999999998764 3346789999999999999999999853211 000000
Q ss_pred cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
... ..+...+.+++.+||+.||++|||+.|++++-
T Consensus 261 ---~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp 295 (320)
T 3a99_A 261 ---FFR-------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295 (320)
T ss_dssp ---CCS-------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred ---ccc-------ccCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 000 11245678899999999999999999999754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.90 Aligned_cols=247 Identities=21% Similarity=0.291 Sum_probs=168.7
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHH-HHhhcccceEEeecceEec----CCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVA-TIGRIHHVNIIHLLGFCCD----GSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~----~~~~~lV~e~~~~ 425 (667)
+.||+|+||+||+|++. +++.||||++..... ..+|+. .++.++||||+++++++.. +...++||||+++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~g 110 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTT
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCC
Confidence 46999999999999986 689999999875432 233333 4556689999999999876 4458999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC---CCceEEEeCCCccccCCCCc
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~---~~~~ki~DFGla~~~~~~~~ 502 (667)
|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 111 g~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~- 185 (336)
T 3fhr_A 111 GELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA- 185 (336)
T ss_dssp EEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred CCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccccc-
Confidence 99999997643 34689999999999999999999998 9999999999999976 4569999999998664332
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
.....||+.|+|||++.. ..++.++||||||+++|||++|+.||........ .......+..... .
T Consensus 186 ---~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~~~~~~-~ 251 (336)
T 3fhr_A 186 ---LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI--------SPGMKRRIRLGQY-G 251 (336)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------C
T ss_pred ---cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh--------hhhHHHhhhcccc-c
Confidence 133457999999999854 3667899999999999999999999965432110 0000001111000 0
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
........+...+.+++.+||+.||++|||+.|++++--
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 111111223557888999999999999999999998654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.35 Aligned_cols=253 Identities=21% Similarity=0.307 Sum_probs=174.9
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHH-HHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVA-TIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.||+|+||.||+|+.. +++.||||++.... ....++..|+. +++.++||||+++++++.+.+..++||||++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~- 104 (327)
T 3aln_A 26 DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS- 104 (327)
T ss_dssp C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred ehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC-
Confidence 4578999999999999985 68999999997653 23345666766 7777899999999999999999999999997
Q ss_pred CCcccccccc--ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 426 GSLGDLLSRE--KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 426 gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
|+|.+++... .....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 105 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 181 (327)
T 3aln_A 105 TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA- 181 (327)
T ss_dssp EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc-
Confidence 5888877531 1235689999999999999999999973 3899999999999999999999999999987654322
Q ss_pred eeecCCCCCccccchhhhhh--hcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMR--NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~--~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
.....||+.|+|||++.. ....++.++||||||+++|||++|+.||........ ....+......
T Consensus 182 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----------~~~~~~~~~~~ 248 (327)
T 3aln_A 182 --KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----------QLTQVVKGDPP 248 (327)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCCCSCCC
T ss_pred --cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----------HHHHHhcCCCC
Confidence 123458999999999842 124678899999999999999999999865321100 00111111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.........+...+.+++.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 11111111234578889999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=334.66 Aligned_cols=248 Identities=23% Similarity=0.269 Sum_probs=182.0
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
..+.||+|+||+||.....+++.||||++..... ..+.+|+.+++++ +||||+++++++.+....++||||+. |+|
T Consensus 28 ~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L 104 (432)
T 3p23_A 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATL 104 (432)
T ss_dssp EEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred cCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCH
Confidence 4578999999996655455899999999865432 3356899999999 79999999999999999999999995 699
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC-----CCceEEEeCCCccccCCCCce
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-----DFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~-----~~~~ki~DFGla~~~~~~~~~ 503 (667)
.+++..... ...+..++.++.|++.||+|||+. +|+||||||+|||++. ...+||+|||+++........
T Consensus 105 ~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 105 QEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp HHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred HHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 999875432 244445678999999999999998 9999999999999943 346889999999876543321
Q ss_pred -eeecCCCCCccccchhhhhhh-cCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 504 -VTMTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 504 -~~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
.......||+.|+|||++... ...++.++|||||||++|||++ |+.||..... ............
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~------------~~~~~~~~~~~~ 247 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ------------RQANILLGACSL 247 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT------------HHHHHHTTCCCC
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH------------HHHHHHhccCCc
Confidence 223446799999999998642 2466789999999999999999 8888743211 011111111111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
... .........+.+++.+||+.||++|||+.||+++
T Consensus 248 ~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 248 DCL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TTS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 111 1112234567789999999999999999999954
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.16 Aligned_cols=248 Identities=21% Similarity=0.329 Sum_probs=174.0
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcc--hHH-HHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNF--SDN-FINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~-~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.||+|+||.||+|++. +++.||||++...... ..+ +.++..+++.++||||+++++++.+.+..++||||+ +
T Consensus 29 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 107 (318)
T 2dyl_A 29 NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-G 107 (318)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred ccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-C
Confidence 4578999999999999985 6899999999765422 223 344445677889999999999999999999999999 4
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+.+..+.... ...+++..+..++.|++.||+|||+ . +|+|+||||+|||++.++.+||+|||+++.......
T Consensus 108 ~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 180 (318)
T 2dyl_A 108 TCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA-- 180 (318)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred CcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc--
Confidence 5555544332 2458999999999999999999997 5 899999999999999999999999999976644322
Q ss_pred eecCCCCCccccchhhhhh---hcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 505 TMTGPRGTIGYIAPEIFMR---NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~---~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
.....||+.|+|||++.. ....++.++||||||+++|||++|+.||..... .......+......
T Consensus 181 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~~~~~~~~~~~~~~ 248 (318)
T 2dyl_A 181 -KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----------DFEVLTKVLQEEPP 248 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-----------HHHHHHHHHHSCCC
T ss_pred -ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----------cHHHHHHHhccCCC
Confidence 123458999999999853 124678899999999999999999999864321 01111111111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
... ....+...+.+++.+||+.||++||++.|++++
T Consensus 249 ~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 249 LLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 110 001134568889999999999999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=347.05 Aligned_cols=261 Identities=23% Similarity=0.317 Sum_probs=194.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEec------CCeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCD------GSTRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------~~~~~l 418 (667)
+.+.++||+|+||+||+|.+. +|+.||||++.... ...+.+.+|++++++++||||+++++++.. ++..++
T Consensus 16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~L 95 (676)
T 3qa8_A 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL 95 (676)
T ss_dssp -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEE
Confidence 456789999999999999884 68999999987643 334678999999999999999999998765 677899
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCc---eEEEeCCCcc
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFT---PKVSDFGLAK 495 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~---~ki~DFGla~ 495 (667)
||||+++|+|.+++........+++..++.|+.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++
T Consensus 96 VmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 96 AMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp EEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 999999999999998755445688999999999999999999998 9999999999999987664 9999999998
Q ss_pred ccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC--CCccccchHHHHH
Q 005953 496 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS--NTTEAYFPDWIYD 573 (667)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~ 573 (667)
....... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......... .............
T Consensus 173 ~~~~~~~---~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 173 ELDQGEL---CTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp BTTSCCC---CCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccccc---cccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 7654432 234568999999999865 47889999999999999999999999653210000 0000000000000
Q ss_pred hhcCc-----ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005953 574 KLIQP-----EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRV 616 (667)
Q Consensus 574 ~~~~~-----~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev 616 (667)
....+ ............+...+.+++.+||+.||++|||+.|+
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 00000 00001111223356788999999999999999999773
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=308.05 Aligned_cols=229 Identities=14% Similarity=0.120 Sum_probs=179.9
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc----chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
|.+.+.||+|+||.||+|++. +++.||||++..... ..+.+.+|+..+.+++||||+++++++.+.+..++||||
T Consensus 33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 112 (286)
T 3uqc_A 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEW 112 (286)
T ss_dssp EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEe
Confidence 445688999999999999986 489999999976533 236799999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++++|.+++.+. .....+.+|+.|++.||+|||+. +|+||||||+|||+++++.+||+++|
T Consensus 113 ~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 113 IRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp CCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred cCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 9999999998532 35567889999999999999998 99999999999999999999997443
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
|++ .++.++||||||+++|||++|+.||......... .... .. ..... .
T Consensus 175 ------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~---~~~~-----~~-~~~~~-~ 223 (286)
T 3uqc_A 175 ------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL---APAE-----RD-TAGQP-I 223 (286)
T ss_dssp ------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS---EECC-----BC-TTSCB-C
T ss_pred ------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh---HHHH-----HH-hccCC-C
Confidence 333 3567999999999999999999999765431100 0000 00 00000 0
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
........+...+.+++.+||+.||++| |+.|+++.|+++...
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0001112235578899999999999999 999999999976554
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=341.71 Aligned_cols=234 Identities=21% Similarity=0.294 Sum_probs=187.6
Q ss_pred HhhhhcccCCCeEEEEEEeC--CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCe-----eEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP--DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGST-----RALI 419 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~-----~~lV 419 (667)
.+.++||+|+||+||+|.+. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+. .++|
T Consensus 83 ~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv 162 (681)
T 2pzi_A 83 EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIV 162 (681)
T ss_dssp EEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEE
Confidence 35678999999999999985 58999999987543 334578899999999999999999999987655 6999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||+++++|.+++.. .+++..++.|+.||+.||+|||++ +|+||||||+|||++.+ .+||+|||+++....
T Consensus 163 ~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 163 MEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred EEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 999999999988744 589999999999999999999998 99999999999999986 999999999987654
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
. ....||+.|+|||++.+. .+.++||||||+++|||++|..|+....... .+
T Consensus 234 ~------~~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------~~----------- 285 (681)
T 2pzi_A 234 F------GYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------LP----------- 285 (681)
T ss_dssp C------SCCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------CC-----------
T ss_pred C------CccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCccccccc--------cc-----------
Confidence 3 234589999999998653 4889999999999999999988775321100 00
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhc
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRP-SMTRVVEMLSSA 623 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~evl~~L~~~ 623 (667)
...........+.+++.+||+.||++|| +++++.+.|...
T Consensus 286 ----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 ----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0011112345688899999999999999 566677766644
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=303.12 Aligned_cols=227 Identities=19% Similarity=0.258 Sum_probs=175.8
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHH-hhcccceEEeecceEec----CCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATI-GRIHHVNIIHLLGFCCD----GSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l-~~l~h~niv~l~g~~~~----~~~~~lV~e~~~~ 425 (667)
+.||+|+||.||++... +++.||+|++.. ...+.+|+.++ +..+||||+++++++.. ....++||||+++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 99 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 99 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence 67999999999999884 689999999864 34677899888 45589999999999876 6678999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC---CCceEEEeCCCccccCCCCc
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~---~~~~ki~DFGla~~~~~~~~ 502 (667)
|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 100 ~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~--- 172 (299)
T 3m2w_A 100 GELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG--- 172 (299)
T ss_dssp CBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT---
T ss_pred CcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccccccc---
Confidence 99999997643 34689999999999999999999998 9999999999999998 78999999999864321
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
..++.++||||||+++|||++|+.||............. ..+... ...
T Consensus 173 -----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~--------~~~~~~-~~~ 220 (299)
T 3m2w_A 173 -----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIRMG-QYE 220 (299)
T ss_dssp -----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC--------CSSCTT-CCS
T ss_pred -----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH--------HHHhhc-ccc
Confidence 245678999999999999999999996543211000000 000000 001
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
........+...+.+++.+||+.||++|||+.|++++--
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 111111234567889999999999999999999998643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=318.03 Aligned_cols=237 Identities=16% Similarity=0.133 Sum_probs=173.5
Q ss_pred hhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhccc-ceE---------------Eeec--
Q 005953 351 KEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHH-VNI---------------IHLL-- 407 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h-~ni---------------v~l~-- 407 (667)
.++||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.+++.++| +|. +.+.
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 467999999999999964 69999999987432 235779999999999976 221 1111
Q ss_pred ----ceEec-----CCeeEEEEEEcCCCCcccccccc----ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCC
Q 005953 408 ----GFCCD-----GSTRALIYEYMPNGSLGDLLSRE----KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIK 474 (667)
Q Consensus 408 ----g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dik 474 (667)
.+... ....+++|+++ +++|.+++... .....+++..++.++.|+++||+|||+. +|+|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiK 238 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLR 238 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcc
Confidence 11111 12355666655 78999988521 1233577889999999999999999998 99999999
Q ss_pred CCcEEECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhh--------cCCCCCcccHHHHHHHHHHHHh
Q 005953 475 PQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN--------LGNPSGKSDVYSYGMLLLEMIE 546 (667)
Q Consensus 475 p~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~s~k~DvwSlGvvl~ellt 546 (667)
|+||||+.++.+||+|||+++..... .....| +.|+|||++... ...++.++|||||||++|||++
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred cceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 99999999999999999998765432 244567 999999999422 1246779999999999999999
Q ss_pred CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 005953 547 EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618 (667)
Q Consensus 547 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 618 (667)
|+.||....... . ...+..... .++..+.+++.+||+.||++||++.|+++
T Consensus 313 g~~Pf~~~~~~~---~---------~~~~~~~~~---------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 313 ADLPNTDDAALG---G---------SEWIFRSCK---------NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp SSCCCCTTGGGS---C---------SGGGGSSCC---------CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcchhh---h---------HHHHHhhcc---------cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999996543210 0 001111000 12356888999999999999999777753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=307.50 Aligned_cols=240 Identities=15% Similarity=0.133 Sum_probs=181.1
Q ss_pred HHHHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC---------cchHHHHHHHHHHhhcc---------c-------
Q 005953 346 MTNGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---------NFSDNFINEVATIGRIH---------H------- 400 (667)
Q Consensus 346 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~---------~~~~~~~~Ei~~l~~l~---------h------- 400 (667)
..+.+.++||+|+||+||+|++ +|+.||||++.... ...+.+.+|+.++++++ |
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 3456678999999999999998 78999999997542 22377899999999886 4
Q ss_pred ----------ceEEeecceEec-------------CCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHH
Q 005953 401 ----------VNIIHLLGFCCD-------------GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAI 457 (667)
Q Consensus 401 ----------~niv~l~g~~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl 457 (667)
|||+++++++.+ ....++||||+++|++.+.+.+ ..+++..+..|+.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 555555555443 6789999999999977776643 3589999999999999999
Q ss_pred HHHH-cCCCCCeeecCCCCCcEEECCCC--------------------ceEEEeCCCccccCCCCceeeecCCCCCcccc
Q 005953 458 EYLH-NGCELRILHLDIKPQNVLLDPDF--------------------TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 516 (667)
Q Consensus 458 ~yLH-~~~~~~ivH~Dikp~NIll~~~~--------------------~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~ 516 (667)
+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~ 244 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTT
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeeccc
Confidence 9999 87 999999999999999887 8999999999876532 124899999
Q ss_pred chhhhhhhcCCCCCcccHHHHHHH-HHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc-c-cccccchhhHHHHH
Q 005953 517 APEIFMRNLGNPSGKSDVYSYGML-LLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP-E-KEDFVEEEDDCIAR 593 (667)
Q Consensus 517 aPE~~~~~~~~~s~k~DvwSlGvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~ 593 (667)
|||++.+. .+.++||||+|++ .+++++|..||... .......+.+... . ...........+..
T Consensus 245 aPE~~~g~---~~~~~Diwsl~~~~~~~~~~g~~p~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 245 DEDLFTGD---GDYQFDIYRLMKKENNNRWGEYHPYSNV-----------LWLHYLTDKMLKQMTFKTKCNTPAMKQIKR 310 (336)
T ss_dssp CSGGGCCC---SSHHHHHHHHHHHHHTTCTTSCCTHHHH-----------HHHHHHHHHHHHTCCCSSCCCSHHHHHHHH
T ss_pred ChhhhcCC---CccceehhhhhCCCCcccccccCCCcch-----------hhhhHHHHhhhhhhccCcccchhhhhhcCH
Confidence 99999754 3789999998777 77788887776311 0001111121111 1 11122233456788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHH-HH
Q 005953 594 KMIIVGLWCIQINPKDRPSMTRVV-EM 619 (667)
Q Consensus 594 ~l~~l~~~cl~~~P~~RPt~~evl-~~ 619 (667)
.+.+++.+||+.| |++|++ ++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHHhccC-----CHHHHHhcC
Confidence 9999999999976 999988 53
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-30 Score=287.19 Aligned_cols=183 Identities=16% Similarity=0.134 Sum_probs=128.9
Q ss_pred hcccCCCeEEEEEEe-CCCcEEEEEEcccCC-----------cchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEE
Q 005953 353 KLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-----------NFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----------~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV 419 (667)
.++.|+.|.+..++. --|+.+|+|++.... ...++|.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456777776666533 258899999986542 1235799999999999 699999999999999999999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
|||++|++|.++|.+.. .++.. +|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999997643 45554 5889999999999998 999999999999999999999999999987654
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCC
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK 549 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~ 549 (667)
.... .....||+.|||||++.+ ....++|+||+|+++++|.++..
T Consensus 392 ~~~~--~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DCSW--PTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp --CC--SHHHHHHHHHHHHHHC--------------------CCCCTTHH
T ss_pred CCcc--ccCceechhhccHHHhCC---CCCCcccccccccchhhhccccc
Confidence 4322 234568999999999975 45678999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.1e-27 Score=259.96 Aligned_cols=184 Identities=18% Similarity=0.229 Sum_probs=145.1
Q ss_pred hhhcccCCCeEEEEEEeCCCcEEEEEEcccCCc---------chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 351 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN---------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
.++||+|+||+||+|+. .++.+++|+...... ..+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999965 678888887643221 12458999999999999999977777777888899999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++.. +..++.|+++||+|||++ +|+||||||+|||+++ .+||+|||+++......
T Consensus 420 ~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 420 YINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp CCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred CCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 9999999999865 458999999999999998 9999999999999998 99999999999875532
Q ss_pred cee-----eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCC
Q 005953 502 SVV-----TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHL 551 (667)
Q Consensus 502 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~ 551 (667)
... ......||+.|||||++......++.++|+|+..+-.++.+.++.++
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 211 01234589999999999764335677889999999999988776554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.4e-23 Score=209.24 Aligned_cols=140 Identities=16% Similarity=0.091 Sum_probs=115.7
Q ss_pred hhhcccCCCeEEEEEEeCCCcEEEEEEcccCCc-------------------chHHHHHHHHHHhhcccceEEeecceEe
Q 005953 351 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN-------------------FSDNFINEVATIGRIHHVNIIHLLGFCC 411 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-------------------~~~~~~~Ei~~l~~l~h~niv~l~g~~~ 411 (667)
.+.||+|+||.||+|.+.+|+.||||+++.... ....+.+|+.++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 378999999999999997799999999864321 2356889999999999 5 67777554
Q ss_pred cCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeC
Q 005953 412 DGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDF 491 (667)
Q Consensus 412 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DF 491 (667)
. +..++||||+++|+|.+ +.. .....++.|++.||+|||+. +|+||||||+|||++ ++.+||+||
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCC
T ss_pred c-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 3 56799999999999998 422 12347999999999999998 999999999999999 999999999
Q ss_pred CCccccCCCCceeeecCCCCCccccchhhhhh
Q 005953 492 GLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523 (667)
Q Consensus 492 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 523 (667)
|+|+. +..++|||++.+
T Consensus 237 G~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 237 PQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp TTCEE---------------TTSTTHHHHHHH
T ss_pred CCCeE---------------CCCCCHHHHHHH
Confidence 99863 345789999854
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.6e-19 Score=181.76 Aligned_cols=133 Identities=20% Similarity=0.224 Sum_probs=102.3
Q ss_pred hhhhcccCCCeEEEEEEe-CCCcE--EEEEEcccCCcc-------------------------hHHHHHHHHHHhhcccc
Q 005953 350 FKEKLGTGGYGNVYKGKF-PDGRL--VAVKVLEKTSNF-------------------------SDNFINEVATIGRIHHV 401 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~~-------------------------~~~~~~Ei~~l~~l~h~ 401 (667)
+.+.||+|+||.||+|.+ .+|+. ||||+++..... ...+.+|+..|.+++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 446899999999999998 67888 999987543211 12578999999999887
Q ss_pred eE--EeecceEecCCeeEEEEEEcCC-C----CccccccccccCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeeecCC
Q 005953 402 NI--IHLLGFCCDGSTRALIYEYMPN-G----SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH-NGCELRILHLDI 473 (667)
Q Consensus 402 ni--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH-~~~~~~ivH~Di 473 (667)
++ +.++.. ...+|||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+||||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHrDl 197 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHADL 197 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSC
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCC
Confidence 54 333332 356899999942 5 44443321 123456789999999999999 87 9999999
Q ss_pred CCCcEEECCCCceEEEeCCCcccc
Q 005953 474 KPQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 474 kp~NIll~~~~~~ki~DFGla~~~ 497 (667)
||+|||+++ .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=5.3e-17 Score=169.94 Aligned_cols=137 Identities=12% Similarity=0.106 Sum_probs=95.8
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC---------------cchHHHHHHHHHHhhcccceEEeecceEec-
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---------------NFSDNFINEVATIGRIHHVNIIHLLGFCCD- 412 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~---------------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~- 412 (667)
.+.+.||+|+||.||+|...+|+.||||+++... ........++++.....|+|+++++.....
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v 177 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV 177 (397)
T ss_dssp EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 3457899999999999999899999999875321 011122233333333334444444322111
Q ss_pred -----CCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC---
Q 005953 413 -----GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF--- 484 (667)
Q Consensus 413 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~--- 484 (667)
....+|||||+++++|.++.... ....++.|++.+|.|||+. +||||||||.|||+++++
T Consensus 178 p~p~~~~~~~LVME~i~G~~L~~l~~~~---------~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 178 PEPIAQSRHTIVMSLVDALPMRQVSSVP---------DPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CCEEEEETTEEEEECCSCEEGGGCCCCS---------CHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSS
T ss_pred CeeeeccCceEEEEecCCccHhhhcccH---------HHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCcc
Confidence 11236999999998887765321 2346789999999999998 999999999999998876
Q ss_pred -------ceEEEeCCCcccc
Q 005953 485 -------TPKVSDFGLAKAH 497 (667)
Q Consensus 485 -------~~ki~DFGla~~~ 497 (667)
.+.|+||+-+...
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 3899999977543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=1.7e-11 Score=123.21 Aligned_cols=135 Identities=14% Similarity=0.073 Sum_probs=106.0
Q ss_pred hhhcccCCCeEEEEEEeCCCcEEEEEEcccCC-cchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 351 KEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-NFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 351 ~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
...++.|+.+.||+... +++.+++|+..... .....+.+|+.+++.+. +..+.+++++..+.+..++||||++|.+|
T Consensus 19 ~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 97 (263)
T 3tm0_A 19 VKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLC 97 (263)
T ss_dssp EECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEH
T ss_pred EeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeeh
Confidence 35677788899999986 46889999986421 22346889999999984 67788899999888899999999999988
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------------
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC-------------------------------------------- 464 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~-------------------------------------------- 464 (667)
.+.+.. ......++.+++++|+.||+..
T Consensus 98 ~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 98 SEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp HHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred hhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 775321 1123468889999999999810
Q ss_pred ------------CCCeeecCCCCCcEEECCCCceEEEeCCCc
Q 005953 465 ------------ELRILHLDIKPQNVLLDPDFTPKVSDFGLA 494 (667)
Q Consensus 465 ------------~~~ivH~Dikp~NIll~~~~~~ki~DFGla 494 (667)
...++|+|+++.||+++++..+.|+||+.+
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 135899999999999987666789999876
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=1.1e-10 Score=116.81 Aligned_cols=130 Identities=17% Similarity=0.120 Sum_probs=98.3
Q ss_pred hcc-cCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccce--EEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 353 KLG-TGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN--IIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 353 ~LG-~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
.++ .|..+.||+....+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++...++..++||||++|.+|.
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 344 55569999998877888999997654 2356788999999996444 556888888777899999999998884
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------------
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC--------------------------------------------- 464 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~--------------------------------------------- 464 (667)
... .+ ...++.++++.|+.||+..
T Consensus 104 --~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 --SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp --TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred --cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 11 1256778888888888642
Q ss_pred ----------CCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 465 ----------ELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 465 ----------~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
...++|+|++|.||+++++..++|+|||.+.
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999887667899999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=5.4e-10 Score=117.65 Aligned_cols=139 Identities=19% Similarity=0.257 Sum_probs=106.0
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcc--cCC--cchHHHHHHHHHHhhcc--cceEEeecceEecC---CeeEEEEEE
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLE--KTS--NFSDNFINEVATIGRIH--HVNIIHLLGFCCDG---STRALIYEY 422 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~--~~~--~~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~~---~~~~lV~e~ 422 (667)
+.|+.|.++.||+.... +..+++|+.. ... .....+.+|+.+++.+. +..+.++++++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 56899999999999875 4678888776 332 22356788999999996 45688888888766 458999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC-------------------------------------- 464 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~-------------------------------------- 464 (667)
++|..+.+.. ...++......++.++++.|+.||+..
T Consensus 123 v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 123 VSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred cCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 9988875522 123678888899999999999999731
Q ss_pred -----------------CCCeeecCCCCCcEEECCCCc--eEEEeCCCccc
Q 005953 465 -----------------ELRILHLDIKPQNVLLDPDFT--PKVSDFGLAKA 496 (667)
Q Consensus 465 -----------------~~~ivH~Dikp~NIll~~~~~--~ki~DFGla~~ 496 (667)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999987753 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=1.3e-09 Score=112.00 Aligned_cols=187 Identities=18% Similarity=0.161 Sum_probs=120.6
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcc-cce--EEeecceEecCC---eeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVN--IIHLLGFCCDGS---TRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~n--iv~l~g~~~~~~---~~~lV~e~~~~ 425 (667)
+.++.|....||+.. +.+++|+.... .....+.+|.++|+.+. +.. +.+++....... ..++|||+++|
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458899999999864 45788885532 33467889999998883 322 334444433332 35889999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcC------------------------------------------
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG------------------------------------------ 463 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~------------------------------------------ 463 (667)
.+|.+... ..++..+...++.++++.|+.||+.
T Consensus 101 ~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 101 VPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp EECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred eECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 88865332 1366777788888888888888861
Q ss_pred -------------CCCCeeecCCCCCcEEECC--CCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhh---hhc
Q 005953 464 -------------CELRILHLDIKPQNVLLDP--DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM---RNL 525 (667)
Q Consensus 464 -------------~~~~ivH~Dikp~NIll~~--~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~ 525 (667)
..+.++|+|+++.||++++ +..+.|+||+.+.............. ...-..|+... ..+
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~---~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLME---DDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCC---TTTSCCHHHHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHh---hccccCHHHHHHHHHHc
Confidence 1135899999999999988 56689999999865432211110000 00002222211 111
Q ss_pred CCC---------CCcccHHHHHHHHHHHHhCCCCC
Q 005953 526 GNP---------SGKSDVYSYGMLLLEMIEEKKHL 551 (667)
Q Consensus 526 ~~~---------s~k~DvwSlGvvl~elltg~~p~ 551 (667)
+.. ....+.|++|.++|++.+|+.++
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 11258999999999999987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=1.2e-06 Score=87.87 Aligned_cols=134 Identities=15% Similarity=0.155 Sum_probs=95.9
Q ss_pred hcccCCCe-EEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 353 KLGTGGYG-NVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 353 ~LG~G~fg-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
.+..|..| .||+.... ++..+++|+-... ...++.+|...|+.+. +--+.++++++.+.+..++|||++++.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34556555 69998765 4677889986532 3467888999998884 444677888888889999999999988876
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------------
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC--------------------------------------------- 464 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~--------------------------------------------- 464 (667)
+..... ......++.++++.|+-||...
T Consensus 109 ~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 109 QVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 654321 1122345566666666666321
Q ss_pred ----------CCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 465 ----------ELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 465 ----------~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
...++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999988778899999764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=2e-06 Score=88.05 Aligned_cols=135 Identities=19% Similarity=0.148 Sum_probs=92.2
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccc---eEEeecceEe-cCCeeEEEEEEcCCCC
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV---NIIHLLGFCC-DGSTRALIYEYMPNGS 427 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~g~~~-~~~~~~lV~e~~~~gs 427 (667)
+.++.|....||+. ++.+++|+... ......+.+|.++|+.+.+. .+.+++.+.. ..+..++|||+++|.+
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 45788888899988 45678887432 23346788999999999642 3555666653 4456789999999888
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------------------------
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG-------------------------------------------- 463 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~-------------------------------------------- 463 (667)
|.+... ..++......++.++++.|+.||+.
T Consensus 100 l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 100 LGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp CHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred Cchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 765321 1234444555555555555555532
Q ss_pred -------------CCCCeeecCCCCCcEEECC---CCc-eEEEeCCCccc
Q 005953 464 -------------CELRILHLDIKPQNVLLDP---DFT-PKVSDFGLAKA 496 (667)
Q Consensus 464 -------------~~~~ivH~Dikp~NIll~~---~~~-~ki~DFGla~~ 496 (667)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 455 58999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=2.2e-06 Score=89.70 Aligned_cols=80 Identities=11% Similarity=0.044 Sum_probs=57.2
Q ss_pred hhc-ccCCCeEEEEEEeC-------CCcEEEEEEcccCC---c-chHHHHHHHHHHhhcc-c--ceEEeecceEecC---
Q 005953 352 EKL-GTGGYGNVYKGKFP-------DGRLVAVKVLEKTS---N-FSDNFINEVATIGRIH-H--VNIIHLLGFCCDG--- 413 (667)
Q Consensus 352 ~~L-G~G~fg~Vy~~~~~-------~~~~vavK~l~~~~---~-~~~~~~~Ei~~l~~l~-h--~niv~l~g~~~~~--- 413 (667)
+.| +.|....+|+.... +++.+++|+..... . ....+.+|+.+++.+. + ..+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999998764 26678889865432 1 1246788999998885 3 3566778777655
Q ss_pred CeeEEEEEEcCCCCcccc
Q 005953 414 STRALIYEYMPNGSLGDL 431 (667)
Q Consensus 414 ~~~~lV~e~~~~gsL~~~ 431 (667)
+..++||||++|.++.+.
T Consensus 106 g~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp SSCEEEEECCCCBCCCBT
T ss_pred CCceEEEEecCCCChhhc
Confidence 357899999998887653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=1.4e-05 Score=82.84 Aligned_cols=140 Identities=13% Similarity=0.106 Sum_probs=81.4
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhccc--ceEEeecc------eEecCCeeEEEEEEc
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH--VNIIHLLG------FCCDGSTRALIYEYM 423 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~g------~~~~~~~~~lV~e~~ 423 (667)
+.|+.|..+.||+....+| .+++|+.... ..+...|+.+++.+.. -.+.+++. +....+..++|+||+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 3466677899999987555 4889988753 2344556666666642 12333433 123456788999999
Q ss_pred CCCCccc--------------cccccccCC-----------CCCHHHH-------------------------------H
Q 005953 424 PNGSLGD--------------LLSREKENL-----------SLKPARL-------------------------------L 447 (667)
Q Consensus 424 ~~gsL~~--------------~l~~~~~~~-----------~l~~~~~-------------------------------~ 447 (667)
+|.++.. .+|...... ...|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 9876531 112111000 1122211 0
Q ss_pred HHHHHHHHHHHHHHc----------CCCCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 448 EIALGVAHAIEYLHN----------GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 448 ~i~~~i~~gl~yLH~----------~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
.+...+.+++++|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666653 124589999999999999888899999999763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=3.1e-05 Score=82.17 Aligned_cols=73 Identities=14% Similarity=0.069 Sum_probs=49.2
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--------cchHHHHHHHHHHhhccc--c-eEEeecceEecCCeeEEE
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--------NFSDNFINEVATIGRIHH--V-NIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~Ei~~l~~l~h--~-niv~l~g~~~~~~~~~lV 419 (667)
+.||.|..+.||+++.. +++.++||...... ...+.+..|.++++.+.. + .+.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 57899999999999764 46889999764321 123467789999888742 3 34455543 34556899
Q ss_pred EEEcCCC
Q 005953 420 YEYMPNG 426 (667)
Q Consensus 420 ~e~~~~g 426 (667)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=6.3e-05 Score=76.79 Aligned_cols=137 Identities=18% Similarity=0.181 Sum_probs=91.7
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcc---cceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH---HVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
+.|+.|....+|+... +++.+++|+.... ....+.+|...|+.+. ...+.+++++....+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4688999999999987 5677888987643 3567889999999884 25678888888878889999999998876
Q ss_pred cc-----------ccccccc--C-----------------CCCCHHHHH---HHHH----------------HHH-HHHH
Q 005953 429 GD-----------LLSREKE--N-----------------LSLKPARLL---EIAL----------------GVA-HAIE 458 (667)
Q Consensus 429 ~~-----------~l~~~~~--~-----------------~~l~~~~~~---~i~~----------------~i~-~gl~ 458 (667)
.. .||+... . ..-+|.... ++.. .+. ....
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 31 1222111 0 012444321 1111 111 1122
Q ss_pred HHHc-CCCCCeeecCCCCCcEEECCCCceEEEeCC
Q 005953 459 YLHN-GCELRILHLDIKPQNVLLDPDFTPKVSDFG 492 (667)
Q Consensus 459 yLH~-~~~~~ivH~Dikp~NIll~~~~~~ki~DFG 492 (667)
.|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3421 2356899999999999999887 8888874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00011 Score=74.06 Aligned_cols=73 Identities=18% Similarity=0.302 Sum_probs=53.5
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCC-cchHHHHHHHHHHhhcc-c--ceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS-NFSDNFINEVATIGRIH-H--VNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~-h--~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
+.+|.|..+.||+.+..||+.|.+|+..... .....|.+|...|+.+. . -.+.+++++ +..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 4689999999999999999999999876443 23356788999998884 2 123444443 23478999998765
Q ss_pred c
Q 005953 428 L 428 (667)
Q Consensus 428 L 428 (667)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00026 Score=75.60 Aligned_cols=82 Identities=11% Similarity=0.088 Sum_probs=47.8
Q ss_pred CCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcC-CCCCcccHHHHHHHHHH
Q 005953 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG-NPSGKSDVYSYGMLLLE 543 (667)
Q Consensus 465 ~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~s~k~DvwSlGvvl~e 543 (667)
...++|+|+++.|||++.++ ++|+||+.+..-........... .-...|.+|+......+ ......++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLG-NLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHH-HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHH-HHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 35899999999999998876 99999998865332111100000 00124556554421100 00113455678888888
Q ss_pred HHhCC
Q 005953 544 MIEEK 548 (667)
Q Consensus 544 lltg~ 548 (667)
.+.++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0014 Score=67.24 Aligned_cols=141 Identities=14% Similarity=0.123 Sum_probs=83.4
Q ss_pred hcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccc--eEEeecce-----EecCCeeEEEEEEcCC
Q 005953 353 KLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHV--NIIHLLGF-----CCDGSTRALIYEYMPN 425 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~g~-----~~~~~~~~lV~e~~~~ 425 (667)
.|+ |....||+....+|+.+++|+..........+..|..++..+... .+++++.. ....+..++|+||++|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 356 788899998877787899999874433456677888888888522 24444443 1224456789999987
Q ss_pred CCccc-----------c---cccccc------CCCCCHHHH----HHH---------------HHHHHHHHHHHHcC---
Q 005953 426 GSLGD-----------L---LSREKE------NLSLKPARL----LEI---------------ALGVAHAIEYLHNG--- 463 (667)
Q Consensus 426 gsL~~-----------~---l~~~~~------~~~l~~~~~----~~i---------------~~~i~~gl~yLH~~--- 463 (667)
..+.. . +|.... ....++... ..+ ...+.+.++.+...
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 65431 0 111000 011222211 000 11111223333221
Q ss_pred -CCCCeeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 464 -CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 464 -~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999987753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00054 Score=71.79 Aligned_cols=140 Identities=15% Similarity=0.172 Sum_probs=83.7
Q ss_pred hhcccCCCeEEEEEEeC--------CCcEEEEEEcccCCcchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEE
Q 005953 352 EKLGTGGYGNVYKGKFP--------DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.|..|-...+|+.... +++.+++|+..........+.+|..+++.+. +.-..++++++.+ .+|+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 45777888999999874 2478999986443334566779999998884 3323556666543 299999
Q ss_pred cCCCCcccc-c----------------cccc--cCCCCC--HHHHHHHHHHHHH-------------------HHHHHH-
Q 005953 423 MPNGSLGDL-L----------------SREK--ENLSLK--PARLLEIALGVAH-------------------AIEYLH- 461 (667)
Q Consensus 423 ~~~gsL~~~-l----------------~~~~--~~~~l~--~~~~~~i~~~i~~-------------------gl~yLH- 461 (667)
++|.+|..- + |... ...... +.++.++..++.. .+..|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998666421 0 1110 011122 3455555443322 233332
Q ss_pred ---cC-CCCCeeecCCCCCcEEECCC----CceEEEeCCCcc
Q 005953 462 ---NG-CELRILHLDIKPQNVLLDPD----FTPKVSDFGLAK 495 (667)
Q Consensus 462 ---~~-~~~~ivH~Dikp~NIll~~~----~~~ki~DFGla~ 495 (667)
.. ....++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 21 23478999999999999876 789999998874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00051 Score=73.51 Aligned_cols=72 Identities=14% Similarity=0.282 Sum_probs=49.8
Q ss_pred hhcccCCCeEEEEEEeCC--------CcEEEEEEcccCCcchHHHHHHHHHHhhcccceE-EeecceEecCCeeEEEEEE
Q 005953 352 EKLGTGGYGNVYKGKFPD--------GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~ 422 (667)
+.|+.|....||+....+ ++.+++|+.... ...+.+.+|..+++.+...++ .++++.+.+ .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 457888889999998753 578899987432 222566789999998853333 456665532 289999
Q ss_pred cCCCCc
Q 005953 423 MPNGSL 428 (667)
Q Consensus 423 ~~~gsL 428 (667)
++|.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986555
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00056 Score=69.40 Aligned_cols=70 Identities=14% Similarity=0.146 Sum_probs=43.6
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceE-EeecceEecCCeeEEEEEEc-CCCCc
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEYM-PNGSL 428 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~-~~gsL 428 (667)
+.|+.|....+|+. +.+++|+.........+..+|+.+++.+....+ .+++++ +.+.-++|+||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 56888999999999 457888876432222233568888877743222 345543 333457899999 55455
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0011 Score=67.86 Aligned_cols=142 Identities=14% Similarity=0.099 Sum_probs=80.3
Q ss_pred hhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccce--EEeecce------EecCCeeEEEEEEc
Q 005953 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN--IIHLLGF------CCDGSTRALIYEYM 423 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~------~~~~~~~~lV~e~~ 423 (667)
+.|+.|....+|+....+| .+++|+.... ...+++..|+.++..+.... +.+++.. ....+..+++++|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 3467788899999987666 5778887652 12345667888887774222 3333321 12235678999999
Q ss_pred CCCCcccc--------------ccccccCC------CC---CHHHHHH------------HHHHHHHHHHHHHcC----C
Q 005953 424 PNGSLGDL--------------LSREKENL------SL---KPARLLE------------IALGVAHAIEYLHNG----C 464 (667)
Q Consensus 424 ~~gsL~~~--------------l~~~~~~~------~l---~~~~~~~------------i~~~i~~gl~yLH~~----~ 464 (667)
+|..+... +|...... .. .|...+. +...+.+.++.++.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 88765321 11110000 01 1221110 001234455555531 2
Q ss_pred CCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 465 ~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
...++|+|+++.|||++++..+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3479999999999999987666899998763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0018 Score=66.52 Aligned_cols=142 Identities=15% Similarity=0.148 Sum_probs=73.2
Q ss_pred hhcccCCCeE-EEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhccc--ceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 352 EKLGTGGYGN-VYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH--VNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 352 ~~LG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
+.|+.|+... +|+....+++.+++|...... ..++..|+.+++.+.. -.+.+++.+..+.+ +++||++.+.++
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 3465565554 678776446777777654432 1234456777776642 23455665533333 789999976665
Q ss_pred cccccccc---------------------cC--CCCCHHHHH-------HH-------------HHHHHHHHHHHH---c
Q 005953 429 GDLLSREK---------------------EN--LSLKPARLL-------EI-------------ALGVAHAIEYLH---N 462 (667)
Q Consensus 429 ~~~l~~~~---------------------~~--~~l~~~~~~-------~i-------------~~~i~~gl~yLH---~ 462 (667)
.+.+.... .. ..++..... .+ ...+...++.+. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 44332100 00 012221110 00 001112222331 1
Q ss_pred CCCCCeeecCCCCCcEEECCC----CceEEEeCCCcccc
Q 005953 463 GCELRILHLDIKPQNVLLDPD----FTPKVSDFGLAKAH 497 (667)
Q Consensus 463 ~~~~~ivH~Dikp~NIll~~~----~~~ki~DFGla~~~ 497 (667)
.....++|+|+.+.||+++.+ ..+.|+||+.+..-
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 124589999999999999875 68999999988654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0017 Score=69.86 Aligned_cols=73 Identities=16% Similarity=0.051 Sum_probs=47.2
Q ss_pred hhcccCCCeEEEEEEeCC-CcEEEEEEcccCCcchHHHHHHHHHHhhcccceE-EeecceEecCCeeEEEEEEcCCCCc
Q 005953 352 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
+.|+.|-...+|+....+ ++.+++|+........-+..+|..++..+...++ .++++.+. + .+|+||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 457888889999998865 4778899875432211122588888888864333 46666663 2 259999987655
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.00 E-value=0.001 Score=69.68 Aligned_cols=73 Identities=15% Similarity=0.168 Sum_probs=44.7
Q ss_pred hhcccCCCeEEEEEEeCC---------CcEEEEEEcccCCcchHHHHHHHHHHhhcccce-EEeecceEecCCeeEEEEE
Q 005953 352 EKLGTGGYGNVYKGKFPD---------GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVN-IIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~~~~lV~e 421 (667)
+.|+.|....+|+....+ ++.+++|+.........+...|..+++.+...+ ..++++.. . -++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 457788889999998754 268889987643322223467888888885333 33555443 2 368999
Q ss_pred EcCCCCc
Q 005953 422 YMPNGSL 428 (667)
Q Consensus 422 ~~~~gsL 428 (667)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0064 Score=62.70 Aligned_cols=68 Identities=12% Similarity=0.087 Sum_probs=44.5
Q ss_pred ccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhccc---ceEEeecce------EecCCeeEEEEEEcCC
Q 005953 355 GTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHH---VNIIHLLGF------CCDGSTRALIYEYMPN 425 (667)
Q Consensus 355 G~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h---~niv~l~g~------~~~~~~~~lV~e~~~~ 425 (667)
|.|....||+....+| .+++|+...... .+|+..+..|.. +++++++.. ....+..++||+|++|
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 4444689999988667 889998765432 356666666632 224444432 2335678899999998
Q ss_pred CCc
Q 005953 426 GSL 428 (667)
Q Consensus 426 gsL 428 (667)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 766
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0056 Score=57.86 Aligned_cols=99 Identities=10% Similarity=0.076 Sum_probs=64.1
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
-||.++|... +.+++++++|.++.|.+.+|.-+-.... + ..+=+.|..|+|..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 3688888754 3579999999999999999877622101 1 1333557899999999988753 1110
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE 546 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt 546 (667)
.....+.|||... ...+.+.=|||||+++|.-+-
T Consensus 98 ----~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS---SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhh
Confidence 0123466888753 245678899999999999984
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.25 E-value=0.067 Score=56.63 Aligned_cols=139 Identities=12% Similarity=0.118 Sum_probs=83.1
Q ss_pred hhcccCCCeEEEEEEeCC--------CcEEEEEEcccCCcchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEE
Q 005953 352 EKLGTGGYGNVYKGKFPD--------GRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.|..|-...+|+....+ ++.+++|+........-+..+|..+++.+. +.-..++++.+ . -++|+||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence 357778889999998753 578999986543322223457888888885 32234455433 2 2689999
Q ss_pred cCCCCccc--c---------------ccccc----------cCCCCCHHHHHHHHHHH-------------------HHH
Q 005953 423 MPNGSLGD--L---------------LSREK----------ENLSLKPARLLEIALGV-------------------AHA 456 (667)
Q Consensus 423 ~~~gsL~~--~---------------l~~~~----------~~~~l~~~~~~~i~~~i-------------------~~g 456 (667)
++|.+|.. + ||+.. ...+.-+.++.++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 99866531 1 01100 01111234443333222 222
Q ss_pred HHHHHc---------------------CCCCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 457 IEYLHN---------------------GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 457 l~yLH~---------------------~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
+..|.. .....++|+|+.+.||+ +.++.+.|+||..+.
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 333321 11346899999999999 788899999999875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.47 E-value=0.27 Score=51.66 Aligned_cols=29 Identities=24% Similarity=0.293 Sum_probs=24.6
Q ss_pred CeeecCCCCCcEEE------CCCCceEEEeCCCcc
Q 005953 467 RILHLDIKPQNVLL------DPDFTPKVSDFGLAK 495 (667)
Q Consensus 467 ~ivH~Dikp~NIll------~~~~~~ki~DFGla~ 495 (667)
.++|+|+.+.|||+ +++..++++||.+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 35799999999999 456789999999874
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.23 E-value=0.12 Score=55.35 Aligned_cols=59 Identities=8% Similarity=0.041 Sum_probs=18.3
Q ss_pred hhhhcccCCCeEEEEEEeCC-CcEEEE------EEcccCC---cchHHHHHHHHHHhhcccceEEeecceEe
Q 005953 350 FKEKLGTGGYGNVYKGKFPD-GRLVAV------KVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCC 411 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~-~~~vav------K~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~ 411 (667)
+.++|| ||.||+|.+.. ...||| |..+... .....|.+|..+++.++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 456787 99999999854 467888 6655422 23356888999999999999999988765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 667 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 8e-68
Identities = 72/275 (26%), Positives = 126/275 (45%), Gaps = 23/275 (8%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHL 406
+++G+G +G VYKGK+ VAVK+L T+ F NEV + + HVNI+
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
+G+ A++ ++ SL L + + +L++IA A ++YLH
Sbjct: 70 MGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS-- 124
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
I+H D+K N+ L D T K+ DFGLA SR G+I ++APE+
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 527 NP-SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585
NP S +SDVY++G++L E++ + P + D I + + +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQ---LPYSNINN--------RDQIIFMVGRGYLSPDLS 232
Query: 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
+ + M + C++ +RP +++ +
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 1e-65
Identities = 70/271 (25%), Positives = 123/271 (45%), Gaps = 23/271 (8%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
E+LG G +G V+ G + VAVK L++ S D F+ E + ++ H ++ L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
+I EYM NGSL D L + + L +LL++A +A + ++ E +
Sbjct: 77 VTQEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 529
H D++ N+L+ + K++DFGLA+ N G + I + APE G +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINY--GTFT 188
Query: 530 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589
KSDV+S+G+LL E++ + +P ++IQ + + D
Sbjct: 189 IKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMVRPD 233
Query: 590 CIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
++ + C + P+DRP+ + +L
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 6e-63
Identities = 67/271 (24%), Positives = 121/271 (44%), Gaps = 23/271 (8%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
F ++LGTG +G V GK+ VA+K++++ S D FI E + + H ++ L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
C +I EYM NG L + L + +LLE+ V A+EYL + + L
Sbjct: 68 CTKQRPIFIITEYMANGCLLNYLREMRHRFQ--TQQLLEMCKDVCEAMEYLES---KQFL 122
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 529
H D+ +N L++ KVSDFGL++ + + + G + + + PE+ M S
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMY--SKFS 179
Query: 530 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589
KSD++++G+L+ E+ + G E + + + Q +
Sbjct: 180 SKSDIWAFGVLMWEIY-----------SLGKMPYERFTNSETAEHIAQGLRLYR----PH 224
Query: 590 CIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
+ K+ + C +RP+ ++ +
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 4e-62
Identities = 62/272 (22%), Positives = 127/272 (46%), Gaps = 23/272 (8%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
F +++G+G +G V+ G + + VA+K + + + ++FI E + ++ H ++ L G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
C + + L++E+M +G L D L ++ + LL + L V + YL C ++
Sbjct: 69 CLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 529
H D+ +N L+ + KVSDFG+ + ++ + G + + + +PE+F S
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVFSF--SRYS 180
Query: 530 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589
KSDV+S+G+L+ E+ + G E + + + +
Sbjct: 181 SKSDVWSFGVLMWEVF-----------SEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 229
Query: 590 CIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621
+ + C + P+DRP+ +R++ L+
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 1e-60
Identities = 66/302 (21%), Positives = 122/302 (40%), Gaps = 26/302 (8%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
+E +G G +G V++GK+ G VAVK+ S E+ + H NI+ +
Sbjct: 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 410 CCDG----STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC- 464
+ L+ +Y +GSL D L+R + ++++AL A + +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 121
Query: 465 ----ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH--SRNRSVVTMTGPRGTIGYIAP 518
+ I H D+K +N+L+ + T ++D GLA H + + + GT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 519 EIFMRNLGNPSG----KSDVYSYGMLLLEMIEEKKHLRPTETTS----GSNTTEAYFPDW 570
E+ ++ ++D+Y+ G++ E+ E ++ +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 571 IYDKLIQPEKEDFVEEEDDC-IARKMIIVGLWCIQINPKDRPSMTRVVEMLSS-ASAEAI 628
Q + + C R M + C N R + R+ + LS + E I
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301
Query: 629 EM 630
+M
Sbjct: 302 KM 303
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 3e-60
Identities = 64/285 (22%), Positives = 123/285 (43%), Gaps = 24/285 (8%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
+ KLG G +G V+ G + VA+K L+ + + F+ E + ++ H ++ L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
+ ++ EYM GSL + + L+ +L+++A +A + Y+ + +
Sbjct: 81 VSEEP-IYIVTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 135
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 529
H D++ N+L+ + KV+DFGLA+ N G + I + APE + G +
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALY--GRFT 192
Query: 530 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589
KSDV+S+G+LL E+ T G + D++ + + E +
Sbjct: 193 IKSDVWSFGILLTELT-----------TKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 241
Query: 590 CIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAEAIEMPPKP 634
+ + C + P++RP+ + L + E +P
Sbjct: 242 SLHD----LMCQCWRKEPEERPTFEYLQAFLEDYFT-STEPQYQP 281
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (508), Expect = 1e-59
Identities = 70/303 (23%), Positives = 130/303 (42%), Gaps = 42/303 (13%)
Query: 338 YSYNDIKKMTNGF-----------KEKLGTGGYGNVYKGKFP----DGRLVAVKVLEK-- 380
+++ D + F ++ +G G +G V G VA+K L+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 381 TSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLS 440
T +F++E + +G+ H N+IHL G + +I E+M NGSL L + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 441 LKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500
+ +L+ + G+A ++YL + +H D+ +N+L++ + KVSDFGL++ +
Sbjct: 127 VI--QLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 501 RSVVTMT---GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETT 557
S T T G + I + APE + SDV+SYG+++ E++ +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGER------- 232
Query: 558 SGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVV 617
+ D +I ++D+ + + L C Q + RP ++V
Sbjct: 233 --------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 618 EML 620
L
Sbjct: 285 NTL 287
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 4e-59
Identities = 75/272 (27%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGF 409
+ +G G +G+V G + G VAVK + K + F+ E + + ++ H N++ LLG
Sbjct: 11 LLQTIGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 410 CCDGSTR-ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+ ++ EYM GSL D L R + L LL+ +L V A+EYL
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 124
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
+H D+ +NVL+ D KVSDFGL K S T + + + APE
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALRE--KKF 177
Query: 529 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588
S KSDV+S+G+LL E+ + P + ++ + K D +
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIP-----------LKDVVPRVEKGYKMDAPDGCP 226
Query: 589 DCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
+ V C ++ RPS ++ E L
Sbjct: 227 PAVYE----VMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (502), Expect = 7e-59
Identities = 77/274 (28%), Positives = 127/274 (46%), Gaps = 23/274 (8%)
Query: 350 FKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
K KLG G YG VY+G + VAVK L++ + + F+ E A + I H N++ LLG
Sbjct: 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
C +I E+M G+L D L RE + LL +A ++ A+EYL +
Sbjct: 81 VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 136
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
+H D+ +N L+ + KV+DFGL++ + + G + I + APE
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAY--NKF 193
Query: 529 SGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588
S KSDV+++G+LL E+ + +P ++ + ++D+ E
Sbjct: 194 SIKSDVWAFGVLLWEIATYGM---------------SPYPGIDLSQVYELLEKDYRMERP 238
Query: 589 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+ K+ + C Q NP DRPS + + +
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-57
Identities = 60/276 (21%), Positives = 117/276 (42%), Gaps = 29/276 (10%)
Query: 353 KLGTGGYGNVYKGKF---PDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHVNIIHLL 407
+LG G +G+V +G + VA+KVL++ + +D + E + ++ + I+ L+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
G C L+ E G L L ++E + + + E+ V+ ++YL
Sbjct: 76 G-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEE---KN 129
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
+H D+ +NVLL K+SDFGL+KA + + + + + + APE
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--R 187
Query: 527 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586
S +SDV+SYG+ + E + + G + + + Q ++ + E
Sbjct: 188 KFSSRSDVWSYGVTMWEAL-----------SYGQKPYKKMKGPEVMAFIEQGKRMECPPE 236
Query: 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
++ + C +DRP V + + +
Sbjct: 237 ----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (491), Expect = 5e-57
Identities = 66/300 (22%), Positives = 113/300 (37%), Gaps = 49/300 (16%)
Query: 350 FKEKLGTGGYGNVYKGKFP------DGRLVAVKVL--EKTSNFSDNFINEVATIGRIHHV 401
+ +G G +G V++ + P +VAVK+L E +++ +F E A + +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLS--------------------- 440
NI+ LLG C G L++EYM G L + L +
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 441 LKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500
L A L IA VA + YL E + +H D+ +N L+ + K++DFGL++
Sbjct: 137 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS 560
I ++ PE N + +SDV++YG++L E+
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMA---- 247
Query: 561 NTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
+ + + E ++ + C P DRPS + +L
Sbjct: 248 -------HEEVIYYVRDGNILACPENCPL----ELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 5e-57
Identities = 66/277 (23%), Positives = 115/277 (41%), Gaps = 31/277 (11%)
Query: 353 KLGTGGYGNVYKGKFPD---GRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHL 406
+LG+G +G V KG + + VAVK+L+ +N D + E + ++ + I+ +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
+G C S L+ E G L L + + +K ++E+ V+ ++YL
Sbjct: 74 IGICEAES-WMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKA-HSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
+H D+ +NVLL K+SDFGL+KA + T + + + APE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-- 184
Query: 526 GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585
S KSDV+S+G+L+ E + G + L + E+
Sbjct: 185 YKFSSKSDVWSFGVLMWEAF-----------SYGQKPYRGMKGSEVTAMLEKGERMGC-- 231
Query: 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
R+M + C + ++RP V L +
Sbjct: 232 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-56
Identities = 74/301 (24%), Positives = 131/301 (43%), Gaps = 43/301 (14%)
Query: 350 FKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTSNFSD--NFINEVATIGRI-HH 400
F + LG G +G V + VAVK+L+ +++ ++ ++E+ + + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 401 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR---------------EKENLSLKPAR 445
+NI++LLG C G +I EY G L + L R E + L+L
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 446 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505
LL + VA + +L +H D+ +N+LL K+ DFGLA+ + + V
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEA 565
R + ++APE + +SDV+SYG+ L E+ + GS+
Sbjct: 204 KGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELF-----------SLGSSPYPG 250
Query: 566 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625
D + K+I KE F + +M + C +P RP+ ++V+++ +
Sbjct: 251 MPVDSKFYKMI---KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
Query: 626 E 626
E
Sbjct: 308 E 308
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 4e-56
Identities = 61/314 (19%), Positives = 120/314 (38%), Gaps = 43/314 (13%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHL 406
+LG G G V+K P G ++A K++ + I E+ + + I+
Sbjct: 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
G ++ E+M GSL +L + + L ++++ V + YL +
Sbjct: 70 YGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE--KH 124
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
+I+H D+KP N+L++ K+ DFG++ + + GT Y++PE
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQG--T 178
Query: 527 NPSGKSDVYSYGMLLLEMI---------------------------EEKKHLRPTETTSG 559
+ S +SD++S G+ L+EM E R
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238
Query: 560 SNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619
S ++ P I++ L E + + + C+ NP +R + +++
Sbjct: 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298
Query: 620 --LSSASAEAIEMP 631
+ + AE ++
Sbjct: 299 AFIKRSDAEEVDFA 312
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (483), Expect = 7e-56
Identities = 63/273 (23%), Positives = 109/273 (39%), Gaps = 33/273 (12%)
Query: 352 EKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSD----NFINEVATIGRIHHVNIIHL 406
++G G +G VY + + +VA+K + + S+ + I EV + ++ H N I
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
G T L+ EY + L +K L+ + + G + YLH
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM-RNL 525
++H D+K N+LL K+ DFG A + S V GT ++APE+ + +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMDE 188
Query: 526 GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585
G GK DV+S G+ +E+ E P F L + +
Sbjct: 189 GQYDGKVDVWSLGITCIELAE---RKPP------------LFNMNAMSALYHIAQNESPA 233
Query: 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ + C+Q P+DRP+ +++
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 9e-56
Identities = 62/272 (22%), Positives = 108/272 (39%), Gaps = 24/272 (8%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHL 406
+ LG G YG V VAVK+++ + +N E+ ++H N++
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
G +G+ + L EY G L D + + ++ + + + YLH +
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH---GI 122
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
I H DIKP+N+LLD K+SDFGLA N + GT+ Y+APE+ R
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR-E 181
Query: 527 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586
+ DV+S G++L M+ + + + + DW K +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235
Query: 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ + + NP R ++ + +
Sbjct: 236 PLALLHK--------ILVENPSARITIPDIKK 259
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-55
Identities = 77/302 (25%), Positives = 125/302 (41%), Gaps = 48/302 (15%)
Query: 350 FKEKLGTGGYGNVYKGKFPD------GRLVAVKVLEKTSNFSD--NFINEVATIGRI-HH 400
F + LG+G +G V VAVK+L++ ++ S+ ++E+ + ++ H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 401 VNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLS-------------------- 440
NI++LLG C LI+EY G L + L ++E S
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 441 LKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500
L LL A VA +E+L +H D+ +NVL+ K+ DFGLA+ +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS 560
+ V R + ++APE G + KSDV+SYG+LL E+ + P
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP---- 271
Query: 561 NTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
D + KLIQ F ++ ++ I+ C + + RPS + L
Sbjct: 272 -------VDANFYKLIQ---NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
Query: 621 SS 622
Sbjct: 322 GC 323
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-55
Identities = 76/283 (26%), Positives = 113/283 (39%), Gaps = 31/283 (10%)
Query: 350 FKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEK----TSNFSDNFINEVATIGRIHHV 401
EKLG G +G V +G++ VAVK L+ D+FI EV + + H
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
N+I L G + ++ E P GSL D L + + + L L A+ VA + YL
Sbjct: 72 NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLE 128
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-GTIGYIAPEI 520
R +H D+ +N+LL K+ DFGL +A +N M R + APE
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580
S SD + +G+ L EM T G I K+ K
Sbjct: 186 LKT--RTFSHASDTWMFGVTLWEMF-----------TYGQEPWIGLNGSQILHKID---K 229
Query: 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623
E + + + V + C P+DRP+ + + L A
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 1e-54
Identities = 64/278 (23%), Positives = 108/278 (38%), Gaps = 34/278 (12%)
Query: 350 FKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIH 405
F ++G G + VYKG + VA L+ T + F E + + H NI+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 406 LLGFCCDGSTR----ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
L+ E M +G+L L R K +K L + +++LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH 129
Query: 462 NGCELRILHLDIKPQNVLL-DPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 520
I+H D+K N+ + P + K+ D GLA + GT ++APE+
Sbjct: 130 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEM 184
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580
+ DVY++GM +LEM TS +E IY ++ K
Sbjct: 185 YE---EKYDESVDVYAFGMCMLEMA-----------TSEYPYSECQNAAQIYRRVTSGVK 230
Query: 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
++ +++I CI+ N +R S+ ++
Sbjct: 231 PASFDKVAIPEVKEII---EGCIRQNKDERYSIKDLLN 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-54
Identities = 66/278 (23%), Positives = 115/278 (41%), Gaps = 29/278 (10%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIH 405
+GTG YG K + DG+++ K L+ T ++EV + + H NI+
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 406 LLGFCCDGSTRAL--IYEYMPNGSLGDLLSR-EKENLSLKPARLLEIALGVAHAIEYLH- 461
D + L + EY G L ++++ KE L +L + + A++ H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 462 -NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEI 520
+ +LH D+KP NV LD K+ DFGLA+ + + S GT Y++PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQ 185
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580
R + + KSD++S G LL E+ + A+ + K+ + +
Sbjct: 186 MNR--MSYNEKSDIWSLGCLLYELC------------ALMPPFTAFSQKELAGKIREGKF 231
Query: 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
D ++I + + RPS+ ++E
Sbjct: 232 RRIPYRYSDE-LNEII---TRMLNLKDYHRPSVEEILE 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 3e-54
Identities = 67/281 (23%), Positives = 117/281 (41%), Gaps = 30/281 (10%)
Query: 350 FKEKLGTGGYGNVYKGKFPDG-----RLVAVKVLEK--TSNFSDNFINEVATIGRIHHVN 402
++ +G G +G VYKG VA+K L+ T +F+ E +G+ H N
Sbjct: 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
II L G +I EYM NG+L L + S +L+ + G+A ++YL N
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS--VLQLVGMLRGIAAGMKYLAN 128
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVVTMTGPRGTIGYIAPEIF 521
+ +H D+ +N+L++ + KVSDFGL++ + T +G + I + APE
Sbjct: 129 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 522 MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581
+ SDV+S+G+++ E++ T G + + +
Sbjct: 186 SY--RKFTSASDVWSFGIVMWEVM-----------TYGERPYWELSNHEVMKAINDGFRL 232
Query: 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+ + + + C Q RP +V +L
Sbjct: 233 PTPMD----CPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 3e-54
Identities = 76/282 (26%), Positives = 120/282 (42%), Gaps = 31/282 (10%)
Query: 350 FKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNI 403
F E +G G +G VY G D AVK L + ++ F+ E + H N+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 404 IHLLGFCCDGSTRA-LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
+ LLG C ++ YM +G L + + E N ++K L+ L VA +
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKG---MKF 145
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAK--AHSRNRSVVTMTGPRGTIGYIAPEI 520
+ +H D+ +N +LD FT KV+DFGLA+ SV TG + + ++A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580
+ KSDV+S+G+LL E++ P NT + +L+QPE
Sbjct: 206 LQT--QKFTTKSDVWSFGVLLWELMTRGAPPYP-----DVNTFDITVYLLQGRRLLQPEY 258
Query: 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+ V L C + RPS + +V +S+
Sbjct: 259 ----------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 4e-53
Identities = 69/275 (25%), Positives = 111/275 (40%), Gaps = 36/275 (13%)
Query: 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNII 404
LG G +GNVY + ++A+KVL K + EV + H NI+
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
L G+ D + LI EY P G++ L + R +A+A+ Y H
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCH--- 123
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
R++H DIKP+N+LL K++DFG + +R T GT+ Y+ PE+
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEG- 178
Query: 525 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYF-PDWIYDKLIQPEKEDF 583
K D++S G+L E + K P E + T + ++ + + D
Sbjct: 179 -RMHDEKVDLWSLGVLCYEFLVGK---PPFEANTYQETYKRISRVEFTFPDFVTEGARDL 234
Query: 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ ++ NP RP + V+E
Sbjct: 235 IS---------------RLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 4e-53
Identities = 60/289 (20%), Positives = 121/289 (41%), Gaps = 31/289 (10%)
Query: 340 YNDIKKMTNG-----FKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTS-NFSDNFINEV 392
Y + + N +LG G +G VYK + + L A KV++ S ++++ E+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 393 ATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALG 452
+ H NI+ LL + ++ E+ G++ ++ + L+ +++ +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT--ESQIQVVCKQ 118
Query: 453 VAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT 512
A+ YLH + +I+H D+K N+L D K++DFG++ ++R GT
Sbjct: 119 TLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGT 173
Query: 513 IGYIAPEIFMRNLGNPSG---KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPD 569
++APE+ M K+DV+S G+ L+EM P
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA------------EIEPPHHELNPM 221
Query: 570 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ K+ + E + K + C++ N R + +++++
Sbjct: 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFL--KKCLEKNVDARWTTSQLLQ 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-52
Identities = 76/302 (25%), Positives = 136/302 (45%), Gaps = 47/302 (15%)
Query: 339 SYNDIKKMTNGFKEKLGTGGYGNVYKGKFPDG---RLVAVKVLEKTSNFSD--NFINEVA 393
+NDIK F++ +G G +G V K + A+K +++ ++ D +F E+
Sbjct: 8 DWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 62
Query: 394 TIGRI-HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSR-------------EKENL 439
+ ++ HH NII+LLG C L EY P+G+L D L +
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 440 SLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499
+L +LL A VA ++YL + + +H D+ +N+L+ ++ K++DFGL++
Sbjct: 123 TLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 179
Query: 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG 559
V T R + ++A E + SDV+SYG+LL E++ + G
Sbjct: 180 Y---VKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIV-----------SLG 223
Query: 560 SNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619
+Y+KL Q + + DD ++ + C + P +RPS +++
Sbjct: 224 GTPYCGMTCAELYEKLPQGYRLEKPLNCDD----EVYDLMRQCWREKPYERPSFAQILVS 279
Query: 620 LS 621
L+
Sbjct: 280 LN 281
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 7e-52
Identities = 65/319 (20%), Positives = 130/319 (40%), Gaps = 35/319 (10%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN------FINEVATIGRIHHVN 402
+ LG+G +G VYKG + P+G V + V K + + ++E + + + +
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 403 IIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
+ LLG C + + LI + MP G L D + K+N+ + LL + +A + YL +
Sbjct: 73 VCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQIAKGMNYLED 129
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
R++H D+ +NVL+ K++DFGLAK G + I ++A E +
Sbjct: 130 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 523 RNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582
+ +SDV+SYG+ + E++ + ++ ++
Sbjct: 187 H--RIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILEKG 229
Query: 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE-----AIEMPPKPLFP 637
+ + ++ + C I+ RP ++ S + + I+ + P
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 289
Query: 638 SPPQLQTQNEIISFDSITS 656
SP ++ + +
Sbjct: 290 SPTDSNFYRALMDEEDMDD 308
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-51
Identities = 59/279 (21%), Positives = 111/279 (39%), Gaps = 30/279 (10%)
Query: 350 FKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNI 403
+G G +G+V++G + VA+K + ++ + F+ E T+ + H +I
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 404 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 463
+ L+G + +I E G L + SL A L+ A ++ A+ YL
Sbjct: 71 VKLIGVITEN-PVWIIMELCTLGELRSF--LQVRKYSLDLASLILYAYQLSTALAYLE-- 125
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
R +H DI +NVL+ + K+ DFGL++ + G + I ++APE
Sbjct: 126 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKWMAPESINF 183
Query: 524 NLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583
+ SDV+ +G+ + E++ G + + + ++ E+
Sbjct: 184 --RRFTSASDVWMFGVCMWEIL-----------MHGVKPFQGVKNNDVIGRIENGERLPM 230
Query: 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+ M C +P RP T + LS+
Sbjct: 231 PPNCPPTLYSLM----TKCWAYDPSRRPRFTELKAQLST 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-51
Identities = 59/286 (20%), Positives = 118/286 (41%), Gaps = 35/286 (12%)
Query: 350 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSD--NFINEVATIGRIHHV 401
+LG G +G VY+G K VA+K + + ++ + F+NE + + +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLS-------LKPARLLEIALGVA 454
+++ LLG G +I E M G L L + ++ ++++++A +A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 455 HAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 514
+ YL + +H D+ +N ++ DFT K+ DFG+ + +
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 515 YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 574
+++PE G + SDV+S+G++L E+ T + + +
Sbjct: 201 WMSPESLKD--GVFTTYSDVWSFGVVLWEIA-----------TLAEQPYQGLSNEQVLRF 247
Query: 575 LIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620
+++ D + D + + C Q NPK RPS ++ +
Sbjct: 248 VMEGGLLDKPDNCPD----MLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-49
Identities = 70/296 (23%), Positives = 123/296 (41%), Gaps = 42/296 (14%)
Query: 350 FKEKLGTGGYGNVYKG------KFPDGRLVAVKVLEKTSNFSDN--FINEVATIGRI-HH 400
+ LG G +G V + K R VAVK+L++ + S++ ++E+ + I HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 401 VNIIHLLGFCC-DGSTRALIYEYMPNGSLGDLLSREKENLS-------------LKPARL 446
+N+++LLG C G +I E+ G+L L ++ L L
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 447 LEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506
+ + VA +E+L + +H D+ +N+LL K+ DFGLA+ ++ V
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAY 566
R + ++APE + +SDV+S+G+LL E+ P
Sbjct: 194 GDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--------- 242
Query: 567 FPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622
+ +L + + D +M L C P RP+ + +VE L +
Sbjct: 243 -DEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-48
Identities = 62/269 (23%), Positives = 113/269 (42%), Gaps = 27/269 (10%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGF 409
EK+G G G VY G+ VA++ + + INE+ + + NI++ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 410 CCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRIL 469
G ++ EY+ GSL D+++ + ++ + A+E+LH +++
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLH---SNQVI 138
Query: 470 HLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPS 529
H DIK N+LL D + K++DFG + +S + GT ++APE+ R
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTR--KAYG 194
Query: 530 GKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589
K D++S G++ +EMIE + N A + E D
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGTPELQNPEKLSAIFRD 248
Query: 590 CIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ R C+ ++ + R S +++
Sbjct: 249 FLNR--------CLDMDVEKRGSAKELLQ 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 2e-48
Identities = 72/296 (24%), Positives = 119/296 (40%), Gaps = 44/296 (14%)
Query: 350 FKEKLGTGGYGNVYKGKFP--------DGRLVAVKVLEKTSNFSD--NFINEVATIGRI- 398
+ LG G +G V + VAVK+L+ + D + I+E+ + I
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 399 HHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREK-------------ENLSLKPAR 445
H NII+LLG C +I EY G+L + L + L
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 446 LLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505
L+ A VA +EYL + +H D+ +NVL+ D K++DFGLA+
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEA 565
T R + ++APE + +SDV+S+G+LL E+
Sbjct: 194 TTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGS--------------- 236
Query: 566 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621
+P ++L + KE ++ ++ ++ C P RP+ ++VE L
Sbjct: 237 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (420), Expect = 2e-46
Identities = 60/306 (19%), Positives = 118/306 (38%), Gaps = 31/306 (10%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLL 407
E+LGTG +G V++ G A K + + + E+ T+ + H +++L
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
D + +IYE+M G L + ++ E +S A E V + ++H E
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV--EYMRQVCKGLCHMH---ENN 144
Query: 468 ILHLDIKPQNVLLDPDFTP--KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
+HLD+KP+N++ + K+ DFGL +SV TG + APE+
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEGKP 201
Query: 526 GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585
+D++S G+L ++ G N E + ++ + +
Sbjct: 202 VGY--YTDMWSVGVLSYILLSGLSPFG------GENDDETL-------RNVKSCDWNMDD 246
Query: 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM----LSSASAEAIEMPPKPLFPSPPQ 641
I+ + +P R ++ + +E +A ++P
Sbjct: 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306
Query: 642 LQTQNE 647
++T+ +
Sbjct: 307 IKTKYD 312
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-46
Identities = 60/272 (22%), Positives = 103/272 (37%), Gaps = 36/272 (13%)
Query: 350 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDN----FINEVATIGRIHHVNII 404
F + LG G + V + R A+K+LEK +N E + R+ H +
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
L D Y NG L + + S + A+EYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLH--- 125
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
I+H D+KP+N+LL+ D +++DFG AK S GT Y++PE+
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE- 184
Query: 525 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE---KE 581
+ SD+++ G ++ +++ +G A I+ K+I+ E E
Sbjct: 185 -KSACKSSDLWALGCIIYQLV------------AGLPPFRAGNEYLIFQKIIKLEYDFPE 231
Query: 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSM 613
F + D + + + ++ R
Sbjct: 232 KFFPKARDLVEK--------LLVLDATKRLGC 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (402), Expect = 1e-44
Identities = 62/285 (21%), Positives = 113/285 (39%), Gaps = 38/285 (13%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS----------NFSDNFINEVATIGRI 398
KE LG G V + P + AVK+++ T + + EV + ++
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 399 H-HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAI 457
H NII L + L+++ M G L D L+ + +L +I + I
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVI 123
Query: 458 EYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 517
LH +L I+H D+KP+N+LLD D K++DFG + + GT Y+A
Sbjct: 124 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLA 177
Query: 518 PEIFMRNLGNPSG----KSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYD 573
PEI ++ + + D++S G+++ ++ P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS---PPFWHRKQMLMLRMIMSGNY-- 232
Query: 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ PE +D+ + D ++R + + P+ R + +
Sbjct: 233 QFGSPEWDDYSDTVKDLVSR--------FLVVQPQKRYTAEEALA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-43
Identities = 57/308 (18%), Positives = 112/308 (36%), Gaps = 30/308 (9%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
E LG G +G V++ + K ++ E++ + H NI+HL
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+I+E++ + + ++ L+ ++ V A+++LH I
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELN--EREIVSYVHQVCEALQFLH---SHNI 123
Query: 469 LHLDIKPQNVLLDPDFTP--KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
H DI+P+N++ + K+ +FG A+ + + Y APE+
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL---FTAPEYYAPEVHQH--D 178
Query: 527 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586
S +D++S G L+ ++ SG N A I + I + F EE
Sbjct: 179 VVSTATDMWSLGTLVYVLL------------SGINPFLAETNQQIIEN-IMNAEYTFDEE 225
Query: 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS-AEAIEMPPKPLFPSPPQLQTQ 645
I+ + + + K R + + E L + IE + + +
Sbjct: 226 AFKEISIEAMDFVDRLLVKERKSRMTAS---EALQHPWLKQKIERVSTKVIRTLKHRRYY 282
Query: 646 NEIISFDS 653
+ +I D
Sbjct: 283 HTLIKKDL 290
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (394), Expect = 3e-43
Identities = 58/272 (21%), Positives = 104/272 (38%), Gaps = 24/272 (8%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEK--TSNFSDNFINEVATIGRIHHVNIIHL 406
F++ LGTG + V + +LVA+K + K + NE+A + +I H NI+ L
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 407 LGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCEL 466
G LI + + G L D + + + V A++YLH+ +
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 467 RILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLG 526
LD D +SDFGL+K ++ GT GY+APE+ +
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQ--K 184
Query: 527 NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586
S D +S G++ ++ P + + E + P +D +
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGY---PPFYDENDAKLFEQILKAEY--EFDSPYWDDISDS 239
Query: 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
D I ++ +P+ R + + ++
Sbjct: 240 AKDFIRH--------LMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 156 bits (396), Expect = 4e-43
Identities = 58/273 (21%), Positives = 113/273 (41%), Gaps = 27/273 (9%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFS-DNFINEVATIGRIHHVNIIHLL 407
E+LG+G +G V++ GR+ K + NE++ + ++HH +I+L
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
D LI E++ G L D ++ E +S A ++ ++++H E
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS--EAEVINYMRQACEGLKHMH---EHS 147
Query: 468 ILHLDIKPQNVLLDPDFTP--KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNL 525
I+HLDIKP+N++ + K+ DFGLA + + + T + APEI R
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDR-- 202
Query: 526 GNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585
+D+++ G+L ++ SG + ++ +F E
Sbjct: 203 EPVGFYTDMWAIGVLGYVLL------------SGLSPFAGEDDLETLQN-VKRCDWEFDE 249
Query: 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ ++ + +Q P+ R ++ +E
Sbjct: 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (395), Expect = 8e-43
Identities = 71/339 (20%), Positives = 125/339 (36%), Gaps = 47/339 (13%)
Query: 350 FKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTS-------NFSDNFINEVATIGRIHHV 401
+G GG+G VY + D G++ A+K L+K + N ++ +
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
I+ + + I + M G L LS+ A + A + +E++H
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGLEHMH 124
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 521
+++ D+KP N+LLD ++SD GLA S+ + ++ GT GY+APE+
Sbjct: 125 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVL 177
Query: 522 MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581
+ + +D +S G +L +++ R T + + D + + +
Sbjct: 178 QKGVAY-DSSADWFSLGCMLFKLLRGHSPFR------QHKTKDKHEIDRMTLTMAVELPD 230
Query: 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVV--EMLSS--------ASAEAIEMP 631
F E + +Q + R E+ S + P
Sbjct: 231 SFSPELRSLLEG--------LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYP 282
Query: 632 PKPLFPSP--PQLQTQNEIISFDS-ITSELPLQHDSQEL 667
P PL P +I SFD T + L QEL
Sbjct: 283 P-PLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQEL 320
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 2e-42
Identities = 52/283 (18%), Positives = 98/283 (34%), Gaps = 26/283 (9%)
Query: 350 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
K+G+G +G++Y G G VA+K+ E + I +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLE-CVKTKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+C ++ + SL DL + SLK L +A + IEY+H
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLL--LADQMISRIEYIH---SKNF 124
Query: 469 LHLDIKPQNVL---LDPDFTPKVSDFGLAKAHSRNRS-----VVTMTGPRGTIGYIAPEI 520
+H D+KP N L + DFGLAK + R+ GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 521 FMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580
+ S + D+ S G +L+ + + + Y+++ + +
Sbjct: 185 HLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT---------KRQKYERISEKKM 233
Query: 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623
+E + +C + D+P + + ++ +
Sbjct: 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 150 bits (380), Expect = 1e-41
Identities = 64/273 (23%), Positives = 113/273 (41%), Gaps = 31/273 (11%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNII 404
E LG GG V+ + R VAVKVL +F F E ++H I+
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 405 HLLGFCCD----GSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYL 460
+ G ++ EY+ +L D++ E + P R +E+ A+ +
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFS 127
Query: 461 HNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPR-GTIGYIAPE 519
+ I+H D+KP N+++ KV DFG+A+A + + + VT T GT Y++PE
Sbjct: 128 ---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 520 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579
+ +SDVYS G +L E++ + P G + + D +
Sbjct: 185 QARG--DSVDARSDVYSLGCVLYEVLTGE---PPFT---GDSPVSVAYQHVREDPIPPSA 236
Query: 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPS 612
+ + + + ++ L + NP++R
Sbjct: 237 RHEGLSAD----LDAVV---LKALAKNPENRYQ 262
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 4e-41
Identities = 79/347 (22%), Positives = 128/347 (36%), Gaps = 41/347 (11%)
Query: 338 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKFPD-GRLVAVKVLEKTSNFSDNFINEVATIG 396
SY D K +G G +G VY+ K D G LVA+K + + F E+ +
Sbjct: 20 VSYTDTKV--------IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMR 68
Query: 397 RIHHVNIIHLLGFCCDGSTR------ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIA 450
++ H NI+ L F + L+ +Y+P + +L +
Sbjct: 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 451 LGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSVVTMTGP 509
+ ++ Y+H I H DIKPQN+LLDPD K+ DFG AK R V+
Sbjct: 129 YQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI---------EEKKHLRPTETTSGS 560
R Y APE+ + DV+S G +L E++ L G+
Sbjct: 186 R---YYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 561 NTTEAYF---PDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVV 617
T E P++ K Q + + + + I + ++ P R +
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 618 EM--LSSASAEAIEMPPKPLFPSPPQLQTQNEIISFDSITSELPLQH 662
+++P P+ TQ E+ S + + L H
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQ-ELSSNPPLATILIPPH 347
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-41
Identities = 65/326 (19%), Positives = 122/326 (37%), Gaps = 50/326 (15%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN----FINEVATIGR-IHHVNI 403
+ LG G +G V+ +F + A+K L+K D+ + E + H +
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 404 IHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG 463
H+ + EY+ G L + + +R A + +++L
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFL--- 119
Query: 464 CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMR 523
I++ D+K N+LLD D K++DFG+ K + + GT YIAPEI +
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLG 177
Query: 524 NLGNPSGKSDVYSYGMLLLEMIEEK---KHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580
+ D +S+G+LL EM+ + E ++P W ++ E
Sbjct: 178 --QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW-----LEKEA 230
Query: 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVV---EMLSSASAEAI---EMPPKP 634
+D + P+ R + + + + E + E+ P
Sbjct: 231 KDLLV---------------KLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDP-- 273
Query: 635 LFPSPPQLQTQNEIISFDS-ITSELP 659
P P++++ + +FD +E P
Sbjct: 274 --PFRPKVKSPFDCSNFDKEFLNEKP 297
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-41
Identities = 63/327 (19%), Positives = 127/327 (38%), Gaps = 36/327 (11%)
Query: 351 KEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLG 408
+ LG G G V + A+K+L+ EV R +I+ ++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVD 72
Query: 409 FCCDGSTRA----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
+ ++ E + G L + +++ + + EI + AI+YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 465 ELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 521
+ I H D+KP+N+L P+ K++DFG AK + + S+ T T Y+APE+
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVL 185
Query: 522 MRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581
D++S G+++ ++ P + G + I+ +
Sbjct: 186 GP--EKYDKSCDMWSLGVIMYILLCGY---PPFYSNHGLAISPGMK------TRIRMGQY 234
Query: 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS-AEAIEMPPKPLFPSPP 640
+F E ++ ++ ++ ++ P R ++T E ++ ++ ++P PL S
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT---EFMNHPWIMQSTKVPQTPLHTSRV 291
Query: 641 QLQTQNEIISFDS-ITSELPLQHDSQE 666
+ + +TS L E
Sbjct: 292 LKEDKERWEDVKEEMTSALATMRVDYE 318
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (372), Expect = 2e-40
Identities = 42/285 (14%), Positives = 99/285 (34%), Gaps = 28/285 (9%)
Query: 350 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
++G G +G +++G + + VA+K + S+ + +E T + I +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVY 67
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+ ++ + SL DLL S+K + A + ++ +H E +
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAM--AAKQMLARVQSIH---EKSL 122
Query: 469 LHLDIKPQNVLLDPDFTP-----KVSDFGLAKAHSRNRS-----VVTMTGPRGTIGYIAP 518
++ DIKP N L+ + V DFG+ K + + GT Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 519 EIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578
+ S + D+ + G + + + + + + Y+++ +
Sbjct: 183 NTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT---------NKQKYERIGEK 231
Query: 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623
++ + E + + + P + + S
Sbjct: 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-40
Identities = 68/289 (23%), Positives = 116/289 (40%), Gaps = 33/289 (11%)
Query: 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS------NFSDNFINEVATIGRIHHVNII 404
+ LG G + VYK + ++VA+K ++ + + E+ + + H NII
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
LL S +L++++M + + +L L P+ + L +EYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
ILH D+KP N+LLD + K++DFGLAK+ T T Y APE+
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTRWYRAPELLFGA 175
Query: 525 LGNPSGKSDVYSYGMLLLEMI---------EEKKHLRPTETTSGSNTTEAY-----FPDW 570
D+++ G +L E++ + L T G+ T E + PD+
Sbjct: 176 RMY-GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 571 IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619
+ K + +I NP R + T+ ++M
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLI---QGLFLFNPCARITATQALKM 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 7e-40
Identities = 61/322 (18%), Positives = 117/322 (36%), Gaps = 26/322 (8%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLG 408
+G G YG V + VA+K + + + + E+ + R H NII +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
+ + Y+ +G L + + L + + ++Y+H +
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 130
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAK-AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
LH D+KP N+LL+ K+ DFGLA+ A + +T T Y APEI + + G
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 528 PSGKSDVYSYGMLLLEMI---------EEKKHLRPTETTSGSNTTE-----AYFPDWIYD 573
D++S G +L EM+ L GS + E Y
Sbjct: 191 TK-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 574 KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS-AEAIEMPP 632
+ + + K + + + NP R + + L+ + +
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE---QALAHPYLEQYYDPSD 306
Query: 633 KPLFPSPPQLQTQNEIISFDSI 654
+P+ +P + + + + + +
Sbjct: 307 EPIAEAPFKFDMELDDLPKEKL 328
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-39
Identities = 62/280 (22%), Positives = 98/280 (35%), Gaps = 44/280 (15%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN-------FINEVATIGRIH-- 399
LG+GG+G+VY G D VA+K +EK EV + ++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 400 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY 459
+I LL + + LI E DL E +L+ V A+ +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPV--QDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 460 LHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 518
+LH DIK +N+L+D + K+ DFG T GT Y P
Sbjct: 126 C---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPP 178
Query: 519 EIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578
E +R + V+S G+LL +M+ P E + +F + +
Sbjct: 179 EW-IRYHRYHGRSAAVWSLGILLYDMVCGD---IPFEHDEEIIRGQVFFRQRVSSECQ-- 232
Query: 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ WC+ + P DRP+ +
Sbjct: 233 ---HLIR---------------WCLALRPSDRPTFEEIQN 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 142 bits (358), Expect = 1e-38
Identities = 62/282 (21%), Positives = 112/282 (39%), Gaps = 24/282 (8%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLG 408
EK+G G YG VYK + G A+K + I E++ + + H NI+ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 409 FCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRI 468
L++E++ L E L+ L + + I Y H + R+
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 469 LHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNP 528
LH D+KPQN+L++ + K++DFGLA+A T T+ Y AP++ M +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGS-KKY 178
Query: 529 SGKSDVYSYGMLLLEMIEEK---KHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585
S D++S G + EM+ + + + + + K D
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 586 EEDDCIARKMIIVGL---------WCIQINPKDRPSMTRVVE 618
+ + + + GL ++++P R + + +E
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-38
Identities = 70/314 (22%), Positives = 122/314 (38%), Gaps = 46/314 (14%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLL 407
EK+G G YG VYK + G +VA+K + T I E++ + ++H NI+ LL
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
+ L++E++ + + + L + + + + H+
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHSHR--- 122
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
+LH D+KPQN+L++ + K++DFGLA+A T T+ Y APEI +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILLGC-KY 179
Query: 528 PSGKSDVYSYGMLLLEMI---------EEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578
S D++S G + EM+ E L T G+ E +P +P
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP-DEVVWPGVTSMPDYKP 238
Query: 579 EKEDFVEEEDDCIARKMIIVGL----WCIQINPKDRPSMTRVVEMLSSASAEAIEMP--- 631
+ ++ + + G + +P R S A+ P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA-----------KAALAHPFFQ 287
Query: 632 --PKPLFPSPPQLQ 643
KP+ P L+
Sbjct: 288 DVTKPV----PHLR 297
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (350), Expect = 3e-37
Identities = 77/350 (22%), Positives = 130/350 (37%), Gaps = 58/350 (16%)
Query: 338 YSYNDIKKMTNGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS----NFSDNFINEV 392
YS D + LGTG +G V+ + +GR A+KVL+K ++ +E
Sbjct: 1 YSLQDFQ-----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 55
Query: 393 ATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALG 452
+ + H II + G D +I +Y+ G L LL + + A
Sbjct: 56 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAE 112
Query: 453 VAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGT 512
V A+EYLH I++ D+KP+N+LLD + K++DFG AK GT
Sbjct: 113 VCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGT 164
Query: 513 IGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLR---PTETTSGSNTTEAYFPD 569
YIAPE+ + D +S+G+L+ EM+ +T E FP
Sbjct: 165 PDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP 222
Query: 570 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR--VVEMLS------ 621
+ + + D ++R I + R + ++ +
Sbjct: 223 FFNEDVK------------DLLSR--------LITRDLSQRLGNLQNGTEDVKNHPWFKE 262
Query: 622 ----SASAEAIEMPPKPLFPSPPQLQTQNEIISFDSITSELPLQHDSQEL 667
+ IE P +P +Q + + I + + +L
Sbjct: 263 VVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDINYGVQGEDPYADL 312
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-37
Identities = 59/290 (20%), Positives = 115/290 (39%), Gaps = 33/290 (11%)
Query: 352 EKLGTGGYGNVYKGKF--PDGRLVAVKVLEKTSNFSD------NFINEVATIGRIHHVNI 403
++G G YG V+K + GR VA+K + + + + + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 404 IHLLGFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIE 458
+ L C T L++E++ L + + + + ++ + ++
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLD 130
Query: 459 YLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAP 518
+LH R++H D+KPQN+L+ K++DFGLA+ +S ++ ++ T+ Y AP
Sbjct: 131 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---VVTLWYRAP 184
Query: 519 EIFMRNLGNPSGKSDVYSYGMLLLEMI---------EEKKHLRPTETTSGSNTTEAYFPD 569
E+ ++ + + D++S G + EM + L G E + D
Sbjct: 185 EVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 570 WIYDKLIQPEKE-DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ K +E+ I + L C+ NP R S +
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 5e-37
Identities = 60/281 (21%), Positives = 105/281 (37%), Gaps = 36/281 (12%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN-------FINEVATIGRIHHV 401
E+LG+G + V K + G A K ++K S EV+ + I H
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 402 NIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
N+I L + + LI E + G L D EKE+L+ + A + + ++
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFD-FLAEKESLTEEEATEF-----LKQILNGVY 127
Query: 462 NGCELRILHLDIKPQNVLLDPDFTP----KVSDFGLAKAHSRNRSVVTMTGPRGTIGYIA 517
L+I H D+KP+N++L P K+ DFGLA GT ++A
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVA 184
Query: 518 PEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 577
PEI ++D++S G++ ++ G E +
Sbjct: 185 PEIVNY--EPLGLEADMWSIGVITYILLSGASPFL------GDTKQETL-------ANVS 229
Query: 578 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+F +E + + +PK R ++ ++
Sbjct: 230 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 58/299 (19%), Positives = 114/299 (38%), Gaps = 42/299 (14%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLL 407
K+G G +G V+K + G+ VA+K + + F + E+ + + H N+++L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 408 GFCCDGSTRA--------LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY 459
C ++ L++++ + G L + + + R++++ L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL------NG 129
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS--VVTMTGPRGTIGYIA 517
L+ +ILH D+K NVL+ D K++DFGLA+A S ++ T T+ Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 518 PEIFMRNLGNPSGKSDVYSYGMLLLEM------------------IEEKKHLRPTETTSG 559
PE + + D++ G ++ EM I + E
Sbjct: 190 PE-LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 560 SNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ E Y + + K+ D A +I + ++P R +
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI---DKLLVLDPAQRIDSDDALN 304
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 8e-35
Identities = 72/350 (20%), Positives = 131/350 (37%), Gaps = 52/350 (14%)
Query: 338 YSYNDIKKMTNGFK------EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSN---FSDN 387
+ ++ K + + +G+G YG V G VA+K L + F+
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 388 FINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE-YMPNGSLGDLLSREKENLSLKPARL 446
E+ + + H N+I LL T + Y+ +G L + ++ L R+
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 447 LEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506
+ + + Y+H I+H D+KP N+ ++ D K+ DFGLA+ M
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EM 175
Query: 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMI---------------EEKKHL 551
TG T Y APE+ + + D++S G ++ EMI +E +
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQ-TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234
Query: 552 RPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDC--IARKMIIVGLWCIQINPKD 609
T ++ L + EK+DF + +A ++ + ++ +
Sbjct: 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL---EKMLVLDAEQ 291
Query: 610 RPSMTRVVEMLSSASAEAIEMP-PKPLFPSPPQLQTQNEIISFDSITSEL 658
R + EA+ P + L + + Q Q SFD + L
Sbjct: 292 RVTA-----------GEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTL 330
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-34
Identities = 66/335 (19%), Positives = 115/335 (34%), Gaps = 52/335 (15%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDN----FINEVATIGRIHHVNII 404
+ + LG G +G V + GR A+K+L K + + + E + H +
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 405 HLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGC 464
L + EY G L LSRE+ R + A L
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSA---LEYLH 122
Query: 465 ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
+++ DIK +N++LD D K++DFGL K + + TM GT Y+APE+ N
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDN 180
Query: 525 LGNPSGKSDVYSYGMLLLEMIEEKKHLR---PTETTSGSNTTEAYFPDWIYDKLIQPEKE 581
D + G+++ EM+ + E FP + PE +
Sbjct: 181 DYGR--AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT-----LSPEAK 233
Query: 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR--VVEMLSS--------ASAEAIEMP 631
+ ++ +PK R E++ ++
Sbjct: 234 SLLA---------------GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 278
Query: 632 PKPLFPSPPQLQTQNEIISFDSITSELPLQHDSQE 666
P P PQ+ ++ + FD + + +
Sbjct: 279 P----PFKPQVTSEVDTRYFDDEFTAQSITITPPD 309
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (332), Expect = 2e-34
Identities = 68/354 (19%), Positives = 128/354 (36%), Gaps = 52/354 (14%)
Query: 322 NVKQFIKTYRSALLSNYSYNDIKKMT-NGFK--EKLGTGGYGNVYKGKF-PDGRLVAVKV 377
+VK+F+ + L + + F + LGTG +G V K G A+K+
Sbjct: 14 SVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 378 LEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLS 433
L+K ++ +NE + ++ ++ L D S ++ EY+ G + L
Sbjct: 74 LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 434 REKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 493
R A + EYLH L +++ D+KP+N+L+D +V+DFG
Sbjct: 134 RIG---RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 494 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRP 553
AK GT +APEI + + D ++ G+L+ EM
Sbjct: 188 AKRVKGR-----TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFF- 239
Query: 554 TETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSM 613
+ Y + I ++ F + D + +Q++ R
Sbjct: 240 -----ADQPIQIY--EKIVSGKVRF-PSHFSSDLKDLLRN--------LLQVDLTKRFGN 283
Query: 614 TR--VVEMLSS--------ASAEAIEMPPKPLFPSPPQLQTQNEIISFDSITSE 657
+ V ++ + + ++ P P+ + + +FD E
Sbjct: 284 LKNGVNDIKNHKWFATTDWIAIYQRKVEA----PFIPKFKGPGDTSNFDDYEEE 333
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 8e-34
Identities = 55/284 (19%), Positives = 102/284 (35%), Gaps = 26/284 (9%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLL 407
EK+G G YG V+K K +VA+K + + + + E+ + + H NI+ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 408 GFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELR 467
L++E+ S + + + ++ L
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL------DPEIVKSFLFQLLKGLGFCHSRN 121
Query: 468 ILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGN 527
+LH D+KPQN+L++ + K+++FGLA+A + T+ Y P++
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGA-KL 178
Query: 528 PSGKSDVYSYGMLLLEMIEEKKHLRPTETTS---------GSNTTEAYFPDWIYDKLIQP 578
S D++S G + E+ + L P TE +P +P
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 579 EKEDFVEEEDDCIARKMIIVGL----WCIQINPKDRPSMTRVVE 618
+ K+ G ++ NP R S ++
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 62/276 (22%), Positives = 109/276 (39%), Gaps = 30/276 (10%)
Query: 350 FKEKLGTGGYGNVYKGK----FPDGRLVAVKVLEKTS-----NFSDNFINEVATIGRI-H 399
+ LGTG YG V+ + G+L A+KVL+K + +++ E + I
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 400 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEY 459
++ L + LI +Y+ G L LS+ + E+ + V +
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLA 141
Query: 460 LHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPE 519
L + +L I++ DIK +N+LLD + ++DFGL+K + + GTI Y+AP+
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPD 200
Query: 520 IFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579
I D +S G+L+ E++ P N+ + + P
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGA---SPFTVDGEKNSQAEISRRILKSEPPYP- 256
Query: 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTR 615
++ D I R + +PK R
Sbjct: 257 -QEMSALAKDLIQR--------LLMKDPKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (311), Expect = 8e-32
Identities = 52/295 (17%), Positives = 104/295 (35%), Gaps = 41/295 (13%)
Query: 350 FKEKLGTGGYGNVYKGK-FPDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLL 407
KLG G Y V++ + V VK+L+ E+ + + NII L
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLA 96
Query: 408 GFCCDGSTR--ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCE 465
D +R AL++E++ N L L + + A++Y H
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCH---S 147
Query: 466 LRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRN 524
+ I+H D+KP NV++D + ++ D+GLA+ + + + + PE+ +
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDY 204
Query: 525 LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETT---------------------SGSNTT 563
D++S G +L MI K+ +
Sbjct: 205 QMYDY-SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 564 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE 618
+ F D + + + E ++ + + ++ + + R + +E
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (293), Expect = 3e-29
Identities = 56/339 (16%), Positives = 119/339 (35%), Gaps = 53/339 (15%)
Query: 350 FKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLG 408
KLG G + V+ K + VA+K++ +++ +E+ + R++ +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 409 FCCDGSTRALIY-------------EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAH 455
+ + L + + G L ++ E+ + + +I+ +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 456 AIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIG 514
++Y+H C I+H DIKP+NVL++ D + +A + T T
Sbjct: 137 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 515 YIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDW---- 570
Y +PE+ + +D++S L+ E+I P E S + +
Sbjct: 195 YRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 571 -IYDKLIQPEKEDFVEEEDDCIARKMIIVGLW--------------------------CI 603
+ L++ K + R + + W +
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312
Query: 604 QINPKDRPSMTRVVE---MLSSASAEAIEMPPKPLFPSP 639
Q++P+ R +V + + E I +P + L+ S
Sbjct: 313 QLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSG 351
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 3e-28
Identities = 61/325 (18%), Positives = 110/325 (33%), Gaps = 52/325 (16%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEK---TSNFSDNFINEVATIGRIHHVNIIHLL 407
+ +G+G G V R VA+K L + + E+ + ++H NII LL
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 408 GFCCDGSTR------ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLH 461
T L+ E M + R+ + + I++LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE------RMSYLLYQMLCGIKHLH 136
Query: 462 NGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIF 521
+ I+H D+KP N+++ D T K+ DFGLA+ + MT T Y APE+
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVI 190
Query: 522 MRNLGNPSGKSDVYSYGMLLLEM------------------IEEKKHLRPTETTSGSNTT 563
+ D++S G ++ EM + E+ E T
Sbjct: 191 LGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 564 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGL-------WCIQINPKDRPSMTRV 616
+ + + F + + + + I+P R S+
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 617 VE---MLSSASAEAIEMPPKPLFPS 638
++ + +E PP ++
Sbjct: 309 LQHPYINVWYDPAEVEAPPPQIYDK 333
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-27
Identities = 62/338 (18%), Positives = 121/338 (35%), Gaps = 55/338 (16%)
Query: 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLL 407
+G+G YG+V G VAVK L + + E+ + + H N+I LL
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 408 GFCCDGSTRA-----LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN 462
+ + ++ L +++ +K L + + + ++Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFLIYQILRGLKYIH- 138
Query: 463 GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFM 522
I+H D+KP N+ ++ D K+ DFGLA+ MTG T Y APEI +
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIML 191
Query: 523 RNLGNPSGKSDVYSYGMLL------------------LEMIEEKKHLRPTETTSGSNTTE 564
+ + D++S G ++ L++I E ++
Sbjct: 192 NW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 565 AYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVE-----M 619
A ++ + + + +A ++ + ++ R + + +
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANP-LAVDLL---EKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 620 LSSASAEAIEMPPKPLFPSPPQLQTQ------NEIISF 651
E + P F S L + +E+ISF
Sbjct: 307 YHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISF 344
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 90.6 bits (224), Expect = 1e-21
Identities = 28/215 (13%), Positives = 55/215 (25%), Gaps = 52/215 (24%)
Query: 352 EKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDN-----------FINEVATIGRIHH 400
+ +G G V+ VK + F R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 401 VNIIHLLGFCC----DGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHA 456
+ L G A++ E + E ++ E+ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEE 115
Query: 457 IEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYI 516
+ ++ I+H D+ NVL+ + + DF +
Sbjct: 116 VAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG--------------- 156
Query: 517 APEIFMRNLGNPSG--------KSDVYSYGMLLLE 543
EI R++ N + D+ S +L+
Sbjct: 157 WREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 667 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.26 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.04 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.42 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.36 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.55 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-52 Score=420.52 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=198.6
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccC---CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKT---SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.++||+|+||+||+|+++ ..||||+++.. ....+.|.+|+++|++++|||||+++|++.+ ...++||||+++|
T Consensus 12 ~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g 88 (276)
T d1uwha_ 12 VGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGS 88 (276)
T ss_dssp CCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEE
T ss_pred EEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCC
Confidence 4688999999999999874 35999998754 3345789999999999999999999998754 5689999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++.... ..+++..++.|+.||++||+|||++ +||||||||+||||++++.+||+|||+|+...........
T Consensus 89 ~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 89 SLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp EHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence 9999997543 3589999999999999999999998 9999999999999999999999999999887654444444
Q ss_pred cCCCCCccccchhhhhhh-cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 507 TGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
....||+.|||||++... .+.++.++|||||||++|||+||+.||..... .......+......+.. .
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-------~~~~~~~~~~~~~~p~~----~ 232 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQIIFMVGRGYLSPDL----S 232 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHHHHHHTSCCCCG----G
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-------HHHHHHHHhcCCCCCcc----h
Confidence 566799999999999653 23578899999999999999999999964321 00111111111111111 1
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
.....+++.+.+++.+||+.||++||||+||+++|+.+.
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 112234567889999999999999999999999998654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-52 Score=419.16 Aligned_cols=251 Identities=25% Similarity=0.462 Sum_probs=196.9
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
+.++||+|+||+||+|++.+++.||||+++......++|.+|++++++++|||||+++|++.+.+..++||||+++|+|.
T Consensus 9 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~ 88 (263)
T d1sm2a_ 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88 (263)
T ss_dssp EEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred EEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHH
Confidence 56889999999999999988899999999887777789999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCC
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 509 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 509 (667)
+++... ...+++..++.|+.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++........ .....
T Consensus 89 ~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~ 162 (263)
T d1sm2a_ 89 DYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGT 162 (263)
T ss_dssp HHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred HHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce-eecce
Confidence 998654 24588999999999999999999998 9999999999999999999999999999876544332 22345
Q ss_pred CCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhhH
Q 005953 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDD 589 (667)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (667)
.||+.|+|||++.+. .++.|+|||||||++|||+|++.|+..... ...+...+..+..... +.
T Consensus 163 ~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-----------~~~~~~~i~~~~~~~~----p~ 225 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----------NSEVVEDISTGFRLYK----PR 225 (263)
T ss_dssp --CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-----------HHHHHHHHHHTCCCCC----CT
T ss_pred ecCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCCCCCC-----------HHHHHHHHHhcCCCCC----cc
Confidence 689999999999764 789999999999999999996554432211 1111222221111111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 590 CIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 590 ~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
..+..+.+++.+||+.||++||||+||+++|+++
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 2245788999999999999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=420.53 Aligned_cols=252 Identities=27% Similarity=0.445 Sum_probs=207.2
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCc
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSL 428 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 428 (667)
.+.++||+|+||+||+|++++++.||||+++......++|.+|++++++++|||||+++|++.+ +..++||||+++|+|
T Consensus 16 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L 94 (272)
T d1qpca_ 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSL 94 (272)
T ss_dssp EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBH
T ss_pred EEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcH
Confidence 4568899999999999999888999999998877777899999999999999999999998865 567999999999999
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecC
Q 005953 429 GDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTG 508 (667)
Q Consensus 429 ~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~ 508 (667)
.+++.... ...+++..+++|+.||++||+|||+. +|+||||||+||||++++.+||+|||+|+....... .....
T Consensus 95 ~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~~~~ 169 (272)
T d1qpca_ 95 VDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREG 169 (272)
T ss_dssp HHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTT
T ss_pred HHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc-ccccc
Confidence 99886543 33589999999999999999999998 999999999999999999999999999998765433 23355
Q ss_pred CCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhh
Q 005953 509 PRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588 (667)
Q Consensus 509 ~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (667)
..||+.|+|||++... .++.++|||||||++|||+||+.|+..... ...+...+..+..... +
T Consensus 170 ~~gt~~y~APE~~~~~--~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-----------~~~~~~~i~~~~~~~~----p 232 (272)
T d1qpca_ 170 AKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----------NPEVIQNLERGYRMVR----P 232 (272)
T ss_dssp CCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----------HHHHHHHHHTTCCCCC----C
T ss_pred cCCcccccChHHHhCC--CCCchhhhhhhHHHHHHHHhCCCCCCCCCC-----------HHHHHHHHHhcCCCCC----c
Confidence 6789999999999764 678999999999999999997666533211 1122233332221111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 589 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 589 ~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
..++..+.+++.+||+.||++||||+||++.|++.
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 22345788999999999999999999999999854
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-51 Score=420.68 Aligned_cols=266 Identities=25% Similarity=0.432 Sum_probs=201.2
Q ss_pred CCCHHHHHHHHHHhh-----------hhcccCCCeEEEEEEeCC-C---cEEEEEEcccCC--cchHHHHHHHHHHhhcc
Q 005953 337 NYSYNDIKKMTNGFK-----------EKLGTGGYGNVYKGKFPD-G---RLVAVKVLEKTS--NFSDNFINEVATIGRIH 399 (667)
Q Consensus 337 ~~~~~~l~~~~~~~~-----------~~LG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~ 399 (667)
.++++|+++++.+|. ++||+|+||+||+|++.. + ..||||++.... ...++|.+|+++|++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 455666666666553 579999999999998752 3 368999887543 33467999999999999
Q ss_pred cceEEeecceEecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEE
Q 005953 400 HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVL 479 (667)
Q Consensus 400 h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIl 479 (667)
|||||+++|++.+++..++||||+++|+|.+++.... ..+++.++++|+.||++||+|||+. +|+||||||+|||
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNIL 160 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEE
Confidence 9999999999999999999999999999999887543 3589999999999999999999998 9999999999999
Q ss_pred ECCCCceEEEeCCCccccCCCCceee---ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q 005953 480 LDPDFTPKVSDFGLAKAHSRNRSVVT---MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTE 555 (667)
Q Consensus 480 l~~~~~~ki~DFGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~ 555 (667)
|+.++.+||+|||+|+.......... ..+..||+.|||||.+.+ +.++.++|||||||++|||+| |+.||....
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence 99999999999999987754433221 233458999999999875 478999999999999999998 898886432
Q ss_pred cCCCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 556 TTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
. ..+...+..+..... ...++..+.+++.+||+.||++||||.||++.|+++..
T Consensus 239 ~------------~~~~~~i~~~~~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 239 N------------QDVINAIEQDYRLPP----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp H------------HHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred H------------HHHHHHHHcCCCCCC----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1 112222222221111 12235678889999999999999999999999986543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-51 Score=420.32 Aligned_cols=255 Identities=30% Similarity=0.462 Sum_probs=211.3
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
+.+.++||+|+||+||+|++. +++.||||+++.+....++|.+|+++|++++|||||+++|++.+++..++||||+++|
T Consensus 19 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g 98 (287)
T d1opja_ 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 98 (287)
T ss_dssp EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCc
Confidence 345688999999999999985 5889999999887777789999999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++.... ...+++..++.|+.||++||+|||+. +|+||||||+||||++++.+||+|||+|+........ ..
T Consensus 99 ~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~-~~ 173 (287)
T d1opja_ 99 NLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AH 173 (287)
T ss_dssp BHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-EE
T ss_pred chHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce-ee
Confidence 9999997543 35689999999999999999999998 9999999999999999999999999999977654433 33
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
.+..|++.|+|||++.+. .++.|+|||||||++|||++|+.|+..... ...+.+.+...... +
T Consensus 174 ~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----------~~~~~~~i~~~~~~----~ 236 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------LSQVYELLEKDYRM----E 236 (287)
T ss_dssp TTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----------HHHHHHHHHTTCCC----C
T ss_pred ccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcch-----------HHHHHHHHhcCCCC----C
Confidence 555689999999999764 789999999999999999998776643221 11122222222111 1
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
....++..+.+++.+||+.||++||||+||++.|+...
T Consensus 237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11223557889999999999999999999999998653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=411.76 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=200.3
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.+.++||+|+||+||+|++. +|+.||||++.... ...+.+.+|+++|++++|||||++++++.+++..++||||+++
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 87 (271)
T d1nvra_ 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG 87 (271)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCC
Confidence 35688999999999999985 69999999986543 3345789999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+..........
T Consensus 88 g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 88 GELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp EEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 9999999653 3589999999999999999999998 999999999999999999999999999998765544333
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.+...||+.|||||++.+. ...+.++|||||||++|||++|+.||...... . .. ......... ..
T Consensus 162 ~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~------~----~~-~~~~~~~~~---~~ 226 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------C----QE-YSDWKEKKT---YL 226 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT------S----HH-HHHHHTTCT---TS
T ss_pred ccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCChH------H----HH-HHHHhcCCC---CC
Confidence 4567799999999999764 23467899999999999999999999643221 0 00 111111111 01
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.....++..+.+++.+||+.||++|||++|++++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112234567789999999999999999998753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=405.16 Aligned_cols=249 Identities=27% Similarity=0.437 Sum_probs=210.2
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
+.++||+|+||+||+|++++++.||||+++......++|.+|+.++++++||||++++|++.+.+..++||||+++|+|.
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~ 87 (258)
T d1k2pa_ 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87 (258)
T ss_dssp CCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred EeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence 56899999999999999988899999999987777789999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeecCC
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMTGP 509 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~ 509 (667)
+++.... ..+++..+.+++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++........ .....
T Consensus 88 ~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~ 161 (258)
T d1k2pa_ 88 NYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGS 161 (258)
T ss_dssp HHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCS
T ss_pred Hhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce-eeccc
Confidence 9976543 3588999999999999999999998 9999999999999999999999999999876554332 33456
Q ss_pred CCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchhh
Q 005953 510 RGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEED 588 (667)
Q Consensus 510 ~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (667)
.||+.|+|||.+... .++.|+|||||||++|||+| |+.||..... ..+...+..+..... +
T Consensus 162 ~~t~~y~aPE~~~~~--~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~------------~~~~~~i~~~~~~~~----p 223 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------------SETAEHIAQGLRLYR----P 223 (258)
T ss_dssp CCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH------------HHHHHHHHTTCCCCC----C
T ss_pred CCCCCcCCcHHhcCC--CCCcceeecccchhhHhHHhcCCCCCCCCCH------------HHHHHHHHhCCCCCC----c
Confidence 799999999999864 78899999999999999998 7888864321 122333333222111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 005953 589 DCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSS 622 (667)
Q Consensus 589 ~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 622 (667)
...++.+.+++.+||+.||++|||++|++++|.+
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 2234578899999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=403.63 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=202.3
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
|.+.++||+|+||+||+|+.. +|+.||||++.... ...+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 345688999999999999874 69999999987543 4457799999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
|+|.+++.+. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+........
T Consensus 102 g~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-- 172 (293)
T d1yhwa1 102 GSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172 (293)
T ss_dssp CBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--
T ss_pred CcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccccc--
Confidence 9999987543 489999999999999999999998 9999999999999999999999999999877544332
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+......... . .
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----------~~~~~~~~~~~~~-~--~ 236 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----------LRALYLIATNGTP-E--L 236 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHHHHHHHHHCSC-C--C
T ss_pred ccccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCH-----------HHHHHHHHhCCCC-C--C
Confidence 2445699999999999764 678999999999999999999999964321 0111111111100 0 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.....++..+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122345678889999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=403.68 Aligned_cols=254 Identities=25% Similarity=0.418 Sum_probs=201.7
Q ss_pred HHhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
+++.++||+|+||+||+|++++++.||||+++......+.|.+|+.++++++|||||+++|++.+ +..++||||+++|+
T Consensus 19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~ 97 (285)
T d1fmka3 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS 97 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCc
Confidence 45678999999999999999888889999998777777889999999999999999999999865 56789999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|.+++.... ...+++..++.|+.||+.||+|||+. +|+||||||+||||++++++||+|||+|+........ ...
T Consensus 98 l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~ 172 (285)
T d1fmka3 98 LLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQ 172 (285)
T ss_dssp HHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred hhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce-eec
Confidence 999987643 33589999999999999999999998 9999999999999999999999999999876544322 234
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccchh
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEEE 587 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (667)
...||+.|+|||++.. +.++.++||||||+++|||++|+.|+..... ...+...+........
T Consensus 173 ~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-----------~~~~~~~i~~~~~~~~---- 235 (285)
T d1fmka3 173 GAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----------NREVLDQVERGYRMPC---- 235 (285)
T ss_dssp ---CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----------HHHHHHHHHTTCCCCC----
T ss_pred cccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-----------HHHHHHHHHhcCCCCC----
Confidence 4668999999999976 4789999999999999999998776543221 1112222222211111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 588 DDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 588 ~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
...+++.+.+++.+||+.||++||||++|+++|+...
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 1223557889999999999999999999999998543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=395.48 Aligned_cols=243 Identities=28% Similarity=0.427 Sum_probs=202.5
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.+.+.||+|+||+||+|++. +++.||+|++... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 346689999999999999985 6899999998642 34457789999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.+++.... .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 88 ~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 161 (263)
T d2j4za1 88 APLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161 (263)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred cCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence 99999999997543 589999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
....||+.|||||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 162 ----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~------------~~~~~~i~~~~~~- 222 (263)
T d2j4za1 162 ----TTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTY------------QETYKRISRVEFT- 222 (263)
T ss_dssp ----EETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHTTCCC-
T ss_pred ----cccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCH------------HHHHHHHHcCCCC-
Confidence 235689999999999764 678999999999999999999999964321 1222222222211
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.+..+++.+.+++.+||+.||++|||++|++++
T Consensus 223 ----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 223 ----FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 111234578889999999999999999999863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=402.54 Aligned_cols=247 Identities=26% Similarity=0.428 Sum_probs=198.0
Q ss_pred hhcccCCCeEEEEEEeC---CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKFP---DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
++||+|+||+||+|.+. .++.||||+++... ...++|.+|+++|++++|||||+++|+|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 25689999986542 234679999999999999999999999865 567899999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee-
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV- 504 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~- 504 (667)
|+|.+++.+. ..+++..+++|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 9999998753 3589999999999999999999998 99999999999999999999999999998876544332
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
......||+.|+|||.+... .++.++|||||||++|||+| |+.||..... ..+...+..+.....
T Consensus 166 ~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~------------~~~~~~i~~~~~~~~ 231 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------------SEVTAMLEKGERMGC 231 (277)
T ss_dssp C----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------HHHHHHHHTTCCCCC
T ss_pred cccccCCCceecCchhhcCC--CCCchhhhccchhhhhHHhhCCCCCCCCCCH------------HHHHHHHHcCCCCCC
Confidence 22345689999999999764 67899999999999999998 8999864321 112233333222111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
+..++..+.+++.+||+.||++|||+++|++.|+..
T Consensus 232 ----p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 232 ----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 122356788999999999999999999999998753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=404.39 Aligned_cols=253 Identities=25% Similarity=0.398 Sum_probs=195.2
Q ss_pred hhhhcccCCCeEEEEEEeCCC-----cEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFPDG-----RLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~-----~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.++||+|+||+||+|++.+. ..||||++.... ...++|.+|++++++++|||||+++|++.+.+..++||||
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence 347899999999999987532 479999986543 3345799999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+.+|++.+++... ...+++..+++++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+|+.......
T Consensus 91 ~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 91 MENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp CTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred cccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 9999999887654 24689999999999999999999998 999999999999999999999999999987654332
Q ss_pred e-eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 503 V-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 503 ~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
. .......||+.|+|||++.+ +.++.++|||||||++|||++|+.|+..... ...+...+..+...
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-----------~~~~~~~i~~~~~~ 232 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELS-----------NHEVMKAINDGFRL 232 (283)
T ss_dssp --------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------HHHHHHHHHTTCCC
T ss_pred cceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCC-----------HHHHHHHHhccCCC
Confidence 2 22344568999999999976 4788999999999999999997666543211 11223333332221
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
.. +...+..+.+++.+||+.||++||||.||++.|+++.
T Consensus 233 ~~----~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 233 PT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp CC----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CC----chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 11 1123457889999999999999999999999998543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=402.17 Aligned_cols=247 Identities=23% Similarity=0.379 Sum_probs=201.2
Q ss_pred hcccCCCeEEEEEEeC---CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCCC
Q 005953 353 KLGTGGYGNVYKGKFP---DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNGS 427 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 427 (667)
+||+|+||+||+|.+. ++..||||+++... ...++|.+|+++|++++|||||+++|++.+ +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999764 35589999997643 334689999999999999999999999865 56899999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee-ee
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV-TM 506 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~-~~ 506 (667)
|.+++.... ..+++..+.+|+.|+++||+|||++ +|+||||||+||||+.++.+||+|||+|+......... ..
T Consensus 95 L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (285)
T d1u59a_ 95 LHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169 (285)
T ss_dssp HHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred HHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccc
Confidence 999885432 3589999999999999999999998 99999999999999999999999999999876544332 22
Q ss_pred cCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccc
Q 005953 507 TGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVE 585 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (667)
....||+.|+|||++... .++.++|||||||++|||+| |+.||..... ..+...+..+.....
T Consensus 170 ~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~------------~~~~~~i~~~~~~~~-- 233 (285)
T d1u59a_ 170 SAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------------PEVMAFIEQGKRMEC-- 233 (285)
T ss_dssp CSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT------------HHHHHHHHTTCCCCC--
T ss_pred cccccCccccChHHHhCC--CCCccchhhcchHHHHHHHhCCCCCCCCCCH------------HHHHHHHHcCCCCCC--
Confidence 345689999999999764 78899999999999999998 8999864321 112233333222111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 586 EEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 586 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
+..++..+.+++.+||+.||++||||.+|++.|+..
T Consensus 234 --p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 234 --PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp --CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 123456788999999999999999999999999854
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=413.65 Aligned_cols=254 Identities=28% Similarity=0.422 Sum_probs=203.4
Q ss_pred HHhhhhcccCCCeEEEEEEeCC-C-----cEEEEEEcccC--CcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPD-G-----RLVAVKVLEKT--SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~-~-----~~vavK~l~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 418 (667)
+.+.++||+|+||+||+|++.. + ..||||++... ......+.+|+.+|.++ +|||||++++++.+.+..++
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 118 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEE
Confidence 3466899999999999998742 2 36999998654 23456799999999998 89999999999999999999
Q ss_pred EEEEcCCCCcccccccccc--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcE
Q 005953 419 IYEYMPNGSLGDLLSREKE--------------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNV 478 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NI 478 (667)
||||+++|+|.++|+.... ...+++..++.|+.|+++||+|||++ +|+||||||+||
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Ni 195 (325)
T d1rjba_ 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNV 195 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGE
T ss_pred EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhcc
Confidence 9999999999999975421 23589999999999999999999998 999999999999
Q ss_pred EECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcC
Q 005953 479 LLDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETT 557 (667)
Q Consensus 479 ll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~ 557 (667)
|++.++.+||+|||+|+...............||+.|||||++.+ +.++.++|||||||++|||+| |+.||.....
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~- 272 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV- 272 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCCCCCCCH-
Confidence 999999999999999988766555444455668999999999976 478999999999999999998 8999864322
Q ss_pred CCCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 005953 558 SGSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLS 621 (667)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 621 (667)
. ..+...+..+... +.+...+..+.+++.+||+.||++||||+||+++|.
T Consensus 273 ------~----~~~~~~~~~~~~~----~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 ------D----ANFYKLIQNGFKM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp ------S----HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ------H----HHHHHHHhcCCCC----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 0 1111222121111 111223457889999999999999999999999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=404.83 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=190.1
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEec--CCeeEEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD--GSTRALIYEY 422 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~ 422 (667)
.+.+.||+|+||+||+|+.. +|+.||||++.... ...+.+.+|++++++++|||||++++++.+ ....++||||
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy 86 (269)
T d2java1 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 86 (269)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEEC
T ss_pred EEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEec
Confidence 45688999999999999875 68999999987653 234568999999999999999999999865 4568999999
Q ss_pred cCCCCcccccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeeecCCCCCcEEECCCCceEEEeCCCccccCC
Q 005953 423 MPNGSLGDLLSRE-KENLSLKPARLLEIALGVAHAIEYLHNGC--ELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 423 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~gl~yLH~~~--~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~ 499 (667)
+++|+|.+++.+. .....+++..++.++.|++.||+|||+.. ..+|+||||||+||||++++.+||+|||+|+....
T Consensus 87 ~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 166 (269)
T d2java1 87 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166 (269)
T ss_dssp CTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred CCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence 9999999999753 23457999999999999999999999851 12499999999999999999999999999988765
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
.... .....||+.|||||++.+. .++.++|||||||++|||++|+.||..... ..+...+....
T Consensus 167 ~~~~--~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~~~------------~~~~~~i~~~~ 230 (269)
T d2java1 167 DTSF--AKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ------------KELAGKIREGK 230 (269)
T ss_dssp -----------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------------HHHHHHHHHTC
T ss_pred CCCc--cccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCCCH------------HHHHHHHHcCC
Confidence 4322 2346789999999999763 788999999999999999999999964321 11222222222
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.... +..++..+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 231 FRRI----PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1111 12235578889999999999999999999853
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=394.85 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=196.6
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEec----CCeeEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD----GSTRALIY 420 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~~~lV~ 420 (667)
+|.++||+|+||+||+|++. +++.||+|++.... ...+.|.+|+++|++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 35578999999999999985 58899999986543 234678999999999999999999999865 34679999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC-CCCceEEEeCCCccccCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD-PDFTPKVSDFGLAKAHSR 499 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~-~~~~~ki~DFGla~~~~~ 499 (667)
||+++|+|.+++.+.. .+++..+..++.||++||+|||++ .++|+||||||+||||+ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999997543 589999999999999999999987 12399999999999996 578999999999986544
Q ss_pred CCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 500 NRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 500 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
... ....||+.|||||++.+ .++.++|||||||++|||++|+.||..... ...+...+..+.
T Consensus 168 ~~~----~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-----------~~~~~~~i~~~~ 229 (270)
T d1t4ha_ 168 SFA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQN-----------AAQIYRRVTSGV 229 (270)
T ss_dssp TSB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----------HHHHHHHHTTTC
T ss_pred Ccc----CCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCccc-----------HHHHHHHHHcCC
Confidence 332 23569999999999863 588999999999999999999999964321 122333333322
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.... ........+.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~---~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 230 KPAS---FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CCGG---GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCcc---cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 2111 111234467889999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-49 Score=398.53 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=200.8
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.+.+.||+|+||+||+|+.. +|+.||||++... ....+.+.+|+++|++++||||+++++++.+.+..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 346689999999999999985 6899999998642 34457799999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 90 ~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 90 AKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999887543 589999999999999999999998 999999999999999999999999999998765444
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------~~~~~~i~~~~~~- 228 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE------------YLIFQKIIKLEYD- 228 (288)
T ss_dssp ------CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHTTCCC-
T ss_pred ccccccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCCcCH------------HHHHHHHHcCCCC-
Confidence 3334456799999999999764 678999999999999999999999964321 1223333322211
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
. +..++..+.+++.+||+.||++|||++|++++
T Consensus 229 ~----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 229 F----PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp C----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred C----CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1 11234567889999999999999999997654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=401.74 Aligned_cols=250 Identities=23% Similarity=0.359 Sum_probs=201.8
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
++.++||+|+||+||+|++. +++.||||++.... ...+.+.+|+++|++++|||||++++++.+.+..++||||+++|
T Consensus 15 ~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g 94 (288)
T d2jfla1 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCC
Confidence 45678999999999999985 68999999997643 45578999999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTM 506 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~ 506 (667)
+|.+++.+.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....... ..
T Consensus 95 ~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~--~~ 167 (288)
T d2jfla1 95 AVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RR 167 (288)
T ss_dssp EHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--HH
T ss_pred cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc--cc
Confidence 9999886532 3589999999999999999999998 999999999999999999999999999976543211 12
Q ss_pred cCCCCCccccchhhhhhh---cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 507 TGPRGTIGYIAPEIFMRN---LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 507 ~~~~gt~~y~aPE~~~~~---~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
....||+.|+|||++... ...++.++|||||||++|||++|+.||...... .+...+........
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~------------~~~~~i~~~~~~~~ 235 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM------------RVLLKIAKSEPPTL 235 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG------------GHHHHHHHSCCCCC
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH------------HHHHHHHcCCCCCC
Confidence 345699999999998532 235788999999999999999999999653220 01111111111111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.....++..+.+++.+||+.||++|||++|++++
T Consensus 236 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 --AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122345678899999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-49 Score=403.77 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=198.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc----chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+...++||+|+||+||+|+.. +++.||||++..... ..+.+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 445678999999999999874 689999999876532 235689999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+.....
T Consensus 97 ~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 97 CLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp CSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred cCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 9999997666443 3589999999999999999999998 9999999999999999999999999999865432
Q ss_pred eeeecCCCCCccccchhhhhhh-cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRN-LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
....||+.|||||++.+. .+.++.++|||||||++|||++|+.||..... ... ...+......
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-----------~~~-~~~i~~~~~~ 232 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSA-LYHIAQNESP 232 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------HHH-HHHHHHSCCC
T ss_pred ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-----------HHH-HHHHHhCCCC
Confidence 234699999999998642 24678999999999999999999999864321 111 1111111111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
... ...++..+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 233 ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 111 11234578889999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=410.67 Aligned_cols=261 Identities=21% Similarity=0.335 Sum_probs=200.5
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
+.+.++||+|+||+||+|++. +|+.||+|+++... ...+.+.+|+.+|++++|||||++++++.+.+..++||||++
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~ 87 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 87 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 345688999999999999975 68999999987543 335679999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHN-GCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
+|+|.+++.+.. .+++..+..++.|+++||+|||+ + +|+||||||+||||++++.+||+|||+|+......
T Consensus 88 gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 159 (322)
T d1s9ja_ 88 GGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 159 (322)
T ss_dssp TEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred CCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence 999999997543 58999999999999999999996 4 79999999999999999999999999998764322
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCC----------CCCccccchHH---
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG----------SNTTEAYFPDW--- 570 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~----------~~~~~~~~~~~--- 570 (667)
.....||+.|+|||++.+. .++.++||||+||++|||++|+.||........ ..........+
T Consensus 160 --~~~~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 160 --ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp --C---CCSSCCCCHHHHHCS--CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred --cccccCCccccCchHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 1345799999999999864 789999999999999999999999965432100 00000000000
Q ss_pred -----------------HHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhc
Q 005953 571 -----------------IYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM--LSSA 623 (667)
Q Consensus 571 -----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~--L~~~ 623 (667)
............ ......+..+.+++.+||+.||++|||++|++++ +++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPK---LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCC---CCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCcc---CccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 000000000000 0001124568889999999999999999999985 5543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-48 Score=400.14 Aligned_cols=254 Identities=25% Similarity=0.416 Sum_probs=204.1
Q ss_pred HhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
.+.++||+|+||+||+|++. +++.||||+++.... ..++|.+|+++|++++||||+++++++.+....++||
T Consensus 16 ~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~ 95 (301)
T d1lufa_ 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF 95 (301)
T ss_dssp EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEE
Confidence 35688999999999999863 357899999976442 3467999999999999999999999999999999999
Q ss_pred EEcCCCCccccccccc---------------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEE
Q 005953 421 EYMPNGSLGDLLSREK---------------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVL 479 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIl 479 (667)
||+++|+|.+++.... ....+++..++.|+.|++.||+|||+. +||||||||+|||
T Consensus 96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NIL 172 (301)
T d1lufa_ 96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL 172 (301)
T ss_dssp ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceE
Confidence 9999999999986422 123588999999999999999999998 9999999999999
Q ss_pred ECCCCceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCC-CCCCCCcCC
Q 005953 480 LDPDFTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK-HLRPTETTS 558 (667)
Q Consensus 480 l~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~-p~~~~~~~~ 558 (667)
||.++.+||+|||+|+...........+...||+.|+|||.+.+. .++.++|||||||++|||++|.. |+.....
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~-- 248 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-- 248 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC--CCChhhhhccchhhHHHHHccCCCCCCCCCH--
Confidence 999999999999999876544433333456689999999999864 78999999999999999999964 5543221
Q ss_pred CCCCccccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 559 GSNTTEAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
..+...+.++..... +..++..+.+++.+||+.+|++||||.||+++|+++
T Consensus 249 ----------~e~~~~v~~~~~~~~----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 249 ----------EEVIYYVRDGNILAC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp ----------HHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ----------HHHHHHHHcCCCCCC----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 122233333322111 122345788999999999999999999999999964
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-48 Score=396.43 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=187.7
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
|.+.+.||+|+||+||+|++. +++.||||++.... ...+.+.+|+.+|++++|||||++++++.+++..++||||++
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 456789999999999999985 68999999987543 334568899999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC---CCCceEEEeCCCccccCCCC
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD---PDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~---~~~~~ki~DFGla~~~~~~~ 501 (667)
+|+|.++|... ..+++..+..++.||+.||+|||+. +|+||||||+|||+. +++.+||+|||+|+......
T Consensus 91 gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 91 GGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp SCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred CCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 99999999653 3599999999999999999999998 999999999999994 57899999999998765443
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
. .....||+.|||||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 165 ~---~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------~~~~~~i~~~~~~ 227 (307)
T d1a06a_ 165 V---LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDEND------------AKLFEQILKAEYE 227 (307)
T ss_dssp -----------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------------HHHHHHHHTTCCC
T ss_pred e---eeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCH------------HHHHHHHhccCCC
Confidence 2 2345699999999999764 678999999999999999999999964321 1122222222211
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
. .......++..+.+++.+||+.||++|||++|++++
T Consensus 228 ~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 F-DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp C-CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C-CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1 111122345678899999999999999999999985
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=391.99 Aligned_cols=272 Identities=23% Similarity=0.301 Sum_probs=203.0
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCC----eeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGS----TRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----~~~lV~e~~~~ 425 (667)
+.++||+|+||+||+|++ +|+.||||+++........+..|+..+.+++|||||++++++.+.+ ..++||||+++
T Consensus 7 l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~ 85 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence 457899999999999998 6889999999765443333445666677889999999999998654 57899999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNG-----CELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~-----~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
|+|.++|++. .+++..+++++.|++.||+|||+. .+++|+||||||+||||++++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~ 161 (303)
T d1vjya_ 86 GSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence 9999999754 489999999999999999999963 1359999999999999999999999999999877554
Q ss_pred Ccee--eecCCCCCccccchhhhhhhcC----CCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC---CCccccchHHH
Q 005953 501 RSVV--TMTGPRGTIGYIAPEIFMRNLG----NPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS---NTTEAYFPDWI 571 (667)
Q Consensus 501 ~~~~--~~~~~~gt~~y~aPE~~~~~~~----~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~ 571 (667)
.... ......||++|+|||++..... .++.|+|||||||++|||+||..|+......... ..........+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T d1vjya_ 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence 4332 2235679999999999865311 2466899999999999999999887543221110 00111122233
Q ss_pred HHhhcCcccc-ccc-chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 572 YDKLIQPEKE-DFV-EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 572 ~~~~~~~~~~-~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
.......... ... ........+.+.+++.+||+.||++||||.||+++|+++..+
T Consensus 242 ~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 3333322221 111 111233556789999999999999999999999999866543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=389.50 Aligned_cols=247 Identities=29% Similarity=0.457 Sum_probs=194.2
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecC-CeeEEEEEEcCCCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDG-STRALIYEYMPNGS 427 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-~~~~lV~e~~~~gs 427 (667)
.+.++||+|+||.||+|++ .|+.||||+++.+. ..+.|.+|++++++++||||++++|++.+. +..++||||+++|+
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~ 87 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87 (262)
T ss_dssp EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred EEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence 3568899999999999999 57889999997654 457899999999999999999999998654 56899999999999
Q ss_pred ccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceeeec
Q 005953 428 LGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVTMT 507 (667)
Q Consensus 428 L~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~ 507 (667)
|.++|.... ...+++..+++|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 88 L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~ 158 (262)
T d1byga_ 88 LVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----D 158 (262)
T ss_dssp HHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred HHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC-----c
Confidence 999996532 23589999999999999999999998 99999999999999999999999999998754332 2
Q ss_pred CCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccccch
Q 005953 508 GPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFVEE 586 (667)
Q Consensus 508 ~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (667)
...+|..|+|||++.+. .++.++||||||+++|||+| |+.|+..... ..+...+........
T Consensus 159 ~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~~~~~------------~~~~~~i~~~~~~~~--- 221 (262)
T d1byga_ 159 TGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------------KDVVPRVEKGYKMDA--- 221 (262)
T ss_dssp ---CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG------------GGHHHHHTTTCCCCC---
T ss_pred cccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCCCCCH------------HHHHHHHHcCCCCCC---
Confidence 23578999999999764 78999999999999999998 6766653321 112222332222222
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 587 EDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 587 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
+......+.+++.+||+.||++||||.||+++|+++.
T Consensus 222 -~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 222 -PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1223457889999999999999999999999998654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=394.06 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=202.0
Q ss_pred HhhhhcccCCCeEEEEEEeCC----CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEec-CCeeEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCD-GSTRALIYE 421 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~lV~e 421 (667)
+|.++||+|+||+||+|++.+ ...||||+++... ...++|.+|+++|++++|||||+++|++.+ +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 456789999999999998753 2368999987533 334679999999999999999999999876 458899999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++... ....++..+++++.|+++||.|||+. +|+||||||+||||++++.+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999998754 33577888999999999999999998 99999999999999999999999999998765443
Q ss_pred cee--eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcc
Q 005953 502 SVV--TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPE 579 (667)
Q Consensus 502 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 579 (667)
... ......||+.|+|||.+.. +.++.++||||||+++|||++|+.|+...... ......+ ..+.
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-------~~~~~~i----~~g~ 251 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-------FDITVYL----LQGR 251 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHH----HTTC
T ss_pred cccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-------HHHHHHH----HcCC
Confidence 221 2234568999999999976 47899999999999999999988887543211 1111222 2221
Q ss_pred cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 580 KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 580 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
.... +......+.+++.+||+.||++||+|.||+++|+++..
T Consensus 252 ~~~~----p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 252 RLLQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC----cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111 11234568899999999999999999999999997644
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=397.71 Aligned_cols=253 Identities=25% Similarity=0.428 Sum_probs=197.7
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCc----EEEEEEcccC--CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGR----LVAVKVLEKT--SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~l~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
++.++||+|+||+||+|++. +|+ .||+|+++.. ....++|.+|++++++++|||||+++|+|.++ ..++++|
T Consensus 12 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e 90 (317)
T d1xkka_ 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQ 90 (317)
T ss_dssp EEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred EEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEE
Confidence 45689999999999999874 344 6899988643 34567899999999999999999999999865 5678899
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+.+|+|.+++... ...+++..+++|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+|+......
T Consensus 91 ~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 91 LMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp CCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 99999999988654 34689999999999999999999998 99999999999999999999999999999876655
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
.........||+.|+|||++.+. .++.++|||||||++|||+| |+.||..... .. +...+..+..
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--------~~----~~~~i~~~~~ 231 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SE----ISSILEKGER 231 (317)
T ss_dssp C--------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--------GG----HHHHHHHTCC
T ss_pred ccccccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--------HH----HHHHHHcCCC
Confidence 54444556789999999999764 78999999999999999998 7777754321 11 1122221111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
.. .+..++..+.+++.+||+.||++|||+.||+++|+....
T Consensus 232 ~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 232 LP----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC----CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 11 111234578889999999999999999999999986543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=386.07 Aligned_cols=248 Identities=23% Similarity=0.296 Sum_probs=202.7
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-------cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-------NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 419 (667)
|.+.+.||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+.+..++|
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 91 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 456789999999999999984 69999999986432 2356899999999999999999999999999999999
Q ss_pred EEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC----ceEEEeCCCcc
Q 005953 420 YEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF----TPKVSDFGLAK 495 (667)
Q Consensus 420 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~----~~ki~DFGla~ 495 (667)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+|+
T Consensus 92 ~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 92 LELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999999997543 599999999999999999999998 999999999999998876 49999999998
Q ss_pred ccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh
Q 005953 496 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575 (667)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (667)
........ ....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+
T Consensus 166 ~~~~~~~~---~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------~~~~~~i 228 (293)
T d1jksa_ 166 KIDFGNEF---KNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTK------------QETLANV 228 (293)
T ss_dssp ECTTSCBC---SCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHH
T ss_pred hcCCCccc---cccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCH------------HHHHHHH
Confidence 77544332 345689999999999763 678999999999999999999999964321 1112222
Q ss_pred cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
...... ........++..+.+++.+||+.||++|||++|++++
T Consensus 229 ~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 229 SAVNYE-FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HTTCCC-CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HhcCCC-CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 221111 1111122345678899999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.5e-47 Score=395.63 Aligned_cols=249 Identities=21% Similarity=0.295 Sum_probs=202.9
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
|.+.++||+|+||+||+|+.. +|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+.+..++||||+++
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 107 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 345688999999999999985 69999999997654 3346788999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC--CCCceEEEeCCCccccCCCCce
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD--PDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~--~~~~~ki~DFGla~~~~~~~~~ 503 (667)
|+|.+++.... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+|+........
T Consensus 108 g~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 108 GELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred CCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 99999986432 3589999999999999999999998 999999999999995 4688999999999987655443
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
. ...||+.|||||++.+. .++.++|||||||++|||++|+.||..... ..+...+..... ..
T Consensus 183 ~---~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~------------~~~~~~i~~~~~-~~ 244 (350)
T d1koaa2 183 K---VTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGEND------------DETLRNVKSCDW-NM 244 (350)
T ss_dssp E---EECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHTCC-CS
T ss_pred c---eecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCC-CC
Confidence 2 34589999999999764 678899999999999999999999964321 111222211111 01
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.......+++.+.+++.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111122345678889999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=394.17 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=193.7
Q ss_pred HHhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCC--cchHHHHHHHHHHhhc-ccceEEeecceEecC-CeeE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTS--NFSDNFINEVATIGRI-HHVNIIHLLGFCCDG-STRA 417 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~-~~~~ 417 (667)
+.+.++||+|+||+||+|++. +++.||||+++... ...+.+.+|+..+.++ +|+||+.+++++.+. ...+
T Consensus 15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~ 94 (299)
T d1ywna1 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 94 (299)
T ss_dssp EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence 446689999999999999863 34689999997543 3346788899988888 689999999988764 4689
Q ss_pred EEEEEcCCCCcccccccccc-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC
Q 005953 418 LIYEYMPNGSLGDLLSREKE-------------NLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF 484 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~ 484 (667)
+||||+++|+|.++|..... ...+++..++.++.||++||+|||++ +|+||||||+||||++++
T Consensus 95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCC
Confidence 99999999999999975321 23588999999999999999999998 999999999999999999
Q ss_pred ceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCC-CCCCCCcCCCCCCc
Q 005953 485 TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK-HLRPTETTSGSNTT 563 (667)
Q Consensus 485 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~-p~~~~~~~~~~~~~ 563 (667)
.+||+|||+|+...............||+.|+|||++.+. .++.++|||||||++|||++|.. ||.....
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~------- 242 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------- 242 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-------
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCH-------
Confidence 9999999999876655444444556799999999999764 78999999999999999999754 5543221
Q ss_pred cccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 564 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
...+...+..+..... +...+..+.+++.+||+.||++|||++||+++|+.+
T Consensus 243 ----~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 243 ----DEEFCRRLKEGTRMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp ----SHHHHHHHHHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHHhcCCCCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112222222111111 112345688999999999999999999999999854
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=391.72 Aligned_cols=244 Identities=24% Similarity=0.342 Sum_probs=201.9
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEc
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
.+.+.||+|+||+||+|+.. +|+.||||++.+. ....+.+.+|+.+|++++||||+++++++.+.+..++||||+
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~ 87 (337)
T d1o6la_ 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceecc
Confidence 45689999999999999984 6999999998753 334577899999999999999999999999999999999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCce
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~ 503 (667)
++|+|.+++.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+........
T Consensus 88 ~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 88 NGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp TTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred CCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 9999999987643 589999999999999999999998 9999999999999999999999999999876543322
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 162 --~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~~------------~~~~~~i~~~~~~-- 223 (337)
T d1o6la_ 162 --MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------ERLFELILMEEIR-- 223 (337)
T ss_dssp --BCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCCC--
T ss_pred --cccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcCH------------HHHHHHHhcCCCC--
Confidence 2345699999999999764 678999999999999999999999965432 1112222211111
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEM 619 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~~ 619 (667)
.+..++..+.+++.+||+.||++||+ ++|++++
T Consensus 224 ---~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 ---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11223556788999999999999994 8888875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=390.87 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=192.1
Q ss_pred HHhhhhcccCCCeEEEEEEeCC----CcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFPD----GRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
+.+.+.||+|+||+||+|++.. +..||||+++... ...+.|.+|+.++++++|||||+++|++. .+..++|||
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E 87 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 87 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEE
Confidence 4466899999999999998742 3578999986543 33467999999999999999999999986 467899999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++... ...+++..++.++.||++||+|||+. +|+||||||+||++++++.+||+|||+|+......
T Consensus 88 ~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 88 LCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp CCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred eccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 99999999987643 34689999999999999999999998 99999999999999999999999999998765443
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
.. ..+...||+.|+|||++... .++.++|||||||++|||++ |+.|+..... ..+...+.....
T Consensus 163 ~~-~~~~~~gt~~y~apE~l~~~--~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~------------~~~~~~i~~~~~ 227 (273)
T d1mp8a_ 163 YY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKN------------NDVIGRIENGER 227 (273)
T ss_dssp ---------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG------------GGHHHHHHTTCC
T ss_pred ce-eccceecCcccchhhHhccC--CCCCccccccchHHHHHHHhcCCCCCCCCCH------------HHHHHHHHcCCC
Confidence 32 22345689999999999764 78899999999999999998 7888864432 112222322222
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
... +..++..+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 228 ~~~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 228 LPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111 1234567889999999999999999999999998653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=387.96 Aligned_cols=252 Identities=28% Similarity=0.413 Sum_probs=192.7
Q ss_pred HhhhhcccCCCeEEEEEEeC--CC--cEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP--DG--RLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~--~~--~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
++.+.||+|+||+||+|++. ++ ..||||+++.. ....++|.+|+++|++++|||||+++|++.+ ...++||
T Consensus 11 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~ 89 (273)
T d1u46a_ 11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVT 89 (273)
T ss_dssp EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred EEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheee
Confidence 45688999999999999863 23 37899998753 2334689999999999999999999999976 4678999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||+++|+|.+++.... ..+++..+++++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 90 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 90 ELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp ECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 9999999999886543 3589999999999999999999998 9999999999999999999999999999987555
Q ss_pred Cceee-ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 501 RSVVT-MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 501 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
..... .....|+..|+|||++.+. .++.++||||||+++|||+| |+.||..... ..+...+...
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------------~~~~~~i~~~ 230 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------------SQILHKIDKE 230 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------HHHHHHHHTS
T ss_pred CCcceecCccccCcccCCHHHHhCC--CCCcchhhhhhHHHHHHHHhCCCCCCCCcCH------------HHHHHHHHhC
Confidence 43322 2345578999999999864 78889999999999999998 8999864322 1112222221
Q ss_pred ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 579 EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 579 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
.... +....++..+.+++.+||+.||++||||.||++.|+++
T Consensus 231 ~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 GERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111 11122345788999999999999999999999999865
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.1e-47 Score=394.82 Aligned_cols=249 Identities=22% Similarity=0.325 Sum_probs=203.2
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
|++.++||+|+||+||+|+.. +|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+++..++||||+++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 456689999999999999974 69999999987654 3345788999999999999999999999999999999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEEC--CCCceEEEeCCCccccCCCCce
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLD--PDFTPKVSDFGLAKAHSRNRSV 503 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~--~~~~~ki~DFGla~~~~~~~~~ 503 (667)
|+|.+++... ...+++..+..|+.||+.||+|||+. +|+||||||+||||+ .++.+||+|||+|+........
T Consensus 111 g~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 111 GELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp CBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred ChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 9999877543 33589999999999999999999998 999999999999997 6789999999999987765433
Q ss_pred eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccccc
Q 005953 504 VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDF 583 (667)
Q Consensus 504 ~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (667)
. ...||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+...... .
T Consensus 186 ~---~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~------------~~~~~~i~~~~~~-~ 247 (352)
T d1koba_ 186 K---VTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------------LETLQNVKRCDWE-F 247 (352)
T ss_dssp E---EECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------------HHHHHHHHHCCCC-C
T ss_pred e---eccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCCC-C
Confidence 2 24589999999999764 688999999999999999999999965322 1111122111110 1
Q ss_pred cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 584 VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 584 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.......++..+.+++.+||+.||++|||++|++++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111112345678899999999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-46 Score=385.19 Aligned_cols=242 Identities=28% Similarity=0.362 Sum_probs=200.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+++.++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 345689999999999999984 6999999998643 34457899999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+++|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+......
T Consensus 86 ~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 86 IEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp CCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred cCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence 99999999886543 578889999999999999999998 99999999999999999999999999998765432
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
....||+.|||||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 159 ----~~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~------------~~~~~~i~~~~~~- 219 (316)
T d1fota_ 159 ----YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNT------------MKTYEKILNAELR- 219 (316)
T ss_dssp ----CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHHCCCC-
T ss_pred ----ccccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcCH------------HHHHHHHHcCCCC-
Confidence 345699999999999764 678999999999999999999999965322 1122222222111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 619 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~ 619 (667)
. +..++..+.+++.+||+.||++|+ |++|++++
T Consensus 220 ~----p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 F----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp C----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C----CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1 112345678899999999999996 89999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=392.03 Aligned_cols=260 Identities=26% Similarity=0.458 Sum_probs=207.6
Q ss_pred HHhhhhcccCCCeEEEEEEe------CCCcEEEEEEcccCCc--chHHHHHHHHHHhhc-ccceEEeecceEecCCeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF------PDGRLVAVKVLEKTSN--FSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 418 (667)
+.+.++||+|+||.||+|++ .+++.||||+++.... ...+|.+|+.+++++ +|||||+++|++.+....++
T Consensus 25 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~l 104 (311)
T d1t46a_ 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEE
Confidence 34678999999999999985 2467899999976543 345789999999999 69999999999999999999
Q ss_pred EEEEcCCCCccccccccc---------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC
Q 005953 419 IYEYMPNGSLGDLLSREK---------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD 483 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~ 483 (667)
||||+++|+|.+++.... ....+++..+.+++.||++||+|||++ +++||||||+|||++.+
T Consensus 105 vmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181 (311)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETT
T ss_pred EEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccccc
Confidence 999999999999997532 223689999999999999999999998 99999999999999999
Q ss_pred CceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCc
Q 005953 484 FTPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTT 563 (667)
Q Consensus 484 ~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~ 563 (667)
+.+||+|||+++...............||+.|+|||++.. +.++.++|||||||++|||+|++.|+..... .
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~------~ 253 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP------V 253 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------S
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCCC------H
Confidence 9999999999998776555555566779999999999976 4789999999999999999995555432211 0
Q ss_pred cccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcccc
Q 005953 564 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASAE 626 (667)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 626 (667)
...+...+.... ... .+...+..+.+++.+||+.||++||||+||+++|++...+
T Consensus 254 ~~~~~~~i~~~~----~~~----~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 254 DSKFYKMIKEGF----RML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SHHHHHHHHHTC----CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCC----CCC----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 111111121111 111 1112345788999999999999999999999999865433
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=389.52 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=199.4
Q ss_pred hhhhcccCCCeEEEEEEeC-CCc--EEEEEEcccC--CcchHHHHHHHHHHhhc-ccceEEeecceEecCCeeEEEEEEc
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGR--LVAVKVLEKT--SNFSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRALIYEYM 423 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~--~vavK~l~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~ 423 (667)
+.++||+|+||+||+|++. ++. .||||++... ....++|.+|+++|+++ +|||||+++|++.+++..++||||+
T Consensus 14 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~ 93 (309)
T d1fvra_ 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 93 (309)
T ss_dssp EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEec
Confidence 4688999999999999885 344 5788887543 23456899999999999 7999999999999999999999999
Q ss_pred CCCCcccccccc-------------ccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEe
Q 005953 424 PNGSLGDLLSRE-------------KENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSD 490 (667)
Q Consensus 424 ~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~D 490 (667)
++|+|.++|+.. .....+++..+++++.||++||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 94 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~D 170 (309)
T d1fvra_ 94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 170 (309)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECC
T ss_pred CCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEcc
Confidence 999999999653 2245799999999999999999999998 999999999999999999999999
Q ss_pred CCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCC-CCCCCCcCCCCCCccccchH
Q 005953 491 FGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKK-HLRPTETTSGSNTTEAYFPD 569 (667)
Q Consensus 491 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~ 569 (667)
||+++....... .....||..|+|||.+.. +.++.++|||||||++|||++|.. |+.... ..
T Consensus 171 fG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------------~~ 233 (309)
T d1fvra_ 171 FGLSRGQEVYVK---KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------------CA 233 (309)
T ss_dssp TTCEESSCEECC---C----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------------HH
T ss_pred cccccccccccc---ccceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCC------------HH
Confidence 999986543222 123458999999999976 478899999999999999999765 454321 12
Q ss_pred HHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccc
Q 005953 570 WIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSASA 625 (667)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 625 (667)
.+...+..+.... .+..++..+.+++.+||+.||++||||+||+++|+++..
T Consensus 234 ~~~~~i~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 234 ELYEKLPQGYRLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHHHHGGGTCCCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2233333322211 112235678899999999999999999999999986643
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=387.24 Aligned_cols=254 Identities=22% Similarity=0.377 Sum_probs=205.7
Q ss_pred HhhhhcccCCCeEEEEEEeC------CCcEEEEEEcccCCc--chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP------DGRLVAVKVLEKTSN--FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
.+.++||+|+||+||+|.+. +++.||||+++.... ....|.+|++++++++|||||+++|++...+..++||
T Consensus 23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence 35688999999999999863 357899999976543 2346899999999999999999999999999999999
Q ss_pred EEcCCCCccccccccc-------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCC
Q 005953 421 EYMPNGSLGDLLSREK-------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGL 493 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGl 493 (667)
||+++|+|.+++.... ....+++..+.+++.|+++||.|||++ +|+||||||+|||+++++++||+|||+
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeeccc
Confidence 9999999999986421 223578999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCC-CCCCCCCcCCCCCCccccchHHHH
Q 005953 494 AKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEK-KHLRPTETTSGSNTTEAYFPDWIY 572 (667)
Q Consensus 494 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~ 572 (667)
|+...............||+.|+|||.+.+. .++.++||||||+++|||+||+ .|+.... ...+.
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~--~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------------~~~~~ 245 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS------------NEQVL 245 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------------HHHHH
T ss_pred ceeccCCcceeeccceecccccCCHHHHccC--CCCcccccccHHHHHHHHHhCCCCCCCCCC------------HHHHH
Confidence 9877655444444455689999999999864 7888999999999999999986 4553321 11222
Q ss_pred HhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 005953 573 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSA 623 (667)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 623 (667)
..+.++..... +...+..+.+++.+||+.+|++||||+||+++|++.
T Consensus 246 ~~i~~~~~~~~----p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 246 RFVMEGGLLDK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHhCCCCCC----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 33333222111 122345788999999999999999999999999854
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-47 Score=387.31 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=202.6
Q ss_pred HhhhhcccCCCeEEEEEEeCC--------CcEEEEEEcccCCc--chHHHHHHHHHHhhc-ccceEEeecceEecCCeeE
Q 005953 349 GFKEKLGTGGYGNVYKGKFPD--------GRLVAVKVLEKTSN--FSDNFINEVATIGRI-HHVNIIHLLGFCCDGSTRA 417 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~--~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 417 (667)
.+.++||+|+||.||+|+... +..||||+++.... ...++.+|+..+.++ +|||||++++++.++...+
T Consensus 16 ~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~ 95 (299)
T d1fgka_ 16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 95 (299)
T ss_dssp EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEE
Confidence 456889999999999997632 34799999976543 346889999999999 7999999999999999999
Q ss_pred EEEEEcCCCCccccccccc-------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC
Q 005953 418 LIYEYMPNGSLGDLLSREK-------------ENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF 484 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~ 484 (667)
+||||+++|+|.++|.... ....+++..+++++.|++.||+|||+. +||||||||+|||++.++
T Consensus 96 ~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~ 172 (299)
T d1fgka_ 96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDN 172 (299)
T ss_dssp EEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTC
T ss_pred EEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCCC
Confidence 9999999999999996532 124689999999999999999999998 999999999999999999
Q ss_pred ceEEEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCcCCCCCCc
Q 005953 485 TPKVSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIE-EKKHLRPTETTSGSNTT 563 (667)
Q Consensus 485 ~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~ 563 (667)
.+||+|||+++...............||+.|+|||.+.+ +.++.|+||||||+++|||++ |+.||.....
T Consensus 173 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~------- 243 (299)
T d1fgka_ 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------- 243 (299)
T ss_dssp CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------
T ss_pred CeEeccchhhccccccccccccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-------
Confidence 999999999987765544434455678999999999976 488999999999999999998 6777753321
Q ss_pred cccchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 564 EAYFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
..+...+..+..... +...+..+.+++.+||+.||++||||.||++.|+++.
T Consensus 244 -----~~~~~~i~~~~~~~~----p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 244 -----EELFKLLKEGHRMDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -----HHHHHHHHTTCCCCC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHHHHHcCCCCCC----CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 223333333222111 1123457889999999999999999999999998653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.3e-46 Score=377.82 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=202.7
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc----------chHHHHHHHHHHhhcc-cceEEeecceEecCCee
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN----------FSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTR 416 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~ 416 (667)
.+.++||+|+||+||+|+.. +|+.||||++..... ..+.+.+|+.++++++ ||||+++++++.+++..
T Consensus 6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~ 85 (277)
T d1phka_ 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFF 85 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcce
Confidence 45688999999999999984 689999999865431 1246889999999997 99999999999999999
Q ss_pred EEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 417 ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 417 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
++||||+++|+|.++|.... .+++.++..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 86 FLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999997543 589999999999999999999998 999999999999999999999999999988
Q ss_pred cCCCCceeeecCCCCCccccchhhhhhh----cCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHH
Q 005953 497 HSRNRSVVTMTGPRGTIGYIAPEIFMRN----LGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIY 572 (667)
Q Consensus 497 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 572 (667)
....... +...||+.|+|||.+... ...++.++||||+||++|||++|+.||..... ..+.
T Consensus 160 ~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------------~~~~ 224 (277)
T d1phka_ 160 LDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------------MLML 224 (277)
T ss_dssp CCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHH
T ss_pred ccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------------HHHH
Confidence 7654322 345689999999999643 12457899999999999999999999965421 1122
Q ss_pred HhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 573 DKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
..+...... ........+++.+.+++.+||+.||++|||++||+++
T Consensus 225 ~~i~~~~~~-~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 225 RMIMSGNYQ-FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHTCCC-CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHhCCCC-CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 222221111 1111222355678899999999999999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=382.51 Aligned_cols=249 Identities=19% Similarity=0.267 Sum_probs=203.8
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPNG 426 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 426 (667)
|.+.+.||+|+||+||+|.+. +++.||||+++........+.+|+++|++++|||||++++++.+.+..|+||||+++|
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 345689999999999999985 6889999999877665667889999999999999999999999999999999999999
Q ss_pred CccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC--CceEEEeCCCccccCCCCcee
Q 005953 427 SLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD--FTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 427 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~--~~~ki~DFGla~~~~~~~~~~ 504 (667)
+|.+++... +..+++..+..|+.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++.........
T Consensus 87 ~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 87 DIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp BHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 999999654 23589999999999999999999998 99999999999999854 589999999998876554332
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccccc
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKEDFV 584 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (667)
...||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ..+...+..... ...
T Consensus 162 ---~~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~~~~------------~~~~~~i~~~~~-~~~ 223 (321)
T d1tkia_ 162 ---LLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETN------------QQIIENIMNAEY-TFD 223 (321)
T ss_dssp ---EEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHHHTCC-CCC
T ss_pred ---ccccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCCCCH------------HHHHHHHHhCCC-CCC
Confidence 23479999999998764 678899999999999999999999965322 112222222111 111
Q ss_pred chhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 585 EEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 585 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
......++..+.+++.+||+.||++|||++|++++
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11122345678899999999999999999999984
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=378.98 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=193.9
Q ss_pred hhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc------chHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 352 EKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN------FSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
++||+|+||+||+|++. +|+.||||+++.... ..+.+.+|+.+|++++|||||++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 68999999999999985 689999999865431 23568999999999999999999999999999999999998
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
++++..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+........
T Consensus 84 ~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~- 156 (299)
T d1ua2a_ 84 TDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA- 156 (299)
T ss_dssp EEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred chHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc-
Confidence 8877766643 23588889999999999999999998 9999999999999999999999999999876544322
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc----
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK---- 580 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 580 (667)
.....||+.|+|||++... ..++.++|||||||++|||++|+.||...... .....+.+.+..+..
T Consensus 157 -~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--------~~l~~i~~~~~~~~~~~~~ 226 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--------DQLTRIFETLGTPTEEQWP 226 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHHHCCCCTTTSS
T ss_pred -ccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHH--------HHHHHHHHhcCCCChhhcc
Confidence 2345689999999998754 36788999999999999999999998643220 000001111000000
Q ss_pred -----------ccc----cchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 581 -----------EDF----VEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 581 -----------~~~----~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
... .........+.+.+++.+||+.||++|||++|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000 001111234578899999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.3e-45 Score=382.35 Aligned_cols=246 Identities=23% Similarity=0.317 Sum_probs=196.3
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHH---HHHHHhhcccceEEeecceEecCCeeEEEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFIN---EVATIGRIHHVNIIHLLGFCCDGSTRALIY 420 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~---Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 420 (667)
.+.++||+|+||+||+|+.. +|+.||||++.... .....+.+ |+.+++.++|||||++++++.+.+..++||
T Consensus 7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivm 86 (364)
T d1omwa3 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 86 (364)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEE
Confidence 35688999999999999985 69999999986432 22233444 467777888999999999999999999999
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
||+++|+|.++|.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 87 E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 87 DLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp CCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999997543 578999999999999999999998 9999999999999999999999999999877544
Q ss_pred CceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccc
Q 005953 501 RSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEK 580 (667)
Q Consensus 501 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 580 (667)
.. ....||+.|+|||++... ..++.++|||||||++|||++|+.||...... ....+.........
T Consensus 161 ~~----~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---------~~~~~~~~~~~~~~ 226 (364)
T d1omwa3 161 KP----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---------DKHEIDRMTLTMAV 226 (364)
T ss_dssp CC----CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS---------CHHHHHHHSSSCCC
T ss_pred cc----cccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHhcccCCC
Confidence 32 345699999999999654 36789999999999999999999999654321 01112222221111
Q ss_pred ccccchhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 005953 581 EDFVEEEDDCIARKMIIVGLWCIQINPKDRPS-----MTRVVEM 619 (667)
Q Consensus 581 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~~ 619 (667)
.. ...++..+.+++.+||+.||++||| ++|++++
T Consensus 227 -~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 227 -EL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -CC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -CC----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11 1123456888999999999999999 7888865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-45 Score=374.38 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=195.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC----cchHHHHHHHHHHhhcccceEEeecceEecCC----eeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS----NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS----TRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----~~~l 418 (667)
|.+.+.||+|+||+||+|++. +|+.||||+++... ...+.|.+|++++++++|||||++++++.+.+ ..|+
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 345688999999999999874 69999999997543 22357899999999999999999999987643 3789
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
||||+++|+|.+++.... .+++..+..|+.||+.||+|||+. +|+||||||+|||++.++..+|+|||.++...
T Consensus 89 vmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhc
Confidence 999999999999886543 589999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCce-eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcC
Q 005953 499 RNRSV-VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 577 (667)
Q Consensus 499 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (667)
..... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... .+.....+..
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----------~~~~~~~~~~ 229 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----------VSVAYQHVRE 229 (277)
T ss_dssp ----------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------HHHHHHHHHC
T ss_pred cccccccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCH-----------HHHHHHHHhc
Confidence 33222 22344579999999999875 3688999999999999999999999964321 1111222211
Q ss_pred cccccccchhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhc
Q 005953 578 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP-SMTRVVEMLSSA 623 (667)
Q Consensus 578 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~evl~~L~~~ 623 (667)
.... .......++..+.+++.+||+.||++|| |++++++.|.+.
T Consensus 230 ~~~~--~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 230 DPIP--PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CCCC--GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCC--CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 1110 1111123456788899999999999999 899999988754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-44 Score=379.05 Aligned_cols=242 Identities=23% Similarity=0.287 Sum_probs=200.8
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.+.++||+|+||+||+|++. +|+.||||++... ....+.+.+|+.+|++++|||||++++++.+....++||||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence 445689999999999999985 6999999998643 24456789999999999999999999999999999999999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCc
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~ 502 (667)
+.+|+|.+++.+.. .+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+|+......
T Consensus 123 ~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~- 195 (350)
T d1rdqe_ 123 VAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp CTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred ccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence 99999999986543 589999999999999999999998 99999999999999999999999999998775432
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
....||+.|||||++.+. .++.++|||||||++|||++|+.||..... ..+...+......
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~------------~~~~~~i~~~~~~- 256 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP------------IQIYEKIVSGKVR- 256 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCCC-
T ss_pred ----ccccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCcCH------------HHHHHHHhcCCCC-
Confidence 235689999999999764 678999999999999999999999964321 1122222221111
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 619 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~ 619 (667)
.+..++..+.+++.+||+.||++|+ |++|++++
T Consensus 257 ----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 257 ----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 0112345688899999999999994 89999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=379.89 Aligned_cols=244 Identities=21% Similarity=0.320 Sum_probs=199.2
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccC----CcchHHHHHHHHHHh-hcccceEEeecceEecCCeeEEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKT----SNFSDNFINEVATIG-RIHHVNIIHLLGFCCDGSTRALIYE 421 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~Ei~~l~-~l~h~niv~l~g~~~~~~~~~lV~e 421 (667)
+.+.++||+|+||+||+|++. +++.||||++++. ....+.+..|..++. .++|||||++++++.+++..|+|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 346689999999999999985 6899999999643 234566778888766 5799999999999999999999999
Q ss_pred EcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCC
Q 005953 422 YMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 422 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~ 501 (667)
|+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 84 y~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred ecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 999999999997543 588999999999999999999998 99999999999999999999999999998765443
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCcccc
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKE 581 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 581 (667)
.. .+...||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+.....
T Consensus 158 ~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~~~~------------~~~~~~i~~~~~- 220 (320)
T d1xjda_ 158 AK--TNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------------EELFHSIRMDNP- 220 (320)
T ss_dssp CC--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HHHHHHHHHCCC-
T ss_pred cc--ccccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCCCCH------------HHHHHHHHcCCC-
Confidence 32 2445799999999999864 788999999999999999999999975322 122222221111
Q ss_pred cccchhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 005953 582 DFVEEEDDCIARKMIIVGLWCIQINPKDRPSMT-RVVE 618 (667)
Q Consensus 582 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-evl~ 618 (667)
. .+..++..+.+++.+||+.||++|||+. |+++
T Consensus 221 ~----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 F----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1 1112345688999999999999999995 7765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=381.10 Aligned_cols=246 Identities=21% Similarity=0.293 Sum_probs=194.9
Q ss_pred hhcccCCCeEEEEEEe-CCCcEEEEEEcccCCcchHHHHHHHHHHhhc-ccceEEeecceEec----CCeeEEEEEEcCC
Q 005953 352 EKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTSNFSDNFINEVATIGRI-HHVNIIHLLGFCCD----GSTRALIYEYMPN 425 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~----~~~~~lV~e~~~~ 425 (667)
+.||+|+||+||+|++ .+++.||||+++.. +.+.+|++++.++ +|||||++++++.+ ....|+||||+++
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g 93 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence 4699999999999987 46899999998643 4677899987765 89999999999865 4568999999999
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC---CCceEEEeCCCccccCCCCc
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~---~~~~ki~DFGla~~~~~~~~ 502 (667)
|+|.++|.... ...+++..+..|+.||+.||+|||+. +|+||||||+|||+++ ++.+||+|||+|+.......
T Consensus 94 g~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~ 169 (335)
T d2ozaa1 94 GELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169 (335)
T ss_dssp EEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC
T ss_pred CcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCCc
Confidence 99999997542 34699999999999999999999998 9999999999999975 46799999999987765443
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCccccc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQPEKED 582 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (667)
. ....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....+...+.... ..
T Consensus 170 ~---~~~~gt~~y~aPE~~~~~--~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--------~~~~~~~~i~~~~-~~ 235 (335)
T d2ozaa1 170 L---TTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--------ISPGMKTRIRMGQ-YE 235 (335)
T ss_dssp C---CCCSCCCSSCCCCCCCGG--GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------CCCSCS-SS
T ss_pred c---ccccCCcccCCcHHHcCC--CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--------HHHHHHHHHhcCC-CC
Confidence 2 345699999999999764 67899999999999999999999996443210 0001111111111 11
Q ss_pred ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 583 FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 583 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
........++..+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1122233456788999999999999999999999985
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=373.90 Aligned_cols=262 Identities=22% Similarity=0.335 Sum_probs=195.7
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.++||+|+||+||+|++. +|+.||||+++... ...+.+.+|+++|++++|||||++++++.++...++||||+.+
T Consensus 6 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~ 85 (298)
T d1gz8a_ 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 85 (298)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC
Confidence 4578999999999999984 69999999986543 2357899999999999999999999999999999999999965
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
++.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+........
T Consensus 86 -~~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~-- 158 (298)
T d1gz8a_ 86 -DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-- 158 (298)
T ss_dssp -EHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC--
T ss_pred -chhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCccc--
Confidence 4444443322 34699999999999999999999998 9999999999999999999999999999877544332
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCC--------CCCccccchHHHH-Hhhc
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG--------SNTTEAYFPDWIY-DKLI 576 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~-~~~~ 576 (667)
.....||+.|+|||++... ...+.++|||||||++|||++|+.||........ ....+........ ....
T Consensus 159 ~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 2345689999999998765 4568899999999999999999999965321000 0000000000000 0000
Q ss_pred Ccc---cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 577 QPE---KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 577 ~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
... .............+.+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 0000001111234678889999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.8e-44 Score=368.29 Aligned_cols=261 Identities=24% Similarity=0.322 Sum_probs=196.6
Q ss_pred HhhhhcccCCCeEEEEEEeCCCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcCC
Q 005953 349 GFKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
.+.++||+|+||+||+|++++|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+.+..++++|++.+
T Consensus 5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~ 84 (286)
T d1ob3a_ 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ 84 (286)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred eeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehh
Confidence 3458899999999999999999999999997643 3357899999999999999999999999999999999999987
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCceee
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVVT 505 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~ 505 (667)
+.+..+.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 85 ~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 156 (286)
T d1ob3a_ 85 DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-- 156 (286)
T ss_dssp EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred hhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccc--
Confidence 7766665433 4699999999999999999999998 9999999999999999999999999999876543322
Q ss_pred ecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCC---------CCCCccccchHHH-HHhh
Q 005953 506 MTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTS---------GSNTTEAYFPDWI-YDKL 575 (667)
Q Consensus 506 ~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~~~~-~~~~ 575 (667)
.....|++.|+|||.+.+. ..++.++|||||||++|||++|+.||....... +..... ..+... ....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~ 234 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK-NWPNVTELPKY 234 (286)
T ss_dssp -----CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT-TSTTGGGSTTC
T ss_pred cceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChh-hccchhhhhhc
Confidence 2334589999999999764 467899999999999999999999996542210 000000 000000 0000
Q ss_pred cC---cccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 576 IQ---PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 576 ~~---~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.. .................+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000000011112234578899999999999999999999854
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=369.46 Aligned_cols=238 Identities=26% Similarity=0.357 Sum_probs=191.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC-------cchHHHHHHHHHHhhcc--cceEEeecceEecCCeeE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS-------NFSDNFINEVATIGRIH--HVNIIHLLGFCCDGSTRA 417 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-------~~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~~~~~~ 417 (667)
|.+.++||+|+||+||+|+.. +|+.||||++.... ....++.+|+.+|++++ |||||++++++.+.+..+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence 345688999999999999985 68999999986432 11234678999999996 899999999999999999
Q ss_pred EEEEEcCC-CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC-CCceEEEeCCCcc
Q 005953 418 LIYEYMPN-GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-DFTPKVSDFGLAK 495 (667)
Q Consensus 418 lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~-~~~~ki~DFGla~ 495 (667)
+||||+.+ +++.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+
T Consensus 86 lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccce
Confidence 99999976 5777777543 3589999999999999999999998 9999999999999985 4799999999998
Q ss_pred ccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh
Q 005953 496 AHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575 (667)
Q Consensus 496 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (667)
...... .+...||+.|+|||++... ...+.++|||||||++|||++|+.||..... +...
T Consensus 160 ~~~~~~----~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------i~~~- 219 (273)
T d1xwsa_ 160 LLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------IIRG- 219 (273)
T ss_dssp ECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HHHC-
T ss_pred eccccc----ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH--------------Hhhc-
Confidence 754332 2345699999999999764 3446779999999999999999999864211 1110
Q ss_pred cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
... . ...++..+.+++.+||+.||++|||++|++++
T Consensus 220 ---~~~-~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 ---QVF-F----RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---CCC-C----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---ccC-C----CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 000 0 01124567889999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-44 Score=375.54 Aligned_cols=266 Identities=22% Similarity=0.277 Sum_probs=194.8
Q ss_pred hhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceEEeecceEecC------CeeEEEEEE
Q 005953 350 FKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNIIHLLGFCCDG------STRALIYEY 422 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~~lV~e~ 422 (667)
..++||+|+||+||+|++. +|+.||||++...... +.+|+++|++++||||+++++++... ...++||||
T Consensus 24 ~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred eeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 4578999999999999985 6999999999765432 24799999999999999999998543 347899999
Q ss_pred cCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC-ceEEEeCCCccccCCCC
Q 005953 423 MPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF-TPKVSDFGLAKAHSRNR 501 (667)
Q Consensus 423 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~-~~ki~DFGla~~~~~~~ 501 (667)
++++.+..+.........+++..+..|+.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++......
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 98765555444334455799999999999999999999998 999999999999999775 89999999998775544
Q ss_pred ceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC----CccccchHHHHHhhcC
Q 005953 502 SVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN----TTEAYFPDWIYDKLIQ 577 (667)
Q Consensus 502 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 577 (667)
.. ....||+.|+|||.+.+. ..++.++||||+||++|||++|+.||........-. ........++......
T Consensus 178 ~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 178 PN---VSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp CC---CSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred cc---ccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 32 335689999999998764 467899999999999999999999996543210000 0000000111110000
Q ss_pred ---ccc-----ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhccc
Q 005953 578 ---PEK-----EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM--LSSASA 625 (667)
Q Consensus 578 ---~~~-----~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~--L~~~~~ 625 (667)
... ..............+.+|+.+||+.||++|||+.|++++ +++...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 000 000001111234568889999999999999999999975 554433
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=365.46 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=191.1
Q ss_pred HHhhhhcccCCCeEEEEEEeC-C-CcEEEEEEcccC---CcchHHHHHHHHHHhhc---ccceEEeecceEec-----CC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-D-GRLVAVKVLEKT---SNFSDNFINEVATIGRI---HHVNIIHLLGFCCD-----GS 414 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~l~~~---~~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~-----~~ 414 (667)
|.+.++||+|+||+||+|++. + ++.||||+++.. ......+.+|+.+|+.+ +||||+++++++.. ..
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence 345688999999999999873 3 678999998643 22334577888877776 79999999999853 34
Q ss_pred eeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCc
Q 005953 415 TRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLA 494 (667)
Q Consensus 415 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla 494 (667)
..++++||++++++....... ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred eEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhh
Confidence 688999999887765444332 34688999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHh
Q 005953 495 KAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 574 (667)
Q Consensus 495 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 574 (667)
+....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... .....+...
T Consensus 164 ~~~~~~~~---~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~~~--------~~~~~i~~~ 230 (305)
T d1blxa_ 164 RIYSFQMA---LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--------DQLGKILDV 230 (305)
T ss_dssp CCCCGGGG---GCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHH
T ss_pred hhhccccc---CCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCCHH--------HHHHHHHHh
Confidence 86544332 2456799999999999764 7899999999999999999999999754321 000000000
Q ss_pred hcC------------------cccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 575 LIQ------------------PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 575 ~~~------------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
+.. ...............+.+.+|+.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 000001111112234567889999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-43 Score=365.26 Aligned_cols=264 Identities=20% Similarity=0.258 Sum_probs=193.2
Q ss_pred HHhhhhcccCCCeEEEEEEe-CCCcEEEEEEcccCC--cchHHHHHHHHHHhhcccceEEeecceEecCC----eeEEEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKF-PDGRLVAVKVLEKTS--NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS----TRALIY 420 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----~~~lV~ 420 (667)
|.+.++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+.+|++++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 34568999999999999987 479999999997644 33467899999999999999999999987643 335556
Q ss_pred EEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCC
Q 005953 421 EYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 421 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~ 500 (667)
+|+.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||||++++.+||+|||+++.....
T Consensus 90 ~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 90 THLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 677799999999643 489999999999999999999998 9999999999999999999999999999876443
Q ss_pred Ccee-eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC---------CCc-----cc
Q 005953 501 RSVV-TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS---------NTT-----EA 565 (667)
Q Consensus 501 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~---------~~~-----~~ 565 (667)
.... ......||+.|+|||++... ..++.++||||+||+++||++|+.||......... ... ..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 3221 12445689999999998664 46688999999999999999999999654321000 000 00
Q ss_pred cchHHHHHhhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 566 YFPDWIYDKLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
....+.......................++.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000000000001111223468899999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=357.01 Aligned_cols=257 Identities=20% Similarity=0.296 Sum_probs=190.2
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEec--------CCee
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD--------GSTR 416 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--------~~~~ 416 (667)
.+.++||+|+||+||+|++. +|+.||||++.... ...+++.+|+++|++++||||+++++++.. ....
T Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~ 92 (318)
T d3blha1 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 92 (318)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CE
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceE
Confidence 35688999999999999984 79999999986542 345678999999999999999999998865 3467
Q ss_pred EEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 417 ALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 417 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
++||||+.++.+..+... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 93 YLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp EEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeee
Confidence 899999987776655433 33588899999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCcee--eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHh
Q 005953 497 HSRNRSVV--TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDK 574 (667)
Q Consensus 497 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 574 (667)
........ ......||+.|+|||++... ..++.++|||||||++|||++|+.||...... .....+...
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~--------~~~~~i~~~ 237 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--------HQLALISQL 237 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHH
T ss_pred cccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHH--------HHHHHHHHh
Confidence 65433221 12334689999999998764 46789999999999999999999999643210 000000000
Q ss_pred hc--------------------Cccccc-ccchh--hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 005953 575 LI--------------------QPEKED-FVEEE--DDCIARKMIIVGLWCIQINPKDRPSMTRVVEML 620 (667)
Q Consensus 575 ~~--------------------~~~~~~-~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 620 (667)
.. ...... ..... .......+.+++.+||+.||++|||++|++++=
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence 00 000000 00000 011134567899999999999999999999763
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=362.85 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=190.5
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCC------eeEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGS------TRAL 418 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------~~~l 418 (667)
.+.++||+|+||+||+|++. +|+.||||+++... ...+.+.+|+++|++++|||||++++++...+ ..++
T Consensus 21 ~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 100 (346)
T d1cm8a_ 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 100 (346)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEE
Confidence 35578999999999999975 69999999997543 23457889999999999999999999997654 5699
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
||||+ +++|..+++. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 101 v~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 101 VMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp EEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccC
Confidence 99999 5677776643 3599999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCC---CccccchHHHHH--
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSN---TTEAYFPDWIYD-- 573 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~---~~~~~~~~~~~~-- 573 (667)
... +...||+.|+|||++.+. ..++.++||||+||++|||++|+.||.......... ......+.....
T Consensus 173 ~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 173 SEM-----TGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp SSC-----CSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred Ccc-----ccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 432 456689999999999764 467889999999999999999999996543210000 000000000000
Q ss_pred ---------hhcCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhh
Q 005953 574 ---------KLIQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM--LSS 622 (667)
Q Consensus 574 ---------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~--L~~ 622 (667)
.....................+.+|+.+||+.||++|||++|++++ +++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 0000000011111112234567789999999999999999999986 553
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.5e-42 Score=351.90 Aligned_cols=259 Identities=17% Similarity=0.241 Sum_probs=200.3
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhccc-ceEEeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHH-VNIIHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~~~ 425 (667)
+.+.++||+|+||+||+|++. +|+.||||++..... .+.+.+|++.++.++| +|++.+++++.++...++||||+ +
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~ 84 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 84 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence 345688999999999999975 689999999865432 3457789999999965 89999999999999999999999 7
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC-----CCceEEEeCCCccccCCC
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP-----DFTPKVSDFGLAKAHSRN 500 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~-----~~~~ki~DFGla~~~~~~ 500 (667)
|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+.....
T Consensus 85 ~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 85 PSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred CCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 89999886543 3589999999999999999999998 9999999999999964 578999999999876533
Q ss_pred Cce-----eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhh
Q 005953 501 RSV-----VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKL 575 (667)
Q Consensus 501 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (667)
... .......||+.|||||.+.+. .++.++||||||+++|||++|+.||...... .. ......+
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~----~~-----~~~~~~i 228 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAA----TN-----KQKYERI 228 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC----CH-----HHHHHHH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccch----hH-----HHHHHHH
Confidence 211 112345799999999999764 7899999999999999999999999754321 00 0011111
Q ss_pred cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 576 IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
..........+....+++++.+++..|++.+|++||+++.+.+.|+++.
T Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1100001111111223457888999999999999999999998887654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5e-42 Score=357.18 Aligned_cols=257 Identities=21% Similarity=0.273 Sum_probs=194.6
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcc-cceEEeecceEec--CCeeEEEEEEc
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGFCCD--GSTRALIYEYM 423 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~--~~~~~lV~e~~ 423 (667)
+.+.++||+|+||+||+|++. +|+.||||+++... .+++.+|+++|++++ ||||+++++++.. ....++||||+
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence 556789999999999999984 68999999987543 567899999999995 9999999999874 45689999999
Q ss_pred CCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCC-CceEEEeCCCccccCCCCc
Q 005953 424 PNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPD-FTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 424 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~-~~~ki~DFGla~~~~~~~~ 502 (667)
++|+|.++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 115 ~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 115 NNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp CSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred CCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence 9999977642 488999999999999999999998 99999999999999865 4699999999987765433
Q ss_pred eeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCC------ccccchHHHHHhhc
Q 005953 503 VVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNT------TEAYFPDWIYDKLI 576 (667)
Q Consensus 503 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~ 576 (667)
. ....+|+.|+|||.+.+. ..++.++||||+||+++||++|+.||........... .......+....-.
T Consensus 186 ~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 186 Y---NVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C---CSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred c---cccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 2 345689999999998764 3578999999999999999999999865432100000 00000000000000
Q ss_pred C----------cc----c-ccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 577 Q----------PE----K-EDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 577 ~----------~~----~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
. .. . ..........+...+.+|+.+||+.||++|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00 0 001111122345578899999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-42 Score=353.51 Aligned_cols=259 Identities=20% Similarity=0.258 Sum_probs=193.9
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcccceE-EeecceEecCCeeEEEEEEcCC
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI-IHLLGFCCDGSTRALIYEYMPN 425 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~ 425 (667)
|.+.++||+|+||+||+|++. +|+.||||++..... .+++..|++++++++|+|+ +.+.++..+++..++||||+ +
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~ 86 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 86 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-C
Confidence 346689999999999999874 689999999876432 3467899999999987664 55555667788899999999 5
Q ss_pred CCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECC---CCceEEEeCCCccccCCCCc
Q 005953 426 GSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDP---DFTPKVSDFGLAKAHSRNRS 502 (667)
Q Consensus 426 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~---~~~~ki~DFGla~~~~~~~~ 502 (667)
|+|.+.+... ...+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+|+.......
T Consensus 87 ~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 87 PSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred Cchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 6776666443 23589999999999999999999998 9999999999999853 56799999999987754332
Q ss_pred e-----eeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcC
Q 005953 503 V-----VTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 577 (667)
Q Consensus 503 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (667)
. .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ................
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~----~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAA----TKRQKYERISEKKMST 235 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----------HHHHHHHHHHS
T ss_pred ccceeccccCCcCCCccccCHHHHhCC--CCCChhhEEecCHHHHHHHhCCCcccccchH----HHHHHHHHhhcccCCC
Confidence 2 122345799999999999764 6889999999999999999999999654321 0001111111111111
Q ss_pred cccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 005953 578 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEMLSSAS 624 (667)
Q Consensus 578 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 624 (667)
+ .......++..+.+++.+||+.+|++||+++++.+.|+...
T Consensus 236 ~-----~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 236 P-----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp C-----HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred C-----hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 0 11111223467889999999999999999999988887543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=358.85 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=198.8
Q ss_pred HHhhhhcccCCCeEEEEEEeC----CCcEEEEEEcccCC-----cchHHHHHHHHHHhhccc-ceEEeecceEecCCeeE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP----DGRLVAVKVLEKTS-----NFSDNFINEVATIGRIHH-VNIIHLLGFCCDGSTRA 417 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~l~~~~-----~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~ 417 (667)
+.+.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 446789999999999999762 47899999986432 234678899999999976 89999999999999999
Q ss_pred EEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCcccc
Q 005953 418 LIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAH 497 (667)
Q Consensus 418 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~ 497 (667)
+||||+.+|+|.+++.... .+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999997643 467889999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcC
Q 005953 498 SRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQ 577 (667)
Q Consensus 498 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 577 (667)
....... .....|++.|+|||.+......++.++|||||||+||||++|+.||...... .....+......
T Consensus 180 ~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~--------~~~~~i~~~~~~ 250 (322)
T d1vzoa_ 180 VADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--------NSQAEISRRILK 250 (322)
T ss_dssp CGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--------CCHHHHHHHHHH
T ss_pred ccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHhccc
Confidence 4433221 2345689999999999765456788999999999999999999999754321 111112211111
Q ss_pred cccccccchhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 005953 578 PEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRP-----SMTRVVEM 619 (667)
Q Consensus 578 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~ 619 (667)
... .....++..+.+++.+||+.||++|| |++|++++
T Consensus 251 ~~~-----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 251 SEP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCC-----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 111 01112456788899999999999999 58999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=352.43 Aligned_cols=260 Identities=22% Similarity=0.308 Sum_probs=199.0
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEecCCeeEEEEEEcC
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCDGSTRALIYEYMP 424 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 424 (667)
++.++||+|+||+||+|++. +++.||||+++... .....+.+|+.+|++++||||+++++++.+....++|+|++.
T Consensus 5 ~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~ 84 (292)
T d1unla_ 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecc
Confidence 45689999999999999984 68999999986543 345788999999999999999999999999999999999999
Q ss_pred CCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccCCCCcee
Q 005953 425 NGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHSRNRSVV 504 (667)
Q Consensus 425 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~ 504 (667)
+++|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++........
T Consensus 85 ~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~- 157 (292)
T d1unla_ 85 QDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC- 157 (292)
T ss_dssp EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-
T ss_pred ccccccccccc---cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCcc-
Confidence 99888877543 3588999999999999999999998 9999999999999999999999999999877554332
Q ss_pred eecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCC---------CCccccchHHHHHhh
Q 005953 505 TMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGS---------NTTEAYFPDWIYDKL 575 (667)
Q Consensus 505 ~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~ 575 (667)
.....+++.|+|||.+... ..++.++|||||||++|||++|+.||......... .......+.. ...
T Consensus 158 -~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 233 (292)
T d1unla_ 158 -YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM--TKL 233 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG--GGS
T ss_pred -ceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhh--hhc
Confidence 2334578999999998764 35789999999999999999999997432210000 0000000000 000
Q ss_pred cCcc------cccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 576 IQPE------KEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 576 ~~~~------~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
.... .............+.+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 0001111112234567889999999999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=349.87 Aligned_cols=257 Identities=23% Similarity=0.264 Sum_probs=184.6
Q ss_pred HhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCC---cchHHHHHHHHHHhhcccceEEeecceEec------CCeeEE
Q 005953 349 GFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTS---NFSDNFINEVATIGRIHHVNIIHLLGFCCD------GSTRAL 418 (667)
Q Consensus 349 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------~~~~~l 418 (667)
++.++||+|+||+||+|.+. +|+.||||++.... ...+++.+|+.++++++|||||++++++.. ....|+
T Consensus 20 ~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~i 99 (355)
T d2b1pa1 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99 (355)
T ss_dssp EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEE
Confidence 34578999999999999985 69999999997543 233568899999999999999999999863 367899
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
||||+.++.+ +.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+++...
T Consensus 100 v~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 100 VMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccc
Confidence 9999966544 4442 2478999999999999999999998 99999999999999999999999999988765
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCC---------CCCcc--ccc
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSG---------SNTTE--AYF 567 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~---------~~~~~--~~~ 567 (667)
.... .+...||+.|+|||++.+. .++.++||||+||+++||++|+.||........ ....+ ...
T Consensus 171 ~~~~---~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 171 TSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp -------------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred cccc---cccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 4332 2345689999999999764 778999999999999999999999964321100 00000 000
Q ss_pred hHHHHHhh--------------cCcccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 568 PDWIYDKL--------------IQPEKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 568 ~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
........ ...................+.+|+.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 00000111122334567788999999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-41 Score=350.98 Aligned_cols=251 Identities=20% Similarity=0.278 Sum_probs=190.4
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCc---chHHHHHHHHHHhhcccceEEeecceEecC-----CeeEE
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSN---FSDNFINEVATIGRIHHVNIIHLLGFCCDG-----STRAL 418 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~~~l 418 (667)
|...++||+|+||+||+|++. +|+.||||++..... ..+.+.+|+++|++++|||+|++++++... ...++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 345688999999999999874 699999999976532 345788999999999999999999998643 34567
Q ss_pred EEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEeCCCccccC
Q 005953 419 IYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSDFGLAKAHS 498 (667)
Q Consensus 419 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~~~~ 498 (667)
+++|+.+|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++....
T Consensus 100 i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp EEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred EEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence 78888899999998543 489999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCccccchHHHHHhhcCc
Q 005953 499 RNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAYFPDWIYDKLIQP 578 (667)
Q Consensus 499 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 578 (667)
.. .....||+.|+|||.+.+. ...+.++|||||||++|||++|+.||...... .....+.......
T Consensus 173 ~~-----~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~--------~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 173 DE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--------DQLKLILRLVGTP 238 (348)
T ss_dssp GG-----GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHHHCCC
T ss_pred cc-----cccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHHhcCCC
Confidence 32 2345689999999998764 45688999999999999999999999654321 0000000000000
Q ss_pred ----------------------ccccccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 005953 579 ----------------------EKEDFVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRVVEM 619 (667)
Q Consensus 579 ----------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 619 (667)
................+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000001111234567889999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-37 Score=327.78 Aligned_cols=281 Identities=20% Similarity=0.283 Sum_probs=198.9
Q ss_pred HHhhhhcccCCCeEEEEEEeC-CCcEEEEEEcccCCcchHHHHHHHHHHhhcc-----------cceEEeecceEec--C
Q 005953 348 NGFKEKLGTGGYGNVYKGKFP-DGRLVAVKVLEKTSNFSDNFINEVATIGRIH-----------HVNIIHLLGFCCD--G 413 (667)
Q Consensus 348 ~~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~g~~~~--~ 413 (667)
|.+.++||+|+||+||+|+.. +|+.||||+++......+.+.+|+.++++++ |+||+++++++.. .
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~ 94 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 94 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence 456789999999999999984 7999999999877655678889999998886 4789999988764 3
Q ss_pred CeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCC------ceE
Q 005953 414 STRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDF------TPK 487 (667)
Q Consensus 414 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~------~~k 487 (667)
...+++++++..+..............+++..+..++.|+++||+|||+. .+|+||||||+||||+.++ .+|
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 95 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccceee
Confidence 46677888776665544444444456789999999999999999999972 2899999999999997664 399
Q ss_pred EEeCCCccccCCCCceeeecCCCCCccccchhhhhhhcCCCCCcccHHHHHHHHHHHHhCCCCCCCCCcCCCCCCcccc-
Q 005953 488 VSDFGLAKAHSRNRSVVTMTGPRGTIGYIAPEIFMRNLGNPSGKSDVYSYGMLLLEMIEEKKHLRPTETTSGSNTTEAY- 566 (667)
Q Consensus 488 i~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~k~DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~- 566 (667)
++|||.++...... ....||+.|+|||++.. ..++.++||||+||+++||++|+.||...............
T Consensus 173 l~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 173 IADLGNACWYDEHY-----TNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp ECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred Eeeccccccccccc-----ccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 99999997654322 33568999999999876 36789999999999999999999999754321110000000
Q ss_pred --------chHHHHHh------hc------Cccccc----------ccchhhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 005953 567 --------FPDWIYDK------LI------QPEKED----------FVEEEDDCIARKMIIVGLWCIQINPKDRPSMTRV 616 (667)
Q Consensus 567 --------~~~~~~~~------~~------~~~~~~----------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev 616 (667)
.+...... .. ...... ............+.+++.+||+.||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 00000000 00 000000 0011224567789999999999999999999999
Q ss_pred HHH--Hhhc-cccccCCCCCCCCC
Q 005953 617 VEM--LSSA-SAEAIEMPPKPLFP 637 (667)
Q Consensus 617 l~~--L~~~-~~~~~~~~~~p~~~ 637 (667)
+++ +++. ..+..++|+.+...
T Consensus 326 L~Hp~f~~~~~~~~~~~p~~~~~~ 349 (362)
T d1q8ya_ 326 VNHPWLKDTLGMEEIRVPDRELYG 349 (362)
T ss_dssp HTCGGGTTCTTCTTCCCTTSCTTC
T ss_pred hcCcccCCCCCcccCCCCCcccCC
Confidence 986 5422 23345556555553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.3e-23 Score=197.64 Aligned_cols=161 Identities=14% Similarity=0.119 Sum_probs=118.2
Q ss_pred hhhhcccCCCeEEEEEEeCCCcEEEEEEcccCCc-------------------chHHHHHHHHHHhhcccceEEeecceE
Q 005953 350 FKEKLGTGGYGNVYKGKFPDGRLVAVKVLEKTSN-------------------FSDNFINEVATIGRIHHVNIIHLLGFC 410 (667)
Q Consensus 350 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-------------------~~~~~~~Ei~~l~~l~h~niv~l~g~~ 410 (667)
+.++||+|+||+||+|++.+|+.||||+++.... ....+.+|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4578999999999999998999999998753210 012345688899999999998877553
Q ss_pred ecCCeeEEEEEEcCCCCccccccccccCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeeecCCCCCcEEECCCCceEEEe
Q 005953 411 CDGSTRALIYEYMPNGSLGDLLSREKENLSLKPARLLEIALGVAHAIEYLHNGCELRILHLDIKPQNVLLDPDFTPKVSD 490 (667)
Q Consensus 411 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ivH~Dikp~NIll~~~~~~ki~D 490 (667)
..+++|||++++.+.+ ++......++.|++++|+|||+. +|+||||||+|||++++ .++|+|
T Consensus 84 ----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred ----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 2379999998765433 22334567899999999999998 99999999999999865 589999
Q ss_pred CCCccccCCCCceeeecCCCCCccccc------hhhhhhhcCCCCCcccHHHHHHHH
Q 005953 491 FGLAKAHSRNRSVVTMTGPRGTIGYIA------PEIFMRNLGNPSGKSDVYSYGMLL 541 (667)
Q Consensus 491 FGla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~s~k~DvwSlGvvl 541 (667)
||+|+....+... .|.. .|.+.+ .++.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r---~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR----------EILERDVRNIITYFSR---TYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH----------HHHHHHHHHHHHHHHH---HHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH----------HHHHHHHHHHHHHHcC---CCCCcccHHHHHHHH
Confidence 9999766533321 1211 123322 456789999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.26 E-value=1.3e-06 Score=84.73 Aligned_cols=131 Identities=16% Similarity=0.109 Sum_probs=89.4
Q ss_pred cCC-CeEEEEEEeCCCcEEEEEEcccC-CcchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEEcCCCCccccc
Q 005953 356 TGG-YGNVYKGKFPDGRLVAVKVLEKT-SNFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEYMPNGSLGDLL 432 (667)
Q Consensus 356 ~G~-fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l 432 (667)
+|+ .+.||+... +++.++||+.... ......+.+|...+..+. +--+.+++.+..+++..++||+++++.++.+..
T Consensus 23 ~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 23 EGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp CCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred CCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence 344 468999876 5556677876543 233446778888888774 444667777888888999999999988775543
Q ss_pred cccccCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------------------
Q 005953 433 SREKENLSLKPARLLEIALGVAHAIEYLHNGC------------------------------------------------ 464 (667)
Q Consensus 433 ~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~------------------------------------------------ 464 (667)
... .. ...++.++++.++.||+..
T Consensus 102 ~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (263)
T d1j7la_ 102 EDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF 173 (263)
T ss_dssp TTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHH
T ss_pred ccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHH
Confidence 211 11 2234555666666666321
Q ss_pred --------CCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 465 --------ELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 465 --------~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 174 l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987777899998763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.04 E-value=4.7e-06 Score=80.15 Aligned_cols=130 Identities=19% Similarity=0.182 Sum_probs=86.4
Q ss_pred hcccCCC-eEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcc--cceEEeecceEecCCeeEEEEEEcCCCCcc
Q 005953 353 KLGTGGY-GNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIH--HVNIIHLLGFCCDGSTRALIYEYMPNGSLG 429 (667)
Q Consensus 353 ~LG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 429 (667)
.+..|.. +.||+...+++..+++|...... ...+..|...++.+. .-.+.+++++..+++..++||++++|.++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 3455554 68999998888888999865443 335677888887774 334666788888888899999999887664
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 005953 430 DLLSREKENLSLKPARLLEIALGVAHAIEYLH------------------------------------------------ 461 (667)
Q Consensus 430 ~~l~~~~~~~~l~~~~~~~i~~~i~~gl~yLH------------------------------------------------ 461 (667)
+.. .... .++.++++.|+-||
T Consensus 95 ~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 95 SSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred ccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 421 1111 11222333333333
Q ss_pred ---cC----CCCCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 462 ---NG----CELRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 462 ---~~----~~~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
.. ..+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11 11247999999999999988777899998763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.42 E-value=0.00034 Score=71.42 Aligned_cols=75 Identities=15% Similarity=0.120 Sum_probs=48.7
Q ss_pred hhcccCCCeEEEEEEeCC-CcEEEEEEccc----C----CcchHHHHHHHHHHhhcc-c--ceEEeecceEecCCeeEEE
Q 005953 352 EKLGTGGYGNVYKGKFPD-GRLVAVKVLEK----T----SNFSDNFINEVATIGRIH-H--VNIIHLLGFCCDGSTRALI 419 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~-~~~vavK~l~~----~----~~~~~~~~~Ei~~l~~l~-h--~niv~l~g~~~~~~~~~lV 419 (667)
+.||.|....||+....+ ++.++||.-.. . ....++...|.+.|+.+. + ..+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 568999999999998754 67889996432 1 112345567888887763 2 345555544 45566899
Q ss_pred EEEcCCCCc
Q 005953 420 YEYMPNGSL 428 (667)
Q Consensus 420 ~e~~~~gsL 428 (667)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.36 E-value=0.0003 Score=69.87 Aligned_cols=135 Identities=13% Similarity=0.099 Sum_probs=79.9
Q ss_pred eEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceE--Eeecc-----eEecCCeeEEEEEEcCCCCcccc-
Q 005953 360 GNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI--IHLLG-----FCCDGSTRALIYEYMPNGSLGDL- 431 (667)
Q Consensus 360 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~ni--v~l~g-----~~~~~~~~~lV~e~~~~gsL~~~- 431 (667)
-.||+.+.++|+.+++|+.+......+++..|...+..|....+ +..+. .....+..+.++++++|..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 57999999999999999987665566778889998888853222 11111 22345667889999976544210
Q ss_pred ---c----------cc----c--ccCCCCCHH-------------------HHHHHHHHHHHHHHHHH----cCCCCCee
Q 005953 432 ---L----------SR----E--KENLSLKPA-------------------RLLEIALGVAHAIEYLH----NGCELRIL 469 (667)
Q Consensus 432 ---l----------~~----~--~~~~~l~~~-------------------~~~~i~~~i~~gl~yLH----~~~~~~iv 469 (667)
+ |. . ......++. ....+...+.+.++.+. .....+++
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 0 00 0 000111111 11111222222333332 22245799
Q ss_pred ecCCCCCcEEECCCCceEEEeCCCccc
Q 005953 470 HLDIKPQNVLLDPDFTPKVSDFGLAKA 496 (667)
Q Consensus 470 H~Dikp~NIll~~~~~~ki~DFGla~~ 496 (667)
|+|+.+.|||++++ ..++||+-+..
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCCCCcccEEEeCC--ceEEechhccc
Confidence 99999999999754 45899997753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.55 E-value=0.003 Score=64.20 Aligned_cols=72 Identities=14% Similarity=0.219 Sum_probs=49.7
Q ss_pred hhcccCCCeEEEEEEeCCC--------cEEEEEEcccCCcchHHHHHHHHHHhhcc-cceEEeecceEecCCeeEEEEEE
Q 005953 352 EKLGTGGYGNVYKGKFPDG--------RLVAVKVLEKTSNFSDNFINEVATIGRIH-HVNIIHLLGFCCDGSTRALIYEY 422 (667)
Q Consensus 352 ~~LG~G~fg~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~ 422 (667)
+.|+.|-.-.+|+...+++ +.|.+++..... ..-+..+|..+++.+. +.-..++++++.+ .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 5688888899999987542 467777765433 3345668999999885 4333467776643 578999
Q ss_pred cCCCCc
Q 005953 423 MPNGSL 428 (667)
Q Consensus 423 ~~~gsL 428 (667)
+++.+|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.19 E-value=0.0065 Score=59.37 Aligned_cols=141 Identities=13% Similarity=0.050 Sum_probs=74.1
Q ss_pred hcccCCCeEEEEEEeCCCcEEEEEEcccCCcchHHHHHHHHHHhhcccceE--Eeecc------eEecCCeeEEEEEEcC
Q 005953 353 KLGTGGYGNVYKGKFPDGRLVAVKVLEKTSNFSDNFINEVATIGRIHHVNI--IHLLG------FCCDGSTRALIYEYMP 424 (667)
Q Consensus 353 ~LG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~Ei~~l~~l~h~ni--v~l~g------~~~~~~~~~lV~e~~~ 424 (667)
.|..|---+.|+.+.++|+ +++|+..... ..++...|++++..+...++ ...+. +.........++.+..
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 3556667888999886665 7889876432 23455667777777753221 11111 1222445667777776
Q ss_pred CCCccccccc--------------c------ccCCCCCH------------------HHHHHHHHHHHHHHHHHHc-CCC
Q 005953 425 NGSLGDLLSR--------------E------KENLSLKP------------------ARLLEIALGVAHAIEYLHN-GCE 465 (667)
Q Consensus 425 ~gsL~~~l~~--------------~------~~~~~l~~------------------~~~~~i~~~i~~gl~yLH~-~~~ 465 (667)
+......-.. . ........ ......+......+.-.+. ...
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 6544221100 0 00000000 0111122222222222222 224
Q ss_pred CCeeecCCCCCcEEECCCCceEEEeCCCcc
Q 005953 466 LRILHLDIKPQNVLLDPDFTPKVSDFGLAK 495 (667)
Q Consensus 466 ~~ivH~Dikp~NIll~~~~~~ki~DFGla~ 495 (667)
.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 589999999999999988777899999763
|